Citrus Sinensis ID: 030430
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 177 | 2.2.26 [Sep-21-2011] | |||||||
| Q9QY01 | 1037 | Serine/threonine-protein | yes | no | 0.864 | 0.147 | 0.452 | 1e-38 | |
| Q8IYT8 | 1036 | Serine/threonine-protein | yes | no | 0.864 | 0.147 | 0.452 | 2e-38 | |
| Q5ZJH6 | 468 | Serine/threonine-protein | no | no | 0.937 | 0.354 | 0.467 | 1e-37 | |
| A7KAL2 | 960 | Serine/threonine-protein | yes | no | 0.943 | 0.173 | 0.376 | 3e-37 | |
| Q86CS2 | 668 | Serine/threonine-protein | yes | no | 0.937 | 0.248 | 0.431 | 5e-37 | |
| Q0CLX3 | 964 | Serine/threonine-protein | N/A | no | 0.943 | 0.173 | 0.381 | 6e-37 | |
| Q3U3Q1 | 472 | Serine/threonine-protein | no | no | 0.932 | 0.349 | 0.476 | 8e-37 | |
| D3ZHP7 | 472 | Serine/threonine-protein | no | no | 0.932 | 0.349 | 0.476 | 9e-37 | |
| Q2UGZ7 | 934 | Serine/threonine-protein | yes | no | 0.943 | 0.178 | 0.376 | 1e-36 | |
| Q1DN93 | 969 | Serine/threonine-protein | N/A | no | 0.960 | 0.175 | 0.371 | 2e-36 |
| >sp|Q9QY01|ULK2_MOUSE Serine/threonine-protein kinase ULK2 OS=Mus musculus GN=Ulk2 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 159 bits (401), Expect = 1e-38, Method: Composition-based stats.
Identities = 72/159 (45%), Positives = 103/159 (64%), Gaps = 6/159 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ L + H NI+ L+D + N +FLV+E+C GG+L+ Y++ G + E T R FL Q+
Sbjct: 56 EIKILKELQHENIVALYDVQELPNSVFLVMEYCNGGDLADYLQAKGTLSEDTIRVFLHQI 115
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLD------DDVMLKIADFGLSCTLYPGNYAEKVC 129
A + IL+S IIHRDLKP+NILLS + + +KIADFG + L+ A +C
Sbjct: 116 AAAMRILHSKGIIHRDLKPQNILLSYANRRKSNVSGIRIKIADFGFARYLHSNTMAATLC 175
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
GSP+YMAPEV+ Q YD K D+WS+G ++++ L G PPF
Sbjct: 176 GSPMYMAPEVIMSQHYDAKADLWSIGTVIYQCLVGKPPF 214
|
Serine/threonine-protein kinase involved in autophagy in response to starvation. Acts upstream of phosphatidylinositol 3-kinase PIK3C3 to regulate the formation of autophagophores, the precursors of autophagosomes. Part of regulatory feedback loops in autophagy: acts both as a downstream effector and negative regulator of mammalian target of rapamycin complex 1 (mTORC1) via interaction with RPTOR. Activated via phosphorylation by AMPK and also acts as a regulator of AMPK by mediating phosphorylation of AMPK subunits PRKAA1, PRKAB2 and PRKAG1, leading to negatively regulate AMPK activity. May phosphorylate ATG13/KIAA0652, FRS2, FRS3 and RPTOR; however such data need additional evidences. Not involved in ammonia-induced autophagy or in autophagic response of cerebellar granule neurons (CGN) to low potassium concentration. Plays a role early in neuronal differentiation and is required for granule cell axon formation: may govern axon formation via Ras-like GTPase signaling and through regulation of the Rab5-mediated endocytic pathways within developing axons. Mus musculus (taxid: 10090) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8IYT8|ULK2_HUMAN Serine/threonine-protein kinase ULK2 OS=Homo sapiens GN=ULK2 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 158 bits (399), Expect = 2e-38, Method: Composition-based stats.
Identities = 72/159 (45%), Positives = 103/159 (64%), Gaps = 6/159 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ L + H NI+ L+D + N +FLV+E+C GG+L+ Y++ G + E T R FL Q+
Sbjct: 56 EIKILKELQHENIVALYDVQELPNSVFLVMEYCNGGDLADYLQAKGTLSEDTIRVFLHQI 115
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLD------DDVMLKIADFGLSCTLYPGNYAEKVC 129
A + IL+S IIHRDLKP+NILLS + + +KIADFG + L+ A +C
Sbjct: 116 AAAMRILHSKGIIHRDLKPQNILLSYANRRKSSVSGIRIKIADFGFARYLHSNMMAATLC 175
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
GSP+YMAPEV+ Q YD K D+WS+G ++++ L G PPF
Sbjct: 176 GSPMYMAPEVIMSQHYDAKADLWSIGTVIYQCLVGKPPF 214
|
Serine/threonine-protein kinase involved in autophagy in response to starvation. Acts upstream of phosphatidylinositol 3-kinase PIK3C3 to regulate the formation of autophagophores, the precursors of autophagosomes. Part of regulatory feedback loops in autophagy: acts both as a downstream effector and negative regulator of mammalian target of rapamycin complex 1 (mTORC1) via interaction with RPTOR. Activated via phosphorylation by AMPK and also acts as a regulator of AMPK by mediating phosphorylation of AMPK subunits PRKAA1, PRKAB2 and PRKAG1, leading to negatively regulate AMPK activity. May phosphorylate ATG13/KIAA0652, FRS2, FRS3 and RPTOR; however such data need additional evidences. Not involved in ammonia-induced autophagy or in autophagic response of cerebellar granule neurons (CGN) to low potassium concentration. Plays a role early in neuronal differentiation and is required for granule cell axon formation: may govern axon formation via Ras-like GTPase signaling and through regulation of the Rab5-mediated endocytic pathways within developing axons. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5ZJH6|ULK3_CHICK Serine/threonine-protein kinase ULK3 OS=Gallus gallus GN=ULK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 155 bits (392), Expect = 1e-37, Method: Compositional matrix adjust.
Identities = 78/167 (46%), Positives = 112/167 (67%), Gaps = 1/167 (0%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
+ LN+ L E+ L ++ HP+I+ L D + I+L++EFCAGG+LS +IR+
Sbjct: 49 RSLNRASVENLLTEIEILKTIRHPHIVELKDFQWDSDHIYLIMEFCAGGDLSRFIRMRRI 108
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
+PE+ AR FLQQL L+ L+ H+I H DLKP+NILLS ++ LK+ADFG + + P
Sbjct: 109 LPEKVARIFLQQLACALKFLHDHNISHLDLKPQNILLST-PENPQLKLADFGFAQYMSPW 167
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
+ + GSPLYMAPE++ Q+YD +VD+WSVG IL+E L G PPF+
Sbjct: 168 DEKHVLRGSPLYMAPEMVCRQQYDARVDLWSVGVILYEALFGRPPFA 214
|
Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy. Gallus gallus (taxid: 9031) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A7KAL2|ATG1_PENCW Serine/threonine-protein kinase ATG1 OS=Penicillium chrysogenum (strain ATCC 28089 / DSM 1075 / Wisconsin 54-1255) GN=atg1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 154 bits (389), Expect = 3e-37, Method: Composition-based stats.
Identities = 81/215 (37%), Positives = 120/215 (55%), Gaps = 48/215 (22%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
L KLNK LK L E++ L ++HP+I+ L D ++ + I LV+E+CA G+LS +I+
Sbjct: 55 LSKLNKKLKENLSSEIDILKGLHHPHIVALIDCHESTSHIHLVMEYCALGDLSLFIKRRD 114
Query: 61 --------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL- 99
G + E R FL+QL + L+ L ++IHRD+KP+N+LL
Sbjct: 115 TLGSHKYTRDMIAKYPNPPGGSLNEVVTRHFLKQLSSALKFLRDRNLIHRDIKPQNLLLC 174
Query: 100 --------------------------SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
+GL+ MLKIADFG + +L + AE +CGSPL
Sbjct: 175 PSPSSYRSGHAQVMPYKGSDDSYEPTTGLESLPMLKIADFGFARSLPATSLAETLCGSPL 234
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
YMAPE+L++++YD K D+WSVG +L+E++ G PPF
Sbjct: 235 YMAPEILRYEKYDAKADLWSVGTVLYEMVVGRPPF 269
|
Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes. Penicillium chrysogenum (strain ATCC 28089 / DSM 1075 / Wisconsin 54-1255) (taxid: 500485) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q86CS2|ATG1_DICDI Serine/threonine-protein kinase atg1 OS=Dictyostelium discoideum GN=atg1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 153 bits (387), Expect = 5e-37, Method: Compositional matrix adjust.
Identities = 73/169 (43%), Positives = 107/169 (63%), Gaps = 3/169 (1%)
Query: 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN---CIFLVVEFCAGGNLSSYIRLHGR 62
N L L+ E+ L ++H NI+RL+D E I++++E C GG+ S YIR H +
Sbjct: 47 NSKLTENLNYEIRILKELSHTNIVRLYDVLNEETDPTFIYMIMECCEGGDFSKYIRTHKK 106
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
+ E+ A F++QL GL+ L I+HRDLKP+N+LLS + +LKI DFG + + P
Sbjct: 107 LTEEKALYFMKQLANGLKFLRQKQIVHRDLKPQNLLLSDDSEHPILKIGDFGFAKFIDPF 166
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVG 171
+ ++ CGSPLYMAPE+L + Y K D+WSVG IL+E+L G P ++ G
Sbjct: 167 SLSDTFCGSPLYMAPEILHRKNYTVKADLWSVGIILYEMLVGEPAYNSG 215
|
Serine/threonine protein kinase involved in autophagy. Involved in the control of autophagic vacuolar cell death. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0CLX3|ATG1_ASPTN Serine/threonine-protein kinase atg1 OS=Aspergillus terreus (strain NIH 2624 / FGSC A1156) GN=atg1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 153 bits (386), Expect = 6e-37, Method: Composition-based stats.
Identities = 82/215 (38%), Positives = 118/215 (54%), Gaps = 48/215 (22%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
L +LNK LK L E++ L + HP+I+ L D + + I LV+E+CA G+LS +IR
Sbjct: 59 LSQLNKKLKENLFSEIHILKGLYHPHIVALIDCHETTSHIHLVMEYCALGDLSQFIRHRN 118
Query: 61 --------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL- 99
G + E R FL+QL + L+ L ++IHRD+KP+N+LL
Sbjct: 119 TLGEHRYTRDMIAKYPNPRGGALNEVVVRHFLKQLASALKFLRDRNLIHRDIKPQNLLLC 178
Query: 100 --------------------------SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
+GLD MLKIADFG + +L + AE +CGSPL
Sbjct: 179 PSPTSYRAGVAQIVPFKGSEDSFSPATGLDSLPMLKIADFGFARSLPATSLAETLCGSPL 238
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
YMAPE+L++++YD K D+WSVG +L+E++ G PPF
Sbjct: 239 YMAPEILRYEKYDAKADLWSVGTVLYEMVVGKPPF 273
|
Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes. Aspergillus terreus (strain NIH 2624 / FGSC A1156) (taxid: 341663) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3U3Q1|ULK3_MOUSE Serine/threonine-protein kinase ULK3 OS=Mus musculus GN=Ulk3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 152 bits (385), Expect = 8e-37, Method: Compositional matrix adjust.
Identities = 80/168 (47%), Positives = 113/168 (67%), Gaps = 3/168 (1%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHG 61
K LNK L E+ L + HP+I++L D FQ +N I+L++EFCAGG+LS +I
Sbjct: 49 KSLNKASVENLLTEIEILKGIRHPHIVQLKD-FQWDNDNIYLIMEFCAGGDLSRFIHTRR 107
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
+PE+ AR F+QQL + L+ L+ +I H DLKP+NILLS L+ LK+ADFG + + P
Sbjct: 108 ILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKP-HLKLADFGFAQHMSP 166
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
+ + GSPLYMAPE++ ++YD +VD+WSVG IL+E L G PPF+
Sbjct: 167 WDEKHVLRGSPLYMAPEMVCRRQYDARVDLWSVGVILYEALFGQPPFA 214
|
Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy. Acts as a negative regulator of SHH signaling in the absence of SHH ligand: interacts with SUFU, thereby inactivating the protein kinase activity and preventing phosphorylation of GLI proteins (GLI1, GLI2 and/or GLI3). Positively regulates SHH signaling in the presence of SHH: dissociates from SUFU, autophosphorylates and mediates phosphorylation of GLI2, activating it and promoting its nuclear translocation. Phosphorylates in vitro GLI2, as well as GLI1 and GLI3, although less efficiently. Also acts as a regulator of autophagy: following cellular senescence, able to induce autophagy. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|D3ZHP7|ULK3_RAT Serine/threonine-protein kinase ULK3 OS=Rattus norvegicus GN=Ulk3 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 152 bits (385), Expect = 9e-37, Method: Compositional matrix adjust.
Identities = 80/168 (47%), Positives = 113/168 (67%), Gaps = 3/168 (1%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHG 61
K LNK L E+ L + HP+I++L D FQ +N I+L++EFCAGG+LS +I
Sbjct: 49 KSLNKASVENLLTEIEILKGIRHPHIVQLKD-FQWDNDNIYLIMEFCAGGDLSRFIHTRR 107
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
+PE+ AR F+QQL + L+ L+ +I H DLKP+NILLS L+ LK+ADFG + + P
Sbjct: 108 ILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKP-HLKLADFGFAQHMSP 166
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
+ + GSPLYMAPE++ ++YD +VD+WSVG IL+E L G PPF+
Sbjct: 167 WDEKHVLRGSPLYMAPEMVCRRQYDARVDLWSVGVILYEALFGQPPFA 214
|
Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy. Acts as a negative regulator of SHH signaling in the absence of SHH ligand: interacts with SUFU, thereby inactivating the protein kinase activity and preventing phosphorylation of GLI proteins (GLI1, GLI2 and/or GLI3). Positively regulates SHH signaling in the presence of SHH: dissociates from SUFU, autophosphorylates and mediates phosphorylation of GLI2, activating it and promoting its nuclear translocation. Phosphorylates in vitro GLI2, as well as GLI1 and GLI3, although less efficiently. Also acts as a regulator of autophagy: following cellular senescence, able to induce autophagy. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2UGZ7|ATG1_ASPOR Serine/threonine-protein kinase atg1 OS=Aspergillus oryzae (strain ATCC 42149 / RIB 40) GN=atg1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 152 bits (383), Expect = 1e-36, Method: Composition-based stats.
Identities = 81/215 (37%), Positives = 118/215 (54%), Gaps = 48/215 (22%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
L KLNK LK L E++ L + HP+I+ L D + + I LV+E+CA G+LS +I+
Sbjct: 55 LSKLNKKLKENLSSEIHILKGLYHPHIVALIDCHETTSHIHLVMEYCALGDLSLFIKRRD 114
Query: 61 --------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL- 99
G + E R FL+QL + L+ L ++IHRD+KP+N+LL
Sbjct: 115 TLGDHRYTQDMIAKYPNPRGGALNEVVVRHFLKQLASALKFLRDRNLIHRDIKPQNLLLC 174
Query: 100 --------------------------SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
+GL+ MLKIADFG + +L + AE +CGSPL
Sbjct: 175 PSPSSYRSGVAQVVPFKGCDESFSPATGLESLPMLKIADFGFARSLPSTSLAETLCGSPL 234
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
YMAPE+L++++YD K D+WSVG +L+E++ G PPF
Sbjct: 235 YMAPEILRYEKYDAKADLWSVGTVLYEMVVGKPPF 269
|
Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes. Aspergillus oryzae (strain ATCC 42149 / RIB 40) (taxid: 510516) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1DN93|ATG1_COCIM Serine/threonine-protein kinase ATG1 OS=Coccidioides immitis (strain RS) GN=ATG1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 151 bits (382), Expect = 2e-36, Method: Composition-based stats.
Identities = 81/218 (37%), Positives = 117/218 (53%), Gaps = 48/218 (22%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
+ LN LK L E+ L + HP+I+ L D ++ +CI LV+E+CA G+LS +IR
Sbjct: 63 ISSLNPKLKDNLKLEIEILKGLQHPHIVALIDCDESTSCIHLVMEYCALGDLSLFIRKRD 122
Query: 61 --------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS 100
G + E R FL+QL + L+ L + +IHRDLKP+N+LL+
Sbjct: 123 TLSKHELTRDMIAKYPNPPAGGLNEVIVRHFLKQLASALQFLRTKDLIHRDLKPQNLLLN 182
Query: 101 ---------------------------GLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
G++ MLKIADFG + +L + AE +CGSPL
Sbjct: 183 PPPSTYAKGLLRIVPYKTREDSFTPLVGVESLPMLKIADFGFARSLPATSLAETLCGSPL 242
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVG 171
YMAPE+L++++YD K D+WSVG +LFE++ G PF G
Sbjct: 243 YMAPEILRYEKYDAKADLWSVGTVLFEMVVGKSPFRAG 280
|
Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes. Coccidioides immitis (strain RS) (taxid: 246410) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 177 | ||||||
| 255581995 | 321 | serine/threonine-protein kinase, putativ | 0.943 | 0.520 | 0.820 | 1e-74 | |
| 359476946 | 260 | PREDICTED: serine/threonine-protein kina | 0.943 | 0.642 | 0.766 | 1e-71 | |
| 225431573 | 275 | PREDICTED: serine/threonine-protein kina | 0.943 | 0.607 | 0.766 | 1e-71 | |
| 224116060 | 266 | predicted protein [Populus trichocarpa] | 0.943 | 0.627 | 0.739 | 2e-68 | |
| 357464547 | 290 | Serine/threonine protein kinase GE16371 | 0.954 | 0.582 | 0.710 | 3e-66 | |
| 297852566 | 266 | hypothetical protein ARALYDRAFT_314341 [ | 0.943 | 0.627 | 0.682 | 1e-62 | |
| 334183174 | 376 | protein kinase-like protein [Arabidopsis | 0.943 | 0.444 | 0.658 | 2e-61 | |
| 7770326 | 392 | F27J15.5 [Arabidopsis thaliana] | 0.943 | 0.426 | 0.658 | 2e-61 | |
| 30694500 | 408 | protein kinase-like protein [Arabidopsis | 0.943 | 0.409 | 0.658 | 2e-61 | |
| 110736434 | 295 | similar to MAP/ERK kinase kinase 3 [Arab | 0.943 | 0.566 | 0.658 | 5e-61 |
| >gi|255581995|ref|XP_002531795.1| serine/threonine-protein kinase, putative [Ricinus communis] gi|223528561|gb|EEF30583.1| serine/threonine-protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 284 bits (726), Expect = 1e-74, Method: Compositional matrix adjust.
Identities = 137/167 (82%), Positives = 148/167 (88%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L KLNKHLK+CLDCELNFLSSVNHPNIIRLF FQAE+ IFLV+EFCAGG+LSSYIR HG
Sbjct: 53 LSKLNKHLKNCLDCELNFLSSVNHPNIIRLFHVFQAESSIFLVLEFCAGGSLSSYIRHHG 112
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
RV E+ AR+ +QQLGAGLEIL+SHHIIHRDLKPENILLSG DV+LKIADFGLS + P
Sbjct: 113 RVQEEIARRLMQQLGAGLEILHSHHIIHRDLKPENILLSGQFADVVLKIADFGLSRRVQP 172
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
G YAE VCGSPLYMAPEVLQFQ YD+K DMWSVG ILFELLNGYPPF
Sbjct: 173 GKYAETVCGSPLYMAPEVLQFQSYDDKADMWSVGVILFELLNGYPPF 219
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359476946|ref|XP_003631917.1| PREDICTED: serine/threonine-protein kinase ULK3 isoform 2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 273 bits (699), Expect = 1e-71, Method: Compositional matrix adjust.
Identities = 128/167 (76%), Positives = 150/167 (89%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L KLN++LK+ LDCE+NFLSSV+HPNIIRL FQAE CIFLV+EFC+GG+L SYIR HG
Sbjct: 43 LSKLNRNLKTSLDCEINFLSSVSHPNIIRLLHVFQAEGCIFLVLEFCSGGDLESYIRHHG 102
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
RV E AR+F+QQLGAGLE+L+SHHIIHRDLKP NILLSG + DV+LKIADFGLS T++P
Sbjct: 103 RVQEWVARRFMQQLGAGLEVLHSHHIIHRDLKPGNILLSGPESDVLLKIADFGLSRTVHP 162
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
G +AE VCG+PLYMAPEVL+F++YDEKVDMWS+GAILFELLNGYPPF
Sbjct: 163 GEHAETVCGTPLYMAPEVLRFKKYDEKVDMWSLGAILFELLNGYPPF 209
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225431573|ref|XP_002282420.1| PREDICTED: serine/threonine-protein kinase ULK3 isoform 1 [Vitis vinifera] gi|296088603|emb|CBI37594.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 273 bits (699), Expect = 1e-71, Method: Compositional matrix adjust.
Identities = 128/167 (76%), Positives = 150/167 (89%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L KLN++LK+ LDCE+NFLSSV+HPNIIRL FQAE CIFLV+EFC+GG+L SYIR HG
Sbjct: 43 LSKLNRNLKTSLDCEINFLSSVSHPNIIRLLHVFQAEGCIFLVLEFCSGGDLESYIRHHG 102
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
RV E AR+F+QQLGAGLE+L+SHHIIHRDLKP NILLSG + DV+LKIADFGLS T++P
Sbjct: 103 RVQEWVARRFMQQLGAGLEVLHSHHIIHRDLKPGNILLSGPESDVLLKIADFGLSRTVHP 162
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
G +AE VCG+PLYMAPEVL+F++YDEKVDMWS+GAILFELLNGYPPF
Sbjct: 163 GEHAETVCGTPLYMAPEVLRFKKYDEKVDMWSLGAILFELLNGYPPF 209
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116060|ref|XP_002332038.1| predicted protein [Populus trichocarpa] gi|222875263|gb|EEF12394.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 263 bits (672), Expect = 2e-68, Method: Compositional matrix adjust.
Identities = 125/169 (73%), Positives = 145/169 (85%), Gaps = 2/169 (1%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L KLNK+L++CLDCELNFLSSVNH NIIRL D F+ + C+FLV+EFC+GGNL+SY++ HG
Sbjct: 38 LSKLNKNLRNCLDCELNFLSSVNHTNIIRLLDVFEDDCCMFLVLEFCSGGNLASYLQQHG 97
Query: 62 RVPEQTARKFLQQLGAG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
RV E+ A++F QQ+G+G L+IL SHHIIHRDLKPENILLSG + DV+LKIADFGLS +
Sbjct: 98 RVQEKIAKRFTQQMGSGDGLKILQSHHIIHRDLKPENILLSGKESDVVLKIADFGLSRRV 157
Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
P NY E VCGSP YMAPEVLQFQRYD KVDMWSVG ILFELLNGYPPF
Sbjct: 158 LPDNYVETVCGSPFYMAPEVLQFQRYDYKVDMWSVGVILFELLNGYPPF 206
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357464547|ref|XP_003602555.1| Serine/threonine protein kinase GE16371 [Medicago truncatula] gi|355491603|gb|AES72806.1| Serine/threonine protein kinase GE16371 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 256 bits (654), Expect = 3e-66, Method: Compositional matrix adjust.
Identities = 120/169 (71%), Positives = 140/169 (82%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
L KLN HL++ LDCE+NFLSSVNHPNI+ L FQ C++LV+EFCAGGNL+SYIR H
Sbjct: 57 FLSKLNSHLRASLDCEINFLSSVNHPNIVHLLHFFQGNGCVYLVLEFCAGGNLASYIRCH 116
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
RV + TA+KF+QQLG+GL++L+SH IIHRDLKPENILLS D +LKIADFGLS T+
Sbjct: 117 ERVHQLTAKKFIQQLGSGLKVLHSHGIIHRDLKPENILLSSHGADAVLKIADFGLSRTVR 176
Query: 121 PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
PG Y E VCG+P YMAPEVLQFQRYD K DMWSVGA+LFELLNGYPPF+
Sbjct: 177 PGEYVETVCGTPSYMAPEVLQFQRYDHKADMWSVGAMLFELLNGYPPFN 225
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297852566|ref|XP_002894164.1| hypothetical protein ARALYDRAFT_314341 [Arabidopsis lyrata subsp. lyrata] gi|297340006|gb|EFH70423.1| hypothetical protein ARALYDRAFT_314341 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 244 bits (623), Expect = 1e-62, Method: Compositional matrix adjust.
Identities = 114/167 (68%), Positives = 138/167 (82%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L KLN++L++CL+ EL FLSSV+HPNIIRL FQ E + +V+E+C GG LSSYI+ HG
Sbjct: 39 LSKLNRNLRTCLNNELEFLSSVDHPNIIRLLHVFQDEEFLVMVMEYCDGGTLSSYIQRHG 98
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
RV E A++FL+Q+GAGLEI++ +HIIHRDLKPENIL+ G DD++LKIADF L+ L P
Sbjct: 99 RVEEDIAKRFLKQIGAGLEIIHDNHIIHRDLKPENILIVGSGDDLVLKIADFSLARKLLP 158
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
G Y E VCGSP YMAPEVLQFQRY+EK DMWSVGAILFELL+GYPPF
Sbjct: 159 GKYLETVCGSPFYMAPEVLQFQRYNEKADMWSVGAILFELLHGYPPF 205
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|334183174|ref|NP_001185178.1| protein kinase-like protein [Arabidopsis thaliana] gi|332194280|gb|AEE32401.1| protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 240 bits (612), Expect = 2e-61, Method: Compositional matrix adjust.
Identities = 110/167 (65%), Positives = 138/167 (82%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L KLN++L+ CL+ EL FLSSV+HPNIIRL Q ++ + +V+E+C GG LSSYI+ +G
Sbjct: 40 LSKLNRNLRDCLNNELEFLSSVDHPNIIRLLHVSQDDDFLVMVLEYCDGGTLSSYIQRYG 99
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
RV E A++F++Q+GAGLEI++ +HIIHRDLKPENIL+ G DD++LKIADF L+ L+P
Sbjct: 100 RVEEDIAKRFMKQIGAGLEIIHDNHIIHRDLKPENILIDGSGDDLVLKIADFSLARKLHP 159
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
G Y E VCGSP YMAPEVLQFQRY+EK DMWSVGAILFELL+GYPPF
Sbjct: 160 GKYLETVCGSPFYMAPEVLQFQRYNEKADMWSVGAILFELLHGYPPF 206
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|7770326|gb|AAF69696.1|AC016041_1 F27J15.5 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 240 bits (612), Expect = 2e-61, Method: Compositional matrix adjust.
Identities = 110/167 (65%), Positives = 138/167 (82%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L KLN++L+ CL+ EL FLSSV+HPNIIRL Q ++ + +V+E+C GG LSSYI+ +G
Sbjct: 38 LSKLNRNLRDCLNNELEFLSSVDHPNIIRLLHVSQDDDFLVMVLEYCDGGTLSSYIQRYG 97
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
RV E A++F++Q+GAGLEI++ +HIIHRDLKPENIL+ G DD++LKIADF L+ L+P
Sbjct: 98 RVEEDIAKRFMKQIGAGLEIIHDNHIIHRDLKPENILIDGSGDDLVLKIADFSLARKLHP 157
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
G Y E VCGSP YMAPEVLQFQRY+EK DMWSVGAILFELL+GYPPF
Sbjct: 158 GKYLETVCGSPFYMAPEVLQFQRYNEKADMWSVGAILFELLHGYPPF 204
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|30694500|ref|NP_175344.2| protein kinase-like protein [Arabidopsis thaliana] gi|332194279|gb|AEE32400.1| protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 240 bits (612), Expect = 2e-61, Method: Compositional matrix adjust.
Identities = 110/167 (65%), Positives = 138/167 (82%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L KLN++L+ CL+ EL FLSSV+HPNIIRL Q ++ + +V+E+C GG LSSYI+ +G
Sbjct: 40 LSKLNRNLRDCLNNELEFLSSVDHPNIIRLLHVSQDDDFLVMVLEYCDGGTLSSYIQRYG 99
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
RV E A++F++Q+GAGLEI++ +HIIHRDLKPENIL+ G DD++LKIADF L+ L+P
Sbjct: 100 RVEEDIAKRFMKQIGAGLEIIHDNHIIHRDLKPENILIDGSGDDLVLKIADFSLARKLHP 159
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
G Y E VCGSP YMAPEVLQFQRY+EK DMWSVGAILFELL+GYPPF
Sbjct: 160 GKYLETVCGSPFYMAPEVLQFQRYNEKADMWSVGAILFELLHGYPPF 206
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|110736434|dbj|BAF00185.1| similar to MAP/ERK kinase kinase 3 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 238 bits (608), Expect = 5e-61, Method: Compositional matrix adjust.
Identities = 110/167 (65%), Positives = 138/167 (82%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L KLN++L+ CL+ EL FLSSV+HPNIIRL Q ++ + +V+E+C GG LSSYI+ +G
Sbjct: 68 LSKLNRNLRDCLNNELEFLSSVDHPNIIRLLHVSQDDDFLVMVLEYCDGGTLSSYIQRYG 127
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
RV E A++F++Q+GAGLEI++ +HIIHRDLKPENIL+ G DD++LKIADF L+ L+P
Sbjct: 128 RVEEDIAKRFMKQIGAGLEIIHDNHIIHRDLKPENILIDGSGDDLVLKIADFSLARKLHP 187
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
G Y E VCGSP YMAPEVLQFQRY+EK DMWSVGAILFELL+GYPPF
Sbjct: 188 GKYLETVCGSPFYMAPEVLQFQRYNEKADMWSVGAILFELLHGYPPF 234
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 177 | ||||||
| TAIR|locus:2028496 | 408 | AT1G49180 [Arabidopsis thalian | 0.943 | 0.409 | 0.658 | 3.2e-58 | |
| TAIR|locus:2084440 | 712 | AT3G53930 [Arabidopsis thalian | 0.994 | 0.247 | 0.539 | 4.7e-48 | |
| TAIR|locus:2065680 | 733 | AT2G37840 [Arabidopsis thalian | 0.994 | 0.240 | 0.528 | 9.5e-48 | |
| TAIR|locus:2079527 | 626 | AT3G61960 [Arabidopsis thalian | 0.966 | 0.273 | 0.505 | 2.1e-45 | |
| UNIPROTKB|Q5ZJH6 | 468 | ULK3 "Serine/threonine-protein | 0.932 | 0.352 | 0.476 | 1.2e-35 | |
| MGI|MGI:1918992 | 472 | Ulk3 "unc-51-like kinase 3" [M | 0.932 | 0.349 | 0.476 | 3.1e-35 | |
| RGD|1587417 | 472 | Ulk3 "unc-51-like kinase 3 (C. | 0.932 | 0.349 | 0.476 | 3.1e-35 | |
| MGI|MGI:1352758 | 1037 | Ulk2 "unc-51 like kinase 2" [M | 0.943 | 0.161 | 0.446 | 6.8e-35 | |
| UNIPROTKB|F1N332 | 472 | ULK3 "Uncharacterized protein" | 0.926 | 0.347 | 0.473 | 8.3e-35 | |
| UNIPROTKB|F1SJ29 | 479 | ULK3 "Uncharacterized protein" | 0.926 | 0.342 | 0.473 | 8.3e-35 |
| TAIR|locus:2028496 AT1G49180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 598 (215.6 bits), Expect = 3.2e-58, P = 3.2e-58
Identities = 110/167 (65%), Positives = 138/167 (82%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L KLN++L+ CL+ EL FLSSV+HPNIIRL Q ++ + +V+E+C GG LSSYI+ +G
Sbjct: 40 LSKLNRNLRDCLNNELEFLSSVDHPNIIRLLHVSQDDDFLVMVLEYCDGGTLSSYIQRYG 99
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
RV E A++F++Q+GAGLEI++ +HIIHRDLKPENIL+ G DD++LKIADF L+ L+P
Sbjct: 100 RVEEDIAKRFMKQIGAGLEIIHDNHIIHRDLKPENILIDGSGDDLVLKIADFSLARKLHP 159
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
G Y E VCGSP YMAPEVLQFQRY+EK DMWSVGAILFELL+GYPPF
Sbjct: 160 GKYLETVCGSPFYMAPEVLQFQRYNEKADMWSVGAILFELLHGYPPF 206
|
|
| TAIR|locus:2084440 AT3G53930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 502 (181.8 bits), Expect = 4.7e-48, P = 4.7e-48
Identities = 95/176 (53%), Positives = 125/176 (71%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
+ +LNK L+ L E+ L +NHPNIIR D +A I LV+E+C GG+LS YI HG
Sbjct: 53 MARLNKKLQESLMSEIIILRKINHPNIIRFIDMIEAPGKINLVLEYCKGGDLSMYIHKHG 112
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
VPE TA+ F+ QL AGL++L ++IIHRDLKP+N+LLS D+D LKIADFG + +L P
Sbjct: 113 SVPEATAKHFMLQLAAGLQVLRDNNIIHRDLKPQNLLLSTDDNDAALKIADFGFARSLQP 172
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 177
AE +CGSPLYMAPE++Q Q+YD K D+WSVGAILF+L+ G PF+ + Q +
Sbjct: 173 RGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGRTPFTGNSQIQLL 228
|
|
| TAIR|locus:2065680 AT2G37840 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 501 (181.4 bits), Expect = 9.5e-48, P = 9.5e-48
Identities = 93/176 (52%), Positives = 128/176 (72%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
+ +LNK L+ L E+ L +NHPNIIRL D ++ + LV+E+C GG+LS Y++ HG
Sbjct: 45 MDRLNKKLQESLMSEIFILRRINHPNIIRLIDMIKSPGKVHLVLEYCKGGDLSVYVQRHG 104
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
VPE TA+ F+QQL AGL++L ++IIHRDLKP+N+LLS ++D LKIADFG + +L P
Sbjct: 105 IVPEATAKHFMQQLAAGLQVLRDNNIIHRDLKPQNLLLSTNENDADLKIADFGFARSLQP 164
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 177
AE +CGSPLYMAPE++Q Q+YD K D+WSVGAILF+L+ G PF+ + Q +
Sbjct: 165 RGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGRTPFTGNSQIQLL 220
|
|
| TAIR|locus:2079527 AT3G61960 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 477 (173.0 bits), Expect = 2.1e-45, P = 2.1e-45
Identities = 87/172 (50%), Positives = 124/172 (72%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
K L+ ++ L E++ LS+++HPNIIR ++A + + IFLV+E+C+GG+L+ YI HG+
Sbjct: 44 KLLSPKVRDNLLKEISILSTIDHPNIIRFYEAIETGDRIFLVLEYCSGGDLAGYINRHGK 103
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
VPE A+ F++QL GL++L H IHRDLKP+N+LLS + +LKI DFG + +L P
Sbjct: 104 VPEAVAKHFMRQLALGLQVLQEKHFIHRDLKPQNLLLSSKEVTPLLKIGDFGFARSLTPE 163
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 174
+ AE CGSPLYMAPE+++ Q+YD K D+WS GAILF+L+ G PPF G H
Sbjct: 164 SMAETFCGSPLYMAPEIIRNQKYDAKADLWSAGAILFQLVTGKPPFD-GNNH 214
|
|
| UNIPROTKB|Q5ZJH6 ULK3 "Serine/threonine-protein kinase ULK3" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 385 (140.6 bits), Expect = 1.2e-35, P = 1.2e-35
Identities = 80/168 (47%), Positives = 115/168 (68%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLSSYIRLHG 61
+ LN+ L E+ L ++ HP+I+ L D FQ ++ I+L++EFCAGG+LS +IR+
Sbjct: 49 RSLNRASVENLLTEIEILKTIRHPHIVELKD-FQWDSDHIYLIMEFCAGGDLSRFIRMRR 107
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
+PE+ AR FLQQL L+ L+ H+I H DLKP+NILLS ++ LK+ADFG + + P
Sbjct: 108 ILPEKVARIFLQQLACALKFLHDHNISHLDLKPQNILLS-TPENPQLKLADFGFAQYMSP 166
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
+ + GSPLYMAPE++ Q+YD +VD+WSVG IL+E L G PPF+
Sbjct: 167 WDEKHVLRGSPLYMAPEMVCRQQYDARVDLWSVGVILYEALFGRPPFA 214
|
|
| MGI|MGI:1918992 Ulk3 "unc-51-like kinase 3" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 381 (139.2 bits), Expect = 3.1e-35, P = 3.1e-35
Identities = 80/168 (47%), Positives = 113/168 (67%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLSSYIRLHG 61
K LNK L E+ L + HP+I++L D FQ +N I+L++EFCAGG+LS +I
Sbjct: 49 KSLNKASVENLLTEIEILKGIRHPHIVQLKD-FQWDNDNIYLIMEFCAGGDLSRFIHTRR 107
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
+PE+ AR F+QQL + L+ L+ +I H DLKP+NILLS L+ LK+ADFG + + P
Sbjct: 108 ILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKP-HLKLADFGFAQHMSP 166
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
+ + GSPLYMAPE++ ++YD +VD+WSVG IL+E L G PPF+
Sbjct: 167 WDEKHVLRGSPLYMAPEMVCRRQYDARVDLWSVGVILYEALFGQPPFA 214
|
|
| RGD|1587417 Ulk3 "unc-51-like kinase 3 (C. elegans)" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 381 (139.2 bits), Expect = 3.1e-35, P = 3.1e-35
Identities = 80/168 (47%), Positives = 113/168 (67%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLSSYIRLHG 61
K LNK L E+ L + HP+I++L D FQ +N I+L++EFCAGG+LS +I
Sbjct: 49 KSLNKASVENLLTEIEILKGIRHPHIVQLKD-FQWDNDNIYLIMEFCAGGDLSRFIHTRR 107
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
+PE+ AR F+QQL + L+ L+ +I H DLKP+NILLS L+ LK+ADFG + + P
Sbjct: 108 ILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKP-HLKLADFGFAQHMSP 166
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
+ + GSPLYMAPE++ ++YD +VD+WSVG IL+E L G PPF+
Sbjct: 167 WDEKHVLRGSPLYMAPEMVCRRQYDARVDLWSVGVILYEALFGQPPFA 214
|
|
| MGI|MGI:1352758 Ulk2 "unc-51 like kinase 2" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 389 (142.0 bits), Expect = 6.8e-35, P = 6.8e-35
Identities = 79/177 (44%), Positives = 113/177 (63%)
Query: 2 LKKLNK-HL-KS--CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
+K +NK +L KS L E+ L + H NI+ L+D + N +FLV+E+C GG+L+ Y+
Sbjct: 38 IKSINKKNLSKSQILLGKEIKILKELQHENIVALYDVQELPNSVFLVMEYCNGGDLADYL 97
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD------DDVMLKIA 111
+ G + E T R FL Q+ A + IL+S IIHRDLKP+NILLS + + +KIA
Sbjct: 98 QAKGTLSEDTIRVFLHQIAAAMRILHSKGIIHRDLKPQNILLSYANRRKSNVSGIRIKIA 157
Query: 112 DFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
DFG + L+ A +CGSP+YMAPEV+ Q YD K D+WS+G ++++ L G PPF
Sbjct: 158 DFGFARYLHSNTMAATLCGSPMYMAPEVIMSQHYDAKADLWSIGTVIYQCLVGKPPF 214
|
|
| UNIPROTKB|F1N332 ULK3 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 377 (137.8 bits), Expect = 8.3e-35, P = 8.3e-35
Identities = 80/169 (47%), Positives = 114/169 (67%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLH 60
K LNK L E+ L + HP+I++L D FQ ++N I+L++EFCAGG+LS +I
Sbjct: 49 KSLNKASVENLLTEIEILKGIRHPHIVQLKD-FQWDSDN-IYLIMEFCAGGDLSRFIHTR 106
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
+PE+ AR F+QQL + L+ L+ +I H DLKP+NILLS L+ LK+ADFG + +
Sbjct: 107 RILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKP-HLKLADFGFAQHMS 165
Query: 121 PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
P + + GSPLYMAPE++ ++YD +VD+WSVG IL+E L G PPF+
Sbjct: 166 PRDEKHVLRGSPLYMAPEMVCQRQYDARVDLWSVGVILYEALFGQPPFA 214
|
|
| UNIPROTKB|F1SJ29 ULK3 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 377 (137.8 bits), Expect = 8.3e-35, P = 8.3e-35
Identities = 80/169 (47%), Positives = 114/169 (67%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLH 60
K LNK L E+ L + HP+I++L D FQ ++N I+L++EFCAGG+LS +I
Sbjct: 56 KSLNKASVENLLTEIEILKGIRHPHIVQLKD-FQWDSDN-IYLIMEFCAGGDLSRFIHTR 113
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
+PE+ AR F+QQL + L+ L+ +I H DLKP+NILLS L+ LK+ADFG + +
Sbjct: 114 RILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKP-HLKLADFGFAQHMS 172
Query: 121 PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
P + + GSPLYMAPE++ ++YD +VD+WSVG IL+E L G PPF+
Sbjct: 173 PWDEKHVLRGSPLYMAPEMVCQRQYDARVDLWSVGVILYEALFGQPPFA 221
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00034887001 | SubName- Full=Chromosome chr4 scaffold_73, whole genome shotgun sequence; (275 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 177 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-71 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-60 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-55 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-54 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-50 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-50 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-49 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-48 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-46 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-46 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-42 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-42 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-41 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-41 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-40 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-40 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-38 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-38 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-38 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-37 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-37 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-37 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-37 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-37 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-36 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-36 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-36 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-36 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-36 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-36 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-36 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-36 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-35 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-35 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-34 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-34 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-33 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-33 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-33 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-33 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-33 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-33 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-32 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-32 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-32 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-31 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-31 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-31 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-31 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-31 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-30 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-30 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-30 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-30 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-30 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-30 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-30 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-30 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-30 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-30 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-30 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-29 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-29 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-29 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-29 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-29 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-29 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-28 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-28 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-28 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-28 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-28 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-28 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-28 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-28 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-27 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-27 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-27 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-27 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-27 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-27 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-27 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-27 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-27 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-27 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-27 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-27 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-27 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-27 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-27 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-26 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-26 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-26 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-26 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-26 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-26 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-26 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-26 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-26 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-26 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-25 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-25 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-25 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-25 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-25 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-25 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-25 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-25 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-25 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-25 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-24 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-24 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-24 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-24 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-24 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-24 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-24 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-24 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-24 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-24 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-24 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-24 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-23 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-23 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-23 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-23 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-23 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-23 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-23 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-23 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-23 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-23 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-23 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-23 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-23 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-23 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-23 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-23 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-23 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-23 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-23 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-22 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-22 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-22 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-22 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-22 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-22 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-22 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-22 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-22 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-22 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-22 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-22 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-22 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-22 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-22 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-22 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-21 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-21 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-21 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-21 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-21 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-21 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-21 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-21 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-21 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-21 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-21 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-21 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-21 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-20 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-20 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-20 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-20 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-20 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-20 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-20 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-20 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-20 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-19 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-19 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-19 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-19 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-19 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-19 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-19 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-19 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-19 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-19 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-19 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-19 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-19 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-19 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-18 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-18 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-18 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-18 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-18 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-18 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-18 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-18 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-18 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-17 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-17 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-17 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-17 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-17 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-17 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-17 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-17 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-16 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-16 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-16 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-16 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-16 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-16 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-15 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-15 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-15 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-15 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-13 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-13 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-13 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-13 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 9e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-12 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-12 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-12 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-12 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-11 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 9e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-09 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-09 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 5e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-08 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 7e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 9e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 6e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.002 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 215 bits (551), Expect = 2e-71
Identities = 78/180 (43%), Positives = 113/180 (62%), Gaps = 7/180 (3%)
Query: 2 LKKLNKHLKSCLDC----ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
+K + K E+ L + HPNI+RL+D F+ E+ ++LV+E+C GG+L +
Sbjct: 29 IKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLL 88
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
+ GR+ E AR +L+Q+ + LE L+S I+HRDLKPENIL LD+D +K+ADFGL+
Sbjct: 89 KKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENIL---LDEDGHVKLADFGLAR 145
Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 177
L PG G+P YMAPEVL + Y + VD+WS+G IL+ELL G PPF ++ +
Sbjct: 146 QLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLEL 205
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 5e-60
Identities = 80/175 (45%), Positives = 110/175 (62%), Gaps = 10/175 (5%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY 56
+K L K + E+ L ++HPNI+RL DAF+ ++ ++LV+E+C GG+L Y
Sbjct: 29 VKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDY 88
Query: 57 IRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
+ G + E A+K Q+ GLE L+S+ IIHRDLKPENIL LD++ ++KIADFGL+
Sbjct: 89 LSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENIL---LDENGVVKIADFGLA 145
Query: 117 CTLY-PGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFS 169
L + G+P YMAPEVL Y KVD+WS+G IL+ELL G PPFS
Sbjct: 146 KKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFS 200
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 7e-55
Identities = 73/167 (43%), Positives = 104/167 (62%), Gaps = 9/167 (5%)
Query: 2 LKKLNKHLKSCLDC----ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
+K + K S L E+ L +NHPNI++L+ F+ EN ++LV+E+C GG+L +
Sbjct: 23 IKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLL 82
Query: 58 -RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
G++ E + L Q+ GLE L+S+ IIHRDLKPENILL D+ +K+ADFGLS
Sbjct: 83 KENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD--SDNGKVKLADFGLS 140
Query: 117 CTL-YPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFEL 161
L + + + G+P YMAPEVL + Y EK D+WS+G IL+EL
Sbjct: 141 KLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 171 bits (437), Expect = 3e-54
Identities = 71/161 (44%), Positives = 99/161 (61%), Gaps = 4/161 (2%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E N LS +NHP I++L AFQ E ++LV+E+ GG L S++ GR E+ AR + ++
Sbjct: 43 ERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEI 102
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLY 134
LE L+S II+RDLKPENIL LD D +K+ DFGL+ L CG+P Y
Sbjct: 103 VLALEYLHSLGIIYRDLKPENIL---LDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY 159
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 175
+APEVL + Y + VD WS+G +L+E+L G PPF + +
Sbjct: 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE 200
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 2e-50
Identities = 57/158 (36%), Positives = 96/158 (60%), Gaps = 8/158 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----PEQTARKF 71
E+ L +NHPNII+ +++F+ + + +V+E+ GG+LS I+ + PE+ +
Sbjct: 49 EVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW 108
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCG 130
QL L+ L+S I+HRD+KP+NI L + ++K+ DFG+S L + A+ V G
Sbjct: 109 FVQLCLALKYLHSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSSTVDLAKTVVG 165
Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
+P Y++PE+ Q + Y+ K D+WS+G +L+EL PF
Sbjct: 166 TPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPF 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 2e-50
Identities = 62/164 (37%), Positives = 101/164 (61%), Gaps = 8/164 (4%)
Query: 11 SCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
L+ E+ LSS+ HPNI+R + + + E N + + +E+ +GG+LSS ++ G++PE
Sbjct: 44 EALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI 103
Query: 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL---YPGNYA 125
RK+ +Q+ GL L+S+ I+HRD+K NIL+ D ++K+ADFG + L G
Sbjct: 104 RKYTRQILEGLAYLHSNGIVHRDIKGANILVDS---DGVVKLADFGCAKRLGDIETGEGT 160
Query: 126 EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
V G+P +MAPEV++ + Y D+WS+G + E+ G PP+S
Sbjct: 161 GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWS 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 3e-49
Identities = 64/175 (36%), Positives = 102/175 (58%), Gaps = 12/175 (6%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
+ K+ + E + LS P +++L+ +FQ + ++LV+E+ GG+L+S + G
Sbjct: 30 DMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGS 89
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS------ 116
+ E AR ++ ++ LE L+S+ IIHRDLKP+NIL +D + LK+ DFGLS
Sbjct: 90 LDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNIL---IDSNGHLKLTDFGLSKVGLVR 146
Query: 117 --CTLYPGNYAE-KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
L + ++ G+P Y+APEV+ Q + + VD WS+G IL+E L G PPF
Sbjct: 147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPF 201
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 5e-48
Identities = 58/155 (37%), Positives = 91/155 (58%), Gaps = 4/155 (2%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
E+ L HPNI++ + ++ ++ +++V+EFC+GG+L ++ + E ++
Sbjct: 47 EIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKE 106
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
L GLE L+S+ IIHRD+K NILL+ D +K+ DFGLS L + G+P +
Sbjct: 107 LLKGLEYLHSNGIIHRDIKAANILLT---SDGEVKLIDFGLSAQLSDTKARNTMVGTPYW 163
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
MAPEV+ + YD K D+WS+G EL G PP+S
Sbjct: 164 MAPEVINGKPYDYKADIWSLGITAIELAEGKPPYS 198
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 3e-46
Identities = 66/182 (36%), Positives = 101/182 (55%), Gaps = 9/182 (4%)
Query: 2 LKKLNKH------LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
LK + K + + E L NHP I++L+ F+ + I++++E+C GG L +
Sbjct: 23 LKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWT 82
Query: 56 YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
+R G E TAR ++ + E L++ II+RDLKPEN+L LD + +K+ DFG
Sbjct: 83 ILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLL---LDSNGYVKLVDFGF 139
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 175
+ L G CG+P Y+APE++ + YD VD WS+G +L+ELL G PPF +E
Sbjct: 140 AKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP 199
Query: 176 FM 177
Sbjct: 200 ME 201
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 8e-46
Identities = 64/153 (41%), Positives = 99/153 (64%), Gaps = 5/153 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E L S+ HP ++ L+ +FQ ++ ++LV+E+ GG L S++R GR PE AR + Q+
Sbjct: 51 EKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQV 110
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
LE L+S I++RDLKPEN+L LD D +KI DFG + + Y +CG+P Y+
Sbjct: 111 VLALEYLHSLDIVYRDLKPENLL---LDSDGYIKITDFGFAKRVKGRTYT--LCGTPEYL 165
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
APE++ + Y + VD W++G +++E+L GYPPF
Sbjct: 166 APEIILSKGYGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 6e-42
Identities = 60/174 (34%), Positives = 90/174 (51%), Gaps = 26/174 (14%)
Query: 17 LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76
L L+ HP II+L+ FQ E ++ V+E+ G L YIR +G + E+ R + ++
Sbjct: 55 LTRLN--GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEIL 112
Query: 77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----------------- 119
LE L+S IIHRDLKPENIL LD D+ +KI DFG + L
Sbjct: 113 LALEYLHSKGIIHRDLKPENIL---LDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 120 --YPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
N G+ Y++PE+L + + D+W++G I++++L G PPF
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 9e-42
Identities = 59/166 (35%), Positives = 86/166 (51%), Gaps = 27/166 (16%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E++ L + HPNI++L D E ++LV E+C +L Y+ + + + Q
Sbjct: 48 EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQ 106
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
L GL +SH I+HRDLKP+NIL ++ D +LK+ADFGL+ + G PL
Sbjct: 107 LLRGLAYCHSHRILHRDLKPQNIL---INRDGVLKLADFGLA----------RAFGIPLR 153
Query: 134 ----------YMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPF 168
Y APE+L + Y VD+WSVG I E++ G P F
Sbjct: 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLF 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 1e-41
Identities = 56/153 (36%), Positives = 86/153 (56%), Gaps = 3/153 (1%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E L +NHP ++ L+ +FQ E ++LVV+ GG+L ++ + E+ + ++ ++
Sbjct: 50 ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEI 109
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
LE L+S IIHRD+KP+NIL LD+ + I DF ++ + P G+P YM
Sbjct: 110 VLALEYLHSKGIIHRDIKPDNIL---LDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYM 166
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
APEVL Q Y VD WS+G +E L G P+
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY 199
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 2e-41
Identities = 60/178 (33%), Positives = 95/178 (53%), Gaps = 15/178 (8%)
Query: 4 KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYI---- 57
+ + K L E+N L + HPNI+R +D ++ +++V+E+C GG+L+ I
Sbjct: 37 NMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCK 96
Query: 58 RLHGRVPEQTARKFLQQLGAGLE-----ILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 112
+ + E+ + L QL L + ++HRDLKP NI L D + +K+ D
Sbjct: 97 KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGD 153
Query: 113 FGLSCTLYPGNYAEKVC-GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
FGL+ L + K G+P YM+PE L YDEK D+WS+G +++EL PPF+
Sbjct: 154 FGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 5e-40
Identities = 61/153 (39%), Positives = 95/153 (62%), Gaps = 5/153 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E L V+HP IIRLF + +++++E+ GG L SY+R GR T + ++
Sbjct: 51 EKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI 110
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
LE L+S I++RDLKPENIL LD + +K+ DFG + L + +CG+P Y+
Sbjct: 111 VCALEYLHSKEIVYRDLKPENIL---LDKEGHIKLTDFGFAKKLRDRTWT--LCGTPEYL 165
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
APEV+Q + +++ VD W++G +++E+L GYPPF
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 8e-40
Identities = 64/157 (40%), Positives = 89/157 (56%), Gaps = 8/157 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
E+ L+SVNHPNII +AF N + +V+E+ G+LS I +PEQ +
Sbjct: 49 EIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRI 108
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
QL GL+ L+ I+HRDLK NILL D +KI D G+S + N A+ G+
Sbjct: 109 FIQLLRGLQALHEQKILHRDLKSANILLVANDL---VKIGDLGIS-KVLKKNMAKTQIGT 164
Query: 132 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
P YMAPEV + + Y K D+WS+G +L+E+ PPF
Sbjct: 165 PHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 1e-38
Identities = 60/159 (37%), Positives = 90/159 (56%), Gaps = 10/159 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E+ L + HP +++L D F + LV+E+ LS +R R +PE + +++
Sbjct: 49 EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRM 107
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGS 131
L G+ ++++ I+HRDLKP N+L+S D +LKIADFGL+ Y+ +V +
Sbjct: 108 LLKGVAYMHANGIMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEEPRLYSHQV-AT 163
Query: 132 PLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFS 169
Y APE+L R YD VD+W+VG I ELLNG P F
Sbjct: 164 RWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFP 202
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 2e-38
Identities = 62/184 (33%), Positives = 97/184 (52%), Gaps = 33/184 (17%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E + L+ + P I++L+ +FQ E ++LV+E+ GG+L + + PE+TAR ++ +L
Sbjct: 51 ERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAEL 110
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-----------------CT 118
L+ ++ IHRD+KP+NIL +D D +K+ADFGL
Sbjct: 111 VLALDSVHKLGFIHRDIKPDNIL---IDADGHIKLADFGLCKKMNKAKDREYYLNDSHNL 167
Query: 119 LYPGN-------------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165
L+ N A G+P Y+APEVL+ Y + D WS+G IL+E+L G+
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227
Query: 166 PPFS 169
PPF
Sbjct: 228 PPFY 231
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 3e-38
Identities = 54/159 (33%), Positives = 92/159 (57%), Gaps = 9/159 (5%)
Query: 16 ELNFLSSVNHPNIIRLF-DAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
E + ++HPN+++L + E +++V+E+ GG+L SY+R + ++ F
Sbjct: 51 EARIMRKLDHPNVVKLLGVCTEEEP-LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFAL 109
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG-SP 132
Q+ G+E L S + IHRDL N L + +++++KI+DFGLS LY +Y K G P
Sbjct: 110 QIARGMEYLESKNFIHRDLAARNCL---VGENLVVKISDFGLSRDLYDDDYYRKRGGKLP 166
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFS 169
+ +MAPE L+ ++ K D+WS G +L+E+ G P+
Sbjct: 167 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYP 205
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 1e-37
Identities = 63/169 (37%), Positives = 96/169 (56%), Gaps = 8/169 (4%)
Query: 12 CLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
C E L+ HP + +L FQ ++ +F V+E+ GG+L +I+ GR E AR
Sbjct: 41 CTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF 100
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKV 128
+ ++ GL+ L+ II+RDLK +N+L LD + +KIADFG+ C + G
Sbjct: 101 YAAEIVLGLQFLHERGIIYRDLKLDNVL---LDSEGHIKIADFGM-CKEGILGGVTTSTF 156
Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF-SVGEEHQF 176
CG+P Y+APE+L +Q Y VD W++G +L+E+L G PF E+ F
Sbjct: 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF 205
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-37
Identities = 53/156 (33%), Positives = 89/156 (57%), Gaps = 5/156 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
E++ L + P I++ + ++ +++V+E+C G++S +++ + E+ L Q
Sbjct: 48 EISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQ 107
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPL 133
GLE L+S+ IHRD+K NILL +++ K+ADFG+S L V G+P
Sbjct: 108 TLKGLEYLHSNKKIHRDIKAGNILL---NEEGQAKLADFGVSGQLTDTMAKRNTVIGTPF 164
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
+MAPEV+Q Y+ K D+WS+G E+ G PP+S
Sbjct: 165 WMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYS 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 3e-37
Identities = 65/174 (37%), Positives = 100/174 (57%), Gaps = 11/174 (6%)
Query: 2 LKKLNKHLKSCLD------CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
LK++ K L L+ E + L++ +++L AFQ + ++L +E+ GG+ +
Sbjct: 31 LKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRT 90
Query: 56 YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
+ G + E AR ++ ++ ++ L+ IHRDLKPEN L+ D +K+ DFGL
Sbjct: 91 LLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGL 147
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
S + YA V GSP YMAPEVL+ + YD VD WS+G +L+E L G+PPFS
Sbjct: 148 SKGIV--TYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 4e-37
Identities = 57/146 (39%), Positives = 92/146 (63%), Gaps = 6/146 (4%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
P + +L+ +FQ+++ ++LV+E+ GG+ +S I+ G +PE A++++ ++ G+E L+
Sbjct: 57 PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR 116
Query: 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
IIHRD+KPEN+L +D LK+ DFGLS G +K G+P Y+APE +
Sbjct: 117 GIIHRDIKPENLL---IDQTGHLKLTDFGLSRN---GLENKKFVGTPDYLAPETILGVGD 170
Query: 146 DEKVDMWSVGAILFELLNGYPPFSVG 171
D+ D WS+G ++FE L GYPPF
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPPFHAE 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 131 bits (328), Expect = 6e-37
Identities = 75/187 (40%), Positives = 103/187 (55%), Gaps = 22/187 (11%)
Query: 2 LKKLNKHLKSC------LDCELNFLSSVNHP-NIIRLFDAFQAENCIFLVVEFCAGGNLS 54
LK L K L+S E+ L+S+NHP NI++L+D FQ E ++LV+E+ GG+L
Sbjct: 27 LKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLE 86
Query: 55 SYIRLHGR---VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
++ GR + E A L Q+ + LE L+S IIHRD+KPENILL D ++K+
Sbjct: 87 DLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD--RDGRVVKLI 144
Query: 112 DFGLSCTLYPGNYAEKV-------CGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFEL 161
DFGL+ L + G+P YMAPEVL D+WS+G L+EL
Sbjct: 145 DFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYEL 204
Query: 162 LNGYPPF 168
L G PPF
Sbjct: 205 LTGLPPF 211
|
Length = 384 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-36
Identities = 53/160 (33%), Positives = 89/160 (55%), Gaps = 10/160 (6%)
Query: 16 ELNFLSSVNHPNIIRLF-DAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFL 72
E + ++HPNI++L + E + +V+E+ GG+L Y+R + + F
Sbjct: 51 EARIMRKLDHPNIVKLLGVCTEEEP-LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFA 109
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG-S 131
Q+ G+E L S + IHRDL N L+ +++++KI+DFGLS LY +Y + G
Sbjct: 110 LQIARGMEYLESKNFIHRDLAARNCLVG---ENLVVKISDFGLSRDLYDDDYYKVKGGKL 166
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFS 169
P+ +MAPE L+ ++ K D+WS G +L+E+ G P+
Sbjct: 167 PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYP 206
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-36
Identities = 61/163 (37%), Positives = 94/163 (57%), Gaps = 12/163 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL---HGRVPEQTARKFL 72
E+ +S NHPN+++ + +F + ++LV+ + +GG+L ++ G + E L
Sbjct: 49 EVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL 108
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKV--- 128
+++ GLE L+S+ IHRD+K NIL L +D +KIADFG+S +L G+ KV
Sbjct: 109 KEVLKGLEYLHSNGQIHRDIKAGNIL---LGEDGSVKIADFGVSASLADGGDRTRKVRKT 165
Query: 129 -CGSPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFS 169
G+P +MAPEV+ Q YD K D+WS G EL G P+S
Sbjct: 166 FVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYS 208
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 1e-36
Identities = 54/167 (32%), Positives = 93/167 (55%), Gaps = 5/167 (2%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
K + LKS + E++ L ++ HPNI++ + + + +++++E+ G+L I+ G
Sbjct: 37 KIKEEALKSIMQ-EIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP 95
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP- 121
PE ++ Q+ GL L+ +IHRD+K NIL + D ++K+ADFG++ L
Sbjct: 96 FPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTK---DGVVKLADFGVATKLNDV 152
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
V G+P +MAPEV++ D+WS+G + ELL G PP+
Sbjct: 153 SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPY 199
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-36
Identities = 53/171 (30%), Positives = 96/171 (56%), Gaps = 8/171 (4%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
+ K + + L+CE+ L ++ H I++ + + + + + +E+ GG++ ++ +G
Sbjct: 42 PETKKEVNA-LECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA 100
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP- 121
+ E RK+ +Q+ G+E L+S+ I+HRD+K NIL D +K+ DFG S L
Sbjct: 101 LTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTI 157
Query: 122 ---GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
G + V G+P +M+PEV+ + Y K D+WSVG + E+L PP++
Sbjct: 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWA 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-36
Identities = 52/159 (32%), Positives = 89/159 (55%), Gaps = 8/159 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E + + ++HPNI+RL +++V E+ GG+L ++R HG + + + Q
Sbjct: 51 EASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQ 110
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
+ G+E L S + +HRDL N L+ +++++KI+DFGLS +Y +Y K G L
Sbjct: 111 IAKGMEYLESKNFVHRDLAARNCLV---TENLVVKISDFGLSRDIYEDDYYRKRGGGKLP 167
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFS 169
+MAPE L+ ++ K D+WS G +L+E+ G P+
Sbjct: 168 IKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYP 206
|
Length = 258 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 4e-36
Identities = 61/183 (33%), Positives = 92/183 (50%), Gaps = 30/183 (16%)
Query: 3 KKLNKHLKSCLDC----ELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
KK+ K S +C E+ L +N HPNI++L + F+ + ++ V E+ G NL +
Sbjct: 30 KKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLM 88
Query: 58 RLHGRVP--EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
+ P E R + Q+ GL ++ H HRDLKPEN+L+SG + ++KIADFGL
Sbjct: 89 KDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE---VVKIADFGL 145
Query: 116 SCTLYPGNYAEKVCGSP---------LYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGY 165
A ++ P Y APE+ L+ Y VD+W++G I+ EL
Sbjct: 146 ---------AREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
Query: 166 PPF 168
P F
Sbjct: 197 PLF 199
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 7e-36
Identities = 55/147 (37%), Positives = 89/147 (60%), Gaps = 5/147 (3%)
Query: 24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEIL 82
HPNI+ +D++ + +++V+E+ GG+L+ I + R+ E +++ GLE L
Sbjct: 73 KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYL 132
Query: 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLYMAPEVLQ 141
+S ++IHRD+K +NILLS D V K+ADFG + L V G+P +MAPEV++
Sbjct: 133 HSQNVIHRDIKSDNILLS-KDGSV--KLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIK 189
Query: 142 FQRYDEKVDMWSVGAILFELLNGYPPF 168
+ Y KVD+WS+G + E+ G PP+
Sbjct: 190 RKDYGPKVDIWSLGIMCIEMAEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 8e-36
Identities = 59/174 (33%), Positives = 94/174 (54%), Gaps = 18/174 (10%)
Query: 16 ELNFLSSVNHPNIIRLF--DAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFL 72
E+ L + HPN+++ + + + + IF+ E+C+GG L + HGR+ E R +
Sbjct: 49 EMKVLELLKHPNLVKYYGVEVHREKVYIFM--EYCSGGTLEELLE-HGRILDEHVIRVYT 105
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-----TLYPGNYAEK 127
QL GL L+SH I+HRD+KP NI LD + ++K+ DFG + T G +
Sbjct: 106 LQLLEGLAYLHSHGIVHRDIKPANIF---LDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS 162
Query: 128 VCGSPLYMAPEVLQFQRYDEK---VDMWSVGAILFELLNGYPPFS-VGEEHQFM 177
+ G+P YMAPEV+ + D+WS+G ++ E+ G P+S + E Q M
Sbjct: 163 LAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM 216
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-35
Identities = 56/166 (33%), Positives = 98/166 (59%), Gaps = 4/166 (2%)
Query: 13 LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
L+ E+ LS + HPNI++ + E+ +++ +E GG+L+ ++ +G PE R +
Sbjct: 49 LEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYT 108
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
+Q+ GLE L+ + +HRD+K NIL +D + ++K+ADFG++ + ++A+ GSP
Sbjct: 109 RQILLGLEYLHDRNTVHRDIKGANIL---VDTNGVVKLADFGMAKQVVEFSFAKSFKGSP 165
Query: 133 LYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 177
+MAPEV+ Q Y D+WS+G + E+ G PP+S E +
Sbjct: 166 YWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV 211
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-35
Identities = 62/160 (38%), Positives = 97/160 (60%), Gaps = 19/160 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E + L ++HP I+ + +FQ EN ++ ++EF GG L +++R GR P A+ + +L
Sbjct: 68 EKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAEL 127
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV------- 128
E L+S II+RDLKPEN+L LD+ +K+ DFG +A+KV
Sbjct: 128 VLAFEYLHSKDIIYRDLKPENLL---LDNKGHVKVTDFG---------FAKKVPDRTFTL 175
Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
CG+P Y+APEV+Q + + + VD W++G +L+E + GYPPF
Sbjct: 176 CGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-34
Identities = 64/157 (40%), Positives = 89/157 (56%), Gaps = 9/157 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E+ L +NHPNII+L D F+ + ++LV EF +L I+ R +PE + +L Q
Sbjct: 48 EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQ 106
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSP 132
L GL +SH I+HRDLKPEN+L++ LK+ADFGL+ + Y V +
Sbjct: 107 LLQGLAFCHSHGILHRDLKPENLLINTEGV---LKLADFGLARSFGSPVRPYTHYVV-TR 162
Query: 133 LYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPF 168
Y APE+L + Y VD+WSVG I ELL+ P F
Sbjct: 163 WYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLF 199
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 9e-34
Identities = 61/180 (33%), Positives = 96/180 (53%), Gaps = 8/180 (4%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
K + L E+ L ++H NI++ E + + +E+ GG++ S +R +GR
Sbjct: 45 DSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR 104
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL---SCTL 119
EQ R F +Q+ GL L+S I+HRDLK +N+L +D D + KI+DFG+ S +
Sbjct: 105 FEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLL---VDADGICKISDFGISKKSDDI 161
Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQR--YDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 177
Y + + GS +MAPEV+ Y KVD+WS+G ++ E+ G P+S E M
Sbjct: 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM 221
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-33
Identities = 55/167 (32%), Positives = 84/167 (50%), Gaps = 16/167 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR---------LHGRVPEQ 66
E + + HPN++RL E ++LV+E+ GG+L Y+R + +
Sbjct: 46 EARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLK 105
Query: 67 TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
F Q+ G+E L S +HRDL N L+ +D V+ KI+DFGLS +Y +Y
Sbjct: 106 DLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG--EDLVV-KISDFGLSRDVYDDDYYR 162
Query: 127 KVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFS 169
K G L +MAPE L+ + K D+WS G +L+E+ G P+
Sbjct: 163 KKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP 209
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-33
Identities = 64/156 (41%), Positives = 96/156 (61%), Gaps = 8/156 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
E + L+ VNHP I++L AFQ E ++L+++F GG+L + RL V E+ + +L
Sbjct: 48 ERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLA 105
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSP 132
+L L+ L+S II+RDLKPENILL D++ +K+ DFGLS ++ A CG+
Sbjct: 106 ELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 162
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
YMAPEV+ + + + D WS G ++FE+L G PF
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-33
Identities = 62/152 (40%), Positives = 92/152 (60%), Gaps = 4/152 (2%)
Query: 25 HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84
HP + LF FQ + +F V+E+ GG+L +I+ GR E AR + ++ GL+ L+
Sbjct: 55 HPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK 114
Query: 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT-LYPGNYAEKVCGSPLYMAPEVLQFQ 143
II+RDLK +N+LL D D +KIADFG+ + A CG+P Y+APE+L+ Q
Sbjct: 115 KGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQ 171
Query: 144 RYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 175
+Y+E VD WS G +L+E+L G PF +E +
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 4e-33
Identities = 59/167 (35%), Positives = 87/167 (52%), Gaps = 11/167 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
EL L S P +++ + AF E I +V+E+ GG+L+ ++ G++PE +Q+
Sbjct: 49 ELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQI 108
Query: 76 GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFG----LSCTLYPGNYAEKVCG 130
GL+ L HIIHRD+KP N+L++ +V KIADFG L TL N G
Sbjct: 109 LKGLDYLHTKRHIIHRDIKPSNLLIN-SKGEV--KIADFGISKVLENTLDQCNTF---VG 162
Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 177
+ YM+PE +Q + Y D+WS+G L E G PF + F
Sbjct: 163 TVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFF 209
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 4e-33
Identities = 53/176 (30%), Positives = 98/176 (55%), Gaps = 8/176 (4%)
Query: 2 LKKLNKHLKS-CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
L K+N+ + +D E L+ ++ IIR +++F + + +V+E+ G+L +++
Sbjct: 35 LSKMNRREREEAID-EARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQ 93
Query: 61 G--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
+PE +F Q+ GL L+S I+HRD+K N+ L D+ +KI D G++
Sbjct: 94 RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN---VKIGDLGVAKL 150
Query: 119 LYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 173
L N+A + G+P Y++PE+ + + Y+EK D+W++G +L+E G PF +
Sbjct: 151 LSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ 206
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 6e-33
Identities = 63/156 (40%), Positives = 94/156 (60%), Gaps = 6/156 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E N L +V HP I+ L AFQ ++L++E+ +GG L ++ G E TA +L ++
Sbjct: 50 ERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEI 109
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVCGSPL 133
LE L+ II+RDLKPENIL LD +K+ DFGL C +++ G CG+
Sbjct: 110 SLALEHLHQQGIIYRDLKPENIL---LDAQGHVKLTDFGL-CKESIHEGTVTHTFCGTIE 165
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
YMAPE+L + + VD WS+GA+++++L G PPF+
Sbjct: 166 YMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT 201
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-32
Identities = 52/150 (34%), Positives = 89/150 (59%), Gaps = 4/150 (2%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
E L ++HPNII ++ F + + +V+E+ GG L+ YI+ + E T F
Sbjct: 49 ECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFV 108
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
Q+ L +++ I+HRDLK +NILL +++KI DFG+S L + A V G+P
Sbjct: 109 QILLALHHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKSKAYTVVGTPC 166
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
Y++PE+ + + Y++K D+W++G +L+EL +
Sbjct: 167 YISPELCEGKPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 5e-32
Identities = 66/169 (39%), Positives = 98/169 (57%), Gaps = 11/169 (6%)
Query: 3 KKLNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
KK KH+ + E N L +V HP ++ L +FQ + ++ V+++ GG L +++
Sbjct: 36 KKEQKHIMA----ERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRER 91
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--L 119
PE AR + ++ + L L+S +II+RDLKPENILL D + + DFGL C +
Sbjct: 92 SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGL-CKEGI 147
Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
CG+P Y+APEVL+ Q YD VD W +GA+L+E+L G PPF
Sbjct: 148 EHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-32
Identities = 57/165 (34%), Positives = 90/165 (54%), Gaps = 7/165 (4%)
Query: 12 CLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
C E L+ + HP + L FQ ++ +F V+E+ GG+L I+ + E +R
Sbjct: 41 CTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF 100
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKV 128
+ ++ L L+ H +I+RDLK +NILL D + K+ADFG+ C + G
Sbjct: 101 YAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGM-CKEGILNGVTTTTF 156
Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 173
CG+P Y+APE+LQ Y VD W++G +++E++ G PPF E
Sbjct: 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-31
Identities = 57/155 (36%), Positives = 88/155 (56%), Gaps = 7/155 (4%)
Query: 21 SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE 80
+S HP ++ LF FQ E+ + V+E+ AGG+L +I E A + + GL+
Sbjct: 57 NSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQ 115
Query: 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMAPE 138
L+ + I++RDLK +N+LL D + +KIADFGL C + G+ CG+P ++APE
Sbjct: 116 YLHENKIVYRDLKLDNLLL---DTEGFVKIADFGL-CKEGMGFGDRTSTFCGTPEFLAPE 171
Query: 139 VLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 173
VL Y VD W +G +++E+L G PF +E
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE 206
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-31
Identities = 55/154 (35%), Positives = 96/154 (62%), Gaps = 6/154 (3%)
Query: 19 FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
F ++ NHP ++ L FQ E+ +F V+EF +GG+L +++ ++PE+ AR + ++
Sbjct: 49 FETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA 108
Query: 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMA 136
L L+ II+RDLK +N+L LD + +K+ D+G+ C + PG+ CG+P Y+A
Sbjct: 109 LNFLHERGIIYRDLKLDNVL---LDAEGHIKLTDYGM-CKEGIRPGDTTSTFCGTPNYIA 164
Query: 137 PEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 170
PE+L+ + Y VD W++G ++FE++ G PF +
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-31
Identities = 62/157 (39%), Positives = 86/157 (54%), Gaps = 13/157 (8%)
Query: 20 LSSVNHPNIIRLFDAF---QAENC--IFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFL 72
L S HPNI+RL D + + + LV E +L++Y+ + +P +T + +
Sbjct: 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLM 113
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
+QL G++ L+SH I+HRDLKP+NIL++ D +KIADFGL+ +Y A
Sbjct: 114 RQLLRGVDFLHSHRIVHRDLKPQNILVT---SDGQVKIADFGLA-RIYSFEMALTSVVVT 169
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
L Y APEVL Y VDMWSVG I EL P F
Sbjct: 170 LWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLF 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 6e-31
Identities = 52/152 (34%), Positives = 86/152 (56%), Gaps = 10/152 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQ 73
E+ LS + HPNII ++ F +N + + +E+ GG L I + E+ +L
Sbjct: 49 EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF 108
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL---YPGNYAEKVCG 130
Q+ + + ++ I+HRD+K NI L+ ++K+ DFG+S L Y AE V G
Sbjct: 109 QIVSAVSYIHKAGILHRDIKTLNIFLT---KAGLIKLGDFGISKILGSEYSM--AETVVG 163
Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
+P YM+PE+ Q +Y+ K D+W++G +L+ELL
Sbjct: 164 TPYYMSPELCQGVKYNFKSDIWALGCVLYELL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 7e-31
Identities = 63/174 (36%), Positives = 98/174 (56%), Gaps = 7/174 (4%)
Query: 5 LNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV 63
LN+ + + E N L +V HP ++ L +FQ ++ V++F GG L +++
Sbjct: 34 LNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSF 93
Query: 64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYP 121
PE AR + ++ + L L+S +I++RDLKPENILL V+ DFGL C +
Sbjct: 94 PEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVL---TDFGL-CKEGIAQ 149
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 175
+ CG+P Y+APEV++ Q YD VD W +GA+L+E+L G PPF + +
Sbjct: 150 SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 1e-30
Identities = 55/154 (35%), Positives = 94/154 (61%), Gaps = 6/154 (3%)
Query: 19 FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
F + NHP ++ L FQ E+ +F V+E+ GG+L +++ ++PE+ AR + ++
Sbjct: 49 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 108
Query: 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMA 136
L L+ II+RDLK +N+L LD + +K+ D+G+ C L PG+ CG+P Y+A
Sbjct: 109 LNYLHERGIIYRDLKLDNVL---LDSEGHIKLTDYGM-CKEGLRPGDTTSTFCGTPNYIA 164
Query: 137 PEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 170
PE+L+ + Y VD W++G ++FE++ G PF +
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-30
Identities = 59/168 (35%), Positives = 87/168 (51%), Gaps = 28/168 (16%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
E++ L +NHPNI+RL D +EN ++LV EF +L Y+ + +L
Sbjct: 48 EISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLY 106
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
QL G+ +SH ++HRDLKP+N+L +D + LK+ADFGL+ + G P+
Sbjct: 107 QLLQGIAYCHSHRVLHRDLKPQNLL---IDREGALKLADFGLA----------RAFGVPV 153
Query: 134 -----------YMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFS 169
Y APE+L R Y VD+WS+G I E++N P F
Sbjct: 154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-30
Identities = 59/165 (35%), Positives = 87/165 (52%), Gaps = 20/165 (12%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPE-QTA---RK 70
E++ L HPNI+ F ++ + +++V+E+C GG+L Y G + E Q A R+
Sbjct: 50 EISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRE 109
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--- 127
L+ GL L+ IHRD+K NILL+ +D +K+ADFG+S L K
Sbjct: 110 TLK----GLAYLHETGKIHRDIKGANILLT---EDGDVKLADFGVSAQL--TATIAKRKS 160
Query: 128 VCGSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFS 169
G+P +MAPEV +R YD K D+W++G EL PP
Sbjct: 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMF 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-30
Identities = 55/168 (32%), Positives = 92/168 (54%), Gaps = 22/168 (13%)
Query: 14 DC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGR-VPEQT 67
DC E++ L ++HPN+I+ +F N + +V+E G+LS I + R +PE+T
Sbjct: 48 DCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERT 107
Query: 68 ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--- 124
K+ QL + LE ++S I+HRD+KP N+ ++ ++K+ D GL G +
Sbjct: 108 IWKYFVQLCSALEHMHSKRIMHRDIKPANVFITA---TGVVKLGDLGL------GRFFSS 158
Query: 125 ----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
A + G+P YM+PE + Y+ K D+WS+G +L+E+ PF
Sbjct: 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-30
Identities = 57/157 (36%), Positives = 90/157 (57%), Gaps = 9/157 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ FLS P I + + +F + +++++E+C GG+ ++ G++ E L+++
Sbjct: 49 EIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-GKLDETYIAFILREV 107
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSP 132
GLE L+ IHRD+K NILLS ++ +K+ADFG+S L + K G+P
Sbjct: 108 LLGLEYLHEEGKIHRDIKAANILLS---EEGDVKLADFGVSGQL--TSTMSKRNTFVGTP 162
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
+MAPEV++ YDEK D+WS+G EL G PP S
Sbjct: 163 FWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLS 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-30
Identities = 57/152 (37%), Positives = 89/152 (58%), Gaps = 6/152 (3%)
Query: 19 FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
L ++ HP ++ L +FQ ++ V+++ GG L +++ E AR + ++ +
Sbjct: 49 LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASA 108
Query: 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMA 136
+ L+S +II+RDLKPENILL D + + DFGL C + P CG+P Y+A
Sbjct: 109 IGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGL-CKEGVEPEETTSTFCGTPEYLA 164
Query: 137 PEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
PEVL+ + YD VD W +GA+L+E+L G PPF
Sbjct: 165 PEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-30
Identities = 66/165 (40%), Positives = 92/165 (55%), Gaps = 18/165 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
E++ LS HPNI+ L++A+ EN +++++EFC GG L S + R E R +Q
Sbjct: 52 EIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQ 111
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-----VC 129
+ L L+SH +IHRDLK NILL+ LD DV K+ADFG+S N +
Sbjct: 112 MLEALNFLHSHKVIHRDLKAGNILLT-LDGDV--KLADFGVSAK----NKSTLQKRDTFI 164
Query: 130 GSPLYMAPEVL-----QFQRYDEKVDMWSVGAILFELLNGYPPFS 169
G+P +MAPEV+ + YD K D+WS+G L EL PP
Sbjct: 165 GTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHH 209
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 4e-30
Identities = 61/189 (32%), Positives = 108/189 (57%), Gaps = 25/189 (13%)
Query: 2 LKKLNKH---LKSCLD---CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
+KK+NK L++ + E + L+ +P ++ +F +F+ + + +V+E+ GG+ ++
Sbjct: 31 MKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCAT 90
Query: 56 YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
++ G +P AR + + LE L+++ I+HRDLKP+N+L++ + +K+ DFGL
Sbjct: 91 LLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH---IKLTDFGL 147
Query: 116 S--------CTLYPGNYA--------EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159
S LY G+ ++VCG+P Y+APEV+ Q Y + VD W++G IL+
Sbjct: 148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILY 207
Query: 160 ELLNGYPPF 168
E L G PF
Sbjct: 208 EFLVGCVPF 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-30
Identities = 56/150 (37%), Positives = 91/150 (60%), Gaps = 7/150 (4%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
P + +L FQ + ++ V+E+ GG+L +I+ G+ E A + ++ GL L+S
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVCGSPLYMAPEVLQFQ 143
II+RDLK +N++L D + +KIADFG+ C ++ G CG+P Y+APE++ +Q
Sbjct: 121 GIIYRDLKLDNVML---DAEGHIKIADFGM-CKENIFGGKTTRTFCGTPDYIAPEIIAYQ 176
Query: 144 RYDEKVDMWSVGAILFELLNGYPPFSVGEE 173
Y + VD W+ G +L+E+L G PPF GE+
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQPPFD-GED 205
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 5e-30
Identities = 65/169 (38%), Positives = 96/169 (56%), Gaps = 11/169 (6%)
Query: 3 KKLNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
KK KH+ S E N L +V HP ++ L +FQ + ++ V+++ GG L +++
Sbjct: 36 KKEEKHIMS----ERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER 91
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TL 119
E AR + ++ + L L+S +I++RDLKPENILL D + + DFGL C +
Sbjct: 92 CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGL-CKENI 147
Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
CG+P Y+APEVL Q YD VD W +GA+L+E+L G PPF
Sbjct: 148 EHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 7e-30
Identities = 60/155 (38%), Positives = 88/155 (56%), Gaps = 5/155 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
E L V+ I+ L AF+ ++ + LV+ GG+L +I G PE A +
Sbjct: 43 EKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA 102
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
Q+ GLE L+ I++RDLKPEN+LL DD ++I+D GL+ L G + G+P
Sbjct: 103 QIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPG 159
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
YMAPEVLQ + YD VD +++G L+E++ G PF
Sbjct: 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-29
Identities = 60/185 (32%), Positives = 90/185 (48%), Gaps = 27/185 (14%)
Query: 3 KKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGN 52
KK++ +D E+ L + H NII L D + N +++V E +
Sbjct: 31 KKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTEL-METD 89
Query: 53 LSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 112
L I+ + + + FL Q+ GL+ L+S ++IHRDLKP NIL+ + + LKI D
Sbjct: 90 LHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICD 146
Query: 113 FGLSCTLYPGNYAEKVCGSPL--------YMAPEV-LQFQRYDEKVDMWSVGAILFELLN 163
FGL+ + P ++ L Y APE+ L RY + +D+WSVG I ELL
Sbjct: 147 FGLARGVDP----DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLT 202
Query: 164 GYPPF 168
P F
Sbjct: 203 RKPLF 207
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 2e-29
Identities = 54/154 (35%), Positives = 94/154 (61%), Gaps = 6/154 (3%)
Query: 19 FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
F + ++P ++ L FQ + +FLV+E+ GG+L +++ ++PE+ AR + ++
Sbjct: 49 FEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA 108
Query: 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMA 136
L L+ II+RDLK +N+L LD D +K+ D+G+ C L PG+ CG+P Y+A
Sbjct: 109 LNFLHERGIIYRDLKLDNVL---LDADGHIKLTDYGM-CKEGLGPGDTTSTFCGTPNYIA 164
Query: 137 PEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 170
PE+L+ + Y VD W++G ++FE++ G PF +
Sbjct: 165 PEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 7e-29
Identities = 60/155 (38%), Positives = 91/155 (58%), Gaps = 6/155 (3%)
Query: 24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
+P + L+ FQ + +F V+EF GG+L +I+ GR A + ++ GL+ L+
Sbjct: 54 ENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH 113
Query: 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVCGSPLYMAPEVLQ 141
S II+RDLK +N++L D D +KIADFG+ C ++ N A CG+P Y+APE+LQ
Sbjct: 114 SKGIIYRDLKLDNVML---DRDGHIKIADFGM-CKENVFGDNRASTFCGTPDYIAPEILQ 169
Query: 142 FQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQF 176
+Y VD WS G +L+E+L G PF +E +
Sbjct: 170 GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 7e-29
Identities = 61/155 (39%), Positives = 89/155 (57%), Gaps = 6/155 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E L+ VN P I+ L +FQ+ ++LV+ F GG L +++ GR AR + +L
Sbjct: 43 ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAEL 102
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPL 133
LE L+ ++I+RDLKPENIL LD + + DFGL C L + CG+P
Sbjct: 103 LCALENLHKFNVIYRDLKPENIL---LDYQGHIALCDFGL-CKLNMKDDDKTNTFCGTPE 158
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
Y+APE+L Y + VD W++G +L+E+L G PPF
Sbjct: 159 YLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPF 193
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 7e-29
Identities = 58/152 (38%), Positives = 89/152 (58%), Gaps = 6/152 (3%)
Query: 24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
NHP + +L+ FQ + +F V+EF GG+L +I+ R E AR + ++ + L L+
Sbjct: 54 NHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLH 113
Query: 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMAPEVLQ 141
II+RDLK +N+L LD + K+ADFG+ C ++ G CG+P Y+APE+LQ
Sbjct: 114 DKGIIYRDLKLDNVL---LDHEGHCKLADFGM-CKEGIFNGKTTSTFCGTPDYIAPEILQ 169
Query: 142 FQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 173
Y VD W++G +L+E+L G+ PF E
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 8e-29
Identities = 62/159 (38%), Positives = 92/159 (57%), Gaps = 10/159 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPEQTARKFLQQ 74
E++ L+S +HPNI++L DAF EN +++++EFCAGG + + + L + E R +Q
Sbjct: 52 EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQ 111
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSPL 133
L L+ + IIHRDLK NIL + LD D+ K+ADFG+S + G+P
Sbjct: 112 TLEALNYLHENKIIHRDLKAGNILFT-LDGDI--KLADFGVSAKNTRTIQRRDSFIGTPY 168
Query: 134 YMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPP 167
+MAPEV+ + YD K D+WS+G L E+ PP
Sbjct: 169 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 1e-28
Identities = 58/161 (36%), Positives = 90/161 (55%), Gaps = 14/161 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFL 72
E+ L + HPNI+RL + + + I++V E+ +L+ + + E + ++
Sbjct: 48 EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYM 106
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL---YPGNYAEKVC 129
+QL GL+ L+S+ I+HRD+K NIL+ ++D +LK+ADFGL+ +Y +V
Sbjct: 107 KQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRNSADYTNRVI 163
Query: 130 GSPL-YMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPF 168
L Y PE+L RY +VDMWSVG IL EL G P F
Sbjct: 164 --TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-28
Identities = 57/165 (34%), Positives = 93/165 (56%), Gaps = 5/165 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRV-PEQTARKFLQ 73
E+ L+ + HPNI+ F +FQ +F+V+E+C GG+L I R G + E +
Sbjct: 49 EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV 108
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC-GSP 132
Q+ GL+ ++ I+HRD+K +NI LS + ++ K+ DFG++ L C G+P
Sbjct: 109 QISLGLKHIHDRKILHRDIKSQNIFLS--KNGMVAKLGDFGIARQLNDSMELAYTCVGTP 166
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 177
Y++PE+ Q + Y+ K D+WS+G +L+EL PF HQ +
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-28
Identities = 56/157 (35%), Positives = 91/157 (57%), Gaps = 5/157 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E L+ +NHP + L+ +F+ E+ ++LV+EF GG +++R + R P + Q+
Sbjct: 81 ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQI 140
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
E L S +I++RDLKPEN+L LD D +K+ DFG + + Y +CG+P Y+
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLL---LDKDGFIKMTDFGFAKVVDTRTYT--LCGTPEYI 195
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGE 172
APE+L + + D W++G ++E+L G PPF E
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE 232
|
Length = 340 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-28
Identities = 54/158 (34%), Positives = 89/158 (56%), Gaps = 7/158 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ ++ +NHP+IIR+ A ++ L VE+ AGG++S + +G E + +QL
Sbjct: 53 EIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL 112
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-----GNYAEKVCG 130
GL L+ + IIHRD+K N+L+ L+IADFG + L G + ++ G
Sbjct: 113 LRGLSYLHENQIIHRDVKGANLLIDSTGQR--LRIADFGAAARLAAKGTGAGEFQGQLLG 170
Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
+ +MAPEVL+ ++Y D+WSVG ++ E+ PP+
Sbjct: 171 TIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPW 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-28
Identities = 55/158 (34%), Positives = 84/158 (53%), Gaps = 9/158 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFL 72
E++ + + H NI+RL D EN + LV E+ +L Y+ HG + T + F
Sbjct: 48 EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFT 106
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
QL G+ + + ++HRDLKP+N+L++ LK+ADFGL+ P N +
Sbjct: 107 YQLLKGIAFCHENRVLHRDLKPQNLLINK---RGELKLADFGLARAFGIPVNTFSNEVVT 163
Query: 132 PLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPF 168
Y AP+VL R Y +D+WSVG I+ E++ G P F
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLF 201
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-28
Identities = 64/166 (38%), Positives = 93/166 (56%), Gaps = 21/166 (12%)
Query: 16 ELNFLSSV-NHPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
E+ FL + +HPNI++L + +AEN I+LV E+ +L + IR + + R +
Sbjct: 56 EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEY-METDLHAVIR-ANILEDVHKRYIM 113
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
QL L+ ++S ++IHRDLKP NILL + D +K+ADFGL+ +L +P
Sbjct: 114 YQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGLARSLSELEENP---ENP 167
Query: 133 L---------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
+ Y APE+L RY + VDMWSVG IL E+L G P F
Sbjct: 168 VLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-28
Identities = 56/152 (36%), Positives = 89/152 (58%), Gaps = 5/152 (3%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
P I+ L +FQ ++ ++LV ++ +GG L +++ GR E A+ ++ +L LE L+ +
Sbjct: 56 PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY 115
Query: 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCGSPLYMAPEVLQFQR 144
I++RDLKPENIL LD + + DFGLS L CG+ Y+APEVL ++
Sbjct: 116 DIVYRDLKPENIL---LDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEK 172
Query: 145 -YDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 175
Y + VD WS+G ++FE+ G+ PF + Q
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ 204
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 8e-28
Identities = 54/155 (34%), Positives = 86/155 (55%), Gaps = 8/155 (5%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
P ++ L AFQ + + L++++ GG L +++ E R ++ ++ L+ L+
Sbjct: 65 PFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL 124
Query: 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ 143
II+RD+K ENIL LD + + + DFGLS A CG+ YMAPEV++
Sbjct: 125 GIIYRDIKLENIL---LDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGG 181
Query: 144 R--YDEKVDMWSVGAILFELLNGYPPFSV-GEEHQ 175
+D+ VD WS+G + FELL G PF+V GE++
Sbjct: 182 SGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS 216
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 1e-27
Identities = 61/156 (39%), Positives = 83/156 (53%), Gaps = 11/156 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA--RKFLQ 73
E+ L + HPNII L D F ++ I LV EF +L I+ + A + ++
Sbjct: 52 EIKLLQELKHPNIIGLLDVFGHKSNINLVFEFMET-DLEKVIK-DKSIVLTPADIKSYML 109
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPG-NYAEKVCGS 131
GLE L+S+ I+HRDLKP N+L + D +LK+ADFGL+ + P +V +
Sbjct: 110 MTLRGLEYLHSNWILHRDLKPNNLL---IASDGVLKLADFGLARSFGSPNRKMTHQVV-T 165
Query: 132 PLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYP 166
Y APE+L R Y VDMWSVG I ELL P
Sbjct: 166 RWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-27
Identities = 55/158 (34%), Positives = 86/158 (54%), Gaps = 10/158 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQ 74
E+ L + H NI+ L +AF+ + ++LV E+ L + G +P R ++ Q
Sbjct: 50 EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQ 108
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGS 131
L + +SH+IIHRD+KPENIL+S + +LK+ DFG + L + V +
Sbjct: 109 LLQAIAYCHSHNIIHRDIKPENILVS---ESGVLKLCDFGFARALRARPASPLTDYV-AT 164
Query: 132 PLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
Y APE+L Y + VD+W++G I+ ELL+G P F
Sbjct: 165 RWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-27
Identities = 55/153 (35%), Positives = 90/153 (58%), Gaps = 6/153 (3%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
P + +L FQ + ++ V+E+ GG+L I+ GR E A + ++ GL L+S
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVCGSPLYMAPEVLQFQ 143
II+RDLK +N++L D + +KIADFG+ C ++ G + CG+P Y+APE++ +Q
Sbjct: 121 GIIYRDLKLDNVML---DSEGHIKIADFGM-CKENMWDGVTTKTFCGTPDYIAPEIIAYQ 176
Query: 144 RYDEKVDMWSVGAILFELLNGYPPFSVGEEHQF 176
Y + VD W+ G +L+E+L G PF +E +
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-27
Identities = 55/159 (34%), Positives = 95/159 (59%), Gaps = 6/159 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRV-PEQTARKFLQ 73
E L+ + HPNI+ ++F+A+ +++V+E+C GG+L I+L G++ PE T ++
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSP 132
Q+ G++ ++ ++HRD+K +NI L+ + +K+ DFG + L PG YA G+P
Sbjct: 108 QMCLGVQHIHEKRVLHRDIKSKNIFLT---QNGKVKLGDFGSARLLTSPGAYACTYVGTP 164
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVG 171
Y+ PE+ + Y+ K D+WS+G IL+EL PF
Sbjct: 165 YYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-27
Identities = 64/179 (35%), Positives = 96/179 (53%), Gaps = 22/179 (12%)
Query: 3 KKLNKHLKSCLDCELNF-----LSSVN-HPNIIRL----FDAFQAENCIFLVVEFCAGGN 52
K + KH KS L+ N L ++ HPNI+RL FD + + LV E N
Sbjct: 30 KCMKKHFKS-LEQVNNLREIQALRRLSPHPNILRLIEVLFD--RKTGRLALVFEL-MDMN 85
Query: 53 LSSYIRLHGR-VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
L I+ R +PE+ + ++ QL L+ ++ + I HRD+KPENIL+ D +LK+A
Sbjct: 86 LYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI----KDDILKLA 141
Query: 112 DFGLSCTLYP-GNYAEKVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
DFG +Y Y E + + Y APE +L Y K+D+W+VG + FE+L+ +P F
Sbjct: 142 DFGSCRGIYSKPPYTEYI-STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLF 199
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-27
Identities = 64/195 (32%), Positives = 100/195 (51%), Gaps = 29/195 (14%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYI--- 57
+ L + KS L E+N + + H NI+R D F +A +++++EFC G+LS I
Sbjct: 49 RGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKC 108
Query: 58 -RLHGRVPEQTARKFLQQLGAGLEIL-------NSHHIIHRDLKPENILLS--------- 100
++ G++ E +QL L N ++HRDLKP+NI LS
Sbjct: 109 YKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168
Query: 101 -----GLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL--QFQRYDEKVDMWS 153
L+ + KI DFGLS + + A G+P Y +PE+L + + YD+K DMW+
Sbjct: 169 TAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWA 228
Query: 154 VGAILFELLNGYPPF 168
+G I++EL +G PF
Sbjct: 229 LGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-27
Identities = 52/181 (28%), Positives = 84/181 (46%), Gaps = 35/181 (19%)
Query: 20 LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQLGA 77
L++++HP + L+ +FQ E + LV+++C GG L ++ + E+ AR + ++
Sbjct: 55 LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL 114
Query: 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE----------- 126
LE L+ I++RDLKPENILL +ML +DF LS
Sbjct: 115 ALEYLHLLGIVYRDLKPENILLHE-SGHIML--SDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 127 ---------KVC----------GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167
G+ Y+APEV+ + VD W++G +L+E+L G P
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
Query: 168 F 168
F
Sbjct: 232 F 232
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-27
Identities = 53/173 (30%), Positives = 91/173 (52%), Gaps = 10/173 (5%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
K + + L E+ L + H NI++ + + + + +E+ GG++++ + +G
Sbjct: 43 KDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA 102
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP- 121
E R F++Q+ GL L++ IIHRD+K NIL +D+ +KI+DFG+S L
Sbjct: 103 FEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANIL---VDNKGGIKISDFGISKKLEAN 159
Query: 122 ------GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
+ GS +MAPEV++ Y K D+WS+G ++ E+L G PF
Sbjct: 160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 5e-27
Identities = 54/153 (35%), Positives = 89/153 (58%), Gaps = 6/153 (3%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
P + +L FQ + ++ V+E+ GG+L +I+ G+ E A + ++ GL L+
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVCGSPLYMAPEVLQFQ 143
II+RDLK +N++L D + +KIADFG+ C + G CG+P Y+APE++ +Q
Sbjct: 121 GIIYRDLKLDNVML---DSEGHIKIADFGM-CKEHMVDGVTTRTFCGTPDYIAPEIIAYQ 176
Query: 144 RYDEKVDMWSVGAILFELLNGYPPFSVGEEHQF 176
Y + VD W+ G +L+E+L G PPF +E +
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-27
Identities = 56/154 (36%), Positives = 81/154 (52%), Gaps = 7/154 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQ 74
EL+ L N P I+ + AF I + +E+ GG+L ++ GR+PE+ K
Sbjct: 49 ELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA 108
Query: 75 LGAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
+ GL L H IIHRD+KP NIL++ +K+ DFG+S L + A+ G+
Sbjct: 109 VLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ---IKLCDFGVSGQLV-NSLAKTFVGTSS 164
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFEL-LNGYP 166
YMAPE +Q Y K D+WS+G L EL +P
Sbjct: 165 YMAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-27
Identities = 59/171 (34%), Positives = 99/171 (57%), Gaps = 14/171 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI--RLHGRVP--EQTARKF 71
EL+ L++ +H I++ FD F++++ + L++E+ +GG+L+ I RL +P E
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILL--SGLDDDVMLKIADFGLSCTLYPG---NYAE 126
Q+ L+ ++S ++HRDLK NI L +G+ +K+ DFG S + A
Sbjct: 175 FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI-----IKLGDFGFSKQYSDSVSLDVAS 229
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 177
CG+P Y+APE+ + +RY +K DMWS+G IL+ELL + PF + + M
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIM 280
|
Length = 478 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 7e-27
Identities = 53/165 (32%), Positives = 92/165 (55%), Gaps = 9/165 (5%)
Query: 11 SCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
S L+CE+ L ++ H I++ + + AE + + +E+ GG++ ++ +G + E
Sbjct: 49 SALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVT 108
Query: 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----YPGNY 124
RK+ +Q+ G+ L+S+ I+HRD+K NIL D +K+ DFG S L G
Sbjct: 109 RKYTRQILEGMSYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICMSGTG 165
Query: 125 AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
V G+P +M+PEV+ + Y K D+WS+G + E+L PP++
Sbjct: 166 IRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWA 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 8e-27
Identities = 54/166 (32%), Positives = 94/166 (56%), Gaps = 10/166 (6%)
Query: 10 KSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----V 63
K+ DC E++ L +NHPN+I+ D+F +N + +V+E G+LS I+ + +
Sbjct: 44 KARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLI 103
Query: 64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
PE+T K+ QL + +E ++S ++HRD+KP N+ ++ ++K+ D GL
Sbjct: 104 PERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG---VVKLGDLGLGRFFSSKT 160
Query: 124 YA-EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
A + G+P YM+PE + Y+ K D+WS+G +L+E+ PF
Sbjct: 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 8e-27
Identities = 58/209 (27%), Positives = 106/209 (50%), Gaps = 49/209 (23%)
Query: 1 MLKKLN-KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
ML+K H+++ E + L+ ++P +++L+ +FQ EN ++L++E+ GG++ + +
Sbjct: 39 MLEKEQVAHVRA----ERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK 94
Query: 60 HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT- 118
E+ R ++ + ++ ++ IHRD+KP+N+L LD +K++DFGL CT
Sbjct: 95 KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLL---LDAKGHIKLSDFGL-CTG 150
Query: 119 --------LY-------PGNYAEKVC------------------------GSPLYMAPEV 139
Y P N+ + + G+P Y+APEV
Sbjct: 151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEV 210
Query: 140 LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
Y+++ D WS+G I++E+L GYPPF
Sbjct: 211 FLQTGYNKECDWWSLGVIMYEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 8e-27
Identities = 55/148 (37%), Positives = 88/148 (59%), Gaps = 11/148 (7%)
Query: 25 HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFLQQLGAGLEI 81
HPNI+ D++ + +++V+E+ AGG+L+ + Q A R+ LQ LE
Sbjct: 75 HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ----ALEF 130
Query: 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVL 140
L+S+ +IHRD+K +NILL G+D V K+ DFG + P + + G+P +MAPEV+
Sbjct: 131 LHSNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187
Query: 141 QFQRYDEKVDMWSVGAILFELLNGYPPF 168
+ Y KVD+WS+G + E++ G PP+
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 9e-27
Identities = 56/162 (34%), Positives = 84/162 (51%), Gaps = 16/162 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73
EL S P I++ + AF ++ + I + +E+C GG+L S ++ +V ++ R +
Sbjct: 49 ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS---IYKKVKKRGGRIGEK 105
Query: 74 QLG-------AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
LG GL L+S IIHRD+KP NIL L +K+ DFG+S L + A
Sbjct: 106 VLGKIAESVLKGLSYLHSRKIIHRDIKPSNIL---LTRKGQVKLCDFGVSGELV-NSLAG 161
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
G+ YMAPE +Q + Y D+WS+G L E+ PF
Sbjct: 162 TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-26
Identities = 54/166 (32%), Positives = 94/166 (56%), Gaps = 10/166 (6%)
Query: 10 KSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----V 63
K+ DC E++ L +NHPN+I+ + +F +N + +V+E G+LS I+ + +
Sbjct: 44 KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI 103
Query: 64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
PE+T K+ QL + LE ++S ++HRD+KP N+ ++ ++K+ D GL
Sbjct: 104 PEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG---VVKLGDLGLGRFFSSKT 160
Query: 124 YA-EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
A + G+P YM+PE + Y+ K D+WS+G +L+E+ PF
Sbjct: 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-26
Identities = 60/171 (35%), Positives = 88/171 (51%), Gaps = 20/171 (11%)
Query: 16 ELNFLSSV-NHPNIIRLFDAFQAENC------IFLVVEFCAGG---NLSSYIRLHG-RVP 64
E N L NHPNI + AF +N ++LV+E C GG +L +R G R+
Sbjct: 52 EYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLK 111
Query: 65 EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 124
E+ L++ GL L+ + +IHRD+K +NILL+ + +K+ DFG+S L
Sbjct: 112 EEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT---KNAEVKLVDFGVSAQLDSTLG 168
Query: 125 AEKVC-GSPLYMAPEVL----QFQR-YDEKVDMWSVGAILFELLNGYPPFS 169
G+P +MAPEV+ Q YD + D+WS+G EL +G PP
Sbjct: 169 RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-26
Identities = 57/159 (35%), Positives = 91/159 (57%), Gaps = 10/159 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPEQTARKFLQQ 74
E+ L++ NHP I++L AF + +++++EFC GG + + + L + E + +Q
Sbjct: 59 EIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQ 118
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSPL 133
+ L+ L+S IIHRDLK N+LL+ LD D+ K+ADFG+S + + G+P
Sbjct: 119 MLEALQYLHSMKIIHRDLKAGNVLLT-LDGDI--KLADFGVSAKNVKTLQRRDSFIGTPY 175
Query: 134 YMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPP 167
+MAPEV+ + YD K D+WS+G L E+ PP
Sbjct: 176 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-26
Identities = 54/159 (33%), Positives = 81/159 (50%), Gaps = 5/159 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
EL + P I+ + AF EN I + +EF G+L + G +P + K +
Sbjct: 53 ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAV 112
Query: 76 GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
GL L N H I+HRD+KP NIL++ +K+ DFG+S L + A+ G+ Y
Sbjct: 113 VEGLTYLYNVHRIMHRDIKPSNILVNSRGQ---IKLCDFGVSGELI-NSIADTFVGTSTY 168
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 173
M+PE +Q +Y K D+WS+G + EL G PF+
Sbjct: 169 MSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-26
Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 53/206 (25%)
Query: 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQT 67
H+K+ E + L+ ++ +++L+ +FQ ++ ++ V+++ GG++ S + G E
Sbjct: 47 HVKA----ERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL 102
Query: 68 ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY------- 120
AR ++ +L +E ++ IHRD+KP+NIL +D D +K+ DFGL CT +
Sbjct: 103 ARFYIAELTCAIESVHKMGFIHRDIKPDNIL---IDRDGHIKLTDFGL-CTGFRWTHDSK 158
Query: 121 ---PGNY-----------------------------------AEKVCGSPLYMAPEVLQF 142
G++ A + G+P Y+APEVL
Sbjct: 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR 218
Query: 143 QRYDEKVDMWSVGAILFELLNGYPPF 168
Y + D WSVG IL+E+L G PPF
Sbjct: 219 TGYTQLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-26
Identities = 58/164 (35%), Positives = 92/164 (56%), Gaps = 20/164 (12%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNL----SSYIRLHGRVPEQTARKF 71
E + ++ N I++L AFQ + +++V+E+ GG+L S+Y +PE+ AR +
Sbjct: 93 ERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-----DIPEKWARFY 147
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKV 128
++ L+ ++S IHRD+KP+N+L LD LK+ADFG +C N +
Sbjct: 148 TAEVVLALDAIHSMGFIHRDVKPDNML---LDKSGHLKLADFG-TCMKMDANGMVRCDTA 203
Query: 129 CGSPLYMAPEVLQFQR----YDEKVDMWSVGAILFELLNGYPPF 168
G+P Y++PEVL+ Q Y + D WSVG L+E+L G PF
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 4e-26
Identities = 53/155 (34%), Positives = 84/155 (54%), Gaps = 6/155 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E L + HP + L +FQ + + V+E+ GG L ++ E AR + ++
Sbjct: 45 ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 104
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPL 133
+ L L+S +++RDLK EN++ LD D +KI DFGL C + G + CG+P
Sbjct: 105 VSALGYLHSCDVVYRDLKLENLM---LDKDGHIKITDFGL-CKEGISDGATMKTFCGTPE 160
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
Y+APEVL+ Y VD W +G +++E++ G PF
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 5e-26
Identities = 54/160 (33%), Positives = 93/160 (58%), Gaps = 17/160 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQ 74
E+ + HPNI+ ++ ++ + +++V+EF GG L+ I H R+ E Q A L
Sbjct: 66 EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAV 124
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV------ 128
L A L L++ +IHRD+K ++ILL+ D +K++DFG C +++V
Sbjct: 125 LKA-LSFLHAQGVIHRDIKSDSILLT---SDGRVKLSDFGF-C----AQVSKEVPRRKSL 175
Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
G+P +MAPEV+ Y +VD+WS+G ++ E+++G PP+
Sbjct: 176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 6e-26
Identities = 54/165 (32%), Positives = 84/165 (50%), Gaps = 27/165 (16%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQ 74
E+ L + H NI+RL+D ++ + LV E+C +L Y +G + + + F+ Q
Sbjct: 49 EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQ 107
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
L GL +SH+++HRDLKP+N+L++ + LK+ADFGL+ + G P+
Sbjct: 108 LLKGLAFCHSHNVLHRDLKPQNLLINKNGE---LKLADFGLA----------RAFGIPVR 154
Query: 134 ----------YMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPP 167
Y P+VL + Y +DMWS G I EL N P
Sbjct: 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 8e-26
Identities = 57/154 (37%), Positives = 88/154 (57%), Gaps = 4/154 (2%)
Query: 24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
HP + L+ FQ + +F V+E+ GG+L +I+ + A + ++ GL+ L+
Sbjct: 54 EHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH 113
Query: 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQF 142
S I++RDLK +NILL D D +KIADFG+ G+ CG+P Y+APE+L
Sbjct: 114 SKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG 170
Query: 143 QRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQF 176
Q+Y+ VD WS G +L+E+L G PF +E +
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 1e-25
Identities = 51/151 (33%), Positives = 81/151 (53%), Gaps = 9/151 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----VPEQTARKF 71
E LS ++HP I++ +F + ++ E+C G +L + + E ++
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCG 130
QL G+ ++ I+HRDLK +NI L + +LKI DFG+S L + A G
Sbjct: 112 FIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVSRLLMGSCDLATTFTG 167
Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161
+P YM+PE L+ Q YD K D+WS+G IL+E+
Sbjct: 168 TPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 2e-25
Identities = 51/163 (31%), Positives = 91/163 (55%), Gaps = 9/163 (5%)
Query: 13 LDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
L+CE+ L ++ H I++ + + E + + VE+ GG++ ++ +G + E R+
Sbjct: 51 LECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRR 110
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS---CTLY-PGNYAE 126
+ +Q+ G+ L+S+ I+HRD+K NIL D +K+ DFG S T+ G +
Sbjct: 111 YTRQILQGVSYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRIQTICMSGTGIK 167
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
V G+P +M+PEV+ + Y K D+WSV + E+L PP++
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWA 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 3e-25
Identities = 53/167 (31%), Positives = 85/167 (50%), Gaps = 18/167 (10%)
Query: 16 ELNFLSSVNH-PNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGR-----VP 64
E++ L ++ I+RL D E ++LV E+ +L ++ +GR +P
Sbjct: 50 EISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLP 108
Query: 65 EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS--CTLYPG 122
+T + F+ QL G+ + H ++HRDLKP+N+L+ +LKIAD GL ++
Sbjct: 109 AKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLGLGRAFSIPVK 166
Query: 123 NYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPF 168
+Y ++ + Y APEVL Y VD+WSVG I E+ P F
Sbjct: 167 SYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF 212
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 3e-25
Identities = 50/161 (31%), Positives = 89/161 (55%), Gaps = 10/161 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E++ L S+ H NI++ +N I + +EF GG++SS + G +PE K+ +Q+
Sbjct: 52 EVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI 111
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG-------LSCTLYPGNYAEKV 128
G+ L+++ ++HRD+K N++L + ++K+ DFG + N + +
Sbjct: 112 LDGVAYLHNNCVVHRDIKGNNVMLM---PNGIIKLIDFGCARRLAWVGLHGTHSNMLKSM 168
Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
G+P +MAPEV+ Y K D+WS+G +FE+ G PP +
Sbjct: 169 HGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLA 209
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 3e-25
Identities = 52/174 (29%), Positives = 87/174 (50%), Gaps = 20/174 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGR-----VPEQTA 68
E+ L + H N++ L + F A+ ++L+ ++ A +L I+ H + +P
Sbjct: 52 EIALLRELKHENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMV 110
Query: 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGL-DDDVMLKIADFGLS-------CTLY 120
+ L Q+ G+ L+S+ ++HRDLKP NIL+ G + ++KI D GL+ L
Sbjct: 111 KSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170
Query: 121 PGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSVGEE 173
+ V + Y APE+L R Y + +D+W++G I ELL P F E
Sbjct: 171 DLD---PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 4e-25
Identities = 51/165 (30%), Positives = 92/165 (55%), Gaps = 9/165 (5%)
Query: 11 SCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
+ L+CE+ L ++ H I++ + + E + + +E GG++ ++ +G + E
Sbjct: 49 NALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVT 108
Query: 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----YPGNY 124
RK+ +Q+ G+ L+S+ I+HRD+K NIL + + +K+ DFG S L G
Sbjct: 109 RKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN---VKLGDFGASKRLQTICLSGTG 165
Query: 125 AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
+ V G+P +M+PEV+ + Y K D+WSVG + E+L PP++
Sbjct: 166 MKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWA 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 5e-25
Identities = 53/155 (34%), Positives = 85/155 (54%), Gaps = 5/155 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
E L VN ++ L A++ ++ + LV+ GG+L +I G E+ A +
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA 109
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
++ GLE L+ I++RDLKPENILL DD ++I+D GL+ + G G+
Sbjct: 110 EITCGLEDLHRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGETIRGRVGTVG 166
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
YMAPEV++ +RY D W +G +++E++ G PF
Sbjct: 167 YMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 6e-25
Identities = 53/166 (31%), Positives = 77/166 (46%), Gaps = 32/166 (19%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENC----IFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
EL L H NII + D + +++V++ +L I + E+ R F
Sbjct: 54 ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDL-MESDLHHIIHSDQPLTEEHIRYF 112
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
L QL GL+ ++S ++IHRDLKP N+L++ D L+I DFG+ A + S
Sbjct: 113 LYQLLRGLKYIHSANVIHRDLKPSNLLVNE---DCELRIGDFGM---------ARGLSSS 160
Query: 132 PL--------------YMAPEVL-QFQRYDEKVDMWSVGAILFELL 162
P Y APE+L Y +DMWSVG I E+L
Sbjct: 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 6e-25
Identities = 52/159 (32%), Positives = 81/159 (50%), Gaps = 9/159 (5%)
Query: 16 ELNFL-SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNL----SSYIRLHGRVPEQTARK 70
E+ + + HPNI+R + F + +++V++ G L +S R E+
Sbjct: 58 EVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117
Query: 71 FLQQLGAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
Q+ L L+ I+HRDL P NI+L G DD V I DFGL+ P + V
Sbjct: 118 IFVQMVLALRYLHKEKRIVHRDLTPNNIML-GEDDKVT--ITDFGLAKQKQPESKLTSVV 174
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
G+ LY PE+++ + Y EK D+W+ G IL+++ PPF
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 7e-25
Identities = 60/165 (36%), Positives = 87/165 (52%), Gaps = 27/165 (16%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ FL + HPN I + E+ +LV+E+C G + S + +H +K LQ++
Sbjct: 65 EVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILEVH--------KKPLQEV 115
Query: 76 -------GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
GA GL L+SH IHRD+K NILL+ + +K+ADFG + + P N
Sbjct: 116 EIAAICHGALQGLAYLHSHERIHRDIKAGNILLT---EPGTVKLADFGSASLVSPAN--- 169
Query: 127 KVCGSPLYMAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPPF 168
G+P +MAPEV+ +YD KVD+WS+G EL PP
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 1e-24
Identities = 62/165 (37%), Positives = 89/165 (53%), Gaps = 12/165 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
EL L + H NII L D F I+ V E G +L + + +Q + FL Q
Sbjct: 59 ELKLLKHLRHENIISLSDIFISPLEDIYFVTEL-LGTDLHRLLT-SRPLEKQFIQYFLYQ 116
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
+ GL+ ++S ++HRDLKP NIL+ +++ LKI DFGL+ P + Y
Sbjct: 117 ILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARIQDP--QMTGYVSTRYY 171
Query: 135 MAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH--QF 176
APE+ L +Q+YD +VD+WS G I E+L G P F G++H QF
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFP-GKDHVNQF 215
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 1e-24
Identities = 57/169 (33%), Positives = 92/169 (54%), Gaps = 21/169 (12%)
Query: 16 ELNFLSSVNHPNIIRLFDAF----QAENC--IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
EL L ++H N+I L D F E+ ++LV G +L++ ++ ++ + +
Sbjct: 64 ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHL-MGADLNNIVK-CQKLSDDHIQ 121
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
+ Q+ GL+ ++S IIHRDLKP NI +++D LKI DFGL+ +++
Sbjct: 122 FLVYQILRGLKYIHSAGIIHRDLKPSNI---AVNEDCELKILDFGLARHT-----DDEMT 173
Query: 130 G---SPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 174
G + Y APE+ L + Y++ VD+WSVG I+ ELL G F G +H
Sbjct: 174 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP-GSDH 221
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 2e-24
Identities = 55/157 (35%), Positives = 91/157 (57%), Gaps = 11/157 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
E+ + + +PNI+ D+F + +F+V+E+ AGG+L+ + Q A R+ L
Sbjct: 66 EILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL 125
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGS 131
Q LE L+++ +IHRD+K +N+LL G+D V K+ DFG + P + G+
Sbjct: 126 Q----ALEFLHANQVIHRDIKSDNVLL-GMDGSV--KLTDFGFCAQITPEQSKRSTMVGT 178
Query: 132 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
P +MAPEV+ + Y KVD+WS+G + E++ G PP+
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 95.6 bits (237), Expect = 3e-24
Identities = 55/157 (35%), Positives = 91/157 (57%), Gaps = 11/157 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
E+ + +PNI+ D++ + +++V+E+ AGG+L+ + Q A R+ L
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 126
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGS 131
Q LE L+S+ +IHRD+K +NILL G+D V K+ DFG + P + + G+
Sbjct: 127 Q----ALEFLHSNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSTMVGT 179
Query: 132 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
P +MAPEV+ + Y KVD+WS+G + E++ G PP+
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-24
Identities = 56/159 (35%), Positives = 93/159 (58%), Gaps = 10/159 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E + ++ N P +++LF AFQ + +++V+E+ GG+L + + + VPE+ A+ + ++
Sbjct: 93 ERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEV 151
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPL 133
L+ ++S +IHRD+KP+N+L LD LK+ADFG + + G+P
Sbjct: 152 VLALDAIHSMGLIHRDVKPDNML---LDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPD 208
Query: 134 YMAPEVLQFQ----RYDEKVDMWSVGAILFELLNGYPPF 168
Y++PEVL+ Q Y + D WSVG LFE+L G PF
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 3e-24
Identities = 54/155 (34%), Positives = 86/155 (55%), Gaps = 5/155 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
E L VN ++ L A++ ++ + LV+ GG+L +I G E A +
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
++ GLE L+ I++RDLKPENILL DD ++I+D GL+ + G + G+
Sbjct: 110 EICCGLEDLHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVG 166
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
YMAPEV++ +RY D W++G +L+E++ G PF
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 3e-24
Identities = 46/167 (27%), Positives = 92/167 (55%), Gaps = 9/167 (5%)
Query: 16 ELNFLSSVNH---PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
E+ LS + PNI + + ++ +++++E+ GG++ + ++ G + E+ +
Sbjct: 49 EVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVII 107
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGS 131
+++ L+ ++ +IHRD+K NIL++ +V L DFG++ L + G+
Sbjct: 108 REVLVALKYIHKVGVIHRDIKAANILVT-NTGNVKL--CDFGVAALLNQNSSKRSTFVGT 164
Query: 132 PLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 177
P +MAPEV+ + YD K D+WS+G ++E+ G PP+S + + M
Sbjct: 165 PYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM 211
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 4e-24
Identities = 59/158 (37%), Positives = 89/158 (56%), Gaps = 8/158 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI----RLHGRVPEQTARKF 71
E L+ V+ I+ L AFQ + + LV+ GG+L +I + PE A +
Sbjct: 43 EKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFY 102
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCG 130
Q+ +GLE L+ II+RDLKPEN+LL D+D ++I+D GL+ L G K G
Sbjct: 103 TAQIISGLEHLHQRRIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKGYAG 159
Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
+P +MAPE+LQ + YD VD +++G L+E++ PF
Sbjct: 160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 4e-24
Identities = 54/155 (34%), Positives = 86/155 (55%), Gaps = 6/155 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E L + HP + L AFQ + + V+E+ GG L ++ E+ AR + ++
Sbjct: 45 ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI 104
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPL 133
+ LE L+S +++RD+K EN++L D D +KI DFGL C + G + CG+P
Sbjct: 105 VSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGL-CKEGISDGATMKTFCGTPE 160
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
Y+APEVL+ Y VD W +G +++E++ G PF
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 5e-24
Identities = 55/160 (34%), Positives = 86/160 (53%), Gaps = 5/160 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
E L VN ++ L A++ ++ + LV+ GG+L +I G E+ A +
Sbjct: 50 EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
++ GLE L+ + ++RDLKPENILL DD ++I+D GL+ + G G+
Sbjct: 110 EILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVG 166
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 173
YMAPEVL QRY D W +G +++E++ G PF +E
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 5e-24
Identities = 47/161 (29%), Positives = 93/161 (57%), Gaps = 10/161 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----VPEQTARKF 71
E+ LS++ HPNI++ ++F+ +++V+++C GG+L Y +++ + PE +
Sbjct: 49 EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDL--YKKINAQRGVLFPEDQILDW 106
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC-G 130
Q+ L+ ++ I+HRD+K +NI L+ D +K+ DFG++ L + C G
Sbjct: 107 FVQICLALKHVHDRKILHRDIKSQNIFLT---KDGTIKLGDFGIARVLNSTVELARTCIG 163
Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVG 171
+P Y++PE+ + + Y+ K D+W++G +L+E+ F G
Sbjct: 164 TPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 5e-24
Identities = 61/159 (38%), Positives = 86/159 (54%), Gaps = 11/159 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFL 72
E+ L ++ HPNI+ L + + + IFLV+E+C +L+S + + E + +
Sbjct: 56 EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLM 114
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCG 130
QL GL+ L+ + IIHRDLK N+LL+ D LKIADFGL+ T L KV
Sbjct: 115 LQLLRGLQYLHENFIIHRDLKVSNLLLT---DKGCLKIADFGLARTYGLPAKPMTPKVV- 170
Query: 131 SPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
+ Y APE+L Y +DMW+VG IL ELL P
Sbjct: 171 TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLL 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 8e-24
Identities = 52/155 (33%), Positives = 84/155 (54%), Gaps = 5/155 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ LS + P I R + ++ +++++E+ GG+ ++ G + E L+++
Sbjct: 52 EITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK-PGPLEETYIATILREI 110
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 134
GL+ L+S IHRD+K N+LLS D +K+ADFG++ L G+P +
Sbjct: 111 LKGLDYLHSERKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTPFW 167
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
MAPEV++ YD K D+WS+G EL G PP S
Sbjct: 168 MAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 1e-23
Identities = 51/172 (29%), Positives = 98/172 (56%), Gaps = 16/172 (9%)
Query: 1 MLKKLN-----KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLS 54
++KKLN + + + E LS + HPNI+ ++++ E+ +++V+ FC GG+L
Sbjct: 29 VIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDL- 87
Query: 55 SYIRLHGR----VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
Y +L + +PE ++ Q+ L+ L+ HI+HRDLK +N+ L+ + ++K+
Sbjct: 88 -YHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN---IIKV 143
Query: 111 ADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161
D G++ L A + G+P YM+PE+ + Y+ K D+W++G ++E+
Sbjct: 144 GDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-23
Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 53/213 (24%)
Query: 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
LN++ + + E + L+ ++ +++L+ +FQ ++ ++ V+++ GG++ S + P
Sbjct: 40 LNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFP 99
Query: 65 EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT------ 118
E AR ++ +L +E ++ IHRD+KP+NIL +D D +K+ DFGL CT
Sbjct: 100 EVLARFYIAELTLAIESVHKMGFIHRDIKPDNIL---IDLDGHIKLTDFGL-CTGFRWTH 155
Query: 119 ---------------LYPGNY----------------------------AEKVCGSPLYM 135
+ P + A + G+P Y+
Sbjct: 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYI 215
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
APEVL + Y + D WSVG ILFE+L G PPF
Sbjct: 216 APEVLLRKGYTQLCDWWSVGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-23
Identities = 56/159 (35%), Positives = 92/159 (57%), Gaps = 10/159 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E + ++ N P +++LF AFQ + +++V+E+ GG+L + + + VPE+ AR + ++
Sbjct: 93 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEV 151
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPL 133
L+ ++S IHRD+KP+N+L LD LK+ADFG + + G+P
Sbjct: 152 VLALDAIHSMGFIHRDVKPDNML---LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 208
Query: 134 YMAPEVLQFQ----RYDEKVDMWSVGAILFELLNGYPPF 168
Y++PEVL+ Q Y + D WSVG L+E+L G PF
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-23
Identities = 60/166 (36%), Positives = 89/166 (53%), Gaps = 7/166 (4%)
Query: 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
N+ +K EL L ++ NI+ L +AF+ ++LV E+ L + VP
Sbjct: 40 NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP 99
Query: 66 QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--- 122
+ R ++ QL + + + I+HRD+KPEN+L+S D +LK+ DFG + L G
Sbjct: 100 EKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND---VLKLCDFGFARNLSEGSNA 156
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
NY E V + Y +PE+L Y + VDMWSVG IL EL +G P F
Sbjct: 157 NYTEYV-ATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-23
Identities = 53/161 (32%), Positives = 85/161 (52%), Gaps = 28/161 (17%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
E++ L +NHPNI++L D EN ++LV EF +L ++ +P + +L
Sbjct: 49 EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLF 107
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
QL GL +SH ++HRDLKP+N+L ++ + +K+ADFGL+ + G P+
Sbjct: 108 QLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLA----------RAFGVPV 154
Query: 134 -----------YMAPEVLQFQR-YDEKVDMWSVGAILFELL 162
Y APE+L + Y VD+WS+G I E++
Sbjct: 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 2e-23
Identities = 54/157 (34%), Positives = 90/157 (57%), Gaps = 11/157 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
E+ + +PNI+ D++ + +++V+E+ AGG+L+ + Q A R+ L
Sbjct: 66 EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 125
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGS 131
Q L+ L+S+ +IHRD+K +NILL G+D V K+ DFG + P + G+
Sbjct: 126 Q----ALDFLHSNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSTMVGT 178
Query: 132 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
P +MAPEV+ + Y KVD+WS+G + E++ G PP+
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 2e-23
Identities = 64/191 (33%), Positives = 92/191 (48%), Gaps = 30/191 (15%)
Query: 1 MLKKLNKHLKSCLD--CELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
MLK + K D E+ + + H NII L E +++VVE+ A GNL ++
Sbjct: 49 MLKD-DATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL 107
Query: 58 RLHGRVPEQTARK-----------------FLQQLGAGLEILNSHHIIHRDLKPENILLS 100
R R P + A F Q+ G+E L S IHRDL N+L++
Sbjct: 108 RAR-RPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166
Query: 101 GLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAI 157
+D VM KIADFGL+ ++ +Y K L +MAPE L + Y + D+WS G +
Sbjct: 167 --EDHVM-KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 223
Query: 158 LFEL--LNGYP 166
L+E+ L G P
Sbjct: 224 LWEIFTLGGSP 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 2e-23
Identities = 47/159 (29%), Positives = 79/159 (49%), Gaps = 21/159 (13%)
Query: 24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
++PN I+L+ + L++++ G+L ++ G++ E +K ++QL L L+
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH 126
Query: 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-------YMA 136
H+IIH D+K EN+L D + + D+GL K+ G+P Y +
Sbjct: 127 KHNIIHNDIKLENVLYDRAKDRI--YLCDYGLC----------KIIGTPSCYDGTLDYFS 174
Query: 137 PEVLQFQRYDEKVDMWSVGAILFELLNGYPPF--SVGEE 173
PE ++ YD D W+VG + +ELL G PF EE
Sbjct: 175 PEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213
|
Length = 267 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 3e-23
Identities = 57/173 (32%), Positives = 99/173 (57%), Gaps = 13/173 (7%)
Query: 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRV 63
L + +C E + L + ++ I L AFQ EN ++LV+++ GG+L + + + R+
Sbjct: 40 LKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL 99
Query: 64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYP 121
PE AR +L ++ ++ ++ H +HRD+KP+NIL +D + +++ADFG SC +
Sbjct: 100 PEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL---MDMNGHIRLADFG-SCLKLMED 155
Query: 122 GNYAEKVC-GSPLYMAPEVLQFQ-----RYDEKVDMWSVGAILFELLNGYPPF 168
G V G+P Y++PE+LQ +Y + D WS+G ++E+L G PF
Sbjct: 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 3e-23
Identities = 58/158 (36%), Positives = 80/158 (50%), Gaps = 18/158 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRL---HGRVPEQ 66
EL + VNH NII L + F + ++LV+E NL I++ H R+
Sbjct: 65 ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMEL-MDANLCQVIQMDLDHERM--- 120
Query: 67 TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
L Q+ G++ L+S IIHRDLKP NI++ D LKI DFGL+ T
Sbjct: 121 --SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTAGTSFMMT 175
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164
+ Y APEV+ Y E VD+WSVG I+ E++ G
Sbjct: 176 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 4e-23
Identities = 52/168 (30%), Positives = 85/168 (50%), Gaps = 29/168 (17%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY---IRLHGRVPEQTARKFL 72
E++ L + HPNI+ L D E+ ++L+ EF + +L Y + + + + +L
Sbjct: 49 EISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYL 107
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
Q+ G+ +S ++HRDLKP+N+L +D+ ++K+ADFGL+ + G P
Sbjct: 108 YQILQGILFCHSRRVLHRDLKPQNLL---IDNKGVIKLADFGLA----------RAFGIP 154
Query: 133 L-----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
+ Y APEVL RY VD+WS+G I E+ P F
Sbjct: 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 4e-23
Identities = 56/169 (33%), Positives = 90/169 (53%), Gaps = 12/169 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQ 74
E + LS N P I +L AFQ ++ ++LV+E+ GG+L S + R + E A+ +L +
Sbjct: 51 ERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAE 110
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSP 132
L + ++ +HRD+KPEN+L +D +K+ADFG + L ++ G+P
Sbjct: 111 LVLAIHSVHQMGYVHRDIKPENVL---IDRTGHIKLADFGSAARLTANKMVNSKLPVGTP 167
Query: 133 LYMAPEVLQFQR------YDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 175
Y+APEVL Y + D WS+G I +E++ G PF G +
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK 216
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 6e-23
Identities = 60/160 (37%), Positives = 84/160 (52%), Gaps = 13/160 (8%)
Query: 17 LNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTAR 69
L L + HPN++RLFD E + LV E +L++Y+ VP +T +
Sbjct: 55 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTETIK 113
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
+ QL GL+ L+SH ++HRDLKP+NIL++ +K+ADFGL+ +Y A
Sbjct: 114 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLA-RIYSFQMALTSV 169
Query: 130 GSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
L Y APEVL Y VD+WSVG I E+ P F
Sbjct: 170 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 6e-23
Identities = 54/155 (34%), Positives = 83/155 (53%), Gaps = 5/155 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
E L VN ++ L A++ ++ + LV+ GG+L +I G EQ A +
Sbjct: 50 EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAA 109
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
+L GLE L I++RDLKPENILL DD ++I+D GL+ + G G+
Sbjct: 110 ELCCGLEDLQRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPEGETVRGRVGTVG 166
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
YMAPEV+ ++Y D W +G +++E++ G PF
Sbjct: 167 YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 6e-23
Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 57/217 (26%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+L+ H+K+ E + L+ ++ ++RL+ +FQ ++ ++ V+++ GG++ S +
Sbjct: 40 LLRNQVAHVKA----ERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM 95
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
G PE AR ++ +L +E ++ IHRD+KP+NIL +D D +K+ DFGL CT +
Sbjct: 96 GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNIL---IDRDGHIKLTDFGL-CTGF 151
Query: 121 ----------------------------PGN---------------------YAEKVCGS 131
P N A + G+
Sbjct: 152 RWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGT 211
Query: 132 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
P Y+APEVL Y + D WSVG IL+E+L G PPF
Sbjct: 212 PNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 6e-23
Identities = 52/155 (33%), Positives = 83/155 (53%), Gaps = 5/155 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ LS + P + + + ++ +++++E+ GG+ +R G E L+++
Sbjct: 52 EITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEI 110
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKVCGSPLY 134
GL+ L+S IHRD+K N+LLS D +K+ADFG++ L G+P +
Sbjct: 111 LKGLDYLHSEKKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTPFW 167
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
MAPEV+Q YD K D+WS+G EL G PP S
Sbjct: 168 MAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 7e-23
Identities = 58/165 (35%), Positives = 90/165 (54%), Gaps = 5/165 (3%)
Query: 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
+K +K E+ L + H N++ L + F+ + ++LV EF L + + E
Sbjct: 40 DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDE 99
Query: 66 QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNY 124
RK+L Q+ G+E +SH+IIHRD+KPENIL+S ++K+ DFG + TL PG
Sbjct: 100 SRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEV 156
Query: 125 AEKVCGSPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
+ Y APE+L +Y VD+W+VG ++ E+L G P F
Sbjct: 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 8e-23
Identities = 56/166 (33%), Positives = 90/166 (54%), Gaps = 8/166 (4%)
Query: 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQT 67
LK+ E L +HPNI+RL + I++V+E GG+ +++R G R+ +
Sbjct: 36 LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKE 95
Query: 68 ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 127
+ ++ AG+E L S H IHRDL N L++ + +LKI+DFG+S G YA
Sbjct: 96 LIQMVENAAAGMEYLESKHCIHRDLAARNCLVT---EKNVLKISDFGMSREEEDGVYAST 152
Query: 128 --VCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFS 169
+ P+ + APE L + RY + D+WS G +L+E + G P++
Sbjct: 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYA 198
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 8e-23
Identities = 55/164 (33%), Positives = 81/164 (49%), Gaps = 15/164 (9%)
Query: 16 ELNFLSSV-NHPNIIRLFDA----FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
EL L H NI L+D N ++L E +L IR + + +
Sbjct: 51 ELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQS 109
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-----NYA 125
F+ Q+ GL+ ++S +++HRDLKP N+L++ D LKI DFGL+ +
Sbjct: 110 FIYQILCGLKYIHSANVLHRDLKPGNLLVNA---DCELKICDFGLARGFSENPGENAGFM 166
Query: 126 EKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
+ + Y APE+ L FQ Y + +D+WSVG IL ELL P F
Sbjct: 167 TEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF 210
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 1e-22
Identities = 49/167 (29%), Positives = 87/167 (52%), Gaps = 16/167 (9%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
LK + ++ L E + ++++ HPN+++L N +++V E+ A G+L Y+R
Sbjct: 36 CLKDDSTAAQAFLA-EASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSR 94
Query: 61 GR--VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL--- 115
GR + F + G+E L + +HRDL N+L+S +D++ K++DFGL
Sbjct: 95 GRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS---EDLVAKVSDFGLAKE 151
Query: 116 -SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161
S G K + APE L+ +++ K D+WS G +L+E+
Sbjct: 152 ASQGQDSGKLPVK------WTAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 2e-22
Identities = 59/158 (37%), Positives = 85/158 (53%), Gaps = 13/158 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ FL + HPN I + E+ +LV+E+C G + S + +H + P Q
Sbjct: 75 EVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKK-PLQEVEIAAITH 132
Query: 76 GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
GA GL L+SH++IHRD+K NILL+ + +K+ADFG + P N G+P
Sbjct: 133 GALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASIASPAN---SFVGTPY 186
Query: 134 YMAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPPF 168
+MAPEV+ +YD KVD+WS+G EL PP
Sbjct: 187 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-22
Identities = 53/154 (34%), Positives = 89/154 (57%), Gaps = 8/154 (5%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
P ++ L AFQ + + L++++ GG L +++ R EQ + + ++ LE L+
Sbjct: 65 PFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL 124
Query: 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQ 143
II+RD+K ENIL LD + + + DFGLS + A CG+ YMAP++++
Sbjct: 125 GIIYRDIKLENIL---LDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGG 181
Query: 144 R--YDEKVDMWSVGAILFELLNGYPPFSV-GEEH 174
+D+ VD WS+G +++ELL G PF+V GE++
Sbjct: 182 DGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-22
Identities = 59/177 (33%), Positives = 98/177 (55%), Gaps = 16/177 (9%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RL 59
MLK+ +C E N L + + I L AFQ EN ++LV+++ GG+L + + +
Sbjct: 39 MLKRAET---ACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKF 95
Query: 60 HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-- 117
R+PE AR ++ ++ + ++ H +HRD+KP+N+L LD + +++ADFG SC
Sbjct: 96 EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVL---LDMNGHIRLADFG-SCLK 151
Query: 118 TLYPGNYAEKVC-GSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFELLNGYPPF 168
G V G+P Y++PE+LQ +Y + D WS+G ++E+L G PF
Sbjct: 152 MNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 3e-22
Identities = 59/158 (37%), Positives = 85/158 (53%), Gaps = 13/158 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ FL + HPN I + E+ +LV+E+C G + S + +H + P Q
Sbjct: 71 EVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLG-SASDLLEVHKK-PLQEVEIAAITH 128
Query: 76 GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
GA GL L+SH++IHRD+K NILL+ + +K+ADFG + P N G+P
Sbjct: 129 GALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASKSSPAN---SFVGTPY 182
Query: 134 YMAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPPF 168
+MAPEV+ +YD KVD+WS+G EL PP
Sbjct: 183 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 3e-22
Identities = 53/162 (32%), Positives = 88/162 (54%), Gaps = 7/162 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E L + HP + L +FQ ++ + V+E+ GG L ++ E R + ++
Sbjct: 45 ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEI 104
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPL 133
+ L+ L+S I++RDLK EN++L D D +KI DFGL C + + CG+P
Sbjct: 105 VSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGL-CKEGITDAATMKTFCGTPE 160
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 175
Y+APEVL+ Y VD W +G +++E++ G PF ++H+
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 3e-22
Identities = 60/224 (26%), Positives = 101/224 (45%), Gaps = 56/224 (25%)
Query: 1 MLKKLN-KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
M KK H+K+ E + L+ + P ++ L+ +FQ ++L++EF GG+L + +
Sbjct: 39 MFKKDQLAHVKA----ERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK 94
Query: 60 HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
+ E R ++ + +E ++ IHRD+KP+NIL +D +K++DFGLS
Sbjct: 95 YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNIL---IDRGGHIKLSDFGLSTGF 151
Query: 120 YP---GNYAEKV---------------------------------------------CGS 131
+ Y +K+ G+
Sbjct: 152 HKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGT 211
Query: 132 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 175
P Y+APE+ Q Y ++ D WS+GAI+FE L G+PPF H+
Sbjct: 212 PDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHE 255
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 4e-22
Identities = 55/170 (32%), Positives = 82/170 (48%), Gaps = 13/170 (7%)
Query: 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLHGRVP-E 65
H ++ E + + HPNI+ L D+ +A +F V E+ G L + G +P
Sbjct: 20 HQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAG 79
Query: 66 QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--- 122
+T R LQ L A L ++ I+HRDLKP+NI++S K+ DFG+ TL PG
Sbjct: 80 ETGRLMLQVLDA-LACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIG-TLLPGVRD 137
Query: 123 ------NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166
+V G+P Y APE L+ + D+++ G I E L G
Sbjct: 138 ADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-22
Identities = 54/169 (31%), Positives = 80/169 (47%), Gaps = 20/169 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
EL ++ + H NI+ L D + + I LV++ A +L + R+ E + L Q+
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQI 128
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS----CTLYPGNYAEKVCGS 131
GL +L+ + +HRDL P NI + + + KIADFGL+ Y ++
Sbjct: 129 LNGLNVLHKWYFMHRDLSPANIFI---NSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 132 P-----------LYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPF 168
Y APE+L ++Y VDMWSVG I ELL G P F
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF 234
|
Length = 335 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 4e-22
Identities = 50/158 (31%), Positives = 81/158 (51%), Gaps = 9/158 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E + ++ ++HP I+RL + E + LV+E G L Y++ +P ++ Q+
Sbjct: 46 EASVMAQLDHPCIVRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV 104
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGS-P 132
G+ L S H +HRDL N+LL + KI+DFG+S L G+ Y G P
Sbjct: 105 AMGMAYLESKHFVHRDLAARNVLLV---NRHQAKISDFGMSRALGAGSDYYRATTAGRWP 161
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
L + APE + + ++ K D+WS G L+E + G P+
Sbjct: 162 LKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-22
Identities = 52/182 (28%), Positives = 96/182 (52%), Gaps = 25/182 (13%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAE--------------NCIFLVVEFCAGGNLSSYIRLHG 61
E+ + ++H NI+++++ N +++V E +L++ + G
Sbjct: 52 EIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQE-YMETDLANVLE-QG 109
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
+ E+ AR F+ QL GL+ ++S +++HRDLKP N+ ++ +D++LKI DFGL+ + P
Sbjct: 110 PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN--TEDLVLKIGDFGLARIVDP 167
Query: 122 -----GNYAEKVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 175
G +E + + Y +P +L Y + +DMW+ G I E+L G P F+ E +
Sbjct: 168 HYSHKGYLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE 226
Query: 176 FM 177
M
Sbjct: 227 QM 228
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 4e-22
Identities = 56/172 (32%), Positives = 92/172 (53%), Gaps = 19/172 (11%)
Query: 13 LDCELNFLSSV-NHPNIIRLFDAF-QAENCI----FLVVEFCAGGNLSSYI----RLHGR 62
++ E N L S+ NHPN+++ + F +A+ + +LV+E C GG+++ + R
Sbjct: 65 IEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR 124
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
+ E L GL+ L+++ IIHRD+K NILL+ + +K+ DFG+S L
Sbjct: 125 LDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTT---EGGVKLVDFGVSAQLTST 181
Query: 123 NYAEKV-CGSPLYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPF 168
G+P +MAPEV+ ++ YD + D+WS+G EL +G PP
Sbjct: 182 RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 6e-22
Identities = 59/158 (37%), Positives = 87/158 (55%), Gaps = 13/158 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ FL + HPN I+ + E+ +LV+E+C G + S + +H + P Q
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKK-PLQEVEIAAVTH 122
Query: 76 GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
GA GL L+SH++IHRD+K NILLS + ++K+ DFG + + P N G+P
Sbjct: 123 GALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPAN---XFVGTPY 176
Query: 134 YMAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPPF 168
+MAPEV+ +YD KVD+WS+G EL PP
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 7e-22
Identities = 54/174 (31%), Positives = 84/174 (48%), Gaps = 41/174 (23%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFC---------AGGNLSSYIRLHGRVPEQ 66
E++ L + H NI+RL D +E ++LV E+ + + + RL
Sbjct: 51 EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRL------- 103
Query: 67 TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
+ +L Q+ G+ +SH ++HRDLKP+N+L+ + LK+ADFGL+
Sbjct: 104 -IKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLA---------- 150
Query: 127 KVCGSPL-----------YMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPF 168
+ G P+ Y APE+L R Y VD+WSVG I E++N P F
Sbjct: 151 RAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLF 204
|
Length = 294 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 7e-22
Identities = 55/153 (35%), Positives = 81/153 (52%), Gaps = 6/153 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
EL L N P I+ + AF ++ I + +E GG+L ++ GR+PE K +
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAV 108
Query: 76 GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
GL L H I+HRD+KP NIL++ + +K+ DFG+S L + A G+ Y
Sbjct: 109 LRGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 164
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNG-YP 166
M+PE LQ Y + D+WS+G L E+ G YP
Sbjct: 165 MSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 9e-22
Identities = 49/155 (31%), Positives = 84/155 (54%), Gaps = 5/155 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ LS + P + + + ++ + +++++E+ GG+ + G + E L+++
Sbjct: 52 EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREI 110
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 134
GL+ L+S IHRD+K N+LLS + +K+ADFG++ L G+P +
Sbjct: 111 LKGLDYLHSEKKIHRDIKAANVLLSEHGE---VKLADFGVAGQLTDTQIKRNTFVGTPFW 167
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
MAPEV++ YD K D+WS+G EL G PP S
Sbjct: 168 MAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-21
Identities = 52/153 (33%), Positives = 88/153 (57%), Gaps = 5/153 (3%)
Query: 17 LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76
L+ +S+ + P I+ + AF + + +++ GG+L ++ HG E+ R + ++
Sbjct: 48 LSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEII 107
Query: 77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMA 136
GLE +++ +++RDLKP NIL LD+ ++I+D GL+C + G+ YMA
Sbjct: 108 LGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLACD-FSKKKPHASVGTHGYMA 163
Query: 137 PEVLQF-QRYDEKVDMWSVGAILFELLNGYPPF 168
PEVLQ YD D +S+G +LF+LL G+ PF
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-21
Identities = 62/165 (37%), Positives = 82/165 (49%), Gaps = 13/165 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
EL L VNH NII L + F + ++LV+E NL I H + +
Sbjct: 70 ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL-MDANLCQVI--HMELDHERMS 126
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
L Q+ G++ L+S IIHRDLKP NI++ D LKI DFGL+ T
Sbjct: 127 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTACTNFMMTPYV 183
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 174
+ Y APEV+ Y E VD+WSVG I+ EL+ G F G +H
Sbjct: 184 VTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ-GTDH 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 1e-21
Identities = 52/153 (33%), Positives = 87/153 (56%), Gaps = 5/153 (3%)
Query: 17 LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76
L+ +S+ + P I+ + AF + + +++ GG+L ++ HG E R + ++
Sbjct: 48 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEII 107
Query: 77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMA 136
GLE +++ +++RDLKP NIL LD+ ++I+D GL+C + G+ YMA
Sbjct: 108 LGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLACD-FSKKKPHASVGTHGYMA 163
Query: 137 PEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPF 168
PEVLQ YD D +S+G +LF+LL G+ PF
Sbjct: 164 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 2e-21
Identities = 51/173 (29%), Positives = 85/173 (49%), Gaps = 23/173 (13%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK----- 70
E +S + HPNI+ L E ++ E+ A G+L ++ + + A
Sbjct: 58 EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117
Query: 71 --------FLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
FL Q+ AG+E L+SHH +HRDL N L+ + + +KI+DFGLS +
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG---EGLTVKISDFGLSRDI 174
Query: 120 YPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
Y +Y S L +M PE + + ++ + D+WS G +L+E+ + G P+
Sbjct: 175 YSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 2e-21
Identities = 59/170 (34%), Positives = 85/170 (50%), Gaps = 33/170 (19%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL- 72
E+N L + HPNI+ + + N I++V+E+ +L S + + Q+ K L
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLM 112
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLS--GLDDDVMLKIADFGLSCTLYPGNYAEKVCG 130
QL +G+ L+ + I+HRDLK N+LL+ G+ LKI DFGL+ + G
Sbjct: 113 LQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI-----LKICDFGLA----------REYG 157
Query: 131 SPL-----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
SPL Y APE+L + Y +DMWSVG I ELL P F
Sbjct: 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLF 207
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-21
Identities = 53/156 (33%), Positives = 86/156 (55%), Gaps = 7/156 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E L + HP + L +FQ + + V+E+ GG L ++ E AR + ++
Sbjct: 45 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 104
Query: 76 GAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSP 132
+ L+ L+S ++++RDLK EN++L D D +KI DFGL C + G + CG+P
Sbjct: 105 VSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGL-CKEGIKDGATMKTFCGTP 160
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
Y+APEVL+ Y VD W +G +++E++ G PF
Sbjct: 161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 3e-21
Identities = 52/160 (32%), Positives = 80/160 (50%), Gaps = 7/160 (4%)
Query: 7 KHLKSCLDCELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
K L+ + L+ + H PN++ L +E+ +FLV++ GG L S+I +P
Sbjct: 24 KGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIP 83
Query: 65 EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 124
E+ +++ ++ L+ L+ I+ RDL P NIL LDD +++ F +
Sbjct: 84 EECVKRWAAEMVVALDALHREGIVCRDLNPNNIL---LDDRGHIQLTYFSRWSEVEDSCD 140
Query: 125 AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164
E V +Y APEV E D WS+GAILFELL G
Sbjct: 141 GEAV--ENMYCAPEVGGISEETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 3e-21
Identities = 52/170 (30%), Positives = 80/170 (47%), Gaps = 27/170 (15%)
Query: 16 ELNFLSSVNHPNIIRLFD-----AFQAENC---IFLVVEFC----AGGNLSSYIRLHGRV 63
E+ L + H N++ L + A +LV EFC AG L S + +
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAG--LLSNKNVKFTL 118
Query: 64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY--- 120
E +K ++ L GL ++ + I+HRD+K NIL++ D +LK+ADFGL+
Sbjct: 119 SE--IKKVMKMLLNGLYYIHRNKILHRDMKAANILIT---KDGILKLADFGLARAFSLSK 173
Query: 121 ---PGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYP 166
P Y +V + Y PE+L +R Y +DMW G I+ E+ P
Sbjct: 174 NSKPNRYTNRVV-TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSP 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 3e-21
Identities = 56/177 (31%), Positives = 78/177 (44%), Gaps = 25/177 (14%)
Query: 9 LKSCLD---CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRV 63
L +D E + S++H N+IRL+ + +V E G+L +R G
Sbjct: 36 LSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHF 94
Query: 64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL---- 119
T + Q+ G+ L S IHRDL NILL+ DD V KI DFGL L
Sbjct: 95 LISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLAS-DDKV--KIGDFGLMRALPQNE 151
Query: 120 --YPGNYAEKVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 173
Y KV P + APE L+ + + D+W G L+E+ F+ GEE
Sbjct: 152 DHYVMEEHLKV---PFAWCAPESLRTRTFSHASDVWMFGVTLWEM------FTYGEE 199
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-21
Identities = 54/150 (36%), Positives = 88/150 (58%), Gaps = 13/150 (8%)
Query: 28 IIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQLGAGLEILNSHH 86
I L AFQ EN ++LV+++ GG+L + + + R+PE AR +L ++ ++ ++
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122
Query: 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVC-GSPLYMAPEVLQFQ 143
+HRD+KP+N+L LD + +++ADFG SC L G V G+P Y++PE+LQ
Sbjct: 123 YVHRDIKPDNVL---LDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQAM 178
Query: 144 -----RYDEKVDMWSVGAILFELLNGYPPF 168
RY + D WS+G ++E+L G PF
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 4e-21
Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 7/154 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ L + HPN++ L + F+ + + LV E+C L+ + VPE +K + Q
Sbjct: 50 EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQT 109
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--NYAEKVCGSPL 133
+ + H+ IHRD+KPENIL++ +K+ DFG + L +Y + V +
Sbjct: 110 LQAVNFCHKHNCIHRDVKPENILIT---KQGQIKLCDFGFARILTGPGDDYTDYV-ATRW 165
Query: 134 YMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYP 166
Y APE+L +Y VD+W++G + ELL G P
Sbjct: 166 YRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 4e-21
Identities = 55/164 (33%), Positives = 83/164 (50%), Gaps = 17/164 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
E+ L H NII + D + N +++V E +L I+ + +
Sbjct: 53 EIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQ-HLSNDHIQY 110
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-----SCTLYPGNYA 125
FL Q+ GL+ ++S +++HRDLKP N+LL+ D LKI DFGL + G
Sbjct: 111 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD---LKICDFGLARIADPEHDHTGFLT 167
Query: 126 EKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
E V + Y APE+ L + Y + +D+WSVG IL E+L+ P F
Sbjct: 168 EYV-ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 4e-21
Identities = 52/162 (32%), Positives = 84/162 (51%), Gaps = 11/162 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E L +HPNI++L + I++V+E GG+L +++R R+ + +
Sbjct: 42 EAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLD 101
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSP 132
AG+E L S + IHRDL N L+ ++ +LKI+DFG+S G Y + + P
Sbjct: 102 AAAGMEYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTVSDGLKQIP 158
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLNG----YPPFS 169
+ + APE L + RY + D+WS G +L+E + YP S
Sbjct: 159 IKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS 200
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 5e-21
Identities = 52/155 (33%), Positives = 85/155 (54%), Gaps = 5/155 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
E L VN P I+ L AF+++ + LV+ GG+L +I G + R +
Sbjct: 43 EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
Q+ G+ L+S I++RD+KPEN+LL DD +++D GL+ L G + G+
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAGTNG 159
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
YMAPE+L+ + Y VD +++G ++E++ G PF
Sbjct: 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 9e-21
Identities = 55/153 (35%), Positives = 81/153 (52%), Gaps = 5/153 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
EL L N P I+ + AF ++ I + +E GG+L ++ GR+PEQ K +
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 112
Query: 76 GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
GL L H I+HRD+KP NIL++ + +K+ DFG+S L + A G+ Y
Sbjct: 113 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 168
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167
M+PE LQ Y + D+WS+G L E+ G P
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-20
Identities = 51/173 (29%), Positives = 93/173 (53%), Gaps = 19/173 (10%)
Query: 13 LDCELNFLSSV-NHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSS----YIRLHGR 62
++ E N L ++ +HPN+++ + + ++ ++LV+E C GG+++ +++ R
Sbjct: 61 IEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER 120
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
+ E L + GL+ L+ + IHRD+K NILL+ + +K+ DFG+S L
Sbjct: 121 MEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT---TEGGVKLVDFGVSAQLTST 177
Query: 123 NYAEKV-CGSPLYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPFS 169
G+P +MAPEV+ ++ YD + D+WS+G EL +G PP +
Sbjct: 178 RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-20
Identities = 45/154 (29%), Positives = 89/154 (57%), Gaps = 5/154 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ + H N++ +++++ + +++V+EF GG L+ I H R+ E+ +
Sbjct: 67 EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAV 125
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 134
L +L++ +IHRD+K ++ILL+ D +K++DFG + K + G+P +
Sbjct: 126 LKALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYW 182
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
MAPE++ Y +VD+WS+G ++ E+++G PP+
Sbjct: 183 MAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-20
Identities = 54/157 (34%), Positives = 79/157 (50%), Gaps = 9/157 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E + L + H NI+ L D + + LV E+ +L Y+ G + R FL Q
Sbjct: 53 EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQ 111
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGN-YAEKVCGSP 132
L GL + ++HRDLKP+N+L+S + LK+ADFGL+ P Y+ +V +
Sbjct: 112 LLRGLAYCHQRRVLHRDLKPQNLLISERGE---LKLADFGLARAKSVPSKTYSNEVV-TL 167
Query: 133 LYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPF 168
Y P+VL Y +DMW VG I +E+ G P F
Sbjct: 168 WYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-20
Identities = 50/156 (32%), Positives = 81/156 (51%), Gaps = 7/156 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ + H NI+ F ++ + +++ +EFC GG+L + G + E ++
Sbjct: 56 EIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRET 115
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 134
GL L+S +HRD+K NILL+ D+ +K+ADFG+S + K G+P +
Sbjct: 116 LQGLYYLHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQITATIAKRKSFIGTPYW 172
Query: 135 MAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPP 167
MAPEV +R Y++ D+W+VG EL PP
Sbjct: 173 MAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-20
Identities = 63/188 (33%), Positives = 98/188 (52%), Gaps = 26/188 (13%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
+KKL + +S L EL L + H N+I L D F + + +LV+ F G
Sbjct: 45 IKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPF-MG 103
Query: 51 GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
+L ++ H ++ E + + Q+ GL+ +++ IIHRDLKP N+ +++D LKI
Sbjct: 104 TDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNL---AVNEDCELKI 159
Query: 111 ADFGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYP 166
DFGL+ ++ G + Y APEV L + Y + VD+WSVG I+ E+L G P
Sbjct: 160 LDFGLA-----RQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKP 214
Query: 167 PFSVGEEH 174
F G +H
Sbjct: 215 LFK-GHDH 221
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 1e-20
Identities = 51/155 (32%), Positives = 92/155 (59%), Gaps = 7/155 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
E+ + +H N++ +++++ + +++V+EF GG L+ I H R+ EQ A L
Sbjct: 69 EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSV 127
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPL 133
L A L L++ +IHRD+K ++ILL+ D +K++DFG + K + G+P
Sbjct: 128 LRA-LSYLHNQGVIHRDIKSDSILLT---SDGRIKLSDFGFCAQVSKEVPKRKSLVGTPY 183
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
+MAPEV+ Y +VD+WS+G ++ E+++G PP+
Sbjct: 184 WMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-20
Identities = 56/169 (33%), Positives = 83/169 (49%), Gaps = 20/169 (11%)
Query: 16 ELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFL 72
E L +VNHP++IR+ D A C+ L +L +Y+ + +P A
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS---DLYTYLTKRSRPLPIDQALIIE 163
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLY-PGNYAEKVCG 130
+Q+ GL L++ IIHRD+K ENI + +D + I D G + + P + G
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVAPAFLG--LAG 218
Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP------PFSVGEE 173
+ APEVL +Y+ K D+WS G +LFE+L YP P S EE
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEML-AYPSTIFEDPPSTPEE 266
|
Length = 357 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-20
Identities = 52/165 (31%), Positives = 82/165 (49%), Gaps = 17/165 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
EL+ L P I+ + AF E +++ +E+ G+L +PE R+
Sbjct: 49 ELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRIT 108
Query: 73 QQLGAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
+ GL+ L H+IIHRD+KP N+L++G + +K+ DFG+S L + A+ G
Sbjct: 109 YAVVKGLKFLKEEHNIIHRDVKPTNVLVNG---NGQVKLCDFGVSGNLV-ASLAKTNIGC 164
Query: 132 PLYMAPEVL------QFQRYDEKVDMWSVGAILFELLNG---YPP 167
YMAPE + Q Y + D+WS+G + E+ G YPP
Sbjct: 165 QSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-20
Identities = 53/153 (34%), Positives = 78/153 (50%), Gaps = 8/153 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
EL L + P II + AF EN I + EF GG+L Y ++PE + +
Sbjct: 49 ELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAV 104
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
GL L S I+HRD+KP N+L++ +K+ DFG+S L + A+ G+ YM
Sbjct: 105 VKGLTYLWSLKILHRDVKPSNMLVNTRGQ---VKLCDFGVSTQLV-NSIAKTYVGTNAYM 160
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
APE + ++Y D+WS+G EL G P+
Sbjct: 161 APERISGEQYGIHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-20
Identities = 55/153 (35%), Positives = 81/153 (52%), Gaps = 6/153 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
EL L N P I+ + AF ++ I + +E GG+L ++ R+PE+ K +
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 112
Query: 76 GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
GL L H I+HRD+KP NIL++ + +K+ DFG+S L + A G+ Y
Sbjct: 113 LRGLAYLREKHQIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 168
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNG-YP 166
M+PE LQ Y + D+WS+G L EL G YP
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 3e-20
Identities = 48/162 (29%), Positives = 81/162 (50%), Gaps = 20/162 (12%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
E + + N +++RL +V+E A G+L SY+R R PE
Sbjct: 59 EASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLR--SRRPEAENNPGLGPP 116
Query: 67 TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
T +KF+Q ++ G+ L + +HRDL N +++ +D+ +KI DFG++ +Y +
Sbjct: 117 TLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA---EDLTVKIGDFGMTRDIYETD 173
Query: 124 YAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
Y K L +MAPE L+ + K D+WS G +L+E+
Sbjct: 174 YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 3e-20
Identities = 43/150 (28%), Positives = 78/150 (52%), Gaps = 8/150 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQ 74
E + ++H +++L+ + I++V E+ + G L +Y+R HG+ + + +
Sbjct: 49 EAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKD 108
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
+ G+ L S IHRDL N L +DD +K++DFGLS + Y V GS
Sbjct: 109 VCEGMAYLESKQFIHRDLAARNCL---VDDQGCVKVSDFGLSRYVLDDEYTSSV-GSKFP 164
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
+ PEVL + ++ K D+W+ G +++E+
Sbjct: 165 VRWSPPEVLLYSKFSSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 4e-20
Identities = 55/182 (30%), Positives = 92/182 (50%), Gaps = 34/182 (18%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV------------ 63
E N L VNHP++I+L+ A + + L+VE+ G+L S++R +V
Sbjct: 53 EFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRN 112
Query: 64 ------PEQTAR------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
P++ A F Q+ G++ L ++HRDL N+L++ + +KI+
Sbjct: 113 SSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA---EGRKMKIS 169
Query: 112 DFGLSCTLYPGN-YAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELL----NG 164
DFGLS +Y + Y ++ G P+ +MA E L Y + D+WS G +L+E++ N
Sbjct: 170 DFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229
Query: 165 YP 166
YP
Sbjct: 230 YP 231
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 4e-20
Identities = 59/160 (36%), Positives = 84/160 (52%), Gaps = 13/160 (8%)
Query: 17 LNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTAR 69
L L + +HPNI+RL D E + LV E +L +Y+ +P +T +
Sbjct: 53 LKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEH-VDQDLRTYLDKVPPPGLPAETIK 111
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKV 128
++Q GL+ L+++ I+HRDLKPENIL++ +K+ADFGL+ +Y A V
Sbjct: 112 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG---QVKLADFGLA-RIYSCQMALTPV 167
Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
+ Y APEVL Y VDMWSVG I E+ P F
Sbjct: 168 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 6e-20
Identities = 52/164 (31%), Positives = 90/164 (54%), Gaps = 14/164 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
E ++ ++H N++RL N +++V+E + GNL +++R GR V +F
Sbjct: 49 ETAVMTKLHHKNLVRLLGVI-LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL 107
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
+ G+E L S ++HRDL NIL+S +D + K++DFGL+ G K+ P+
Sbjct: 108 DVAEGMEYLESKKLVHRDLAARNILVS---EDGVAKVSDFGLARVGSMGVDNSKL---PV 161
Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN----GYPPFSVGE 172
+ APE L+ +++ K D+WS G +L+E+ + YP S+ E
Sbjct: 162 KWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE 205
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 8e-20
Identities = 46/151 (30%), Positives = 82/151 (54%), Gaps = 7/151 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
E N + ++ H ++RL+ E I+++ E+ A G+L +++ G+V F
Sbjct: 51 EANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 110
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 132
Q+ G+ + + IHRDL+ N+L+S + +M KIADFGL+ + Y A + P
Sbjct: 111 QIAEGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNEYTAREGAKFP 167
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
+ + APE + F + K D+WS G +L+E++
Sbjct: 168 IKWTAPEAINFGSFTIKSDVWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-19
Identities = 57/167 (34%), Positives = 85/167 (50%), Gaps = 19/167 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ L VNHPN+++ D F I +++EF GG+L + AR+ L
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQIL--- 178
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG----LSCTLYPGNYAEKVCGS 131
+G+ L+ HI+HRD+KP N+L ++ +KIADFG L+ T+ P N + G+
Sbjct: 179 -SGIAYLHRRHIVHRDIKPSNLL---INSAKNVKIADFGVSRILAQTMDPCNSS---VGT 231
Query: 132 PLYMAPEV----LQFQRYDEKV-DMWSVGAILFELLNGYPPFSVGEE 173
YM+PE L YD D+WS+G + E G PF VG +
Sbjct: 232 IAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ 278
|
Length = 353 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-19
Identities = 57/171 (33%), Positives = 90/171 (52%), Gaps = 26/171 (15%)
Query: 25 HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----------RVPEQ--TARKF 71
H NII L A + ++++VE+ + GNL Y+R ++PE+ T +
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 72 LQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
+ Q+ G+E L S IHRDL N+L++ +D+VM KIADFGL+ ++ +Y +K
Sbjct: 137 VSCAYQVARGMEYLASQKCIHRDLAARNVLVT--EDNVM-KIADFGLARDVHNIDYYKKT 193
Query: 129 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELL----NGYPPFSVGE 172
L +MAPE L + Y + D+WS G +L+E+ + YP V E
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-19
Identities = 57/172 (33%), Positives = 90/172 (52%), Gaps = 15/172 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFL 72
E+ S + H NI++ + + +E GG+LS+ +R + EQT +
Sbjct: 55 EIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYT 114
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILL---SGLDDDVMLKIADFGLSCTLYPGN-YAEKV 128
+Q+ GL+ L+ + I+HRD+K +N+L+ SG+ +KI+DFG S L N E
Sbjct: 115 KQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGV-----VKISDFGTSKRLAGINPCTETF 169
Query: 129 CGSPLYMAPEVL-QFQR-YDEKVDMWSVGAILFELLNGYPPF-SVGEEHQFM 177
G+ YMAPEV+ + R Y D+WS+G + E+ G PPF +GE M
Sbjct: 170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM 221
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-19
Identities = 43/164 (26%), Positives = 81/164 (49%), Gaps = 22/164 (13%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------------- 61
E L++ H NI++ + + +V E+ G+L+ ++R HG
Sbjct: 58 EAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMG 117
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
+ + Q+ +G+ L S H +HRDL N L+ D+++KI DFG+S +Y
Sbjct: 118 ELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG---YDLVVKIGDFGMSRDVYT 174
Query: 122 GNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
+Y +V G + +M PE + ++++ + D+WS G +L+E+
Sbjct: 175 TDYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-19
Identities = 58/171 (33%), Positives = 90/171 (52%), Gaps = 26/171 (15%)
Query: 25 HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------GRVPEQ--TARKF 71
H NII L A + ++++VE+ + GNL Y+R RVP++ T +
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 72 LQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
+ Q+ G+E L S IHRDL N+L++ +++VM KIADFGL+ + +Y +K
Sbjct: 140 VSCTYQVARGMEYLASQKCIHRDLAARNVLVT--ENNVM-KIADFGLARDVNNIDYYKKT 196
Query: 129 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNG--YPPFSVGE 172
L +MAPE L + Y + D+WS G +++E+ L G YP V E
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-19
Identities = 59/173 (34%), Positives = 91/173 (52%), Gaps = 24/173 (13%)
Query: 25 HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------GRVPEQ--TARKF 71
H NII L A + ++++VE+ + GNL Y+R +VPE+ + +
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 72 LQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
+ Q+ G+E L S IHRDL N+L++ +D+VM KIADFGL+ ++ +Y +K
Sbjct: 143 VSCAYQVARGMEYLASKKCIHRDLAARNVLVT--EDNVM-KIADFGLARDIHHIDYYKKT 199
Query: 129 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYPPFSVGEEHQF 176
L +MAPE L + Y + D+WS G +L+E+ L G P V E F
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-19
Identities = 45/150 (30%), Positives = 75/150 (50%), Gaps = 7/150 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
E + + HPN+++L E +++ EF GNL Y+R R V
Sbjct: 52 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 111
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 132
Q+ + +E L + IHRDL N L+ ++ ++K+ADFGLS + Y A P
Sbjct: 112 QISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFP 168
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
+ + APE L + ++ K D+W+ G +L+E+
Sbjct: 169 IKWTAPESLAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-19
Identities = 51/200 (25%), Positives = 95/200 (47%), Gaps = 39/200 (19%)
Query: 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
L K + + E + L + ++++F +FQ + ++L++EF GG++ + + +
Sbjct: 40 LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLS 99
Query: 65 EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---- 120
E+ + ++ + ++ ++ IHRD+KP+N+L LD +K++DFGL L
Sbjct: 100 EEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLL---LDAKGHVKLSDFGLCTGLKKAHR 156
Query: 121 -----------PGNY---------------------AEKVCGSPLYMAPEVLQFQRYDEK 148
P ++ A G+P Y+APEV Y++
Sbjct: 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL 216
Query: 149 VDMWSVGAILFELLNGYPPF 168
D WS+G I++E+L GYPPF
Sbjct: 217 CDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-19
Identities = 60/188 (31%), Positives = 100/188 (53%), Gaps = 26/188 (13%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
+KKL++ +S + EL L + H N+I L D F N ++LV G
Sbjct: 47 VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-MG 105
Query: 51 GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
+L++ ++ ++ + + + Q+ GL+ ++S IIHRDLKP N+ +++D LKI
Sbjct: 106 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 161
Query: 111 ADFGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYP 166
DFGL+ + +++ G + Y APE+ L + Y++ VD+WSVG I+ ELL G
Sbjct: 162 LDFGLA-----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 216
Query: 167 PFSVGEEH 174
F G +H
Sbjct: 217 LFP-GTDH 223
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-19
Identities = 54/157 (34%), Positives = 83/157 (52%), Gaps = 9/157 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + L + H NI+ L D + + V E+ +L+ Y+ H G + R F+ Q
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQ 111
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL--SCTLYPGNYAEKVCGSP 132
L GL ++ HI+HRDLKP+N+L+S L + LK+ADFGL + ++ Y+ +V +
Sbjct: 112 LLRGLAYIHGQHILHRDLKPQNLLISYLGE---LKLADFGLARAKSIPSQTYSSEVV-TL 167
Query: 133 LYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPF 168
Y P+VL Y +D+W G I E+L G P F
Sbjct: 168 WYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 3e-19
Identities = 39/112 (34%), Positives = 72/112 (64%), Gaps = 3/112 (2%)
Query: 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
+NK++ + E + L+ P I+ L+ + Q+ N ++LV+E+ GG++ S + ++G
Sbjct: 43 INKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFD 102
Query: 65 EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
E+ A K++ ++ L+ L+ H IIHRDLKP+N+L+S ++ +K+ DFGLS
Sbjct: 103 EEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS---NEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 4e-19
Identities = 58/163 (35%), Positives = 87/163 (53%), Gaps = 24/163 (14%)
Query: 25 HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------GRVPE-QTARKFL 72
H NII L E ++++VE+ A GNL ++R +VPE Q + K L
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 73 ----QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
Q+ G+E L S IHRDL N+L++ +D+VM KIADFGL+ ++ +Y +K
Sbjct: 137 VSCAYQVARGMEYLESRRCIHRDLAARNVLVT--EDNVM-KIADFGLARGVHDIDYYKKT 193
Query: 129 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
L +MAPE L + Y + D+WS G +++E+ L G P
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 4e-19
Identities = 49/151 (32%), Positives = 83/151 (54%), Gaps = 6/151 (3%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
P ++ L AFQ E + L++++ +GG + +++ E R + ++ LE L+
Sbjct: 65 PFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL 124
Query: 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQ 143
I++RD+K ENIL LD + + + DFGLS CG+ YMAPE+++ +
Sbjct: 125 GIVYRDIKLENIL---LDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGK 181
Query: 144 R-YDEKVDMWSVGAILFELLNGYPPFSVGEE 173
+ + VD WS+G ++FELL G PF++ E
Sbjct: 182 GGHGKAVDWWSLGILIFELLTGASPFTLEGE 212
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-19
Identities = 55/155 (35%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
EL + VNH NII L + F + +++V+E NL I++ + +
Sbjct: 73 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQME--LDHERMS 129
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
L Q+ G++ L+S IIHRDLKP NI++ D LKI DFGL+ T
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTAGTSFMMTPYV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164
+ Y APEV+ Y E VD+WSVG I+ E++ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 7e-19
Identities = 46/177 (25%), Positives = 85/177 (48%), Gaps = 39/177 (22%)
Query: 28 IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87
++++F +FQ + ++L++EF GG++ + + + E+ + ++ + ++ ++
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--------------------- 126
IHRD+KP+N+L LD +K++DFGL L + E
Sbjct: 123 IHRDIKPDNLL---LDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSK 179
Query: 127 ---------------KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
G+P Y+APEV Y++ D WS+G I++E+L GYPPF
Sbjct: 180 RKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-19
Identities = 57/165 (34%), Positives = 88/165 (53%), Gaps = 12/165 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQ 74
E++ L ++ H NI+ L D E C+ LV E+ +L Y+ G + + F+ Q
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQ 111
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL--SCTLYPGNYAEKVCGSP 132
L GL + I+HRDLKP+N+L +++ LK+ADFGL + ++ Y+ +V +
Sbjct: 112 LLRGLSYCHKRKILHRDLKPQNLL---INEKGELKLADFGLARAKSVPTKTYSNEVV-TL 167
Query: 133 LYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF---SVGEE 173
Y P+V L Y +DMW VG IL+E+ G P F +V EE
Sbjct: 168 WYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 8e-19
Identities = 46/155 (29%), Positives = 89/155 (57%), Gaps = 7/155 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ + H N++ ++ ++ +++++EF GG L+ + R+ E+ + +
Sbjct: 68 EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-QTRLNEEQIATVCESV 126
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--VCGSPL 133
L L+S +IHRD+K ++ILL+ LD V K++DFG C + ++ + G+P
Sbjct: 127 LQALCYLHSQGVIHRDIKSDSILLT-LDGRV--KLSDFGF-CAQISKDVPKRKSLVGTPY 182
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
+MAPEV+ Y +VD+WS+G ++ E+++G PP+
Sbjct: 183 WMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 9e-19
Identities = 43/156 (27%), Positives = 83/156 (53%), Gaps = 13/156 (8%)
Query: 17 LNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTAR 69
L+FL+ +HPNIIRL + ++ E+ G+L ++R + G+
Sbjct: 50 LDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLV 109
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP--GNYAEK 127
L+ + +G++ L+ + +HRDL NIL++ +++ K++DFGLS L Y K
Sbjct: 110 GMLRGIASGMKYLSEMNYVHRDLAARNILVN---SNLVCKVSDFGLSRRLEDSEATYTTK 166
Query: 128 VCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
P+ + APE + ++++ D+WS G +++E++
Sbjct: 167 GGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-18
Identities = 47/148 (31%), Positives = 71/148 (47%), Gaps = 8/148 (5%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
P I++ + F ++ +F+ +E + R+ G +PE K + L L
Sbjct: 74 PYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK 133
Query: 86 H-IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL---- 140
H +IHRD+KP NIL LD +K+ DFG+S L + G YMAPE +
Sbjct: 134 HGVIHRDVKPSNIL---LDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPD 190
Query: 141 QFQRYDEKVDMWSVGAILFELLNGYPPF 168
+YD + D+WS+G L EL G P+
Sbjct: 191 PNPKYDIRADVWSLGISLVELATGQFPY 218
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-18
Identities = 53/168 (31%), Positives = 86/168 (51%), Gaps = 18/168 (10%)
Query: 16 ELNFLSSVNH-PNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIR--LHGRVPEQ 66
E+N L +H NI + AF +N ++LV+EFC G+++ I+ + E+
Sbjct: 52 EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 111
Query: 67 TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYA 125
+++ GL L+ H +IHRD+K +N+LL+ ++ +K+ DFG+S L
Sbjct: 112 WIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRR 168
Query: 126 EKVCGSPLYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPF 168
G+P +MAPEV+ YD K D+WS+G E+ G PP
Sbjct: 169 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-18
Identities = 54/170 (31%), Positives = 85/170 (50%), Gaps = 17/170 (10%)
Query: 16 ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
E +FL S NH NI+RL F+++E AGG+L S++R + PE+ +
Sbjct: 53 ESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSS 112
Query: 70 KFLQQL-------GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
++ L G + L +H IHRD+ N LL+ + KIADFG++ +Y
Sbjct: 113 LTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRA 172
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
+Y K + L +M PE + K D+WS G +L+E+ + GY P+
Sbjct: 173 SYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-18
Identities = 48/165 (29%), Positives = 85/165 (51%), Gaps = 12/165 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + ++HPN+++L+ + IF+V E+ A G L +Y+R G++ +
Sbjct: 49 EAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSD 108
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--P 132
+ +E L S+ IHRDL N L+ +D ++K++DFGL+ + Y G+ P
Sbjct: 109 VCEAMEYLESNGFIHRDLAARNCLVG---EDNVVKVSDFGLARYVLDDQYTSSQ-GTKFP 164
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLNG----YPPFSVGE 172
+ + PEV + R+ K D+WS G +++E+ + Y FS E
Sbjct: 165 VKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-18
Identities = 51/168 (30%), Positives = 91/168 (54%), Gaps = 19/168 (11%)
Query: 24 NHPNIIRLFD-AFQAENC-----IFLVVEFCAGGNLSSYI---RLHG---RVPEQTARKF 71
+HPN+++L F+A + +++ F G+L S++ RL G ++P QT KF
Sbjct: 59 DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF 118
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
+ + G+E L++ + IHRDL N + L +D+ + +ADFGLS +Y G+Y + +
Sbjct: 119 MVDIALGMEYLSNRNFIHRDLAARNCM---LREDMTVCVADFGLSKKIYSGDYYRQGRIA 175
Query: 132 PL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSVGEEHQ 175
+ ++A E L + Y K D+W+ G ++E+ G P+ E H+
Sbjct: 176 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE 223
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-18
Identities = 58/182 (31%), Positives = 97/182 (53%), Gaps = 25/182 (13%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
+KKL++ +S + EL L + H N+I L D F N ++LV G
Sbjct: 45 VKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNL-MG 103
Query: 51 GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
+L++ ++ ++ ++ + + QL GL+ ++S IIHRDLKP N+ +++D L+I
Sbjct: 104 ADLNNIVKCQ-KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNV---AVNEDCELRI 159
Query: 111 ADFGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYP 166
DFGL+ +++ G + Y APE+ L + Y++ VD+WSVG I+ ELL G
Sbjct: 160 LDFGLA-----RQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKA 214
Query: 167 PF 168
F
Sbjct: 215 LF 216
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-18
Identities = 42/147 (28%), Positives = 71/147 (48%), Gaps = 8/147 (5%)
Query: 20 LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAG 78
++SV+HP+++RL + + L+ + G L Y+R H + Q + Q+ G
Sbjct: 63 MASVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKG 121
Query: 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--PL-YM 135
+ L ++HRDL N+L+ +KI DFGL+ L G P+ +M
Sbjct: 122 MSYLEEKRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELL 162
A E + + Y K D+WS G ++EL+
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-18
Identities = 55/153 (35%), Positives = 78/153 (50%), Gaps = 12/153 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
EL + VNH NII L + F + ++LV+E NL I++ + +
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL-MDANLCQVIQM--ELDHERMS 122
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
L Q+ G++ L+S IIHRDLKP NI++ D LKI DFGL+ T
Sbjct: 123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTAGTSFMMTPYV 179
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
+ Y APEV+ Y E VD+WSVG I+ E++
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-18
Identities = 57/178 (32%), Positives = 84/178 (47%), Gaps = 21/178 (11%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
LKK+ ++ + C EL L H N++ D Q + I++V E
Sbjct: 30 LKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQS- 88
Query: 52 NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
+L I + + FL Q+ GL+ L+S I+HRD+KP N+L ++ + +LKI
Sbjct: 89 DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLL---VNSNCVLKIC 145
Query: 112 DFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNG 164
DFGL+ P E V + Y APE+L + Y VD+WSVG I ELL
Sbjct: 146 DFGLARVEEPDESKHMTQEVV--TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-18
Identities = 43/164 (26%), Positives = 86/164 (52%), Gaps = 21/164 (12%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------------R 62
E L+++ H +I++ + + + +V E+ G+L+ ++R HG
Sbjct: 57 EAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE 116
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
+ + QQ+ AG+ L S H +HRDL N L+ +++++KI DFG+S +Y
Sbjct: 117 LTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMSRDVYST 173
Query: 123 NYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
+Y +V G + +M PE + ++++ + D+WS+G +L+E+
Sbjct: 174 DYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-18
Identities = 47/168 (27%), Positives = 89/168 (52%), Gaps = 23/168 (13%)
Query: 21 SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL---HGRV----PEQTARKFLQ 73
S + HPNI+ L E + ++ +C+ +L ++ + H V ++T + L+
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 74 ---------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 124
Q+ AG+E L+SHH++H+DL N+L+ D + +KI+D GL +Y +Y
Sbjct: 123 PADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF---DKLNVKISDLGLFREVYAADY 179
Query: 125 AEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
+ + S L +M+PE + + ++ D+WS G +L+E+ + G P+
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-18
Identities = 50/168 (29%), Positives = 89/168 (52%), Gaps = 18/168 (10%)
Query: 16 ELNFLSSVNH-PNIIRLFDAF------QAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQT 67
E+N L +H NI + AF ++ ++LV+EFC G+++ ++ G ++
Sbjct: 62 EINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKED 121
Query: 68 ARKFL-QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYA 125
++ +++ GL L++H +IHRD+K +N+LL+ ++ +K+ DFG+S L
Sbjct: 122 WIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRR 178
Query: 126 EKVCGSPLYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPF 168
G+P +MAPEV+ YD + D+WS+G E+ G PP
Sbjct: 179 NTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-18
Identities = 55/170 (32%), Positives = 84/170 (49%), Gaps = 12/170 (7%)
Query: 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRV 63
L + LK E L +HPNI++L I++V+E GG+ S++R +
Sbjct: 31 LPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDEL 90
Query: 64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
+ KF AG+ L S + IHRDL N L+ ++ +LKI+DFG+S G
Sbjct: 91 KTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG---ENNVLKISDFGMSRQEDDGI 147
Query: 124 YAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVG 171
Y+ P+ + APE L + RY + D+WS G +L+E FS+G
Sbjct: 148 YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWE------TFSLG 191
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 7e-18
Identities = 48/174 (27%), Positives = 76/174 (43%), Gaps = 28/174 (16%)
Query: 16 ELNFLSSVNHPNIIRLFDAF-------QAENCIFLVVEFCAGGNLSSYIRLHG---RVPE 65
E+ L + HPN++ L D + + +V +LS L ++ E
Sbjct: 57 EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGL--LENPSVKLTE 114
Query: 66 QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 125
+ ++ QL G+ L+ +HI+HRD+K NIL +D+ +LKIADFGL+
Sbjct: 115 SQIKCYMLQLLEGINYLHENHILHRDIKAANIL---IDNQGILKIADFGLARPYDGPPPN 171
Query: 126 EKVCGSPL------------YMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYP 166
K G Y PE +L +RY VD+W +G + E+ P
Sbjct: 172 PKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRP 225
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 9e-18
Identities = 48/181 (26%), Positives = 82/181 (45%), Gaps = 10/181 (5%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-H 60
LK + + E+ L + H ++I LF ++++ E G+L +++R
Sbjct: 38 LKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPE 97
Query: 61 GRV-PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
G+V P + Q+ G+ L + IHRDL NIL+ +D++ K+ADFGL+ +
Sbjct: 98 GQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLI 154
Query: 120 YPGNYAEKVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN----GYPPFSVGEEH 174
Y P + APE + K D+WS G +L+E+ YP + E +
Sbjct: 155 KEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY 214
Query: 175 Q 175
Sbjct: 215 D 215
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 9e-18
Identities = 45/154 (29%), Positives = 80/154 (51%), Gaps = 10/154 (6%)
Query: 16 ELNFLSSVNHPNIIRL--FDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFL 72
E+ L +++H NI++ + L++E+ G+L Y++ H ++ + F
Sbjct: 56 EIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFS 115
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVC 129
Q+ G++ L S IHRDL NIL ++ + ++KI+DFGL+ L Y ++
Sbjct: 116 SQICKGMDYLGSQRYIHRDLAARNIL---VESEDLVKISDFGLAKVLPEDKDYYYVKEPG 172
Query: 130 GSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
SP+ + APE L+ ++ D+WS G L+EL
Sbjct: 173 ESPIFWYAPECLRTSKFSSASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 9e-18
Identities = 63/185 (34%), Positives = 95/185 (51%), Gaps = 32/185 (17%)
Query: 13 LDCELN--FLSSVN-HPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLHGRVPEQT 67
+ C LN F S V H + + D EN I LV+++ G+L I+ + T
Sbjct: 82 VCCLLNCDFFSIVKCHEDFAKK-DPRNPENVLMIALVLDYANAGDLRQEIKSRAK----T 136
Query: 68 ARKFLQQLGAGL---EIL------NSHHIIHRDLKPENILL--SGLDDDVMLKIADFGLS 116
R F + AGL ++L +S H+IHRD+K NILL +GL +K+ DFG S
Sbjct: 137 NRTFREH-EAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL-----VKLGDFGFS 190
Query: 117 CTLYPGNYAEKV----CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGE 172
+Y ++ V CG+P Y+APE+ + + Y +K DM+S+G +L+ELL PF
Sbjct: 191 -KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249
Query: 173 EHQFM 177
+ M
Sbjct: 250 MEEVM 254
|
Length = 496 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-17
Identities = 50/182 (27%), Positives = 85/182 (46%), Gaps = 35/182 (19%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQT-------- 67
E ++ +HPNI++L + L+ E+ A G+L+ ++R R P
Sbjct: 58 EAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLR--HRSPRAQCSLSHSTS 115
Query: 68 -ARKFLQ---------------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
ARK Q+ AG+ L+ +HRDL N L+ ++++KIA
Sbjct: 116 SARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGE---NMVVKIA 172
Query: 112 DFGLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYP 166
DFGLS +Y +Y K + +M PE + + RY + D+W+ G +L+E+ + G
Sbjct: 173 DFGLSRNIYSADYY-KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQ 231
Query: 167 PF 168
P+
Sbjct: 232 PY 233
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-17
Identities = 48/161 (29%), Positives = 83/161 (51%), Gaps = 7/161 (4%)
Query: 11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
S + E+ + H NI+ F ++ + +++ +E+C GG+L + G + E
Sbjct: 51 SLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY 110
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VC 129
++ GL L+S +HRD+K NILL+ D+ +K+ADFG++ + K
Sbjct: 111 VCRETLQGLAYLHSKGKMHRDIKGANILLT---DNGDVKLADFGVAAKITATIAKRKSFI 167
Query: 130 GSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPP 167
G+P +MAPEV ++ Y++ D+W+VG EL PP
Sbjct: 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-17
Identities = 46/152 (30%), Positives = 77/152 (50%), Gaps = 11/152 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73
E++ L +++H II L A++ ++ C+ + C +L +Y+ G +P + A +
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC---DLFTYVDRSGPLPLEQAITIQR 192
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
+L L L+ IIHRD+K ENI L ++ V+ DFG +C L + G
Sbjct: 193 RLLEALAYLHGRGIIHRDVKTENIFLDEPENAVL---GDFGAACKLDAHPDTPQCYGWSG 249
Query: 134 YM---APEVLQFQRYDEKVDMWSVGAILFELL 162
+ +PE+L Y K D+WS G +LFE+
Sbjct: 250 TLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-17
Identities = 45/172 (26%), Positives = 80/172 (46%), Gaps = 19/172 (11%)
Query: 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
+ + + E+ LS ++ PNI RL + + +++E+ G+L+ +++ H
Sbjct: 59 SDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETS 118
Query: 66 QTARKFLQ-----------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
A Q+ +G+ L S + +HRDL N L+ +KIADFG
Sbjct: 119 GLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKN---YTIKIADFG 175
Query: 115 LSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
+S LY +Y +V G +MA E + ++ K D+W+ G L+E+L
Sbjct: 176 MSRNLYSSDYY-RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-17
Identities = 57/174 (32%), Positives = 87/174 (50%), Gaps = 30/174 (17%)
Query: 16 ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-------------HG 61
EL L + +HPNII L A + +++ +E+ GNL ++R HG
Sbjct: 52 ELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHG 111
Query: 62 RVPEQTARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
T+++ LQ + G++ L+ IHRDL N+L+ +++ KIADFGLS
Sbjct: 112 TASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG---ENLASKIADFGLS-- 166
Query: 119 LYPGN--YAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
G Y +K G P+ +MA E L + Y K D+WS G +L+E+ L G P
Sbjct: 167 --RGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-17
Identities = 54/169 (31%), Positives = 88/169 (52%), Gaps = 12/169 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E++ L + H NI+ L D E + LV E+ +L Y+ G + + FL Q
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQ 112
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL--SCTLYPGNYAEKVCGSP 132
L GL + ++HRDLKP+N+L +++ LK+ADFGL + ++ Y+ +V +
Sbjct: 113 LLRGLNYCHRRKVLHRDLKPQNLL---INERGELKLADFGLARAKSIPTKTYSNEVV-TL 168
Query: 133 LYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF---SVGEEHQFM 177
Y P++ L Y ++DMW VG I +E+ G P F +V E+ F+
Sbjct: 169 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-17
Identities = 48/174 (27%), Positives = 87/174 (50%), Gaps = 24/174 (13%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL---HGRV-----PEQT 67
E + ++ ++HPNI+ L E + ++ E+ G+L ++ + H V + T
Sbjct: 57 EASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGT 116
Query: 68 ARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
+ L Q+ AG+E L+SH +H+DL NIL+ + + +KI+D GLS
Sbjct: 117 VKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG---EQLHVKISDLGLSRE 173
Query: 119 LYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
+Y +Y S L +M PE + + ++ D+WS G +L+E+ + G P+
Sbjct: 174 IYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 3e-17
Identities = 53/156 (33%), Positives = 79/156 (50%), Gaps = 7/156 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + L + H NI+ L D + + LV E+ +L Y+ H G + + + FL Q
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTLVFEY-VHTDLCQYMDKHPGGLHPENVKLFLFQ 111
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCGSPL 133
L GL ++ +I+HRDLKP+N+L+S D LK+ADFGL+ P + +
Sbjct: 112 LLRGLSYIHQRYILHRDLKPQNLLIS---DTGELKLADFGLARAKSVPSHTYSNEVVTLW 168
Query: 134 YMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
Y P+V L Y +DMW VG I E++ G F
Sbjct: 169 YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 6e-17
Identities = 43/160 (26%), Positives = 84/160 (52%), Gaps = 9/160 (5%)
Query: 15 CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
E + + +HPNII L + +V E+ G+L +++R H G+ L+
Sbjct: 54 SEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR 113
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCG 130
+ +G++ L+ +HRDL NIL+ + +++ K++DFGLS L Y +
Sbjct: 114 GIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 170
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
P+ + APE + ++++ D+WS G +++E+++ G P+
Sbjct: 171 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 7e-17
Identities = 52/153 (33%), Positives = 82/153 (53%), Gaps = 10/153 (6%)
Query: 16 ELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73
E+N L ++ H NI++ + Q + L++E+ G+L Y+ H Q F Q
Sbjct: 56 EINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLL-FAQ 114
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC---G 130
Q+ G+ L+S H IHRDL N+L LD+D ++KI DFGL+ + G+ +V
Sbjct: 115 QICEGMAYLHSQHYIHRDLAARNVL---LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171
Query: 131 SPLY-MAPEVLQFQRYDEKVDMWSVGAILFELL 162
SP++ A E L+ ++ D+WS G L+ELL
Sbjct: 172 SPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 7e-17
Identities = 57/166 (34%), Positives = 89/166 (53%), Gaps = 12/166 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAF-----QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
E+ L ++H N+I + D +A N +++V E +L IR + + +
Sbjct: 54 EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYEL-MDTDLHQIIRSSQTLSDDHCQY 112
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVC 129
FL QL GL+ ++S +++HRDLKP N+LL+ D LKI DFGL+ T G++ +
Sbjct: 113 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLARTTSEKGDFMTEYV 169
Query: 130 GSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 174
+ Y APE+ L Y +D+WSVG I ELL P F G+++
Sbjct: 170 VTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFP-GKDY 214
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 7e-17
Identities = 45/164 (27%), Positives = 86/164 (52%), Gaps = 17/164 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + + +HPNII L + ++ EF G L S++R + G+ L+
Sbjct: 55 EASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRG 114
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL--------YPGNYAE 126
+ AG++ L+ + +HRDL NIL ++ +++ K++DFGLS L Y +
Sbjct: 115 IAAGMKYLSEMNYVHRDLAARNIL---VNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGG 171
Query: 127 KVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
K+ P+ + APE + ++++ D+WS G +++E+++ G P+
Sbjct: 172 KI---PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 8e-17
Identities = 50/168 (29%), Positives = 88/168 (52%), Gaps = 9/168 (5%)
Query: 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
+ LK L E N + +++P I+R+ +AE+ + LV+E G L+ +++ + V E
Sbjct: 36 DPALKDELLREANVMQQLDNPYIVRMIGICEAESWM-LVMELAELGPLNKFLQKNKHVTE 94
Query: 66 QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-- 123
+ + + Q+ G++ L + +HRDL N+LL KI+DFGLS L
Sbjct: 95 KNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV---TQHYAKISDFGLSKALGADENY 151
Query: 124 YAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
Y K G P+ + APE + + ++ K D+WS G +++E + G P+
Sbjct: 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 8e-17
Identities = 45/158 (28%), Positives = 82/158 (51%), Gaps = 9/158 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + ++HP +++L+ + I LV EF G LS Y+R G+ ++T
Sbjct: 49 EAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLD 108
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
+ G+ L S ++IHRDL N L+ ++ ++K++DFG++ + Y G+
Sbjct: 109 VCEGMAYLESSNVIHRDLAARNCLVG---ENQVVKVSDFGMTRFVLDDQYTSST-GTKFP 164
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
+ +PEV F +Y K D+WS G +++E+ + G P+
Sbjct: 165 VKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPY 202
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 9e-17
Identities = 57/167 (34%), Positives = 86/167 (51%), Gaps = 16/167 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAF------QAENCIFL--VVEFCAGGNLSSYIRLHGR----V 63
EL + ++NH NII L D + + E IFL V+EF + Y++ + R +
Sbjct: 109 ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHAL 167
Query: 64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
P + + QL L ++S I HRDLKP+N+L+ + LK+ DFG + L G
Sbjct: 168 PLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLID--PNTHTLKLCDFGSAKNLLAGQ 225
Query: 124 YAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
+ S Y APE+ L Y +D+WS+G I+ E++ GYP FS
Sbjct: 226 RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFS 272
|
Length = 440 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-16
Identities = 46/180 (25%), Positives = 89/180 (49%), Gaps = 23/180 (12%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
LK+ ++ + E L+ + H +I+R + + +V E+ G+L+ ++R HG
Sbjct: 43 LKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHG 102
Query: 62 ---RVPEQ---------TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDV 106
++ T + L Q+ +G+ L S H +HRDL N L+ +
Sbjct: 103 PDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG---QGL 159
Query: 107 MLKIADFGLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
++KI DFG+S +Y +Y +V G + +M PE + ++++ + D+WS G +L+E+
Sbjct: 160 VVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 1e-16
Identities = 53/160 (33%), Positives = 84/160 (52%), Gaps = 23/160 (14%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
EL L + H N+I L D F + +LV+ + +L + + E +
Sbjct: 64 ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHP--LSEDKVQ 120
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-KV 128
+ Q+ GL+ ++S IIHRDLKP N+ +++D LKI DFGL+ +A+ ++
Sbjct: 121 YLVYQMLCGLKYIHSAGIIHRDLKPGNL---AVNEDCELKILDFGLA------RHADAEM 171
Query: 129 CG---SPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNG 164
G + Y APEV L + Y++ VD+WSVG I+ E+L G
Sbjct: 172 TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-16
Identities = 44/150 (29%), Positives = 82/150 (54%), Gaps = 10/150 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFL 72
E + ++ + H N+++L E +++V E+ A G+L Y+R GR + KF
Sbjct: 49 EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 108
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
+ +E L +++ +HRDL N+L+S +D + K++DFGL+ K+ P
Sbjct: 109 LDVCEAMEYLEANNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL---P 162
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
+ + APE L+ +++ K D+WS G +L+E+
Sbjct: 163 VKWTAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-16
Identities = 42/151 (27%), Positives = 76/151 (50%), Gaps = 9/151 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGR-VPEQTARKFLQ 73
E + + H +++L+ E I++V E+ + G+L +++ G+ +
Sbjct: 51 EAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAA 110
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
Q+ G+ L S + IHRDL NIL+ ++++ KIADFGL+ + Y + G+
Sbjct: 111 QIAEGMAYLESRNYIHRDLAARNILVG---ENLVCKIADFGLARLIEDDEYTARE-GAKF 166
Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
+ APE + R+ K D+WS G +L E+
Sbjct: 167 PIKWTAPEAANYGRFTIKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-16
Identities = 51/157 (32%), Positives = 83/157 (52%), Gaps = 9/157 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQ 74
E++ L + H NI+ L D + + LV E+ +L Y+ G + + FL Q
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQ 112
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS--CTLYPGNYAEKVCGSP 132
+ GL + ++HRDLKP+N+L++ + LK+ADFGL+ ++ Y+ +V +
Sbjct: 113 ILRGLAYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTYSNEVV-TL 168
Query: 133 LYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
Y P+VL Y ++DMW VG I FE+ +G P F
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-16
Identities = 54/166 (32%), Positives = 83/166 (50%), Gaps = 13/166 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E + +S+ NHPNI++L ++++E GG+L SY+R L++L
Sbjct: 49 EAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKEL 108
Query: 76 GA-------GLEILNSHHIIHRDLKPENILLS--GLDDDVMLKIADFGLSCTLYPGNYAE 126
G L H IHRDL N L+S G D D ++KI DFGL+ +Y +Y
Sbjct: 109 LDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR 168
Query: 127 KVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
K L +MAPE L ++ + D+WS G +++E+L G P+
Sbjct: 169 KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-16
Identities = 42/154 (27%), Positives = 77/154 (50%), Gaps = 13/154 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKF 71
E + + HP +I+L+ E I++V E G+L Y++ ++P+
Sbjct: 51 EAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLI--DM 108
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
Q+ +G+ L + + IHRDL N+L+ ++ + K+ADFGL+ + Y + G+
Sbjct: 109 AAQVASGMAYLEAQNYIHRDLAARNVLVG---ENNICKVADFGLARVIKEDIYEARE-GA 164
Query: 132 PL---YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
+ APE + R+ K D+WS G +L E++
Sbjct: 165 KFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-16
Identities = 47/158 (29%), Positives = 82/158 (51%), Gaps = 9/158 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
E N + ++ H +++L A + I+++ EF A G+L +++ + P F
Sbjct: 51 EANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 109
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 132
Q+ G+ + + IHRDL+ NIL+S ++ KIADFGL+ + Y A + P
Sbjct: 110 QIAEGMAFIEQRNYIHRDLRAANILVSAS---LVCKIADFGLARVIEDNEYTAREGAKFP 166
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
+ + APE + F + K D+WS G +L E++ G P+
Sbjct: 167 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-16
Identities = 52/160 (32%), Positives = 82/160 (51%), Gaps = 15/160 (9%)
Query: 20 LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK---FLQQL 75
+ +HPN++ L +E +V+ + G+L ++IR P T + F Q+
Sbjct: 50 MKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNP--TVKDLIGFGLQV 107
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL 133
G+E L S +HRDL N +L D+ +K+ADFGL+ +Y Y G+ L
Sbjct: 108 AKGMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYYSVHNHTGAKL 164
Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFS 169
+MA E LQ Q++ K D+WS G +L+EL+ G PP+
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-16
Identities = 47/155 (30%), Positives = 83/155 (53%), Gaps = 9/155 (5%)
Query: 20 LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAG 78
+ S++H I+RL + + LV + G+L ++R H + Q + Q+ G
Sbjct: 63 MGSLDHAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKG 121
Query: 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPL-YM 135
+ L H ++HR+L NILL D +++IADFG++ LYP + Y +P+ +M
Sbjct: 122 MYYLEEHRMVHRNLAARNILLK---SDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM 178
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFS 169
A E + F RY + D+WS G ++E+++ G P++
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYA 213
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 4e-16
Identities = 49/171 (28%), Positives = 88/171 (51%), Gaps = 21/171 (12%)
Query: 16 ELNFLSSVNHPNIIRLFD------AFQAENCIFLVVEFCAGGNLSSYIRLHGR------- 62
E + +HPN+I+L A +++ F G+L +++ L R
Sbjct: 51 EAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFL-LMSRIGEEPFT 109
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
+P QT +F+ + +G+E L+S + IHRDL N + L++++ + +ADFGLS +Y G
Sbjct: 110 LPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCM---LNENMTVCVADFGLSKKIYSG 166
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFS 169
+Y + C S L ++A E L Y D+W+ G ++E++ G P++
Sbjct: 167 DYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYA 217
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-16
Identities = 47/181 (25%), Positives = 90/181 (49%), Gaps = 30/181 (16%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--------VPEQT 67
E L+++ H +I++ + + + +V E+ G+L+ ++R HG P Q
Sbjct: 57 EAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 116
Query: 68 ARKF--------LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
+ Q+ +G+ L S H +HRDL N L+ ++++KI DFG+S +
Sbjct: 117 KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---ANLLVKIGDFGMSRDV 173
Query: 120 YPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 175
Y +Y +V G + +M PE + ++++ + D+WS G IL+E+ F+ G++
Sbjct: 174 YSTDYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI------FTYGKQPW 226
Query: 176 F 176
F
Sbjct: 227 F 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-16
Identities = 58/186 (31%), Positives = 89/186 (47%), Gaps = 32/186 (17%)
Query: 1 MLK-KLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR 58
MLK + + L EL +S + NH NI+ L A I ++ E+C G+L +++R
Sbjct: 72 MLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR 131
Query: 59 LHGRVPEQTARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLK 109
+ FL Q+ G+ L S + IHRDL N+LL+ ++K
Sbjct: 132 -------RKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT---HGKIVK 181
Query: 110 IADFGLSC-TLYPGNYAEKVCGS---PL-YMAPEVLQFQRYDEKVDMWSVGAILFEL--- 161
I DFGL+ + NY K G+ P+ +MAPE + Y + D+WS G +L+E+
Sbjct: 182 ICDFGLARDIMNDSNYVVK--GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSL 239
Query: 162 -LNGYP 166
N YP
Sbjct: 240 GSNPYP 245
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 4e-16
Identities = 50/166 (30%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
E+ + HPNI+ +F ++ +++V A G+ ++ H PE L+
Sbjct: 49 EIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILK 108
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSP 132
+ L+ ++S IHR +K +ILLSG D V+L + S ++ G V P
Sbjct: 109 DVLNALDYIHSKGFIHRSVKASHILLSG-DGKVVL--SGLRYSVSMIKHGKRQRVVHDFP 165
Query: 133 LY-------MAPEVLQ--FQRYDEKVDMWSVGAILFELLNGYPPFS 169
++PEVLQ Q Y+EK D++SVG EL NG+ PF
Sbjct: 166 KSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 5e-16
Identities = 52/180 (28%), Positives = 85/180 (47%), Gaps = 19/180 (10%)
Query: 4 KLNKHLKSC-LDCEL----NFLS------SVNHPNIIRLFDAFQAENCIFLVVEFCAGGN 52
K+ +K+C FL +HP+I++L EN +++V+E G
Sbjct: 34 KIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT-ENPVWIVMELAPLGE 92
Query: 53 LSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
L SY++++ + + + QL L L S +HRD+ N+L+S D +K+
Sbjct: 93 LRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD---CVKLG 149
Query: 112 DFGLSCTL-YPGNYAEKVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
DFGLS L Y P+ +MAPE + F+R+ D+W G ++E+L G PF
Sbjct: 150 DFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 7e-16
Identities = 44/158 (27%), Positives = 79/158 (50%), Gaps = 9/158 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQ 74
E + ++HP +++L+ + +++V EF G L +Y+R G++ + Q
Sbjct: 49 EAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQD 108
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
+ G+E L + IHRDL N L+S ++K++DFG++ + Y G+
Sbjct: 109 VCEGMEYLERNSFIHRDLAARNCLVS---STGVVKVSDFGMTRYVLDDEYTSS-SGAKFP 164
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
+ PEV F +Y K D+WS G +++E+ G PF
Sbjct: 165 VKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPF 202
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 8e-16
Identities = 50/166 (30%), Positives = 89/166 (53%), Gaps = 21/166 (12%)
Query: 20 LSSVNHPNIIRLFDA-FQ-AENCIF----LVVEFCAGGNLSSYIRLHGRV-------PEQ 66
+ +HPN++RL Q E+ + +++ F G+L S++ L+ R+ P Q
Sbjct: 54 MKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFL-LYSRLGDCPQYLPTQ 112
Query: 67 TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
KF+ + +G+E L+S IHRDL N + L++++ + +ADFGLS +Y G+Y
Sbjct: 113 MLVKFMTDIASGMEYLSSKSFIHRDLAARNCM---LNENMNVCVADFGLSKKIYNGDYYR 169
Query: 127 --KVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
++ P+ ++A E L + Y K D+WS G ++E+ G P+
Sbjct: 170 QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY 215
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-16
Identities = 47/161 (29%), Positives = 84/161 (52%), Gaps = 14/161 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFL 72
E + +++P I+R+ +AE + LV+E +GG L+ + L G+ + + +
Sbjct: 45 EAEIMHQLDNPYIVRMIGVCEAEA-LMLVMEMASGGPLNKF--LSGKKDEITVSNVVELM 101
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCG 130
Q+ G++ L + +HRDL N+LL + KI+DFGLS L + Y + G
Sbjct: 102 HQVSMGMKYLEGKNFVHRDLAARNVLLV---NQHYAKISDFGLSKALGADDSYYKARSAG 158
Query: 131 S-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
PL + APE + F+++ + D+WS G ++E + G P+
Sbjct: 159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 9e-16
Identities = 54/174 (31%), Positives = 83/174 (47%), Gaps = 30/174 (17%)
Query: 16 ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-------------HG 61
EL L + +HPNII L A + ++L +E+ GNL ++R +
Sbjct: 45 ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 104
Query: 62 RVPEQTAR---KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
+++ F + G++ L+ IHRDL NIL+ ++ + KIADFGLS
Sbjct: 105 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS-- 159
Query: 119 LYPGN--YAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
G Y +K G P+ +MA E L + Y D+WS G +L+E+ L G P
Sbjct: 160 --RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-15
Identities = 54/175 (30%), Positives = 88/175 (50%), Gaps = 18/175 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHG---------RVP 64
E+ L + HPN+I L F A+ ++L+ ++ A +L I+ H ++P
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLP 106
Query: 65 EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV-MLKIADFGLS----CTL 119
+ L Q+ G+ L+++ ++HRDLKP NIL+ G + +KIAD G + L
Sbjct: 107 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166
Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSVGEE 173
P + V + Y APE+L R Y + +D+W++G I ELL P F +E
Sbjct: 167 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-15
Identities = 53/175 (30%), Positives = 88/175 (50%), Gaps = 18/175 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHG---------RVP 64
E+ L + HPN+I L F ++ ++L+ ++ A +L I+ H ++P
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLP 106
Query: 65 EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV-MLKIADFGLS----CTL 119
+ L Q+ G+ L+++ ++HRDLKP NIL+ G + +KIAD G + L
Sbjct: 107 RSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166
Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSVGEE 173
P + V + Y APE+L R Y + +D+W++G I ELL P F +E
Sbjct: 167 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-15
Identities = 42/151 (27%), Positives = 78/151 (51%), Gaps = 8/151 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQ 73
E N + + HP ++RL+ A + I+++ E+ G+L +++ ++
Sbjct: 51 EANLMKQLQHPRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAA 109
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 132
Q+ G+ + + IHRDL+ NIL+S + + KIADFGL+ + Y A + P
Sbjct: 110 QIAEGMAFIERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIEDNEYTAREGAKFP 166
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
+ + APE + + + K D+WS G +L E++
Sbjct: 167 IKWTAPEAINYGTFTIKSDVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 4e-15
Identities = 51/168 (30%), Positives = 83/168 (49%), Gaps = 23/168 (13%)
Query: 16 ELNFLSSVNHPNI-----IRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
E+ L + HP+I I L + + I++V E +L I+ + + + +
Sbjct: 49 EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL-MESDLHQVIKANDDLTPEHHQF 107
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS--------CTLYPG 122
FL QL L+ +++ ++ HRDLKP+NIL + D LKI DFGL+ ++
Sbjct: 108 FLYQLLRALKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVAFNDTPTAIFWT 164
Query: 123 NYAEKVCGSPLYMAPEVLQ--FQRYDEKVDMWSVGAILFELLNGYPPF 168
+Y + Y APE+ F +Y +D+WS+G I E+L G P F
Sbjct: 165 DYV----ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 208
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-15
Identities = 47/178 (26%), Positives = 89/178 (50%), Gaps = 22/178 (12%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR---------LHGRVPEQ 66
E+ +S + +PNIIRL +++ + ++ E+ G+L+ ++ +P
Sbjct: 67 EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSV 126
Query: 67 TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
+ L Q+ +G++ L S + +HRDL N L + + +KIADFG+S LY G+
Sbjct: 127 SIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL---VGNHYTIKIADFGMSRNLYSGD 183
Query: 124 YAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYPPFSVGEEHQ 175
Y ++ G + +MA E + ++ D+W+ G L+E+ L P+S+ + Q
Sbjct: 184 YY-RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 8e-15
Identities = 41/118 (34%), Positives = 56/118 (47%), Gaps = 7/118 (5%)
Query: 56 YIRLHGRVPEQTARKFLQQLGAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
Y L +PE+ K L L IIHRD+KP NIL LD + +K+ DFG
Sbjct: 97 YEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNIL---LDRNGNIKLCDFG 153
Query: 115 LSCTLYPGNYAEKVCGSPLYMAPEVL---QFQRYDEKVDMWSVGAILFELLNGYPPFS 169
+S L + G YMAPE + YD + D+WS+G L+E+ G P+
Sbjct: 154 ISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP 211
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 8e-15
Identities = 49/180 (27%), Positives = 89/180 (49%), Gaps = 27/180 (15%)
Query: 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----- 60
NK+ ++ E+ LS + PNIIRL E+ + ++ E+ G+L+ ++ H
Sbjct: 59 NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDK 118
Query: 61 -----------GRVPEQTARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDV 106
+P + L Q+ +G++ L+S + +HRDL N L+ ++
Sbjct: 119 EENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGE---NL 175
Query: 107 MLKIADFGLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
+KIADFG+S LY G+Y ++ G + +MA E + ++ D+W+ G L+E+L
Sbjct: 176 TIKIADFGMSRNLYAGDYY-RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 8e-15
Identities = 55/165 (33%), Positives = 78/165 (47%), Gaps = 31/165 (18%)
Query: 25 HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-----------------QT 67
HPNII L A + ++L +E+ GNL ++R RV E Q
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQQ 125
Query: 68 ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YA 125
F + G++ L+ IHRDL NIL+ ++ + KIADFGLS G Y
Sbjct: 126 LLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS----RGQEVYV 178
Query: 126 EKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
+K G P+ +MA E L + Y D+WS G +L+E+ L G P
Sbjct: 179 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 9e-15
Identities = 47/185 (25%), Positives = 88/185 (47%), Gaps = 19/185 (10%)
Query: 1 MLKKLNK----HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY 56
++K L K +L+S EL+ ++H N++RL + ++++E+ G+L +
Sbjct: 39 LVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQF 98
Query: 57 IRLHGRVPEQTARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVM 107
+R E+ L Q+ G++ L++ +HRDL N L+S
Sbjct: 99 LRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSS---QRE 155
Query: 108 LKIADFGLSCTLYPGNYAE-KVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164
+K++ LS +Y Y + + PL ++APE +Q + K D+WS G +++E+ G
Sbjct: 156 VKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQG 215
Query: 165 YPPFS 169
PF
Sbjct: 216 ELPFY 220
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-14
Identities = 48/168 (28%), Positives = 84/168 (50%), Gaps = 9/168 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + + +H NIIRL ++ E+ G L Y+R H G L+
Sbjct: 56 EASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRG 115
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL--YP-GNYAEKVCGS 131
+ AG++ L+ + +HRDL NIL+ + ++ K++DFGLS L P G Y
Sbjct: 116 IAAGMKYLSDMNYVHRDLAARNILV---NSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI 172
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSVGEEHQFM 177
P+ + APE + ++++ D+WS G +++E+++ G P+ H+ M
Sbjct: 173 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVM 220
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 3e-14
Identities = 42/152 (27%), Positives = 82/152 (53%), Gaps = 12/152 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
E + + H +++L+ A +E I++V E+ + G+L +++ + R+P+
Sbjct: 51 EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DM 107
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
Q+ +G+ + + +HRDL+ NIL+ ++++ K+ADFGL+ + Y A +
Sbjct: 108 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 164
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
P+ + APE + R+ K D+WS G +L EL
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 6e-14
Identities = 45/163 (27%), Positives = 79/163 (48%), Gaps = 19/163 (11%)
Query: 23 VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ-----LGA 77
+NHPN+++ LV+EFC G+L +Y+R + + Q A+K + Q + +
Sbjct: 52 LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVAS 111
Query: 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLY 134
GL L+ IH DL N L+ D+ +KI D+GL+ YP +Y + +
Sbjct: 112 GLLWLHQADFIHSDLALRNCQLTA---DLSVKIGDYGLALEQYPEDYYITKDCHAVPLRW 168
Query: 135 MAPEVLQFQRYDEKV-------DMWSVGAILFELL-NGYPPFS 169
+APE+++ + D ++WS+G ++EL P+
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYP 211
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 6e-14
Identities = 47/160 (29%), Positives = 83/160 (51%), Gaps = 13/160 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
E + + H ++ L+ A +E I++V EF G+L +++ + ++P+
Sbjct: 51 EAQIMKKLRHDKLVPLY-AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLV--DM 107
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
Q+ G+ + + IHRDL+ NIL+ D+++ KIADFGL+ + Y A +
Sbjct: 108 AAQIADGMAYIERMNYIHRDLRAANILVG---DNLVCKIADFGLARLIEDNEYTARQGAK 164
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
P+ + APE + R+ K D+WS G +L EL+ G P+
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-13
Identities = 58/178 (32%), Positives = 83/178 (46%), Gaps = 30/178 (16%)
Query: 16 ELNFLSSVNHPNIIRL----------FDAFQAENCIFLVVEFCAG---GNLSSYIRLHGR 62
E+ L +NH NI+ L D + + +LV E+ G L S G
Sbjct: 56 EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLES-----GL 110
Query: 63 V--PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
V E + F++QL GL + + +HRD+K NIL L++ +K+ADFGL+ LY
Sbjct: 111 VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNIL---LNNKGQIKLADFGLA-RLY 166
Query: 121 PGN----YAEKVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 173
Y KV + Y PE +L +RY +D+WS G IL EL P F +E
Sbjct: 167 NSEESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-13
Identities = 49/160 (30%), Positives = 84/160 (52%), Gaps = 13/160 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGR---VPEQTARKF 71
E + + H +++L+ A +E I++V E+ + G+L +++ GR +P
Sbjct: 51 EAQIMKKLRHDKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLV--DM 107
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
Q+ AG+ + + IHRDL+ NIL+ D ++ KIADFGL+ + Y A +
Sbjct: 108 AAQVAAGMAYIERMNYIHRDLRSANILVG---DGLVCKIADFGLARLIEDNEYTARQGAK 164
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
P+ + APE + R+ K D+WS G +L EL+ G P+
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-13
Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 21/174 (12%)
Query: 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
NK+ ++ E+ +S + PNIIRL + + ++ E+ G+L+ ++ H E
Sbjct: 59 NKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRH-EPQE 117
Query: 66 Q------------TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
T Q+ +G++ L+S + +HRDL N L+ + +KIADF
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG---KNYTIKIADF 174
Query: 114 GLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
G+S LY G+Y ++ G + +M+ E + ++ D+W+ G L+E+L
Sbjct: 175 GMSRNLYSGDYY-RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-13
Identities = 45/164 (27%), Positives = 76/164 (46%), Gaps = 10/164 (6%)
Query: 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTA 68
K LD E ++SV++P++ RL + + L+ + G L Y+R H + Q
Sbjct: 54 KEILD-EAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL 111
Query: 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
+ Q+ G+ L ++HRDL N+L+ +KI DFGL+ L
Sbjct: 112 LNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGADEKEYHA 168
Query: 129 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
G + +MA E + + Y + D+WS G ++EL+ G P+
Sbjct: 169 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 5e-13
Identities = 42/109 (38%), Positives = 61/109 (55%), Gaps = 14/109 (12%)
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGS- 131
Q+ G+E L S IHRDL NILLS ++ ++KI DFGL+ +Y +Y K G
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRK--GDA 235
Query: 132 --PL-YMAPEVLQFQRYDEKVDMWSVGAILFELL----NGYPPFSVGEE 173
PL +MAPE + + Y + D+WS G +L+E+ + YP + EE
Sbjct: 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 7e-13
Identities = 46/160 (28%), Positives = 77/160 (48%), Gaps = 18/160 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQT 67
E + + +++RL +V+E A G+L SY+R GR P T
Sbjct: 59 EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPT 117
Query: 68 ARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 124
++ +Q ++ G+ LN+ +HRDL N +++ D +KI DFG++ +Y +Y
Sbjct: 118 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIYETDY 174
Query: 125 AEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
K L +MAPE L+ + DMWS G +L+E+
Sbjct: 175 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 7e-13
Identities = 44/109 (40%), Positives = 63/109 (57%), Gaps = 14/109 (12%)
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGS- 131
Q+ G+E L S IHRDL NILLS +++V +KI DFGL+ +Y +Y K GS
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLS--ENNV-VKICDFGLARDIYKDPDYVRK--GSA 236
Query: 132 --PL-YMAPEVLQFQRYDEKVDMWSVGAILFELL----NGYPPFSVGEE 173
PL +MAPE + + Y + D+WS G +L+E+ + YP + EE
Sbjct: 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE 285
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 9e-13
Identities = 56/170 (32%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 13 LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARK 70
L EL+ NHPNI+ F A+N +++V F A G+ I H + E
Sbjct: 46 LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAY 105
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--- 127
LQ + L+ ++ +HR +K +IL+S +D V L GL L N+ ++
Sbjct: 106 ILQGVLKALDYIHHMGYVHRSVKASHILIS-VDGKVYLS----GLRSNLSMINHGQRLRV 160
Query: 128 VCGSPLY-------MAPEVLQ--FQRYDEKVDMWSVGAILFELLNGYPPF 168
V P Y ++PEVLQ Q YD K D++SVG EL NG+ PF
Sbjct: 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-12
Identities = 50/156 (32%), Positives = 81/156 (51%), Gaps = 16/156 (10%)
Query: 16 ELNFLSSVNHPNIIRL----FDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARK 70
E+ L S+ H NI++ + A + LV+E+ G+L Y++ H R+ +
Sbjct: 55 EIEILKSLQHDNIVKYKGVCYSA--GRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLL 112
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEK 127
+ Q+ G+E L S +HRDL NIL ++ + +KI DFGL+ L P + Y +
Sbjct: 113 YASQICKGMEYLGSKRYVHRDLATRNIL---VESENRVKIGDFGLTKVL-PQDKEYYKVR 168
Query: 128 VCG-SPLY-MAPEVLQFQRYDEKVDMWSVGAILFEL 161
G SP++ APE L ++ D+WS G +L+EL
Sbjct: 169 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-12
Identities = 41/154 (26%), Positives = 73/154 (47%), Gaps = 6/154 (3%)
Query: 12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARK 70
E L +H NI+RL N + +V E+ + G L S++R H G++
Sbjct: 52 GFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMG 111
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG-LSCTLYPGNYAEKVC 129
L L +G++ L+ +H+ L +L++ D++ KI+ F L Y
Sbjct: 112 MLPGLASGMKYLSEMGYVHKGLAAHKVLVN---SDLVCKISGFRRLQEDKSEAIYTTMSG 168
Query: 130 GSP-LYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
SP L+ APE +Q+ + D+WS G +++E++
Sbjct: 169 KSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-12
Identities = 45/159 (28%), Positives = 75/159 (47%), Gaps = 28/159 (17%)
Query: 16 ELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARK 70
E L ++HP ++ L D C+ L +L +Y+ R + + TA
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS---DLYTYLGARLRPLGLAQVTA-- 264
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG 130
+QL + ++ ++ IIHRD+K EN+L++G +D + + DFG +C +A
Sbjct: 265 VARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED---ICLGDFGAAC------FARGSWS 315
Query: 131 SPLYM---------APEVLQFQRYDEKVDMWSVGAILFE 160
+P + APEVL Y VD+WS G ++FE
Sbjct: 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-12
Identities = 41/107 (38%), Positives = 60/107 (56%), Gaps = 10/107 (9%)
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGS- 131
Q+ G+E L S IHRDL NILLS ++ ++KI DFGL+ +Y +Y K
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELL----NGYPPFSVGEE 173
PL +MAPE + + Y + D+WS G +L+E+ + YP + EE
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 290
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-12
Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFL 72
E+ L ++ H NI++ + N I L++EF G+L Y+ R ++ + K+
Sbjct: 56 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYA 115
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY--PGNYAEK-VC 129
Q+ G++ L S +HRDL N+L ++ + +KI DFGL+ + Y K
Sbjct: 116 VQICKGMDYLGSRQYVHRDLAARNVL---VESEHQVKIGDFGLTKAIETDKEYYTVKDDL 172
Query: 130 GSPLY-MAPEVLQFQRYDEKVDMWSVGAILFELL 162
SP++ APE L ++ D+WS G L+ELL
Sbjct: 173 DSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-12
Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 18/162 (11%)
Query: 23 VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ----QLGAG 78
+ HPNI++ LV E+C G+L SY+ + LQ ++ AG
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111
Query: 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE---KVCGSPLYM 135
+ ++ H+ +H DL N L+ D+ +K+ D+G+ + Y +Y E C ++
Sbjct: 112 VTHMHKHNFLHSDLALRNCFLTS---DLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL 168
Query: 136 APE-VLQFQ------RYDEKVDMWSVGAILFELL-NGYPPFS 169
APE V +F + ++W++G L+EL N P+S
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-12
Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 10/154 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E + L ++NHP+II+L F L++ +L Y+ + + +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSV 191
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP----GNYAEKVCGS 131
++ L+ + IIHRD+K ENI ++ D + + DFG +C +P N G+
Sbjct: 192 LRAIQYLHENRIIHRDIKAENIFINHPGD---VCLGDFGAAC--FPVDINANKYYGWAGT 246
Query: 132 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165
APE+L Y VD+WS G +LFE+ +
Sbjct: 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 4e-12
Identities = 42/160 (26%), Positives = 77/160 (48%), Gaps = 18/160 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------T 67
E + + N +++RL +++E G+L SY+R R + +
Sbjct: 59 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR-SLRPEMENNPVQAPPS 117
Query: 68 ARKFLQQLGA---GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 124
+K +Q G G+ LN++ +HRDL N +++ +D +KI DFG++ +Y +Y
Sbjct: 118 LKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDY 174
Query: 125 AEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
K L +M+PE L+ + D+WS G +L+E+
Sbjct: 175 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 6e-12
Identities = 40/166 (24%), Positives = 73/166 (43%), Gaps = 21/166 (12%)
Query: 11 SCLDCELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
+ L E L ++H NI+ + + F++ + GNL +++ +
Sbjct: 53 TLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQ 112
Query: 70 KFLQ--------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
Q+ G+ L+ +IH+D+ N ++ D+++ +KI D LS L+P
Sbjct: 113 ALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKITDNALSRDLFP 169
Query: 122 GNYAEKVC-----GSPL-YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
+Y C P+ +MA E L + Y D+WS G +L+EL
Sbjct: 170 MDYH---CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWEL 212
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 2e-11
Identities = 41/154 (26%), Positives = 75/154 (48%), Gaps = 9/154 (5%)
Query: 20 LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAG 78
++S++HP+++RL + I LV + G L Y+ H + Q + Q+ G
Sbjct: 63 MASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKG 121
Query: 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YM 135
+ L ++HRDL N+L+ + +KI DFGL+ L G + +M
Sbjct: 122 MMYLEERRLVHRDLAARNVLVKSPNH---VKITDFGLARLLEGDEKEYNADGGKMPIKWM 178
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
A E + ++++ + D+WS G ++EL+ G P+
Sbjct: 179 ALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-11
Identities = 49/170 (28%), Positives = 83/170 (48%), Gaps = 14/170 (8%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
++K++N + S E+ + + HPNI++L ++E +L+ E+ G NLS +R
Sbjct: 719 VVKEIND-VNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-- 775
Query: 61 GRVPEQTARKFLQQLGAGLEILNSH---HIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
+ + RK + L L+ ++ +L PE I++ G D+ L+++ GL C
Sbjct: 776 -NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG-KDEPHLRLSLPGLLC 833
Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167
T K S Y+APE + + EK D++ G IL ELL G P
Sbjct: 834 T------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 4e-11
Identities = 39/112 (34%), Positives = 56/112 (50%), Gaps = 8/112 (7%)
Query: 62 RVPEQTARKFLQQLGAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
+PE K + LE L+S +IHRD+KP N+L ++ + +K+ DFG+S L
Sbjct: 99 TIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVL---INRNGQVKLCDFGISGYLV 155
Query: 121 PGNYAEKVCGSPLYMAPE----VLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
G YMAPE L + YD K D+WS+G + EL G P+
Sbjct: 156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY 207
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 9e-10
Identities = 38/103 (36%), Positives = 55/103 (53%), Gaps = 12/103 (11%)
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVC 129
F Q+ G+E L S + +HRDL N+LL+ ++KI DFGL+ ++ NY K
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLA---QGKIVKICDFGLARDIMHDSNYVSK-- 296
Query: 130 GSPL----YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
GS +MAPE + Y D+WS G +L+E+ L G P
Sbjct: 297 GSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTP 339
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 1e-09
Identities = 43/167 (25%), Positives = 79/167 (47%), Gaps = 21/167 (12%)
Query: 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVV---EFCAGGNLSSYI-----RLH 60
L+ E+ L +NH NI+++ + ++E +++ +F +L S++
Sbjct: 206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWK 261
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL- 119
R + R ++QL +E ++ +IHRD+K ENI L+ D + + DFG +
Sbjct: 262 DRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC---DGKIVLGDFGTAMPFE 318
Query: 120 ---YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
+Y G+ +PE+L Y E D+WS G IL ++L+
Sbjct: 319 KEREAFDYG--WVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-09
Identities = 42/144 (29%), Positives = 63/144 (43%), Gaps = 16/144 (11%)
Query: 35 FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH-HIIHRDLK 93
FQ E +V G L +I HG + + + Q G L+ ++ H++H DLK
Sbjct: 200 FQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLK 259
Query: 94 PENILLSGLD-------------DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL 140
PENIL+ D D ++I D G C A + + Y +PEV+
Sbjct: 260 PENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTA--IVSTRHYRSPEVV 317
Query: 141 QFQRYDEKVDMWSVGAILFELLNG 164
+ DMWS+G I++EL G
Sbjct: 318 LGLGWMYSTDMWSMGCIIYELYTG 341
|
Length = 467 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-09
Identities = 41/112 (36%), Positives = 60/112 (53%), Gaps = 14/112 (12%)
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVC 129
F Q+ G+E L S + +HRDL N+L+ + ++KI DFGL+ + NY K
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLIC---EGKLVKICDFGLARDIMRDSNYISK-- 298
Query: 130 GS---PL-YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNG--YPPFSVGEE 173
GS PL +MAPE + Y D+WS G +L+E+ L G YP + E+
Sbjct: 299 GSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-09
Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 10/164 (6%)
Query: 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTA 68
K LD E ++ V P + RL + + LV + G L Y+R + R+ Q
Sbjct: 54 KEILD-EAYVMAGVGSPYVCRLL-GICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDL 111
Query: 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
+ Q+ G+ L ++HRDL N+L+ + +KI DFGL+ L
Sbjct: 112 LNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH---VKITDFGLARLLDIDETEYHA 168
Query: 129 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
G + +MA E + +R+ + D+WS G ++EL+ G P+
Sbjct: 169 DGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 4e-09
Identities = 36/113 (31%), Positives = 56/113 (49%), Gaps = 26/113 (23%)
Query: 77 AGLEILNSHHIIHRDLKPENILLS----------------GLDDDVMLKIADFGLSCTLY 120
A +E ++S ++HRDLKP+NILL L+++ +L I D Y
Sbjct: 124 ATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDI-DVDERNICY 182
Query: 121 -----PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
PG K+ G+P YMAPE L E D++++G IL+++L P+
Sbjct: 183 SSMTIPG----KIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 5e-09
Identities = 39/126 (30%), Positives = 59/126 (46%), Gaps = 18/126 (14%)
Query: 51 GNLSSYIRLHGR-VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLK 109
+L+ + + GR + E+ Q L L HR K NILL+ D +LK
Sbjct: 1 VSLADILEVRGRPLNEEEIWAVCLQCLGALREL------HRQAKSGNILLT---WDGLLK 51
Query: 110 IADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
+ G S + P +MAPEV+Q Q Y EK D++S+G L+E L+ P++
Sbjct: 52 L--DG-SVAFKTPEQSR---PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYN 105
Query: 170 VGEEHQ 175
EE +
Sbjct: 106 --EERE 109
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-08
Identities = 52/183 (28%), Positives = 87/183 (47%), Gaps = 30/183 (16%)
Query: 9 LKSCLDCELNFLSS-------VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L++C + L L + HPNI+ + F + ++++ F A G+ +S ++ +
Sbjct: 35 LENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTY- 93
Query: 62 RVPEQTARKFLQQL--GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS- 116
PE + + + GA GL L+ + IHR++K +IL+SG D V L GLS
Sbjct: 94 -FPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISG-DGLVSLS----GLSH 147
Query: 117 --CTLYPGNYAEKVCGSPLY-------MAPEVLQ--FQRYDEKVDMWSVGAILFELLNGY 165
+ G A+ V P + ++PE+L+ Y+ K D++SVG EL G
Sbjct: 148 LYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
Query: 166 PPF 168
PF
Sbjct: 208 VPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-08
Identities = 38/110 (34%), Positives = 59/110 (53%), Gaps = 14/110 (12%)
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKV 128
+F Q+ G++ L S + IHRD+ N+LL+ D + KI DFGL+ + NY K
Sbjct: 216 RFSSQVAQGMDFLASKNCIHRDVAARNVLLT---DGRVAKICDFGLARDIMNDSNYVVK- 271
Query: 129 CGS---PL-YMAPEVLQFQRYDEKVDMWSVGAILFEL----LNGYPPFSV 170
G+ P+ +MAPE + Y + D+WS G +L+E+ + YP V
Sbjct: 272 -GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV 320
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 5e-08
Identities = 20/43 (46%), Positives = 29/43 (67%)
Query: 126 EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
E++ G+P Y+APE+L + + VD W++G LFE L G PPF
Sbjct: 538 ERILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPF 580
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 6e-08
Identities = 46/164 (28%), Positives = 77/164 (46%), Gaps = 21/164 (12%)
Query: 22 SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA--RKFLQQLG--- 76
S+ H N+++ LV+EFC G+L Y+R R E LQ++
Sbjct: 51 SLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSC-RKAELMTPDPTTLQRMACEI 109
Query: 77 -AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSP 132
GL L+ ++ IH DL N LL+ D+ +KI D+GLS Y +Y +++
Sbjct: 110 ALGLLHLHKNNFIHSDLALRNCLLTA---DLTVKIGDYGLSHNKYKEDYYVTPDQLWVPL 166
Query: 133 LYMAPEV-------LQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
++APE+ L ++ ++WS+G ++EL G P+
Sbjct: 167 RWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 8e-08
Identities = 39/106 (36%), Positives = 56/106 (52%), Gaps = 16/106 (15%)
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVC 129
F Q+ G+ L S + IHRDL NILL+ + KI DFGL+ + NY K
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIRNDSNYVVK-- 273
Query: 130 GS---PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVG 171
G+ P+ +MAPE + Y + D+WS G +L+E+ FS+G
Sbjct: 274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI------FSLG 313
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 7e-06
Identities = 35/129 (27%), Positives = 59/129 (45%), Gaps = 16/129 (12%)
Query: 51 GNLSSYIRLHGRVPEQTA---------RKFLQQLGAGLEILNSHHIIHRDLKPENILLSG 101
G L ++ ++P+ + ++Q+ GL L+ I+HRD+KPEN+L++
Sbjct: 285 GCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTV 344
Query: 102 LDDDVMLKIADFGLSCTLYPGNYAEKVCG--SPLYMAPEVLQFQRYDEKVDMWSVGAIL- 158
D +KI DFG + + G + G P Y PE L + + ++ A+L
Sbjct: 345 ---DGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLS 401
Query: 159 -FELLNGYP 166
F L G P
Sbjct: 402 PFAWLYGRP 410
|
Length = 507 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-05
Identities = 27/72 (37%), Positives = 39/72 (54%), Gaps = 4/72 (5%)
Query: 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEK 127
+ ++Q+ L+ L+S I+HRD+KP+NI+ S + KI D G + L G NY K
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFS--EGSGSFKIIDLGAAADLRVGINYIPK 315
Query: 128 -VCGSPLYMAPE 138
P Y APE
Sbjct: 316 EFLLDPRYAAPE 327
|
Length = 566 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-05
Identities = 41/133 (30%), Positives = 63/133 (47%), Gaps = 10/133 (7%)
Query: 43 LVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS- 100
+V EF G L +R GRVP QQL + L L +++H ++ +NILL+
Sbjct: 93 MVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLAR 152
Query: 101 -GLDDDVM--LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGA 156
GL + +K++D G+S T + E+V P ++APE + D WS G
Sbjct: 153 LGLAEGTSPFIKLSDPGVSFTAL--SREERVERIP-WIAPECVPGGNSLSTAADKWSFGT 209
Query: 157 ILFEL-LNGYPPF 168
L E+ +G P
Sbjct: 210 TLLEICFDGEVPL 222
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 9e-05
Identities = 38/175 (21%), Positives = 81/175 (46%), Gaps = 15/175 (8%)
Query: 1 MLKKLNKHLKSCLDCEL---NFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
+LK L+K ++ + + +S ++H +++ + + +V E+ G+L +Y+
Sbjct: 31 LLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYL 90
Query: 58 RL-HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV-----MLKIA 111
+ + + +QL L L + H ++ +N+LL +D +K++
Sbjct: 91 KKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLS 150
Query: 112 DFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNG 164
D G+S T+ P E++ P ++ PE ++ Q D WS G L+E+ +G
Sbjct: 151 DPGISITVLPKEILLERI---P-WVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 1e-04
Identities = 37/159 (23%), Positives = 72/159 (45%), Gaps = 14/159 (8%)
Query: 20 LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF--LQQLGA 77
+S ++H ++++L+ + I +V E+ G L ++ K +QL +
Sbjct: 55 MSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNV-SLHWKLDVAKQLAS 112
Query: 78 GLEILNSHHIIHRDLKPENILLSGLDDDV----MLKIADFGLSCTLYPGNYAEKVCGSPL 133
L L ++H ++ +NIL++ + +K++D G+ T+ + E+V P
Sbjct: 113 ALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV--LSREERVERIP- 169
Query: 134 YMAPEVLQ--FQRYDEKVDMWSVGAILFELL-NGYPPFS 169
++APE ++ D WS G L E+ NG P S
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLS 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 3e-04
Identities = 46/174 (26%), Positives = 82/174 (47%), Gaps = 23/174 (13%)
Query: 18 NFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF--LQQL 75
+ + V+H +I+ L+ + +V EF G L ++ T KF +QL
Sbjct: 56 SMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD-VLTTPWKFKVAKQL 114
Query: 76 GAGLEILNSHHIIHRDLKPENILLS--GLDDDV--MLKIADFGLSCTLYPGNYAEKVCGS 131
+ L L ++H ++ +NILL+ G+D + +K++D G+ T+ + E V
Sbjct: 115 ASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVL--SRQECVERI 172
Query: 132 PLYMAPEVLQFQRYDEKV-----DMWSVGAILFEL-LNGYPPF---SVGEEHQF 176
P ++APE ++ D K D WS G L+E+ NG P ++ E+ +F
Sbjct: 173 P-WIAPECVE----DSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF 221
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 3e-04
Identities = 41/178 (23%), Positives = 77/178 (43%), Gaps = 17/178 (9%)
Query: 2 LKKLNKHLKSCLDC---ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNL 53
KK +K K +D E+ L ++ NI++++ F + + L++E+C G L
Sbjct: 51 FKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY-GFIIDIVDDLPRLSLILEYCTRGYL 109
Query: 54 SSYIRLHGRVPEQTARKFLQQLGAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIAD 112
+ + +T GL L + +++L + L+ ++ LKI
Sbjct: 110 REVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV---TENYKLKIIC 166
Query: 113 FGLSCTLYPGNYAEKVCGSPLYMAPEVLQ--FQRYDEKVDMWSVGAILFELLNGYPPF 168
GL L + K +Y + ++L F Y K D++S+G +L+E+ G PF
Sbjct: 167 HGLEKILSSPPF--KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF 222
|
Length = 283 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 6e-04
Identities = 29/94 (30%), Positives = 44/94 (46%), Gaps = 13/94 (13%)
Query: 23 VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82
VN P + D +V+E+ G L I +G + +R+ + +G L
Sbjct: 61 VNVP-AVYFVD----PENFIIVMEYIEGEPLKDLINSNGMEELELSREIGRLVG----KL 111
Query: 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
+S IIH DL N++LSG + L I DFGL+
Sbjct: 112 HSAGIIHGDLTTSNMILSG--GKIYL-I-DFGLA 141
|
Length = 211 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 36.6 bits (85), Expect = 0.002
Identities = 26/108 (24%), Positives = 45/108 (41%), Gaps = 15/108 (13%)
Query: 17 LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76
L L+ P + ++ + +++ +L++E+ G L V E+ +QL
Sbjct: 45 LQLLARKGLP-VPKVLASGESDGWSYLLMEWIEGETLDE-------VSEEEKEDIAEQLA 96
Query: 77 AGLEILNSH---HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
L L+ + H DL P NIL +DD +L I D+ P
Sbjct: 97 ELLAKLHQLPLLVLCHGDLHPGNIL---VDDGKILGIIDWE-YAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 177 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.98 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.98 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.98 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.98 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.98 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.98 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.98 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.98 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.98 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.98 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.98 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.98 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.98 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.98 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.98 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.98 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.98 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.98 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.98 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.98 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.98 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.98 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.98 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.98 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.98 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.94 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.91 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.91 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.91 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.83 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.78 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.77 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.74 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.74 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.72 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.7 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.7 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.68 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.65 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.63 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.62 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.55 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.5 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.48 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.45 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.45 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.44 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.42 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.41 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.4 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.31 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.29 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.28 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.28 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.21 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.2 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.2 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.1 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.91 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.9 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.9 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.89 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.86 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.84 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.67 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.65 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.56 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.33 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.26 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.15 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.15 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.08 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.04 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.91 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.84 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.78 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.7 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.66 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.52 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.23 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.22 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.19 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.0 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.79 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.72 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.49 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.03 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 95.93 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.87 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.84 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 95.27 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 95.11 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.65 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 94.61 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 94.58 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 94.48 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 94.41 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 94.18 | |
| PLN02236 | 344 | choline kinase | 93.47 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 92.55 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 92.17 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 92.11 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 92.04 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 91.92 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 91.88 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 91.82 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 91.73 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 90.84 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 90.8 | |
| PRK14559 | 645 | putative protein serine/threonine phosphatase; Pro | 90.68 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 90.6 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=269.19 Aligned_cols=172 Identities=52% Similarity=0.958 Sum_probs=160.1
Q ss_pred cchhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 5 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
+.+..++.+..|+.+|+.++|||||.++++..+++.+|+|||||.||+|.+|+.+.+.+++.+++.++.|++.|+++||+
T Consensus 48 l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~ 127 (429)
T KOG0595|consen 48 LNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHE 127 (429)
T ss_pred cCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46678899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCC---eeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDD---VMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~ 161 (177)
++|+||||||.||+++..... ..+|+.|||+++...+.....+.+|++.|||||++....|+.+.|+||+|+++|++
T Consensus 128 ~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~ 207 (429)
T KOG0595|consen 128 NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQC 207 (429)
T ss_pred CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHH
Confidence 999999999999999764222 67999999999999888888889999999999999999999999999999999999
Q ss_pred HhCCCCCCCCCcccC
Q 030430 162 LNGYPPFSVGEEHQF 176 (177)
Q Consensus 162 ~~~~~pf~~~~~~~~ 176 (177)
++|..||...+..++
T Consensus 208 l~g~~Pf~a~t~~eL 222 (429)
T KOG0595|consen 208 LTGKPPFDAETPKEL 222 (429)
T ss_pred HhCCCCccccCHHHH
Confidence 999999997665543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=259.11 Aligned_cols=165 Identities=39% Similarity=0.714 Sum_probs=151.2
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
...+++|+++|++|+|||||+++++++.....|||+||+.||+|.+.+-.++.+.+..-+.++.|++.|+.|||++||+|
T Consensus 220 ~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~H 299 (475)
T KOG0615|consen 220 TRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIH 299 (475)
T ss_pred hhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCccc
Confidence 34478999999999999999999999999999999999999999999998989999999999999999999999999999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCC--C-CcchHHHHHHHHHHHHhCCC
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY--D-EKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~--~-~~~Di~slg~~~~~~~~~~~ 166 (177)
|||||+||++...++...+|++|||+++..+......+.+||+.|.|||.+.+... . .+.|+|||||++|-+++|.+
T Consensus 300 RDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~p 379 (475)
T KOG0615|consen 300 RDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYP 379 (475)
T ss_pred ccCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCC
Confidence 99999999998656678899999999999888888889999999999999976553 3 37799999999999999999
Q ss_pred CCCCCCcc
Q 030430 167 PFSVGEEH 174 (177)
Q Consensus 167 pf~~~~~~ 174 (177)
||++...+
T Consensus 380 PFS~~~~~ 387 (475)
T KOG0615|consen 380 PFSEEYTD 387 (475)
T ss_pred CcccccCC
Confidence 99886543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=249.06 Aligned_cols=162 Identities=34% Similarity=0.589 Sum_probs=151.5
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCC-eEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
+++.++.+.+|+++++..+||+||++++.|..++ .+.++||||.||+|++.+...+.+++..+.+++.+++.+|.|||+
T Consensus 117 ~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~ 196 (364)
T KOG0581|consen 117 DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHE 196 (364)
T ss_pred CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 8899999999999999999999999999999988 499999999999999999988889999999999999999999996
Q ss_pred -CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh
Q 030430 85 -HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 85 -~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~ 163 (177)
.+|+||||||+|+++ +..+++||||||.+...-.. ...+..||..|||||.+.+..|+.++||||||..++|+++
T Consensus 197 ~~~IIHRDIKPsNlLv---NskGeVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~ 272 (364)
T KOG0581|consen 197 ERKIIHRDIKPSNLLV---NSKGEVKICDFGVSGILVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAI 272 (364)
T ss_pred ccCeeeccCCHHHeee---ccCCCEEeccccccHHhhhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhh
Confidence 899999999999999 57889999999999777555 4556679999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 030430 164 GYPPFSVG 171 (177)
Q Consensus 164 ~~~pf~~~ 171 (177)
|+.||...
T Consensus 273 GrfP~~~~ 280 (364)
T KOG0581|consen 273 GRFPYPPP 280 (364)
T ss_pred CCCCCCCc
Confidence 99999774
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=257.17 Aligned_cols=164 Identities=36% Similarity=0.686 Sum_probs=155.5
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
++..++++.+|+++.++|+|||||+++++|+|+++.|+|.|+|..++|..++++.+.++|..++.++.||+.++.|||+.
T Consensus 58 k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~ 137 (592)
T KOG0575|consen 58 KPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL 137 (592)
T ss_pred CcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc
Confidence 67789999999999999999999999999999999999999999999999999888999999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCC-CccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhC
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~ 164 (177)
+|+|||+|..|+++ +...++|++|||+|.....+ ....+.+||+.|.|||++.....+..+||||+||++|-++.|
T Consensus 138 ~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G 214 (592)
T KOG0575|consen 138 GIIHRDLKLGNLFL---NENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVG 214 (592)
T ss_pred Cceecccchhheee---cCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhC
Confidence 99999999999999 57788999999999988755 667789999999999999988999999999999999999999
Q ss_pred CCCCCCCC
Q 030430 165 YPPFSVGE 172 (177)
Q Consensus 165 ~~pf~~~~ 172 (177)
++||...+
T Consensus 215 ~PPFetk~ 222 (592)
T KOG0575|consen 215 RPPFETKT 222 (592)
T ss_pred CCCcccch
Confidence 99998764
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=244.06 Aligned_cols=163 Identities=41% Similarity=0.715 Sum_probs=151.8
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+...+|..+|.+++||.||+++..|++.+.+|+|+||+.||.|..++.+.+.++++.++.++++|+.||.|||+.||
T Consensus 67 ~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gI 146 (357)
T KOG0598|consen 67 KEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGI 146 (357)
T ss_pred hhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCe
Confidence 34677899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccC-CCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
+|||+||+|||+ +..+.++|+|||+++..- .+..+.+.+||+.|+|||.+.+.+++.++|-||||+++|+|++|.+
T Consensus 147 iyRDlKPENILL---d~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~p 223 (357)
T KOG0598|consen 147 IYRDLKPENILL---DEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKP 223 (357)
T ss_pred eeccCCHHHeee---cCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCC
Confidence 999999999999 688999999999998644 3455566789999999999999999999999999999999999999
Q ss_pred CCCCCCc
Q 030430 167 PFSVGEE 173 (177)
Q Consensus 167 pf~~~~~ 173 (177)
||.+.+.
T Consensus 224 PF~~~~~ 230 (357)
T KOG0598|consen 224 PFYAEDV 230 (357)
T ss_pred CCcCccH
Confidence 9988764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=229.31 Aligned_cols=161 Identities=38% Similarity=0.742 Sum_probs=151.3
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+...+|.++|+.+.||.++++++.+.+.+.+|+||||++||.|..++++.+.+++..++.+++|++.|++|||++++
T Consensus 86 KQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~i 165 (355)
T KOG0616|consen 86 KQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDI 165 (355)
T ss_pred HHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCe
Confidence 34566788999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
++||+||+||++ +..+.++++|||.+++.... +.+.+||+.|+|||.+.+.++..+.|=||||+++|||+.|++|
T Consensus 166 iYRDLKPENiLl---D~~G~iKitDFGFAK~v~~r--T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pP 240 (355)
T KOG0616|consen 166 IYRDLKPENLLL---DQNGHIKITDFGFAKRVSGR--TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPP 240 (355)
T ss_pred eeccCChHHeee---ccCCcEEEEeccceEEecCc--EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCC
Confidence 999999999999 68899999999999887655 5578899999999999999999999999999999999999999
Q ss_pred CCCCCc
Q 030430 168 FSVGEE 173 (177)
Q Consensus 168 f~~~~~ 173 (177)
|.+.++
T Consensus 241 F~~~~~ 246 (355)
T KOG0616|consen 241 FYDDNP 246 (355)
T ss_pred CcCCCh
Confidence 987654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=235.14 Aligned_cols=164 Identities=33% Similarity=0.637 Sum_probs=146.0
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeE-EE-eeCCeEEEEEecCCCCChHHHHhhc----CCCCHHHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFD-AF-QAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGL 79 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~-~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l 79 (177)
++..++....|+.+|++|+||||+++++ .+ ++...++++||+|.+|+|.+.++.. ..+++..+|+++.|++.||
T Consensus 58 d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL 137 (375)
T KOG0591|consen 58 DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRAL 137 (375)
T ss_pred cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHH
Confidence 5677889999999999999999999998 44 4455599999999999999988732 3499999999999999999
Q ss_pred HHHhh--CC--CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccCCCCCcchHHHH
Q 030430 80 EILNS--HH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSV 154 (177)
Q Consensus 80 ~~lh~--~~--~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~sl 154 (177)
..+|. .. +.||||||.||++ +..+.+||+|||+++.+.+.. ...+..|||.||+||.+.+.+++.+|||||+
T Consensus 138 ~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWsl 214 (375)
T KOG0591|consen 138 YHCHSKIPRGTVMHRDIKPANIFL---TANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSL 214 (375)
T ss_pred HHHhccccccceeeccCcchheEE---cCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHH
Confidence 99999 44 9999999999999 578899999999998886654 3456779999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCC
Q 030430 155 GAILFELLNGYPPFSVGE 172 (177)
Q Consensus 155 g~~~~~~~~~~~pf~~~~ 172 (177)
||++|||+..++||.+++
T Consensus 215 GCllyEMcaL~~PF~g~n 232 (375)
T KOG0591|consen 215 GCLLYEMCALQSPFYGDN 232 (375)
T ss_pred HHHHHHHHhcCCCccccc
Confidence 999999999999999873
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=240.58 Aligned_cols=161 Identities=37% Similarity=0.597 Sum_probs=145.4
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCC-eEEEEEecCCCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
.+.|.+|+.+|.+++|||||+++|++.++. .+++||||+++|+|.+++.. ...++...+..++.||+.++.|||+++
T Consensus 83 ~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~ 162 (362)
T KOG0192|consen 83 RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEG 162 (362)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 679999999999999999999999999887 79999999999999999987 467999999999999999999999999
Q ss_pred -CeeecCCCCcEEEecCCCCe-eEEEeeeccccccCCC-CccccccCCCccccccccc--cCCCCCcchHHHHHHHHHHH
Q 030430 87 -IIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ--FQRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 87 -~~H~~i~~~nil~~~~~~~~-~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~--~~~~~~~~Di~slg~~~~~~ 161 (177)
++|+|+||+|+++ +... .+||+|||+++..... .......||..|||||.+. ...++.++||||+|+++||+
T Consensus 163 ~iIHrDLK~~NiLv---~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl 239 (362)
T KOG0192|consen 163 PIIHRDLKSDNILV---DLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWEL 239 (362)
T ss_pred CeeecccChhhEEE---cCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHH
Confidence 9999999999999 4564 8999999999776554 3333367899999999998 56899999999999999999
Q ss_pred HhCCCCCCCCCc
Q 030430 162 LNGYPPFSVGEE 173 (177)
Q Consensus 162 ~~~~~pf~~~~~ 173 (177)
+||+.||.+...
T Consensus 240 ~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 240 LTGEIPFEDLAP 251 (362)
T ss_pred HHCCCCCCCCCH
Confidence 999999987653
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=242.39 Aligned_cols=164 Identities=37% Similarity=0.658 Sum_probs=149.0
Q ss_pred hhHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
+.-.+.+..|...|.+| .||.|++++..|.|...+|+|+||+++|+|.+++.+.+.|++.-.+-++.+|+.|++|||++
T Consensus 114 e~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~ 193 (604)
T KOG0592|consen 114 EKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSN 193 (604)
T ss_pred hcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhc
Confidence 33456788899999999 89999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--------------cccccCCCccccccccccCCCCCcchH
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------------AEKVCGSPLYMAPEVLQFQRYDEKVDM 151 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--------------~~~~~~~~~~~~pe~~~~~~~~~~~Di 151 (177)
||+||||||+|||+ ++++.++|.|||.++.+.+... .....||..|++||++.....++++|+
T Consensus 194 GIIHRDlKPENILL---d~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDi 270 (604)
T KOG0592|consen 194 GIIHRDLKPENILL---DKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDL 270 (604)
T ss_pred CceeccCChhheeE---cCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccch
Confidence 99999999999999 6889999999999977643211 123568899999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCc
Q 030430 152 WSVGAILFELLNGYPPFSVGEE 173 (177)
Q Consensus 152 ~slg~~~~~~~~~~~pf~~~~~ 173 (177)
|+|||++|+|+.|++||.+.++
T Consensus 271 WAlGCilyQmlaG~PPFra~Ne 292 (604)
T KOG0592|consen 271 WALGCILYQMLAGQPPFRAANE 292 (604)
T ss_pred HHHHHHHHHHhcCCCCCccccH
Confidence 9999999999999999998765
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=232.83 Aligned_cols=167 Identities=29% Similarity=0.551 Sum_probs=147.0
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
++..+.-..+|+++|++|+|+|+|.++++|.....+++|+|||+. ++.+.++.. ..++++.+.+++.|++.|+.|+|+
T Consensus 41 d~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk 119 (396)
T KOG0593|consen 41 DPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHK 119 (396)
T ss_pred cHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhh
Confidence 467788899999999999999999999999999999999999965 555555555 459999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCC-CCccccccCCCcccccccccc-CCCCCcchHHHHHHHHHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~ 162 (177)
.+++||||||+||++ ..++.+||||||.++.... +..-.....|.+|.|||.+.+ ..|++..||||+||++.||+
T Consensus 120 ~n~IHRDIKPENILi---t~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~ 196 (396)
T KOG0593|consen 120 NNCIHRDIKPENILI---TQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELL 196 (396)
T ss_pred cCeecccCChhheEE---ecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHh
Confidence 999999999999999 4788999999999988773 333334567899999999876 67999999999999999999
Q ss_pred hCCCCCCCCCcccC
Q 030430 163 NGYPPFSVGEEHQF 176 (177)
Q Consensus 163 ~~~~pf~~~~~~~~ 176 (177)
+|++.|.++++-+.
T Consensus 197 ~G~pL~PG~SDiDQ 210 (396)
T KOG0593|consen 197 TGEPLWPGRSDIDQ 210 (396)
T ss_pred cCCcCCCCcchHHH
Confidence 99999999887553
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=238.00 Aligned_cols=161 Identities=43% Similarity=0.774 Sum_probs=148.0
Q ss_pred HHHHHHHHHHHHhhCC-CCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
..+.+.+|+.+++.++ ||||+++++++.....+++||||+.||+|.+++...+.+.+..+.++++|++.|++|||++|+
T Consensus 62 ~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi 141 (370)
T KOG0583|consen 62 LDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGI 141 (370)
T ss_pred cchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCE
Confidence 4566779999999998 999999999999999999999999999999999988889999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCC-eeEEEeeecccccc-CCCCccccccCCCccccccccccCC-CC-CcchHHHHHHHHHHHHh
Q 030430 88 IHRDLKPENILLSGLDDD-VMLKIADFGLSCTL-YPGNYAEKVCGSPLYMAPEVLQFQR-YD-EKVDMWSVGAILFELLN 163 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~-~~~~l~d~~~~~~~-~~~~~~~~~~~~~~~~~pe~~~~~~-~~-~~~Di~slg~~~~~~~~ 163 (177)
+||||||+|++++ .. +.+||+|||++... .......+.+|++.|+|||++.+.. |+ .+.|+||+|+++|.|++
T Consensus 142 ~HRDLK~ENilld---~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~ 218 (370)
T KOG0583|consen 142 VHRDLKPENILLD---GNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLC 218 (370)
T ss_pred eeCCCCHHHEEec---CCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHh
Confidence 9999999999994 45 88999999999877 4566677888999999999998877 75 78999999999999999
Q ss_pred CCCCCCCCC
Q 030430 164 GYPPFSVGE 172 (177)
Q Consensus 164 ~~~pf~~~~ 172 (177)
|+.||...+
T Consensus 219 G~~PF~d~~ 227 (370)
T KOG0583|consen 219 GRLPFDDSN 227 (370)
T ss_pred CCCCCCCcc
Confidence 999998854
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=233.93 Aligned_cols=158 Identities=37% Similarity=0.674 Sum_probs=138.6
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCC--eEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
.+.+++|+++|++++|||||++++...... .+++.|||++||+|.+++.+.+ .++++.+..+.+|++.+|+|||++|
T Consensus 58 ~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g 137 (313)
T KOG0198|consen 58 SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG 137 (313)
T ss_pred HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 567999999999999999999999754444 6999999999999999999887 6999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCC-CeeEEEeeeccccccCC----CCccccccCCCcccccccccc-CCCCCcchHHHHHHHHHH
Q 030430 87 IIHRDLKPENILLSGLDD-DVMLKIADFGLSCTLYP----GNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFE 160 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~-~~~~~l~d~~~~~~~~~----~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~ 160 (177)
++|+||||+||++. . ++.++|.|||.+..... ........|++.|+|||.+.. ....+++||||+||++.|
T Consensus 138 ~vH~DiK~~NiLl~---~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvE 214 (313)
T KOG0198|consen 138 IVHCDIKPANILLD---PSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVE 214 (313)
T ss_pred EeccCcccceEEEe---CCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEe
Confidence 99999999999995 4 67899999999877663 122334668999999999984 334469999999999999
Q ss_pred HHhCCCCCCC
Q 030430 161 LLNGYPPFSV 170 (177)
Q Consensus 161 ~~~~~~pf~~ 170 (177)
|+||+.||..
T Consensus 215 M~Tg~~PW~~ 224 (313)
T KOG0198|consen 215 MLTGKPPWSE 224 (313)
T ss_pred ccCCCCcchh
Confidence 9999999986
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=219.25 Aligned_cols=173 Identities=38% Similarity=0.630 Sum_probs=159.3
Q ss_pred cccchhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHH
Q 030430 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82 (177)
Q Consensus 3 ~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l 82 (177)
+++..+..+.+.+|+++-+.|+||||+++.+.+...+..|+|+|++.|++|..-+-....+++..+-..++||+++|.|+
T Consensus 47 ~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yC 126 (355)
T KOG0033|consen 47 KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYC 126 (355)
T ss_pred hhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 45667788999999999999999999999999999999999999999999987776556688899999999999999999
Q ss_pred hhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHH
Q 030430 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 83 h~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~ 162 (177)
|.+||+|||++|.|+++.+.+.+.-+||+|||.+...+.+.......|++.|++||.....+++..+|+|+.|++++-++
T Consensus 127 H~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL 206 (355)
T KOG0033|consen 127 HSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 206 (355)
T ss_pred HhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHH
Confidence 99999999999999999877778889999999999998777777888999999999999999999999999999999999
Q ss_pred hCCCCCCCCCccc
Q 030430 163 NGYPPFSVGEEHQ 175 (177)
Q Consensus 163 ~~~~pf~~~~~~~ 175 (177)
.|++||.+.+.++
T Consensus 207 ~G~~PF~~~~~~r 219 (355)
T KOG0033|consen 207 VGYPPFWDEDQHR 219 (355)
T ss_pred hCCCCCCCccHHH
Confidence 9999999976554
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=243.74 Aligned_cols=168 Identities=38% Similarity=0.732 Sum_probs=155.9
Q ss_pred cchhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 5 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
+..+....+++|+-+|+.+.|||++.++++|++...+|+|.||++||.|.+++.+.+.+++..+.++++||+.++.|||.
T Consensus 51 ~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~ 130 (786)
T KOG0588|consen 51 LSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHA 130 (786)
T ss_pred cccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhh
Confidence 45566788999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCC-CCcchHHHHHHHHHHHHh
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLN 163 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slg~~~~~~~~ 163 (177)
.+++|||+||+|+++ +...++|+.|||+|.....+....+.+|++.|.+||++.+.+| +.++||||.|++++.++|
T Consensus 131 ~~icHRDLKpENlLL---d~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLt 207 (786)
T KOG0588|consen 131 FNICHRDLKPENLLL---DVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLT 207 (786)
T ss_pred hcceeccCCchhhhh---hcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHh
Confidence 999999999999999 5666699999999988777777888899999999999999988 568999999999999999
Q ss_pred CCCCCCCCCccc
Q 030430 164 GYPPFSVGEEHQ 175 (177)
Q Consensus 164 ~~~pf~~~~~~~ 175 (177)
|..||.+.+-..
T Consensus 208 G~LPFdDdNir~ 219 (786)
T KOG0588|consen 208 GKLPFDDDNIRV 219 (786)
T ss_pred CCCCCCCccHHH
Confidence 999999765443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=241.94 Aligned_cols=158 Identities=38% Similarity=0.738 Sum_probs=146.9
Q ss_pred HHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCeee
Q 030430 11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHR 90 (177)
Q Consensus 11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H~ 90 (177)
..+.+|+++++.++||||+.++++|+...++++|+||+.| +|..++...+.++++.+..++.+++.||.|||+.+++|+
T Consensus 46 ~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhr 124 (808)
T KOG0597|consen 46 KNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHR 124 (808)
T ss_pred HHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccc
Confidence 3499999999999999999999999999999999999977 999999999999999999999999999999999999999
Q ss_pred cCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 030430 91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169 (177)
Q Consensus 91 ~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf~ 169 (177)
|+||.||++ ++++.+|+||||+++....+.. .....|++.|||||...+.+++..+|+|||||++||+++|++||-
T Consensus 125 d~kPqniLl---~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~ 201 (808)
T KOG0597|consen 125 DMKPQNILL---EKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY 201 (808)
T ss_pred cCCcceeee---cCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch
Confidence 999999999 6888999999999988876654 345679999999999999999999999999999999999999996
Q ss_pred CCC
Q 030430 170 VGE 172 (177)
Q Consensus 170 ~~~ 172 (177)
..+
T Consensus 202 a~s 204 (808)
T KOG0597|consen 202 ARS 204 (808)
T ss_pred HHH
Confidence 643
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=236.48 Aligned_cols=164 Identities=29% Similarity=0.558 Sum_probs=145.0
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
.+.+.+|+++|++|+|++||++++++..+..+||||||++.|+|.++++. ...++..+...++.||+++++||+++++
T Consensus 245 ~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~ 324 (468)
T KOG0197|consen 245 PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNY 324 (468)
T ss_pred hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCc
Confidence 36788999999999999999999999998899999999999999999997 3459999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcccc--ccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-C
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~--~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-~ 164 (177)
||||+...|||| ++...+|++|||+++.......... ..-...|.|||.+....++.+|||||+|++++|++| |
T Consensus 325 IHRDLAARNiLV---~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G 401 (468)
T KOG0197|consen 325 IHRDLAARNILV---DEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYG 401 (468)
T ss_pred cchhhhhhheee---ccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccC
Confidence 999999999999 5677899999999996554443322 223567999999999999999999999999999999 8
Q ss_pred CCCCCCCCcccC
Q 030430 165 YPPFSVGEEHQF 176 (177)
Q Consensus 165 ~~pf~~~~~~~~ 176 (177)
+.||.+.+..++
T Consensus 402 ~~py~~msn~ev 413 (468)
T KOG0197|consen 402 RVPYPGMSNEEV 413 (468)
T ss_pred CCCCCCCCHHHH
Confidence 999988765543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=231.37 Aligned_cols=166 Identities=32% Similarity=0.662 Sum_probs=147.3
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
......-+..|-.+|...++|++|+++..|++..++|+||||++||++..++.+.+.++++.++.++.+++.|+..+|..
T Consensus 181 ~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~ 260 (550)
T KOG0605|consen 181 KKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQL 260 (550)
T ss_pred hhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHc
Confidence 34446678889999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCC----------------------CCcc------c-----------
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP----------------------GNYA------E----------- 126 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~----------------------~~~~------~----------- 126 (177)
|++||||||+|+++ +..+.+||+|||++..... +... .
T Consensus 261 gyIHRDIKPdNlLi---D~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w 337 (550)
T KOG0605|consen 261 GYIHRDIKPDNLLI---DAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTW 337 (550)
T ss_pred CcccccCChhheee---cCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHH
Confidence 99999999999999 6899999999999843211 0000 0
Q ss_pred ---------cccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcc
Q 030430 127 ---------KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 174 (177)
Q Consensus 127 ---------~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf~~~~~~ 174 (177)
...|||.|+|||++.+.+++..+|-|||||++|||+.|++||.+.++.
T Consensus 338 ~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~ 394 (550)
T KOG0605|consen 338 KRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQ 394 (550)
T ss_pred HhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 124899999999999999999999999999999999999999987654
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=230.44 Aligned_cols=162 Identities=30% Similarity=0.609 Sum_probs=143.2
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
....+.+|.+++.+++|++|+++++.+.+...+|+||||++|++|.+++.+.+.+++..+..++.|++.||+|||+.|++
T Consensus 44 ~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~giv 123 (363)
T cd05628 44 QVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFI 123 (363)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence 44678899999999999999999999999999999999999999999998888899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCC------------------------------------ccccccCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------------------------------------YAEKVCGSP 132 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~------------------------------------~~~~~~~~~ 132 (177)
||||||+||++ +..+.++|+|||++....... ......|++
T Consensus 124 HrDlKp~NILi---~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~ 200 (363)
T cd05628 124 HRDIKPDNLLL---DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTP 200 (363)
T ss_pred ecCCCHHHeEE---CCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCc
Confidence 99999999999 456789999999886532110 011235889
Q ss_pred ccccccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 030430 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 173 (177)
Q Consensus 133 ~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf~~~~~ 173 (177)
.|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+.
T Consensus 201 ~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~ 241 (363)
T cd05628 201 DYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241 (363)
T ss_pred cccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCH
Confidence 99999999888899999999999999999999999987543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=230.35 Aligned_cols=166 Identities=34% Similarity=0.523 Sum_probs=145.1
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeC--CeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEIL 82 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~l 82 (177)
++....-..+|+.+|++|+||||+++.+...+. +.+|+|+||+ .-+|.-++... -.|++.+++.+++|++.+|+||
T Consensus 156 ~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYM-dhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~c 234 (560)
T KOG0600|consen 156 KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYM-DHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYC 234 (560)
T ss_pred CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecc-cchhhhhhcCCCcccChHHHHHHHHHHHHHHHHH
Confidence 355566788999999999999999999987765 7899999999 56999888754 3699999999999999999999
Q ss_pred hhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC--ccccccCCCccccccccccC-CCCCcchHHHHHHHHH
Q 030430 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILF 159 (177)
Q Consensus 83 h~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~ 159 (177)
|.+|++|||||.+|||+ +..+.+||.|||++..+.... .......|.+|.|||++.+. .|+++.|+||.||++.
T Consensus 235 H~~gvlHRDIK~SNiLi---dn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~ 311 (560)
T KOG0600|consen 235 HSRGVLHRDIKGSNILI---DNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILA 311 (560)
T ss_pred hhcCeeeccccccceEE---cCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHH
Confidence 99999999999999999 688999999999998665443 23345578999999998765 5899999999999999
Q ss_pred HHHhCCCCCCCCCccc
Q 030430 160 ELLNGYPPFSVGEEHQ 175 (177)
Q Consensus 160 ~~~~~~~pf~~~~~~~ 175 (177)
||++|++.|.|+++-+
T Consensus 312 El~~gkPI~~G~tEve 327 (560)
T KOG0600|consen 312 ELFLGKPILQGRTEVE 327 (560)
T ss_pred HHHcCCCCcCCccHHH
Confidence 9999999999987654
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=231.55 Aligned_cols=166 Identities=34% Similarity=0.648 Sum_probs=152.5
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCe-EEEEEecCCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEIL 82 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~l 82 (177)
+...++...+|+.+++++.||||+.+.+.|..++. .+|+|+|++||++.+.+.+.+ .++++.++.|+.|++.|+.||
T Consensus 43 t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~yl 122 (426)
T KOG0589|consen 43 TEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYL 122 (426)
T ss_pred CchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence 45556788999999999999999999999988887 999999999999999998654 499999999999999999999
Q ss_pred hhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccCCCCCcchHHHHHHHHHHH
Q 030430 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 83 h~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~ 161 (177)
|+.+++|||+|+.||+.. ....++|+|||+++...+.. ...+..||+.|++||.+.+.+|+.++|+|||||++|||
T Consensus 123 H~~~iLHRDlK~~Niflt---k~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm 199 (426)
T KOG0589|consen 123 HENRVLHRDLKCANIFLT---KDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEM 199 (426)
T ss_pred Hhhhhhcccchhhhhhcc---ccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHH
Confidence 999999999999999994 66668999999999998876 77788899999999999999999999999999999999
Q ss_pred HhCCCCCCCCCcc
Q 030430 162 LNGYPPFSVGEEH 174 (177)
Q Consensus 162 ~~~~~pf~~~~~~ 174 (177)
++-+++|.+.+-.
T Consensus 200 ~~lk~aF~a~~m~ 212 (426)
T KOG0589|consen 200 CTLKPAFKASNMS 212 (426)
T ss_pred HhcccccCccchH
Confidence 9999999987643
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=227.86 Aligned_cols=162 Identities=32% Similarity=0.539 Sum_probs=143.9
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
....+.+|++++++++||||+++.+++..++.+++||||++|++|.+++.....+++..+..++.|++.+|+|||+.|++
T Consensus 38 ~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iv 117 (323)
T cd05571 38 EVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVV 117 (323)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence 34567789999999999999999999999999999999999999999998888899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCC-CCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
|+||||+||++ +..+.++|+|||.+..... ........+++.|+|||.+.+..++.++|+||+|+++++|++|..|
T Consensus 118 HrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P 194 (323)
T cd05571 118 YRDLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194 (323)
T ss_pred eCCCCHHHEEE---CCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCC
Confidence 99999999999 4667899999998865322 2223345689999999999888899999999999999999999999
Q ss_pred CCCCCc
Q 030430 168 FSVGEE 173 (177)
Q Consensus 168 f~~~~~ 173 (177)
|.+.+.
T Consensus 195 f~~~~~ 200 (323)
T cd05571 195 FYNQDH 200 (323)
T ss_pred CCCCCH
Confidence 977543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=227.84 Aligned_cols=160 Identities=34% Similarity=0.660 Sum_probs=144.3
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
..+.+.+|+++++.++||||+++++++.+.+.++++|||++|++|.+++.....+++..+..++.|++.+|+|||+.|++
T Consensus 74 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv 153 (340)
T PTZ00426 74 QVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIV 153 (340)
T ss_pred hHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 45568889999999999999999999999999999999999999999999888899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf 168 (177)
||||+|+||++ +..+.++|+|||.+...... .....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||
T Consensus 154 HrDLkp~NILl---~~~~~ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf 228 (340)
T PTZ00426 154 YRDLKPENLLL---DKDGFIKMTDFGFAKVVDTR--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228 (340)
T ss_pred ccCCCHHHEEE---CCCCCEEEecCCCCeecCCC--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCC
Confidence 99999999999 46778999999998765332 22445888999999998888899999999999999999999999
Q ss_pred CCCCc
Q 030430 169 SVGEE 173 (177)
Q Consensus 169 ~~~~~ 173 (177)
.+.+.
T Consensus 229 ~~~~~ 233 (340)
T PTZ00426 229 YANEP 233 (340)
T ss_pred CCCCH
Confidence 87653
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=225.09 Aligned_cols=163 Identities=36% Similarity=0.591 Sum_probs=144.5
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
.....+.+|++++++++||||+++++++.+....++++||+++++|.+++.....+++..+..++.|++.||+|||+.|+
T Consensus 35 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 114 (312)
T cd05585 35 SEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNV 114 (312)
T ss_pred hHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 34566788999999999999999999999999999999999999999999888789999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCC-CccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
+||||+|+||++ +..+.++++|||.+...... .......+++.|+|||.+.+..++.++|+||+|++++++++|..
T Consensus 115 ~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~ 191 (312)
T cd05585 115 IYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLP 191 (312)
T ss_pred EeCCCCHHHeEE---CCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCC
Confidence 999999999999 46778999999998654322 22234458899999999988889999999999999999999999
Q ss_pred CCCCCCc
Q 030430 167 PFSVGEE 173 (177)
Q Consensus 167 pf~~~~~ 173 (177)
||.+.+.
T Consensus 192 pf~~~~~ 198 (312)
T cd05585 192 PFYDENV 198 (312)
T ss_pred CcCCCCH
Confidence 9977543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=225.44 Aligned_cols=162 Identities=32% Similarity=0.542 Sum_probs=143.2
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
....+.+|+++++.++||||+++.+++...+.+++||||+++++|..++.....+++..+..++.|++.||+|||+.|++
T Consensus 38 ~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv 117 (323)
T cd05595 38 EVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 117 (323)
T ss_pred HHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 34567789999999999999999999999999999999999999999988777899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCC-CccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
|+||+|+||++ +.++.++|+|||.+...... .......++..|+|||.+.+..++.++|+||+|+++|++++|+.|
T Consensus 118 H~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~P 194 (323)
T cd05595 118 YRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194 (323)
T ss_pred ecCCCHHHEEE---cCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCC
Confidence 99999999999 46678999999988653322 222334588999999999888899999999999999999999999
Q ss_pred CCCCCc
Q 030430 168 FSVGEE 173 (177)
Q Consensus 168 f~~~~~ 173 (177)
|...+.
T Consensus 195 f~~~~~ 200 (323)
T cd05595 195 FYNQDH 200 (323)
T ss_pred CCCCCH
Confidence 977643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=223.85 Aligned_cols=160 Identities=38% Similarity=0.702 Sum_probs=143.7
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
..+.+.+|++++++++||||+++++++.+...++++|||+++++|.+++...+.+++..+..++.|++.||+|||+.|++
T Consensus 44 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 123 (291)
T cd05612 44 QEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIV 123 (291)
T ss_pred HHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 45678899999999999999999999999999999999999999999998888899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf 168 (177)
|+||+|+||++ +..+.++++|||.+....... ....+++.|+|||.+.+..++.++|+||||++++++++|..||
T Consensus 124 H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf 198 (291)
T cd05612 124 YRDLKPENILL---DKEGHIKLTDFGFAKKLRDRT--WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPF 198 (291)
T ss_pred ecCCCHHHeEE---CCCCCEEEEecCcchhccCCc--ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999 456789999999987654322 2345788999999998888899999999999999999999999
Q ss_pred CCCCc
Q 030430 169 SVGEE 173 (177)
Q Consensus 169 ~~~~~ 173 (177)
.+.+.
T Consensus 199 ~~~~~ 203 (291)
T cd05612 199 FDDNP 203 (291)
T ss_pred CCCCH
Confidence 87653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=230.57 Aligned_cols=162 Identities=33% Similarity=0.626 Sum_probs=141.6
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
..+.+.+|++++++++||||+++++++.++..+|+||||++|++|.+++.....+++..+..++.|++.||+|||+.|++
T Consensus 44 ~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~giv 123 (377)
T cd05629 44 QLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFI 123 (377)
T ss_pred HHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 45678899999999999999999999999999999999999999999998778899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCC------------c--------------------------------
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------------Y-------------------------------- 124 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~------------~-------------------------------- 124 (177)
|+||||+||++ +..+.++++|||++....... .
T Consensus 124 HrDlkp~NIll---~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (377)
T cd05629 124 HRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKN 200 (377)
T ss_pred ccCCCHHHEEE---CCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhc
Confidence 99999999999 466789999999885321100 0
Q ss_pred ----cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 030430 125 ----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 173 (177)
Q Consensus 125 ----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf~~~~~ 173 (177)
.....|++.|+|||.+.+..++.++|+||+||+++++++|..||.+.+.
T Consensus 201 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~ 253 (377)
T cd05629 201 RRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENS 253 (377)
T ss_pred ccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCH
Confidence 0013478899999999888899999999999999999999999977543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=225.45 Aligned_cols=163 Identities=31% Similarity=0.530 Sum_probs=143.9
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
.....+.+|+++++.++||||+++.+++...+.+++||||+++++|..++.....+++..+..++.|++.||+|||+.|+
T Consensus 37 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~i 116 (328)
T cd05593 37 DEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKI 116 (328)
T ss_pred hHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 34567788999999999999999999999999999999999999999999877789999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCC-CccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
+|+||||+||++ +..+.++|+|||.+...... .......+++.|+|||.+.+..++.++|+||+|++++++++|+.
T Consensus 117 vHrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~ 193 (328)
T cd05593 117 VYRDLKLENLML---DKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 193 (328)
T ss_pred EecccCHHHeEE---CCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCC
Confidence 999999999999 46778999999988653322 22233458899999999988889999999999999999999999
Q ss_pred CCCCCCc
Q 030430 167 PFSVGEE 173 (177)
Q Consensus 167 pf~~~~~ 173 (177)
||.+.+.
T Consensus 194 Pf~~~~~ 200 (328)
T cd05593 194 PFYNQDH 200 (328)
T ss_pred CCCCCCH
Confidence 9976543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=225.80 Aligned_cols=159 Identities=37% Similarity=0.697 Sum_probs=143.8
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
..+.+.+|++++++++||||+++++++.+.+..+++|||+.|++|.+++.....+++..+..++.|++.||+|||+.|++
T Consensus 61 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv 140 (329)
T PTZ00263 61 QVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDII 140 (329)
T ss_pred hHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 34678899999999999999999999999999999999999999999999888899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf 168 (177)
|+||+|+||++ +..+.++|+|||.+....... ....+++.|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus 141 H~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 215 (329)
T PTZ00263 141 YRDLKPENLLL---DNKGHVKVTDFGFAKKVPDRT--FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPF 215 (329)
T ss_pred ecCCCHHHEEE---CCCCCEEEeeccCceEcCCCc--ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCC
Confidence 99999999999 467789999999987654332 2345788999999998888899999999999999999999999
Q ss_pred CCCC
Q 030430 169 SVGE 172 (177)
Q Consensus 169 ~~~~ 172 (177)
.+.+
T Consensus 216 ~~~~ 219 (329)
T PTZ00263 216 FDDT 219 (329)
T ss_pred CCCC
Confidence 7654
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=229.12 Aligned_cols=162 Identities=35% Similarity=0.649 Sum_probs=141.7
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
....+.+|++++++++||||+++++.+.+...+++||||++|++|.+++.+.+.+++..+..++.|++.||+|||+.|++
T Consensus 44 ~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~iv 123 (382)
T cd05625 44 QVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFI 123 (382)
T ss_pred HHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 45678899999999999999999999999999999999999999999998777899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCC----------------------------------------------
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---------------------------------------------- 122 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~---------------------------------------------- 122 (177)
||||||+||++ +..+.++|+|||++......
T Consensus 124 HrDlKp~NILl---~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (382)
T cd05625 124 HRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQH 200 (382)
T ss_pred cCCCCHHHEEE---CCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhcccc
Confidence 99999999999 46778999999986432100
Q ss_pred --CccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 030430 123 --NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 173 (177)
Q Consensus 123 --~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf~~~~~ 173 (177)
.......|++.|+|||.+.+..++.++|+||+||++++|++|+.||.+.+.
T Consensus 201 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~ 253 (382)
T cd05625 201 QRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTP 253 (382)
T ss_pred ccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCH
Confidence 001123478899999999888899999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=230.99 Aligned_cols=161 Identities=32% Similarity=0.631 Sum_probs=146.3
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
.+.-++-+.+|+.+|+..+|+|||++++.|.-.+.+++||||++||+|.+.+... .+++.++..++.+++.||+|||.+
T Consensus 310 ~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~ 388 (550)
T KOG0578|consen 310 KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHAR 388 (550)
T ss_pred cCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhc
Confidence 3445778999999999999999999999988889999999999999999988844 599999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhC
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~ 164 (177)
|++|+|||.+||+.+ .++.+||+|||++..+.... ...+..||+.|||||......|+++.||||||++++||+.|
T Consensus 389 gIiHrDIKSDnILL~---~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveG 465 (550)
T KOG0578|consen 389 GIIHRDIKSDNILLT---MDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEG 465 (550)
T ss_pred ceeeeccccceeEec---cCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcC
Confidence 999999999999994 67779999999998776544 45567799999999999999999999999999999999999
Q ss_pred CCCCCC
Q 030430 165 YPPFSV 170 (177)
Q Consensus 165 ~~pf~~ 170 (177)
++||-.
T Consensus 466 EPPYln 471 (550)
T KOG0578|consen 466 EPPYLN 471 (550)
T ss_pred CCCccC
Confidence 999854
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=224.49 Aligned_cols=160 Identities=38% Similarity=0.678 Sum_probs=144.0
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
..+.+.+|++++..++||||+++++++.+....|++|||++|++|.+++.....+++..+..++.|++.+|+|||+.|++
T Consensus 44 ~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv 123 (333)
T cd05600 44 EVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYI 123 (333)
T ss_pred HHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 34568889999999999999999999999999999999999999999998878899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf 168 (177)
|+||+|+||++ +..+.++|+|||.+..... ......+++.|+|||.+.+..++.++|+||+|+++++|++|..||
T Consensus 124 H~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf 198 (333)
T cd05600 124 HRDLKPENFLI---DASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPF 198 (333)
T ss_pred ccCCCHHHEEE---CCCCCEEEEeCcCCccccc--ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCC
Confidence 99999999999 4677899999999866543 223445788999999998888999999999999999999999999
Q ss_pred CCCCc
Q 030430 169 SVGEE 173 (177)
Q Consensus 169 ~~~~~ 173 (177)
.+.+.
T Consensus 199 ~~~~~ 203 (333)
T cd05600 199 SGSTP 203 (333)
T ss_pred CCCCH
Confidence 87543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=227.54 Aligned_cols=163 Identities=34% Similarity=0.628 Sum_probs=142.1
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
.....+.+|++++++++||||+++++++.+...+++||||++|++|.+++.....+++..+..++.|++.+|+|||+.|+
T Consensus 43 ~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~gi 122 (381)
T cd05626 43 NQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122 (381)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 34567889999999999999999999999999999999999999999999888889999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC--------------------------------------------
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-------------------------------------------- 123 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-------------------------------------------- 123 (177)
+||||||+||++ +..+.++|+|||++.......
T Consensus 123 vHrDlKp~Nili---~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (381)
T cd05626 123 IHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQ 199 (381)
T ss_pred eecCCcHHHEEE---CCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhcccccc
Confidence 999999999999 466789999999864321000
Q ss_pred ----ccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 030430 124 ----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 173 (177)
Q Consensus 124 ----~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf~~~~~ 173 (177)
......|+..|+|||.+.+..++.++|+||+||++++|++|+.||...+.
T Consensus 200 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~ 253 (381)
T cd05626 200 HQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTP 253 (381)
T ss_pred ccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCH
Confidence 00123578899999999888899999999999999999999999977553
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=220.78 Aligned_cols=165 Identities=37% Similarity=0.723 Sum_probs=156.1
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
++++.-.+.+|+++|..|+||||+.++++|+..+.+.+||||..+|.|.+|+...+.+++..+..++.||+.|+.|||..
T Consensus 93 deqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn 172 (668)
T KOG0611|consen 93 DEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKN 172 (668)
T ss_pred cHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc
Confidence 56667789999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCC-CCcchHHHHHHHHHHHHhC
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slg~~~~~~~~~ 164 (177)
+++|||+|.+||++ +.+.++++.|||++..+.......+.+|++.|.+||...+.+| ++..|-||||+++|-+.-|
T Consensus 173 rVvHRDLKLENILL---D~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyG 249 (668)
T KOG0611|consen 173 RVVHRDLKLENILL---DQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYG 249 (668)
T ss_pred cceecccchhheee---cCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhc
Confidence 99999999999999 6788999999999988888888888999999999999998887 7899999999999999999
Q ss_pred CCCCCCCCc
Q 030430 165 YPPFSVGEE 173 (177)
Q Consensus 165 ~~pf~~~~~ 173 (177)
.+||.|.+-
T Consensus 250 tMPFDG~Dh 258 (668)
T KOG0611|consen 250 TMPFDGRDH 258 (668)
T ss_pred ccccCCchH
Confidence 999998763
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=222.74 Aligned_cols=161 Identities=38% Similarity=0.644 Sum_probs=142.5
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
...+.+|++++++++||||+++++++..++.+|++|||++|++|.+++...+.+++..+..++.|++.+|+|||+.|++|
T Consensus 44 ~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH 123 (323)
T cd05584 44 TAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIY 123 (323)
T ss_pred HHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 34577899999999999999999999999999999999999999999988878999999999999999999999999999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeeccccccCCC-CccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf 168 (177)
+||+|+||++ +..+.++|+|||.+...... .......+++.|+|||.+.+..++.++|+||+|++++++++|+.||
T Consensus 124 ~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf 200 (323)
T cd05584 124 RDLKPENILL---DAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPF 200 (323)
T ss_pred CCCCHHHeEE---CCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCC
Confidence 9999999999 46778999999988653322 2223345789999999998888899999999999999999999999
Q ss_pred CCCCc
Q 030430 169 SVGEE 173 (177)
Q Consensus 169 ~~~~~ 173 (177)
.+.+.
T Consensus 201 ~~~~~ 205 (323)
T cd05584 201 TAENR 205 (323)
T ss_pred CCCCH
Confidence 87543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=227.21 Aligned_cols=162 Identities=31% Similarity=0.664 Sum_probs=142.5
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
.....+.+|+++++.++||||+++++++.++..+++||||++|++|.+++...+.+++..+..++.|++.||+|||+.|+
T Consensus 43 ~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i 122 (364)
T cd05599 43 EQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY 122 (364)
T ss_pred hHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 34456788999999999999999999999999999999999999999999877789999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC---------------------------------------ccccc
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---------------------------------------YAEKV 128 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---------------------------------------~~~~~ 128 (177)
+|+||||+||++ +..+.++|+|||.+....... .....
T Consensus 123 vH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (364)
T cd05599 123 IHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYST 199 (364)
T ss_pred EeccCCHHHeEE---CCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhccccccccc
Confidence 999999999999 567789999999886542211 00123
Q ss_pred cCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 030430 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGE 172 (177)
Q Consensus 129 ~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf~~~~ 172 (177)
.|++.|+|||.+....++.++|+||+||++++|++|..||.+.+
T Consensus 200 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~ 243 (364)
T cd05599 200 VGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDN 243 (364)
T ss_pred ccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCC
Confidence 47889999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=216.35 Aligned_cols=161 Identities=34% Similarity=0.542 Sum_probs=141.7
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+.+|++++++++|++++++.+++.+++.+++++||+++++|.+++... ..+++..+..++.|++.+++|||+.|+
T Consensus 44 ~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 123 (285)
T cd05631 44 EAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERI 123 (285)
T ss_pred HHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 345778999999999999999999999999999999999999998887543 358999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
+|+||+|+||++ +..+.++|+|||.+.............++..|+|||.+.+..++.++|+||+|++++++++|+.|
T Consensus 124 iH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~p 200 (285)
T cd05631 124 VYRDLKPENILL---DDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200 (285)
T ss_pred EeCCCCHHHEEE---CCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCC
Confidence 999999999999 46678999999998765443333345688999999999888899999999999999999999999
Q ss_pred CCCCCc
Q 030430 168 FSVGEE 173 (177)
Q Consensus 168 f~~~~~ 173 (177)
|.+...
T Consensus 201 f~~~~~ 206 (285)
T cd05631 201 FRKRKE 206 (285)
T ss_pred CCCCCc
Confidence 987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=224.45 Aligned_cols=170 Identities=35% Similarity=0.675 Sum_probs=157.5
Q ss_pred cchhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh
Q 030430 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 5 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh 83 (177)
++...+..+.+|++.|+.+.|||||+++++......+|+|.|+-.+|+|.+|+-++. .++++.+.+++.||+.|+.|+|
T Consensus 56 lD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH 135 (864)
T KOG4717|consen 56 LDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH 135 (864)
T ss_pred cchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh
Confidence 466778889999999999999999999999999999999999999999999999885 4999999999999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCC-CcchHHHHHHHHHHHH
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELL 162 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Di~slg~~~~~~~ 162 (177)
...+||||+||+|+.+. .+-+.+||.|||++..+.++....+.+|+..|.|||++.+..|+ ++.||||||+++|.+.
T Consensus 136 qLHVVHRDLKPENVVFF--EKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLV 213 (864)
T KOG4717|consen 136 QLHVVHRDLKPENVVFF--EKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLV 213 (864)
T ss_pred hhhhhcccCCcceeEEe--eecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHH
Confidence 99999999999999886 56788999999999999998888889999999999999988885 7899999999999999
Q ss_pred hCCCCCCCCCcccC
Q 030430 163 NGYPPFSVGEEHQF 176 (177)
Q Consensus 163 ~~~~pf~~~~~~~~ 176 (177)
+|++||...++.+-
T Consensus 214 CGq~PFqeANDSET 227 (864)
T KOG4717|consen 214 CGQPPFQEANDSET 227 (864)
T ss_pred hCCCccccccchhh
Confidence 99999988776553
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=228.11 Aligned_cols=162 Identities=33% Similarity=0.635 Sum_probs=141.6
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
....+.+|++++++++||||+++++.+.+++.+++||||++|++|.+++...+.+++..+..++.|++.||+|||+.|++
T Consensus 44 ~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~iv 123 (376)
T cd05598 44 QAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFI 123 (376)
T ss_pred hHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 34668899999999999999999999999999999999999999999998877899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCC--------------------------------------------Cc
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--------------------------------------------NY 124 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~--------------------------------------------~~ 124 (177)
||||||+||++ +..+.++|+|||++...... ..
T Consensus 124 HrDlkp~Nill---~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (376)
T cd05598 124 HRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCL 200 (376)
T ss_pred eCCCCHHHEEE---CCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhccccc
Confidence 99999999999 46778999999987422100 00
Q ss_pred cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 030430 125 AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 173 (177)
Q Consensus 125 ~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf~~~~~ 173 (177)
.....|++.|+|||.+.+..++.++|+||+||++|+|++|+.||.+.+.
T Consensus 201 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 249 (376)
T cd05598 201 AHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTP 249 (376)
T ss_pred ccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCH
Confidence 0123578899999999888899999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=229.90 Aligned_cols=164 Identities=34% Similarity=0.620 Sum_probs=143.2
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEIL 82 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~l 82 (177)
......+.+|+++++.++||||+++++++...+.+++||||++|++|.+++.. ...+++..+..++.|++.+|+|+
T Consensus 106 ~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~l 185 (478)
T PTZ00267 106 ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEV 185 (478)
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 34456788899999999999999999999999999999999999999987753 34589999999999999999999
Q ss_pred hhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC---ccccccCCCccccccccccCCCCCcchHHHHHHHHH
Q 030430 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (177)
Q Consensus 83 h~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~ 159 (177)
|+.|++||||||+||++ +..+.++|+|||++....... ......+++.|+|||.+.+..++.++|+||+|++++
T Consensus 186 H~~~ivHrDlkp~NIll---~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ 262 (478)
T PTZ00267 186 HSRKMMHRDLKSANIFL---MPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILY 262 (478)
T ss_pred HhCCEEECCcCHHhEEE---CCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHH
Confidence 99999999999999999 467789999999987654332 123445889999999998888999999999999999
Q ss_pred HHHhCCCCCCCCCc
Q 030430 160 ELLNGYPPFSVGEE 173 (177)
Q Consensus 160 ~~~~~~~pf~~~~~ 173 (177)
+|++|..||.+.+.
T Consensus 263 el~tg~~Pf~~~~~ 276 (478)
T PTZ00267 263 ELLTLHRPFKGPSQ 276 (478)
T ss_pred HHHhCCCCCCCCCH
Confidence 99999999987543
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=211.01 Aligned_cols=161 Identities=40% Similarity=0.805 Sum_probs=149.5
Q ss_pred hHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
+..+.-.+|+.+|+++ .||+|.++.++|+.+...++|+|.++.|.|.+++.+.-.+++....+++.|++++++|+|.++
T Consensus 64 ~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~ 143 (411)
T KOG0599|consen 64 EMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN 143 (411)
T ss_pred HHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh
Confidence 4566777899999999 799999999999999999999999999999999998888999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCcccccccccc------CCCCCcchHHHHHHHHHH
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF------QRYDEKVDMWSVGAILFE 160 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~------~~~~~~~Di~slg~~~~~ 160 (177)
|+|||+||+||+. +++.+++++|||.++...++......+||++|+|||.+.. .+|+...|.||+|+++|.
T Consensus 144 IVHRDLKpENILl---ddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyT 220 (411)
T KOG0599|consen 144 IVHRDLKPENILL---DDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYT 220 (411)
T ss_pred hhhcccChhheee---ccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHH
Confidence 9999999999999 6788899999999999999988888999999999998752 357889999999999999
Q ss_pred HHhCCCCCCCC
Q 030430 161 LLNGYPPFSVG 171 (177)
Q Consensus 161 ~~~~~~pf~~~ 171 (177)
++.|.+||..+
T Consensus 221 LLaGcpPFwHR 231 (411)
T KOG0599|consen 221 LLAGCPPFWHR 231 (411)
T ss_pred HHcCCCchhHH
Confidence 99999999654
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=221.30 Aligned_cols=163 Identities=37% Similarity=0.618 Sum_probs=143.2
Q ss_pred HHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
..+.+..|.+++..+ +||||+++++++.+.+.+++||||++|++|.+++.....+++..+..++.|++.+|+|||+.|+
T Consensus 38 ~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~i 117 (320)
T cd05590 38 DVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGI 117 (320)
T ss_pred HHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 455677888888877 7999999999999999999999999999999999888889999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCC-CccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
+||||+|+||++ +..+.++|+|||.+...... .......+++.|+|||.+.+..++.++|+||+|++++++++|+.
T Consensus 118 vH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 194 (320)
T cd05590 118 IYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHA 194 (320)
T ss_pred EeCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCC
Confidence 999999999999 46678999999988654322 22334558899999999988888999999999999999999999
Q ss_pred CCCCCCcc
Q 030430 167 PFSVGEEH 174 (177)
Q Consensus 167 pf~~~~~~ 174 (177)
||.+.+..
T Consensus 195 Pf~~~~~~ 202 (320)
T cd05590 195 PFEAENED 202 (320)
T ss_pred CCCCCCHH
Confidence 99876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=223.86 Aligned_cols=162 Identities=32% Similarity=0.546 Sum_probs=143.0
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-CCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-HHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~ 87 (177)
....+.+|.++++.++||||+++.+++..+..+++||||+++++|..++.....+++..+..++.|++.+|+|||+ .|+
T Consensus 38 ~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~i 117 (325)
T cd05594 38 EVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV 117 (325)
T ss_pred HHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCE
Confidence 3456788999999999999999999999999999999999999999998877789999999999999999999997 799
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCC-CCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
+|+||||+||++ +..+.++|+|||.+..... ........++..|+|||.+.+..++.++|+||+|++++++++|..
T Consensus 118 vHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~ 194 (325)
T cd05594 118 VYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 194 (325)
T ss_pred EecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCC
Confidence 999999999999 4677899999998865332 222334458899999999988889999999999999999999999
Q ss_pred CCCCCCc
Q 030430 167 PFSVGEE 173 (177)
Q Consensus 167 pf~~~~~ 173 (177)
||.+.+.
T Consensus 195 Pf~~~~~ 201 (325)
T cd05594 195 PFYNQDH 201 (325)
T ss_pred CCCCCCH
Confidence 9977654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=221.55 Aligned_cols=162 Identities=35% Similarity=0.565 Sum_probs=142.5
Q ss_pred HHHHHHHHHHhhCCCCceeeEeEEEeeCC-----eEEEEEecCCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHH
Q 030430 11 SCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEI 81 (177)
Q Consensus 11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~ 81 (177)
+.-.+|+++|+.++|||||++..+|.... +..+|+||++ .+|.+.++. +..++.-.++-+..||++|++|
T Consensus 62 r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~y 140 (364)
T KOG0658|consen 62 RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAY 140 (364)
T ss_pred CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHH
Confidence 45568999999999999999999885322 4579999995 599988883 4568888999999999999999
Q ss_pred HhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccC-CCCCcchHHHHHHHHHH
Q 030430 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFE 160 (177)
Q Consensus 82 lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~ 160 (177)
||+.|++||||||.|++++ ...+.+||||||.|+....+....+...+..|.|||.+.+. .|+.+.|+||.||++.|
T Consensus 141 Lh~~~IcHRDIKPqNlLvD--~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aE 218 (364)
T KOG0658|consen 141 LHSHGICHRDIKPQNLLVD--PDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAE 218 (364)
T ss_pred HHhcCcccCCCChheEEEc--CCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHH
Confidence 9999999999999999996 56788999999999999888887788889999999998765 58999999999999999
Q ss_pred HHhCCCCCCCCCccc
Q 030430 161 LLNGYPPFSVGEEHQ 175 (177)
Q Consensus 161 ~~~~~~pf~~~~~~~ 175 (177)
|+-|++.|.|.+..+
T Consensus 219 Ll~g~plFpG~s~~d 233 (364)
T KOG0658|consen 219 LLKGQPLFPGDSSVD 233 (364)
T ss_pred HhcCCcccCCCCHHH
Confidence 999999999976544
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=231.71 Aligned_cols=168 Identities=37% Similarity=0.663 Sum_probs=154.5
Q ss_pred cchhHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh
Q 030430 5 LNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 5 ~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (177)
++++..++.+.|.+++... +||.+++++..|+...++|+||||+.||++..+ .....+++..+..+++.++.||.|||
T Consensus 407 l~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH 485 (694)
T KOG0694|consen 407 LQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLH 485 (694)
T ss_pred eccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHH
Confidence 4677889999999999999 599999999999999999999999999996554 33567999999999999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccC-CCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHH
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~ 162 (177)
+.||+|||+|.+||++ +..+.+||.|||+++..- .+..+++.+||+.|+|||.+.+..|+.+.|=||||+++|+|+
T Consensus 486 ~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML 562 (694)
T KOG0694|consen 486 ENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEML 562 (694)
T ss_pred hcCceeeecchhheEE---cccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHH
Confidence 9999999999999999 678899999999998764 566778899999999999999999999999999999999999
Q ss_pred hCCCCCCCCCcccC
Q 030430 163 NGYPPFSVGEEHQF 176 (177)
Q Consensus 163 ~~~~pf~~~~~~~~ 176 (177)
.|+.||.|.+++++
T Consensus 563 ~Gq~PF~gddEee~ 576 (694)
T KOG0694|consen 563 VGESPFPGDDEEEV 576 (694)
T ss_pred cCCCCCCCCCHHHH
Confidence 99999999888764
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=223.66 Aligned_cols=159 Identities=30% Similarity=0.440 Sum_probs=141.5
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCC-eEEEEEecCCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
..+|.+|+.++.+++|||+++++|||.+.+ ..++||||+++|+|.+++.... .++.++..+|+.+++.||+|||+..
T Consensus 115 ~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~ 194 (361)
T KOG1187|consen 115 EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGC 194 (361)
T ss_pred hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCC
Confidence 456999999999999999999999999988 5999999999999999987554 7899999999999999999999954
Q ss_pred ---CeeecCCCCcEEEecCCCCeeEEEeeeccccccCC-CCccccc-cCCCccccccccccCCCCCcchHHHHHHHHHHH
Q 030430 87 ---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKV-CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 87 ---~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~-~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~ 161 (177)
++|||||++||++ +.+..+|++|||++..... ....... .|+.+|++||+...+..+.++||||+|+++.|+
T Consensus 195 ~~~iiHrDiKssNILL---D~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllEl 271 (361)
T KOG1187|consen 195 PPPIIHRDIKSSNILL---DEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLEL 271 (361)
T ss_pred CCCEecCCCCHHHeeE---CCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHH
Confidence 9999999999999 6889999999999965544 3333333 789999999999888889999999999999999
Q ss_pred HhCCCCCCCC
Q 030430 162 LNGYPPFSVG 171 (177)
Q Consensus 162 ~~~~~pf~~~ 171 (177)
+||+.|....
T Consensus 272 itgr~~~d~~ 281 (361)
T KOG1187|consen 272 ITGRKAVDQS 281 (361)
T ss_pred HhCCcccCCC
Confidence 9999887654
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=220.23 Aligned_cols=159 Identities=34% Similarity=0.695 Sum_probs=141.6
Q ss_pred HHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
..+.+.+|..+++++ +||||+++++++.+.+.++++|||++|++|.+++.+...+++..+..++.|++.+|+|||+.|+
T Consensus 38 ~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 117 (329)
T cd05588 38 DIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGI 117 (329)
T ss_pred HHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 455688999999999 7999999999999999999999999999999998877889999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccC-CCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
+|+||+|+||++ +..+.++|+|||.+.... .........++..|+|||.+.+..++.++|+||+|+++|++++|+.
T Consensus 118 vH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~ 194 (329)
T cd05588 118 IYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 194 (329)
T ss_pred EecCCCHHHeEE---CCCCCEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCC
Confidence 999999999999 466789999999886532 2223334568899999999988889999999999999999999999
Q ss_pred CCCC
Q 030430 167 PFSV 170 (177)
Q Consensus 167 pf~~ 170 (177)
||..
T Consensus 195 Pf~~ 198 (329)
T cd05588 195 PFDI 198 (329)
T ss_pred Cccc
Confidence 9963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=225.97 Aligned_cols=163 Identities=29% Similarity=0.622 Sum_probs=143.4
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
.....+.+|.+++.+++||+++++++.+.+.+.+++||||++|++|.+++.+...+++..+..++.|++.+|+|||+.|+
T Consensus 43 ~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~gi 122 (360)
T cd05627 43 EQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122 (360)
T ss_pred hhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 34567888999999999999999999999999999999999999999999888889999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC------------------------------------ccccccCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------------------------------------YAEKVCGS 131 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~------------------------------------~~~~~~~~ 131 (177)
+|+||||+||++ +..+.++|+|||++....... ......|+
T Consensus 123 vHrDLkp~NIli---~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 199 (360)
T cd05627 123 IHRDIKPDNLLL---DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGT 199 (360)
T ss_pred EccCCCHHHEEE---CCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCC
Confidence 999999999999 467789999999876432110 01123578
Q ss_pred CccccccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 030430 132 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 173 (177)
Q Consensus 132 ~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf~~~~~ 173 (177)
+.|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+.
T Consensus 200 ~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~ 241 (360)
T cd05627 200 PDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241 (360)
T ss_pred ccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCH
Confidence 899999999888899999999999999999999999977543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=220.99 Aligned_cols=165 Identities=39% Similarity=0.703 Sum_probs=151.8
Q ss_pred HHHHHHHHHHHHhhCC-CCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
.+..+.+|+++|+++. ||||+.+.+++++...+++|||++.||.|.+.+... .+++..+..++.|++.+++|||+.|+
T Consensus 78 ~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gv 156 (382)
T KOG0032|consen 78 DREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGV 156 (382)
T ss_pred cHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 4578999999999998 999999999999999999999999999999999866 59999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCC-CeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 88 IHRDLKPENILLSGLDD-DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
+|+|+||+|+++..... .+.++++|||++.............|++.|+|||.+...+++...|+||+|++.|.|++|.+
T Consensus 157 vHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~ 236 (382)
T KOG0032|consen 157 VHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVP 236 (382)
T ss_pred eeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCC
Confidence 99999999999975443 45899999999988877666677889999999999998899999999999999999999999
Q ss_pred CCCCCCcc
Q 030430 167 PFSVGEEH 174 (177)
Q Consensus 167 pf~~~~~~ 174 (177)
||.+.++.
T Consensus 237 PF~~~~~~ 244 (382)
T KOG0032|consen 237 PFWGETEF 244 (382)
T ss_pred CCcCCChh
Confidence 99987644
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=224.55 Aligned_cols=162 Identities=38% Similarity=0.618 Sum_probs=143.8
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
....+.+|++++++++||||+++++++.+++.+|+|+||+++++|.+++.+...+++..+..++.|++.+|+|||+.|++
T Consensus 41 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~ 120 (318)
T cd05582 41 DRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120 (318)
T ss_pred hHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 34567789999999999999999999999999999999999999999998777899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCC-CccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
|+||+|+||++ +.++.++|+|||.+...... .......++..|+|||.+.+..++.++|+||+|+++++|++|+.|
T Consensus 121 H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 197 (318)
T cd05582 121 YRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197 (318)
T ss_pred cCCCCHHHeEE---CCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCC
Confidence 99999999999 46678999999998765433 223345578899999999888889999999999999999999999
Q ss_pred CCCCCc
Q 030430 168 FSVGEE 173 (177)
Q Consensus 168 f~~~~~ 173 (177)
|.+.+.
T Consensus 198 ~~~~~~ 203 (318)
T cd05582 198 FQGKDR 203 (318)
T ss_pred CCCCCH
Confidence 987653
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=220.77 Aligned_cols=164 Identities=34% Similarity=0.605 Sum_probs=143.6
Q ss_pred hHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
...+.+..|.+++..+ +||+|+++++++.+++.+++||||+++++|..++.....+++..+..++.|++.||+|||+.|
T Consensus 37 ~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ 116 (321)
T cd05591 37 DDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG 116 (321)
T ss_pred hHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3455677899998876 899999999999999999999999999999999988888999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCC-CccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCC
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~ 165 (177)
++|+||+|+||++ +..+.++|+|||.+...... .......++..|+|||.+.+..++.++|+||+|++++++++|+
T Consensus 117 ivHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~ 193 (321)
T cd05591 117 VIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193 (321)
T ss_pred eeccCCCHHHeEE---CCCCCEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCC
Confidence 9999999999999 46778999999988654322 2233445788999999998888999999999999999999999
Q ss_pred CCCCCCCcc
Q 030430 166 PPFSVGEEH 174 (177)
Q Consensus 166 ~pf~~~~~~ 174 (177)
.||.+.+..
T Consensus 194 ~Pf~~~~~~ 202 (321)
T cd05591 194 PPFEADNED 202 (321)
T ss_pred CCCCCCCHH
Confidence 999876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=218.67 Aligned_cols=161 Identities=32% Similarity=0.645 Sum_probs=142.2
Q ss_pred hHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
...+.+.+|..++.++ +||+|+++++++.+.+.+++||||++|++|.+++.....+++..+..++.|++.|++|||+.|
T Consensus 37 ~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ 116 (327)
T cd05617 37 EDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG 116 (327)
T ss_pred hHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3456688999999998 699999999999999999999999999999999887778999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccC-CCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCC
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~ 165 (177)
++|+||+|+||+++ ..+.++|+|||.+.... .........+++.|+|||.+.+..++.++|+||+|+++++|++|.
T Consensus 117 ivHrDlkp~Nili~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~ 193 (327)
T cd05617 117 IIYRDLKLDNVLLD---ADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGR 193 (327)
T ss_pred eeccCCCHHHEEEe---CCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCC
Confidence 99999999999994 66779999999886532 222333456889999999998888999999999999999999999
Q ss_pred CCCCCC
Q 030430 166 PPFSVG 171 (177)
Q Consensus 166 ~pf~~~ 171 (177)
.||...
T Consensus 194 ~pf~~~ 199 (327)
T cd05617 194 SPFDII 199 (327)
T ss_pred CCCCcc
Confidence 999653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=220.09 Aligned_cols=160 Identities=35% Similarity=0.632 Sum_probs=138.5
Q ss_pred HHHHHHH-HHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 11 SCLDCEL-NFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 11 ~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
..+.+|. .+++.++||||+++++++.+.+..+++|||++|++|...+.....+++..+..++.|++.+|+|||+.|++|
T Consensus 40 ~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH 119 (321)
T cd05603 40 NHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIY 119 (321)
T ss_pred HHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 3444554 467889999999999999999999999999999999998887778999999999999999999999999999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeeccccccCC-CCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf 168 (177)
+||||+||++ +..+.++|+|||.+..... ........+++.|+|||.+.+..++.++|+||+|+++|+|++|..||
T Consensus 120 ~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf 196 (321)
T cd05603 120 RDLKPENILL---DSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPF 196 (321)
T ss_pred ccCCHHHeEE---CCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCC
Confidence 9999999999 4677899999998865322 22233445788999999998888999999999999999999999999
Q ss_pred CCCCc
Q 030430 169 SVGEE 173 (177)
Q Consensus 169 ~~~~~ 173 (177)
.+.+.
T Consensus 197 ~~~~~ 201 (321)
T cd05603 197 YSRDV 201 (321)
T ss_pred CCCCH
Confidence 87653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=234.02 Aligned_cols=168 Identities=28% Similarity=0.601 Sum_probs=149.9
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC----------C----CCHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------R----VPEQTARKF 71 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~----~~~~~~~~~ 71 (177)
+...+..|++|++++..|+|||||+++|++..++.+++|+||+..|||.+|++.+. . ++..+.+.|
T Consensus 529 ~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~i 608 (774)
T KOG1026|consen 529 ENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHI 608 (774)
T ss_pred cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHH
Confidence 34478899999999999999999999999999999999999999999999998442 2 778899999
Q ss_pred HHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccc---cccCCCccccccccccCCCCCc
Q 030430 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE---KVCGSPLYMAPEVLQFQRYDEK 148 (177)
Q Consensus 72 ~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~---~~~~~~~~~~pe~~~~~~~~~~ 148 (177)
+.||+.++.||-++.+||||+-+.|++| ++...+|++|||+++...+.+.-. ...-..+|||||.+....++.+
T Consensus 609 A~QIAaGM~YLs~~~FVHRDLATRNCLV---ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTte 685 (774)
T KOG1026|consen 609 ATQIAAGMEYLSSHHFVHRDLATRNCLV---GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTE 685 (774)
T ss_pred HHHHHHHHHHHHhCcccccchhhhhcee---ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccch
Confidence 9999999999999999999999999999 478889999999999887665322 2335678999999999999999
Q ss_pred chHHHHHHHHHHHHh-CCCCCCCCCcccC
Q 030430 149 VDMWSVGAILFELLN-GYPPFSVGEEHQF 176 (177)
Q Consensus 149 ~Di~slg~~~~~~~~-~~~pf~~~~~~~~ 176 (177)
|||||+|+++||+++ |..||.+.+.++.
T Consensus 686 SDVWs~GVvLWEIFsyG~QPy~glSn~EV 714 (774)
T KOG1026|consen 686 SDVWSFGVVLWEIFSYGKQPYYGLSNQEV 714 (774)
T ss_pred hhhhhhhhhhhhhhccccCcccccchHHH
Confidence 999999999999999 8999988776653
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=217.77 Aligned_cols=163 Identities=33% Similarity=0.539 Sum_probs=144.4
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
++...+.+.+|++++++++||||+++++++.+++..+++|||+++++|.+++.....+++..+..++.|++.+++|||+.
T Consensus 43 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 122 (331)
T cd06649 43 KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122 (331)
T ss_pred CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhc
Confidence 34566789999999999999999999999999999999999999999999998877899999999999999999999986
Q ss_pred -CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhC
Q 030430 86 -HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 86 -~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~ 164 (177)
+++|+||+|+||++ +..+.++|+|||.+....... .....++..|+|||.+.+..++.++|+||+|++++++++|
T Consensus 123 ~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg 198 (331)
T cd06649 123 HQIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIG 198 (331)
T ss_pred CCEEcCCCChhhEEE---cCCCcEEEccCcccccccccc-cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhC
Confidence 69999999999999 456779999999886653322 2234578899999999888899999999999999999999
Q ss_pred CCCCCCCC
Q 030430 165 YPPFSVGE 172 (177)
Q Consensus 165 ~~pf~~~~ 172 (177)
+.||...+
T Consensus 199 ~~p~~~~~ 206 (331)
T cd06649 199 RYPIPPPD 206 (331)
T ss_pred CCCCCCCC
Confidence 99997543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=223.02 Aligned_cols=160 Identities=35% Similarity=0.632 Sum_probs=140.1
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
....+.+|+++++.++||||+++++++.++..+++||||++|++|.+++... .+++..+..++.|++.||+|||+.|++
T Consensus 86 ~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~Iv 164 (370)
T cd05621 86 DSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLI 164 (370)
T ss_pred hHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 3456788999999999999999999999999999999999999999998754 689999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--cccccCCCccccccccccCC----CCCcchHHHHHHHHHHHH
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQR----YDEKVDMWSVGAILFELL 162 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~----~~~~~Di~slg~~~~~~~ 162 (177)
||||||+||++ +..+.++|+|||.+........ .....+++.|+|||.+.+.. ++.++|+||+|+++|+|+
T Consensus 165 HrDLKp~NILl---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell 241 (370)
T cd05621 165 HRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241 (370)
T ss_pred ecCCCHHHEEE---CCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHH
Confidence 99999999999 5677899999999876543322 23456899999999986543 678999999999999999
Q ss_pred hCCCCCCCCC
Q 030430 163 NGYPPFSVGE 172 (177)
Q Consensus 163 ~~~~pf~~~~ 172 (177)
+|..||.+.+
T Consensus 242 ~G~~Pf~~~~ 251 (370)
T cd05621 242 VGDTPFYADS 251 (370)
T ss_pred hCCCCCCCCC
Confidence 9999997754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=218.50 Aligned_cols=162 Identities=41% Similarity=0.706 Sum_probs=140.9
Q ss_pred HHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
.+.+..|..++... +||||+++++++...+..++||||++|++|.+++.....+++..+..++.|++.||+|||+.|++
T Consensus 39 ~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~iv 118 (316)
T cd05592 39 VECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGII 118 (316)
T ss_pred HHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 44556677777655 89999999999999999999999999999999998878899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCC-CccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
|+||+|+||++ +..+.++|+|||.+...... .......+++.|+|||.+.+..++.++|+||+|+++++|++|+.|
T Consensus 119 H~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~P 195 (316)
T cd05592 119 YRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195 (316)
T ss_pred eCCCCHHHeEE---CCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCC
Confidence 99999999999 46678999999998754332 222344588999999999888899999999999999999999999
Q ss_pred CCCCCcc
Q 030430 168 FSVGEEH 174 (177)
Q Consensus 168 f~~~~~~ 174 (177)
|.+.+..
T Consensus 196 f~~~~~~ 202 (316)
T cd05592 196 FHGEDED 202 (316)
T ss_pred CCCCCHH
Confidence 9876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=223.53 Aligned_cols=159 Identities=36% Similarity=0.546 Sum_probs=143.5
Q ss_pred HHHHHHHHhhCC-CCceeeEeEEEeeCC-eEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 13 LDCELNFLSSVN-HPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 13 ~~~e~~~l~~l~-h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
-.+|+.-|++|+ ||||+++.+++.++. .+|+||||+ ..+|.++++.. ..|+++.+..|+.||+.+|+++|..|+.|
T Consensus 55 nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFH 133 (538)
T KOG0661|consen 55 NLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFH 133 (538)
T ss_pred HHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCccc
Confidence 468999999997 999999999999888 999999999 67999998744 45999999999999999999999999999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccc-cCCCCCcchHHHHHHHHHHHHhCCCCC
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPF 168 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Di~slg~~~~~~~~~~~pf 168 (177)
||+||+||++. ....+||.|||+|+...+...-.....|.+|.|||++. +..|+...|+||+||+++|+++.++.|
T Consensus 134 RDlKPENiLi~---~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLF 210 (538)
T KOG0661|consen 134 RDLKPENILIS---GNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLF 210 (538)
T ss_pred ccCChhheEec---ccceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccC
Confidence 99999999994 46779999999999988877766777899999999875 556899999999999999999999999
Q ss_pred CCCCccc
Q 030430 169 SVGEEHQ 175 (177)
Q Consensus 169 ~~~~~~~ 175 (177)
.|.++-|
T Consensus 211 PG~sE~D 217 (538)
T KOG0661|consen 211 PGASEID 217 (538)
T ss_pred CCCcHHH
Confidence 9987643
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=219.64 Aligned_cols=159 Identities=38% Similarity=0.691 Sum_probs=138.0
Q ss_pred HHHHHHH-HHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCeee
Q 030430 12 CLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHR 90 (177)
Q Consensus 12 ~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H~ 90 (177)
.+..|.. +++.++||||+++++++.+.+..+++|||++|++|..++.....+++..+..++.|++.+|+|||+.|++|+
T Consensus 41 ~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~ 120 (323)
T cd05575 41 HIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120 (323)
T ss_pred HHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeC
Confidence 3444444 567899999999999999999999999999999999999887889999999999999999999999999999
Q ss_pred cCCCCcEEEecCCCCeeEEEeeeccccccCC-CCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 030430 91 DLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169 (177)
Q Consensus 91 ~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf~ 169 (177)
||+|+||++ +..+.++|+|||.+..... ........+++.|+|||.+.+..++.++|+||||+++++|++|+.||.
T Consensus 121 dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~ 197 (323)
T cd05575 121 DLKPENILL---DSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFY 197 (323)
T ss_pred CCCHHHeEE---CCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCC
Confidence 999999999 4677899999998865322 222334457889999999988889999999999999999999999998
Q ss_pred CCCc
Q 030430 170 VGEE 173 (177)
Q Consensus 170 ~~~~ 173 (177)
..+.
T Consensus 198 ~~~~ 201 (323)
T cd05575 198 SRDT 201 (323)
T ss_pred CCCH
Confidence 7643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=219.65 Aligned_cols=158 Identities=37% Similarity=0.654 Sum_probs=137.5
Q ss_pred HHHHH-HHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCeeec
Q 030430 13 LDCEL-NFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRD 91 (177)
Q Consensus 13 ~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H~~ 91 (177)
+..|. .+++.++||||+++++++...+.++++|||++|++|.+++.....+++..+..++.|++.+|+|||+.|++|+|
T Consensus 42 ~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrD 121 (325)
T cd05602 42 IMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRD 121 (325)
T ss_pred HHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecC
Confidence 33343 45788899999999999999999999999999999999998777899999999999999999999999999999
Q ss_pred CCCCcEEEecCCCCeeEEEeeeccccccCC-CCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 030430 92 LKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 170 (177)
Q Consensus 92 i~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf~~ 170 (177)
|||+||++ +..+.++|+|||.+..... ........+++.|+|||.+.+..++.++|+||+|+++++|++|..||.+
T Consensus 122 lkp~Nili---~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 198 (325)
T cd05602 122 LKPENILL---DSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (325)
T ss_pred CCHHHeEE---CCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC
Confidence 99999999 4667899999999865432 2223345588999999999888899999999999999999999999987
Q ss_pred CCc
Q 030430 171 GEE 173 (177)
Q Consensus 171 ~~~ 173 (177)
.+.
T Consensus 199 ~~~ 201 (325)
T cd05602 199 RNT 201 (325)
T ss_pred CCH
Confidence 553
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=217.19 Aligned_cols=164 Identities=35% Similarity=0.645 Sum_probs=142.3
Q ss_pred hHHHHHHHHHHHHhhCCCC-ceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 8 HLKSCLDCELNFLSSVNHP-NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
...+.+..|.+++..++|+ +++++.+++.+.+.+|+||||++|++|.+++.....+++..+..++.|++.||+|||+.|
T Consensus 42 ~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ 121 (324)
T cd05587 42 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG 121 (324)
T ss_pred hHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3456788899999999765 588899999999999999999999999999988788999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCC-CCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCC
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~ 165 (177)
++|+||+|+||++ +..+.++|+|||.+..... ........++..|+|||.+.+..++.++|+||+|++++++++|+
T Consensus 122 ivH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~ 198 (324)
T cd05587 122 IIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198 (324)
T ss_pred eEecCCCHHHeEE---cCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCC
Confidence 9999999999999 4667899999998865322 22223445889999999998888999999999999999999999
Q ss_pred CCCCCCCcc
Q 030430 166 PPFSVGEEH 174 (177)
Q Consensus 166 ~pf~~~~~~ 174 (177)
.||.+.+..
T Consensus 199 ~pf~~~~~~ 207 (324)
T cd05587 199 PPFDGEDED 207 (324)
T ss_pred CCCCCCCHH
Confidence 999876543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=216.89 Aligned_cols=163 Identities=37% Similarity=0.677 Sum_probs=143.2
Q ss_pred hHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
.....+.+|.++++.+ +||||+++++++.+.+.+++||||++|++|..++.....+++..+..++.|++.+|+|||+.|
T Consensus 37 ~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ 116 (318)
T cd05570 37 DDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG 116 (318)
T ss_pred hHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3456778899999888 799999999999999999999999999999999987778999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCC-CCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCC
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~ 165 (177)
++|+||+|+||++ +..+.++|+|||.+..... ........++..|+|||.+.+..++.++|+||+|++++++++|+
T Consensus 117 ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~ 193 (318)
T cd05570 117 IIYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193 (318)
T ss_pred eEccCCCHHHeEE---CCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCC
Confidence 9999999999999 4677899999998865322 22223345788999999998888999999999999999999999
Q ss_pred CCCCCCCc
Q 030430 166 PPFSVGEE 173 (177)
Q Consensus 166 ~pf~~~~~ 173 (177)
.||.+.+.
T Consensus 194 ~pf~~~~~ 201 (318)
T cd05570 194 SPFEGDDE 201 (318)
T ss_pred CCCCCCCH
Confidence 99987654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=218.10 Aligned_cols=158 Identities=33% Similarity=0.665 Sum_probs=140.5
Q ss_pred HHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
....+..|..++.++ +||||+++++++...+.+++||||+++++|..++.....+++..+..++.|++.+++|||+.|+
T Consensus 38 ~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i 117 (329)
T cd05618 38 DIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGI 117 (329)
T ss_pred HHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 445678899988887 8999999999999999999999999999999998877889999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCC-CCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
+|+||+|+||++ +..+.++|+|||.+..... ........++..|+|||.+.+..++.++|+||+|++++++++|+.
T Consensus 118 vH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 194 (329)
T cd05618 118 IYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 194 (329)
T ss_pred eeCCCCHHHEEE---CCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCC
Confidence 999999999999 4667899999998865322 222334568899999999988889999999999999999999999
Q ss_pred CCC
Q 030430 167 PFS 169 (177)
Q Consensus 167 pf~ 169 (177)
||.
T Consensus 195 Pf~ 197 (329)
T cd05618 195 PFD 197 (329)
T ss_pred CCc
Confidence 995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=210.30 Aligned_cols=159 Identities=32% Similarity=0.523 Sum_probs=139.7
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+..|++++++++||||+++.+++.++..++++|||++|++|.+++.... .++...+..++.|++.++++||+.|+
T Consensus 37 ~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i 116 (277)
T cd05607 37 EKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDI 116 (277)
T ss_pred hHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 3456679999999999999999999999999999999999999998876443 48889999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
+|+||+|+||++ +..+.++++|||.+.............++..|+|||.+.+..++.++|+||+|++++++++|+.|
T Consensus 117 vH~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p 193 (277)
T cd05607 117 VYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193 (277)
T ss_pred EEccCChHhEEE---cCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCC
Confidence 999999999999 46677999999998776544433345578899999999888899999999999999999999999
Q ss_pred CCCC
Q 030430 168 FSVG 171 (177)
Q Consensus 168 f~~~ 171 (177)
|...
T Consensus 194 ~~~~ 197 (277)
T cd05607 194 FKDH 197 (277)
T ss_pred CCCC
Confidence 9764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=220.53 Aligned_cols=160 Identities=35% Similarity=0.628 Sum_probs=139.5
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
....+.+|..+++.++||||+++++.+.+++.++++|||++|++|.+++.. ..+++..+..++.|++.||+|||+.|++
T Consensus 86 ~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iv 164 (371)
T cd05622 86 DSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFI 164 (371)
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 345678899999999999999999999999999999999999999998874 4689999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--cccccCCCccccccccccCC----CCCcchHHHHHHHHHHHH
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQR----YDEKVDMWSVGAILFELL 162 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~----~~~~~Di~slg~~~~~~~ 162 (177)
||||||+||++ +..+.++|+|||.+........ .....+++.|+|||.+.... ++.++|+||+|+++|+|+
T Consensus 165 HrDLkp~NIll---~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell 241 (371)
T cd05622 165 HRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241 (371)
T ss_pred eCCCCHHHEEE---CCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHH
Confidence 99999999999 4677899999999876543321 22455899999999986433 678999999999999999
Q ss_pred hCCCCCCCCC
Q 030430 163 NGYPPFSVGE 172 (177)
Q Consensus 163 ~~~~pf~~~~ 172 (177)
+|..||.+.+
T Consensus 242 ~G~~Pf~~~~ 251 (371)
T cd05622 242 VGDTPFYADS 251 (371)
T ss_pred hCCCCCCCCC
Confidence 9999998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=216.80 Aligned_cols=162 Identities=38% Similarity=0.623 Sum_probs=141.4
Q ss_pred HHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
.......|.+++... +||+++++++++.+.+.+|+||||+.|++|..++.....+++..+..++.|++.+|+|||+.|+
T Consensus 38 ~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 117 (316)
T cd05620 38 DVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGI 117 (316)
T ss_pred hHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 345677788888765 8999999999999999999999999999999999887789999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCC-CCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
+|+||+|+||++ +.++.++|+|||.+..... ........++..|+|||.+.+..++.++|+||+|++++++++|+.
T Consensus 118 vHrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~ 194 (316)
T cd05620 118 IYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQS 194 (316)
T ss_pred EecCCCHHHeEE---CCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCC
Confidence 999999999999 4667899999998764322 222334557899999999988889999999999999999999999
Q ss_pred CCCCCCc
Q 030430 167 PFSVGEE 173 (177)
Q Consensus 167 pf~~~~~ 173 (177)
||.+.+.
T Consensus 195 Pf~~~~~ 201 (316)
T cd05620 195 PFHGDDE 201 (316)
T ss_pred CCCCCCH
Confidence 9987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=222.89 Aligned_cols=162 Identities=37% Similarity=0.692 Sum_probs=144.9
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
.....+.+|++++..++||||+++++++.+...+++||||++|++|.+++.+...+++..+..++.|++.||+|||+.|+
T Consensus 43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi 122 (350)
T cd05573 43 NQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGF 122 (350)
T ss_pred cHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 34567889999999999999999999999999999999999999999999887789999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC------------------------------ccccccCCCccccc
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------------------------------YAEKVCGSPLYMAP 137 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~------------------------------~~~~~~~~~~~~~p 137 (177)
+|+||+|+||++ +..+.++|+|||.+....... ......+++.|+||
T Consensus 123 iH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 199 (350)
T cd05573 123 IHRDIKPDNILI---DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAP 199 (350)
T ss_pred eccCCCHHHeEE---CCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCH
Confidence 999999999999 467789999999987654332 12234578899999
Q ss_pred cccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 030430 138 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGE 172 (177)
Q Consensus 138 e~~~~~~~~~~~Di~slg~~~~~~~~~~~pf~~~~ 172 (177)
|.+.+..++.++|+||||+++++|++|+.||.+.+
T Consensus 200 E~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 200 EVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred HHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 99988889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=217.09 Aligned_cols=162 Identities=35% Similarity=0.631 Sum_probs=141.7
Q ss_pred HHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
.+....|.+++..+ .|++++++.+++.+.+.+++||||+++++|.+++.....+++..+..++.|++.+|+|||+.|++
T Consensus 44 ~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv 123 (323)
T cd05616 44 VECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGII 123 (323)
T ss_pred HHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 44567788888887 58999999999999999999999999999999998878899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCC-CccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
|+||+|+||++ +..+.++|+|||.+...... .......+++.|+|||.+.+..++.++|+||+|++++++++|+.|
T Consensus 124 HrDlkp~Nill---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~P 200 (323)
T cd05616 124 YRDLKLDNVML---DSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 200 (323)
T ss_pred ecCCCHHHeEE---CCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCC
Confidence 99999999999 46778999999988654322 223345578999999999988899999999999999999999999
Q ss_pred CCCCCcc
Q 030430 168 FSVGEEH 174 (177)
Q Consensus 168 f~~~~~~ 174 (177)
|.+.+..
T Consensus 201 f~~~~~~ 207 (323)
T cd05616 201 FEGEDED 207 (323)
T ss_pred CCCCCHH
Confidence 9876543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=218.71 Aligned_cols=160 Identities=38% Similarity=0.686 Sum_probs=139.1
Q ss_pred HHHHHHHH-HHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 11 SCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 11 ~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
..+..|.. +++.++||||+++++++...+.++++|||++|++|..++.....+++..+..++.|++.||+|||+.|++|
T Consensus 40 ~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH 119 (325)
T cd05604 40 KHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVY 119 (325)
T ss_pred HHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence 44455554 57778999999999999999999999999999999999988788999999999999999999999999999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeeccccccCC-CCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf 168 (177)
+||||+||++ +..+.++|+|||.+..... ........++..|+|||.+.+..++.++|+||+|+++++|++|..||
T Consensus 120 ~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf 196 (325)
T cd05604 120 RDLKPENILL---DSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPF 196 (325)
T ss_pred cCCCHHHeEE---CCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCC
Confidence 9999999999 4677899999998865322 22233455888999999998888999999999999999999999999
Q ss_pred CCCCc
Q 030430 169 SVGEE 173 (177)
Q Consensus 169 ~~~~~ 173 (177)
...+.
T Consensus 197 ~~~~~ 201 (325)
T cd05604 197 YCRDV 201 (325)
T ss_pred CCCCH
Confidence 87653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=212.12 Aligned_cols=159 Identities=21% Similarity=0.332 Sum_probs=139.3
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEee----CCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS- 84 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~- 84 (177)
.+.+.+|++++++++||||+++++++.+ ...+++++||++|++|.+++.+.+.++......++.+++.+++++|+
T Consensus 62 ~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~ 141 (283)
T PHA02988 62 IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKY 141 (283)
T ss_pred HHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhc
Confidence 5678899999999999999999999876 45789999999999999999987789999999999999999999998
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCcccccccccc--CCCCCcchHHHHHHHHHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF--QRYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slg~~~~~~~ 162 (177)
.+++|+||+|+|+++ +.++.++++|||.+........ ...++..|+|||.+.+ ..++.++|+||+|+++|+++
T Consensus 142 ~~~~Hrdlkp~nill---~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~ 216 (283)
T PHA02988 142 TNKPYKNLTSVSFLV---TENYKLKIICHGLEKILSSPPF--KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIF 216 (283)
T ss_pred CCCCCCcCChhhEEE---CCCCcEEEcccchHhhhccccc--cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHH
Confidence 599999999999999 4677899999999865533322 3346788999999875 57899999999999999999
Q ss_pred hCCCCCCCCCc
Q 030430 163 NGYPPFSVGEE 173 (177)
Q Consensus 163 ~~~~pf~~~~~ 173 (177)
+|..||.+.+.
T Consensus 217 ~g~~Pf~~~~~ 227 (283)
T PHA02988 217 TGKIPFENLTT 227 (283)
T ss_pred HCCCCCCCCCH
Confidence 99999987653
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=205.18 Aligned_cols=166 Identities=34% Similarity=0.497 Sum_probs=146.8
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
++.......+|+..|+.++|+||+.++++|...+.+.+|+||+ ..+|+..++.. ..++..+++.++.+++.+++|||+
T Consensus 41 kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~ 119 (318)
T KOG0659|consen 41 KDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHS 119 (318)
T ss_pred ccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHh
Confidence 4455677899999999999999999999999999999999999 66999998844 349999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcccc-ccCCCccccccccccC-CCCCcchHHHHHHHHHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~ 162 (177)
..++|||+||.|+++ +.++.+|+.|||+++.+.+...... ..-|.+|.|||.+.+. .|+...|+||.||++.|++
T Consensus 120 ~~IlHRDlKPnNLLi---s~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELl 196 (318)
T KOG0659|consen 120 KWILHRDLKPNNLLI---SSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELL 196 (318)
T ss_pred hhhhcccCCccceEE---cCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHH
Confidence 999999999999999 5788999999999998876654332 3578999999998765 4899999999999999999
Q ss_pred hCCCCCCCCCccc
Q 030430 163 NGYPPFSVGEEHQ 175 (177)
Q Consensus 163 ~~~~pf~~~~~~~ 175 (177)
-+.+.|.|.++=+
T Consensus 197 lr~P~fpG~sDid 209 (318)
T KOG0659|consen 197 LRVPFFPGDSDID 209 (318)
T ss_pred ccCCCCCCCchHH
Confidence 9999999887643
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=219.47 Aligned_cols=158 Identities=34% Similarity=0.626 Sum_probs=134.6
Q ss_pred HHHHHHHHHHhhCCCCceeeEeEEEeeC--CeEEEEEecCCCCChHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 11 SCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
+...+|+.+|+++.|||||+++++..+. ..+|||+|||..|.+... ...+. +++.++++++.+++.+|+|||.+|+
T Consensus 153 ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~-p~d~~els~~~Ar~ylrDvv~GLEYLH~Qgi 231 (576)
T KOG0585|consen 153 EKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC-PPDKPELSEQQARKYLRDVVLGLEYLHYQGI 231 (576)
T ss_pred HHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccC-CCCcccccHHHHHHHHHHHHHHHHHHHhcCe
Confidence 6889999999999999999999999765 479999999998888653 32334 9999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCC------CccccccCCCccccccccccCC----CCCcchHHHHHHH
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG------NYAEKVCGSPLYMAPEVLQFQR----YDEKVDMWSVGAI 157 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~------~~~~~~~~~~~~~~pe~~~~~~----~~~~~Di~slg~~ 157 (177)
+||||||+|++++ ..+.+|+.|||.+.....+ .......||+.|+|||...++. .+.+.||||+|++
T Consensus 232 iHRDIKPsNLLl~---~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVT 308 (576)
T KOG0585|consen 232 IHRDIKPSNLLLS---SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVT 308 (576)
T ss_pred eccccchhheEEc---CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhh
Confidence 9999999999994 6689999999999766332 2223456999999999987532 3568999999999
Q ss_pred HHHHHhCCCCCCCCC
Q 030430 158 LFELLNGYPPFSVGE 172 (177)
Q Consensus 158 ~~~~~~~~~pf~~~~ 172 (177)
+|+++.|+.||-+..
T Consensus 309 LYCllfG~~PF~~~~ 323 (576)
T KOG0585|consen 309 LYCLLFGQLPFFDDF 323 (576)
T ss_pred HHHhhhccCCcccch
Confidence 999999999997653
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=215.60 Aligned_cols=161 Identities=38% Similarity=0.634 Sum_probs=140.8
Q ss_pred HHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
......|.+++... +||||+++++++.+.+.++++|||++|++|.+++.....+++..+..++.|++.|++|||+.|++
T Consensus 39 ~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~iv 118 (316)
T cd05619 39 VECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIV 118 (316)
T ss_pred HHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence 45567788888765 99999999999999999999999999999999998777899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCC-CccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
|+||+|+||++ +..+.++|+|||.+...... .......++..|+|||.+.+..++.++|+||+|+++|++++|+.|
T Consensus 119 Hrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~p 195 (316)
T cd05619 119 YRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195 (316)
T ss_pred eCCCCHHHEEE---CCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCC
Confidence 99999999999 46678999999988653222 222344578899999999888899999999999999999999999
Q ss_pred CCCCCc
Q 030430 168 FSVGEE 173 (177)
Q Consensus 168 f~~~~~ 173 (177)
|.+.+.
T Consensus 196 f~~~~~ 201 (316)
T cd05619 196 FHGHDE 201 (316)
T ss_pred CCCCCH
Confidence 987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=208.51 Aligned_cols=162 Identities=36% Similarity=0.669 Sum_probs=145.8
Q ss_pred HHHHHHHHHHhhC-CCCceeeEeEEEe----eCCeEEEEEecCCCCChHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHh
Q 030430 11 SCLDCELNFLSSV-NHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 11 ~~~~~e~~~l~~l-~h~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh 83 (177)
...++|+++--.. .|||||.++++|+ +..++.+|||.++||.|.+.+...+. +++.++..|+.||..|++|||
T Consensus 99 ~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH 178 (400)
T KOG0604|consen 99 PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH 178 (400)
T ss_pred HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH
Confidence 5567888877777 6999999999875 45688999999999999999987755 999999999999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~ 163 (177)
+.+|.|||+||+|+++.....+..+||+|||+++.-..+....+.+.|+.|.|||++....++..+|+||+|+++|-+++
T Consensus 179 ~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLC 258 (400)
T KOG0604|consen 179 SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 258 (400)
T ss_pred hcchhhccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhc
Confidence 99999999999999998766778899999999998877777778889999999999988889999999999999999999
Q ss_pred CCCCCCCCC
Q 030430 164 GYPPFSVGE 172 (177)
Q Consensus 164 ~~~pf~~~~ 172 (177)
|++||..+.
T Consensus 259 GyPPFYS~h 267 (400)
T KOG0604|consen 259 GYPPFYSNH 267 (400)
T ss_pred CCCcccccC
Confidence 999996543
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=209.62 Aligned_cols=159 Identities=36% Similarity=0.548 Sum_probs=139.2
Q ss_pred HHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
+.+..|+++++.++|++++++.+++......+++|||++|++|..++.. +..+++..++.++.|++.+++|||+.|
T Consensus 38 ~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ 117 (280)
T cd05608 38 EGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR 117 (280)
T ss_pred HHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 5667899999999999999999999999999999999999999887742 345899999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCC
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~ 165 (177)
++|+||+|+||++ +..+.++++|||.+........ .....+++.|+|||.+.+..++.++|+||+|++++++++|+
T Consensus 118 i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~ 194 (280)
T cd05608 118 IIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194 (280)
T ss_pred cccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCC
Confidence 9999999999999 4567799999999876544322 22345788999999998888999999999999999999999
Q ss_pred CCCCCCC
Q 030430 166 PPFSVGE 172 (177)
Q Consensus 166 ~pf~~~~ 172 (177)
.||....
T Consensus 195 ~pf~~~~ 201 (280)
T cd05608 195 GPFRARG 201 (280)
T ss_pred CCCCCCC
Confidence 9997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=218.88 Aligned_cols=161 Identities=34% Similarity=0.591 Sum_probs=139.5
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
....+.+|+++++.++||||+++++++.++...++||||++|++|.+++.. ..+++..+..++.|++.||+|||+.|++
T Consensus 86 ~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~iv 164 (370)
T cd05596 86 DSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFI 164 (370)
T ss_pred hHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 345577899999999999999999999999999999999999999998874 4688999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCC--ccccccCCCccccccccccC----CCCCcchHHHHHHHHHHHH
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ----RYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~----~~~~~~Di~slg~~~~~~~ 162 (177)
||||+|+||++ +..+.++|+|||.+....... ......+++.|+|||.+.+. .++.++|+||+|+++|+|+
T Consensus 165 HrDLkp~NILl---~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyell 241 (370)
T cd05596 165 HRDVKPDNMLL---DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241 (370)
T ss_pred ccCCCHHHEEE---cCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHH
Confidence 99999999999 567789999999987654332 12234588999999987643 3788999999999999999
Q ss_pred hCCCCCCCCCc
Q 030430 163 NGYPPFSVGEE 173 (177)
Q Consensus 163 ~~~~pf~~~~~ 173 (177)
+|..||.+.+.
T Consensus 242 tG~~Pf~~~~~ 252 (370)
T cd05596 242 VGDTPFYADSL 252 (370)
T ss_pred hCCCCcCCCCH
Confidence 99999987543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=209.98 Aligned_cols=161 Identities=33% Similarity=0.541 Sum_probs=141.2
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+.+|+++++.++||+|+++.+.+..+...+++|||+++++|.+++... ..+++..+..++.|++.+++|||+.|+
T Consensus 44 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 123 (285)
T cd05605 44 EAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERI 123 (285)
T ss_pred HHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 345678999999999999999999999999999999999999999887643 358999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
+|+||+|+||++ ++.+.++++|||.+.............++..|+|||.+.+..++.++|+||+|+++|++++|+.|
T Consensus 124 vH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~p 200 (285)
T cd05605 124 VYRDLKPENILL---DDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200 (285)
T ss_pred EecCCCHHHEEE---CCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCC
Confidence 999999999999 46678999999998765443333344578899999999888899999999999999999999999
Q ss_pred CCCCCc
Q 030430 168 FSVGEE 173 (177)
Q Consensus 168 f~~~~~ 173 (177)
|.+.+.
T Consensus 201 f~~~~~ 206 (285)
T cd05605 201 FRQRKE 206 (285)
T ss_pred CCCCch
Confidence 987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=214.50 Aligned_cols=163 Identities=33% Similarity=0.555 Sum_probs=143.3
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
++.....+.+|++++++++||||+++++++.+++..+++|||+++++|.+++...+.+++..+..++.+++.+++|||+.
T Consensus 43 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 122 (333)
T cd06650 43 KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 122 (333)
T ss_pred CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc
Confidence 34556789999999999999999999999999999999999999999999998877899999999999999999999985
Q ss_pred -CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhC
Q 030430 86 -HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 86 -~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~ 164 (177)
+++|+||+|+||++ +..+.++|+|||.+....... .....++..|+|||.+.+..++.++|+||+|++++++++|
T Consensus 123 ~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g 198 (333)
T cd06650 123 HKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIG 198 (333)
T ss_pred CCEEecCCChhhEEE---cCCCCEEEeeCCcchhhhhhc-cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHC
Confidence 79999999999999 456679999999886543222 2234578899999999888889999999999999999999
Q ss_pred CCCCCCCC
Q 030430 165 YPPFSVGE 172 (177)
Q Consensus 165 ~~pf~~~~ 172 (177)
+.||....
T Consensus 199 ~~p~~~~~ 206 (333)
T cd06650 199 RYPIPPPD 206 (333)
T ss_pred CCCCCCcc
Confidence 99997643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=224.83 Aligned_cols=167 Identities=37% Similarity=0.534 Sum_probs=148.1
Q ss_pred chhHHHHHHHHHHHHhhCC-C-----CceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC--CCCHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVN-H-----PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGA 77 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~-h-----~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~ 77 (177)
+++.-+....|+++|+.|+ | -|+|+++++|...+++|||+|++ +.+|.++++.+. .++...++.++.||+.
T Consensus 222 ~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~ 300 (586)
T KOG0667|consen 222 KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILT 300 (586)
T ss_pred ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHH
Confidence 5666777888999999996 3 38999999999999999999999 789999999764 4999999999999999
Q ss_pred HHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHH
Q 030430 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAI 157 (177)
Q Consensus 78 ~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~ 157 (177)
+|..||+.||+|+||||+|||+.. .....+|++|||.++....... +...+..|.|||++.+.+++.+.|+|||||+
T Consensus 301 ~L~~L~~l~IIHcDLKPENILL~~-~~r~~vKVIDFGSSc~~~q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCI 377 (586)
T KOG0667|consen 301 ALLFLHELGIIHCDLKPENILLKD-PKRSRIKVIDFGSSCFESQRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCI 377 (586)
T ss_pred HHHHHHhCCeeeccCChhheeecc-CCcCceeEEecccccccCCcce--eeeeccccccchhhccCCCCCccceeehhhh
Confidence 999999999999999999999964 2345899999999988755544 5668899999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCcccC
Q 030430 158 LFELLNGYPPFSVGEEHQF 176 (177)
Q Consensus 158 ~~~~~~~~~pf~~~~~~~~ 176 (177)
++||++|.+.|.|.++-+.
T Consensus 378 lAEL~tG~PLfpG~ne~DQ 396 (586)
T KOG0667|consen 378 LAELFTGEPLFPGDNEYDQ 396 (586)
T ss_pred HHhHhcCccccCCCCHHHH
Confidence 9999999999999876543
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=212.42 Aligned_cols=162 Identities=33% Similarity=0.555 Sum_probs=140.6
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+.+.+|+++++.++||||+++.+++..++..++||||++++.+..+......+++..+..++.|++.+|+|||+.|+
T Consensus 42 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i 121 (287)
T cd07848 42 EVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDI 121 (287)
T ss_pred cchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 34567889999999999999999999999999999999999887777665545569999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~ 165 (177)
+|+||+|+||++ +..+.++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|++++++++|+
T Consensus 122 ~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~ 198 (287)
T cd07848 122 VHRDIKPENLLI---SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198 (287)
T ss_pred ecCCCCHHHEEE---cCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCC
Confidence 999999999999 4667899999999876543221 22345788999999998888999999999999999999999
Q ss_pred CCCCCCC
Q 030430 166 PPFSVGE 172 (177)
Q Consensus 166 ~pf~~~~ 172 (177)
.||.+.+
T Consensus 199 ~pf~~~~ 205 (287)
T cd07848 199 PLFPGES 205 (287)
T ss_pred CCCCCCC
Confidence 9998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=215.26 Aligned_cols=160 Identities=37% Similarity=0.664 Sum_probs=137.9
Q ss_pred HHHHHHHHHHH---hhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 10 KSCLDCELNFL---SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 10 ~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
.+.+.+|.+++ +.++||||+++++++.+++..|+||||++|++|..++.. ..+++..+..++.|++.|++|||+.|
T Consensus 43 ~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ 121 (324)
T cd05589 43 VESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK 121 (324)
T ss_pred HHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 45677777665 456799999999999999999999999999999988764 47999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCC-CCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCC
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~ 165 (177)
++|+||+|+||++ +..+.++|+|||.+..... ........+++.|+|||.+.+..++.++|+||+|++++++++|+
T Consensus 122 ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~ 198 (324)
T cd05589 122 IVYRDLKLDNLLL---DTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGE 198 (324)
T ss_pred eEecCCCHHHeEE---CCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCC
Confidence 9999999999999 4677899999998765322 22233455788999999998888999999999999999999999
Q ss_pred CCCCCCCc
Q 030430 166 PPFSVGEE 173 (177)
Q Consensus 166 ~pf~~~~~ 173 (177)
.||.+.+.
T Consensus 199 ~pf~~~~~ 206 (324)
T cd05589 199 SPFPGDDE 206 (324)
T ss_pred CCCCCCCH
Confidence 99987654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=214.74 Aligned_cols=159 Identities=33% Similarity=0.558 Sum_probs=139.4
Q ss_pred HHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
.+.+.+|+++++.+ .||+|+++.+++...+.++++|||++|++|.+++.....+++..+..++.|++.+|+|||+.|++
T Consensus 48 ~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv 127 (332)
T cd05614 48 VEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIV 127 (332)
T ss_pred HHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Confidence 45678899999999 58999999999999999999999999999999998777899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCC--ccccccCCCccccccccccC-CCCCcchHHHHHHHHHHHHhCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~~~ 165 (177)
||||||+||++ +..+.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||+|++++++++|.
T Consensus 128 HrDlkp~Nili---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~ 204 (332)
T cd05614 128 YRDIKLENILL---DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGA 204 (332)
T ss_pred ecCCCHHHeEE---CCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCC
Confidence 99999999999 456789999999987653322 22234588999999998754 3688999999999999999999
Q ss_pred CCCCCC
Q 030430 166 PPFSVG 171 (177)
Q Consensus 166 ~pf~~~ 171 (177)
.||...
T Consensus 205 ~pf~~~ 210 (332)
T cd05614 205 SPFTLE 210 (332)
T ss_pred CCCCCC
Confidence 999653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=209.87 Aligned_cols=163 Identities=37% Similarity=0.585 Sum_probs=142.8
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEee-----CCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (177)
+..-.+..+|+++|+.++|+||+.+.+++.. -..+|+|+|++ +.+|.+.++.++.++++.+.-++.|++.+|+|
T Consensus 62 ~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKy 140 (359)
T KOG0660|consen 62 QIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKY 140 (359)
T ss_pred hHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcch
Confidence 4445678899999999999999999998764 34789999999 88999999987779999999999999999999
Q ss_pred HhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCC---CCccccccCCCccccccccc-cCCCCCcchHHHHHHH
Q 030430 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP---GNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAI 157 (177)
Q Consensus 82 lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~---~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Di~slg~~ 157 (177)
+|+.|++|||+||+|+++ +.+..+|+||||+++.... ....+....|.+|.|||... ...++.+.||||+||+
T Consensus 141 iHSAnViHRDLKPsNll~---n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI 217 (359)
T KOG0660|consen 141 IHSANVIHRDLKPSNLLL---NADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCI 217 (359)
T ss_pred hhcccccccccchhheee---ccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHH
Confidence 999999999999999999 5677789999999987753 33334556799999999874 4579999999999999
Q ss_pred HHHHHhCCCCCCCCCc
Q 030430 158 LFELLNGYPPFSVGEE 173 (177)
Q Consensus 158 ~~~~~~~~~pf~~~~~ 173 (177)
+.||++|++.|.|.+.
T Consensus 218 ~AEmL~gkplFpG~d~ 233 (359)
T KOG0660|consen 218 LAEMLTGKPLFPGKDY 233 (359)
T ss_pred HHHHHcCCCCCCCCch
Confidence 9999999999998764
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=212.27 Aligned_cols=160 Identities=36% Similarity=0.608 Sum_probs=142.3
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
.+.+++|++.++.++||||++++..|..+..+++||.++.+|++.+.+... ..+++..+..++++++.||.|||.+|.
T Consensus 68 ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~ 147 (516)
T KOG0582|consen 68 LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGH 147 (516)
T ss_pred HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCc
Confidence 678999999999999999999999999999999999999999999999854 349999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc-----ccccCCCccccccccc--cCCCCCcchHHHHHHHHHH
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-----EKVCGSPLYMAPEVLQ--FQRYDEKVDMWSVGAILFE 160 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~pe~~~--~~~~~~~~Di~slg~~~~~ 160 (177)
+|||||+.||++ +.++.++|.|||.+.....+... .+..+++.|+|||.+. ..+|+.++||||+|++..|
T Consensus 148 IHRdvKAgnILi---~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~E 224 (516)
T KOG0582|consen 148 IHRDVKAGNILI---DSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACE 224 (516)
T ss_pred eecccccccEEE---cCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHH
Confidence 999999999999 57889999999988665544321 2346899999999854 4569999999999999999
Q ss_pred HHhCCCCCCCCC
Q 030430 161 LLNGYPPFSVGE 172 (177)
Q Consensus 161 ~~~~~~pf~~~~ 172 (177)
+++|..||..-.
T Consensus 225 LA~G~aPf~k~p 236 (516)
T KOG0582|consen 225 LAHGHAPFSKYP 236 (516)
T ss_pred HhcCCCCcccCC
Confidence 999999997643
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=214.31 Aligned_cols=162 Identities=33% Similarity=0.630 Sum_probs=140.2
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
...+.+.+|..++..++|++|+++++++.+++.+++|+||++|++|.+++.+. ..+++..+..++.|++.+|+|||+.|
T Consensus 43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 122 (331)
T cd05597 43 AETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122 (331)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34566889999999999999999999999999999999999999999999763 56999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--cccccCCCcccccccccc-----CCCCCcchHHHHHHHHH
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQF-----QRYDEKVDMWSVGAILF 159 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~-----~~~~~~~Di~slg~~~~ 159 (177)
++|+||+|+||++ +..+.++|+|||.+........ .....+++.|+|||.+.. ..++.++|+||+|++++
T Consensus 123 ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~ 199 (331)
T cd05597 123 YVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMY 199 (331)
T ss_pred eEECCCCHHHEEE---CCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHH
Confidence 9999999999999 4677899999999866543322 122457899999999863 34678999999999999
Q ss_pred HHHhCCCCCCCCC
Q 030430 160 ELLNGYPPFSVGE 172 (177)
Q Consensus 160 ~~~~~~~pf~~~~ 172 (177)
+|++|+.||.+.+
T Consensus 200 el~~g~~Pf~~~~ 212 (331)
T cd05597 200 EMLYGETPFYAES 212 (331)
T ss_pred HHhhCCCCCCCCC
Confidence 9999999997654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=213.55 Aligned_cols=162 Identities=34% Similarity=0.642 Sum_probs=141.1
Q ss_pred HHHHHHHHHHHHhhCC-CCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
..+.+..|.+++..+. |++++++.+++.+...+|+||||++|++|.+++.....+++..+..++.|++.|++|||+.|+
T Consensus 43 ~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~i 122 (323)
T cd05615 43 DVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGI 122 (323)
T ss_pred HHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 3456778899998885 577888999999999999999999999999999887889999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
+|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|++++++++|..
T Consensus 123 vHrDikp~Nill---~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~ 199 (323)
T cd05615 123 IYRDLKLDNVML---DSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQP 199 (323)
T ss_pred eccCCCHHHeEE---CCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCC
Confidence 999999999999 466789999999886543322 2233457899999999988889999999999999999999999
Q ss_pred CCCCCCc
Q 030430 167 PFSVGEE 173 (177)
Q Consensus 167 pf~~~~~ 173 (177)
||.+.+.
T Consensus 200 pf~~~~~ 206 (323)
T cd05615 200 PFDGEDE 206 (323)
T ss_pred CCCCCCH
Confidence 9987654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=216.18 Aligned_cols=158 Identities=26% Similarity=0.396 Sum_probs=138.0
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
.+..+.+|++++++++||||+++++++......++++|++ +++|..++.....++...+..++.|++.||+|||+.|++
T Consensus 126 ~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~Iv 204 (391)
T PHA03212 126 QRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRII 204 (391)
T ss_pred hhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 3456789999999999999999999999999999999999 578988888777899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCC--CccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
|+||||+||++ +..+.++|+|||.+...... .......+++.|+|||.+.+..++.++|+||+|+++|++++|+.
T Consensus 205 HrDiKP~NIll---~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~ 281 (391)
T PHA03212 205 HRDIKAENIFI---NHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHD 281 (391)
T ss_pred cCCCChHhEEE---cCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 99999999999 46677999999998643221 12223458899999999988889999999999999999999998
Q ss_pred CCCC
Q 030430 167 PFSV 170 (177)
Q Consensus 167 pf~~ 170 (177)
||-.
T Consensus 282 p~~~ 285 (391)
T PHA03212 282 SLFE 285 (391)
T ss_pred CcCC
Confidence 7644
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=213.47 Aligned_cols=160 Identities=29% Similarity=0.534 Sum_probs=136.2
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeC-----CeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (177)
....+.+|+++++.++||||+++++++... ..+|++|||+ +++|.+++.....+++..+..++.|++.||+|||
T Consensus 42 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH 120 (338)
T cd07859 42 DATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120 (338)
T ss_pred hHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHH
Confidence 345688999999999999999999987533 2589999999 5799999987778999999999999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC----ccccccCCCcccccccccc--CCCCCcchHHHHHHH
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQF--QRYDEKVDMWSVGAI 157 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slg~~ 157 (177)
+.|++|+||||+||++ +..+.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||+|++
T Consensus 121 ~~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvv 197 (338)
T cd07859 121 TANVFHRDLKPKNILA---NADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 197 (338)
T ss_pred HCCeecCCCCHHHeEE---CCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHH
Confidence 9999999999999999 567789999999986543221 1123457889999998865 568899999999999
Q ss_pred HHHHHhCCCCCCCCC
Q 030430 158 LFELLNGYPPFSVGE 172 (177)
Q Consensus 158 ~~~~~~~~~pf~~~~ 172 (177)
++++++|+.||.+.+
T Consensus 198 l~el~tg~~pf~~~~ 212 (338)
T cd07859 198 FAEVLTGKPLFPGKN 212 (338)
T ss_pred HHHHHcCCCCCCCCC
Confidence 999999999997654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=207.10 Aligned_cols=159 Identities=34% Similarity=0.490 Sum_probs=140.4
Q ss_pred HHHHHHHHHhhCCCCceeeEeEEEeeC--CeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 12 CLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 12 ~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
.-.+|+.+|.+.+|||||.+.++.... +.+|+||||+ ..+|..+++..+ ++...+++.++.|++.+++|||...|+
T Consensus 121 tsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~-EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wil 199 (419)
T KOG0663|consen 121 TSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYV-EHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWIL 199 (419)
T ss_pred hhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHH-HhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeE
Confidence 356899999999999999999988754 4799999999 569999998765 699999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc-ccccCCCccccccccccC-CCCCcchHHHHHHHHHHHHhCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
|||+||+|+++ ...+.+|++|||+|+.++++... ....-|.+|.|||++.+. .|+.+.|+||+||++.|++++.+
T Consensus 200 HRDLK~SNLLm---~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kP 276 (419)
T KOG0663|consen 200 HRDLKTSNLLL---SHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKP 276 (419)
T ss_pred ecccchhheee---ccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCC
Confidence 99999999999 46788999999999998776433 234568999999998765 48999999999999999999999
Q ss_pred CCCCCCcc
Q 030430 167 PFSVGEEH 174 (177)
Q Consensus 167 pf~~~~~~ 174 (177)
.|.|.++-
T Consensus 277 lf~G~sE~ 284 (419)
T KOG0663|consen 277 LFPGKSEI 284 (419)
T ss_pred CCCCCchH
Confidence 99997654
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=209.75 Aligned_cols=159 Identities=33% Similarity=0.568 Sum_probs=136.7
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
...+.+|++++++++||||+++++++......++++||+++ +|.+++...+ .+++..+..++.|++.||+|||+.|++
T Consensus 47 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv 125 (288)
T cd07871 47 PCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKIL 125 (288)
T ss_pred chhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 45678999999999999999999999999999999999964 9998887554 478999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCcccccccccc-CCCCCcchHHHHHHHHHHHHhCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
|+||+|+||++ +..+.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||+|++++++++|+.
T Consensus 126 H~dlkp~Nil~---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~ 202 (288)
T cd07871 126 HRDLKPQNLLI---NEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRP 202 (288)
T ss_pred cCCCCHHHEEE---CCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999 466789999999986543322 2223456888999998764 457899999999999999999999
Q ss_pred CCCCCC
Q 030430 167 PFSVGE 172 (177)
Q Consensus 167 pf~~~~ 172 (177)
||.+.+
T Consensus 203 pf~~~~ 208 (288)
T cd07871 203 MFPGST 208 (288)
T ss_pred CCCCCC
Confidence 997754
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=206.37 Aligned_cols=162 Identities=36% Similarity=0.584 Sum_probs=141.8
Q ss_pred HHHHHHHHHHHHhhCCCCc-eeeEeEEEeeCC------eEEEEEecCCCCChHHHHhhcC----CCCHHHHHHHHHHHHH
Q 030430 9 LKSCLDCELNFLSSVNHPN-IIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQLGA 77 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~ 77 (177)
.-....+|+-+++.++|+| |+.+.+++...+ .+++|+||+ ..+|.++++... .++...++.++.|++.
T Consensus 53 ~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~ 131 (323)
T KOG0594|consen 53 VPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLR 131 (323)
T ss_pred CCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHH
Confidence 3445689999999999999 999999987766 899999999 679999999765 4778899999999999
Q ss_pred HHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCC-CccccccCCCccccccccccC-CCCCcchHHHHH
Q 030430 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVG 155 (177)
Q Consensus 78 ~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg 155 (177)
|++|||+.||+|||+||.|+++ +..+.+|++|||++....-+ ..-.....|.+|.|||.+.+. .|+...|+||+|
T Consensus 132 gl~~~H~~~IlHRDLKPQNlLi---~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~G 208 (323)
T KOG0594|consen 132 GLAFLHSHGILHRDLKPQNLLI---SSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLG 208 (323)
T ss_pred HHHHHHhCCeecccCCcceEEE---CCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHH
Confidence 9999999999999999999999 46888999999999876633 333455678999999998766 689999999999
Q ss_pred HHHHHHHhCCCCCCCCCcc
Q 030430 156 AILFELLNGYPPFSVGEEH 174 (177)
Q Consensus 156 ~~~~~~~~~~~pf~~~~~~ 174 (177)
|++.||++++..|.+.++-
T Consensus 209 cIfaEm~~~~~LFpG~se~ 227 (323)
T KOG0594|consen 209 CIFAEMFTRRPLFPGDSEI 227 (323)
T ss_pred HHHHHHHhCCCCCCCCcHH
Confidence 9999999999999987654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=211.64 Aligned_cols=162 Identities=33% Similarity=0.565 Sum_probs=135.6
Q ss_pred hHHHHHHHHHHHHhhC-CCCceeeEeEEEeeC-CeEEEEEecCCCCChHHHHhhc-------------------------
Q 030430 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLH------------------------- 60 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~------------------------- 60 (177)
.....+.+|+++++.+ +||||+++++++... +.++++|||+++|+|.+++...
T Consensus 52 ~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 131 (338)
T cd05102 52 SEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQS 131 (338)
T ss_pred HHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhh
Confidence 3456789999999999 899999999987654 4689999999999999998743
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCC
Q 030430 61 -------------------------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD 103 (177)
Q Consensus 61 -------------------------------------~~~~~~~~~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~ 103 (177)
..++...+..++.|++.||+|||+.|++|+||||+||+++
T Consensus 132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~--- 208 (338)
T cd05102 132 RVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLS--- 208 (338)
T ss_pred ccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEc---
Confidence 1367788899999999999999999999999999999994
Q ss_pred CCeeEEEeeeccccccCCCC---ccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 030430 104 DDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSVGE 172 (177)
Q Consensus 104 ~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-~~~pf~~~~ 172 (177)
..+.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|+++|++++ |..||.+..
T Consensus 209 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~ 281 (338)
T cd05102 209 ENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281 (338)
T ss_pred CCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence 56789999999987643221 1112334567999999988889999999999999999997 999997743
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=214.41 Aligned_cols=161 Identities=32% Similarity=0.628 Sum_probs=140.3
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
....+.+|..++..++|++|+++.+++.+.+..|+||||++|++|.+++.+. ..+++..+..++.|++.+|+|+|+.|+
T Consensus 44 ~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~i 123 (331)
T cd05624 44 ETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHY 123 (331)
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 4556888999999999999999999999999999999999999999999864 568999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc--ccccCCCcccccccccc-----CCCCCcchHHHHHHHHHH
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQF-----QRYDEKVDMWSVGAILFE 160 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~-----~~~~~~~Di~slg~~~~~ 160 (177)
+|+||||+||++ +..+.++|+|||.+......... ....+++.|+|||.+.+ ..++.++|+||+|+++|+
T Consensus 124 iHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~e 200 (331)
T cd05624 124 VHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYE 200 (331)
T ss_pred eeccCchHHEEE---cCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhh
Confidence 999999999999 46678999999998765443221 23458899999998864 457889999999999999
Q ss_pred HHhCCCCCCCCC
Q 030430 161 LLNGYPPFSVGE 172 (177)
Q Consensus 161 ~~~~~~pf~~~~ 172 (177)
|++|+.||.+.+
T Consensus 201 ll~g~~Pf~~~~ 212 (331)
T cd05624 201 MLYGETPFYAES 212 (331)
T ss_pred hhhCCCCccCCC
Confidence 999999997654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=217.01 Aligned_cols=161 Identities=35% Similarity=0.588 Sum_probs=141.3
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
....+.+|+++++.++||+|+++.+++.+....++||||++|++|.+++.+. ..+++..+..++.|++.+|++||+.|+
T Consensus 44 ~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i 123 (330)
T cd05601 44 TVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGY 123 (330)
T ss_pred HHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 4567889999999999999999999999999999999999999999999876 579999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--cccccCCCccccccccc------cCCCCCcchHHHHHHHHH
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQ------FQRYDEKVDMWSVGAILF 159 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~------~~~~~~~~Di~slg~~~~ 159 (177)
+|+||+|+||++ +..+.++|+|||.+........ .....+++.|+|||.+. ...++.++|+||+|++++
T Consensus 124 ~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~ 200 (330)
T cd05601 124 VHRDIKPENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAY 200 (330)
T ss_pred EcccCchHheEE---CCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceee
Confidence 999999999999 4677899999999876543322 12345788999999875 345778999999999999
Q ss_pred HHHhCCCCCCCCC
Q 030430 160 ELLNGYPPFSVGE 172 (177)
Q Consensus 160 ~~~~~~~pf~~~~ 172 (177)
+|++|..||...+
T Consensus 201 el~~g~~Pf~~~~ 213 (330)
T cd05601 201 EMIYGRSPFHEGT 213 (330)
T ss_pred eeccCCCCCCCCC
Confidence 9999999997654
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=212.95 Aligned_cols=161 Identities=33% Similarity=0.637 Sum_probs=139.6
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
....+..|..++..++|++|+++.+++.+...+++||||+++++|.+++.+. ..+++..+..++.|++.+++|||+.|+
T Consensus 44 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~i 123 (332)
T cd05623 44 ETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY 123 (332)
T ss_pred HHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 3456888999999999999999999999999999999999999999999864 568999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--cccccCCCccccccccc-----cCCCCCcchHHHHHHHHHH
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFE 160 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~slg~~~~~ 160 (177)
+||||||+||++ +..+.++|+|||.+........ .....+++.|+|||.+. ...++.++|+||+|+++++
T Consensus 124 iHrDlkp~Nili---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~e 200 (332)
T cd05623 124 VHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYE 200 (332)
T ss_pred EecCCCHHHEEE---CCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHH
Confidence 999999999999 4677899999999866533222 22345889999999875 3457889999999999999
Q ss_pred HHhCCCCCCCCC
Q 030430 161 LLNGYPPFSVGE 172 (177)
Q Consensus 161 ~~~~~~pf~~~~ 172 (177)
+++|+.||.+.+
T Consensus 201 ll~g~~Pf~~~~ 212 (332)
T cd05623 201 MLYGETPFYAES 212 (332)
T ss_pred HhcCCCCCCCCC
Confidence 999999997654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=203.37 Aligned_cols=160 Identities=33% Similarity=0.634 Sum_probs=141.0
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
...+.+|++++++++||||+++++++.++...++++|+++|++|.+++...+.+++..+..++.|++.++++||+.|++|
T Consensus 48 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H 127 (263)
T cd06625 48 VNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVH 127 (263)
T ss_pred HHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 35688999999999999999999999999999999999999999999988778999999999999999999999999999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc----ccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCC
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~ 165 (177)
+||+|+||++ +..+.++++|||.+......... ....++..|+|||...+..++.++|+||+|++++++++|+
T Consensus 128 ~dl~p~nilv---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 204 (263)
T cd06625 128 RDIKGANILR---DSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204 (263)
T ss_pred CCCCHHHEEE---cCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCC
Confidence 9999999999 46678999999988654332111 1234667899999998888999999999999999999999
Q ss_pred CCCCCCC
Q 030430 166 PPFSVGE 172 (177)
Q Consensus 166 ~pf~~~~ 172 (177)
.||...+
T Consensus 205 ~p~~~~~ 211 (263)
T cd06625 205 PPWAEFE 211 (263)
T ss_pred CCccccc
Confidence 9997643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=208.96 Aligned_cols=158 Identities=32% Similarity=0.520 Sum_probs=135.0
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
...+.+|+++++.++||||+++++++.+....+++|||+ +++|.+++... ..++++.+..++.|++.||+|||+.|++
T Consensus 47 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iv 125 (303)
T cd07869 47 PFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYIL 125 (303)
T ss_pred chhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC-CcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 346778999999999999999999999999999999999 56888877654 4589999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCcccccccccc-CCCCCcchHHHHHHHHHHHHhCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
|+||||+||++ +..+.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||+|++++++++|..
T Consensus 126 H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 202 (303)
T cd07869 126 HRDLKPQNLLI---SDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVA 202 (303)
T ss_pred cCCCCHHHEEE---CCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999 466789999999886543222 2223456888999998764 457889999999999999999999
Q ss_pred CCCCC
Q 030430 167 PFSVG 171 (177)
Q Consensus 167 pf~~~ 171 (177)
||.+.
T Consensus 203 pf~~~ 207 (303)
T cd07869 203 AFPGM 207 (303)
T ss_pred CCCCC
Confidence 99764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=205.48 Aligned_cols=160 Identities=39% Similarity=0.738 Sum_probs=143.8
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+.+.+|++++++++||||+++++++.++..+++++||+++++|.+++.+...+++..+..++.|++.+|++||+.|+
T Consensus 43 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i 122 (290)
T cd05580 43 KQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDI 122 (290)
T ss_pred hHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 34567889999999999999999999999999999999999999999999888889999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
+|+||+|+||++ +..+.++++|||.+...... .....+++.|++||...+...+.++|+||+|++++++++|+.|
T Consensus 123 ~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 197 (290)
T cd05580 123 VYRDLKPENLLL---DSDGYIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197 (290)
T ss_pred ecCCCCHHHEEE---CCCCCEEEeeCCCccccCCC--CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCC
Confidence 999999999999 45678999999988766444 2334578889999998877888999999999999999999999
Q ss_pred CCCCC
Q 030430 168 FSVGE 172 (177)
Q Consensus 168 f~~~~ 172 (177)
|...+
T Consensus 198 ~~~~~ 202 (290)
T cd05580 198 FFDDN 202 (290)
T ss_pred CCCCC
Confidence 97654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=218.10 Aligned_cols=161 Identities=34% Similarity=0.583 Sum_probs=146.9
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCC--eEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (177)
++...++|..|+.+|+.|+||||++++++|.+.. .+.+|+|++.+|+|..|+++++..+...++.|+.||+++|.|||
T Consensus 81 ~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLH 160 (632)
T KOG0584|consen 81 SPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLH 160 (632)
T ss_pred ChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhh
Confidence 3445589999999999999999999999997654 58899999999999999999999999999999999999999999
Q ss_pred hCC--CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHH
Q 030430 84 SHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 84 ~~~--~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~ 161 (177)
++. |+|||||-+||+++ +..+.+|++|+|+|.....+.... ..|||-|||||.+. ..|+...||||+|+|+.||
T Consensus 161 s~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl~r~s~aks-vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEM 236 (632)
T KOG0584|consen 161 SQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATLLRKSHAKS-VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEM 236 (632)
T ss_pred cCCCCccccccccceEEEc--CCcCceeecchhHHHHhhccccce-eccCccccChHHHh-hhcchhhhhhhhhHHHHHH
Confidence 997 99999999999997 677889999999998776666554 67999999999987 7899999999999999999
Q ss_pred HhCCCCCCC
Q 030430 162 LNGYPPFSV 170 (177)
Q Consensus 162 ~~~~~pf~~ 170 (177)
+|+..||+.
T Consensus 237 vT~eYPYsE 245 (632)
T KOG0584|consen 237 VTSEYPYSE 245 (632)
T ss_pred HhccCChhh
Confidence 999999964
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=219.42 Aligned_cols=166 Identities=31% Similarity=0.521 Sum_probs=145.9
Q ss_pred cchhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHh
Q 030430 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 5 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lh 83 (177)
+.+..+.++.+|++++++++||||++++|+..+...++++||+|.||+|.+++++.+. ++..+...++.+.+.+|+|||
T Consensus 200 ~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh 279 (474)
T KOG0194|consen 200 LTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH 279 (474)
T ss_pred ccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH
Confidence 4577889999999999999999999999999999999999999999999999998875 999999999999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccc-cccCCCccccccccccCCCCCcchHHHHHHHHHHHH
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~ 162 (177)
+.+++||||-..|++++ ....+|++|||++.....-.... ......+|+|||.+....++.++||||+|+++||++
T Consensus 280 ~k~~IHRDIAARNcL~~---~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif 356 (474)
T KOG0194|consen 280 SKNCIHRDIAARNCLYS---KKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIF 356 (474)
T ss_pred HCCCcchhHhHHHheec---CCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeee
Confidence 99999999999999994 55568999999986543222211 222457899999999889999999999999999999
Q ss_pred h-CCCCCCCCCc
Q 030430 163 N-GYPPFSVGEE 173 (177)
Q Consensus 163 ~-~~~pf~~~~~ 173 (177)
+ |..||.+...
T Consensus 357 ~~g~~Py~g~~~ 368 (474)
T KOG0194|consen 357 ENGAEPYPGMKN 368 (474)
T ss_pred ccCCCCCCCCCH
Confidence 9 7889988653
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=205.26 Aligned_cols=164 Identities=29% Similarity=0.569 Sum_probs=141.2
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc----------------CCCCHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTARK 70 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~ 70 (177)
......+.+|++++++++|||++++++++.+....++++||+++++|.+++... ..++...+..
T Consensus 49 ~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 128 (283)
T cd05048 49 PKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128 (283)
T ss_pred HHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHH
Confidence 345677899999999999999999999999989999999999999999999754 3478889999
Q ss_pred HHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCCC
Q 030430 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDE 147 (177)
Q Consensus 71 ~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~ 147 (177)
++.|++.+++|||+.|++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||.+.+..++.
T Consensus 129 ~~~~l~~al~~lH~~~i~H~dlkp~Nil~---~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 205 (283)
T cd05048 129 IAIQIAAGMEYLSSHHFVHRDLAARNCLV---GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTT 205 (283)
T ss_pred HHHHHHHHHHHHHhCCeeccccccceEEE---cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCch
Confidence 99999999999999999999999999999 4567899999999876543321 12233567899999988888999
Q ss_pred cchHHHHHHHHHHHHh-CCCCCCCCCc
Q 030430 148 KVDMWSVGAILFELLN-GYPPFSVGEE 173 (177)
Q Consensus 148 ~~Di~slg~~~~~~~~-~~~pf~~~~~ 173 (177)
++|+||+|++++++++ |..||.+.+.
T Consensus 206 ~sDv~slG~il~el~~~g~~p~~~~~~ 232 (283)
T cd05048 206 ESDIWSFGVVLWEIFSYGLQPYYGFSN 232 (283)
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9999999999999998 9999977543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=204.44 Aligned_cols=160 Identities=34% Similarity=0.548 Sum_probs=140.4
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+.+|++++++++|++++++.+.+.+++..++++||++|++|.+++... ..+++..+..++.|++.++.|||+.|+
T Consensus 44 ~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 123 (285)
T cd05630 44 ESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERI 123 (285)
T ss_pred HHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 355778999999999999999999999999999999999999999988644 348999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
+|+||+|+||++ +..+.++++|||.+.............++..|+|||.+.+..++.++|+||+|++++++++|+.|
T Consensus 124 iH~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~P 200 (285)
T cd05630 124 VYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200 (285)
T ss_pred EeCCCCHHHEEE---CCCCCEEEeeccceeecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCC
Confidence 999999999999 46677999999988665433333344578899999999888899999999999999999999999
Q ss_pred CCCCC
Q 030430 168 FSVGE 172 (177)
Q Consensus 168 f~~~~ 172 (177)
|....
T Consensus 201 f~~~~ 205 (285)
T cd05630 201 FQQRK 205 (285)
T ss_pred CCCCC
Confidence 98643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=214.60 Aligned_cols=158 Identities=28% Similarity=0.452 Sum_probs=139.5
Q ss_pred HHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCeee
Q 030430 11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHR 90 (177)
Q Consensus 11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H~ 90 (177)
....+|++++++++||||+++++++......+++||++ +++|.+++.....+++..+..++.|++.||+|||+.|++|+
T Consensus 131 ~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHr 209 (392)
T PHA03207 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY-KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHR 209 (392)
T ss_pred ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 34578999999999999999999999999999999999 56899988777789999999999999999999999999999
Q ss_pred cCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 91 ~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
||||+||++ +..+.++|+|||.+........ .....++..|+|||.+....++.++|+||+|+++|++++|+.|
T Consensus 210 Dlkp~Nill---~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~p 286 (392)
T PHA03207 210 DVKTENIFL---DEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286 (392)
T ss_pred CCCHHHEEE---cCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 999999999 4677899999999876544322 2234578999999999888899999999999999999999999
Q ss_pred CCCCC
Q 030430 168 FSVGE 172 (177)
Q Consensus 168 f~~~~ 172 (177)
|.+..
T Consensus 287 f~~~~ 291 (392)
T PHA03207 287 LFGKQ 291 (392)
T ss_pred CCCCC
Confidence 97653
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=201.79 Aligned_cols=164 Identities=29% Similarity=0.578 Sum_probs=144.3
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh 83 (177)
+......+.+|+++++.++|||++++++++.+.+..++++||++|++|.+++... ..++...+..++.+++.++++||
T Consensus 39 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH 118 (256)
T cd08529 39 NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH 118 (256)
T ss_pred CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4566788999999999999999999999999999999999999999999999864 45899999999999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccCCCCCcchHHHHHHHHHHHH
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~ 162 (177)
+.|++|+|++|+||+++ ..+.++++|||.+........ .....++..|+|||...+..++.++|+||+|+++++++
T Consensus 119 ~~~i~h~dl~~~nili~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 195 (256)
T cd08529 119 SKKILHRDIKSLNLFLD---AYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECC 195 (256)
T ss_pred HCCcccCCCCcceEEEe---CCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHH
Confidence 99999999999999994 567899999998876544322 22345678899999998888899999999999999999
Q ss_pred hCCCCCCCCC
Q 030430 163 NGYPPFSVGE 172 (177)
Q Consensus 163 ~~~~pf~~~~ 172 (177)
+|+.||...+
T Consensus 196 ~g~~p~~~~~ 205 (256)
T cd08529 196 TGKHPFDANN 205 (256)
T ss_pred hCCCCCCCCC
Confidence 9999997654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=203.47 Aligned_cols=168 Identities=35% Similarity=0.563 Sum_probs=144.5
Q ss_pred chhHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
--+.+.++.+|++++.+. .|+||++++++|++...+|+|||-+.||+|..++.+...+++..+.++.++|+.||.+||+
T Consensus 115 ~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~ 194 (463)
T KOG0607|consen 115 PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHT 194 (463)
T ss_pred CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhh
Confidence 346789999999999999 6999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC--------ccccccCCCccccccccc-----cCCCCCcchH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQ-----FQRYDEKVDM 151 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di 151 (177)
+||.|||+||+||+-...+.-..+|+|||.+.....-.. ...+..|+..|||||+.. ...|+.++|+
T Consensus 195 kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDl 274 (463)
T KOG0607|consen 195 KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDL 274 (463)
T ss_pred cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccH
Confidence 999999999999998655556669999998775432111 112455777899999753 2347899999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCc
Q 030430 152 WSVGAILFELLNGYPPFSVGEE 173 (177)
Q Consensus 152 ~slg~~~~~~~~~~~pf~~~~~ 173 (177)
||||+++|-|+.|++||.|.=+
T Consensus 275 wSLGvIlYImLsGYpPFvG~Cg 296 (463)
T KOG0607|consen 275 WSLGVILYIMLSGYPPFVGHCG 296 (463)
T ss_pred HHHHHHHHHHHhCCCCccCccC
Confidence 9999999999999999988533
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=204.97 Aligned_cols=164 Identities=26% Similarity=0.605 Sum_probs=140.7
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-------------CCCHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------------RVPEQTARKFLQ 73 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~ 73 (177)
......+.+|++++++++||+++++++++...+.+++++||+++++|.+++...+ .+++.++..++.
T Consensus 48 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 127 (288)
T cd05093 48 DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127 (288)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHH
Confidence 3456679999999999999999999999999999999999999999999987543 389999999999
Q ss_pred HHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCCCcch
Q 030430 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVD 150 (177)
Q Consensus 74 ~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~D 150 (177)
|++.++++||+.|++|+||+|+||++ +..+.++|+|||.+........ .....++..|+|||.+.+..++.++|
T Consensus 128 ql~~aL~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sD 204 (288)
T cd05093 128 QIAAGMVYLASQHFVHRDLATRNCLV---GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESD 204 (288)
T ss_pred HHHHHHHHHHhCCeeecccCcceEEE---ccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhh
Confidence 99999999999999999999999999 4677899999999876533221 11222456799999998888899999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCCc
Q 030430 151 MWSVGAILFELLN-GYPPFSVGEE 173 (177)
Q Consensus 151 i~slg~~~~~~~~-~~~pf~~~~~ 173 (177)
+||+|+++++|++ |..||.....
T Consensus 205 iwslG~il~~l~t~g~~p~~~~~~ 228 (288)
T cd05093 205 VWSLGVVLWEIFTYGKQPWYQLSN 228 (288)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999998 8999976543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=203.71 Aligned_cols=160 Identities=34% Similarity=0.531 Sum_probs=140.7
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+.+|+++++.++|++++++.+.+..++..++++||+++++|.+++... ..+++..+..++.|++.++.|||+.|+
T Consensus 44 ~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i 123 (285)
T cd05632 44 ESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENT 123 (285)
T ss_pred HHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 445788999999999999999999999999999999999999999888643 359999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
+|+||+|+||++ +..+.++++|||.+.............++..|+|||.+.+..++.++|+||+|++++++++|..|
T Consensus 124 iH~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P 200 (285)
T cd05632 124 VYRDLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200 (285)
T ss_pred eecCCCHHHEEE---CCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCC
Confidence 999999999999 45667999999988665433333344678999999999888899999999999999999999999
Q ss_pred CCCCC
Q 030430 168 FSVGE 172 (177)
Q Consensus 168 f~~~~ 172 (177)
|.+..
T Consensus 201 ~~~~~ 205 (285)
T cd05632 201 FRGRK 205 (285)
T ss_pred CCCCC
Confidence 98754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=205.23 Aligned_cols=162 Identities=26% Similarity=0.580 Sum_probs=139.8
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC----------------CCCHHHHHHHH
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARKFL 72 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~ 72 (177)
..+.+.+|+++++.++|+|++++++++......+++|||+++++|.+++..+. .+++..+..++
T Consensus 50 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 129 (291)
T cd05094 50 ARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129 (291)
T ss_pred HHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHH
Confidence 34678999999999999999999999999999999999999999999997542 37889999999
Q ss_pred HHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCCCcc
Q 030430 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKV 149 (177)
Q Consensus 73 ~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~ 149 (177)
.|++.++++||+.|++|+||+|+||++ +.++.++++|||.+........ .....++..|+|||...+..++.++
T Consensus 130 ~~i~~al~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 206 (291)
T cd05094 130 SQIASGMVYLASQHFVHRDLATRNCLV---GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES 206 (291)
T ss_pred HHHHHHHHHHHhCCeeecccCcceEEE---ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchh
Confidence 999999999999999999999999999 4667899999999866543321 1223346779999999888899999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCCc
Q 030430 150 DMWSVGAILFELLN-GYPPFSVGEE 173 (177)
Q Consensus 150 Di~slg~~~~~~~~-~~~pf~~~~~ 173 (177)
|+||+|++++++++ |..||.....
T Consensus 207 Di~slG~il~el~t~g~~p~~~~~~ 231 (291)
T cd05094 207 DVWSFGVILWEIFTYGKQPWFQLSN 231 (291)
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999 9999866443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=217.57 Aligned_cols=163 Identities=33% Similarity=0.595 Sum_probs=148.4
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
-+++.-+-+++=|++|+||||+.+.+++.....+|||||||..|.|...++....++...+..|.++|+.++.|||...|
T Consensus 154 KV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKI 233 (904)
T KOG4721|consen 154 KVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKI 233 (904)
T ss_pred HHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhH
Confidence 34555667888999999999999999999999999999999999999999988889999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
+|||+|.-||+|+ ....+|++|||-++............||..|||||.+.+.+.+.+.||||+|+++|||+||..|
T Consensus 234 IHRDLKSPNiLIs---~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiP 310 (904)
T KOG4721|consen 234 IHRDLKSPNILIS---YDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIP 310 (904)
T ss_pred hhhccCCCceEee---ccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCC
Confidence 9999999999995 4567999999998887766666667799999999999999999999999999999999999999
Q ss_pred CCCCCc
Q 030430 168 FSVGEE 173 (177)
Q Consensus 168 f~~~~~ 173 (177)
|..-+.
T Consensus 311 YkdVds 316 (904)
T KOG4721|consen 311 YKDVDS 316 (904)
T ss_pred ccccch
Confidence 976543
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=203.62 Aligned_cols=163 Identities=24% Similarity=0.446 Sum_probs=138.9
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
.....+.+|++.+++++|||++++.+++..++..++||||+++++|.+++... ..+++..+..++.|++.|+++||+.|
T Consensus 48 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~ 127 (266)
T cd05064 48 KQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG 127 (266)
T ss_pred HHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 44567899999999999999999999999999999999999999999998864 46899999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccc--cccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~- 163 (177)
++|+||+|+||++ +.++.++++|||.+.......... ...++..|+|||...+..++.++|+||+|++++++++
T Consensus 128 iiH~dikp~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~ 204 (266)
T cd05064 128 YVHKGLAAHKVLV---NSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSY 204 (266)
T ss_pred EeeccccHhhEEE---cCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcC
Confidence 9999999999999 466789999999765543222111 1223467999999988889999999999999999775
Q ss_pred CCCCCCCCCc
Q 030430 164 GYPPFSVGEE 173 (177)
Q Consensus 164 ~~~pf~~~~~ 173 (177)
|..||...+.
T Consensus 205 g~~p~~~~~~ 214 (266)
T cd05064 205 GERPYWDMSG 214 (266)
T ss_pred CCCCcCcCCH
Confidence 9999976543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=206.14 Aligned_cols=163 Identities=28% Similarity=0.539 Sum_probs=137.6
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-------------------CCCHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------------------RVPEQT 67 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~ 67 (177)
...+..+.+|++++++++||||+++++++.+.+..++++||+++++|.+++.... .++...
T Consensus 60 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (304)
T cd05096 60 KNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSS 139 (304)
T ss_pred HHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHH
Confidence 3456679999999999999999999999999999999999999999999886431 256778
Q ss_pred HHHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCC
Q 030430 68 ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQR 144 (177)
Q Consensus 68 ~~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~ 144 (177)
+..++.|++.|++|||+.|++|+||+|+||++ +..+.++|+|||.+........ .....++..|+|||.+....
T Consensus 140 ~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 216 (304)
T cd05096 140 LLHVALQIASGMKYLSSLNFVHRDLATRNCLV---GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK 216 (304)
T ss_pred HHHHHHHHHHHHHHHHHCCccccCcchhheEE---cCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC
Confidence 89999999999999999999999999999999 4667899999999876543321 12233467899999988888
Q ss_pred CCCcchHHHHHHHHHHHHh--CCCCCCCCC
Q 030430 145 YDEKVDMWSVGAILFELLN--GYPPFSVGE 172 (177)
Q Consensus 145 ~~~~~Di~slg~~~~~~~~--~~~pf~~~~ 172 (177)
++.++|+||+|++++++++ +..||...+
T Consensus 217 ~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 246 (304)
T cd05096 217 FTTASDVWAFGVTLWEILMLCKEQPYGELT 246 (304)
T ss_pred CCchhhhHHHHHHHHHHHHccCCCCCCcCC
Confidence 9999999999999999987 567886543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=201.22 Aligned_cols=162 Identities=38% Similarity=0.722 Sum_probs=145.0
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+.+.+|+++++.++|||++++++.+.++...++++||+++++|.+++.+...+++..+..++.|++.+++++|+.|+
T Consensus 35 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~ 114 (262)
T cd05572 35 GQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGI 114 (262)
T ss_pred hHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCc
Confidence 45678999999999999999999999999999999999999999999999877779999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
+|+||+|+||++ +..+.++++|||.+.............++..|++||.+.+..++.++|+||+|+++|++++|..|
T Consensus 115 ~h~dl~~~nilv---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p 191 (262)
T cd05572 115 IYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191 (262)
T ss_pred ccCCCCHHHEEE---cCCCCEEEeeCCcccccCcccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCC
Confidence 999999999999 45678999999998776544333334577889999998877889999999999999999999999
Q ss_pred CCCCC
Q 030430 168 FSVGE 172 (177)
Q Consensus 168 f~~~~ 172 (177)
|...+
T Consensus 192 ~~~~~ 196 (262)
T cd05572 192 FGEDD 196 (262)
T ss_pred cCCCC
Confidence 97765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=213.79 Aligned_cols=159 Identities=36% Similarity=0.616 Sum_probs=136.3
Q ss_pred HHHHHHHHHhhC---CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 12 CLDCELNFLSSV---NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 12 ~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
....|..++... +||+|+++.+++.....++++|||+++++|.+++...+.+++..+..++.|++.||+|||+.|++
T Consensus 39 ~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~iv 118 (330)
T cd05586 39 HTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIV 118 (330)
T ss_pred HHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 344566666655 69999999999999999999999999999999998888899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCC-CccccccCCCccccccccccC-CCCCcchHHHHHHHHHHHHhCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
|+||+|+||++ +..+.++|+|||.+...... .......++..|+|||.+.+. .++.++|+||+|+++|+|++|..
T Consensus 119 HrDlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~ 195 (330)
T cd05586 119 YRDLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWS 195 (330)
T ss_pred eccCCHHHeEE---CCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCC
Confidence 99999999999 46678999999998654332 223345588899999988654 47899999999999999999999
Q ss_pred CCCCCCc
Q 030430 167 PFSVGEE 173 (177)
Q Consensus 167 pf~~~~~ 173 (177)
||.+.+.
T Consensus 196 Pf~~~~~ 202 (330)
T cd05586 196 PFYAEDT 202 (330)
T ss_pred CCCCCCH
Confidence 9977653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=218.35 Aligned_cols=165 Identities=33% Similarity=0.561 Sum_probs=144.7
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCC------eEEEEEecCCCCChHHHHhhcC---CCCHHHHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQLGA 77 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~ 77 (177)
...+++--+|++++++++|||||++.++-+... ...++||||.||||+..+++.. .+++..++.++.++..
T Consensus 52 ~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~ 131 (732)
T KOG4250|consen 52 LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVS 131 (732)
T ss_pred cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHH
Confidence 455678889999999999999999999865433 5689999999999999998653 4999999999999999
Q ss_pred HHHHHhhCCCeeecCCCCcEEEec-CCCCeeEEEeeeccccccCCCCccccccCCCcccccccccc-CCCCCcchHHHHH
Q 030430 78 GLEILNSHHIIHRDLKPENILLSG-LDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVG 155 (177)
Q Consensus 78 ~l~~lh~~~~~H~~i~~~nil~~~-~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg 155 (177)
|+.+||+.||+||||||.||+.-. .+.....||+|||.|+....+....+..||..|.+||.+.. +.++...|.||+|
T Consensus 132 al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~G 211 (732)
T KOG4250|consen 132 ALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFG 211 (732)
T ss_pred HHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhh
Confidence 999999999999999999998753 22344579999999999988887778889999999999984 7788999999999
Q ss_pred HHHHHHHhCCCCCCCC
Q 030430 156 AILFELLNGYPPFSVG 171 (177)
Q Consensus 156 ~~~~~~~~~~~pf~~~ 171 (177)
+++|+++||+.||...
T Consensus 212 vtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 212 VTLYECATGELPFIPF 227 (732)
T ss_pred hHHHHHhccCCCCCcC
Confidence 9999999999999653
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=201.53 Aligned_cols=161 Identities=32% Similarity=0.597 Sum_probs=141.6
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
..+.+.+|++++++++||||+++.+++.+....++++||+++++|.+++...+.+++..+..++.|++.++++||+.|++
T Consensus 49 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~iv 128 (267)
T cd06628 49 MLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGII 128 (267)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcc
Confidence 34678899999999999999999999999999999999999999999998888899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-------cccccCCCccccccccccCCCCCcchHHHHHHHHHHH
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~ 161 (177)
|+||+|+||++ +..+.++++|||.+........ .....++..|+|||.+.+..++.++|+||+|++++++
T Consensus 129 H~di~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l 205 (267)
T cd06628 129 HRDIKGANILV---DNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEM 205 (267)
T ss_pred cccCCHHHEEE---cCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHH
Confidence 99999999999 4677899999998876542211 1123367789999999888889999999999999999
Q ss_pred HhCCCCCCCCC
Q 030430 162 LNGYPPFSVGE 172 (177)
Q Consensus 162 ~~~~~pf~~~~ 172 (177)
++|..||...+
T Consensus 206 ~~g~~p~~~~~ 216 (267)
T cd06628 206 LTGKHPFPDCT 216 (267)
T ss_pred hhCCCCCCCcc
Confidence 99999997643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=205.01 Aligned_cols=162 Identities=33% Similarity=0.562 Sum_probs=142.3
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-C
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-H 85 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~ 85 (177)
......+.+|++++++++||||+++++++.+++.+++++||++|++|.+++.+...+++..+..++.|++.++.|||+ .
T Consensus 40 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 119 (308)
T cd06615 40 PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH 119 (308)
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC
Confidence 445667889999999999999999999999999999999999999999999888889999999999999999999997 6
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCC
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~ 165 (177)
+++|+||+|+||++. .++.++++|||.+....... .....++..|++||...+..++.++|+||+|++++++++|+
T Consensus 120 ~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~ 195 (308)
T cd06615 120 KIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195 (308)
T ss_pred CEEECCCChHHEEEe---cCCcEEEccCCCcccccccc-cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCC
Confidence 899999999999994 56679999999876543322 22345778899999988778899999999999999999999
Q ss_pred CCCCCCC
Q 030430 166 PPFSVGE 172 (177)
Q Consensus 166 ~pf~~~~ 172 (177)
.||...+
T Consensus 196 ~p~~~~~ 202 (308)
T cd06615 196 YPIPPPD 202 (308)
T ss_pred CCCCCcc
Confidence 9996543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=205.95 Aligned_cols=159 Identities=36% Similarity=0.575 Sum_probs=134.7
Q ss_pred HHHHHHHHHHhhC---CCCceeeEeEEEe-----eCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHH
Q 030430 11 SCLDCELNFLSSV---NHPNIIRLFDAFQ-----AENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLE 80 (177)
Q Consensus 11 ~~~~~e~~~l~~l---~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~ 80 (177)
..+.+|+++++.+ +||||+++++++. ....+++++|++. ++|.+++... ..+++..+..++.|++.||+
T Consensus 46 ~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~ 124 (290)
T cd07862 46 LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124 (290)
T ss_pred HHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHH
Confidence 4566777777766 6999999999875 3456899999995 6999988754 34899999999999999999
Q ss_pred HHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHH
Q 030430 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (177)
Q Consensus 81 ~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~ 160 (177)
|||+.|++|+||+|+||++ +..+.++|+|||.+.............++..|+|||.+....++.++|+||+|+++++
T Consensus 125 ~lH~~~iiH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~e 201 (290)
T cd07862 125 FLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAE 201 (290)
T ss_pred HHHHCCeeeCCCCHHHEEE---cCCCCEEEccccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHH
Confidence 9999999999999999999 4667899999999876554444444567889999999988888999999999999999
Q ss_pred HHhCCCCCCCCCc
Q 030430 161 LLNGYPPFSVGEE 173 (177)
Q Consensus 161 ~~~~~~pf~~~~~ 173 (177)
+++|.+||.+.++
T Consensus 202 l~~g~~~f~~~~~ 214 (290)
T cd07862 202 MFRRKPLFRGSSD 214 (290)
T ss_pred HHcCCCCcCCCCH
Confidence 9999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=207.41 Aligned_cols=163 Identities=31% Similarity=0.506 Sum_probs=138.0
Q ss_pred hhHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC----------------CCCHHHHH
Q 030430 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTAR 69 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~ 69 (177)
+.....+.+|++++.++ +|+|++++.+++..++.+++++||+++++|.+++.... .+++.++.
T Consensus 48 ~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 127 (303)
T cd05088 48 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127 (303)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHH
Confidence 34566788999999999 89999999999999999999999999999999987542 47889999
Q ss_pred HHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcc
Q 030430 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149 (177)
Q Consensus 70 ~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~ 149 (177)
.++.|++.|+++||+.|++|+||+|+||++ +..+.++|+|||.+..............+..|+|||...+..++.++
T Consensus 128 ~~~~qi~~al~~LH~~gi~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 204 (303)
T cd05088 128 HFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNS 204 (303)
T ss_pred HHHHHHHHHHHHHHhCCccccccchheEEe---cCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccc
Confidence 999999999999999999999999999999 46678999999988543221111112235579999998877889999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCC
Q 030430 150 DMWSVGAILFELLN-GYPPFSVGE 172 (177)
Q Consensus 150 Di~slg~~~~~~~~-~~~pf~~~~ 172 (177)
|+||+|+++++++| |..||.+.+
T Consensus 205 Di~slG~il~ellt~g~~p~~~~~ 228 (303)
T cd05088 205 DVWSYGVLLWEIVSLGGTPYCGMT 228 (303)
T ss_pred cchhhhhHHHHHHhcCCCCcccCC
Confidence 99999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=211.34 Aligned_cols=162 Identities=29% Similarity=0.518 Sum_probs=137.6
Q ss_pred hHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-------------------------
Q 030430 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG------------------------- 61 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------------- 61 (177)
.....+.+|+++++.+ +|+||+++++++...+..+++|||+++++|.+++....
T Consensus 83 ~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (374)
T cd05106 83 DEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITL 162 (374)
T ss_pred HHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccch
Confidence 3456788999999999 89999999999999999999999999999999886421
Q ss_pred ---------------------------------------------CCCHHHHHHHHHHHHHHHHHHhhCCCeeecCCCCc
Q 030430 62 ---------------------------------------------RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPEN 96 (177)
Q Consensus 62 ---------------------------------------------~~~~~~~~~~~~~i~~~l~~lh~~~~~H~~i~~~n 96 (177)
.++.+.+.+++.|++.||+|||+.|++||||||+|
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~N 242 (374)
T cd05106 163 EKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARN 242 (374)
T ss_pred hcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchhe
Confidence 36778899999999999999999999999999999
Q ss_pred EEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 030430 97 ILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSVGE 172 (177)
Q Consensus 97 il~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-~~~pf~~~~ 172 (177)
|+++ ....++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|++++++++ |..||....
T Consensus 243 il~~---~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~ 319 (374)
T cd05106 243 VLLT---DGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL 319 (374)
T ss_pred EEEe---CCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccc
Confidence 9994 567799999999876533221 112224567999999988889999999999999999997 999997643
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=198.89 Aligned_cols=164 Identities=32% Similarity=0.545 Sum_probs=144.0
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh 83 (177)
++...+.+.+|++++++++|+|++++++++.+.+..++++||+++++|.+++... ..++...+..++.|++.++++||
T Consensus 39 ~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh 118 (256)
T cd08221 39 SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118 (256)
T ss_pred chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 4556678899999999999999999999999999999999999999999999865 35899999999999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccCCCCCcchHHHHHHHHHHHH
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~ 162 (177)
+.|++|+||+|+||++. ..+.++++|||.+....... ......++..|.|||...+..++.++|+||+|+++++++
T Consensus 119 ~~~i~h~dl~p~ni~~~---~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~ 195 (256)
T cd08221 119 KAGILHRDIKTLNIFLT---KAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELL 195 (256)
T ss_pred hCCccccCCChHhEEEe---CCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHH
Confidence 99999999999999994 56779999999886654433 223345788999999988777889999999999999999
Q ss_pred hCCCCCCCCC
Q 030430 163 NGYPPFSVGE 172 (177)
Q Consensus 163 ~~~~pf~~~~ 172 (177)
+|..||...+
T Consensus 196 ~g~~~~~~~~ 205 (256)
T cd08221 196 TLKRTFDATN 205 (256)
T ss_pred HCCCCCCCCC
Confidence 9999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=203.78 Aligned_cols=164 Identities=32% Similarity=0.542 Sum_probs=142.1
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
...+.+.|.+||..++||.++.++..++.+...|++||||+||+|..++.+.. .++++.++.++.+++.||+|||.+|
T Consensus 120 Kl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG 199 (459)
T KOG0610|consen 120 KLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG 199 (459)
T ss_pred HHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc
Confidence 34678889999999999999999999999999999999999999999887653 3999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCC---------------------------------CCcc--------
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP---------------------------------GNYA-------- 125 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~---------------------------------~~~~-------- 125 (177)
|++||+||+|||+ .+++.+-|+||.++.+... ....
T Consensus 200 ivYRDLKPENILv---redGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~ 276 (459)
T KOG0610|consen 200 IVYRDLKPENILV---REDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESA 276 (459)
T ss_pred eeeccCCcceeEE---ecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccc
Confidence 9999999999999 5788999999987643210 0000
Q ss_pred ----------------ccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCccc
Q 030430 126 ----------------EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 175 (177)
Q Consensus 126 ----------------~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf~~~~~~~ 175 (177)
....||-.|+|||++.+.+-+.+.|=|++|+.+|||+.|.-||.|.+.++
T Consensus 277 ~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~ 342 (459)
T KOG0610|consen 277 SRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE 342 (459)
T ss_pred cccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh
Confidence 01135666999999999999999999999999999999999999987665
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=200.14 Aligned_cols=162 Identities=32% Similarity=0.563 Sum_probs=142.0
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
...+.+.+|++++++++|||++++++++.+...++++|||+++++|.+++... ..+++..+..++.|++.++++||+.|
T Consensus 42 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~ 121 (262)
T cd06613 42 DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG 121 (262)
T ss_pred hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 35678999999999999999999999999999999999999999999998876 67999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccC---CCCCcchHHHHHHHHHHHH
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ---RYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~---~~~~~~Di~slg~~~~~~~ 162 (177)
++|+|++|+||++ +..+.++++|||.+....... ......++..|++||..... .++.++|+||+|+++++|+
T Consensus 122 i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~ 198 (262)
T cd06613 122 KIHRDIKGANILL---TEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELA 198 (262)
T ss_pred ceecCCChhhEEE---CCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHH
Confidence 9999999999999 467789999999886654332 22233467789999998766 7888999999999999999
Q ss_pred hCCCCCCCCC
Q 030430 163 NGYPPFSVGE 172 (177)
Q Consensus 163 ~~~~pf~~~~ 172 (177)
+|..||...+
T Consensus 199 tg~~p~~~~~ 208 (262)
T cd06613 199 ELQPPMFDLH 208 (262)
T ss_pred hCCCCCCCCC
Confidence 9999997643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=198.54 Aligned_cols=163 Identities=36% Similarity=0.642 Sum_probs=149.0
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR--LHGRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
......+.+|+++...|+||||.+++++|-++...|+++||..+|++.+.+. .+..+++.....++.|++.|+.|+|.
T Consensus 63 ~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~ 142 (281)
T KOG0580|consen 63 TQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL 142 (281)
T ss_pred hcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc
Confidence 3456778999999999999999999999999999999999999999999998 66679999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhC
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~ 164 (177)
.+++||||+|+|+++ +..+.+++.|||.+.-.. .....+.+||..|.|||...+...+...|+|++|++.||++.|
T Consensus 143 k~VIhRdiKpenlLl---g~~~~lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg 218 (281)
T KOG0580|consen 143 KRVIHRDIKPENLLL---GSAGELKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVG 218 (281)
T ss_pred CCcccCCCCHHHhcc---CCCCCeeccCCCceeecC-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhc
Confidence 999999999999999 467789999999986655 5556678899999999999999999999999999999999999
Q ss_pred CCCCCCCCc
Q 030430 165 YPPFSVGEE 173 (177)
Q Consensus 165 ~~pf~~~~~ 173 (177)
.+||...+.
T Consensus 219 ~ppFes~~~ 227 (281)
T KOG0580|consen 219 LPPFESQSH 227 (281)
T ss_pred CCchhhhhh
Confidence 999987653
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=228.70 Aligned_cols=168 Identities=29% Similarity=0.542 Sum_probs=149.6
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-------CCCCHHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-------GRVPEQTARKFLQQLGAG 78 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~ 78 (177)
+.+.+..|.+|+.+|+.++||||++++|++.+.+..++++|||.||+|..|+++. ..++...+..++.|++.+
T Consensus 735 ~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G 814 (1025)
T KOG1095|consen 735 SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKG 814 (1025)
T ss_pred CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhh
Confidence 6778899999999999999999999999999999999999999999999999976 238999999999999999
Q ss_pred HHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccc---cccCCCccccccccccCCCCCcchHHHHH
Q 030430 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE---KVCGSPLYMAPEVLQFQRYDEKVDMWSVG 155 (177)
Q Consensus 79 l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~---~~~~~~~~~~pe~~~~~~~~~~~Di~slg 155 (177)
+.||++++++||||..+|+|+ +....+|+.|||+++.....+.-. ......+|||||.+....++.++||||+|
T Consensus 815 ~~YLe~~~fvHRDLAaRNCLL---~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFG 891 (1025)
T KOG1095|consen 815 MNYLESKHFVHRDLAARNCLL---DERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFG 891 (1025)
T ss_pred hHHHHhCCCcCcchhhhheee---cccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhH
Confidence 999999999999999999999 466889999999998665443211 12345789999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCCCcccC
Q 030430 156 AILFELLN-GYPPFSVGEEHQF 176 (177)
Q Consensus 156 ~~~~~~~~-~~~pf~~~~~~~~ 176 (177)
+++||++| |..||.+.+..++
T Consensus 892 VllWEifslG~~PY~~~~n~~v 913 (1025)
T KOG1095|consen 892 VLLWEIFSLGATPYPSRSNFEV 913 (1025)
T ss_pred HHHHHHHhCCCCCCCCcchHHH
Confidence 99999999 8999999877654
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=208.42 Aligned_cols=159 Identities=37% Similarity=0.533 Sum_probs=135.6
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCC------eEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (177)
.....+.+|+.+++.++||||+++++++.... .+|++|||+. ++|.+.+. ..+++..+..++.|++.||+|
T Consensus 62 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~ 138 (359)
T cd07876 62 THAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIH--MELDHERMSYLLYQMLCGIKH 138 (359)
T ss_pred hHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCC-cCHHHHHh--ccCCHHHHHHHHHHHHHHHHH
Confidence 45667889999999999999999999886443 5799999995 46766654 358899999999999999999
Q ss_pred HhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHH
Q 030430 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 82 lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~ 161 (177)
||+.|++||||+|+||++ +..+.++|+|||.+.............++..|+|||.+.+..++.++|+||+|+++++|
T Consensus 139 LH~~~ivHrDlkp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el 215 (359)
T cd07876 139 LHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215 (359)
T ss_pred HHhCCcccCCCCHHHEEE---CCCCCEEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHH
Confidence 999999999999999999 46778999999998765443333345578899999999888899999999999999999
Q ss_pred HhCCCCCCCCC
Q 030430 162 LNGYPPFSVGE 172 (177)
Q Consensus 162 ~~~~~pf~~~~ 172 (177)
++|+.||.+.+
T Consensus 216 ~tg~~pf~~~~ 226 (359)
T cd07876 216 VKGSVIFQGTD 226 (359)
T ss_pred HhCCCCCCCCC
Confidence 99999998754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=214.84 Aligned_cols=166 Identities=41% Similarity=0.759 Sum_probs=154.0
Q ss_pred cchhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 5 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
+++..++.+.+|+++++.++||||++++.+......+|+||||+.++.+.+++.+++...+..+..++.|++.|++|||+
T Consensus 94 ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~ 173 (596)
T KOG0586|consen 94 LNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHS 173 (596)
T ss_pred cChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhh
Confidence 35556677899999999999999999999999999999999999999999999999998899999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCC-CCcchHHHHHHHHHHHHh
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLN 163 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slg~~~~~~~~ 163 (177)
++++|||+|+.|+++ +....++++|||++..+.......+.+|++.|.|||+..+..+ +++.|+||+|+++|-++.
T Consensus 174 k~ivHrdLk~eNilL---~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~ 250 (596)
T KOG0586|consen 174 KNIVHRDLKAENILL---DENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVE 250 (596)
T ss_pred cceeccccchhhccc---ccccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeee
Confidence 999999999999999 5777899999999998888777888899999999999987776 689999999999999999
Q ss_pred CCCCCCCCCc
Q 030430 164 GYPPFSVGEE 173 (177)
Q Consensus 164 ~~~pf~~~~~ 173 (177)
|..||.+.+-
T Consensus 251 GsLPFDG~~l 260 (596)
T KOG0586|consen 251 GSLPFDGQNL 260 (596)
T ss_pred cccccCCccc
Confidence 9999998653
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=201.94 Aligned_cols=162 Identities=27% Similarity=0.571 Sum_probs=140.2
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC--------------CCCHHHHHHHHHH
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--------------RVPEQTARKFLQQ 74 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~ 74 (177)
..+.+.+|+++++.++|+|++++++++......++++||+++++|.+++...+ .+++..+..++.|
T Consensus 51 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 130 (280)
T cd05049 51 ARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130 (280)
T ss_pred HHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHH
Confidence 56789999999999999999999999999999999999999999999997542 3788899999999
Q ss_pred HHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCCCcchH
Q 030430 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDM 151 (177)
Q Consensus 75 i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di 151 (177)
++.+++++|+.|++|+||+|+||++ +..+.++|+|||.+........ .....++..|+|||.+.+..+++++|+
T Consensus 131 i~~~l~~lH~~~i~h~dlkp~nili---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 207 (280)
T cd05049 131 IASGMVYLASQHFVHRDLATRNCLV---GYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV 207 (280)
T ss_pred HHHHHHHHhhCCeeccccccceEEE---cCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhH
Confidence 9999999999999999999999999 4668899999998865433221 122234577999999988889999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCc
Q 030430 152 WSVGAILFELLN-GYPPFSVGEE 173 (177)
Q Consensus 152 ~slg~~~~~~~~-~~~pf~~~~~ 173 (177)
||+|++++++++ |..||...+.
T Consensus 208 ~slG~il~e~~~~g~~p~~~~~~ 230 (280)
T cd05049 208 WSFGVVLWEIFTYGKQPWYGLSN 230 (280)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=201.52 Aligned_cols=163 Identities=31% Similarity=0.506 Sum_probs=137.6
Q ss_pred hhHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC----------------CCCHHHHH
Q 030430 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTAR 69 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~ 69 (177)
....+.+.+|++++.++ +|||++++++++...+.++++|||+++++|.+++.... .++..++.
T Consensus 36 ~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 115 (270)
T cd05047 36 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115 (270)
T ss_pred HHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHH
Confidence 44567888999999999 89999999999999999999999999999999987532 37889999
Q ss_pred HHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcc
Q 030430 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149 (177)
Q Consensus 70 ~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~ 149 (177)
.++.|++.|++|||+.|++|+||+|+||++ +.++.++++|||.+..............+..|+|||......++.++
T Consensus 116 ~~~~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~ 192 (270)
T cd05047 116 HFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNS 192 (270)
T ss_pred HHHHHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEECCCCCccccchhhhccCCCCccccCChHHHccCCCCchh
Confidence 999999999999999999999999999999 46778999999987533221111112234569999998878889999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCC
Q 030430 150 DMWSVGAILFELLN-GYPPFSVGE 172 (177)
Q Consensus 150 Di~slg~~~~~~~~-~~~pf~~~~ 172 (177)
|+||+|++++++++ |..||.+.+
T Consensus 193 Di~slG~il~el~~~g~~pf~~~~ 216 (270)
T cd05047 193 DVWSYGVLLWEIVSLGGTPYCGMT 216 (270)
T ss_pred hHHHHHHHHHHHHcCCCCCccccC
Confidence 99999999999997 999997643
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=199.16 Aligned_cols=159 Identities=33% Similarity=0.606 Sum_probs=140.5
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
...+.+|++++++++|+|++++.+++.+.+..++++||++|++|.+++.+...+++..+..++.|++.++++||+.|++|
T Consensus 46 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H 125 (265)
T cd06631 46 YEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVH 125 (265)
T ss_pred HHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 46689999999999999999999999999999999999999999999988778999999999999999999999999999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeeccccccCCC-------CccccccCCCccccccccccCCCCCcchHHHHHHHHHHHH
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-------NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-------~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~ 162 (177)
+||+|+||++ +..+.++++|||.+...... .......++..|+|||...+..++.++|+||+|+++++++
T Consensus 126 ~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~ 202 (265)
T cd06631 126 RDIKGNNVML---MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMA 202 (265)
T ss_pred CCcCHHhEEE---CCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHH
Confidence 9999999999 46778999999988654221 1112234677899999998888899999999999999999
Q ss_pred hCCCCCCCC
Q 030430 163 NGYPPFSVG 171 (177)
Q Consensus 163 ~~~~pf~~~ 171 (177)
+|..||...
T Consensus 203 ~g~~p~~~~ 211 (265)
T cd06631 203 TGKPPLASM 211 (265)
T ss_pred hCCCccccC
Confidence 999999754
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=223.29 Aligned_cols=163 Identities=25% Similarity=0.396 Sum_probs=139.1
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-----------CCCCHHHHHHHHHHHH
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------GRVPEQTARKFLQQLG 76 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~i~ 76 (177)
..++++.+|++++++++|||++++++++.+++..+++|||++|++|.+++... ...+...+..++.|++
T Consensus 44 ~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa 123 (932)
T PRK13184 44 LLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123 (932)
T ss_pred HHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHH
Confidence 45678999999999999999999999999999999999999999999988632 1245667889999999
Q ss_pred HHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-------------------ccccccCCCccccc
Q 030430 77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-------------------YAEKVCGSPLYMAP 137 (177)
Q Consensus 77 ~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-------------------~~~~~~~~~~~~~p 137 (177)
.||+|||+.|++||||||+||++ +..+.++++|||.+....... ......|++.|+||
T Consensus 124 ~AL~yLHs~GIIHRDLKPeNILL---d~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAP 200 (932)
T PRK13184 124 ATIEYVHSKGVLHRDLKPDNILL---GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAP 200 (932)
T ss_pred HHHHHHHHCCccccCCchheEEE---cCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCH
Confidence 99999999999999999999999 466779999999987652110 01123578999999
Q ss_pred cccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 030430 138 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 173 (177)
Q Consensus 138 e~~~~~~~~~~~Di~slg~~~~~~~~~~~pf~~~~~ 173 (177)
|...+..++.++|+||+|+++++|++|..||...+.
T Consensus 201 E~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~ 236 (932)
T PRK13184 201 ERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236 (932)
T ss_pred HHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence 999888899999999999999999999999976543
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=198.57 Aligned_cols=162 Identities=28% Similarity=0.507 Sum_probs=138.4
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
+...+.+.+|+.+++.++||||+++++++.. ...++++||+++++|.+++.....+++..+..++.|++.+++++|+.|
T Consensus 37 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ 115 (257)
T cd05116 37 PALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN 115 (257)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3456788999999999999999999998764 457899999999999999987778999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc----ccccCCCccccccccccCCCCCcchHHHHHHHHHHHH
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~ 162 (177)
++|+||+|.||++. .++.++++|||.+......... ....++..|+|||.+....++.++|+||||+++++++
T Consensus 116 i~H~dlkp~nill~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 192 (257)
T cd05116 116 FVHRDLAARNVLLV---TQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAF 192 (257)
T ss_pred EeecccchhhEEEc---CCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHH
Confidence 99999999999994 5678999999998765433211 1122346799999988778889999999999999999
Q ss_pred h-CCCCCCCCC
Q 030430 163 N-GYPPFSVGE 172 (177)
Q Consensus 163 ~-~~~pf~~~~ 172 (177)
+ |..||.+..
T Consensus 193 t~g~~p~~~~~ 203 (257)
T cd05116 193 SYGQKPYKGMK 203 (257)
T ss_pred hCCCCCCCCCC
Confidence 8 999997654
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=214.90 Aligned_cols=159 Identities=33% Similarity=0.538 Sum_probs=131.8
Q ss_pred HHHHHHHHHhhCCCCceeeEeEEEeeC--------CeEEEEEecCCCCChHHHHh----hcCCCCHHHHHHHHHHHHHHH
Q 030430 12 CLDCELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKFLQQLGAGL 79 (177)
Q Consensus 12 ~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l 79 (177)
...+|+.++++++||||+++.+++... ..++++|||++ ++|.+++. ....+++..++.++.|++.||
T Consensus 105 ~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL 183 (440)
T PTZ00036 105 YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRAL 183 (440)
T ss_pred hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHH
Confidence 456799999999999999999876432 25779999996 47777664 235699999999999999999
Q ss_pred HHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccC-CCCCcchHHHHHHHH
Q 030430 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAIL 158 (177)
Q Consensus 80 ~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~ 158 (177)
+|||+.|++||||||+||+++ .....++|+|||++.............+++.|+|||.+.+. .++.++|+||+|+++
T Consensus 184 ~yLH~~~IiHrDLKp~NILl~--~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil 261 (440)
T PTZ00036 184 AYIHSKFICHRDLKPQNLLID--PNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCII 261 (440)
T ss_pred HHHHHCCEecCCcCHHHEEEc--CCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHH
Confidence 999999999999999999995 23456999999999876554444445678899999987654 589999999999999
Q ss_pred HHHHhCCCCCCCCCc
Q 030430 159 FELLNGYPPFSVGEE 173 (177)
Q Consensus 159 ~~~~~~~~pf~~~~~ 173 (177)
++|++|.+||.+.+.
T Consensus 262 ~elltG~~pf~~~~~ 276 (440)
T PTZ00036 262 AEMILGYPIFSGQSS 276 (440)
T ss_pred HHHHhCCCCCCCCCh
Confidence 999999999987643
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=201.17 Aligned_cols=167 Identities=29% Similarity=0.490 Sum_probs=140.4
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-------CCCHHHHHHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------RVPEQTARKFLQQLGAGL 79 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~~l 79 (177)
......+.+|+.+++.++|+|++++++++.+....++++||++|++|.+++.... .+++..+..++.|++.++
T Consensus 50 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l 129 (277)
T cd05036 50 EQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129 (277)
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHH
Confidence 3445678999999999999999999999988888999999999999999987553 488899999999999999
Q ss_pred HHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc---ccccCCCccccccccccCCCCCcchHHHHHH
Q 030430 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA 156 (177)
Q Consensus 80 ~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~ 156 (177)
+|||+.|++|+||+|+||++...+....++++|||.+......... .....+..|+|||.+.+..++.++|+||||+
T Consensus 130 ~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 209 (277)
T cd05036 130 KYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGV 209 (277)
T ss_pred HHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHH
Confidence 9999999999999999999974334456899999998765332211 1222345799999998888999999999999
Q ss_pred HHHHHHh-CCCCCCCCCc
Q 030430 157 ILFELLN-GYPPFSVGEE 173 (177)
Q Consensus 157 ~~~~~~~-~~~pf~~~~~ 173 (177)
+++++++ |..||.+.+.
T Consensus 210 il~el~~~g~~pf~~~~~ 227 (277)
T cd05036 210 LLWEIFSLGYMPYPGRTN 227 (277)
T ss_pred HHHHHHcCCCCCCCCCCH
Confidence 9999997 9999987543
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=205.44 Aligned_cols=162 Identities=30% Similarity=0.534 Sum_probs=133.7
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEee--CCeEEEEEecCCCCChHHHHhhc---------CCCCHHHHHHHHHHHHHH
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLH---------GRVPEQTARKFLQQLGAG 78 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~i~~~ 78 (177)
...+.+|+++++.++||||+++.+++.. +...++++||+ +++|.+++... ..+++..+..++.|++.|
T Consensus 42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 120 (317)
T cd07868 42 SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120 (317)
T ss_pred cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHH
Confidence 3467889999999999999999998854 45789999998 56888887532 248899999999999999
Q ss_pred HHHHhhCCCeeecCCCCcEEEecC-CCCeeEEEeeeccccccCCCC----ccccccCCCccccccccccC-CCCCcchHH
Q 030430 79 LEILNSHHIIHRDLKPENILLSGL-DDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMW 152 (177)
Q Consensus 79 l~~lh~~~~~H~~i~~~nil~~~~-~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~ 152 (177)
|+|||+.|++|+||||+||++... +..+.++|+|||.+....... ......+++.|+|||.+.+. .++.++|+|
T Consensus 121 l~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 200 (317)
T cd07868 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW 200 (317)
T ss_pred HHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHH
Confidence 999999999999999999999532 345679999999987654322 11234578889999988764 478899999
Q ss_pred HHHHHHHHHHhCCCCCCCCC
Q 030430 153 SVGAILFELLNGYPPFSVGE 172 (177)
Q Consensus 153 slg~~~~~~~~~~~pf~~~~ 172 (177)
|+|++++++++|++||....
T Consensus 201 slG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 201 AIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred HHHHHHHHHHhCCCCccCCc
Confidence 99999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=203.84 Aligned_cols=163 Identities=29% Similarity=0.493 Sum_probs=137.0
Q ss_pred hHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC----------------CCCHHHHHH
Q 030430 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARK 70 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~ 70 (177)
...+.+.+|++++.++ +|||++++++++.+.+.+++++||+++++|.+++.+.. .++...+..
T Consensus 44 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 123 (297)
T cd05089 44 NDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123 (297)
T ss_pred HHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHH
Confidence 3456789999999999 79999999999999999999999999999999987532 378889999
Q ss_pred HHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcch
Q 030430 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVD 150 (177)
Q Consensus 71 ~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~D 150 (177)
++.|++.|+++||+.|++|+||+|+||++ +....++|+|||.+..............+..|++||...+..++.++|
T Consensus 124 i~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 200 (297)
T cd05089 124 FASDVATGMQYLSEKQFIHRDLAARNVLV---GENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSD 200 (297)
T ss_pred HHHHHHHHHHHHHHCCcccCcCCcceEEE---CCCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhh
Confidence 99999999999999999999999999999 456779999999875432211111122345699999988888899999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCCc
Q 030430 151 MWSVGAILFELLN-GYPPFSVGEE 173 (177)
Q Consensus 151 i~slg~~~~~~~~-~~~pf~~~~~ 173 (177)
+||||+++++|++ |..||.+...
T Consensus 201 vwSlG~il~el~t~g~~pf~~~~~ 224 (297)
T cd05089 201 VWSFGVLLWEIVSLGGTPYCGMTC 224 (297)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9999999999997 9999976543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=198.51 Aligned_cols=162 Identities=25% Similarity=0.523 Sum_probs=136.1
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
+...+.+.+|++++++++||||+++++++.. ...++++||+++++|.+++... ..+++..++.++.|++.++++||+.
T Consensus 36 ~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 114 (257)
T cd05115 36 KSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK 114 (257)
T ss_pred hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc
Confidence 3446779999999999999999999998764 4689999999999999998743 4689999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc----ccccCCCccccccccccCCCCCcchHHHHHHHHHHH
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~ 161 (177)
|++|+||+|+||++ +....++++|||.+......... ....++..|+|||......++.++|+||+|++++++
T Consensus 115 ~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el 191 (257)
T cd05115 115 NFVHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEA 191 (257)
T ss_pred CeeecccchheEEE---cCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHH
Confidence 99999999999999 45678999999988654332211 111124579999998877889999999999999999
Q ss_pred Hh-CCCCCCCCC
Q 030430 162 LN-GYPPFSVGE 172 (177)
Q Consensus 162 ~~-~~~pf~~~~ 172 (177)
++ |..||....
T Consensus 192 ~~~g~~p~~~~~ 203 (257)
T cd05115 192 FSYGQKPYKKMK 203 (257)
T ss_pred hcCCCCCcCcCC
Confidence 96 999997654
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=197.22 Aligned_cols=164 Identities=34% Similarity=0.593 Sum_probs=139.2
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
.......+.+|++++++++||||+++++++...+..++++||+++++|.+++.... .+++..+..++.|++.+|+|||+
T Consensus 33 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~ 112 (252)
T cd05084 33 PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLES 112 (252)
T ss_pred CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34567789999999999999999999999999999999999999999999987543 58999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccc---cccCCCccccccccccCCCCCcchHHHHHHHHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE---KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~---~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~ 161 (177)
.|++|+||+|+||+++ ..+.++++|||.+.......... ....+..|+|||.+.+..++.++|+||+|++++++
T Consensus 113 ~~i~H~dl~p~nil~~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~ 189 (252)
T cd05084 113 KHCIHRDLAARNCLVT---EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEA 189 (252)
T ss_pred CCccccccchheEEEc---CCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHH
Confidence 9999999999999994 56679999999886543321111 11123469999999888889999999999999999
Q ss_pred Hh-CCCCCCCCC
Q 030430 162 LN-GYPPFSVGE 172 (177)
Q Consensus 162 ~~-~~~pf~~~~ 172 (177)
++ |..||....
T Consensus 190 ~~~~~~p~~~~~ 201 (252)
T cd05084 190 FSLGAVPYANLS 201 (252)
T ss_pred HhCCCCCccccC
Confidence 98 888986543
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=200.86 Aligned_cols=162 Identities=35% Similarity=0.590 Sum_probs=145.9
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+.+.+|++++++++|||++++++.+.++...++++||++|++|.+++.....+++..+..++.|++.++++||+.|+
T Consensus 42 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i 121 (258)
T cd05578 42 GSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121 (258)
T ss_pred hHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 45678999999999999999999999999999999999999999999999877789999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
+|+||+|+||++ +..+.++++|||.+.............++..|+|||...+..++.++|+||+|++++++++|+.|
T Consensus 122 ~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p 198 (258)
T cd05578 122 IHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198 (258)
T ss_pred eccCCCHHHeEE---cCCCCEEEeecccccccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCC
Confidence 999999999999 46778999999998776554433445577889999999877889999999999999999999999
Q ss_pred CCCCC
Q 030430 168 FSVGE 172 (177)
Q Consensus 168 f~~~~ 172 (177)
|...+
T Consensus 199 ~~~~~ 203 (258)
T cd05578 199 YRGHS 203 (258)
T ss_pred CCCCC
Confidence 98765
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=199.60 Aligned_cols=160 Identities=38% Similarity=0.563 Sum_probs=140.3
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+.+|++++++++||+++++.+++...+..|+++||+++++|.+++.+.. .+++..+..++.|++.++.+||+.|+
T Consensus 37 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i 116 (277)
T cd05577 37 EQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRI 116 (277)
T ss_pred hHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 4566789999999999999999999999999999999999999999987665 69999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
+|+||+|+||++ +..+.++++|||.+.............++..|++||...+..++.++|+||+|++++++++|+.|
T Consensus 117 ~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p 193 (277)
T cd05577 117 VYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193 (277)
T ss_pred ccCCCCHHHEEE---CCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCC
Confidence 999999999999 46678999999988665433333334467789999998877789999999999999999999999
Q ss_pred CCCCC
Q 030430 168 FSVGE 172 (177)
Q Consensus 168 f~~~~ 172 (177)
|....
T Consensus 194 ~~~~~ 198 (277)
T cd05577 194 FRQRK 198 (277)
T ss_pred CCCCc
Confidence 97654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=207.26 Aligned_cols=159 Identities=33% Similarity=0.554 Sum_probs=133.8
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
....+..+.+|+++++.++|+||+++++++.+.+.+++++||+++++|.+. ...++..+..++.|++.+|+|||+.
T Consensus 112 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~ 187 (353)
T PLN00034 112 EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRR 187 (353)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHC
Confidence 345567899999999999999999999999999999999999999998653 2356788889999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCcccccccccc-----CCCCCcchHHHHHHHHH
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-----QRYDEKVDMWSVGAILF 159 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~-----~~~~~~~Di~slg~~~~ 159 (177)
|++|+||+|+||++ +..+.++|+|||.+....... ......++..|+|||.+.. ...+.++|+||||++++
T Consensus 188 ~ivHrDlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~ 264 (353)
T PLN00034 188 HIVHRDIKPSNLLI---NSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSIL 264 (353)
T ss_pred CEeecCCCHHHEEE---cCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHH
Confidence 99999999999999 466789999999987654322 2233457889999998742 22356899999999999
Q ss_pred HHHhCCCCCCCC
Q 030430 160 ELLNGYPPFSVG 171 (177)
Q Consensus 160 ~~~~~~~pf~~~ 171 (177)
++++|+.||...
T Consensus 265 el~~g~~pf~~~ 276 (353)
T PLN00034 265 EFYLGRFPFGVG 276 (353)
T ss_pred HHHhCCCCCCCC
Confidence 999999999743
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=196.69 Aligned_cols=160 Identities=33% Similarity=0.605 Sum_probs=141.6
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
.+.+.+|++++++++|||++++.+++.+....++++|++++++|.+++... ..+++..+..++.|++.++++||+.|++
T Consensus 42 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~ 121 (256)
T cd06612 42 LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKI 121 (256)
T ss_pred HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 678999999999999999999999999999999999999999999998754 4589999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
|+|++|+||++ +..+.++++|||.+....... ......++..|+|||.+.+..++.++|+||+|++++++++|+.|
T Consensus 122 H~dl~~~ni~~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p 198 (256)
T cd06612 122 HRDIKAGNILL---NEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198 (256)
T ss_pred cCCCCcceEEE---CCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999 456779999999987654433 22234467789999999888889999999999999999999999
Q ss_pred CCCCC
Q 030430 168 FSVGE 172 (177)
Q Consensus 168 f~~~~ 172 (177)
|....
T Consensus 199 ~~~~~ 203 (256)
T cd06612 199 YSDIH 203 (256)
T ss_pred CCCcc
Confidence 97643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=198.53 Aligned_cols=160 Identities=30% Similarity=0.522 Sum_probs=139.2
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
....+.+|+.+++.++|||++++.+++.....+++++||+++++|.+++...+.+++.++..++.|++.+++|||+.|++
T Consensus 49 ~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 128 (267)
T cd06645 49 DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKM 128 (267)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 34567889999999999999999999999999999999999999999998888899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccc---cCCCCCcchHHHHHHHHHHHHhC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slg~~~~~~~~~ 164 (177)
|+||+|+||++ +..+.++++|||.+....... ......++..|+|||.+. ...++.++|+||+|++++++++|
T Consensus 129 H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~ 205 (267)
T cd06645 129 HRDIKGANILL---TDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAEL 205 (267)
T ss_pred cCCCCHHHEEE---CCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcC
Confidence 99999999999 466779999999886553322 122345788899999874 34578899999999999999999
Q ss_pred CCCCCCC
Q 030430 165 YPPFSVG 171 (177)
Q Consensus 165 ~~pf~~~ 171 (177)
..||...
T Consensus 206 ~~p~~~~ 212 (267)
T cd06645 206 QPPMFDL 212 (267)
T ss_pred CCCcccc
Confidence 9998543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=198.95 Aligned_cols=161 Identities=34% Similarity=0.601 Sum_probs=141.6
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
..+.+.+|+++++.++|+|++++++++.+++.+++++||++|++|.+++.....+++..+..++.|++.|+++||+.|++
T Consensus 46 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~ 125 (268)
T cd06630 46 VVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQII 125 (268)
T ss_pred HHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 56789999999999999999999999999999999999999999999998877899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-----cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~ 163 (177)
|+||+|+||++. ..+..++|+|||.+........ .....++..|+|||...+..++.++|+||+|++++++++
T Consensus 126 H~~i~~~nil~~--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 203 (268)
T cd06630 126 HRDVKGANLLID--STGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMAT 203 (268)
T ss_pred cCCCCHHHEEEc--CCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHh
Confidence 999999999994 2334699999999866543311 122346778999999887788999999999999999999
Q ss_pred CCCCCCCC
Q 030430 164 GYPPFSVG 171 (177)
Q Consensus 164 ~~~pf~~~ 171 (177)
|..||...
T Consensus 204 g~~p~~~~ 211 (268)
T cd06630 204 AKPPWNAE 211 (268)
T ss_pred CCCCCCCC
Confidence 99999654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=208.29 Aligned_cols=161 Identities=30% Similarity=0.502 Sum_probs=136.9
Q ss_pred hHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-------------------------
Q 030430 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG------------------------- 61 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------------- 61 (177)
...+.+.+|+++++.+ +||||+++++++.+.+..+++|||++||+|.+++....
T Consensus 80 ~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (375)
T cd05104 80 TEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQRE 159 (375)
T ss_pred HHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhc
Confidence 3456788999999999 89999999999999999999999999999999986421
Q ss_pred --------------------------------------------------CCCHHHHHHHHHHHHHHHHHHhhCCCeeec
Q 030430 62 --------------------------------------------------RVPEQTARKFLQQLGAGLEILNSHHIIHRD 91 (177)
Q Consensus 62 --------------------------------------------------~~~~~~~~~~~~~i~~~l~~lh~~~~~H~~ 91 (177)
.++...+..++.|++.+++|||+.|++|+|
T Consensus 160 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~D 239 (375)
T cd05104 160 MSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRD 239 (375)
T ss_pred ccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Confidence 367788899999999999999999999999
Q ss_pred CCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-CCCC
Q 030430 92 LKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPP 167 (177)
Q Consensus 92 i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-~~~p 167 (177)
|||+||+++ ....++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|++++++++ |..|
T Consensus 240 lkp~Nill~---~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p 316 (375)
T cd05104 240 LAARNILLT---HGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316 (375)
T ss_pred CchhhEEEE---CCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCC
Confidence 999999995 566799999999876543221 112224557999999988889999999999999999998 8899
Q ss_pred CCCC
Q 030430 168 FSVG 171 (177)
Q Consensus 168 f~~~ 171 (177)
|...
T Consensus 317 ~~~~ 320 (375)
T cd05104 317 YPGM 320 (375)
T ss_pred CCCC
Confidence 9764
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=197.76 Aligned_cols=162 Identities=31% Similarity=0.559 Sum_probs=143.0
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc---------CCCCHHHHHHHHHHHHHHH
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---------GRVPEQTARKFLQQLGAGL 79 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~i~~~l 79 (177)
..+.+.+|++.++.++|++++++++++.+...+++++||+++++|.+++... ..+++..+..++.|++.|+
T Consensus 39 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al 118 (262)
T cd00192 39 ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118 (262)
T ss_pred HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHH
Confidence 3678999999999999999999999999999999999999999999999875 6799999999999999999
Q ss_pred HHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC---ccccccCCCccccccccccCCCCCcchHHHHHH
Q 030430 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA 156 (177)
Q Consensus 80 ~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~ 156 (177)
++||+.|++|+||+|+||++ +..+.++++|||.+....... ......++..|+|||......++.++|+||+|+
T Consensus 119 ~~lH~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 195 (262)
T cd00192 119 EYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGV 195 (262)
T ss_pred HHHHcCCcccCccCcceEEE---CCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHH
Confidence 99999999999999999999 466889999999987765432 122334577899999988778899999999999
Q ss_pred HHHHHHh-CCCCCCCCCc
Q 030430 157 ILFELLN-GYPPFSVGEE 173 (177)
Q Consensus 157 ~~~~~~~-~~~pf~~~~~ 173 (177)
+++++++ |..||...+.
T Consensus 196 il~~l~~~g~~p~~~~~~ 213 (262)
T cd00192 196 LLWEIFTLGATPYPGLSN 213 (262)
T ss_pred HHHHHHhcCCCCCCCCCH
Confidence 9999999 6999977643
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=201.75 Aligned_cols=162 Identities=33% Similarity=0.601 Sum_probs=139.9
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
....+.+|+++++.++||||+++++.+..++..++++||++|++|.+++...+.+++..+..++.|++.+++|+|+.|++
T Consensus 44 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 123 (305)
T cd05609 44 QIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIV 123 (305)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 34578899999999999999999999999999999999999999999998877899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCC----------------ccccccCCCccccccccccCCCCCcchHH
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----------------YAEKVCGSPLYMAPEVLQFQRYDEKVDMW 152 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~----------------~~~~~~~~~~~~~pe~~~~~~~~~~~Di~ 152 (177)
|+||+|+||++ +..+.++++|||.+....... ......++..|+|||.+....++.++|+|
T Consensus 124 H~dl~p~NIll---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 200 (305)
T cd05609 124 HRDLKPDNLLI---TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWW 200 (305)
T ss_pred ccCCchHHEEE---CCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHH
Confidence 99999999999 467789999999875311100 00112356789999998888889999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCc
Q 030430 153 SVGAILFELLNGYPPFSVGEE 173 (177)
Q Consensus 153 slg~~~~~~~~~~~pf~~~~~ 173 (177)
|+|++++++++|..||.+.+.
T Consensus 201 slG~vl~el~~g~~pf~~~~~ 221 (305)
T cd05609 201 AMGIILYEFLVGCVPFFGDTP 221 (305)
T ss_pred HHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999987544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=196.61 Aligned_cols=164 Identities=33% Similarity=0.621 Sum_probs=143.7
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
......+.+|++++++++|||++++++.+..++..++++||+++++|.+++... ..+++..+..++.+++.++++||+
T Consensus 40 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~ 119 (256)
T cd08220 40 KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119 (256)
T ss_pred cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 345678999999999999999999999999999999999999999999999764 348999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhC
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~ 164 (177)
.|++|+||+|+||++. +....++++|||.+.............++..|+|||...+..++.++|+||+|++++++++|
T Consensus 120 ~~i~h~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~ 197 (256)
T cd08220 120 KLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASL 197 (256)
T ss_pred CCeecCCCCHHHEEEc--CCCCEEEEccCCCceecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhC
Confidence 9999999999999995 34556899999998776554443345578889999999887889999999999999999999
Q ss_pred CCCCCCCC
Q 030430 165 YPPFSVGE 172 (177)
Q Consensus 165 ~~pf~~~~ 172 (177)
..||...+
T Consensus 198 ~~~~~~~~ 205 (256)
T cd08220 198 KRAFEAAN 205 (256)
T ss_pred CCCcccCc
Confidence 99997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=199.80 Aligned_cols=161 Identities=30% Similarity=0.537 Sum_probs=139.6
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
..+.+.+|++++++++|+|++++.+++......++++||+++++|..+......+++..+..++.|++.+|++||+.|++
T Consensus 43 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~ 122 (286)
T cd07847 43 IKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCI 122 (286)
T ss_pred ccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence 34567899999999999999999999999999999999999998888877666799999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCcccccccccc-CCCCCcchHHHHHHHHHHHHhCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
|+||+|+||++ +..+.++++|||.+....... ......++..|++||.+.+ ..++.++|+||+|++++++++|+.
T Consensus 123 H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~ 199 (286)
T cd07847 123 HRDVKPENILI---TKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQP 199 (286)
T ss_pred ecCCChhhEEE---cCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCC
Confidence 99999999999 456789999999987664433 2223346778999998765 447889999999999999999999
Q ss_pred CCCCCC
Q 030430 167 PFSVGE 172 (177)
Q Consensus 167 pf~~~~ 172 (177)
||.+.+
T Consensus 200 p~~~~~ 205 (286)
T cd07847 200 LWPGKS 205 (286)
T ss_pred CCCCCC
Confidence 998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=197.63 Aligned_cols=160 Identities=29% Similarity=0.507 Sum_probs=138.6
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
....+.+|+.++++++|||++++.+++.....+++++||+++++|.+++.....+++..+..++.|++.++++||+.|++
T Consensus 49 ~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 128 (267)
T cd06646 49 DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKM 128 (267)
T ss_pred hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 34568899999999999999999999999999999999999999999988777899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccc---cCCCCCcchHHHHHHHHHHHHhC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slg~~~~~~~~~ 164 (177)
|+|++|.||++ +..+.++++|||.+........ .....++..|+|||.+. ...++.++|+||+|++++++++|
T Consensus 129 H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g 205 (267)
T cd06646 129 HRDIKGANILL---TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAEL 205 (267)
T ss_pred ccCCCHHHEEE---CCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhC
Confidence 99999999999 4667799999999876543221 22344678899999874 34467899999999999999999
Q ss_pred CCCCCCC
Q 030430 165 YPPFSVG 171 (177)
Q Consensus 165 ~~pf~~~ 171 (177)
+.||...
T Consensus 206 ~~p~~~~ 212 (267)
T cd06646 206 QPPMFDL 212 (267)
T ss_pred CCCcccc
Confidence 9998543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=199.32 Aligned_cols=164 Identities=26% Similarity=0.572 Sum_probs=139.9
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC---------------CCCHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---------------RVPEQTARK 70 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~ 70 (177)
.......+.+|+++++.++|+||+++.+++.+.+..++++||+++++|.+++.... .+++..+..
T Consensus 47 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 126 (280)
T cd05092 47 SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126 (280)
T ss_pred CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHH
Confidence 34556789999999999999999999999999999999999999999999987543 378899999
Q ss_pred HHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCCC
Q 030430 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDE 147 (177)
Q Consensus 71 ~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~ 147 (177)
++.|++.|++|||+.|++|+||+|+||+++ ..+.++|+|||.+........ .....++..|+|||...+..++.
T Consensus 127 ~~~qi~~al~~LH~~~i~H~dlkp~nil~~---~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 203 (280)
T cd05092 127 IASQIASGMVYLASLHFVHRDLATRNCLVG---QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTT 203 (280)
T ss_pred HHHHHHHHHHHHHHCCeecccccHhhEEEc---CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCc
Confidence 999999999999999999999999999994 567899999998865533221 11222356799999988888999
Q ss_pred cchHHHHHHHHHHHHh-CCCCCCCCC
Q 030430 148 KVDMWSVGAILFELLN-GYPPFSVGE 172 (177)
Q Consensus 148 ~~Di~slg~~~~~~~~-~~~pf~~~~ 172 (177)
++|+||||++++++++ |..||....
T Consensus 204 ~~Di~slG~il~el~~~g~~p~~~~~ 229 (280)
T cd05092 204 ESDIWSFGVVLWEIFTYGKQPWYQLS 229 (280)
T ss_pred hhhHHHHHHHHHHHHcCCCCCCccCC
Confidence 9999999999999998 899996543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=202.11 Aligned_cols=166 Identities=33% Similarity=0.572 Sum_probs=139.2
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh 83 (177)
.....+.+.+|++.+++++||||+++++++...+..++|+||+++++|.+++... ..++..++..++.|++.||+|||
T Consensus 41 ~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh 120 (259)
T PF07714_consen 41 SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH 120 (259)
T ss_dssp SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH
T ss_pred ccccceeeeecccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 3445789999999999999999999999999888899999999999999999976 56999999999999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCCCcchHHHHHHHHHH
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~ 160 (177)
+.+++|++|+++||++. ..+.++|+|||.+........ .........|+|||.+....++.++||||+|++++|
T Consensus 121 ~~~iiH~~l~~~nill~---~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~e 197 (259)
T PF07714_consen 121 SNNIIHGNLSPSNILLD---SNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYE 197 (259)
T ss_dssp HTTEEEST-SGGGEEEE---TTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999994 577899999999877632221 122335677999999988889999999999999999
Q ss_pred HHh-CCCCCCCCCcc
Q 030430 161 LLN-GYPPFSVGEEH 174 (177)
Q Consensus 161 ~~~-~~~pf~~~~~~ 174 (177)
+++ |+.||...+..
T Consensus 198 i~~~~~~p~~~~~~~ 212 (259)
T PF07714_consen 198 ILTLGKFPFSDYDNE 212 (259)
T ss_dssp HHTTSSGTTTTSCHH
T ss_pred ccccccccccccccc
Confidence 999 68999776443
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=207.33 Aligned_cols=159 Identities=35% Similarity=0.530 Sum_probs=136.2
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeC------CeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (177)
.....+.+|+.+++.++||||+++++++... ...|+||||++ ++|.+.+.. .++...+..++.|++.||+|
T Consensus 65 ~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~ 141 (364)
T cd07875 65 THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKH 141 (364)
T ss_pred hhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCC-CCHHHHHHh--cCCHHHHHHHHHHHHHHHHH
Confidence 4456788999999999999999999987533 35799999995 578777653 58889999999999999999
Q ss_pred HhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHH
Q 030430 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 82 lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~ 161 (177)
||+.|++|+||+|+||++ +..+.++|+|||.+.............++..|+|||.+.+..++.++|+||||+++++|
T Consensus 142 LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el 218 (364)
T cd07875 142 LHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218 (364)
T ss_pred HhhCCeecCCCCHHHEEE---CCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHH
Confidence 999999999999999999 46678999999999766544433445678899999999888899999999999999999
Q ss_pred HhCCCCCCCCC
Q 030430 162 LNGYPPFSVGE 172 (177)
Q Consensus 162 ~~~~~pf~~~~ 172 (177)
++|+.||.+.+
T Consensus 219 l~g~~pf~~~~ 229 (364)
T cd07875 219 IKGGVLFPGTD 229 (364)
T ss_pred HhCCCCCCCCC
Confidence 99999998754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=196.34 Aligned_cols=162 Identities=35% Similarity=0.652 Sum_probs=143.5
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+.+.+|+++++.++|+|++++.+++.+...+++++||+++++|.+++.+...+++..+..++.|++.++++||+.|+
T Consensus 44 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i 123 (258)
T cd06632 44 EAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNT 123 (258)
T ss_pred HHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 35677999999999999999999999999999999999999999999999887779999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCC-CCCcchHHHHHHHHHHHHhCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slg~~~~~~~~~~~ 166 (177)
+|+||+|+||++ +..+.++++|||.+.............++..|++||...... ++.++|+||+|++++++++|+.
T Consensus 124 ~H~dl~~~ni~~---~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~ 200 (258)
T cd06632 124 VHRDIKGANILV---DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKP 200 (258)
T ss_pred ccCCCCHHHEEE---CCCCCEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCC
Confidence 999999999999 466789999999887654444333455778899999887665 8899999999999999999999
Q ss_pred CCCCCC
Q 030430 167 PFSVGE 172 (177)
Q Consensus 167 pf~~~~ 172 (177)
||....
T Consensus 201 pf~~~~ 206 (258)
T cd06632 201 PWSQLE 206 (258)
T ss_pred CcccCc
Confidence 996644
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=196.89 Aligned_cols=160 Identities=31% Similarity=0.577 Sum_probs=138.2
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeC--CeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
..+.+.+|+++++.++|||++++.+++.+. ..+++++||+++++|.+++.....+++..+..++.|++.+|++||+.|
T Consensus 47 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~ 126 (265)
T cd06652 47 EVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM 126 (265)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 346788999999999999999999988763 568899999999999999987777899999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC----ccccccCCCccccccccccCCCCCcchHHHHHHHHHHHH
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~ 162 (177)
++|+||+|+||++ +..+.++|+|||.+....... ......++..|+|||...+..++.++|+||+|+++++++
T Consensus 127 i~H~dl~p~nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~ 203 (265)
T cd06652 127 IVHRDIKGANILR---DSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEML 203 (265)
T ss_pred EecCCCCHHHEEe---cCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHh
Confidence 9999999999999 466789999999886543211 112234677899999998888899999999999999999
Q ss_pred hCCCCCCCC
Q 030430 163 NGYPPFSVG 171 (177)
Q Consensus 163 ~~~~pf~~~ 171 (177)
+|..||...
T Consensus 204 ~g~~p~~~~ 212 (265)
T cd06652 204 TEKPPWAEF 212 (265)
T ss_pred hCCCCCCcc
Confidence 999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=202.99 Aligned_cols=161 Identities=29% Similarity=0.419 Sum_probs=134.9
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
...+.+.+|+++++.++||||+++++++..++..++|+||+++++|.+++..+ ..+++..+..++.|++.||+|||+.
T Consensus 41 ~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~ 120 (327)
T cd08227 41 EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM 120 (327)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 44567889999999999999999999999999999999999999999998754 3589999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC--------ccccccCCCcccccccccc--CCCCCcchHHHHH
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQF--QRYDEKVDMWSVG 155 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slg 155 (177)
|++|+||+|+||++. ..+.+++.||+......... ......++..|+|||.+.+ ..++.++|+||+|
T Consensus 121 ~iiH~dlkp~Nil~~---~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG 197 (327)
T cd08227 121 GYVHRSVKASHILIS---VDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVG 197 (327)
T ss_pred CEecCCCChhhEEEe---cCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHH
Confidence 999999999999994 56678899987543322111 1112234567999999865 3578999999999
Q ss_pred HHHHHHHhCCCCCCCC
Q 030430 156 AILFELLNGYPPFSVG 171 (177)
Q Consensus 156 ~~~~~~~~~~~pf~~~ 171 (177)
++++++++|..||...
T Consensus 198 ~il~el~~g~~pf~~~ 213 (327)
T cd08227 198 ITACELANGHVPFKDM 213 (327)
T ss_pred HHHHHHHHCCCCCCCc
Confidence 9999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=206.94 Aligned_cols=159 Identities=35% Similarity=0.503 Sum_probs=136.1
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeC------CeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (177)
.....+.+|+.+++.++||||+++++++... ...+++|||++ +++.+.+. ..++...+..++.|++.||+|
T Consensus 58 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~l~~~~~~~~~~qi~~aL~~ 134 (355)
T cd07874 58 THAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKH 134 (355)
T ss_pred HHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhc-ccHHHHHh--hcCCHHHHHHHHHHHHHHHHH
Confidence 4456788899999999999999999987543 35799999995 47777665 358899999999999999999
Q ss_pred HhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHH
Q 030430 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 82 lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~ 161 (177)
||+.|++||||||+||++ +..+.++|+|||.+.............++..|+|||.+.+..++.++|+||+|+++++|
T Consensus 135 LH~~givHrDikp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el 211 (355)
T cd07874 135 LHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211 (355)
T ss_pred HHhCCcccCCCChHHEEE---CCCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHH
Confidence 999999999999999999 46678999999998766544444445678899999999888899999999999999999
Q ss_pred HhCCCCCCCCC
Q 030430 162 LNGYPPFSVGE 172 (177)
Q Consensus 162 ~~~~~pf~~~~ 172 (177)
++|+.||.+.+
T Consensus 212 ~~g~~pf~~~~ 222 (355)
T cd07874 212 VRHKILFPGRD 222 (355)
T ss_pred HhCCCCCCCCC
Confidence 99999998754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=222.08 Aligned_cols=167 Identities=36% Similarity=0.654 Sum_probs=139.1
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEee--CCeEEEEEecCCCCChHHHHhhc----CCCCHHHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGL 79 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l 79 (177)
.......+..|+.++++++||||+++++++.+ ...+|+||||+++++|.+++... ..+++..++.|+.||+.||
T Consensus 52 ~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~AL 131 (1021)
T PTZ00266 52 KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131 (1021)
T ss_pred CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHH
Confidence 44556789999999999999999999998754 45789999999999999998753 4699999999999999999
Q ss_pred HHHhhC-------CCeeecCCCCcEEEecC--------------CCCeeEEEeeeccccccCCCCccccccCCCcccccc
Q 030430 80 EILNSH-------HIIHRDLKPENILLSGL--------------DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPE 138 (177)
Q Consensus 80 ~~lh~~-------~~~H~~i~~~nil~~~~--------------~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe 138 (177)
+|||+. +|+|+||+|+||++... +....++|+|||++.............+++.|+|||
T Consensus 132 aYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPE 211 (1021)
T PTZ00266 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPE 211 (1021)
T ss_pred HHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHH
Confidence 999985 49999999999999531 123458999999987664444334456899999999
Q ss_pred cccc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 030430 139 VLQF--QRYDEKVDMWSVGAILFELLNGYPPFSVGE 172 (177)
Q Consensus 139 ~~~~--~~~~~~~Di~slg~~~~~~~~~~~pf~~~~ 172 (177)
.+.. ..++.++|||||||++|+|++|..||...+
T Consensus 212 vL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 212 LLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred HHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 8854 347889999999999999999999997543
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=209.37 Aligned_cols=161 Identities=32% Similarity=0.496 Sum_probs=137.7
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCC-----eEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (177)
....+.+|+++++.++||||+++++++.... ..|+++||+. ++|.+.+.....+++..+..++.|++.||+|||
T Consensus 42 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH 120 (372)
T cd07853 42 SCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH 120 (372)
T ss_pred HHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4467889999999999999999999988766 7899999994 689888887778999999999999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC--ccccccCCCccccccccccC-CCCCcchHHHHHHHHHH
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFE 160 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~ 160 (177)
+.|++|+||+|+||++ +..+.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||+|+++++
T Consensus 121 ~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~e 197 (372)
T cd07853 121 SAGILHRDIKPGNLLV---NSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAE 197 (372)
T ss_pred hCCeeCCCCChHHEEE---CCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHH
Confidence 9999999999999999 467789999999886543322 12233467889999988764 46889999999999999
Q ss_pred HHhCCCCCCCCCc
Q 030430 161 LLNGYPPFSVGEE 173 (177)
Q Consensus 161 ~~~~~~pf~~~~~ 173 (177)
|++|+.||.+.+.
T Consensus 198 l~~g~~pf~~~~~ 210 (372)
T cd07853 198 LLGRRILFQAQSP 210 (372)
T ss_pred HHcCCCCCCCCCH
Confidence 9999999987653
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=196.78 Aligned_cols=161 Identities=26% Similarity=0.557 Sum_probs=138.7
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
.+.+.+|+++++.++|||++++++++.+.+..+++|||+++++|.+++... ..++...+..++.|++.+++|||+.|++
T Consensus 43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 122 (256)
T cd05114 43 EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFI 122 (256)
T ss_pred HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 457889999999999999999999999999999999999999999998754 4589999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccc--cccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-CC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY 165 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-~~ 165 (177)
|+||+|+|+++ +..+.++++|||.+.......... ...++..|+|||...+..++.++|+||+|++++++++ |+
T Consensus 123 H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~ 199 (256)
T cd05114 123 HRDLAARNCLV---SSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGK 199 (256)
T ss_pred ccccCcceEEE---cCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCC
Confidence 99999999999 466789999999886553322211 1223457999999987888999999999999999999 89
Q ss_pred CCCCCCCc
Q 030430 166 PPFSVGEE 173 (177)
Q Consensus 166 ~pf~~~~~ 173 (177)
.||...+.
T Consensus 200 ~p~~~~~~ 207 (256)
T cd05114 200 MPFEKKSN 207 (256)
T ss_pred CCCCCCCH
Confidence 99977553
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=198.75 Aligned_cols=162 Identities=26% Similarity=0.491 Sum_probs=134.0
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCC-----CCHHHHHHHHHHHHHHHHHH
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-----VPEQTARKFLQQLGAGLEIL 82 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~~l~~l 82 (177)
.....+.+|++.++.++||||+++++.+.+...++++|||+++++|.+++..... .++..+..++.|++.+++||
T Consensus 37 ~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l 116 (269)
T cd05042 37 DEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116 (269)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999999999999999999999999999976432 46778899999999999999
Q ss_pred hhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCcccccccccc-------CCCCCcchHH
Q 030430 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQF-------QRYDEKVDMW 152 (177)
Q Consensus 83 h~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~-------~~~~~~~Di~ 152 (177)
|++|++|+||+|+||++ +.++.++++|||.+........ .....++..|+|||.... ..++.++|+|
T Consensus 117 H~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diw 193 (269)
T cd05042 117 HQADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIW 193 (269)
T ss_pred HhcCEecccccHhheEe---cCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHH
Confidence 99999999999999999 4677899999998865432211 112234567999998642 3467899999
Q ss_pred HHHHHHHHHHh-CCCCCCCCC
Q 030430 153 SVGAILFELLN-GYPPFSVGE 172 (177)
Q Consensus 153 slg~~~~~~~~-~~~pf~~~~ 172 (177)
|+|++++++++ |..||...+
T Consensus 194 slG~~l~el~~~~~~p~~~~~ 214 (269)
T cd05042 194 SLGVTMWELFTAADQPYPDLS 214 (269)
T ss_pred HHHHHHHHHHhCCCCCCCcCC
Confidence 99999999999 788987654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=197.01 Aligned_cols=160 Identities=26% Similarity=0.518 Sum_probs=138.3
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
.+.+.+|++++++++||||+++++++.+....++++||+++++|.+++... ..+++..+..++.|++.++++||+.|++
T Consensus 43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 122 (256)
T cd05113 43 EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFI 122 (256)
T ss_pred HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 456889999999999999999999999888899999999999999999764 3589999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccc--cccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-CC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY 165 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-~~ 165 (177)
|+||+|+||++ +.++.++++|||.+.......... ...++..|.+||...+..++.++|+||||++++++++ |.
T Consensus 123 H~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~ 199 (256)
T cd05113 123 HRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGK 199 (256)
T ss_pred ccccCcceEEE---cCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCC
Confidence 99999999999 456789999999886554332211 1224567999999987788999999999999999998 99
Q ss_pred CCCCCCC
Q 030430 166 PPFSVGE 172 (177)
Q Consensus 166 ~pf~~~~ 172 (177)
.||...+
T Consensus 200 ~p~~~~~ 206 (256)
T cd05113 200 MPYERFN 206 (256)
T ss_pred CCcCcCC
Confidence 9997654
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=196.59 Aligned_cols=161 Identities=32% Similarity=0.615 Sum_probs=138.8
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEee--CCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
....+.+|++++++++|||++++++++.+ +..+++++||+++++|.+++.....++....+.++.|++.++++||+.|
T Consensus 47 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ 126 (266)
T cd06651 47 EVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126 (266)
T ss_pred HHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34578899999999999999999998865 3578999999999999999987777999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC----ccccccCCCccccccccccCCCCCcchHHHHHHHHHHHH
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~ 162 (177)
++|+|++|+||++ +..+.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|+++++++
T Consensus 127 i~H~~l~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~ 203 (266)
T cd06651 127 IVHRDIKGANILR---DSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEML 203 (266)
T ss_pred eeeCCCCHHHEEE---CCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHH
Confidence 9999999999999 466779999999886543211 111234677899999998888899999999999999999
Q ss_pred hCCCCCCCCC
Q 030430 163 NGYPPFSVGE 172 (177)
Q Consensus 163 ~~~~pf~~~~ 172 (177)
+|+.||....
T Consensus 204 ~g~~pf~~~~ 213 (266)
T cd06651 204 TEKPPWAEYE 213 (266)
T ss_pred HCCCCccccc
Confidence 9999997543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=195.95 Aligned_cols=161 Identities=29% Similarity=0.505 Sum_probs=138.0
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
..+.+.+|++++++++|||++++++++.. ...++++||+++++|.+++.....+++..+..++.|++.++++||+.|++
T Consensus 39 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~ 117 (257)
T cd05060 39 GKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117 (257)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCee
Confidence 45678999999999999999999998764 45799999999999999998877899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccc----cccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE----KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~----~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~- 163 (177)
|+||+|+||++ +..+.++|+|||.+.......... ...++..|+|||...+..++.++|+||+|++++++++
T Consensus 118 H~di~p~nili---~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~ 194 (257)
T cd05060 118 HRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSY 194 (257)
T ss_pred ccCcccceEEE---cCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcC
Confidence 99999999999 467789999999987654332211 1112356999999988889999999999999999998
Q ss_pred CCCCCCCCCc
Q 030430 164 GYPPFSVGEE 173 (177)
Q Consensus 164 ~~~pf~~~~~ 173 (177)
|+.||...+.
T Consensus 195 g~~p~~~~~~ 204 (257)
T cd05060 195 GAKPYGEMKG 204 (257)
T ss_pred CCCCcccCCH
Confidence 9999976543
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=200.02 Aligned_cols=160 Identities=31% Similarity=0.597 Sum_probs=139.8
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
....+.+|+++++.++|+|++++++.+..+...++|+||++|++|.+++.. ..++..++..++.|++.++++||+.|++
T Consensus 60 ~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~ 138 (296)
T cd06654 60 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVI 138 (296)
T ss_pred hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 356788999999999999999999999999999999999999999998864 4688999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
|+||+|+||++ +.++.++++|||.+........ .....++..|+|||...+..++.++|+||+|++++++++|+.|
T Consensus 139 H~dLkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~p 215 (296)
T cd06654 139 HRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215 (296)
T ss_pred cCCCCHHHEEE---cCCCCEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCC
Confidence 99999999999 4567899999998765433221 2233567889999999888889999999999999999999999
Q ss_pred CCCCC
Q 030430 168 FSVGE 172 (177)
Q Consensus 168 f~~~~ 172 (177)
|...+
T Consensus 216 f~~~~ 220 (296)
T cd06654 216 YLNEN 220 (296)
T ss_pred CCCCC
Confidence 97654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=197.94 Aligned_cols=161 Identities=34% Similarity=0.601 Sum_probs=142.2
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
.....+.+|+++++.++|+|++++.+++.++..+++++|++++++|.+++... .+++..+..++.|++.++.+||+.|+
T Consensus 41 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i 119 (274)
T cd06609 41 DEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGK 119 (274)
T ss_pred hHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 34567889999999999999999999999999999999999999999998855 78999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
+|+|++|+|+++ +.++.++++|||.+....... ......++..|++||...+..++.++|+||+|++++++++|+.
T Consensus 120 ~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~ 196 (274)
T cd06609 120 IHRDIKAANILL---SEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEP 196 (274)
T ss_pred ccCCCCHHHEEE---CCCCCEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999 467789999999987765432 2223446778999999988889999999999999999999999
Q ss_pred CCCCCC
Q 030430 167 PFSVGE 172 (177)
Q Consensus 167 pf~~~~ 172 (177)
||...+
T Consensus 197 p~~~~~ 202 (274)
T cd06609 197 PLSDLH 202 (274)
T ss_pred CcccCc
Confidence 997643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=196.83 Aligned_cols=161 Identities=26% Similarity=0.473 Sum_probs=139.0
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
.+.+.+|++++++++|||++++.+++...+..++++|++++++|.+++.... .++...+..++.|++.++++||+.|+
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i 124 (261)
T cd05068 45 PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY 124 (261)
T ss_pred HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 4568899999999999999999999999999999999999999999997654 58999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccc--cccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-C
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-~ 164 (177)
+|+||+|+||+++ ..+.++++|||.+.......... ....+..|+|||...+..++.++|+||+|++++++++ |
T Consensus 125 ~H~dl~p~Nil~~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g 201 (261)
T cd05068 125 IHRDLAARNVLVG---ENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYG 201 (261)
T ss_pred eeccCCcceEEEc---CCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcC
Confidence 9999999999994 56779999999887665332211 1112357999999888888999999999999999999 9
Q ss_pred CCCCCCCCc
Q 030430 165 YPPFSVGEE 173 (177)
Q Consensus 165 ~~pf~~~~~ 173 (177)
+.||.+.+.
T Consensus 202 ~~p~~~~~~ 210 (261)
T cd05068 202 RMPYPGMTN 210 (261)
T ss_pred CCCCCCCCH
Confidence 999977543
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=212.29 Aligned_cols=168 Identities=29% Similarity=0.535 Sum_probs=144.9
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
+++.-+.|++|+..+++-+|.||+=++|++..++. .||+.+|+|-+|..++.-. ..|...+...|++|++.++.|||.
T Consensus 428 t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHA 506 (678)
T KOG0193|consen 428 TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHA 506 (678)
T ss_pred CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhh
Confidence 56778999999999999999999999999998887 9999999999999998744 358889999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccc---cCCCCccccccCCCccccccccc---cCCCCCcchHHHHHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT---LYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAIL 158 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~---~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slg~~~ 158 (177)
++|+|+|+|..||++. ++..++|+|||++.- ...........+...|+|||++. ..++++.+||||+|+|.
T Consensus 507 K~IIHrDLKSnNIFl~---~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~ 583 (678)
T KOG0193|consen 507 KNIIHRDLKSNNIFLH---EDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVW 583 (678)
T ss_pred hhhhhhhccccceEEc---cCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHH
Confidence 9999999999999994 568899999998743 22222333445777899999985 34689999999999999
Q ss_pred HHHHhCCCCCCCCCcccCC
Q 030430 159 FELLNGYPPFSVGEEHQFM 177 (177)
Q Consensus 159 ~~~~~~~~pf~~~~~~~~l 177 (177)
|||++|..||.....++++
T Consensus 584 YELltg~lPysi~~~dqIi 602 (678)
T KOG0193|consen 584 YELLTGELPYSIQNRDQII 602 (678)
T ss_pred HHHHhCcCCcCCCChhheE
Confidence 9999999999987777653
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=197.28 Aligned_cols=156 Identities=35% Similarity=0.583 Sum_probs=137.1
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
....+.+.+|++++++++|||++++++.+......++++||+++++|..+ ..+++..+..++.|++.++.|||+.|
T Consensus 40 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ 115 (279)
T cd06619 40 VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK 115 (279)
T ss_pred hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34456789999999999999999999999999999999999999999754 35788899999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
++|+||+|+||++ +..+.++|+|||.+....... .....++..|+|||.+.+..++.++|+||+|++++++++|..
T Consensus 116 i~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 191 (279)
T cd06619 116 ILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLVNSI-AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRF 191 (279)
T ss_pred EeeCCCCHHHEEE---CCCCCEEEeeCCcceeccccc-ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCC
Confidence 9999999999999 467789999999886654332 223457889999999988889999999999999999999999
Q ss_pred CCCC
Q 030430 167 PFSV 170 (177)
Q Consensus 167 pf~~ 170 (177)
||..
T Consensus 192 pf~~ 195 (279)
T cd06619 192 PYPQ 195 (279)
T ss_pred Cchh
Confidence 9965
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=196.85 Aligned_cols=157 Identities=41% Similarity=0.739 Sum_probs=140.3
Q ss_pred HHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCeeec
Q 030430 12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRD 91 (177)
Q Consensus 12 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H~~ 91 (177)
...+|+.++++++||||+++.+++.+....++++|++++++|.+++.....++...+..++.|++.+|++||+.|++|+|
T Consensus 44 ~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~d 123 (260)
T PF00069_consen 44 ENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRD 123 (260)
T ss_dssp HHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESS
T ss_pred hhhhhhhccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 34569999999999999999999999999999999999989999999778899999999999999999999999999999
Q ss_pred CCCCcEEEecCCCCeeEEEeeecccccc-CCCCccccccCCCccccccccc-cCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 030430 92 LKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPFS 169 (177)
Q Consensus 92 i~~~nil~~~~~~~~~~~l~d~~~~~~~-~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Di~slg~~~~~~~~~~~pf~ 169 (177)
|+|+||++ +..+.++|+|||.+... ..........++..|.|||... +...+.++|+||+|+++++|++|..||.
T Consensus 124 ikp~NIl~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~ 200 (260)
T PF00069_consen 124 IKPENILL---DENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFE 200 (260)
T ss_dssp BSGGGEEE---STTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSST
T ss_pred cccccccc---ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999 57788999999998753 2223333455788999999987 7788999999999999999999999998
Q ss_pred CC
Q 030430 170 VG 171 (177)
Q Consensus 170 ~~ 171 (177)
..
T Consensus 201 ~~ 202 (260)
T PF00069_consen 201 ES 202 (260)
T ss_dssp TS
T ss_pred cc
Confidence 75
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=198.29 Aligned_cols=162 Identities=23% Similarity=0.446 Sum_probs=136.8
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC----------CCCHHHHHHHHHHHHHH
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------RVPEQTARKFLQQLGAG 78 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~i~~~ 78 (177)
....+.+|+++++.++|||++++.+++..++..++++||+++++|.+++.... .++...+..++.|++.+
T Consensus 52 ~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 131 (277)
T cd05062 52 ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131 (277)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHH
Confidence 45568899999999999999999999999999999999999999999987532 25677889999999999
Q ss_pred HHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc---ccccCCCccccccccccCCCCCcchHHHHH
Q 030430 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVG 155 (177)
Q Consensus 79 l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~Di~slg 155 (177)
++|||+.|++|+||+|+||+++ ..+.++++|||.+......... ....++..|+|||.+.+..++.++|+||||
T Consensus 132 l~~lH~~~~vH~dlkp~Nil~~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 208 (277)
T cd05062 132 MAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFG 208 (277)
T ss_pred HHHHHHCCcccCCcchheEEEc---CCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHH
Confidence 9999999999999999999994 5677999999988655432211 112345679999999888899999999999
Q ss_pred HHHHHHHh-CCCCCCCCCc
Q 030430 156 AILFELLN-GYPPFSVGEE 173 (177)
Q Consensus 156 ~~~~~~~~-~~~pf~~~~~ 173 (177)
++++++++ |..||.+...
T Consensus 209 ~~l~el~~~~~~p~~~~~~ 227 (277)
T cd05062 209 VVLWEIATLAEQPYQGMSN 227 (277)
T ss_pred HHHHHHHcCCCCCCCCCCH
Confidence 99999999 7889976543
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=212.73 Aligned_cols=165 Identities=34% Similarity=0.634 Sum_probs=155.8
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
+....+.+..|-++|.+.+.|.||+++..|.++.+.|++||-|.||.++..++..+.|++.+...++.-+++|++|||++
T Consensus 460 dtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k 539 (732)
T KOG0614|consen 460 DTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRK 539 (732)
T ss_pred chhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhc
Confidence 45556778889999999999999999999999999999999999999999999889999999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCC
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~ 165 (177)
||++||+||+|+++ +..+.+||.|||.++...++..+-+.+||+.|+|||.+.+...+.+.|.||||+++||+++|+
T Consensus 540 ~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~ 616 (732)
T KOG0614|consen 540 GIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGS 616 (732)
T ss_pred CceeccCChhheee---ccCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCC
Confidence 99999999999999 678899999999999999888888889999999999999999999999999999999999999
Q ss_pred CCCCCCCc
Q 030430 166 PPFSVGEE 173 (177)
Q Consensus 166 ~pf~~~~~ 173 (177)
+||++.++
T Consensus 617 pPFs~~dp 624 (732)
T KOG0614|consen 617 PPFSGVDP 624 (732)
T ss_pred CCCCCCch
Confidence 99998654
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=202.06 Aligned_cols=162 Identities=30% Similarity=0.539 Sum_probs=132.7
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEe--eCCeEEEEEecCCCCChHHHHhhc---------CCCCHHHHHHHHHHHHHH
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLH---------GRVPEQTARKFLQQLGAG 78 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~i~~~ 78 (177)
...+.+|++++++++|||++++.+++. .+...++++||+. ++|.+++... ..+++..+..++.|++.|
T Consensus 42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 120 (317)
T cd07867 42 SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120 (317)
T ss_pred cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHH
Confidence 346788999999999999999999875 4567899999984 5887777522 248889999999999999
Q ss_pred HHHHhhCCCeeecCCCCcEEEecC-CCCeeEEEeeeccccccCCCCc----cccccCCCccccccccccC-CCCCcchHH
Q 030430 79 LEILNSHHIIHRDLKPENILLSGL-DDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQ-RYDEKVDMW 152 (177)
Q Consensus 79 l~~lh~~~~~H~~i~~~nil~~~~-~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~-~~~~~~Di~ 152 (177)
|+|||+.|++|+||||+||++... +..+.++|+|||.+........ .....++..|+|||.+.+. .++.++|+|
T Consensus 121 L~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 200 (317)
T cd07867 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW 200 (317)
T ss_pred HHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHH
Confidence 999999999999999999998532 3456799999999876543321 1233468889999988654 478899999
Q ss_pred HHHHHHHHHHhCCCCCCCCC
Q 030430 153 SVGAILFELLNGYPPFSVGE 172 (177)
Q Consensus 153 slg~~~~~~~~~~~pf~~~~ 172 (177)
|+|+++++++||..||....
T Consensus 201 SlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 201 AIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred hHHHHHHHHHhCCCCccccc
Confidence 99999999999999997654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=199.64 Aligned_cols=163 Identities=26% Similarity=0.480 Sum_probs=140.8
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-----------CCCHHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----------RVPEQTARKFLQQL 75 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~i 75 (177)
......+.+|++++++++|||++++++++..++..++++|++++++|.+++.... .+++..++.++.|+
T Consensus 60 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 139 (296)
T cd05051 60 DNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQI 139 (296)
T ss_pred HHHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHH
Confidence 3456788999999999999999999999999999999999999999999998665 68999999999999
Q ss_pred HHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC---ccccccCCCccccccccccCCCCCcchHH
Q 030430 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMW 152 (177)
Q Consensus 76 ~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Di~ 152 (177)
+.+++|||+.|++|+||+|+||+++ ..+.++++|||.+....... ......++..|+|||...+..++.++|+|
T Consensus 140 ~~al~~LH~~~i~H~dlkp~Nili~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~ 216 (296)
T cd05051 140 ASGMRYLESLNFVHRDLATRNCLVG---KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVW 216 (296)
T ss_pred HHHHHHHHHcCccccccchhceeec---CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhh
Confidence 9999999999999999999999994 56789999999987654332 12233456689999998877889999999
Q ss_pred HHHHHHHHHHh--CCCCCCCCC
Q 030430 153 SVGAILFELLN--GYPPFSVGE 172 (177)
Q Consensus 153 slg~~~~~~~~--~~~pf~~~~ 172 (177)
|+|++++++++ +..||...+
T Consensus 217 slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 217 AFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred hhHHHHHHHHhcCCCCCCCCcC
Confidence 99999999998 677886643
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=195.37 Aligned_cols=161 Identities=27% Similarity=0.543 Sum_probs=137.6
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
.+.+.+|++++++++|||++++++++.+.+..++++||++|++|.+++... ..+++..+..++.|++.++++||+.|++
T Consensus 43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~ 122 (256)
T cd05059 43 EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFI 122 (256)
T ss_pred HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 456888999999999999999999999999999999999999999998754 4589999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccc--cccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-CC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY 165 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-~~ 165 (177)
|+||+|+||++ +..+.++++|||.+.......... ...++..|+|||...+..++.++|+||+|++++++++ |.
T Consensus 123 H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~ 199 (256)
T cd05059 123 HRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199 (256)
T ss_pred cccccHhhEEE---CCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCC
Confidence 99999999999 466779999999886554322111 1123346999999988889999999999999999999 79
Q ss_pred CCCCCCCc
Q 030430 166 PPFSVGEE 173 (177)
Q Consensus 166 ~pf~~~~~ 173 (177)
.||...++
T Consensus 200 ~p~~~~~~ 207 (256)
T cd05059 200 MPYERFSN 207 (256)
T ss_pred CCCCCCCH
Confidence 99976543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=195.99 Aligned_cols=161 Identities=29% Similarity=0.461 Sum_probs=139.8
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
...+.+.+|++.+++++|||++++++.+.+ ...++++|++++++|.+++.... .+++..+..++.|++.+|++||+.
T Consensus 38 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~ 116 (257)
T cd05040 38 DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116 (257)
T ss_pred HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC
Confidence 456789999999999999999999999888 88999999999999999998654 589999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc----cccccCCCccccccccccCCCCCcchHHHHHHHHHHH
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~ 161 (177)
|++|+||+|+||++. ..+.++++|||.+........ .....++..|+|||...+..++.++|+||+|+++++|
T Consensus 117 ~i~H~di~p~nil~~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el 193 (257)
T cd05040 117 RFIHRDLAARNILLA---SDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEM 193 (257)
T ss_pred CccccccCcccEEEe---cCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHH
Confidence 999999999999994 567899999998876544221 1123356679999998888899999999999999999
Q ss_pred Hh-CCCCCCCCC
Q 030430 162 LN-GYPPFSVGE 172 (177)
Q Consensus 162 ~~-~~~pf~~~~ 172 (177)
++ |..||...+
T Consensus 194 ~t~g~~p~~~~~ 205 (257)
T cd05040 194 FTYGEEPWAGLS 205 (257)
T ss_pred HhCCCCCCCCCC
Confidence 99 999996544
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=213.22 Aligned_cols=165 Identities=30% Similarity=0.528 Sum_probs=140.0
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCC--------eEEEEEecCCCCChHHHHhhc----CCCCHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN--------CIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQ 73 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~ 73 (177)
++.....+.+|+..+..++|++++++.+.+.... .+++++||+++++|.+++... ..+++..+..++.
T Consensus 71 ~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~ 150 (496)
T PTZ00283 71 SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFI 150 (496)
T ss_pred CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHH
Confidence 3556678899999999999999999988764322 468999999999999988643 3589999999999
Q ss_pred HHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCC---CccccccCCCccccccccccCCCCCcch
Q 030430 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQFQRYDEKVD 150 (177)
Q Consensus 74 ~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~D 150 (177)
|++.+|+|+|+.|++|+||||+||++. ..+.++|+|||++...... .......+++.|+|||.+.+..++.++|
T Consensus 151 qll~aL~~lH~~~IiHrDLKP~NILl~---~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~D 227 (496)
T PTZ00283 151 QVLLAVHHVHSKHMIHRDIKSANILLC---SNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKAD 227 (496)
T ss_pred HHHHHHHHHHhCCEecCCCCHHHEEEe---CCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHH
Confidence 999999999999999999999999994 5678999999998665332 2223456889999999998888999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCc
Q 030430 151 MWSVGAILFELLNGYPPFSVGEE 173 (177)
Q Consensus 151 i~slg~~~~~~~~~~~pf~~~~~ 173 (177)
+||+|+++|++++|+.||.+.+.
T Consensus 228 VwSlGvilyeLltG~~Pf~~~~~ 250 (496)
T PTZ00283 228 MFSLGVLLYELLTLKRPFDGENM 250 (496)
T ss_pred HHHHHHHHHHHHHCCCCCCCCCH
Confidence 99999999999999999987543
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=196.04 Aligned_cols=163 Identities=31% Similarity=0.620 Sum_probs=140.4
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEI 81 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~ 81 (177)
+......+.+|+++++.++|||++++++++.+.+..++++||+++++|.+++.. ...+++..+..++.|++.+++|
T Consensus 42 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 121 (267)
T cd08228 42 DAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121 (267)
T ss_pred CHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 345566789999999999999999999999999999999999999999988863 2348899999999999999999
Q ss_pred HhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccCCCCCcchHHHHHHHHHH
Q 030430 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (177)
Q Consensus 82 lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~ 160 (177)
||+.|++|+||+|+||+++ ..+.++++|||.+........ .....++..|+|||...+..++.++|+||+|+++++
T Consensus 122 LH~~~i~H~dl~~~nil~~---~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~e 198 (267)
T cd08228 122 MHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE 198 (267)
T ss_pred HhhCCeeCCCCCHHHEEEc---CCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHH
Confidence 9999999999999999994 566799999998866543322 123346778999999988888999999999999999
Q ss_pred HHhCCCCCCCC
Q 030430 161 LLNGYPPFSVG 171 (177)
Q Consensus 161 ~~~~~~pf~~~ 171 (177)
+++|+.||...
T Consensus 199 l~~g~~p~~~~ 209 (267)
T cd08228 199 MAALQSPFYGD 209 (267)
T ss_pred HhcCCCCCccc
Confidence 99999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-32 Score=196.46 Aligned_cols=159 Identities=31% Similarity=0.497 Sum_probs=135.4
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEee--CCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
.....+.+|+++++.++|||++++.+++.. ...++++|||+++++|.+++... .+++.++..++.|++.++++||+.
T Consensus 48 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~ 126 (283)
T cd05080 48 QNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQ 126 (283)
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHC
Confidence 356778899999999999999999998765 34689999999999999998754 699999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc----cccccCCCccccccccccCCCCCcchHHHHHHHHHHH
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~ 161 (177)
|++|+||+|+||++ +....++|+|||.+........ .....++..|+|||......++.++|+||+|++++++
T Consensus 127 ~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el 203 (283)
T cd05080 127 HYIHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYEL 203 (283)
T ss_pred CeeccccChheEEE---cCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHH
Confidence 99999999999999 4567899999999876543221 1112245569999998877889999999999999999
Q ss_pred HhCCCCCCC
Q 030430 162 LNGYPPFSV 170 (177)
Q Consensus 162 ~~~~~pf~~ 170 (177)
++|..||..
T Consensus 204 ~tg~~p~~~ 212 (283)
T cd05080 204 LTHCDSKQS 212 (283)
T ss_pred HhCCCCCCC
Confidence 999999854
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=198.05 Aligned_cols=161 Identities=27% Similarity=0.564 Sum_probs=137.2
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-----------------CCCCHHHHHHH
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------------GRVPEQTARKF 71 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----------------~~~~~~~~~~~ 71 (177)
....+.+|+++++.++|||++++++++......+++|||+++++|.+++... ..+++.++..+
T Consensus 50 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 129 (283)
T cd05090 50 QWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129 (283)
T ss_pred HHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHH
Confidence 3467889999999999999999999999999999999999999999998532 23778889999
Q ss_pred HHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCCCc
Q 030430 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEK 148 (177)
Q Consensus 72 ~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~ 148 (177)
+.|++.+++|||+.|++|+||+|+||+++ ....++++|||.+........ .....++..|+|||...+..++.+
T Consensus 130 ~~~i~~al~~lH~~~i~H~dlkp~nili~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 206 (283)
T cd05090 130 AIQIAAGMEYLSSHFFVHKDLAARNILIG---EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSD 206 (283)
T ss_pred HHHHHHHHHHHHhcCeehhccccceEEEc---CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCch
Confidence 99999999999999999999999999994 566799999999876543321 122234567999999887888999
Q ss_pred chHHHHHHHHHHHHh-CCCCCCCCC
Q 030430 149 VDMWSVGAILFELLN-GYPPFSVGE 172 (177)
Q Consensus 149 ~Di~slg~~~~~~~~-~~~pf~~~~ 172 (177)
+|+||+|++++++++ |..||.+..
T Consensus 207 ~Dv~slG~il~el~~~g~~p~~~~~ 231 (283)
T cd05090 207 SDIWSFGVVLWEIFSFGLQPYYGFS 231 (283)
T ss_pred hhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999999999998 899997644
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=196.52 Aligned_cols=163 Identities=31% Similarity=0.614 Sum_probs=140.9
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEIL 82 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~l 82 (177)
......+.+|+++++.++|||++++++++.+++..++++|++++++|.+++.. ...+++..+..++.|++.++++|
T Consensus 43 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 122 (267)
T cd08229 43 AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122 (267)
T ss_pred HHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34456788999999999999999999999999999999999999999998863 23489999999999999999999
Q ss_pred hhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccCCCCCcchHHHHHHHHHHH
Q 030430 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 83 h~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~ 161 (177)
|+.|++|+||+|+||+++ ..+.++++|||.+........ .....++..|+|||...+..++.++|+||+|++++++
T Consensus 123 H~~~i~H~dl~p~nili~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l 199 (267)
T cd08229 123 HSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199 (267)
T ss_pred HHCCeecCCCCHHHEEEc---CCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHH
Confidence 999999999999999994 567799999998766543322 2234577889999999888889999999999999999
Q ss_pred HhCCCCCCCCC
Q 030430 162 LNGYPPFSVGE 172 (177)
Q Consensus 162 ~~~~~pf~~~~ 172 (177)
++|..||.+..
T Consensus 200 ~~g~~p~~~~~ 210 (267)
T cd08229 200 AALQSPFYGDK 210 (267)
T ss_pred HhCCCCccccc
Confidence 99999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=198.71 Aligned_cols=162 Identities=31% Similarity=0.513 Sum_probs=138.1
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc------------------------CCCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH------------------------GRVP 64 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------------------------~~~~ 64 (177)
....+.+|+++++.++||||+++++.+...+..++++||+.+++|.+++... ..++
T Consensus 46 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 125 (290)
T cd05045 46 ELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125 (290)
T ss_pred HHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccC
Confidence 3567889999999999999999999999999999999999999999998642 2377
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccc
Q 030430 65 EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQ 141 (177)
Q Consensus 65 ~~~~~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~ 141 (177)
..++..++.|++.++++||+.|++|+||+|+||++. ..+.++|+|||.+........ .....++..|++||...
T Consensus 126 ~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~ 202 (290)
T cd05045 126 MGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA---EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF 202 (290)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEc---CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHc
Confidence 889999999999999999999999999999999994 567899999999875433221 11223456799999988
Q ss_pred cCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCc
Q 030430 142 FQRYDEKVDMWSVGAILFELLN-GYPPFSVGEE 173 (177)
Q Consensus 142 ~~~~~~~~Di~slg~~~~~~~~-~~~pf~~~~~ 173 (177)
+..++.++|+||+|++++++++ |..||.+...
T Consensus 203 ~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 203 DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred cCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 8888999999999999999998 9999977554
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=196.25 Aligned_cols=163 Identities=36% Similarity=0.576 Sum_probs=138.6
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
....+.+.+|+++++.++|||++++++++...+..++++||+++++|..++.. ...+++..+..++.|++.+|++||+.
T Consensus 43 ~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~ 122 (282)
T cd06643 43 EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN 122 (282)
T ss_pred HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34456788899999999999999999999999999999999999999988764 35689999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccc-----cCCCCCcchHHHHHHHHH
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILF 159 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~slg~~~~ 159 (177)
|++|+||+|+||++ +.++.++++|||.+....... ......++..|+|||.+. ...++.++|+||+|++++
T Consensus 123 ~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~ 199 (282)
T cd06643 123 KIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLI 199 (282)
T ss_pred CeeecCCCcccEEE---ccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHH
Confidence 99999999999999 466789999999886543321 122344778899999873 345678999999999999
Q ss_pred HHHhCCCCCCCCC
Q 030430 160 ELLNGYPPFSVGE 172 (177)
Q Consensus 160 ~~~~~~~pf~~~~ 172 (177)
++++|+.||...+
T Consensus 200 el~~g~~p~~~~~ 212 (282)
T cd06643 200 EMAQIEPPHHELN 212 (282)
T ss_pred HHccCCCCccccC
Confidence 9999999997654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-32 Score=198.93 Aligned_cols=163 Identities=29% Similarity=0.506 Sum_probs=139.5
Q ss_pred hhHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh
Q 030430 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh 83 (177)
....+.+.+|+++++++ +||||+++++++...+..++++||+++++|.+++.... .+++.++..++.|++.+++|||
T Consensus 79 ~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH 158 (302)
T cd05055 79 SSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA 158 (302)
T ss_pred hHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34456789999999999 79999999999999999999999999999999987543 3899999999999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCCCcchHHHHHHHHHH
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~ 160 (177)
+.|++|+||+|+||+++ ....++++|||.+........ .....++..|+|||.+.+..++.++|+||+|+++++
T Consensus 159 ~~~ivH~dlkp~Nil~~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~e 235 (302)
T cd05055 159 SKNCIHRDLAARNVLLT---HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWE 235 (302)
T ss_pred HCCeehhhhccceEEEc---CCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHH
Confidence 99999999999999994 567799999999876543321 112234567999999988888999999999999999
Q ss_pred HHh-CCCCCCCCC
Q 030430 161 LLN-GYPPFSVGE 172 (177)
Q Consensus 161 ~~~-~~~pf~~~~ 172 (177)
+++ |..||.+..
T Consensus 236 l~t~g~~p~~~~~ 248 (302)
T cd05055 236 IFSLGSNPYPGMP 248 (302)
T ss_pred HHhCCCCCcCCCC
Confidence 998 999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=200.98 Aligned_cols=160 Identities=31% Similarity=0.530 Sum_probs=135.8
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
...+.+|++++++++|||++++++++..++..+++|||++ ++|.+++...+ .++...+..++.|++.+|+|||+.|++
T Consensus 48 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~iv 126 (309)
T cd07872 48 PCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVL 126 (309)
T ss_pred chhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 3457789999999999999999999999999999999996 48888876553 488999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCcccccccccc-CCCCCcchHHHHHHHHHHHHhCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
||||+|+||++ +..+.++|+|||.+........ .....++..|+|||.+.+ ..++.++|+||+|++++++++|+.
T Consensus 127 H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~ 203 (309)
T cd07872 127 HRDLKPQNLLI---NERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRP 203 (309)
T ss_pred cCCCCHHHEEE---CCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999 4667899999999865433222 223346788999998764 457889999999999999999999
Q ss_pred CCCCCCc
Q 030430 167 PFSVGEE 173 (177)
Q Consensus 167 pf~~~~~ 173 (177)
||.+.+.
T Consensus 204 pf~~~~~ 210 (309)
T cd07872 204 LFPGSTV 210 (309)
T ss_pred CCCCCCh
Confidence 9977543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=195.77 Aligned_cols=161 Identities=27% Similarity=0.502 Sum_probs=138.8
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+.+|+++++.++|++++++++++...+.+++++||+++++|.+++... ..++...+..++.|++.++++||+.|+
T Consensus 46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i 125 (263)
T cd05052 46 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 125 (263)
T ss_pred HHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 456889999999999999999999999999999999999999999998754 348899999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccc--cccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-C
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-~ 164 (177)
+|+||+|+||++ +..+.++++|||.+.......... ....+..|++||...+..++.++|+||+|++++++++ |
T Consensus 126 ~H~dlkp~nil~---~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g 202 (263)
T cd05052 126 IHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 202 (263)
T ss_pred eecccCcceEEE---cCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCC
Confidence 999999999999 467789999999987654432221 1223457999999888888999999999999999998 8
Q ss_pred CCCCCCCCc
Q 030430 165 YPPFSVGEE 173 (177)
Q Consensus 165 ~~pf~~~~~ 173 (177)
..||.+.+.
T Consensus 203 ~~p~~~~~~ 211 (263)
T cd05052 203 MSPYPGIDL 211 (263)
T ss_pred CCCCCCCCH
Confidence 999976543
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-32 Score=198.22 Aligned_cols=161 Identities=30% Similarity=0.587 Sum_probs=140.8
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+.+.+|+.+++.++|+|++++++++..+...++++||+++++|.+++.+ ..+++.++..++.|++.++.+||+.|+
T Consensus 58 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i 136 (297)
T cd06656 58 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQV 136 (297)
T ss_pred chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 3456788999999999999999999999999999999999999999998864 468899999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
+|+||+|+||++ +.++.++++|||.+........ .....++..|++||...+..++.++|+||+|++++++++|..
T Consensus 137 ~H~dL~p~Nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~ 213 (297)
T cd06656 137 IHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213 (297)
T ss_pred ccCCCCHHHEEE---CCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999999999999 4677899999998866533322 223456788999999988888999999999999999999999
Q ss_pred CCCCCC
Q 030430 167 PFSVGE 172 (177)
Q Consensus 167 pf~~~~ 172 (177)
||.+.+
T Consensus 214 pf~~~~ 219 (297)
T cd06656 214 PYLNEN 219 (297)
T ss_pred CCCCCC
Confidence 997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=194.50 Aligned_cols=163 Identities=32% Similarity=0.636 Sum_probs=141.9
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
....+.+.+|+++++.++|+|++++.+.+.+++.+++++||+++++|.+++... ..++++.+..++.|++.++++||+
T Consensus 39 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~ 118 (255)
T cd08219 39 SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118 (255)
T ss_pred hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 345677889999999999999999999999999999999999999999988643 348999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~ 163 (177)
.|++|+||+|+||++ +.++.++++|||.+....... ......++..|+|||...+..++.++|+||+|++++++++
T Consensus 119 ~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~ 195 (255)
T cd08219 119 KRVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCT 195 (255)
T ss_pred CCcccCCCCcceEEE---CCCCcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhh
Confidence 999999999999999 467789999999886654322 2223457788999999988888999999999999999999
Q ss_pred CCCCCCCCC
Q 030430 164 GYPPFSVGE 172 (177)
Q Consensus 164 ~~~pf~~~~ 172 (177)
|..||...+
T Consensus 196 g~~p~~~~~ 204 (255)
T cd08219 196 LKHPFQANS 204 (255)
T ss_pred ccCCCCCCC
Confidence 999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=195.30 Aligned_cols=161 Identities=32% Similarity=0.577 Sum_probs=140.9
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
.....+.+|++++++++||+++++.+.+.++...++++||++|++|.+++.. .++++.++..++.|++.+++++|+.++
T Consensus 44 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i 122 (277)
T cd06640 44 DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKK 122 (277)
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 3456788999999999999999999999999999999999999999999874 478999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
+|+||+|+||+++ ..+.++++|||.+........ .....++..|+|||...+..++.++|+||+|++++++++|..
T Consensus 123 vH~dl~p~Nil~~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~ 199 (277)
T cd06640 123 IHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEP 199 (277)
T ss_pred cCcCCChhhEEEc---CCCCEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCC
Confidence 9999999999994 667799999999866543322 222346778999999888888999999999999999999999
Q ss_pred CCCCCC
Q 030430 167 PFSVGE 172 (177)
Q Consensus 167 pf~~~~ 172 (177)
||...+
T Consensus 200 p~~~~~ 205 (277)
T cd06640 200 PNSDMH 205 (277)
T ss_pred CCCCcC
Confidence 997643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-32 Score=196.37 Aligned_cols=163 Identities=37% Similarity=0.593 Sum_probs=139.5
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
....+.+.+|++++++++|||++++.+.+..+...++++||+++++|.+++... ..+++..+..++.|++.++.|||+.
T Consensus 43 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~ 122 (280)
T cd06611 43 EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH 122 (280)
T ss_pred HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 344567889999999999999999999999999999999999999999998764 4599999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccc-----cCCCCCcchHHHHHHHHH
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILF 159 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~slg~~~~ 159 (177)
|++|+|++|+||++ +..+.++++|||.+........ .....++..|++||.+. ...++.++|+||+|++++
T Consensus 123 ~i~h~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~ 199 (280)
T cd06611 123 KVIHRDLKAGNILL---TLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLI 199 (280)
T ss_pred CcccCCCChhhEEE---CCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHH
Confidence 99999999999999 4677899999998765433221 22334678899999874 334678999999999999
Q ss_pred HHHhCCCCCCCCC
Q 030430 160 ELLNGYPPFSVGE 172 (177)
Q Consensus 160 ~~~~~~~pf~~~~ 172 (177)
++++|..||...+
T Consensus 200 ~l~~g~~p~~~~~ 212 (280)
T cd06611 200 ELAQMEPPHHELN 212 (280)
T ss_pred HHHhCCCCcccCC
Confidence 9999999997654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=204.75 Aligned_cols=162 Identities=29% Similarity=0.519 Sum_probs=137.1
Q ss_pred hhHHHHHHHHHHHHhhCC-CCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-------------------------
Q 030430 7 KHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH------------------------- 60 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------------------------- 60 (177)
....+.+.+|+++++.++ ||||+++++++.+.+..++||||+++++|.+++..+
T Consensus 81 ~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (400)
T cd05105 81 SSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPAD 160 (400)
T ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCccc
Confidence 344577899999999995 999999999999999999999999999999987642
Q ss_pred -----------------------------------------------------------------------CCCCHHHHH
Q 030430 61 -----------------------------------------------------------------------GRVPEQTAR 69 (177)
Q Consensus 61 -----------------------------------------------------------------------~~~~~~~~~ 69 (177)
..++...+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~ 240 (400)
T cd05105 161 ESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLL 240 (400)
T ss_pred ccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHH
Confidence 136777888
Q ss_pred HHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCC
Q 030430 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYD 146 (177)
Q Consensus 70 ~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~ 146 (177)
.++.|++.+++|||+.|++|+||+|+||+++ ....++++|||.+........ .....++..|+|||.+.+..++
T Consensus 241 ~~~~qi~~aL~~LH~~~ivH~dikp~Nill~---~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 317 (400)
T cd05105 241 SFTYQVARGMEFLASKNCVHRDLAARNVLLA---QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYT 317 (400)
T ss_pred HHHHHHHHHHHHHHhCCeeCCCCChHhEEEe---CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCC
Confidence 9999999999999999999999999999994 566799999999876533221 1223356779999999888889
Q ss_pred CcchHHHHHHHHHHHHh-CCCCCCCC
Q 030430 147 EKVDMWSVGAILFELLN-GYPPFSVG 171 (177)
Q Consensus 147 ~~~Di~slg~~~~~~~~-~~~pf~~~ 171 (177)
.++|+||+|++++++++ |..||...
T Consensus 318 ~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 318 TLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred chhhHHHHHHHHHHHHHCCCCCCccc
Confidence 99999999999999997 89998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-32 Score=194.40 Aligned_cols=159 Identities=28% Similarity=0.544 Sum_probs=139.5
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
..+.+.+|+.+++.++|+|++++++++.+.+..++++|++++++|.+++.... .+++..+..++.|++.++++||+.|
T Consensus 43 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~ 122 (256)
T cd05039 43 AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122 (256)
T ss_pred HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 35778999999999999999999999998889999999999999999998665 6899999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-CC
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY 165 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-~~ 165 (177)
++|+||+|+||++ +.++.++++|||.+........ ....+..|.|||......++.++|+||+|++++++++ |+
T Consensus 123 i~H~di~p~Nili---~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~ 197 (256)
T cd05039 123 FVHRDLAARNVLV---SEDLVAKVSDFGLAKEASQGQD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197 (256)
T ss_pred ccchhcccceEEE---eCCCCEEEcccccccccccccc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCC
Confidence 9999999999999 4677899999999876633222 2234567999999887788999999999999999997 99
Q ss_pred CCCCCCC
Q 030430 166 PPFSVGE 172 (177)
Q Consensus 166 ~pf~~~~ 172 (177)
.||....
T Consensus 198 ~p~~~~~ 204 (256)
T cd05039 198 VPYPRIP 204 (256)
T ss_pred CCCCCCC
Confidence 9997654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-31 Score=194.74 Aligned_cols=162 Identities=25% Similarity=0.382 Sum_probs=134.8
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
....+.+|++++++++||||+++++++.++...++||||+++++|..++.+. +.+++..+..++.|++.+++|||+.|+
T Consensus 59 ~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 138 (274)
T cd05076 59 IALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNL 138 (274)
T ss_pred HHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCc
Confidence 3456788999999999999999999999999999999999999999998753 568999999999999999999999999
Q ss_pred eeecCCCCcEEEecC----CCCeeEEEeeeccccccCCCCccccccCCCcccccccccc-CCCCCcchHHHHHHHHHHH-
Q 030430 88 IHRDLKPENILLSGL----DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFEL- 161 (177)
Q Consensus 88 ~H~~i~~~nil~~~~----~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~- 161 (177)
+|+||+|+||++... .....++++|||.+....... ...++..|+|||.+.+ ..++.++|+||+|++++++
T Consensus 139 iH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~---~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~ 215 (274)
T cd05076 139 VHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSRE---ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEIC 215 (274)
T ss_pred cCCCCCcccEEEeccCcccCccceeeecCCcccccccccc---ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHH
Confidence 999999999999632 123358999999875432221 2235677999998864 4578999999999999998
Q ss_pred HhCCCCCCCCCc
Q 030430 162 LNGYPPFSVGEE 173 (177)
Q Consensus 162 ~~~~~pf~~~~~ 173 (177)
++|..||.....
T Consensus 216 ~~g~~p~~~~~~ 227 (274)
T cd05076 216 FDGEVPLKERTP 227 (274)
T ss_pred hCCCCCccccCh
Confidence 468999976543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=197.18 Aligned_cols=163 Identities=26% Similarity=0.464 Sum_probs=138.9
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC----------CCCHHHHHHHHHHHHH
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------RVPEQTARKFLQQLGA 77 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~i~~ 77 (177)
.....+.+|+++++.++|||++++++++......++++||+++++|.+++.... .+++..+..++.|++.
T Consensus 51 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 130 (277)
T cd05032 51 RERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130 (277)
T ss_pred HHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHH
Confidence 345678899999999999999999999999999999999999999999986432 3677889999999999
Q ss_pred HHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCCCcchHHHH
Q 030430 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSV 154 (177)
Q Consensus 78 ~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~sl 154 (177)
+++|||+.|++|+||+|+||++ +..+.++++|||.+........ .....++..|+|||...+..++.++|+||+
T Consensus 131 ~l~~lH~~~i~H~di~p~nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 207 (277)
T cd05032 131 GMAYLAAKKFVHRDLAARNCMV---AEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSF 207 (277)
T ss_pred HHHHHHhCCccccccChheEEE---cCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHH
Confidence 9999999999999999999999 4667899999998876543321 112234668999999887889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCc
Q 030430 155 GAILFELLN-GYPPFSVGEE 173 (177)
Q Consensus 155 g~~~~~~~~-~~~pf~~~~~ 173 (177)
|++++++++ |..||.+.+.
T Consensus 208 G~il~el~t~g~~p~~~~~~ 227 (277)
T cd05032 208 GVVLWEMATLAEQPYQGLSN 227 (277)
T ss_pred HHHHHHhhccCCCCCccCCH
Confidence 999999998 8999976553
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-32 Score=194.01 Aligned_cols=158 Identities=21% Similarity=0.352 Sum_probs=134.7
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
...+.+|++++++++|||++++++++.. ...++++||+++++|.+++.... .++...+..++.|++.+|+|||+.|++
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~ 123 (259)
T cd05037 45 SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLV 123 (259)
T ss_pred HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCee
Confidence 6788999999999999999999998877 77899999999999999998765 689999999999999999999999999
Q ss_pred eecCCCCcEEEecCC----CCeeEEEeeeccccccCCCCccccccCCCccccccccccC--CCCCcchHHHHHHHHHHHH
Q 030430 89 HRDLKPENILLSGLD----DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ--RYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 89 H~~i~~~nil~~~~~----~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Di~slg~~~~~~~ 162 (177)
|+||+|+||+++... ....++++|||.+..... .....++..|+|||.+... .++.++|+||+|+++++++
T Consensus 124 H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~ 200 (259)
T cd05037 124 HGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEIC 200 (259)
T ss_pred cccCccceEEEecCccccCCceeEEeCCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHH
Confidence 999999999996322 123699999998876543 1123356679999998765 6789999999999999999
Q ss_pred h-CCCCCCCC
Q 030430 163 N-GYPPFSVG 171 (177)
Q Consensus 163 ~-~~~pf~~~ 171 (177)
+ |..||...
T Consensus 201 ~~~~~p~~~~ 210 (259)
T cd05037 201 SNGEEPLSTL 210 (259)
T ss_pred hCCCCCcccC
Confidence 9 57888665
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-32 Score=195.38 Aligned_cols=164 Identities=26% Similarity=0.502 Sum_probs=139.1
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
++.....+..|++++++++|||++++.+++.++...++++||+++++|.+++... +.++..++..++.|++.++++||+
T Consensus 45 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~ 124 (269)
T cd05065 45 TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE 124 (269)
T ss_pred CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3445678999999999999999999999999999999999999999999998754 458999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcccc---cc---CCCccccccccccCCCCCcchHHHHHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VC---GSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~---~~---~~~~~~~pe~~~~~~~~~~~Di~slg~~~ 158 (177)
.|++|+||+|+||++ +.+..++++|||.+........... .. .+..|++||...+..++.++|+||+|+++
T Consensus 125 ~g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l 201 (269)
T cd05065 125 MNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVM 201 (269)
T ss_pred CCEeecccChheEEE---cCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHH
Confidence 999999999999999 4667899999998765433221111 11 13469999999888889999999999999
Q ss_pred HHHHh-CCCCCCCCC
Q 030430 159 FELLN-GYPPFSVGE 172 (177)
Q Consensus 159 ~~~~~-~~~pf~~~~ 172 (177)
+++++ |..||...+
T Consensus 202 ~e~l~~g~~p~~~~~ 216 (269)
T cd05065 202 WEVMSYGERPYWDMS 216 (269)
T ss_pred HHHhcCCCCCCCCCC
Confidence 99886 999997654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=194.53 Aligned_cols=161 Identities=30% Similarity=0.588 Sum_probs=138.9
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeC--CeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
.....+.+|++++++++|+|++++++++.+. ..+++++||+++++|.+++.....+++..+..++.|++.++.+||+.
T Consensus 46 ~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~ 125 (264)
T cd06653 46 KEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN 125 (264)
T ss_pred HHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3456788999999999999999999988754 46889999999999999998777799999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCC----CccccccCCCccccccccccCCCCCcchHHHHHHHHHHH
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~ 161 (177)
|++|+|++|+||++ +.++.++++|||.+...... .......++..|+|||.+.+..++.++|+||+|++++++
T Consensus 126 ~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 202 (264)
T cd06653 126 MIVHRDIKGANILR---DSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEM 202 (264)
T ss_pred CEecCCCCHHHEEE---cCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHH
Confidence 99999999999999 45677999999988765321 111223467889999999888889999999999999999
Q ss_pred HhCCCCCCCC
Q 030430 162 LNGYPPFSVG 171 (177)
Q Consensus 162 ~~~~~pf~~~ 171 (177)
++|..||...
T Consensus 203 ~~g~~p~~~~ 212 (264)
T cd06653 203 LTEKPPWAEY 212 (264)
T ss_pred HhCCCCCCcc
Confidence 9999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-32 Score=194.75 Aligned_cols=161 Identities=29% Similarity=0.562 Sum_probs=138.9
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
..+.+.+|+++++.++|+|++++++.+.+.+..++++||+++++|.+++... ..++...+..++.|++.+++|||+.|
T Consensus 44 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~ 123 (261)
T cd05072 44 SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 123 (261)
T ss_pred hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3567899999999999999999999999999999999999999999998753 45888999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc--ccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~- 163 (177)
++|+||+|+||++ +..+.++++|||.+......... ....++..|+|||......+++++|+||+|++++++++
T Consensus 124 i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~ 200 (261)
T cd05072 124 YIHRDLRAANVLV---SESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTY 200 (261)
T ss_pred eeccccchhhEEe---cCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHcc
Confidence 9999999999999 46678999999998765432211 12234567999999887888999999999999999998
Q ss_pred CCCCCCCCC
Q 030430 164 GYPPFSVGE 172 (177)
Q Consensus 164 ~~~pf~~~~ 172 (177)
|..||.+..
T Consensus 201 g~~p~~~~~ 209 (261)
T cd05072 201 GKIPYPGMS 209 (261)
T ss_pred CCCCCCCCC
Confidence 999997654
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-32 Score=200.46 Aligned_cols=162 Identities=25% Similarity=0.406 Sum_probs=137.8
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
....+.+.+|+.+++.++||||+++++++... ..+++++++++++|.+++..+. .++...+..++.|++.+|+|||+.
T Consensus 50 ~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~ 128 (316)
T cd05108 50 PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER 128 (316)
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc
Confidence 44567889999999999999999999988765 4678999999999999998653 588999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccc---cccCCCccccccccccCCCCCcchHHHHHHHHHHHH
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE---KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~---~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~ 162 (177)
|++|+||+|+||++ +..+.++|+|||.+.......... ....+..|++||.+.+..++.++|+||+|+++|+++
T Consensus 129 ~iiH~dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~ 205 (316)
T cd05108 129 RLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 205 (316)
T ss_pred CeeccccchhheEe---cCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHH
Confidence 99999999999999 456779999999997654332211 122355799999998888999999999999999999
Q ss_pred h-CCCCCCCCC
Q 030430 163 N-GYPPFSVGE 172 (177)
Q Consensus 163 ~-~~~pf~~~~ 172 (177)
+ |..||.+..
T Consensus 206 t~g~~p~~~~~ 216 (316)
T cd05108 206 TFGSKPYDGIP 216 (316)
T ss_pred cCCCCCCCCCC
Confidence 8 999997754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=203.05 Aligned_cols=163 Identities=37% Similarity=0.573 Sum_probs=152.1
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhh
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
+.......+|.++|.+++.+.||.+-..|+..+.+|+|+..+.||+|.-++.+.+ .+++..+..++++|+.+|+.||+
T Consensus 226 r~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~ 305 (591)
T KOG0986|consen 226 RKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR 305 (591)
T ss_pred hhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh
Confidence 4445677889999999999999999999999999999999999999999998776 59999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhC
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~ 164 (177)
++||+||+||+||++ ++.+.++++|+|++..+..+.......||.+|||||++.+..|+.+.|-|||||++|+|+.|
T Consensus 306 ~~iVYRDLKPeNILL---Dd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G 382 (591)
T KOG0986|consen 306 RRIVYRDLKPENILL---DDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAG 382 (591)
T ss_pred cceeeccCChhheee---ccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcc
Confidence 999999999999999 78999999999999999888777777899999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 030430 165 YPPFSVGE 172 (177)
Q Consensus 165 ~~pf~~~~ 172 (177)
+.||....
T Consensus 383 ~sPFr~~K 390 (591)
T KOG0986|consen 383 HSPFRQRK 390 (591)
T ss_pred cCchhhhh
Confidence 99997754
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=197.44 Aligned_cols=160 Identities=31% Similarity=0.618 Sum_probs=140.5
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
..+.+.+|+.+++.++|||++++++++.....+++++||+++++|..++... .+++.++..++.+++.++++||+.|++
T Consensus 59 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~ 137 (296)
T cd06655 59 KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVI 137 (296)
T ss_pred hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 4567889999999999999999999999999999999999999999988743 689999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
|+||+|+||++ +.++.++++|||.+........ .....++..|+|||.+.+..++.++|+||+|++++++++|..|
T Consensus 138 H~dL~p~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~p 214 (296)
T cd06655 138 HRDIKSDNVLL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214 (296)
T ss_pred cCCCCHHHEEE---CCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999 4567899999998765543322 2233467789999999888889999999999999999999999
Q ss_pred CCCCC
Q 030430 168 FSVGE 172 (177)
Q Consensus 168 f~~~~ 172 (177)
|.+.+
T Consensus 215 f~~~~ 219 (296)
T cd06655 215 YLNEN 219 (296)
T ss_pred CCCCC
Confidence 97754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-31 Score=192.05 Aligned_cols=163 Identities=32% Similarity=0.556 Sum_probs=138.7
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
+..+..+.+|++++++++|||++++.+++...+..++++||+++++|.+++... ..+++..+..++.+++.++.++|+.
T Consensus 33 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 112 (250)
T cd05085 33 QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK 112 (250)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 344567889999999999999999999999999999999999999999998754 4588999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccc--cccCCCccccccccccCCCCCcchHHHHHHHHHHHHh
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~ 163 (177)
|++|+|++|+||++ +..+.++++|||.+.......... ....+..|+|||...+..++.++|+||+|++++++++
T Consensus 113 ~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~ 189 (250)
T cd05085 113 NCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFS 189 (250)
T ss_pred CeeecccChheEEE---cCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhc
Confidence 99999999999999 466789999999886543322111 1223456999999887888999999999999999998
Q ss_pred -CCCCCCCCC
Q 030430 164 -GYPPFSVGE 172 (177)
Q Consensus 164 -~~~pf~~~~ 172 (177)
|..||.+..
T Consensus 190 ~g~~p~~~~~ 199 (250)
T cd05085 190 LGVCPYPGMT 199 (250)
T ss_pred CCCCCCCCCC
Confidence 999997653
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-31 Score=195.85 Aligned_cols=163 Identities=33% Similarity=0.544 Sum_probs=138.0
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
....+.+.+|+++++.++|||++++.+.+..++.++++|||++|++|..++.+ ...+++..+..++.|++.++++||+.
T Consensus 50 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~ 129 (292)
T cd06644 50 EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM 129 (292)
T ss_pred HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence 44566788899999999999999999999999999999999999999887764 35689999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccc-----cCCCCCcchHHHHHHHHH
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILF 159 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~slg~~~~ 159 (177)
|++|+|++|+||++ +.++.++|+|||.+....... ......++..|+|||.+. ...++.++|+||+|+++|
T Consensus 130 ~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~ 206 (292)
T cd06644 130 KIIHRDLKAGNVLL---TLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLI 206 (292)
T ss_pred CeeecCCCcceEEE---cCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHH
Confidence 99999999999999 456789999999876543221 122344678899999874 334678899999999999
Q ss_pred HHHhCCCCCCCCC
Q 030430 160 ELLNGYPPFSVGE 172 (177)
Q Consensus 160 ~~~~~~~pf~~~~ 172 (177)
++++|..||...+
T Consensus 207 el~~g~~p~~~~~ 219 (292)
T cd06644 207 EMAQIEPPHHELN 219 (292)
T ss_pred HHhcCCCCCcccc
Confidence 9999999997643
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=223.66 Aligned_cols=164 Identities=34% Similarity=0.615 Sum_probs=149.0
Q ss_pred cchhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 5 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
++.....+|..|-.+|-.-+.+.|+.+...|+|..++|+||||++||+|-.++.+...++++.++.++..++.||..+|+
T Consensus 114 lKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~ 193 (1317)
T KOG0612|consen 114 LKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHS 193 (1317)
T ss_pred hhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHh
Confidence 45677788999999999999999999999999999999999999999999999988889999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--cccccCCCccccccccc----c-CCCCCcchHHHHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQ----F-QRYDEKVDMWSVGAI 157 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~----~-~~~~~~~Di~slg~~ 157 (177)
.|||||||||+|+++ +..|.++|.|||.+-+....+. .....|||.|++||++. + +.|++.+|-||+|++
T Consensus 194 mgyVHRDiKPDNvLl---d~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~ 270 (1317)
T KOG0612|consen 194 MGYVHRDIKPDNVLL---DKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVF 270 (1317)
T ss_pred ccceeccCCcceeEe---cccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHH
Confidence 999999999999999 6899999999999988764443 34567999999999874 2 458999999999999
Q ss_pred HHHHHhCCCCCCCC
Q 030430 158 LFELLNGYPPFSVG 171 (177)
Q Consensus 158 ~~~~~~~~~pf~~~ 171 (177)
+|||+.|.-||...
T Consensus 271 ~YEMlyG~TPFYad 284 (1317)
T KOG0612|consen 271 MYEMLYGETPFYAD 284 (1317)
T ss_pred HHHHHcCCCcchHH
Confidence 99999999999654
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=199.20 Aligned_cols=162 Identities=31% Similarity=0.537 Sum_probs=139.7
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
..+.+.+|+++++.++|++|+++++.+.++...++++||+.|++|.+++... ..+++..+..++.|++.+|+|||+.|
T Consensus 44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ 123 (316)
T cd05574 44 KVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG 123 (316)
T ss_pred HHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4567899999999999999999999999999999999999999999998754 45899999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc------------------------------cccccCCCcccc
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY------------------------------AEKVCGSPLYMA 136 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~------------------------------~~~~~~~~~~~~ 136 (177)
++|+||+|+||+++ .++.++|+|||.+........ .....++..|+|
T Consensus 124 i~H~dlkp~Nili~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~a 200 (316)
T cd05574 124 IVYRDLKPENILLH---ESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIA 200 (316)
T ss_pred eeccCCChHHeEEc---CCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcC
Confidence 99999999999994 567799999998765422110 011235778999
Q ss_pred ccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 030430 137 PEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 173 (177)
Q Consensus 137 pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf~~~~~ 173 (177)
||...+..++.++|+||+|++++++++|..||.+.+.
T Consensus 201 PE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 201 PEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred HHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 9999888889999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=193.79 Aligned_cols=162 Identities=22% Similarity=0.351 Sum_probs=134.7
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
.....+..|+.++++++||||+++++++.+....++++||+++++|..++... ..+++..+..++.|++.+++|||+.|
T Consensus 46 ~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 125 (262)
T cd05077 46 DISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD 125 (262)
T ss_pred hHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC
Confidence 34457888999999999999999999999988899999999999999988754 45899999999999999999999999
Q ss_pred CeeecCCCCcEEEecCC----CCeeEEEeeeccccccCCCCccccccCCCccccccccc-cCCCCCcchHHHHHHHHHHH
Q 030430 87 IIHRDLKPENILLSGLD----DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~----~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Di~slg~~~~~~ 161 (177)
++|+||+|+||++.... ....++++|||.+....... ...++..|+|||.+. +..++.++|+||+|+++|++
T Consensus 126 ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el 202 (262)
T cd05077 126 LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQ---ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202 (262)
T ss_pred eECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCcc---cccccccccChhhhcCCCCCCchhHHHHHHHHHHHH
Confidence 99999999999996321 12238999999876543222 233567899999876 45688899999999999999
Q ss_pred H-hCCCCCCCCC
Q 030430 162 L-NGYPPFSVGE 172 (177)
Q Consensus 162 ~-~~~~pf~~~~ 172 (177)
+ +|..||....
T Consensus 203 ~~~~~~p~~~~~ 214 (262)
T cd05077 203 CYNGEIPLKDKT 214 (262)
T ss_pred HhCCCCCCCCcc
Confidence 7 5888887643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=194.78 Aligned_cols=162 Identities=26% Similarity=0.503 Sum_probs=139.1
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
.....+.+|++++++++||||+++.+++..++..++++||+++++|.+++... ..++..++..++.|++.++++||+.|
T Consensus 47 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ 126 (267)
T cd05066 47 KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG 126 (267)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 44668899999999999999999999999999999999999999999999865 45899999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccc----cccCCCccccccccccCCCCCcchHHHHHHHHHHHH
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE----KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~----~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~ 162 (177)
++|+||+|+|+++ +.++.++++|||.+.......... ....+..|++||...+..++.++|+||+|+++++++
T Consensus 127 i~h~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell 203 (267)
T cd05066 127 YVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 203 (267)
T ss_pred EeehhhchhcEEE---CCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHh
Confidence 9999999999999 456789999999887654332111 111245799999998888999999999999999988
Q ss_pred h-CCCCCCCCC
Q 030430 163 N-GYPPFSVGE 172 (177)
Q Consensus 163 ~-~~~pf~~~~ 172 (177)
+ |..||...+
T Consensus 204 ~~g~~p~~~~~ 214 (267)
T cd05066 204 SYGERPYWEMS 214 (267)
T ss_pred cCCCCCcccCC
Confidence 6 999997654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=198.03 Aligned_cols=158 Identities=36% Similarity=0.564 Sum_probs=132.2
Q ss_pred HHHHHHHHHHhhC---CCCceeeEeEEEee-----CCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHH
Q 030430 11 SCLDCELNFLSSV---NHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLE 80 (177)
Q Consensus 11 ~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~ 80 (177)
....+|+++++.+ +||||+++++++.. ....++++|++. ++|.+++... ..+++..+..++.|++.|++
T Consensus 44 ~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~ 122 (288)
T cd07863 44 LSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122 (288)
T ss_pred hHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH
Confidence 3456677777665 79999999998764 345899999996 5898888754 34899999999999999999
Q ss_pred HHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHH
Q 030430 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (177)
Q Consensus 81 ~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~ 160 (177)
|+|+.|++|+||+|+||++ +..+.++|+|||.+.............++..|+|||.+.+..++.++|+||+|+++++
T Consensus 123 ~lH~~~ivH~dikp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ 199 (288)
T cd07863 123 FLHANCIVHRDLKPENILV---TSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAE 199 (288)
T ss_pred HHHhCCeecCCCCHHHEEE---CCCCCEEECccCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHH
Confidence 9999999999999999999 4667899999999876544433334457888999999988889999999999999999
Q ss_pred HHhCCCCCCCCC
Q 030430 161 LLNGYPPFSVGE 172 (177)
Q Consensus 161 ~~~~~~pf~~~~ 172 (177)
+++|.+||.+..
T Consensus 200 l~~g~~~f~~~~ 211 (288)
T cd07863 200 MFRRKPLFCGNS 211 (288)
T ss_pred HHhCCcCcCCCC
Confidence 999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=198.90 Aligned_cols=163 Identities=30% Similarity=0.513 Sum_probs=137.4
Q ss_pred hHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc----------------CCCCHHHHHH
Q 030430 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTARK 70 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~ 70 (177)
.....+.+|+++++++ +||||+++++++.+.+.+++++||+++++|.+++... ..++..++..
T Consensus 59 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 138 (314)
T cd05099 59 KDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138 (314)
T ss_pred HHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHH
Confidence 3456788999999999 6999999999999999999999999999999999753 2378889999
Q ss_pred HHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCCC
Q 030430 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDE 147 (177)
Q Consensus 71 ~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~ 147 (177)
++.|++.|++|||+.|++|+||+|+||+++ ..+.++|+|||.+........ .....++..|+|||.+.+..++.
T Consensus 139 ~~~qi~~aL~~lH~~gi~H~dlkp~Nill~---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 215 (314)
T cd05099 139 CAYQVARGMEYLESRRCIHRDLAARNVLVT---EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTH 215 (314)
T ss_pred HHHHHHHHHHHHHHCCeeeccccceeEEEc---CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCc
Confidence 999999999999999999999999999994 567899999999876543221 11112345699999988888899
Q ss_pred cchHHHHHHHHHHHHh-CCCCCCCCCc
Q 030430 148 KVDMWSVGAILFELLN-GYPPFSVGEE 173 (177)
Q Consensus 148 ~~Di~slg~~~~~~~~-~~~pf~~~~~ 173 (177)
++|+||+|++++++++ |..||.+.+.
T Consensus 216 ~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 216 QSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred cchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999 8899976543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=192.82 Aligned_cols=162 Identities=28% Similarity=0.621 Sum_probs=139.1
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEee-CCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
...+.+.+|++++++++|+|++++.+.+.. +..+++++|++++++|.+++... ..+++.++..++.+++.++++||+
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~ 120 (257)
T cd08223 41 RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE 120 (257)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 445678999999999999999999988764 45689999999999999998753 348999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~ 163 (177)
.|++|+||+|+||+++ ..+.++++|||.+....... ......+++.|+|||...+..++.++|+||+|++++++++
T Consensus 121 ~~i~H~di~p~nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~ 197 (257)
T cd08223 121 KHILHRDLKTQNVFLT---RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT 197 (257)
T ss_pred CCeeccCCCchhEEEe---cCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHc
Confidence 9999999999999994 66789999999886653322 2223446788999999988888999999999999999999
Q ss_pred CCCCCCCCC
Q 030430 164 GYPPFSVGE 172 (177)
Q Consensus 164 ~~~pf~~~~ 172 (177)
|+.||...+
T Consensus 198 g~~~~~~~~ 206 (257)
T cd08223 198 LKHAFNAKD 206 (257)
T ss_pred CCCCCCCCC
Confidence 999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-32 Score=194.66 Aligned_cols=162 Identities=26% Similarity=0.484 Sum_probs=140.0
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
....+.+|+++++.++|||++++.+++.+....++++||+++++|.+++... ..++...+..++.|++.++++||+.|
T Consensus 45 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~ 124 (261)
T cd05148 45 KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN 124 (261)
T ss_pred hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4567899999999999999999999999999999999999999999999753 35899999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccc-cccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-C
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-~ 164 (177)
++|+||+|+||++ +.++.++++|||.+.......... ...++..|++||......++.++|+||+|++++++++ |
T Consensus 125 i~h~dl~~~nilv---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g 201 (261)
T cd05148 125 SIHRDLAARNILV---GEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYG 201 (261)
T ss_pred eeccccCcceEEE---cCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCC
Confidence 9999999999999 467789999999887654332211 2224567999999887888999999999999999998 8
Q ss_pred CCCCCCCCc
Q 030430 165 YPPFSVGEE 173 (177)
Q Consensus 165 ~~pf~~~~~ 173 (177)
+.||.+.+.
T Consensus 202 ~~p~~~~~~ 210 (261)
T cd05148 202 QVPYPGMNN 210 (261)
T ss_pred CCCCCcCCH
Confidence 999976543
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=194.24 Aligned_cols=163 Identities=25% Similarity=0.502 Sum_probs=140.0
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
...+..+.+|+.++++++|||++++.+++...+..++++|++++++|.+++..+ +.++...+..++.|++.++++||+.
T Consensus 46 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~ 125 (266)
T cd05033 46 DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM 125 (266)
T ss_pred hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 445667889999999999999999999999999999999999999999998765 4689999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc---ccccCCCccccccccccCCCCCcchHHHHHHHHHHHH
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~ 162 (177)
|++|+||+|+||++ +..+.++++|||.+......... ....++..|+|||...+..++.++|+||+|+++++++
T Consensus 126 ~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~ 202 (266)
T cd05033 126 NYVHRDLAARNILV---NSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVM 202 (266)
T ss_pred CcccCCCCcceEEE---cCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHH
Confidence 99999999999999 46677999999998776422111 1122346799999998888999999999999999999
Q ss_pred h-CCCCCCCCC
Q 030430 163 N-GYPPFSVGE 172 (177)
Q Consensus 163 ~-~~~pf~~~~ 172 (177)
+ |..||....
T Consensus 203 ~~g~~p~~~~~ 213 (266)
T cd05033 203 SYGERPYWDMS 213 (266)
T ss_pred ccCCCCCCCCC
Confidence 8 999996543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=196.37 Aligned_cols=162 Identities=33% Similarity=0.571 Sum_probs=143.0
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-C
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-H 85 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~ 85 (177)
+.....+.+|+++++.++|||++++.+++.....+++++||+++++|.+++.+.+.++...+..++.+++.++.|||+ .
T Consensus 44 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 123 (284)
T cd06620 44 SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123 (284)
T ss_pred chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence 455678999999999999999999999999999999999999999999999887789999999999999999999997 5
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCC
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~ 165 (177)
|++|+||+|+||++ +..+.++++|||.+....... .....++..|+|||.+.+..++.++|+||+|++++++++|+
T Consensus 124 ~i~H~dl~p~nil~---~~~~~~~l~d~gl~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~ 199 (284)
T cd06620 124 RIMHRDIKPSNILV---NSRGQIKLCDFGVSGELINSI-ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199 (284)
T ss_pred CeeccCCCHHHEEE---CCCCcEEEccCCcccchhhhc-cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCC
Confidence 89999999999999 466789999999875542222 22345788999999988788899999999999999999999
Q ss_pred CCCCCCC
Q 030430 166 PPFSVGE 172 (177)
Q Consensus 166 ~pf~~~~ 172 (177)
.||....
T Consensus 200 ~p~~~~~ 206 (284)
T cd06620 200 FPFAFSN 206 (284)
T ss_pred CCCcccc
Confidence 9997644
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=195.35 Aligned_cols=160 Identities=28% Similarity=0.499 Sum_probs=135.7
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
....+..|+..++.++||||+++++++.. ...++++||+++++|.+++... ..+++..+..++.|++.+++|||+.|+
T Consensus 52 ~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 130 (279)
T cd05111 52 TFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRM 130 (279)
T ss_pred HHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 34567788889999999999999998764 4567899999999999999754 468999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~- 163 (177)
+|+||+|+||++ +.++.++++|||.+........ .....++..|++||...+..++.++|+||+|++++++++
T Consensus 131 iH~dlkp~nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~ 207 (279)
T cd05111 131 VHRNLAARNILL---KSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSY 207 (279)
T ss_pred eccccCcceEEE---cCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcC
Confidence 999999999999 4677899999999876543221 112335567999999988889999999999999999998
Q ss_pred CCCCCCCCC
Q 030430 164 GYPPFSVGE 172 (177)
Q Consensus 164 ~~~pf~~~~ 172 (177)
|..||.+..
T Consensus 208 g~~p~~~~~ 216 (279)
T cd05111 208 GAEPYAGMR 216 (279)
T ss_pred CCCCCCCCC
Confidence 999997754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-32 Score=196.58 Aligned_cols=163 Identities=26% Similarity=0.572 Sum_probs=138.1
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc----------------CCCCHHHHHHH
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTARKF 71 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~ 71 (177)
...+.+.+|++++++++||||+++++++......++++||+.+++|.+++... ..++...+..+
T Consensus 50 ~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 129 (283)
T cd05091 50 PLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129 (283)
T ss_pred HHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHH
Confidence 44677899999999999999999999999999999999999999999998532 23778889999
Q ss_pred HHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCCCc
Q 030430 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEK 148 (177)
Q Consensus 72 ~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~ 148 (177)
+.|++.|++|+|+.|++|+||||+||++. +...++++|||.+........ .....++..|+|||...+..++.+
T Consensus 130 ~~ql~~aL~~lH~~gi~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 206 (283)
T cd05091 130 VTQIAAGMEFLSSHHVVHKDLATRNVLVF---DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID 206 (283)
T ss_pred HHHHHHHHHHHHHcCccccccchhheEec---CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcc
Confidence 99999999999999999999999999994 566799999998876533221 122334568999999887889999
Q ss_pred chHHHHHHHHHHHHh-CCCCCCCCCc
Q 030430 149 VDMWSVGAILFELLN-GYPPFSVGEE 173 (177)
Q Consensus 149 ~Di~slg~~~~~~~~-~~~pf~~~~~ 173 (177)
+|+||+|++++++++ |..||.+...
T Consensus 207 ~Dv~slG~~l~el~~~g~~p~~~~~~ 232 (283)
T cd05091 207 SDIWSYGVVLWEVFSYGLQPYCGYSN 232 (283)
T ss_pred hhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999999998 8889877544
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-31 Score=193.45 Aligned_cols=145 Identities=30% Similarity=0.567 Sum_probs=128.4
Q ss_pred CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCC
Q 030430 24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD 103 (177)
Q Consensus 24 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~ 103 (177)
+|||++++++.+..++.++++|||+++++|.+++.....+++..+..++.|++.++++||+.|++|+||+|+||++. .
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~--~ 144 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD--R 144 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe--C
Confidence 79999999999999999999999999999999998777899999999999999999999999999999999999995 2
Q ss_pred CCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 030430 104 DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 173 (177)
Q Consensus 104 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf~~~~~ 173 (177)
..+.++++|||.+....... ...++..|+|||.+.+..++.++|+||+|++++++++|+.||....+
T Consensus 145 ~~~~~~l~dfg~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~ 211 (267)
T PHA03390 145 AKDRIYLCDYGLCKIIGTPS---CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED 211 (267)
T ss_pred CCCeEEEecCccceecCCCc---cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc
Confidence 23379999999886653322 23467889999999888889999999999999999999999975543
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=193.36 Aligned_cols=159 Identities=26% Similarity=0.507 Sum_probs=135.7
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEE-eeCCeEEEEEecCCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
..+.+.+|++++++++|++++++.+++ ..++..++++||+++++|.+++.+.. .+++..+..++.|++.++++||+.
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 121 (256)
T cd05082 42 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121 (256)
T ss_pred hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 355788999999999999999999875 45567899999999999999987643 388899999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-C
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-~ 164 (177)
|++|+||+|+||++ +.++.++++|||.+........ ....+..|+|||...+..++.++|+||+|++++++++ |
T Consensus 122 ~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g 196 (256)
T cd05082 122 NFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 196 (256)
T ss_pred CEeccccchheEEE---cCCCcEEecCCccceeccccCC--CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCC
Confidence 99999999999999 4677899999998865433221 2234567999999988888999999999999999998 9
Q ss_pred CCCCCCCC
Q 030430 165 YPPFSVGE 172 (177)
Q Consensus 165 ~~pf~~~~ 172 (177)
..||...+
T Consensus 197 ~~p~~~~~ 204 (256)
T cd05082 197 RVPYPRIP 204 (256)
T ss_pred CCCCCCCC
Confidence 99997644
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=197.56 Aligned_cols=163 Identities=30% Similarity=0.521 Sum_probs=138.3
Q ss_pred hHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc----------------CCCCHHHHHH
Q 030430 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTARK 70 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~ 70 (177)
...+.+.+|+++++.+ +||||+++++++......++++||+++++|.+++.+. ..++..++..
T Consensus 62 ~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (304)
T cd05101 62 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141 (304)
T ss_pred HHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHH
Confidence 4456789999999999 8999999999999999999999999999999999753 2367788899
Q ss_pred HHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCCC
Q 030430 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDE 147 (177)
Q Consensus 71 ~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~ 147 (177)
++.|++.|++|||+.|++|+||+|+||+++ ..+.++++|||.+........ .....++..|+|||...+..++.
T Consensus 142 ~~~qi~~al~~LH~~givH~dlkp~Nili~---~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 218 (304)
T cd05101 142 CTYQVARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 218 (304)
T ss_pred HHHHHHHHHHHHHHCCeeecccccceEEEc---CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCc
Confidence 999999999999999999999999999994 567899999999876643221 11222456799999998888899
Q ss_pred cchHHHHHHHHHHHHh-CCCCCCCCCc
Q 030430 148 KVDMWSVGAILFELLN-GYPPFSVGEE 173 (177)
Q Consensus 148 ~~Di~slg~~~~~~~~-~~~pf~~~~~ 173 (177)
++|+||+|++++++++ |..||.+.+.
T Consensus 219 ~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 219 QSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred hhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 9999999999999998 7888876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=198.96 Aligned_cols=161 Identities=28% Similarity=0.587 Sum_probs=140.1
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+.+.+|+.+++.++|+|++++++.+..++..++++||+++++|.+++. .+.+++..+..++.|++.++++||+.|+
T Consensus 61 ~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~i 139 (292)
T cd06658 61 QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGV 139 (292)
T ss_pred HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 445678899999999999999999999999999999999999999999876 4468999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
+|+||+|+||++ +.++.++++|||.+........ .....++..|+|||...+..++.++|+||+|++++++++|..
T Consensus 140 vH~dlkp~Nill---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~ 216 (292)
T cd06658 140 IHRDIKSDSILL---TSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP 216 (292)
T ss_pred eecCCCHHHEEE---cCCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999 4567899999998865432221 223457788999999988888999999999999999999999
Q ss_pred CCCCCC
Q 030430 167 PFSVGE 172 (177)
Q Consensus 167 pf~~~~ 172 (177)
||...+
T Consensus 217 p~~~~~ 222 (292)
T cd06658 217 PYFNEP 222 (292)
T ss_pred CCCCCC
Confidence 997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-31 Score=196.74 Aligned_cols=164 Identities=27% Similarity=0.533 Sum_probs=138.2
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-----------CCCHHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----------RVPEQTARKFLQQL 75 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~i 75 (177)
....+.+.+|+++++.++|+|++++++++...+..++++||+++++|.+++.... .++..++..++.|+
T Consensus 60 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 139 (296)
T cd05095 60 KNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQI 139 (296)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHH
Confidence 3446788999999999999999999999999999999999999999999987542 26677899999999
Q ss_pred HHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCCCcchHH
Q 030430 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMW 152 (177)
Q Consensus 76 ~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~ 152 (177)
+.|+++||+.|++|+||+|+||+++ ..+.++++|||.+........ ......+..|++||......++.++|+|
T Consensus 140 ~~al~~lH~~~i~H~dlkp~Nili~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Diw 216 (296)
T cd05095 140 ASGMKYLSSLNFVHRDLATRNCLVG---KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVW 216 (296)
T ss_pred HHHHHHHHHCCeecccCChheEEEc---CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhh
Confidence 9999999999999999999999994 567899999999876543321 1122235679999988777889999999
Q ss_pred HHHHHHHHHHh--CCCCCCCCCc
Q 030430 153 SVGAILFELLN--GYPPFSVGEE 173 (177)
Q Consensus 153 slg~~~~~~~~--~~~pf~~~~~ 173 (177)
|+|++++++++ |..||...+.
T Consensus 217 SlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 217 AFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred HHHHHHHHHHHhCCCCCccccCh
Confidence 99999999998 7788876543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-31 Score=194.61 Aligned_cols=163 Identities=26% Similarity=0.423 Sum_probs=138.9
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
+.....+.+|+++++.++|||++++++++.. ...++++||+++++|.+++... ..+++..+..++.|++.+++|||+.
T Consensus 50 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~ 128 (279)
T cd05057 50 PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK 128 (279)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3456778899999999999999999999887 7789999999999999999865 4589999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccc---cccCCCccccccccccCCCCCcchHHHHHHHHHHHH
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE---KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~---~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~ 162 (177)
|++|+||+|+||++ +..+.++|+|||.+.......... ....+..|++||......++.++|+||+|+++++++
T Consensus 129 ~i~H~di~p~nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~ 205 (279)
T cd05057 129 RLVHRDLAARNVLV---KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELM 205 (279)
T ss_pred CEEecccCcceEEE---cCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHh
Confidence 99999999999999 456779999999987654332111 111245799999988778899999999999999999
Q ss_pred h-CCCCCCCCCc
Q 030430 163 N-GYPPFSVGEE 173 (177)
Q Consensus 163 ~-~~~pf~~~~~ 173 (177)
+ |..||.+...
T Consensus 206 ~~g~~p~~~~~~ 217 (279)
T cd05057 206 TFGAKPYEGIPA 217 (279)
T ss_pred cCCCCCCCCCCH
Confidence 8 9999987543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=197.95 Aligned_cols=163 Identities=31% Similarity=0.528 Sum_probs=137.7
Q ss_pred hHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC----------------CCCHHHHHH
Q 030430 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARK 70 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~ 70 (177)
.....+.+|+++++.+ +|||++++.+++...+..++++||+++++|.+++.... .++..++..
T Consensus 65 ~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 144 (307)
T cd05098 65 KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144 (307)
T ss_pred HHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHH
Confidence 3445788899999999 79999999999999999999999999999999997542 378889999
Q ss_pred HHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCCC
Q 030430 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDE 147 (177)
Q Consensus 71 ~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~ 147 (177)
++.|++.++++||+.|++|+||+|+||+++ ..+.++|+|||.+........ .....++..|+|||...+..++.
T Consensus 145 ~~~qi~~aL~~lH~~gi~H~dlkp~Nill~---~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 221 (307)
T cd05098 145 CAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH 221 (307)
T ss_pred HHHHHHHHHHHHHHCCcccccccHHheEEc---CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCc
Confidence 999999999999999999999999999994 567899999998866533221 11112345799999998888899
Q ss_pred cchHHHHHHHHHHHHh-CCCCCCCCCc
Q 030430 148 KVDMWSVGAILFELLN-GYPPFSVGEE 173 (177)
Q Consensus 148 ~~Di~slg~~~~~~~~-~~~pf~~~~~ 173 (177)
++|+||+|++++++++ |..||.+...
T Consensus 222 ~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 222 QSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 9999999999999998 8899976544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=193.75 Aligned_cols=164 Identities=26% Similarity=0.468 Sum_probs=139.3
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
....+.+.+|++++++++|||++++.+++.+.+..+++|||+++++|.+++... +.++..++..++.|++.+++++|+.
T Consensus 47 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~ 126 (268)
T cd05063 47 EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM 126 (268)
T ss_pred HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 334567899999999999999999999999999999999999999999998754 4689999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccc----cccCCCccccccccccCCCCCcchHHHHHHHHHHH
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE----KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~----~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~ 161 (177)
|++|+|++|+||+++ .+..++++|||.+.......... ....+..|++||...+..++.++|+||+|++++++
T Consensus 127 ~i~H~dlkp~Nili~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~el 203 (268)
T cd05063 127 NYVHRDLAARNILVN---SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEV 203 (268)
T ss_pred CeeccccchhhEEEc---CCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHH
Confidence 999999999999994 56779999999886553322111 11123469999998877889999999999999999
Q ss_pred Hh-CCCCCCCCCc
Q 030430 162 LN-GYPPFSVGEE 173 (177)
Q Consensus 162 ~~-~~~pf~~~~~ 173 (177)
++ |..||...+.
T Consensus 204 l~~g~~p~~~~~~ 216 (268)
T cd05063 204 MSFGERPYWDMSN 216 (268)
T ss_pred HhCCCCCCCcCCH
Confidence 97 9999976543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=196.48 Aligned_cols=160 Identities=32% Similarity=0.570 Sum_probs=140.0
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+.+.+|+++++.++|||++++.+++..+...++|+||+++++|.+++.. ..+++..+..++.|++.++.|||+.|+
T Consensus 44 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i 122 (277)
T cd06642 44 DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERK 122 (277)
T ss_pred HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCe
Confidence 4456789999999999999999999999999999999999999999998864 468999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
+|+||+|+||+++ ..+.++++|||.+........ .....++..|+|||...+..++.++|+||+|++++++++|+.
T Consensus 123 vH~dl~p~ni~i~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~ 199 (277)
T cd06642 123 IHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEP 199 (277)
T ss_pred eccCCChheEEEe---CCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCC
Confidence 9999999999994 567799999998866543322 122346778999999988888999999999999999999999
Q ss_pred CCCCC
Q 030430 167 PFSVG 171 (177)
Q Consensus 167 pf~~~ 171 (177)
||...
T Consensus 200 p~~~~ 204 (277)
T cd06642 200 PNSDL 204 (277)
T ss_pred CCccc
Confidence 99654
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=195.71 Aligned_cols=162 Identities=33% Similarity=0.563 Sum_probs=141.1
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
+.....+.+|++++++++|+|++++.+++.+++..++++||++++.+..+..+...+++..+..++.|++.++++||+.|
T Consensus 41 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 120 (288)
T cd07833 41 EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN 120 (288)
T ss_pred ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34567899999999999999999999999999999999999988777776666667999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC--ccccccCCCccccccccccC-CCCCcchHHHHHHHHHHHHh
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~ 163 (177)
++|+|++|+||++ +..+.++++|||.+....... ......++..|+|||...+. .++.++|+||+|++++++++
T Consensus 121 i~H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~ 197 (288)
T cd07833 121 IIHRDIKPENILV---SESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197 (288)
T ss_pred eecCCCCHHHeEE---CCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHh
Confidence 9999999999999 467789999999987654433 22234467789999998777 78899999999999999999
Q ss_pred CCCCCCCC
Q 030430 164 GYPPFSVG 171 (177)
Q Consensus 164 ~~~pf~~~ 171 (177)
|..||.+.
T Consensus 198 g~~~~~~~ 205 (288)
T cd07833 198 GEPLFPGD 205 (288)
T ss_pred CCCCCCCC
Confidence 99999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=192.16 Aligned_cols=162 Identities=35% Similarity=0.565 Sum_probs=145.1
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-CC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-HH 86 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~ 86 (177)
...+.+.+|++.+.+++|+|++++.+++......++++||+++++|.+++.....+++..+..++.|++.+++++|+ .|
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~ 120 (264)
T cd06623 41 EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH 120 (264)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC
Confidence 45788999999999999999999999999999999999999999999999877889999999999999999999999 99
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccc-cccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCC
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~ 165 (177)
++|+|++|+||++ +..+.++|+|||.+.......... ...++..|+|||...+..++.++|+||||++++++++|.
T Consensus 121 ~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~ 197 (264)
T cd06623 121 IIHRDIKPSNLLI---NSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGK 197 (264)
T ss_pred CccCCCCHHHEEE---CCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999 467789999999887664433322 345678899999998888899999999999999999999
Q ss_pred CCCCCCC
Q 030430 166 PPFSVGE 172 (177)
Q Consensus 166 ~pf~~~~ 172 (177)
.||....
T Consensus 198 ~p~~~~~ 204 (264)
T cd06623 198 FPFLPPG 204 (264)
T ss_pred CCCcccc
Confidence 9997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-31 Score=191.83 Aligned_cols=162 Identities=31% Similarity=0.595 Sum_probs=140.6
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc----CCCCHHHHHHHHHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEIL 82 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~l 82 (177)
......+.+|++++++++|++++++++++.+++..++++||+++++|.+++... ..+++.++..++.+++.++++|
T Consensus 43 ~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~l 122 (267)
T cd08224 43 AKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHM 122 (267)
T ss_pred hhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHH
Confidence 344678999999999999999999999999999999999999999999988642 3489999999999999999999
Q ss_pred hhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccCCCCCcchHHHHHHHHHHH
Q 030430 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 83 h~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~ 161 (177)
|+.|++|+||+|+||++ +..+.++++|||.+........ .....++..|.|||...+..++.++|+||+|++++++
T Consensus 123 h~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l 199 (267)
T cd08224 123 HSKRIMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199 (267)
T ss_pred HhCCEecCCcChhhEEE---CCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHH
Confidence 99999999999999999 4567799999998865543321 2234467889999998888889999999999999999
Q ss_pred HhCCCCCCCC
Q 030430 162 LNGYPPFSVG 171 (177)
Q Consensus 162 ~~~~~pf~~~ 171 (177)
++|+.||...
T Consensus 200 ~~g~~p~~~~ 209 (267)
T cd08224 200 AALQSPFYGD 209 (267)
T ss_pred HHCCCCcccC
Confidence 9999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=194.31 Aligned_cols=160 Identities=24% Similarity=0.465 Sum_probs=135.5
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+.+|+++++.++|||++++.+++.. ...++++||+++++|.+++.+. ..++...+..++.|++.+|+++|+.|+
T Consensus 45 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i 123 (262)
T cd05071 45 PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 123 (262)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 4578999999999999999999998754 4578999999999999999753 348899999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc--ccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-C
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-~ 164 (177)
+|+||+|+||+++ ..+.++|+|||.+......... ....++..|++||...+..++.++|+||+|++++++++ |
T Consensus 124 ~H~dl~p~Nill~---~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g 200 (262)
T cd05071 124 VHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 200 (262)
T ss_pred cccccCcccEEEc---CCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCC
Confidence 9999999999994 5677999999988665433221 12234567999999888889999999999999999999 8
Q ss_pred CCCCCCCCc
Q 030430 165 YPPFSVGEE 173 (177)
Q Consensus 165 ~~pf~~~~~ 173 (177)
..||.+...
T Consensus 201 ~~p~~~~~~ 209 (262)
T cd05071 201 RVPYPGMVN 209 (262)
T ss_pred CCCCCCCCh
Confidence 889976543
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-31 Score=192.52 Aligned_cols=159 Identities=36% Similarity=0.598 Sum_probs=138.7
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
.+.+.+|++++++++|||++++++++......++++||+++++|.+++.....+++..+..++.|++.++.+||+.|++|
T Consensus 52 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H 131 (272)
T cd06629 52 VKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILH 131 (272)
T ss_pred HHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeee
Confidence 45688899999999999999999999999999999999999999999988778999999999999999999999999999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeeccccccCCCC---ccccccCCCccccccccccCC--CCCcchHHHHHHHHHHHHhC
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQR--YDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~--~~~~~Di~slg~~~~~~~~~ 164 (177)
+||+|+||++ +.++.++++|||.+....... ......++..|++||...... ++.++|+||+|++++++++|
T Consensus 132 ~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g 208 (272)
T cd06629 132 RDLKADNLLV---DADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAG 208 (272)
T ss_pred cCCChhhEEE---cCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhC
Confidence 9999999999 467789999999886543221 122334677899999886544 78899999999999999999
Q ss_pred CCCCCCC
Q 030430 165 YPPFSVG 171 (177)
Q Consensus 165 ~~pf~~~ 171 (177)
..||...
T Consensus 209 ~~p~~~~ 215 (272)
T cd06629 209 RRPWSDE 215 (272)
T ss_pred CCCCcCc
Confidence 9999643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-33 Score=210.05 Aligned_cols=167 Identities=28% Similarity=0.537 Sum_probs=147.6
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh 83 (177)
+++.++.|.+|+++|.+++||||+.+.+++..++.+++++||+++|+|.+++..+. ...-....+|++||+.+++||.
T Consensus 575 ~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe 654 (807)
T KOG1094|consen 575 TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE 654 (807)
T ss_pred chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH
Confidence 45668899999999999999999999999999999999999999999999999883 3456677789999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc---ccccCCCccccccccccCCCCCcchHHHHHHHHHH
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~ 160 (177)
+.++||||+.+.|+++ ++.+.+|++|||+++....++.- .......+|+|+|.+..++++.++|+|++|+++||
T Consensus 655 s~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE 731 (807)
T KOG1094|consen 655 SLNFVHRDLATRNCLV---DGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 731 (807)
T ss_pred hhchhhccccccceee---cCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHH
Confidence 9999999999999999 68899999999999877665532 23445688999999998999999999999999999
Q ss_pred HHh--CCCCCCCCCccc
Q 030430 161 LLN--GYPPFSVGEEHQ 175 (177)
Q Consensus 161 ~~~--~~~pf~~~~~~~ 175 (177)
+++ .+.||+.-++++
T Consensus 732 ~~~~C~e~Py~~lt~e~ 748 (807)
T KOG1094|consen 732 VFMLCREQPYSQLTDEQ 748 (807)
T ss_pred HHHHHhhCchhhhhHHH
Confidence 876 678998776654
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=193.06 Aligned_cols=161 Identities=27% Similarity=0.474 Sum_probs=133.2
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHh
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----RVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lh 83 (177)
....+.+|+.++++++|||++++++++.+....+++|||+++++|.+++.... ..+...+..++.|++.+++|||
T Consensus 38 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH 117 (269)
T cd05087 38 EQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH 117 (269)
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH
Confidence 34578889999999999999999999998889999999999999999987432 3566778889999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccC-------CCCCcchHHH
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQ-------RYDEKVDMWS 153 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~-------~~~~~~Di~s 153 (177)
+.|++|+||+|+||+++ ....++++|||.+........ .....++..|+|||.+... .++.++|+||
T Consensus 118 ~~~i~H~dlkp~nil~~---~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws 194 (269)
T cd05087 118 KNNFIHSDLALRNCLLT---ADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWS 194 (269)
T ss_pred HCCEeccccCcceEEEc---CCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHH
Confidence 99999999999999994 567799999998865433221 1123356779999987532 3578999999
Q ss_pred HHHHHHHHHh-CCCCCCCCC
Q 030430 154 VGAILFELLN-GYPPFSVGE 172 (177)
Q Consensus 154 lg~~~~~~~~-~~~pf~~~~ 172 (177)
+|++++++++ |..||...+
T Consensus 195 lG~~l~el~~~g~~p~~~~~ 214 (269)
T cd05087 195 LGVTIWELFELGSQPYRHLS 214 (269)
T ss_pred HHHHHHHHHhCCCCCCCCCC
Confidence 9999999996 999997654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=196.34 Aligned_cols=163 Identities=27% Similarity=0.525 Sum_probs=137.5
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC------------CCCHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG------------RVPEQTARKFLQQ 74 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~ 74 (177)
...++.+.+|++++++++|+|++++++++...+..+++|||+++++|.+++.... .++...+..++.|
T Consensus 58 ~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 137 (295)
T cd05097 58 KTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQ 137 (295)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHH
Confidence 3445678999999999999999999999999999999999999999999986432 3678889999999
Q ss_pred HHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCCCcchH
Q 030430 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDM 151 (177)
Q Consensus 75 i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di 151 (177)
++.+++|||+.|++|+||+|+||+++ ..+.++++|||.+........ .....++..|+|||...+..++.++|+
T Consensus 138 i~~al~~lH~~~i~H~dlkp~Nill~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 214 (295)
T cd05097 138 IASGMKYLASLNFVHRDLATRNCLVG---NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDV 214 (295)
T ss_pred HHHHHHHHHhcCeeccccChhhEEEc---CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhH
Confidence 99999999999999999999999994 566799999998866533221 112234567999999888889999999
Q ss_pred HHHHHHHHHHHh--CCCCCCCCC
Q 030430 152 WSVGAILFELLN--GYPPFSVGE 172 (177)
Q Consensus 152 ~slg~~~~~~~~--~~~pf~~~~ 172 (177)
||||++++++++ +..||...+
T Consensus 215 wSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 215 WAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred HHHHHHHHHHHHcCCCCCCcccC
Confidence 999999999998 567887644
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=193.47 Aligned_cols=165 Identities=30% Similarity=0.517 Sum_probs=138.6
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-------CCCCHHHHHHHHHHHHHHHH
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-------GRVPEQTARKFLQQLGAGLE 80 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~ 80 (177)
.....+.+|+++++.++||||+++++++.+....++++||+++++|.+++... ..++..++..++.|++.+++
T Consensus 41 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 120 (269)
T cd05044 41 QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120 (269)
T ss_pred hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHH
Confidence 45677889999999999999999999999999999999999999999998742 23788999999999999999
Q ss_pred HHhhCCCeeecCCCCcEEEecCC--CCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCCCcchHHHHH
Q 030430 81 ILNSHHIIHRDLKPENILLSGLD--DDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVG 155 (177)
Q Consensus 81 ~lh~~~~~H~~i~~~nil~~~~~--~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg 155 (177)
|||+.+++|+|++|+||++...+ ....++++|||.+........ .....++..|+|||.+.+..++.++|+||||
T Consensus 121 ~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG 200 (269)
T cd05044 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFG 200 (269)
T ss_pred HHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHH
Confidence 99999999999999999996322 223799999998865533221 1122345789999999888899999999999
Q ss_pred HHHHHHHh-CCCCCCCCC
Q 030430 156 AILFELLN-GYPPFSVGE 172 (177)
Q Consensus 156 ~~~~~~~~-~~~pf~~~~ 172 (177)
++++++++ |..||...+
T Consensus 201 ~il~ellt~g~~p~~~~~ 218 (269)
T cd05044 201 VLMWEILTLGQQPYPALN 218 (269)
T ss_pred HHHHHHHHcCCCCCcccC
Confidence 99999998 999997543
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=194.73 Aligned_cols=160 Identities=32% Similarity=0.532 Sum_probs=135.8
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---GRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
....+.+|++++++++|||++++++++.++...++|+||++ ++|.+++... ..+++..+..++.|++.||+|||+.
T Consensus 42 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~ 120 (285)
T cd07861 42 VPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120 (285)
T ss_pred chHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC
Confidence 34678899999999999999999999999999999999996 5888887643 3589999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccC-CCCCcchHHHHHHHHHHHHh
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~ 163 (177)
|++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||.+.+. .++.++|+||+|++++++++
T Consensus 121 ~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~t 197 (285)
T cd07861 121 RVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197 (285)
T ss_pred CeeecCCCHHHEEE---cCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHH
Confidence 99999999999999 4677899999998865533221 1223457789999987643 46889999999999999999
Q ss_pred CCCCCCCCC
Q 030430 164 GYPPFSVGE 172 (177)
Q Consensus 164 ~~~pf~~~~ 172 (177)
|+.||.+..
T Consensus 198 g~~~~~~~~ 206 (285)
T cd07861 198 KKPLFHGDS 206 (285)
T ss_pred CCCCCCCCC
Confidence 999997653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=194.81 Aligned_cols=162 Identities=24% Similarity=0.470 Sum_probs=138.7
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC---------CCCHHHHHHHHHHHHHHH
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---------RVPEQTARKFLQQLGAGL 79 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l 79 (177)
..+.+.+|++++++++|+|++++++++.+.+..++++||+++++|.+++.... .+++..+..++.|++.+|
T Consensus 51 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l 130 (275)
T cd05046 51 LQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130 (275)
T ss_pred HHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHH
Confidence 45679999999999999999999999999899999999999999999998655 689999999999999999
Q ss_pred HHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC--ccccccCCCccccccccccCCCCCcchHHHHHHH
Q 030430 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAI 157 (177)
Q Consensus 80 ~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~ 157 (177)
+|||+.|++|+||+|+||++. ..+.++++||+.+....... ......++..|++||...+..++.++|+||+|++
T Consensus 131 ~~LH~~~i~H~dlkp~Nili~---~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~ 207 (275)
T cd05046 131 DHLSNARFVHRDLAARNCLVS---SQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVL 207 (275)
T ss_pred HHhhhcCcccCcCccceEEEe---CCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHH
Confidence 999999999999999999994 56678999999875443221 1112234567999999887788899999999999
Q ss_pred HHHHHh-CCCCCCCCCc
Q 030430 158 LFELLN-GYPPFSVGEE 173 (177)
Q Consensus 158 ~~~~~~-~~~pf~~~~~ 173 (177)
++++++ |..||....+
T Consensus 208 l~~l~~~~~~p~~~~~~ 224 (275)
T cd05046 208 MWEVFTQGELPFYGLSD 224 (275)
T ss_pred HHHHHhCCCCCccccch
Confidence 999998 7889976443
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=194.88 Aligned_cols=163 Identities=38% Similarity=0.660 Sum_probs=142.5
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
.....+.+|+++++.++|||++++.+.+......++++|++++++|.+++...+.+++..+..++.|++.+|++||+.|+
T Consensus 35 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i 114 (265)
T cd05579 35 NQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGI 114 (265)
T ss_pred hHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCe
Confidence 45678899999999999999999999999999999999999999999999877789999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC---------ccccccCCCccccccccccCCCCCcchHHHHHHHH
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---------~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~ 158 (177)
+|+||+|+||++ +..+.++++|||.+....... ......++..|++||.......+.++|+||+|+++
T Consensus 115 ~H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~ 191 (265)
T cd05579 115 IHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCIL 191 (265)
T ss_pred ecCCCCHHHeEE---cCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHH
Confidence 999999999999 466789999999876543321 11223467789999998877788999999999999
Q ss_pred HHHHhCCCCCCCCCc
Q 030430 159 FELLNGYPPFSVGEE 173 (177)
Q Consensus 159 ~~~~~~~~pf~~~~~ 173 (177)
+++++|..||.....
T Consensus 192 ~~l~~g~~p~~~~~~ 206 (265)
T cd05579 192 YEFLVGIPPFHGETP 206 (265)
T ss_pred HHHHhCCCCCCCCCH
Confidence 999999999976543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-31 Score=191.67 Aligned_cols=162 Identities=33% Similarity=0.521 Sum_probs=137.5
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCC--CHHHHHHHHHHHHHHHHHHhh
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRV--PEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~--~~~~~~~~~~~i~~~l~~lh~ 84 (177)
...+.+.+|++++++++|+||+++++++..++..++++||+++++|.+++... ..+ ++..+..++.|++.++++||+
T Consensus 47 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~ 126 (268)
T cd06624 47 RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD 126 (268)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH
Confidence 35567899999999999999999999999999999999999999999998854 345 788899999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccCC--CCCcchHHHHHHHHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQR--YDEKVDMWSVGAILFEL 161 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~--~~~~~Di~slg~~~~~~ 161 (177)
.|++|+||+|+||+++ ...+.++|+|||.+........ .....++..|+|||...... ++.++|+||+|++++++
T Consensus 127 ~~i~h~dl~p~nil~~--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l 204 (268)
T cd06624 127 NQIVHRDIKGDNVLVN--TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEM 204 (268)
T ss_pred CCEeecCCCHHHEEEc--CCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHH
Confidence 9999999999999995 2356799999998866533222 22334678899999876543 68899999999999999
Q ss_pred HhCCCCCCCC
Q 030430 162 LNGYPPFSVG 171 (177)
Q Consensus 162 ~~~~~pf~~~ 171 (177)
++|..||...
T Consensus 205 ~~g~~p~~~~ 214 (268)
T cd06624 205 ATGKPPFIEL 214 (268)
T ss_pred HhCCCCCccc
Confidence 9999999653
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-33 Score=207.28 Aligned_cols=164 Identities=32% Similarity=0.576 Sum_probs=147.6
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
+.....+++|+.+|.+++++||.++++.+..+..++++|||+.||++.+.++....+.+..+..++.+++.++.|+|.++
T Consensus 52 ~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~ 131 (467)
T KOG0201|consen 52 EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK 131 (467)
T ss_pred chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc
Confidence 34456789999999999999999999999999999999999999999999987766799999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCC
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~ 165 (177)
.+|+||++.||++. ..+.++|+|||.+........ ..+..||+.|||||++....|+.++||||||++.+||++|.
T Consensus 132 kiHrDIKaanil~s---~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~Ge 208 (467)
T KOG0201|consen 132 KIHRDIKAANILLS---ESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGE 208 (467)
T ss_pred eecccccccceeEe---ccCcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCC
Confidence 99999999999996 458899999999977655433 35667999999999999889999999999999999999999
Q ss_pred CCCCCCCc
Q 030430 166 PPFSVGEE 173 (177)
Q Consensus 166 ~pf~~~~~ 173 (177)
+|+....+
T Consensus 209 PP~s~~hP 216 (467)
T KOG0201|consen 209 PPHSKLHP 216 (467)
T ss_pred CCCcccCc
Confidence 99987654
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=198.85 Aligned_cols=160 Identities=28% Similarity=0.567 Sum_probs=139.8
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
..+.+.+|+.+++.++|||++++++++..+...++++||+++++|.+++.. ..+++..+..++.|++.++++||+.|++
T Consensus 61 ~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iv 139 (297)
T cd06659 61 RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVI 139 (297)
T ss_pred hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 456788999999999999999999999999999999999999999997764 5689999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
|+||+|+||++ +..+.++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|++++++++|+.|
T Consensus 140 H~dl~p~Nill---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p 216 (297)
T cd06659 140 HRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216 (297)
T ss_pred cCCCCHHHeEE---ccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999 4677899999998865433221 2234577889999999888889999999999999999999999
Q ss_pred CCCCC
Q 030430 168 FSVGE 172 (177)
Q Consensus 168 f~~~~ 172 (177)
|...+
T Consensus 217 ~~~~~ 221 (297)
T cd06659 217 YFSDS 221 (297)
T ss_pred CCCCC
Confidence 96543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-33 Score=215.60 Aligned_cols=162 Identities=34% Similarity=0.569 Sum_probs=144.0
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCC--CHHHHHHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRV--PEQTARKFLQQLGAGLEIL 82 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~--~~~~~~~~~~~i~~~l~~l 82 (177)
+....+-+..|+.+-++|+|.|||+++|.+..++++-|.||-++||+|.++++.. +++ ++.++..+.+||+++|+||
T Consensus 612 dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYL 691 (1226)
T KOG4279|consen 612 DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYL 691 (1226)
T ss_pred cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhh
Confidence 3444566889999999999999999999999999999999999999999999854 777 8999999999999999999
Q ss_pred hhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccC--CCCCcchHHHHHHHHH
Q 030430 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ--RYDEKVDMWSVGAILF 159 (177)
Q Consensus 83 h~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~--~~~~~~Di~slg~~~~ 159 (177)
|+..|||||||-+|+++. .-++.+|++|||-+++...-+ -+.+..||..|||||.+..+ +|+.+.||||+||++.
T Consensus 692 Hen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~v 769 (1226)
T KOG4279|consen 692 HENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMV 769 (1226)
T ss_pred hhcceeeccccCCcEEEe--eccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeE
Confidence 999999999999999997 457889999999998875433 34456799999999999755 4789999999999999
Q ss_pred HHHhCCCCCC
Q 030430 160 ELLNGYPPFS 169 (177)
Q Consensus 160 ~~~~~~~pf~ 169 (177)
||+||++||-
T Consensus 770 EMATGrPPF~ 779 (1226)
T KOG4279|consen 770 EMATGRPPFV 779 (1226)
T ss_pred eeccCCCCee
Confidence 9999999994
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=201.94 Aligned_cols=162 Identities=27% Similarity=0.516 Sum_probs=141.0
Q ss_pred ccchhHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCC-CCHHHHHHHHHHHHHHHHH
Q 030430 4 KLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGAGLEI 81 (177)
Q Consensus 4 ~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~ 81 (177)
..+.+..+-+.+|+.+|.+| .|.+|+++++|-..++.+|||||+- ..+|.+++++... .+.-.+..+.+|++.++.+
T Consensus 397 ~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~ 475 (677)
T KOG0596|consen 397 EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKT 475 (677)
T ss_pred hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHH
Confidence 34778889999999999999 6899999999999999999999976 7899999986644 4446888999999999999
Q ss_pred HhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC---ccccccCCCccccccccccCC-----------CCC
Q 030430 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQR-----------YDE 147 (177)
Q Consensus 82 lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~-----------~~~ 147 (177)
+|..||||.|+||.|+++ ..+.+||+|||.+.....+. ......||.-||+||.+.... .++
T Consensus 476 IH~~gIVHSDLKPANFLl----VkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r 551 (677)
T KOG0596|consen 476 IHQHGIVHSDLKPANFLL----VKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISR 551 (677)
T ss_pred HHHhceeecCCCcccEEE----EeeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecC
Confidence 999999999999999997 57889999999998887654 334577999999999875322 457
Q ss_pred cchHHHHHHHHHHHHhCCCCCCC
Q 030430 148 KVDMWSVGAILFELLNGYPPFSV 170 (177)
Q Consensus 148 ~~Di~slg~~~~~~~~~~~pf~~ 170 (177)
++|||||||++|+|+-|+.||..
T Consensus 552 ~SDvWSLGCILYqMvYgktPf~~ 574 (677)
T KOG0596|consen 552 KSDVWSLGCILYQMVYGKTPFGQ 574 (677)
T ss_pred ccchhhhhhHHHHHHhcCCchHH
Confidence 89999999999999999999964
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-31 Score=193.64 Aligned_cols=161 Identities=29% Similarity=0.586 Sum_probs=140.3
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+.+.+|+.+++.++|||++++++++..+...++++||++|++|.+++.. ..++...+..++.|++.++++||+.|+
T Consensus 58 ~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i 136 (285)
T cd06648 58 QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGV 136 (285)
T ss_pred hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 3456688999999999999999999999999999999999999999999886 578999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
+|+||+|+||++ +.++.++++|||.+........ .....++..|+|||...+..++.++|+||+|++++++++|+.
T Consensus 137 ~H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~ 213 (285)
T cd06648 137 IHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEP 213 (285)
T ss_pred ecCCCChhhEEE---cCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCC
Confidence 999999999999 4677899999998765433221 223447788999999887788999999999999999999999
Q ss_pred CCCCCC
Q 030430 167 PFSVGE 172 (177)
Q Consensus 167 pf~~~~ 172 (177)
||...+
T Consensus 214 p~~~~~ 219 (285)
T cd06648 214 PYFNEP 219 (285)
T ss_pred CCcCCC
Confidence 986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=194.25 Aligned_cols=161 Identities=34% Similarity=0.636 Sum_probs=141.5
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
....+.+|++.+++++|+|++++.+.+......++++||++|++|.+++.... .++...+..++.|++.++++||+.|+
T Consensus 58 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi 137 (286)
T cd06614 58 NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNV 137 (286)
T ss_pred hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 36778999999999999999999999999999999999999999999999776 79999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
+|+|++|+||++ +..+.++++|||.+........ .....++..|++||.+.+..++.++|+||+|++++++++|..
T Consensus 138 ~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~ 214 (286)
T cd06614 138 IHRDIKSDNILL---SKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEP 214 (286)
T ss_pred eeCCCChhhEEE---cCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCC
Confidence 999999999999 4567799999998765433221 123346778999999888888999999999999999999999
Q ss_pred CCCCCC
Q 030430 167 PFSVGE 172 (177)
Q Consensus 167 pf~~~~ 172 (177)
||...+
T Consensus 215 p~~~~~ 220 (286)
T cd06614 215 PYLREP 220 (286)
T ss_pred CCCCCC
Confidence 997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=206.34 Aligned_cols=155 Identities=25% Similarity=0.387 Sum_probs=133.8
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
...+.+|++++++++|+||+++++++..++..+++++++ .++|..++... ..++..++..++.|++.+|+|||+.|++
T Consensus 204 ~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIv 282 (461)
T PHA03211 204 YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGII 282 (461)
T ss_pred ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 345678999999999999999999999999999999999 56888887654 4599999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~ 165 (177)
|+||||+||++ +..+.++|+|||++........ .....++..|++||++.+..++.++|+||||+++|++++|.
T Consensus 283 HrDLKP~NILl---~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~ 359 (461)
T PHA03211 283 HRDIKTENVLV---NGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHT 359 (461)
T ss_pred ECcCCHHHEEE---CCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcC
Confidence 99999999999 4567799999999876533221 12345889999999998888999999999999999999987
Q ss_pred CCC
Q 030430 166 PPF 168 (177)
Q Consensus 166 ~pf 168 (177)
.|+
T Consensus 360 ~~l 362 (461)
T PHA03211 360 ASL 362 (461)
T ss_pred CCc
Confidence 653
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=195.96 Aligned_cols=163 Identities=33% Similarity=0.550 Sum_probs=138.3
Q ss_pred hHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc----------------CCCCHHHHHH
Q 030430 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTARK 70 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~ 70 (177)
.....+.+|+++++++ +|+|++++++++..++.+++++||+++++|..++... ..+++..+..
T Consensus 57 ~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 136 (293)
T cd05053 57 KDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136 (293)
T ss_pred HHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHH
Confidence 3445688999999999 8999999999999999999999999999999998642 3488899999
Q ss_pred HHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCCC
Q 030430 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDE 147 (177)
Q Consensus 71 ~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~ 147 (177)
++.|++.+++|||+.|++|+||+|+||+++ ..+.++++|||.+........ .....++..|+|||...+..++.
T Consensus 137 i~~qi~~al~~LH~~~ivH~dlkp~Nil~~---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 213 (293)
T cd05053 137 FAYQVARGMEFLASKKCIHRDLAARNVLVT---EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTH 213 (293)
T ss_pred HHHHHHHHHHHHHHCCccccccceeeEEEc---CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCc
Confidence 999999999999999999999999999994 567899999998876543221 11122345799999988888899
Q ss_pred cchHHHHHHHHHHHHh-CCCCCCCCCc
Q 030430 148 KVDMWSVGAILFELLN-GYPPFSVGEE 173 (177)
Q Consensus 148 ~~Di~slg~~~~~~~~-~~~pf~~~~~ 173 (177)
++|+||+|++++++++ |..||.+...
T Consensus 214 ~~Di~slG~il~el~~~g~~p~~~~~~ 240 (293)
T cd05053 214 QSDVWSFGVLLWEIFTLGGSPYPGIPV 240 (293)
T ss_pred ccceeehhhHHHHHhcCCCCCCCCCCH
Confidence 9999999999999997 8999976543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=200.81 Aligned_cols=156 Identities=33% Similarity=0.592 Sum_probs=133.0
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeC------CeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (177)
...+.+|++++++++||||+++++++... ...+++++++ +++|.+++. ...+++..+..++.|++.||+|||
T Consensus 58 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH 135 (343)
T cd07878 58 ARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIH 135 (343)
T ss_pred HHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 45677899999999999999999887533 3578999988 889988776 457999999999999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCcccccccccc-CCCCCcchHHHHHHHHHHHH
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~ 162 (177)
+.|++|+||+|+||++ +.++.++|+|||.+...... .....++..|+|||.+.+ ..++.++|+||+|+++++++
T Consensus 136 ~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~ 210 (343)
T cd07878 136 SAGIIHRDLKPSNVAV---NEDCELRILDFGLARQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 210 (343)
T ss_pred HCCeecccCChhhEEE---CCCCCEEEcCCccceecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHH
Confidence 9999999999999999 46778999999998765432 223457889999999875 45788999999999999999
Q ss_pred hCCCCCCCCC
Q 030430 163 NGYPPFSVGE 172 (177)
Q Consensus 163 ~~~~pf~~~~ 172 (177)
+|+.||.+.+
T Consensus 211 ~g~~pf~~~~ 220 (343)
T cd07878 211 KGKALFPGND 220 (343)
T ss_pred HCCCCCCCCC
Confidence 9999997653
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-31 Score=192.68 Aligned_cols=155 Identities=34% Similarity=0.573 Sum_probs=131.7
Q ss_pred HHHHHHHHh---hCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 13 LDCELNFLS---SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 13 ~~~e~~~l~---~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
..+|..+++ ..+||+++.+.+.+...+..+++|||++|++|.+++..++.+++..+..++.|++.++++||+.|++|
T Consensus 41 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH 120 (279)
T cd05633 41 ALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120 (279)
T ss_pred HHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCC
Confidence 344444333 34799999999999998999999999999999999988888999999999999999999999999999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccc-cCCCCCcchHHHHHHHHHHHHhCCCCC
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPF 168 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Di~slg~~~~~~~~~~~pf 168 (177)
+||+|+||++ +..+.++++|||.+........ ....++..|+|||... +..++.++|+||+|++++++++|..||
T Consensus 121 ~dikp~Nil~---~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 196 (279)
T cd05633 121 RDLKPANILL---DEHGHVRISDLGLACDFSKKKP-HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196 (279)
T ss_pred CCCCHHHEEE---CCCCCEEEccCCcceeccccCc-cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCc
Confidence 9999999999 4667899999998865533322 2345788999999876 345789999999999999999999999
Q ss_pred CCC
Q 030430 169 SVG 171 (177)
Q Consensus 169 ~~~ 171 (177)
...
T Consensus 197 ~~~ 199 (279)
T cd05633 197 RQH 199 (279)
T ss_pred CCC
Confidence 754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-31 Score=191.27 Aligned_cols=161 Identities=20% Similarity=0.363 Sum_probs=134.7
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
...+.+.+|..++++++|||++++++++..+...+++|||+++++|.+++...+ .+++..+..++.|++.+++|||+.|
T Consensus 41 ~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 120 (258)
T cd05078 41 NYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG 120 (258)
T ss_pred HHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 345678899999999999999999999999889999999999999999997654 4899999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCC-----CeeEEEeeeccccccCCCCccccccCCCccccccccccC-CCCCcchHHHHHHHHHH
Q 030430 87 IIHRDLKPENILLSGLDD-----DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFE 160 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~-----~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~ 160 (177)
++|+||+|+||+++..+. ...++++|||.+....... ...++..|+|||.+.+. .++.++|+||+|+++++
T Consensus 121 iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ 197 (258)
T cd05078 121 LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE---ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWE 197 (258)
T ss_pred eecCCCccceEEEecccccccCCCceEEecccccccccCCch---hccccCCccCchhccCCCCCCchhhHHHHHHHHHH
Confidence 999999999999963221 1347899999876553322 23467789999998753 47889999999999999
Q ss_pred HHhC-CCCCCCC
Q 030430 161 LLNG-YPPFSVG 171 (177)
Q Consensus 161 ~~~~-~~pf~~~ 171 (177)
+++| ..||...
T Consensus 198 l~~g~~~~~~~~ 209 (258)
T cd05078 198 IFSGGDKPLSAL 209 (258)
T ss_pred HHcCCCCChhhc
Confidence 9998 4666554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-31 Score=190.88 Aligned_cols=161 Identities=30% Similarity=0.598 Sum_probs=141.7
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+.+.+|+++++.++|+||+++++...+.+.+++++||+++++|.+++.....+++..+..++.+++.++++||+.|+
T Consensus 41 ~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i 120 (264)
T cd06626 41 KTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGI 120 (264)
T ss_pred HHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCc
Confidence 46788999999999999999999999999999999999999999999999877678999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccc-----cccCCCccccccccccCC---CCCcchHHHHHHHHH
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-----KVCGSPLYMAPEVLQFQR---YDEKVDMWSVGAILF 159 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~-----~~~~~~~~~~pe~~~~~~---~~~~~Di~slg~~~~ 159 (177)
+|+||+|+||+++ ..+.++++|||.+.......... ...++..|+|||.+.... ++.++|+||+|++++
T Consensus 121 ~H~dl~~~nil~~---~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~ 197 (264)
T cd06626 121 VHRDIKPANIFLD---HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVL 197 (264)
T ss_pred ccCCCCHHHEEEC---CCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHH
Confidence 9999999999994 57789999999887664432211 234677899999987655 788999999999999
Q ss_pred HHHhCCCCCCCC
Q 030430 160 ELLNGYPPFSVG 171 (177)
Q Consensus 160 ~~~~~~~pf~~~ 171 (177)
++++|+.||...
T Consensus 198 ~l~~g~~pf~~~ 209 (264)
T cd06626 198 EMATGKRPWSEL 209 (264)
T ss_pred HHHhCCCCccCC
Confidence 999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-31 Score=193.12 Aligned_cols=163 Identities=25% Similarity=0.408 Sum_probs=137.3
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
.......+.+|..+++.++|||++++++++... ..+++++++++++|.+++... +.+++..+..++.|++.+++|||+
T Consensus 49 ~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~ 127 (279)
T cd05109 49 SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE 127 (279)
T ss_pred CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 345567888999999999999999999988754 467899999999999999764 458999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc---ccccCCCccccccccccCCCCCcchHHHHHHHHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~ 161 (177)
.|++|+||+|+||++. ..+.++|+|||.+......... ....++..|++||...+..++.++|+||+|+++|++
T Consensus 128 ~~iiH~dlkp~Nil~~---~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el 204 (279)
T cd05109 128 VRLVHRDLAARNVLVK---SPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWEL 204 (279)
T ss_pred CCeeccccccceEEEc---CCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHH
Confidence 9999999999999994 5667999999998765433221 112235679999999888899999999999999999
Q ss_pred Hh-CCCCCCCCC
Q 030430 162 LN-GYPPFSVGE 172 (177)
Q Consensus 162 ~~-~~~pf~~~~ 172 (177)
++ |..||....
T Consensus 205 ~t~g~~p~~~~~ 216 (279)
T cd05109 205 MTFGAKPYDGIP 216 (279)
T ss_pred HcCCCCCCCCCC
Confidence 98 899997643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-31 Score=191.25 Aligned_cols=155 Identities=36% Similarity=0.687 Sum_probs=133.5
Q ss_pred HHHHHHH-HhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCeeec
Q 030430 13 LDCELNF-LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRD 91 (177)
Q Consensus 13 ~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H~~ 91 (177)
+..|..+ ..+.+|+|++++++++..++.+++++||++|++|.+++.....+++..+..++.|++.+|.+||+.|++|+|
T Consensus 43 ~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~d 122 (260)
T cd05611 43 VKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRD 122 (260)
T ss_pred HHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 3445444 445589999999999999999999999999999999998877899999999999999999999999999999
Q ss_pred CCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 030430 92 LKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVG 171 (177)
Q Consensus 92 i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf~~~ 171 (177)
|+|+||+++ ..+.++++|||.+..... .....++..|++||...+..++.++|+||+|++++++++|..||...
T Consensus 123 l~p~nil~~---~~~~~~l~dfg~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 196 (260)
T cd05611 123 IKPENLLID---QTGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE 196 (260)
T ss_pred CCHHHeEEC---CCCcEEEeecccceeccc---cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC
Confidence 999999994 567799999998765432 22334677899999988777889999999999999999999999765
Q ss_pred Cc
Q 030430 172 EE 173 (177)
Q Consensus 172 ~~ 173 (177)
+.
T Consensus 197 ~~ 198 (260)
T cd05611 197 TP 198 (260)
T ss_pred CH
Confidence 43
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-31 Score=190.80 Aligned_cols=161 Identities=32% Similarity=0.580 Sum_probs=140.1
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
....+.+|+++++.++|+|++++++++.+.+..++++|++++++|.+++..... +++.++..++.|++.++++||+.|
T Consensus 44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~ 123 (258)
T smart00219 44 QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN 123 (258)
T ss_pred HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 467899999999999999999999999999999999999999999999976544 999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccc--cccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~- 163 (177)
++|+||+|+||++ +..+.++++|||.+.......... ...++..|++||...+..++.++|+||+|++++++++
T Consensus 124 ~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~ 200 (258)
T smart00219 124 FIHRDLAARNCLV---GENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200 (258)
T ss_pred eeecccccceEEE---ccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhC
Confidence 9999999999999 466689999999987665432211 1225678999999877788999999999999999998
Q ss_pred CCCCCCCCC
Q 030430 164 GYPPFSVGE 172 (177)
Q Consensus 164 ~~~pf~~~~ 172 (177)
|..||...+
T Consensus 201 g~~p~~~~~ 209 (258)
T smart00219 201 GESPYPGMS 209 (258)
T ss_pred CCCCCCCCC
Confidence 788987644
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-31 Score=192.60 Aligned_cols=163 Identities=28% Similarity=0.520 Sum_probs=136.2
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCC------eEEEEEecCCCCChHHHHhhc------CCCCHHHHHHHHHHH
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLH------GRVPEQTARKFLQQL 75 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i 75 (177)
.....+.+|++.++.++|||++++++++.... ..++++||+++++|..++... ..+++..+..++.|+
T Consensus 43 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i 122 (273)
T cd05035 43 SEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122 (273)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHH
Confidence 44567899999999999999999999876544 379999999999999888532 248999999999999
Q ss_pred HHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc---ccccCCCccccccccccCCCCCcchHH
Q 030430 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMW 152 (177)
Q Consensus 76 ~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~Di~ 152 (177)
+.||+|||+.|++|+||+|+||++ ++.+.++++|||.+......... .....+..|++||...+..++.++|+|
T Consensus 123 ~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~ 199 (273)
T cd05035 123 ALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVW 199 (273)
T ss_pred HHHHHHHHhCCeeccccchheEEE---CCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchH
Confidence 999999999999999999999999 46678999999998765433211 112235679999998888889999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCc
Q 030430 153 SVGAILFELLN-GYPPFSVGEE 173 (177)
Q Consensus 153 slg~~~~~~~~-~~~pf~~~~~ 173 (177)
|+|++++++++ |..||.+.+.
T Consensus 200 SlG~il~el~~~g~~p~~~~~~ 221 (273)
T cd05035 200 AFGVTMWEIATRGQTPYPGVEN 221 (273)
T ss_pred HHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999 8899976544
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=192.69 Aligned_cols=162 Identities=27% Similarity=0.497 Sum_probs=139.5
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
....+.+|+.++++++|+|++++++++......++++|++++++|.+++.... .++...+..++.+++.++++||+.|
T Consensus 44 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~ 123 (261)
T cd05034 44 SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN 123 (261)
T ss_pred CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34678999999999999999999999998889999999999999999997653 5899999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc--ccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~- 163 (177)
++|+||+|+||++ +..+.++++|||.+......... .....+..|+|||...+..+++++|+||+|++++++++
T Consensus 124 i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~ 200 (261)
T cd05034 124 YIHRDLAARNILV---GENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTY 200 (261)
T ss_pred cccCCcchheEEE---cCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhC
Confidence 9999999999999 45678999999988765432211 11223457999999988889999999999999999998
Q ss_pred CCCCCCCCCc
Q 030430 164 GYPPFSVGEE 173 (177)
Q Consensus 164 ~~~pf~~~~~ 173 (177)
|+.||.+.+.
T Consensus 201 g~~p~~~~~~ 210 (261)
T cd05034 201 GRVPYPGMTN 210 (261)
T ss_pred CCCCCCCCCH
Confidence 9999977543
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=208.27 Aligned_cols=162 Identities=27% Similarity=0.485 Sum_probs=133.0
Q ss_pred HHHHHHHHHHHHhhCCCC------ceeeEeEEEeeC-CeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Q 030430 9 LKSCLDCELNFLSSVNHP------NIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (177)
..+....|+++++.++|. +++++.+++... ..++++++++ |++|.+++.+.+.+++..+..++.|++.||+|
T Consensus 168 ~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~y 246 (467)
T PTZ00284 168 YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDY 246 (467)
T ss_pred hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHH
Confidence 344567788888887654 588888888754 5789999988 88999999888889999999999999999999
Q ss_pred Hhh-CCCeeecCCCCcEEEecCCC-------------CeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCC
Q 030430 82 LNS-HHIIHRDLKPENILLSGLDD-------------DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDE 147 (177)
Q Consensus 82 lh~-~~~~H~~i~~~nil~~~~~~-------------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~ 147 (177)
||+ .|++||||||+||++...+. ...++|+|||.+...... .....++..|+|||.+.+..++.
T Consensus 247 LH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~--~~~~~gt~~Y~APE~~~~~~~~~ 324 (467)
T PTZ00284 247 FHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS--RTAIVSTRHYRSPEVVLGLGWMY 324 (467)
T ss_pred HHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCccc--cccccCCccccCcHHhhcCCCCc
Confidence 997 69999999999999963211 125899999987543222 22455889999999999888999
Q ss_pred cchHHHHHHHHHHHHhCCCCCCCCCc
Q 030430 148 KVDMWSVGAILFELLNGYPPFSVGEE 173 (177)
Q Consensus 148 ~~Di~slg~~~~~~~~~~~pf~~~~~ 173 (177)
++|+|||||++|+|++|+.||.+.+.
T Consensus 325 ~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 325 STDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 99999999999999999999987553
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-31 Score=193.30 Aligned_cols=162 Identities=35% Similarity=0.586 Sum_probs=139.3
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
+.....+.+|+.++++++|||++++++++.++...++|+||+ +++|.+++... ..+++.++..++.|++.++++||+.
T Consensus 40 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 118 (286)
T cd07832 40 GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118 (286)
T ss_pred chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 344567899999999999999999999999999999999999 99999998643 4589999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--cccccCCCccccccccccC-CCCCcchHHHHHHHHHHHH
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~ 162 (177)
|++|+||+|+||+++ ..+.++++|||.+........ .....++..|+|||.+.+. .++.++|+||+|+++++++
T Consensus 119 ~i~H~dl~p~ni~~~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~ 195 (286)
T cd07832 119 GIMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELL 195 (286)
T ss_pred CeecCCcCHHHEEEc---CCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHH
Confidence 999999999999994 567799999998876654331 2234577889999987644 3588999999999999999
Q ss_pred hCCCCCCCCC
Q 030430 163 NGYPPFSVGE 172 (177)
Q Consensus 163 ~~~~pf~~~~ 172 (177)
+|++||.+.+
T Consensus 196 tg~~~~~~~~ 205 (286)
T cd07832 196 NGSPLFPGEN 205 (286)
T ss_pred cCCcCcCCCC
Confidence 9988887654
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=194.74 Aligned_cols=162 Identities=30% Similarity=0.541 Sum_probs=138.0
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc---CCCCHHHHHHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---GRVPEQTARKFLQQLGAGLEIL 82 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~l 82 (177)
++...+.+.+|++++++++|||++++++.+...+.+++++||+++++|..++... ..+++..+..++.|++.++.||
T Consensus 39 ~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 118 (286)
T cd06622 39 DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118 (286)
T ss_pred CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3444578899999999999999999999999999999999999999999988763 3699999999999999999999
Q ss_pred hh-CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCC------CCCcchHHHHH
Q 030430 83 NS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR------YDEKVDMWSVG 155 (177)
Q Consensus 83 h~-~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~------~~~~~Di~slg 155 (177)
|+ .|++|+||+|+||+++ ..+.++++|||.+....... .....++..|++||.+.+.. ++.++|+||+|
T Consensus 119 H~~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG 194 (286)
T cd06622 119 KEEHNIIHRDVKPTNVLVN---GNGQVKLCDFGVSGNLVASL-AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLG 194 (286)
T ss_pred HhcCCEeeCCCCHHHEEEC---CCCCEEEeecCCcccccCCc-cccCCCccCccCcchhcCCCCCccCCCCcccchHhHH
Confidence 97 5999999999999994 57789999999886553322 22334677899999875433 47889999999
Q ss_pred HHHHHHHhCCCCCCCC
Q 030430 156 AILFELLNGYPPFSVG 171 (177)
Q Consensus 156 ~~~~~~~~~~~pf~~~ 171 (177)
++++++++|..||...
T Consensus 195 ~il~~l~~g~~pf~~~ 210 (286)
T cd06622 195 LSILEMALGRYPYPPE 210 (286)
T ss_pred HHHHHHHhCCCCCCCc
Confidence 9999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=193.65 Aligned_cols=161 Identities=35% Similarity=0.587 Sum_probs=141.8
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh-
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS- 84 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~- 84 (177)
+.....+.+|++++++++|||++++.+.+...+.+++++|++++++|.+++... ..+++..+..++.|++.+++++|+
T Consensus 40 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 119 (265)
T cd06605 40 EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119 (265)
T ss_pred hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCC
Confidence 345677899999999999999999999999999999999999999999999876 679999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhC
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~ 164 (177)
.|++|+||+|+||+++ ..+.++|+|||.+......... ...++..|+|||...+..++.++|+||+|++++++++|
T Consensus 120 ~~i~H~dl~~~ni~~~---~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 195 (265)
T cd06605 120 HKIIHRDVKPSNILVN---SRGQIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATG 195 (265)
T ss_pred CCeecCCCCHHHEEEC---CCCCEEEeecccchhhHHHHhh-cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence 9999999999999994 5678999999987655332221 24567889999999888899999999999999999999
Q ss_pred CCCCCCC
Q 030430 165 YPPFSVG 171 (177)
Q Consensus 165 ~~pf~~~ 171 (177)
..||...
T Consensus 196 ~~p~~~~ 202 (265)
T cd06605 196 RFPYPPE 202 (265)
T ss_pred CCCCCcc
Confidence 9999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-31 Score=194.01 Aligned_cols=159 Identities=27% Similarity=0.468 Sum_probs=135.1
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeC--CeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh 83 (177)
......+.+|+++++.++|||++++.+++.+. ...++++||++|++|.+++.+.. .++...+..++.|++.+++++|
T Consensus 47 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH 126 (284)
T cd05079 47 GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126 (284)
T ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34456799999999999999999999988765 57899999999999999987653 5899999999999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc----cccccCCCccccccccccCCCCCcchHHHHHHHHH
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~ 159 (177)
+.|++|+||+|+||+++ .++.++++|||.+........ .....++..|+|||...+..++.++|+||+|++++
T Consensus 127 ~~gi~H~dlkp~Nil~~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ 203 (284)
T cd05079 127 SRQYVHRDLAARNVLVE---SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLY 203 (284)
T ss_pred HCCeeecccchheEEEc---CCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhh
Confidence 99999999999999994 567799999999876543321 11233556799999988888899999999999999
Q ss_pred HHHhCCCCC
Q 030430 160 ELLNGYPPF 168 (177)
Q Consensus 160 ~~~~~~~pf 168 (177)
+++++..|+
T Consensus 204 ellt~~~~~ 212 (284)
T cd05079 204 ELLTYCDSE 212 (284)
T ss_pred hhhcCCCCC
Confidence 999977654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-31 Score=188.81 Aligned_cols=162 Identities=38% Similarity=0.670 Sum_probs=145.3
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeC--CeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
...+.+.+|++++++++|||++++.+.+.+. ..+++++|++++++|.+++.....+++..+..++.|++.++++||+.
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~ 120 (260)
T cd06606 41 EELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN 120 (260)
T ss_pred HHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4577899999999999999999999999888 88999999999999999998777899999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCCCcchHHHHHHHHHHHH
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~ 162 (177)
|++|+|++|+||++. ..+.++++|||.+........ .....++..|.+||.......+.++|+||+|+++++++
T Consensus 121 ~~~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~ 197 (260)
T cd06606 121 GIVHRDIKGANILVD---SDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMA 197 (260)
T ss_pred CccccCCCHHHEEEc---CCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHH
Confidence 999999999999994 567899999999877655543 33455778899999998777899999999999999999
Q ss_pred hCCCCCCCCC
Q 030430 163 NGYPPFSVGE 172 (177)
Q Consensus 163 ~~~~pf~~~~ 172 (177)
+|..||....
T Consensus 198 ~g~~p~~~~~ 207 (260)
T cd06606 198 TGKPPWSELG 207 (260)
T ss_pred hCCCCCCCCC
Confidence 9999997754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=196.37 Aligned_cols=159 Identities=30% Similarity=0.526 Sum_probs=135.3
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
...+.+|+++++.++||||+++++++......++++||++ ++|.+++... ..+++..+..++.|++.+|++||+.|++
T Consensus 48 ~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~ 126 (301)
T cd07873 48 PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVL 126 (301)
T ss_pred hhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 4467789999999999999999999999999999999995 5898888754 4589999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccC-CCCCcchHHHHHHHHHHHHhCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
|+||+|+||++ +..+.++++|||.+........ .....++..|+|||...+. .++.++|+||+|+++++|++|+.
T Consensus 127 H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~ 203 (301)
T cd07873 127 HRDLKPQNLLI---NERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRP 203 (301)
T ss_pred CCCCCHHHEEE---CCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCC
Confidence 99999999999 4667899999998865433221 2233457889999987643 47889999999999999999999
Q ss_pred CCCCCC
Q 030430 167 PFSVGE 172 (177)
Q Consensus 167 pf~~~~ 172 (177)
||.+.+
T Consensus 204 ~f~~~~ 209 (301)
T cd07873 204 LFPGST 209 (301)
T ss_pred CCCCCC
Confidence 997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=202.23 Aligned_cols=153 Identities=31% Similarity=0.457 Sum_probs=131.8
Q ss_pred HHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCeee
Q 030430 12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIHR 90 (177)
Q Consensus 12 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~H~ 90 (177)
....|+.++++++||||+++++++......++++|++ .++|.+++... ..+++..+..++.|++.||+|||+.|++||
T Consensus 103 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr 181 (357)
T PHA03209 103 TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHR 181 (357)
T ss_pred ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence 4467999999999999999999999999999999999 56888887643 569999999999999999999999999999
Q ss_pred cCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 030430 91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (177)
Q Consensus 91 ~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf 168 (177)
||||+||++ +..+.++|+|||.+.............++..|+|||.+.+..++.++|+||+|+++|+++++..|+
T Consensus 182 Dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 182 DVKTENIFI---NDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred CCCHHHEEE---CCCCCEEEecCccccccccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 999999999 466779999999886543333333455888999999998888999999999999999999865443
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-31 Score=187.75 Aligned_cols=160 Identities=37% Similarity=0.665 Sum_probs=143.4
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
....+.+|++++++++|++++++.+.+..+...++++||+++++|.+++... ..+++..+..++.|++.++++||+.|+
T Consensus 40 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i 119 (253)
T cd05122 40 KKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGI 119 (253)
T ss_pred HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCE
Confidence 5678999999999999999999999999999999999999999999998866 579999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
+|+||+|+||+++ ..+.++|+|||.+.............++..|++||...+..++.++|+||+|++++++++|+.|
T Consensus 120 ~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p 196 (253)
T cd05122 120 IHRDIKAANILLT---SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196 (253)
T ss_pred ecCCCCHHHEEEc---cCCeEEEeeccccccccccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCC
Confidence 9999999999994 5778999999988776554323345577889999999877789999999999999999999999
Q ss_pred CCCC
Q 030430 168 FSVG 171 (177)
Q Consensus 168 f~~~ 171 (177)
|...
T Consensus 197 ~~~~ 200 (253)
T cd05122 197 YSEL 200 (253)
T ss_pred CCCC
Confidence 9765
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-31 Score=191.27 Aligned_cols=164 Identities=36% Similarity=0.670 Sum_probs=141.5
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEe--eCCeEEEEEecCCCCChHHHHhhc----CCCCHHHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGL 79 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l 79 (177)
.+...+.+.+|++++++++|||++++++.+. .....++++||+++++|.+++... ..+++..++.++.|++.++
T Consensus 39 ~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l 118 (265)
T cd08217 39 TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118 (265)
T ss_pred CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHH
Confidence 3455678899999999999999999999775 345789999999999999998753 4689999999999999999
Q ss_pred HHHh-----hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccCCCCCcchHHH
Q 030430 80 EILN-----SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWS 153 (177)
Q Consensus 80 ~~lh-----~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~s 153 (177)
+++| +.+++|+||+|+||++. ..+.++++|||.+........ .....++..|++||...+..++.++|+||
T Consensus 119 ~~lH~~~~~~~~i~h~dl~p~nili~---~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~s 195 (265)
T cd08217 119 YECHNRSDPGNTVLHRDLKPANIFLD---ANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWS 195 (265)
T ss_pred HHHhcCccccCcceecCCCHHHEEEe---cCCCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHH
Confidence 9999 88999999999999994 567899999999877654432 33345788899999998888899999999
Q ss_pred HHHHHHHHHhCCCCCCCCC
Q 030430 154 VGAILFELLNGYPPFSVGE 172 (177)
Q Consensus 154 lg~~~~~~~~~~~pf~~~~ 172 (177)
+|++++++++|..||...+
T Consensus 196 lG~il~~l~~g~~p~~~~~ 214 (265)
T cd08217 196 LGCLIYELCALSPPFTARN 214 (265)
T ss_pred HHHHHHHHHHCCCcccCcC
Confidence 9999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-31 Score=191.26 Aligned_cols=163 Identities=29% Similarity=0.615 Sum_probs=140.9
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhh
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
......+.+|++++++++|||++++.+++...+..++++||+.+++|.+++.... .+++.++..++.|++.++++||+
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~ 119 (256)
T cd08218 40 PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119 (256)
T ss_pred hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3455688999999999999999999999999999999999999999999887543 47899999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~ 163 (177)
.|++|+||+|+||++ +.+..++++|||.+........ .....++..|+|||...+..++.++|+||+|++++++++
T Consensus 120 ~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~ 196 (256)
T cd08218 120 RKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196 (256)
T ss_pred CCEecCCCCHHHEEE---cCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHc
Confidence 999999999999999 4567799999998866543322 112346778999999988888899999999999999999
Q ss_pred CCCCCCCCC
Q 030430 164 GYPPFSVGE 172 (177)
Q Consensus 164 ~~~pf~~~~ 172 (177)
|..||...+
T Consensus 197 g~~~~~~~~ 205 (256)
T cd08218 197 LKHAFEAGN 205 (256)
T ss_pred CCCCccCCC
Confidence 999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=195.22 Aligned_cols=161 Identities=36% Similarity=0.542 Sum_probs=138.2
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
....+..|++++++++|+|++++++++.+....++|+||+ +++|.+++.... .+++..+..++.|++.+|++||+.|+
T Consensus 45 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i 123 (298)
T cd07841 45 INFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWI 123 (298)
T ss_pred hhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 4456788999999999999999999999999999999999 889999998765 79999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCcccccccccc-CCCCCcchHHHHHHHHHHHHhCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~~~~ 165 (177)
+|+||+|+||+++ ..+.++|+|||.+........ .....++..|+|||.+.+ ..++.++|+||+|++++++++|.
T Consensus 124 ~H~dl~p~nill~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~ 200 (298)
T cd07841 124 LHRDLKPNNLLIA---SDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200 (298)
T ss_pred eecCCChhhEEEc---CCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCC
Confidence 9999999999994 567899999999876654322 222345678999998754 35688999999999999999998
Q ss_pred CCCCCCCc
Q 030430 166 PPFSVGEE 173 (177)
Q Consensus 166 ~pf~~~~~ 173 (177)
+||.+.++
T Consensus 201 ~~~~~~~~ 208 (298)
T cd07841 201 PFLPGDSD 208 (298)
T ss_pred ccccCCcc
Confidence 88876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-31 Score=191.19 Aligned_cols=161 Identities=26% Similarity=0.483 Sum_probs=135.8
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
..+.+.+|+++++.++|++++++++++.. ...+++|||+++++|.+++.... .++...+..++.|++.|++|||+.|
T Consensus 44 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~ 122 (260)
T cd05069 44 MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN 122 (260)
T ss_pred cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34678899999999999999999988754 45789999999999999997543 3788999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc--ccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~- 163 (177)
++|+||+|+||++ ++.+.++|+|||.+......... ....++..|++||...+..++.++|+||+|++++++++
T Consensus 123 i~H~dl~~~Nill---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~ 199 (260)
T cd05069 123 YIHRDLRAANILV---GDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTK 199 (260)
T ss_pred EeecccCcceEEE---cCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhC
Confidence 9999999999999 46778999999998665333211 12234567999999888888999999999999999999
Q ss_pred CCCCCCCCCc
Q 030430 164 GYPPFSVGEE 173 (177)
Q Consensus 164 ~~~pf~~~~~ 173 (177)
|..||.+..+
T Consensus 200 g~~p~~~~~~ 209 (260)
T cd05069 200 GRVPYPGMVN 209 (260)
T ss_pred CCCCCCCCCH
Confidence 8999977543
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-31 Score=197.14 Aligned_cols=161 Identities=32% Similarity=0.554 Sum_probs=134.9
Q ss_pred HHHHHHHHHHHHhhC-CCCceeeEeEEEee-CCeEEEEEecCCCCChHHHHhhc--------------------------
Q 030430 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH-------------------------- 60 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-------------------------- 60 (177)
..+.+.+|+++++++ +|+||+++++++.. ...+++++||+++++|.+++...
T Consensus 53 ~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 132 (337)
T cd05054 53 EYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQR 132 (337)
T ss_pred HHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccc
Confidence 345678899999999 89999999998754 45788999999999999988632
Q ss_pred -----------------------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCC
Q 030430 61 -----------------------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDD 105 (177)
Q Consensus 61 -----------------------------------~~~~~~~~~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~ 105 (177)
..++...+..++.|++.+++|||+.|++|+||+|.||+++ ..
T Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~---~~ 209 (337)
T cd05054 133 LDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS---EN 209 (337)
T ss_pred cccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe---CC
Confidence 2478889999999999999999999999999999999995 56
Q ss_pred eeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 030430 106 VMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSVGE 172 (177)
Q Consensus 106 ~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-~~~pf~~~~ 172 (177)
+.++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|++++++++ |..||.+..
T Consensus 210 ~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~ 280 (337)
T cd05054 210 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 280 (337)
T ss_pred CcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCC
Confidence 6799999999876533221 112234567999999988889999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-31 Score=188.92 Aligned_cols=161 Identities=32% Similarity=0.552 Sum_probs=138.0
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
....+.+|++++++++|++|+++++++.+....++++||+.+++|.+++... ..++...+..++.+++.++++||+.|+
T Consensus 35 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i 114 (251)
T cd05041 35 LKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNC 114 (251)
T ss_pred HHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 5678999999999999999999999999999999999999999999998754 458899999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc---ccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~- 163 (177)
+|+||+|+||++ +..+.++++|||.+......... .....+..|+|||...+..++.++|+||||++++++++
T Consensus 115 ~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~ 191 (251)
T cd05041 115 IHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSL 191 (251)
T ss_pred ehhhcCcceEEE---cCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhc
Confidence 999999999999 46678999999988655322211 11223456999999887888999999999999999999
Q ss_pred CCCCCCCCC
Q 030430 164 GYPPFSVGE 172 (177)
Q Consensus 164 ~~~pf~~~~ 172 (177)
|..||....
T Consensus 192 ~~~p~~~~~ 200 (251)
T cd05041 192 GDTPYPGMS 200 (251)
T ss_pred cCCCCccCC
Confidence 788987644
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=206.33 Aligned_cols=157 Identities=27% Similarity=0.415 Sum_probs=132.2
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHh
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----GRVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lh 83 (177)
....+.+|++++++++||||+++++++.+....|++++++ +++|.+++... .......+..++.|++.||+|||
T Consensus 206 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH 284 (501)
T PHA03210 206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH 284 (501)
T ss_pred HHHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 4567889999999999999999999999999999999998 56777766432 12446678889999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--cccccCCCccccccccccCCCCCcchHHHHHHHHHHH
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~ 161 (177)
+.|++|+||||+||++ +..+.++|+|||++........ .....++..|+|||.+.+..++.++|+||+|+++++|
T Consensus 285 ~~gIiHrDLKP~NILl---~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~el 361 (501)
T PHA03210 285 DKKLIHRDIKLENIFL---NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361 (501)
T ss_pred hCCeecCCCCHHHEEE---CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHH
Confidence 9999999999999999 4667899999999976644322 2234588999999999888899999999999999999
Q ss_pred HhCCC-CCC
Q 030430 162 LNGYP-PFS 169 (177)
Q Consensus 162 ~~~~~-pf~ 169 (177)
++|.. ||.
T Consensus 362 l~~~~~p~~ 370 (501)
T PHA03210 362 LSHDFCPIG 370 (501)
T ss_pred HHCCCCCcc
Confidence 99875 444
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=191.98 Aligned_cols=164 Identities=29% Similarity=0.517 Sum_probs=135.4
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEee------CCeEEEEEecCCCCChHHHHhhc------CCCCHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLH------GRVPEQTARKFLQQ 74 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~ 74 (177)
+...+.+.+|+++++.++|+||+++++++.. ....++++||+++++|.+++... ..+++..+..++.|
T Consensus 41 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 120 (272)
T cd05075 41 RSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120 (272)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHH
Confidence 4456778899999999999999999987632 12468999999999999887421 23889999999999
Q ss_pred HHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCCCcchH
Q 030430 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDM 151 (177)
Q Consensus 75 i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di 151 (177)
++.+++|||+.|++|+||+|+||++ +..+.++++|||.+........ ......+..|++||...+..++.++|+
T Consensus 121 i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di 197 (272)
T cd05075 121 IASGMEYLSSKSFIHRDLAARNCML---NENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDV 197 (272)
T ss_pred HHHHHHHHHHCCeeccccchhheEE---cCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHH
Confidence 9999999999999999999999999 4667799999999876543321 112234567999999988889999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCc
Q 030430 152 WSVGAILFELLN-GYPPFSVGEE 173 (177)
Q Consensus 152 ~slg~~~~~~~~-~~~pf~~~~~ 173 (177)
||+|++++++++ |+.||.+.+.
T Consensus 198 ~slG~il~el~~~g~~p~~~~~~ 220 (272)
T cd05075 198 WSFGVTMWEIATRGQTPYPGVEN 220 (272)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999999 8899976543
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=190.55 Aligned_cols=161 Identities=43% Similarity=0.713 Sum_probs=143.5
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
....+..|++++++++|+|++++++.+..+...+++||++++++|.+++.....+++..+..++.|++.++.++|+.|++
T Consensus 36 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~ 115 (250)
T cd05123 36 EVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGII 115 (250)
T ss_pred HHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence 45688999999999999999999999999999999999999999999998777899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCC-CccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
|+||+|+||+++ ..+.++++|||.+...... .......++..|++||...+...+.++|+||+|++++++++|..|
T Consensus 116 H~~l~p~ni~~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p 192 (250)
T cd05123 116 YRDLKPENILLD---ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192 (250)
T ss_pred ecCCCcceEEEc---CCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 999999999994 5667999999988765443 223344567789999998877788999999999999999999999
Q ss_pred CCCCC
Q 030430 168 FSVGE 172 (177)
Q Consensus 168 f~~~~ 172 (177)
|...+
T Consensus 193 ~~~~~ 197 (250)
T cd05123 193 FYAED 197 (250)
T ss_pred CCCCC
Confidence 97665
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=197.31 Aligned_cols=163 Identities=31% Similarity=0.519 Sum_probs=137.5
Q ss_pred hHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC----------------CCCHHHHHH
Q 030430 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARK 70 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~ 70 (177)
...+.+.+|+++++++ +||||+++++++...+..++++||+++++|.+++.+.. .++..++..
T Consensus 59 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 138 (334)
T cd05100 59 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138 (334)
T ss_pred HHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHH
Confidence 3456789999999999 89999999999999999999999999999999987532 367788899
Q ss_pred HHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc---ccccCCCccccccccccCCCCC
Q 030430 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDE 147 (177)
Q Consensus 71 ~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~ 147 (177)
++.|++.+++|||+.|++|+||+|+||+++ ..+.++|+|||.+......... ....++..|+|||.+.+..++.
T Consensus 139 ~~~qi~~al~~LH~~givH~dlkp~Nill~---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 215 (334)
T cd05100 139 CAYQVARGMEYLASQKCIHRDLAARNVLVT---EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 215 (334)
T ss_pred HHHHHHHHHHHHHHCCeeccccccceEEEc---CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCc
Confidence 999999999999999999999999999994 5677999999988665432211 1122345699999998888999
Q ss_pred cchHHHHHHHHHHHHh-CCCCCCCCCc
Q 030430 148 KVDMWSVGAILFELLN-GYPPFSVGEE 173 (177)
Q Consensus 148 ~~Di~slg~~~~~~~~-~~~pf~~~~~ 173 (177)
++|+||+|++++++++ |..||.+.+.
T Consensus 216 ~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 216 QSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred hhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999998 8899977543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=190.06 Aligned_cols=158 Identities=28% Similarity=0.551 Sum_probs=134.7
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
..+.+.+|+.+++.++|||++++.+++.... .++++||+++++|.+++.... .++...+..++.|++.+++++|+.|
T Consensus 42 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ 120 (254)
T cd05083 42 TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK 120 (254)
T ss_pred hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4567889999999999999999999887654 789999999999999997653 4889999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-CC
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY 165 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-~~ 165 (177)
++|+||+|+||++ +..+.++++|||.+....... .....+..|+|||.+.+..++.++|+||+|++++++++ |.
T Consensus 121 ~~H~dl~p~nili---~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~ 195 (254)
T cd05083 121 LVHRDLAARNILV---SEDGVAKVSDFGLARVGSMGV--DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGR 195 (254)
T ss_pred eeccccCcceEEE---cCCCcEEECCCccceeccccC--CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999 456789999999886543221 12223567999999888888999999999999999997 99
Q ss_pred CCCCCCC
Q 030430 166 PPFSVGE 172 (177)
Q Consensus 166 ~pf~~~~ 172 (177)
.||...+
T Consensus 196 ~p~~~~~ 202 (254)
T cd05083 196 APYPKMS 202 (254)
T ss_pred CCCccCC
Confidence 9997654
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=191.51 Aligned_cols=160 Identities=35% Similarity=0.584 Sum_probs=137.0
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEee--CCeEEEEEecCCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHH
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEI 81 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~ 81 (177)
.....+.+|++++++++||||+++++++.+ .+.++++|||++|++|.+++.. ...+++..+..++.|++.+++|
T Consensus 41 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~ 120 (287)
T cd06621 41 DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120 (287)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 456789999999999999999999998754 4478999999999999987653 2458899999999999999999
Q ss_pred HhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHH
Q 030430 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 82 lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~ 161 (177)
||+.|++|+|++|+||++. ..+.++++|||.+........ ....++..|++||...+..++.++|+||+|++++++
T Consensus 121 lH~~~i~H~dl~~~nil~~---~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l 196 (287)
T cd06621 121 LHSRKIIHRDIKPSNILLT---RKGQVKLCDFGVSGELVNSLA-GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196 (287)
T ss_pred HHHCCcccCCCCHHHEEEe---cCCeEEEeecccccccccccc-ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHH
Confidence 9999999999999999994 566799999998765433222 123467789999999888899999999999999999
Q ss_pred HhCCCCCCCC
Q 030430 162 LNGYPPFSVG 171 (177)
Q Consensus 162 ~~~~~pf~~~ 171 (177)
++|..||...
T Consensus 197 ~~g~~p~~~~ 206 (287)
T cd06621 197 AQNRFPFPPE 206 (287)
T ss_pred HhCCCCCCcc
Confidence 9999999765
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=195.33 Aligned_cols=163 Identities=28% Similarity=0.422 Sum_probs=138.7
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
....+.+.+|++++++++|+||+++++++.+....++++||+++++|.+++... ..+++..+..++.|++.||+|||+
T Consensus 40 ~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~ 119 (314)
T cd08216 40 KEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS 119 (314)
T ss_pred hhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 445678999999999999999999999999999999999999999999998854 358899999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--------cccccCCCcccccccccc--CCCCCcchHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQF--QRYDEKVDMWSV 154 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--------~~~~~~~~~~~~pe~~~~--~~~~~~~Di~sl 154 (177)
.|++|+||+|+||+++ .++.++++||+.+........ .....++..|+|||.+.. ..++.++|+||+
T Consensus 120 ~~ivH~dlk~~Nili~---~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~ 196 (314)
T cd08216 120 KGFIHRSVKASHILLS---GDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSV 196 (314)
T ss_pred CCeecCCCCcceEEEe---cCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHH
Confidence 9999999999999994 567799999998765432211 112335667999998865 357889999999
Q ss_pred HHHHHHHHhCCCCCCCCC
Q 030430 155 GAILFELLNGYPPFSVGE 172 (177)
Q Consensus 155 g~~~~~~~~~~~pf~~~~ 172 (177)
|++++++++|..||....
T Consensus 197 G~il~el~~g~~pf~~~~ 214 (314)
T cd08216 197 GITACELANGHVPFKDMP 214 (314)
T ss_pred HHHHHHHHhCCCCCCCCC
Confidence 999999999999997643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=191.77 Aligned_cols=163 Identities=28% Similarity=0.501 Sum_probs=137.3
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
....+.+.+|+++++.++|||++++++++.+. ..++++||+++++|.+++.... .++...+..++.|++.+++++|+.
T Consensus 48 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 126 (270)
T cd05056 48 PSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK 126 (270)
T ss_pred HHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 45567899999999999999999999988764 4679999999999999998654 589999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc--ccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~ 163 (177)
|++|+||+|+||+++ ..+.++++|||.+......... .....+..|+|||.+....++.++|+||||++++++++
T Consensus 127 ~~~H~dl~p~nili~---~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 203 (270)
T cd05056 127 RFVHRDIAARNVLVS---SPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 203 (270)
T ss_pred CeeccccChheEEEe---cCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHH
Confidence 999999999999994 5667999999988665433211 11223457999999887788999999999999999986
Q ss_pred -CCCCCCCCCc
Q 030430 164 -GYPPFSVGEE 173 (177)
Q Consensus 164 -~~~pf~~~~~ 173 (177)
|..||.+.+.
T Consensus 204 ~g~~pf~~~~~ 214 (270)
T cd05056 204 LGVKPFQGVKN 214 (270)
T ss_pred cCCCCCCCCCH
Confidence 9999977543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=189.93 Aligned_cols=160 Identities=28% Similarity=0.564 Sum_probs=137.9
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
...+.+|++++++++||+++++++++......++++||+++++|.+++... ..++++.+..++.+++.++++||+.|++
T Consensus 43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~ 122 (256)
T cd05112 43 EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVI 122 (256)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 456889999999999999999999999999999999999999999998754 4588999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc--ccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-CC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY 165 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-~~ 165 (177)
|+||+|+||++ +.++.++++|||.+......... .....+..|++||...+..++.++|+||+|++++++++ |.
T Consensus 123 h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~ 199 (256)
T cd05112 123 HRDLAARNCLV---GENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGK 199 (256)
T ss_pred ccccccceEEE---cCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCC
Confidence 99999999999 46678999999988655433221 12224567999999887888999999999999999998 89
Q ss_pred CCCCCCC
Q 030430 166 PPFSVGE 172 (177)
Q Consensus 166 ~pf~~~~ 172 (177)
.||....
T Consensus 200 ~p~~~~~ 206 (256)
T cd05112 200 TPYENRS 206 (256)
T ss_pred CCCCcCC
Confidence 9997654
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=210.19 Aligned_cols=164 Identities=27% Similarity=0.499 Sum_probs=137.6
Q ss_pred chhHHHHHHHHHHHHhhCC-CCceeeEeEE-Ee---e---CCeEEEEEecCCCCChHHHHhh--cCCCCHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVN-HPNIIRLFDA-FQ---A---ENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQL 75 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~-~~---~---~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i 75 (177)
++..-+.+.+|+++|++|+ |+|||.+++. .. . ...++|+||||+|++|-++++. ...|++..+++|+.++
T Consensus 74 de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv 153 (738)
T KOG1989|consen 74 DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDV 153 (738)
T ss_pred CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHH
Confidence 7788899999999999995 9999999993 22 1 1257899999999999999983 3459999999999999
Q ss_pred HHHHHHHhhCC--CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc-c---------cccCCCcccccccc---
Q 030430 76 GAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-E---------KVCGSPLYMAPEVL--- 140 (177)
Q Consensus 76 ~~~l~~lh~~~--~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~-~---------~~~~~~~~~~pe~~--- 140 (177)
+.|+++||.+. ++|||||-+|+|++ ..+..||||||.+......... . ...-|+-|.+||.+
T Consensus 154 ~~AVa~mH~~~pPiIHRDLKiENvLls---~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDly 230 (738)
T KOG1989|consen 154 CEAVAAMHYLKPPIIHRDLKIENVLLS---ADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLY 230 (738)
T ss_pred HHHHHHHhcCCCccchhhhhhhheEEc---CCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhh
Confidence 99999999998 99999999999994 6678999999998654322211 1 12357889999976
Q ss_pred ccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 030430 141 QFQRYDEKVDMWSVGAILFELLNGYPPFSVGE 172 (177)
Q Consensus 141 ~~~~~~~~~Di~slg~~~~~~~~~~~pf~~~~ 172 (177)
.+.+.+.++|||||||++|.++....||+...
T Consensus 231 sg~pI~eKsDIWALGclLYkLCy~t~PFe~sg 262 (738)
T KOG1989|consen 231 SGLPIGEKSDIWALGCLLYKLCYFTTPFEESG 262 (738)
T ss_pred cCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc
Confidence 46678999999999999999999999998763
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=191.15 Aligned_cols=160 Identities=28% Similarity=0.457 Sum_probs=133.2
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEe--eCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHh
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh 83 (177)
....+.+.+|++++++++|||++++.+++. +...+++++||+++++|.+++... ..++...+..++.|++.+|+|||
T Consensus 46 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH 125 (284)
T cd05081 46 AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG 125 (284)
T ss_pred HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH
Confidence 344567899999999999999999999764 345689999999999999998754 45899999999999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc----ccccCCCccccccccccCCCCCcchHHHHHHHHH
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~ 159 (177)
+.|++|+||+|+||++ +..+.++++|||.+......... .....+..|+|||...+..++.++|+||+|++++
T Consensus 126 ~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 202 (284)
T cd05081 126 SKRYVHRDLATRNILV---ESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 202 (284)
T ss_pred HCCceeccCCHhhEEE---CCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHH
Confidence 9999999999999999 46678999999998765433211 1111234589999998888899999999999999
Q ss_pred HHHhCCCCCC
Q 030430 160 ELLNGYPPFS 169 (177)
Q Consensus 160 ~~~~~~~pf~ 169 (177)
++++|..|+.
T Consensus 203 el~~~~~~~~ 212 (284)
T cd05081 203 ELFTYSDKSC 212 (284)
T ss_pred HHhhcCCcCC
Confidence 9999876653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=191.07 Aligned_cols=162 Identities=22% Similarity=0.435 Sum_probs=133.5
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHh
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh 83 (177)
...+.+.+|+.+++.++|||++++++.+.+....+++|||+++++|.+++.+. ...+...+..++.|++.||+|||
T Consensus 37 ~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH 116 (268)
T cd05086 37 KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH 116 (268)
T ss_pred HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH
Confidence 34578999999999999999999999999999999999999999999998754 23667788899999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC---ccccccCCCcccccccccc-------CCCCCcchHHH
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQF-------QRYDEKVDMWS 153 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~-------~~~~~~~Di~s 153 (177)
+.+++|+||+|+||++ +..+.++++|||.+....... ......++..|+|||.... ..++.++|+||
T Consensus 117 ~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws 193 (268)
T cd05086 117 KHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWA 193 (268)
T ss_pred HCCeeccCCccceEEE---cCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHH
Confidence 9999999999999999 456779999999875432211 1123346778999998742 23567899999
Q ss_pred HHHHHHHHHh-CCCCCCCCC
Q 030430 154 VGAILFELLN-GYPPFSVGE 172 (177)
Q Consensus 154 lg~~~~~~~~-~~~pf~~~~ 172 (177)
+|++++++++ +..||...+
T Consensus 194 lG~~l~el~~~~~~p~~~~~ 213 (268)
T cd05086 194 LGVTLWELFENAAQPYSHLS 213 (268)
T ss_pred HHHHHHHHHhCCCCCCCCCC
Confidence 9999999997 577886544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=190.99 Aligned_cols=163 Identities=39% Similarity=0.605 Sum_probs=142.9
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEIL 82 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~l 82 (177)
+.....+.+|++++++++|+|++++.+++.+....++++||+++++|.+++.. ...+++..+..++.|++.|+++|
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l 119 (256)
T cd08530 40 QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119 (256)
T ss_pred HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH
Confidence 44567788999999999999999999999999999999999999999999875 24589999999999999999999
Q ss_pred hhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHH
Q 030430 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 83 h~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~ 162 (177)
|+.|++|+||+|+||++. .++.++++|||.+...... ......++..|++||...+..++.++|+||+|+++++++
T Consensus 120 h~~~i~h~~l~~~ni~~~---~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~ 195 (256)
T cd08530 120 HEQKILHRDLKSANILLV---ANDLVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMA 195 (256)
T ss_pred hhCCcccCCCCcceEEEe---cCCcEEEeeccchhhhccC-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHH
Confidence 999999999999999995 5677999999988665444 222345678899999998888899999999999999999
Q ss_pred hCCCCCCCCCc
Q 030430 163 NGYPPFSVGEE 173 (177)
Q Consensus 163 ~~~~pf~~~~~ 173 (177)
+|..||...+.
T Consensus 196 ~g~~p~~~~~~ 206 (256)
T cd08530 196 TFAPPFEARSM 206 (256)
T ss_pred hCCCCCCCCCH
Confidence 99999987654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=189.82 Aligned_cols=161 Identities=37% Similarity=0.619 Sum_probs=140.3
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---GRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
..+.+.+|++.++.++|+|++++.+.+.+....++++|++++++|.+++... ..+++..+..++.|++.++++||+.
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~ 121 (267)
T cd06610 42 SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN 121 (267)
T ss_pred HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 5677899999999999999999999999999999999999999999999764 3589999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc-----ccccCCCccccccccccC-CCCCcchHHHHHHHHH
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-----EKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILF 159 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~ 159 (177)
|++|+|++|+||+++ ..+.++++|||.+......... ....++..|++||.+... .++.++|+||+|++++
T Consensus 122 ~i~h~~l~p~ni~~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~ 198 (267)
T cd06610 122 GQIHRDIKAGNILLG---EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAI 198 (267)
T ss_pred CeecCCCCHHhEEEc---CCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHH
Confidence 999999999999994 5677999999988665443221 223467789999988766 6889999999999999
Q ss_pred HHHhCCCCCCCCC
Q 030430 160 ELLNGYPPFSVGE 172 (177)
Q Consensus 160 ~~~~~~~pf~~~~ 172 (177)
++++|+.||...+
T Consensus 199 ~l~~g~~p~~~~~ 211 (267)
T cd06610 199 ELATGAAPYSKYP 211 (267)
T ss_pred HHHhCCCCccccC
Confidence 9999999997644
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=193.03 Aligned_cols=159 Identities=31% Similarity=0.489 Sum_probs=135.2
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeC--CeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
...+.+|++++++++|||++++.+++... ...++++||++ ++|.+++.... .+++..+..++.|++.||+|||+.|
T Consensus 48 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 126 (293)
T cd07843 48 PITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW 126 (293)
T ss_pred hhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34567899999999999999999998877 88999999996 59998887654 4899999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccCC-CCCcchHHHHHHHHHHHHhC
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slg~~~~~~~~~ 164 (177)
++|+||+|+||++ +..+.++++|||.+....... ......++..|+|||.+.+.. ++.++|+||+|++++++++|
T Consensus 127 i~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g 203 (293)
T cd07843 127 ILHRDLKTSNLLL---NNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203 (293)
T ss_pred eeeccCCHHHEEE---CCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhC
Confidence 9999999999999 466789999999887665432 222334677899999876543 58899999999999999999
Q ss_pred CCCCCCCC
Q 030430 165 YPPFSVGE 172 (177)
Q Consensus 165 ~~pf~~~~ 172 (177)
..||.+.+
T Consensus 204 ~~~f~~~~ 211 (293)
T cd07843 204 KPLFPGKS 211 (293)
T ss_pred CCCCCCCC
Confidence 99997654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=190.31 Aligned_cols=150 Identities=34% Similarity=0.601 Sum_probs=130.4
Q ss_pred HHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCeeecCCCCcE
Q 030430 18 NFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENI 97 (177)
Q Consensus 18 ~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H~~i~~~ni 97 (177)
+.++...||+++++.+.+.+....++++||++|++|.+++...+.+++..+..++.|++.+++|||+.+++|+||+|+||
T Consensus 49 ~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~ni 128 (278)
T cd05606 49 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANI 128 (278)
T ss_pred HHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHE
Confidence 34455689999999999999999999999999999999998777899999999999999999999999999999999999
Q ss_pred EEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 030430 98 LLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPFSVG 171 (177)
Q Consensus 98 l~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~~~~pf~~~ 171 (177)
++ +.++.++++|||.+........ ....++..|+|||.+.+. .++.++|+||+|++++++++|..||...
T Consensus 129 li---~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 129 LL---DEHGHVRISDLGLACDFSKKKP-HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred EE---CCCCCEEEccCcCccccCccCC-cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 99 4567799999998865533322 234578899999998644 5789999999999999999999999765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=193.36 Aligned_cols=163 Identities=28% Similarity=0.581 Sum_probs=137.5
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC----------------------CCC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------------RVP 64 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------------~~~ 64 (177)
......+.+|++++++++|||++++.+++.+....++++||+++++|.+++.... .++
T Consensus 49 ~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 128 (288)
T cd05050 49 ADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128 (288)
T ss_pred HHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccC
Confidence 3456779999999999999999999999999889999999999999999987432 367
Q ss_pred HHHHHHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccc
Q 030430 65 EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQ 141 (177)
Q Consensus 65 ~~~~~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~ 141 (177)
+..++.++.|++.+|+++|+.|++|+||+|+||++ +..+.++++|||.+........ ......+..|+|||...
T Consensus 129 ~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 205 (288)
T cd05050 129 CTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIF 205 (288)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeecccccHhheEe---cCCCceEECccccceecccCccccccCCCccChhhcCHHHHh
Confidence 78889999999999999999999999999999999 4677899999998865433221 11222456799999988
Q ss_pred cCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 030430 142 FQRYDEKVDMWSVGAILFELLN-GYPPFSVGE 172 (177)
Q Consensus 142 ~~~~~~~~Di~slg~~~~~~~~-~~~pf~~~~ 172 (177)
+..++.++|+||+|++++++++ |..||.+.+
T Consensus 206 ~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 206 YNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 8889999999999999999998 888886543
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=190.21 Aligned_cols=162 Identities=28% Similarity=0.601 Sum_probs=139.5
Q ss_pred hhHHHHHHHHHHHHhhCC---CCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh
Q 030430 7 KHLKSCLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (177)
......+.+|++++++++ |||++++.+++.+....++++||++|++|.+++.. ..+++..+..++.|++.++++||
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh 118 (277)
T cd06917 40 DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIH 118 (277)
T ss_pred chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHH
Confidence 344567889999999996 99999999999999999999999999999999875 47899999999999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCcccccccccc-CCCCCcchHHHHHHHHHHH
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~ 161 (177)
+.|++|+||+|+||+++ ..+.++++|||.+........ .....++..|+|||...+ ..++.++|+||+|++++++
T Consensus 119 ~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l 195 (277)
T cd06917 119 KVGVIHRDIKAANILVT---NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEM 195 (277)
T ss_pred hCCcccCCcCHHHEEEc---CCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHH
Confidence 99999999999999994 577899999998876654332 223457788999998764 3468899999999999999
Q ss_pred HhCCCCCCCCC
Q 030430 162 LNGYPPFSVGE 172 (177)
Q Consensus 162 ~~~~~pf~~~~ 172 (177)
++|..||.+.+
T Consensus 196 l~g~~p~~~~~ 206 (277)
T cd06917 196 ATGNPPYSDVD 206 (277)
T ss_pred HhCCCCCCCCC
Confidence 99999997653
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=195.26 Aligned_cols=157 Identities=34% Similarity=0.579 Sum_probs=133.0
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
....+.+|++++++++|||++++++++.+...+++++||+. ++|.+++.. ...+++..+..++.|++.|++|||+.|+
T Consensus 42 ~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i 120 (284)
T cd07839 42 VPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNV 120 (284)
T ss_pred CccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 34567889999999999999999999999999999999995 588887764 4569999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccC-CCCCcchHHHHHHHHHHHHhCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~~~ 165 (177)
+|+||+|+||++ +..+.++|+|||.+........ .....++..|+|||.+.+. .++.++|+||+|+++++|++|.
T Consensus 121 ~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~ 197 (284)
T cd07839 121 LHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 197 (284)
T ss_pred ecCCCCHHHEEE---cCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcC
Confidence 999999999999 4567899999998876543221 2233467889999987654 4688999999999999999998
Q ss_pred CCCC
Q 030430 166 PPFS 169 (177)
Q Consensus 166 ~pf~ 169 (177)
.||.
T Consensus 198 ~p~~ 201 (284)
T cd07839 198 RPLF 201 (284)
T ss_pred CCCc
Confidence 8853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=197.66 Aligned_cols=159 Identities=36% Similarity=0.532 Sum_probs=135.8
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeC------CeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (177)
.....+.+|+.+++.++|||++++++++... ...|+++||+ +++|.+.+... ++...+..++.|++.||++
T Consensus 57 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~ 133 (353)
T cd07850 57 THAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMD--LDHERMSYLLYQMLCGIKH 133 (353)
T ss_pred hHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEecc-CCCHHHHHhhc--CCHHHHHHHHHHHHHHHHH
Confidence 3455677899999999999999999987543 3579999999 45888877643 8899999999999999999
Q ss_pred HhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHH
Q 030430 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 82 lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~ 161 (177)
||+.|++|+||+|+||++ +..+.++|+|||.+.............++..|+|||.+.+..++.++|+||+|++++++
T Consensus 134 LH~~gi~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l 210 (353)
T cd07850 134 LHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 210 (353)
T ss_pred HHhCCeeeCCCCHHHEEE---CCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHH
Confidence 999999999999999999 46678999999998766544333344567889999999888899999999999999999
Q ss_pred HhCCCCCCCCC
Q 030430 162 LNGYPPFSVGE 172 (177)
Q Consensus 162 ~~~~~pf~~~~ 172 (177)
++|+.||...+
T Consensus 211 ~~g~~pf~~~~ 221 (353)
T cd07850 211 IRGTVLFPGTD 221 (353)
T ss_pred HHCCCCCCCCC
Confidence 99999997654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=191.94 Aligned_cols=162 Identities=26% Similarity=0.451 Sum_probs=135.7
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC----------CCCHHHHHHHHHHHHHH
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------RVPEQTARKFLQQLGAG 78 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~i~~~ 78 (177)
....+.+|..+++.++|||++++++++.++...+++|||+++++|.+++.... .++...+..++.|++.+
T Consensus 52 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 131 (288)
T cd05061 52 ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131 (288)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHH
Confidence 34567889999999999999999999999999999999999999999997432 24567888999999999
Q ss_pred HHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc---ccccCCCccccccccccCCCCCcchHHHHH
Q 030430 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVG 155 (177)
Q Consensus 79 l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~Di~slg 155 (177)
++|||+.|++|+||+|+||++. ..+.++++|||.+......... ....++..|+|||...+..++.++|+||+|
T Consensus 132 l~~lH~~~i~H~dikp~nili~---~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG 208 (288)
T cd05061 132 MAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFG 208 (288)
T ss_pred HHHHHhCCCcCCCCChheEEEc---CCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHH
Confidence 9999999999999999999994 5678999999988654332211 112235679999998888889999999999
Q ss_pred HHHHHHHh-CCCCCCCCCc
Q 030430 156 AILFELLN-GYPPFSVGEE 173 (177)
Q Consensus 156 ~~~~~~~~-~~~pf~~~~~ 173 (177)
++++++++ |..||.+...
T Consensus 209 ~~l~el~~~~~~p~~~~~~ 227 (288)
T cd05061 209 VVLWEITSLAEQPYQGLSN 227 (288)
T ss_pred HHHHHHHhCCCCCCCCCCH
Confidence 99999998 7889976543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=186.55 Aligned_cols=161 Identities=31% Similarity=0.631 Sum_probs=143.3
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+.+.+|++++++++|++++++.+++.+.+..++++|++++++|.+++.....+++..+..++.|++.++++||+.|+
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i 120 (254)
T cd06627 41 EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGV 120 (254)
T ss_pred HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCc
Confidence 45678999999999999999999999999999999999999999999999877789999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
+|+||+|+||++. ..+.++++|||.+........ .....++..|++||...+..++.++|+||+|++++++++|..
T Consensus 121 ~H~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~ 197 (254)
T cd06627 121 IHRDIKAANILTT---KDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNP 197 (254)
T ss_pred ccCCCCHHHEEEC---CCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCC
Confidence 9999999999994 567899999999877654433 123446778999999877778899999999999999999999
Q ss_pred CCCCC
Q 030430 167 PFSVG 171 (177)
Q Consensus 167 pf~~~ 171 (177)
||...
T Consensus 198 p~~~~ 202 (254)
T cd06627 198 PYYDL 202 (254)
T ss_pred CCCCc
Confidence 99654
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=189.25 Aligned_cols=161 Identities=27% Similarity=0.534 Sum_probs=136.8
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
..+.+.+|+++++.++|+|++++.+++.+ ...++++||+++++|.+++.+. ..++...+..++.|++.++++||+.|
T Consensus 44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~ 122 (260)
T cd05073 44 SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 122 (260)
T ss_pred HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC
Confidence 35678899999999999999999999887 6789999999999999999753 34788899999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc--ccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~- 163 (177)
++|+||+|+|+++ +..+.++++|||.+......... ....++..|+|||.+....++.++|+||+|++++++++
T Consensus 123 i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~ 199 (260)
T cd05073 123 YIHRDLRAANILV---SASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTY 199 (260)
T ss_pred ccccccCcceEEE---cCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhc
Confidence 9999999999999 46778999999988665432211 12234566999999987788999999999999999999
Q ss_pred CCCCCCCCCc
Q 030430 164 GYPPFSVGEE 173 (177)
Q Consensus 164 ~~~pf~~~~~ 173 (177)
|..||.+.+.
T Consensus 200 g~~p~~~~~~ 209 (260)
T cd05073 200 GRIPYPGMSN 209 (260)
T ss_pred CCCCCCCCCH
Confidence 8999987543
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=192.89 Aligned_cols=162 Identities=31% Similarity=0.597 Sum_probs=140.2
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+.+.+|+.+++.++|||++++++++......++|+||+++++|.+++.+. .++...+..++.|++.++++||+.|+
T Consensus 58 ~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi 136 (293)
T cd06647 58 PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQV 136 (293)
T ss_pred hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 34567889999999999999999999999999999999999999999998743 58899999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
+|+|++|+||+++ .++.++++|||.+........ .....++..|++||.+....++.++|+||+|++++++++|+.
T Consensus 137 ~H~dL~p~Nili~---~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~ 213 (293)
T cd06647 137 IHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213 (293)
T ss_pred eeccCCHHHEEEc---CCCCEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999994 567899999998765543322 223346778999999887788999999999999999999999
Q ss_pred CCCCCCc
Q 030430 167 PFSVGEE 173 (177)
Q Consensus 167 pf~~~~~ 173 (177)
||...+.
T Consensus 214 pf~~~~~ 220 (293)
T cd06647 214 PYLNENP 220 (293)
T ss_pred CCCCCCh
Confidence 9976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=192.30 Aligned_cols=161 Identities=27% Similarity=0.586 Sum_probs=140.1
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
.....+.+|+.+++.++|+|++++.+.+..+...++++||+++++|.+++. ...+++..+..++.|++.++++||+.|+
T Consensus 59 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~gi 137 (292)
T cd06657 59 QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGV 137 (292)
T ss_pred hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 456678999999999999999999999999999999999999999999775 4468999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
+|+||+|+||++ +..+.++++|||.+........ .....++..|++||...+..++.++|+||+|++++++++|..
T Consensus 138 vH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~ 214 (292)
T cd06657 138 IHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 214 (292)
T ss_pred ecCCCCHHHEEE---CCCCCEEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999 4566799999998765543321 223346788999999887788999999999999999999999
Q ss_pred CCCCCC
Q 030430 167 PFSVGE 172 (177)
Q Consensus 167 pf~~~~ 172 (177)
||.+..
T Consensus 215 p~~~~~ 220 (292)
T cd06657 215 PYFNEP 220 (292)
T ss_pred CCCCCC
Confidence 997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=191.70 Aligned_cols=158 Identities=32% Similarity=0.514 Sum_probs=132.5
Q ss_pred HHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
..+.+|+++++.++|+|++++.+++.++...++++||+. +++.+++... ..++...+..++.|++.+|++||+.|++|
T Consensus 48 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H 126 (291)
T cd07870 48 FTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILH 126 (291)
T ss_pred HHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 467789999999999999999999999999999999995 6777766543 45788899999999999999999999999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccC-CCCCcchHHHHHHHHHHHHhCCCC
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
+||+|+||++ +..+.++|+|||.+....... ......++..|+|||...+. .++.++|+||+|++++++++|..|
T Consensus 127 ~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~ 203 (291)
T cd07870 127 RDLKPQNLLI---SYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPA 203 (291)
T ss_pred CCCChHHEEE---cCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999 466789999999886543222 12233467889999988653 478899999999999999999999
Q ss_pred CCCCC
Q 030430 168 FSVGE 172 (177)
Q Consensus 168 f~~~~ 172 (177)
|.+.+
T Consensus 204 f~~~~ 208 (291)
T cd07870 204 FPGVS 208 (291)
T ss_pred CCCch
Confidence 97643
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=191.64 Aligned_cols=158 Identities=32% Similarity=0.522 Sum_probs=133.6
Q ss_pred HHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
..+.+|++++++++|+||+++.+++.+....++|+||+++ +|.+++... ..+++..+..++.|++.||+|||+.|++|
T Consensus 48 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H 126 (291)
T cd07844 48 FTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLH 126 (291)
T ss_pred hhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 4467899999999999999999999999999999999964 999988754 45899999999999999999999999999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCcccccccccc-CCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
+||+|+||++ +..+.++++|||.+........ .....++..|+|||...+ ..++.++|+||+|++++++++|+.|
T Consensus 127 ~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~ 203 (291)
T cd07844 127 RDLKPQNLLI---SERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPL 203 (291)
T ss_pred ccCCHHHEEE---cCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999 4667899999998865432211 112235678999998764 4578899999999999999999999
Q ss_pred CCCCC
Q 030430 168 FSVGE 172 (177)
Q Consensus 168 f~~~~ 172 (177)
|.+..
T Consensus 204 ~~~~~ 208 (291)
T cd07844 204 FPGST 208 (291)
T ss_pred CCCCc
Confidence 97654
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=189.22 Aligned_cols=160 Identities=26% Similarity=0.478 Sum_probs=135.3
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
..+.+.+|+.++++++|++++++++++.. ...+++|||+++++|.+++... ..+++.++..++.|++.+++|||+.|
T Consensus 44 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~ 122 (260)
T cd05070 44 SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN 122 (260)
T ss_pred CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34678999999999999999999998754 4578999999999999998753 34899999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc--ccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~- 163 (177)
++|+||+|+||+++ .++.++++|||.+......... ....++..|+|||...+..++.++|+||+|++++++++
T Consensus 123 i~H~di~p~Nili~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~ 199 (260)
T cd05070 123 YIHRDLRSANILVG---DGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTK 199 (260)
T ss_pred cccCCCccceEEEe---CCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhc
Confidence 99999999999995 5678999999998765433211 11223457999999887888999999999999999999
Q ss_pred CCCCCCCCC
Q 030430 164 GYPPFSVGE 172 (177)
Q Consensus 164 ~~~pf~~~~ 172 (177)
|..||.+.+
T Consensus 200 g~~p~~~~~ 208 (260)
T cd05070 200 GRVPYPGMN 208 (260)
T ss_pred CCCCCCCCC
Confidence 899997644
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=191.00 Aligned_cols=159 Identities=33% Similarity=0.564 Sum_probs=137.8
Q ss_pred HHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
..+.+.+|+++++++ +|++|+++.+++..+...++++||+++++|.+++.....+++..+..++.|++.++++||+.|+
T Consensus 47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i 126 (290)
T cd05613 47 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGI 126 (290)
T ss_pred HHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 346678899999999 5899999999999999999999999999999999887789999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--cccccCCCccccccccccC--CCCCcchHHHHHHHHHHHHh
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQ--RYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~--~~~~~~Di~slg~~~~~~~~ 163 (177)
+|+||+|+||++ +..+.++|+|||.+........ .....++..|++||..... ..+.++|+||+|++++++++
T Consensus 127 ~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~ 203 (290)
T cd05613 127 IYRDIKLENILL---DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT 203 (290)
T ss_pred eccCCCHHHeEE---CCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhc
Confidence 999999999999 4567899999998866543221 1234467889999988643 46788999999999999999
Q ss_pred CCCCCCC
Q 030430 164 GYPPFSV 170 (177)
Q Consensus 164 ~~~pf~~ 170 (177)
|..||..
T Consensus 204 g~~p~~~ 210 (290)
T cd05613 204 GASPFTV 210 (290)
T ss_pred CCCCCCc
Confidence 9999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=188.32 Aligned_cols=153 Identities=31% Similarity=0.469 Sum_probs=131.8
Q ss_pred HHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCeeecC
Q 030430 13 LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDL 92 (177)
Q Consensus 13 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H~~i 92 (177)
..+|...+....|||++++++++.+....++++||++|++|.+++.+...+++..+..++.|++.+++++|+.|++|+||
T Consensus 32 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dl 111 (237)
T cd05576 32 YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDL 111 (237)
T ss_pred hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCC
Confidence 44566666667899999999999999999999999999999999987778999999999999999999999999999999
Q ss_pred CCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 030430 93 KPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 170 (177)
Q Consensus 93 ~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf~~ 170 (177)
+|+||++ +..+.++++|||.+....... .....+..|++||...+..+++++|+||+|++++++++|..||..
T Consensus 112 kp~Nil~---~~~~~~~l~df~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 112 NPNNILL---DDRGHIQLTYFSRWSEVEDSC--DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred CHHHEEE---cCCCCEEEecccchhcccccc--ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 9999999 456779999999775543322 123346679999998877889999999999999999999988754
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=190.55 Aligned_cols=161 Identities=32% Similarity=0.495 Sum_probs=134.2
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
..+.+.+|++++++++|||++++++++.++...++|+||++ ++|.+++..... +++..+..++.|++.||++||+.|
T Consensus 44 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ 122 (294)
T PLN00009 44 VPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR 122 (294)
T ss_pred chHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34568899999999999999999999999999999999995 588887765433 578889999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccC-CCCCcchHHHHHHHHHHHHhC
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~~ 164 (177)
++|+||+|+||++. ..+..++++|||.+........ .....++..|+|||.+.+. .++.++|+||+|++++++++|
T Consensus 123 i~H~dl~p~nill~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg 200 (294)
T PLN00009 123 VLHRDLKPQNLLID--RRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQ 200 (294)
T ss_pred eeCCCCCcceEEEE--CCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99999999999995 3455789999999866543221 1223457789999987653 468899999999999999999
Q ss_pred CCCCCCCC
Q 030430 165 YPPFSVGE 172 (177)
Q Consensus 165 ~~pf~~~~ 172 (177)
..||...+
T Consensus 201 ~~pf~~~~ 208 (294)
T PLN00009 201 KPLFPGDS 208 (294)
T ss_pred CCCCCCCC
Confidence 99997653
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=187.57 Aligned_cols=161 Identities=29% Similarity=0.471 Sum_probs=132.6
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEe-eCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQ-AENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
...+.+.+|+.+++.++|||++++++++. .++..++++||+.+++|.+++... ...+...+..++.|++.+++|||+.
T Consensus 38 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 117 (262)
T cd05058 38 EEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK 117 (262)
T ss_pred HHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 34567889999999999999999999764 456688999999999999999754 3467788889999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-----ccccccCCCccccccccccCCCCCcchHHHHHHHHHH
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~ 160 (177)
|++|+||+|+||+++ ..+.++++|||.+....... ......++..|+|||......++.++|+||+|+++++
T Consensus 118 ~i~H~dlk~~nili~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~e 194 (262)
T cd05058 118 KFVHRDLAARNCMLD---ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 194 (262)
T ss_pred CccccccCcceEEEc---CCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHH
Confidence 999999999999994 56779999999886543221 1112234567999999887888999999999999999
Q ss_pred HHhC-CCCCCCC
Q 030430 161 LLNG-YPPFSVG 171 (177)
Q Consensus 161 ~~~~-~~pf~~~ 171 (177)
+++| .+||...
T Consensus 195 l~~~~~~~~~~~ 206 (262)
T cd05058 195 LMTRGAPPYPDV 206 (262)
T ss_pred HHcCCCCCCCCC
Confidence 9995 5667543
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=190.15 Aligned_cols=163 Identities=25% Similarity=0.447 Sum_probs=138.0
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEee-CCeEEEEEecCCCCChHHHHhhc--------CCCCHHHHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH--------GRVPEQTARKFLQQLGA 77 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~i~~ 77 (177)
......+.+|+++++.++|||++++++++.. +...+++++++++++|.+++... ..++...++.++.|++.
T Consensus 49 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~ 128 (280)
T cd05043 49 EIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128 (280)
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHH
Confidence 4456778999999999999999999998665 56789999999999999998753 34889999999999999
Q ss_pred HHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc---ccccCCCccccccccccCCCCCcchHHHH
Q 030430 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSV 154 (177)
Q Consensus 78 ~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~Di~sl 154 (177)
+++|||+.|++|+||+|+||++ ++...++++|||.++........ ....++..|+|||...+..++.++|+||+
T Consensus 129 ~l~~LH~~~i~H~di~p~nil~---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl 205 (280)
T cd05043 129 GMSYLHKRGVIHKDIAARNCVI---DEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSF 205 (280)
T ss_pred HHHHHHHCCEeecccCHhhEEE---cCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHh
Confidence 9999999999999999999999 46678999999998765433211 12234567999999988888999999999
Q ss_pred HHHHHHHHh-CCCCCCCCC
Q 030430 155 GAILFELLN-GYPPFSVGE 172 (177)
Q Consensus 155 g~~~~~~~~-~~~pf~~~~ 172 (177)
|++++++++ |+.||...+
T Consensus 206 G~~l~el~~~g~~p~~~~~ 224 (280)
T cd05043 206 GVLLWELMTLGQTPYVEID 224 (280)
T ss_pred HHHHHHHhcCCCCCcCcCC
Confidence 999999999 999997643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=214.17 Aligned_cols=167 Identities=25% Similarity=0.512 Sum_probs=147.6
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
.+..+..|..|+.||-|++||||+++-++.......+||+|||++|+|+.|++++ ++|+..++..+++.|+.+++||.+
T Consensus 670 tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd 749 (996)
T KOG0196|consen 670 TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD 749 (996)
T ss_pred cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh
Confidence 4677889999999999999999999999999999999999999999999999977 569999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccc-ccc--CCCccccccccccCCCCCcchHHHHHHHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAE-KVC--GSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~-~~~--~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~ 160 (177)
.|+||||+...|||+ +.+-.+|++|||+++....+. ... +.. ...+|.|||.+....++.+||+||+|+++||
T Consensus 750 m~YVHRDLAARNILV---NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWE 826 (996)
T KOG0196|consen 750 MNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE 826 (996)
T ss_pred cCchhhhhhhhheee---ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEE
Confidence 999999999999999 578889999999998665443 111 222 2467999999999999999999999999999
Q ss_pred HHh-CCCCCCCCCccc
Q 030430 161 LLN-GYPPFSVGEEHQ 175 (177)
Q Consensus 161 ~~~-~~~pf~~~~~~~ 175 (177)
.++ |..||..-++.+
T Consensus 827 VmSyGERPYWdmSNQd 842 (996)
T KOG0196|consen 827 VMSYGERPYWDMSNQD 842 (996)
T ss_pred ecccCCCcccccchHH
Confidence 888 999987765443
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=192.47 Aligned_cols=161 Identities=34% Similarity=0.587 Sum_probs=138.3
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
..+.+.+|+++++.++|||++++++++.+.+..++++||+++++|..+......++...+..++.|++.+++|||+.|++
T Consensus 43 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~ 122 (286)
T cd07846 43 VKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNII 122 (286)
T ss_pred hhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 45568899999999999999999999999999999999999999988877666799999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCcccccccccc-CCCCCcchHHHHHHHHHHHHhCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
|+|++|+||++ +.++.++++|||.+........ .....++..|+|||...+ ..++.++|+||+|++++++++|..
T Consensus 123 h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~ 199 (286)
T cd07846 123 HRDIKPENILV---SQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEP 199 (286)
T ss_pred ccCCCHHHEEE---CCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCC
Confidence 99999999999 4677899999998876543322 223346778999998764 346788999999999999999999
Q ss_pred CCCCCC
Q 030430 167 PFSVGE 172 (177)
Q Consensus 167 pf~~~~ 172 (177)
||...+
T Consensus 200 ~~~~~~ 205 (286)
T cd07846 200 LFPGDS 205 (286)
T ss_pred CCCCCc
Confidence 997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=188.66 Aligned_cols=160 Identities=33% Similarity=0.598 Sum_probs=134.5
Q ss_pred HHHHHHHHHHHHhhC-CCCceeeEeEEEee------CCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHH
Q 030430 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGL 79 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l 79 (177)
....+.+|+.+++++ +|+|++++.+++.. ...+++++||+++++|.+++... ..+++..+..++.|++.++
T Consensus 45 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l 124 (272)
T cd06637 45 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124 (272)
T ss_pred cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHH
Confidence 345788999999999 79999999998864 24689999999999999998864 3589999999999999999
Q ss_pred HHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccc-----cCCCCCcchHHH
Q 030430 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWS 153 (177)
Q Consensus 80 ~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~s 153 (177)
+|||+.|++|+|++|+||++ +.++.++++|||.+....... ......++..|+|||.+. ...++.++|+||
T Consensus 125 ~~LH~~~ivh~dl~~~nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~s 201 (272)
T cd06637 125 SHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWS 201 (272)
T ss_pred HHHHHCCCccCCCCHHHEEE---CCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHH
Confidence 99999999999999999999 466779999999986543322 223345778899999875 335778999999
Q ss_pred HHHHHHHHHhCCCCCCCC
Q 030430 154 VGAILFELLNGYPPFSVG 171 (177)
Q Consensus 154 lg~~~~~~~~~~~pf~~~ 171 (177)
+|++++++++|+.||...
T Consensus 202 lGv~l~el~~g~~p~~~~ 219 (272)
T cd06637 202 LGITAIEMAEGAPPLCDM 219 (272)
T ss_pred HHHHHHHHHhCCCCcccc
Confidence 999999999999999653
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=187.88 Aligned_cols=159 Identities=30% Similarity=0.588 Sum_probs=139.1
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
....+.+|++++++++|||++++++++.++..+++|+||+++++|.+++.. ..++...+..++.+++.++++||+.|++
T Consensus 45 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~ 123 (277)
T cd06641 45 EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKI 123 (277)
T ss_pred HHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCee
Confidence 346788999999999999999999999999999999999999999998874 4689999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
|+|++|+||++ +..+.++++|||.+........ .....++..|++||...+..++.++|+||+|++++++++|..|
T Consensus 124 h~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 200 (277)
T cd06641 124 HRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200 (277)
T ss_pred cCCCCHHhEEE---CCCCCEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 99999999999 4667799999998866543322 1223467789999998877889999999999999999999999
Q ss_pred CCCC
Q 030430 168 FSVG 171 (177)
Q Consensus 168 f~~~ 171 (177)
|...
T Consensus 201 ~~~~ 204 (277)
T cd06641 201 HSEL 204 (277)
T ss_pred CCcc
Confidence 9754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=188.50 Aligned_cols=163 Identities=33% Similarity=0.651 Sum_probs=140.3
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
...+.+.+|+++++.++|+|++++++.+.+.+..++++||+++++|.+++.... .+++..+..++.|++.++++||+.
T Consensus 41 ~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~ 120 (257)
T cd08225 41 KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120 (257)
T ss_pred hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 345678899999999999999999999999999999999999999999987543 378999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhC
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~ 164 (177)
+++|+|++|+||+++ +....++++|||.+........ .....++..|+|||...+..++.++|+||+|++++++++|
T Consensus 121 ~i~H~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g 198 (257)
T cd08225 121 KILHRDIKSQNIFLS--KNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTL 198 (257)
T ss_pred CcccccCCHHHEEEc--CCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence 999999999999995 3334579999998876544322 1223467789999998877889999999999999999999
Q ss_pred CCCCCCCC
Q 030430 165 YPPFSVGE 172 (177)
Q Consensus 165 ~~pf~~~~ 172 (177)
..||...+
T Consensus 199 ~~p~~~~~ 206 (257)
T cd08225 199 KHPFEGNN 206 (257)
T ss_pred CCCCCCcc
Confidence 99997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=186.92 Aligned_cols=163 Identities=35% Similarity=0.654 Sum_probs=143.6
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc----CCCCHHHHHHHHHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEIL 82 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~l 82 (177)
+.....+.+|++++++++|||++++.+.+......++++|++++++|.+++... ..+++..+..++.+++.++++|
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l 119 (258)
T cd08215 40 EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119 (258)
T ss_pred hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHH
Confidence 356778999999999999999999999999999999999999999999998864 5699999999999999999999
Q ss_pred hhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccCCCCCcchHHHHHHHHHHH
Q 030430 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 83 h~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~ 161 (177)
|+.|++|+|++|+||++ +..+.++++|||.+....... ......++..|+|||......++.++|+||+|++++++
T Consensus 120 h~~~~~H~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l 196 (258)
T cd08215 120 HSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYEL 196 (258)
T ss_pred HhCCEecccCChHHeEE---cCCCcEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHH
Confidence 99999999999999999 456789999999886654443 22334567889999998878889999999999999999
Q ss_pred HhCCCCCCCCC
Q 030430 162 LNGYPPFSVGE 172 (177)
Q Consensus 162 ~~~~~pf~~~~ 172 (177)
++|..||...+
T Consensus 197 ~~g~~p~~~~~ 207 (258)
T cd08215 197 CTLKHPFEGEN 207 (258)
T ss_pred HcCCCCCCCCc
Confidence 99999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=187.73 Aligned_cols=160 Identities=26% Similarity=0.530 Sum_probs=135.6
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+.+|+++++.++|+|++++.+++.+ +..++++|++.+++|.+++... ..++..++..++.|++.++++||+.|+
T Consensus 45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i 123 (260)
T cd05067 45 PEAFLAEANLMKQLQHPRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY 123 (260)
T ss_pred HHHHHHHHHHHHhcCCcCeeeEEEEEcc-CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCe
Confidence 4578899999999999999999998754 5689999999999999988754 358899999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc--ccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-C
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-~ 164 (177)
+|+||+|+|+++ +..+.++++|||.+......... ....++..|+|||......++.++|+||+|++++++++ |
T Consensus 124 ~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g 200 (260)
T cd05067 124 IHRDLRAANILV---SETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYG 200 (260)
T ss_pred ecccccHHhEEE---cCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCC
Confidence 999999999999 46677999999988665422211 12234567999999988888999999999999999999 9
Q ss_pred CCCCCCCCc
Q 030430 165 YPPFSVGEE 173 (177)
Q Consensus 165 ~~pf~~~~~ 173 (177)
..||.+.+.
T Consensus 201 ~~p~~~~~~ 209 (260)
T cd05067 201 RIPYPGMTN 209 (260)
T ss_pred CCCCCCCCh
Confidence 999976543
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=186.98 Aligned_cols=161 Identities=30% Similarity=0.589 Sum_probs=138.2
Q ss_pred HHHHHHHHHHHHhh-CCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHh
Q 030430 9 LKSCLDCELNFLSS-VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 9 ~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh 83 (177)
....+.+|++++.+ ++|||++++++++.+++..++++||++|++|.+++.. ...+++..++.++.|++.++.+||
T Consensus 51 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh 130 (269)
T cd08528 51 SIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH 130 (269)
T ss_pred HHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc
Confidence 44557788888875 6999999999999999999999999999999988743 245899999999999999999999
Q ss_pred h-CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHH
Q 030430 84 S-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 84 ~-~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~ 162 (177)
+ .|++|+||+|.||++ +..+.++++|||.+.............++..|++||...+..++.++|+||+|+++++++
T Consensus 131 ~~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~ 207 (269)
T cd08528 131 KEKRIVHRDLTPNNIML---GEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMC 207 (269)
T ss_pred cCCceeecCCCHHHEEE---CCCCcEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHH
Confidence 6 789999999999999 466789999999987655443333455778899999998888899999999999999999
Q ss_pred hCCCCCCCCC
Q 030430 163 NGYPPFSVGE 172 (177)
Q Consensus 163 ~~~~pf~~~~ 172 (177)
+|..||....
T Consensus 208 ~g~~p~~~~~ 217 (269)
T cd08528 208 TLQPPFYSTN 217 (269)
T ss_pred hCCCcccccC
Confidence 9999996543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=190.24 Aligned_cols=160 Identities=32% Similarity=0.636 Sum_probs=133.3
Q ss_pred HHHHHHHHHHHhhC-CCCceeeEeEEEe-----eCCeEEEEEecCCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHH
Q 030430 10 KSCLDCELNFLSSV-NHPNIIRLFDAFQ-----AENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGL 79 (177)
Q Consensus 10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l 79 (177)
...+.+|+.+++.+ +|||++++++++. .++.++++|||++|++|.+++.. ...+++..+..++.|++.++
T Consensus 58 ~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l 137 (286)
T cd06638 58 DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137 (286)
T ss_pred HHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHH
Confidence 46688899999999 7999999999873 45578999999999999998753 24588899999999999999
Q ss_pred HHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCcccccccccc-----CCCCCcchHHH
Q 030430 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-----QRYDEKVDMWS 153 (177)
Q Consensus 80 ~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~-----~~~~~~~Di~s 153 (177)
.|||+.+++|+|++|+||+++ ..+.++++|||.+....... ......++..|+|||.+.. ..++.++|+||
T Consensus 138 ~~lH~~~i~H~dlkp~nili~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~s 214 (286)
T cd06638 138 QHLHVNKTIHRDVKGNNILLT---TEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWS 214 (286)
T ss_pred HHHHhCCccccCCCHHhEEEC---CCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhh
Confidence 999999999999999999994 56679999999886654322 2223457888999998742 34788999999
Q ss_pred HHHHHHHHHhCCCCCCCCC
Q 030430 154 VGAILFELLNGYPPFSVGE 172 (177)
Q Consensus 154 lg~~~~~~~~~~~pf~~~~ 172 (177)
+|++++++++|+.||....
T Consensus 215 lGvi~~el~~g~~p~~~~~ 233 (286)
T cd06638 215 LGITAIELGDGDPPLADLH 233 (286)
T ss_pred HHHHHHHHhcCCCCCCCCc
Confidence 9999999999999987543
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=191.42 Aligned_cols=160 Identities=33% Similarity=0.574 Sum_probs=135.9
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
....+.+|++++++++|||++++.+++.+.+..++++||+. ++|.+++... ..+++..+..++.|++.+++|||+.|
T Consensus 42 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~ 120 (284)
T cd07860 42 VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120 (284)
T ss_pred cchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34578899999999999999999999999999999999995 6898888653 45899999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccCC-CCCcchHHHHHHHHHHHHhC
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slg~~~~~~~~~ 164 (177)
++|+||+|+||++ +.++.++++|||.+........ .....++..|+|||...+.. ++.++|+||+|+++++++||
T Consensus 121 i~H~~l~p~nill---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg 197 (284)
T cd07860 121 VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 197 (284)
T ss_pred eecCCCCHHHEEE---CCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHC
Confidence 9999999999999 4667899999998865543321 12234577899999876544 58889999999999999999
Q ss_pred CCCCCCCC
Q 030430 165 YPPFSVGE 172 (177)
Q Consensus 165 ~~pf~~~~ 172 (177)
+.||.+.+
T Consensus 198 ~~p~~~~~ 205 (284)
T cd07860 198 RALFPGDS 205 (284)
T ss_pred CCCCCCCC
Confidence 99997654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=191.35 Aligned_cols=160 Identities=26% Similarity=0.453 Sum_probs=135.0
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
.....+.+|+++++.++|||++++++++... ..+++++++++++|.+++..+. .+++..+..++.|++.+++|||+.|
T Consensus 51 ~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ 129 (303)
T cd05110 51 KANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR 129 (303)
T ss_pred HHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC
Confidence 3345788999999999999999999988654 4678999999999999987654 5889999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc---ccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~ 163 (177)
++|+||+|+||++. ..+.++|+|||.+......... ....++..|++||.+.+..++.++|+||+|++++++++
T Consensus 130 ivH~dikp~Nill~---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t 206 (303)
T cd05110 130 LVHRDLAARNVLVK---SPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206 (303)
T ss_pred eeccccccceeeec---CCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHh
Confidence 99999999999994 5667999999998765432211 12234567999999988888999999999999999997
Q ss_pred -CCCCCCCC
Q 030430 164 -GYPPFSVG 171 (177)
Q Consensus 164 -~~~pf~~~ 171 (177)
|..||.+.
T Consensus 207 ~g~~p~~~~ 215 (303)
T cd05110 207 FGGKPYDGI 215 (303)
T ss_pred CCCCCCCCC
Confidence 89999764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=195.52 Aligned_cols=158 Identities=34% Similarity=0.506 Sum_probs=135.3
Q ss_pred HHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCeeec
Q 030430 12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRD 91 (177)
Q Consensus 12 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H~~ 91 (177)
.+.+|++++++++|+|++++.+++......++++|++. ++|.+++.....+++..+..++.|++.++++||+.|++|+|
T Consensus 66 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~d 144 (335)
T PTZ00024 66 TTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRD 144 (335)
T ss_pred hHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence 57789999999999999999999999999999999995 69999988777799999999999999999999999999999
Q ss_pred CCCCcEEEecCCCCeeEEEeeeccccccCCCC---------------ccccccCCCccccccccccC-CCCCcchHHHHH
Q 030430 92 LKPENILLSGLDDDVMLKIADFGLSCTLYPGN---------------YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVG 155 (177)
Q Consensus 92 i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---------------~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg 155 (177)
|+|+||++ +..+.++++|||.+....... ......++..|+|||.+.+. .++.++|+||+|
T Consensus 145 l~~~nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 221 (335)
T PTZ00024 145 LSPANIFI---NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG 221 (335)
T ss_pred ccHHHeEE---CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHH
Confidence 99999999 466789999999886654111 11122356779999988654 368899999999
Q ss_pred HHHHHHHhCCCCCCCCCc
Q 030430 156 AILFELLNGYPPFSVGEE 173 (177)
Q Consensus 156 ~~~~~~~~~~~pf~~~~~ 173 (177)
++++++++|..||.+.++
T Consensus 222 ~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 222 CIFAELLTGKPLFPGENE 239 (335)
T ss_pred HHHHHHHhCCCCCCCCCH
Confidence 999999999999976543
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=195.74 Aligned_cols=161 Identities=29% Similarity=0.521 Sum_probs=135.7
Q ss_pred hHHHHHHHHHHHHhhCC-CCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-------------------------
Q 030430 8 HLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG------------------------- 61 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------------- 61 (177)
...+.+.+|++++.++. ||||+++++++..++..++++||+++++|.+++..+.
T Consensus 82 ~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (401)
T cd05107 82 SEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPL 161 (401)
T ss_pred hHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccc
Confidence 33457889999999997 9999999999999999999999999999999986431
Q ss_pred -------------------------------------------------------------------------CCCHHHH
Q 030430 62 -------------------------------------------------------------------------RVPEQTA 68 (177)
Q Consensus 62 -------------------------------------------------------------------------~~~~~~~ 68 (177)
.++...+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 241 (401)
T cd05107 162 SQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDL 241 (401)
T ss_pred cccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHH
Confidence 2566678
Q ss_pred HHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC---ccccccCCCccccccccccCCC
Q 030430 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRY 145 (177)
Q Consensus 69 ~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~ 145 (177)
..++.|++.+++|||+.|++|+||+|+||++. ....++++|||.+....... ......++..|++||.+.+..+
T Consensus 242 ~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~---~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 318 (401)
T cd05107 242 VGFSYQVANGMEFLASKNCVHRDLAARNVLIC---EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY 318 (401)
T ss_pred HHHHHHHHHHHHHHhcCCcCcccCCcceEEEe---CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC
Confidence 88999999999999999999999999999994 56789999999987643221 1122335677999999988888
Q ss_pred CCcchHHHHHHHHHHHHh-CCCCCCCC
Q 030430 146 DEKVDMWSVGAILFELLN-GYPPFSVG 171 (177)
Q Consensus 146 ~~~~Di~slg~~~~~~~~-~~~pf~~~ 171 (177)
+.++|+||+|++++++++ |..||...
T Consensus 319 ~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 319 TTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred CcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999998 88999654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=187.66 Aligned_cols=164 Identities=30% Similarity=0.520 Sum_probs=141.2
Q ss_pred chhHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHh
Q 030430 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh 83 (177)
+++...++.+.++++..- ++|.||+++++|..+....+.||.+ +..+++++++. +++++..+.++...++.||.||.
T Consensus 130 Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLK 208 (391)
T KOG0983|consen 130 NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLK 208 (391)
T ss_pred CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHH
Confidence 445556677777766555 5899999999999999999999988 77888888754 46999999999999999999999
Q ss_pred hC-CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccc---cCCCCCcchHHHHHHHHH
Q 030430 84 SH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILF 159 (177)
Q Consensus 84 ~~-~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slg~~~~ 159 (177)
++ |++|||+||+||++ ++++++|+||||.+-+.-.+.......|-+.||+||.+. ...|+.++||||||++++
T Consensus 209 eKH~viHRDvKPSNILl---De~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlv 285 (391)
T KOG0983|consen 209 EKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLV 285 (391)
T ss_pred HhcceeecccCccceEE---ccCCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchh
Confidence 85 79999999999999 789999999999998887777766777889999999885 345889999999999999
Q ss_pred HHHhCCCCCCCCCc
Q 030430 160 ELLNGYPPFSVGEE 173 (177)
Q Consensus 160 ~~~~~~~pf~~~~~ 173 (177)
|++||+.||.+.+.
T Consensus 286 eLaTg~yPy~~c~t 299 (391)
T KOG0983|consen 286 ELATGQYPYKGCKT 299 (391)
T ss_pred hhhcccCCCCCCCc
Confidence 99999999998543
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-33 Score=224.03 Aligned_cols=159 Identities=32% Similarity=0.610 Sum_probs=140.7
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
-..+.+|..+|.-++|||+|+++++-..+...+|.||||+||+|.+.++.....++.....+..|++.+++|||+.||||
T Consensus 1278 ~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVH 1357 (1509)
T KOG4645|consen 1278 FKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVH 1357 (1509)
T ss_pred CcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCcee
Confidence 34578899999999999999999999999999999999999999999887767888888899999999999999999999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-----ccccccCCCccccccccccC---CCCCcchHHHHHHHHHHH
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQFQ---RYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~~~~~~pe~~~~~---~~~~~~Di~slg~~~~~~ 161 (177)
|||||.||++ +.++.+|++|||.+.....+. ......||+-|||||.+.+. +-..+.|||||||++.||
T Consensus 1358 RDIK~aNI~L---d~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM 1434 (1509)
T KOG4645|consen 1358 RDIKPANILL---DFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEM 1434 (1509)
T ss_pred cCCCccceee---ecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEe
Confidence 9999999999 567799999999998876653 12245699999999998654 356789999999999999
Q ss_pred HhCCCCCCCC
Q 030430 162 LNGYPPFSVG 171 (177)
Q Consensus 162 ~~~~~pf~~~ 171 (177)
+||+.||..-
T Consensus 1435 ~tGkrPW~~~ 1444 (1509)
T KOG4645|consen 1435 ATGKRPWAEL 1444 (1509)
T ss_pred ecCCCchhhc
Confidence 9999999764
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=188.23 Aligned_cols=156 Identities=34% Similarity=0.561 Sum_probs=131.7
Q ss_pred HHHHHHHHHhhCC-CCceeeEeEEEeeC--CeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 12 CLDCELNFLSSVN-HPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 12 ~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+|+..++++. |+|++++++++.++ +.+++++||++ +++.+++... ..+++..+..++.|++.+|++||+.|+
T Consensus 43 ~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i 121 (282)
T cd07831 43 NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGI 121 (282)
T ss_pred hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 3457888999884 99999999999887 88999999996 5777777653 468999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccc-cCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
+|+||+|+||++. . +.++++|||.+.............++..|+|||... +..++.++|+||+|++++++++|..
T Consensus 122 ~H~dl~p~ni~l~---~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~ 197 (282)
T cd07831 122 FHRDIKPENILIK---D-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFP 197 (282)
T ss_pred eecccCHHHEEEc---C-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCc
Confidence 9999999999995 4 889999999987665443333344678899999764 3456889999999999999999999
Q ss_pred CCCCCC
Q 030430 167 PFSVGE 172 (177)
Q Consensus 167 pf~~~~ 172 (177)
||.+.+
T Consensus 198 p~~~~~ 203 (282)
T cd07831 198 LFPGTN 203 (282)
T ss_pred CCCCCC
Confidence 997654
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=188.26 Aligned_cols=161 Identities=34% Similarity=0.641 Sum_probs=133.9
Q ss_pred HHHHHHHHHHHHhhC-CCCceeeEeEEEeeC-----CeEEEEEecCCCCChHHHHhh----cCCCCHHHHHHHHHHHHHH
Q 030430 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAG 78 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~ 78 (177)
....+.+|+++++.+ +|||++++++++... +.+++++||++|++|.+++.. ...+++..+..++.|++.+
T Consensus 61 ~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~a 140 (291)
T cd06639 61 VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLG 140 (291)
T ss_pred HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHH
Confidence 356788899999999 899999999988643 468999999999999998763 3468999999999999999
Q ss_pred HHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccC-----CCCCcchHH
Q 030430 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQ-----RYDEKVDMW 152 (177)
Q Consensus 79 l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~-----~~~~~~Di~ 152 (177)
+++||+.|++|+||+|+||++ +..+.++++|||.+........ .....++..|+|||.+... .++.++|+|
T Consensus 141 l~~lH~~~ivH~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~ 217 (291)
T cd06639 141 LQHLHNNRIIHRDVKGNNILL---TTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVW 217 (291)
T ss_pred HHHHHhCCeeccCCCHHHEEE---cCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchH
Confidence 999999999999999999999 4566799999998866543221 2233467789999987533 357899999
Q ss_pred HHHHHHHHHHhCCCCCCCCC
Q 030430 153 SVGAILFELLNGYPPFSVGE 172 (177)
Q Consensus 153 slg~~~~~~~~~~~pf~~~~ 172 (177)
|+|++++++++|+.||...+
T Consensus 218 slGvi~~el~~g~~p~~~~~ 237 (291)
T cd06639 218 SLGITAIELGDGDPPLFDMH 237 (291)
T ss_pred HHHHHHHHHhhCCCCCCCCc
Confidence 99999999999999997653
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=188.45 Aligned_cols=160 Identities=33% Similarity=0.573 Sum_probs=135.6
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
...+.+|++++++++|+|++++++++.+.+..++++||+++ +|.+++.... .+++..+..++.|++.++++||+.|
T Consensus 42 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 120 (284)
T cd07836 42 PSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR 120 (284)
T ss_pred hHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence 45677899999999999999999999999999999999965 8888877543 4899999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccC-CCCCcchHHHHHHHHHHHHhC
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~~ 164 (177)
++|+||+|+||++ +..+.++++|||.+........ .....++..|++||.+.+. .++.++|+||+|++++++++|
T Consensus 121 i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g 197 (284)
T cd07836 121 VLHRDLKPQNLLI---NKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG 197 (284)
T ss_pred eeeCCCCHHHEEE---CCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 9999999999999 4667899999998865433221 1223457789999987543 468899999999999999999
Q ss_pred CCCCCCCCc
Q 030430 165 YPPFSVGEE 173 (177)
Q Consensus 165 ~~pf~~~~~ 173 (177)
+.||.+.+.
T Consensus 198 ~~~~~~~~~ 206 (284)
T cd07836 198 RPLFPGTNN 206 (284)
T ss_pred CCCCCCCCc
Confidence 999987653
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=188.98 Aligned_cols=160 Identities=35% Similarity=0.577 Sum_probs=136.3
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
....+.+|++++++++||+++++++++.+.+..++++||+ +++|.+++.... .+++..+..++.|++.+|++||+.|
T Consensus 41 ~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~ 119 (283)
T cd07835 41 VPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR 119 (283)
T ss_pred chhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3456888999999999999999999999999999999999 569999988665 6899999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccC-CCCCcchHHHHHHHHHHHHhC
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~~ 164 (177)
++|+|++|+||+++ ..+.++++|||.+....... ......++..|+|||.+.+. .++.++|+||+|++++++++|
T Consensus 120 ~~H~dl~p~nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g 196 (283)
T cd07835 120 VLHRDLKPQNLLID---REGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNR 196 (283)
T ss_pred eeCCCCCHHHEEEc---CCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhC
Confidence 99999999999994 57789999999986543222 11223357789999987654 468899999999999999999
Q ss_pred CCCCCCCC
Q 030430 165 YPPFSVGE 172 (177)
Q Consensus 165 ~~pf~~~~ 172 (177)
+.||.+.+
T Consensus 197 ~~pf~~~~ 204 (283)
T cd07835 197 RPLFPGDS 204 (283)
T ss_pred CCCCCCCC
Confidence 99997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=192.20 Aligned_cols=162 Identities=24% Similarity=0.370 Sum_probs=134.1
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
...+.+.+|+.+++.++||||+++++++..++..++++||+.++++.+++.+. ..+++..+..++.|++.+|+|||+.
T Consensus 41 ~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~ 120 (328)
T cd08226 41 EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN 120 (328)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 34578899999999999999999999999999999999999999999998864 3489999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc--------ccccCCCccccccccccC--CCCCcchHHHHH
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--------EKVCGSPLYMAPEVLQFQ--RYDEKVDMWSVG 155 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--------~~~~~~~~~~~pe~~~~~--~~~~~~Di~slg 155 (177)
|++|+||||+||++. ..+.++++||+.+......... ....++..|++||.+.+. .++.++|+||+|
T Consensus 121 ~ivHrDlkp~Nill~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG 197 (328)
T cd08226 121 GYIHRNIKASHILIS---GDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVG 197 (328)
T ss_pred CeecCCCCHHHEEEe---CCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHH
Confidence 999999999999994 5667899998754332211100 011234569999998653 468899999999
Q ss_pred HHHHHHHhCCCCCCCCC
Q 030430 156 AILFELLNGYPPFSVGE 172 (177)
Q Consensus 156 ~~~~~~~~~~~pf~~~~ 172 (177)
++++++++|..||.+..
T Consensus 198 ~~l~el~~g~~p~~~~~ 214 (328)
T cd08226 198 ITACELATGRVPFQDML 214 (328)
T ss_pred HHHHHHHhCCCCCCCcC
Confidence 99999999999997653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=190.94 Aligned_cols=164 Identities=29% Similarity=0.528 Sum_probs=134.6
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeC--CeEEEEEecCCCCChHHHHhhc-----CCCCHHHHHHHHHHHHHHHHH
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-----GRVPEQTARKFLQQLGAGLEI 81 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~ 81 (177)
..+.+.+|++++++++|||++++.+++.+. ..+++|+|+++ +++.+++... ..+++..++.++.|++.+++|
T Consensus 45 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 123 (316)
T cd07842 45 ISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHY 123 (316)
T ss_pred ccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHH
Confidence 346678899999999999999999999887 78999999995 4777766532 258899999999999999999
Q ss_pred HhhCCCeeecCCCCcEEEec-CCCCeeEEEeeeccccccCCCCc----cccccCCCccccccccccC-CCCCcchHHHHH
Q 030430 82 LNSHHIIHRDLKPENILLSG-LDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVG 155 (177)
Q Consensus 82 lh~~~~~H~~i~~~nil~~~-~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg 155 (177)
||+.|++|+||+|+||++.. .+..+.++++|||.+........ .....++..|+|||...+. .++.++|+||+|
T Consensus 124 lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 203 (316)
T cd07842 124 LHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIG 203 (316)
T ss_pred HHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHH
Confidence 99999999999999999952 11278899999998876533221 1123457789999987654 478899999999
Q ss_pred HHHHHHHhCCCCCCCCCc
Q 030430 156 AILFELLNGYPPFSVGEE 173 (177)
Q Consensus 156 ~~~~~~~~~~~pf~~~~~ 173 (177)
++++++++|+.||.+...
T Consensus 204 ~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 204 CIFAELLTLEPIFKGREA 221 (316)
T ss_pred HHHHHHHhcCCCCcCCcc
Confidence 999999999999987554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=187.49 Aligned_cols=161 Identities=31% Similarity=0.603 Sum_probs=134.2
Q ss_pred hHHHHHHHHHHHHhhC-CCCceeeEeEEEe------eCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHH
Q 030430 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQ------AENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAG 78 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~------~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~ 78 (177)
.....+..|+.+++++ +|+|++++++++. ....++++|||+++++|.+++... ..+++..+..++.|++.+
T Consensus 54 ~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~a 133 (282)
T cd06636 54 DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133 (282)
T ss_pred HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHH
Confidence 4456788999999999 7999999999874 345789999999999999998754 348888999999999999
Q ss_pred HHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCC-CccccccCCCccccccccc-----cCCCCCcchHH
Q 030430 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMW 152 (177)
Q Consensus 79 l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~ 152 (177)
++|||+.|++|+|++|+||+++ ..+.++++|||.+...... .......++..|+|||.+. ...++.++|+|
T Consensus 134 l~~LH~~~ivH~dl~~~nili~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~Dvw 210 (282)
T cd06636 134 LAHLHAHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIW 210 (282)
T ss_pred HHHHHHCCcccCCCCHHHEEEC---CCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchh
Confidence 9999999999999999999994 5667999999987654322 1222345778899999875 34577899999
Q ss_pred HHHHHHHHHHhCCCCCCCC
Q 030430 153 SVGAILFELLNGYPPFSVG 171 (177)
Q Consensus 153 slg~~~~~~~~~~~pf~~~ 171 (177)
|+|++++++++|..||...
T Consensus 211 slG~~l~el~~g~~p~~~~ 229 (282)
T cd06636 211 SLGITAIEMAEGAPPLCDM 229 (282)
T ss_pred HHHHHHHHHHhCCCCcccc
Confidence 9999999999999999654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=197.56 Aligned_cols=163 Identities=34% Similarity=0.664 Sum_probs=143.3
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
+....-++.|-.||..-+.+.+|+++..|.+...+|+||||++||++-.++=+.+-|.++.++.++.++.+|+++.|..|
T Consensus 670 rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG 749 (1034)
T KOG0608|consen 670 RNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG 749 (1034)
T ss_pred hhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc
Confidence 33455677899999999999999999999999999999999999999999988888999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCC---------CCc---------------------------------
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP---------GNY--------------------------------- 124 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~---------~~~--------------------------------- 124 (177)
++||||||+|||| +..+.+||.|||++..+.. ++.
T Consensus 750 FIHRDiKPDNILI---DrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~ 826 (1034)
T KOG0608|consen 750 FIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRI 826 (1034)
T ss_pred ceecccCccceEE---ccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhh
Confidence 9999999999999 6788999999999865421 000
Q ss_pred -cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 030430 125 -AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGE 172 (177)
Q Consensus 125 -~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf~~~~ 172 (177)
.....|++.|+|||++...+++..+|-||.|+++++|+.|+.||-+.+
T Consensus 827 ~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~t 875 (1034)
T KOG0608|consen 827 LAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADT 875 (1034)
T ss_pred hhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCC
Confidence 001248889999999999999999999999999999999999997654
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-30 Score=188.13 Aligned_cols=156 Identities=35% Similarity=0.568 Sum_probs=133.2
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
..+.+.+|+++++.++|||++++.+++.+....++++||++ +++.+++.. ...+++..+..++.|++.++.|||+.|+
T Consensus 58 ~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i 136 (307)
T cd06607 58 KWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER 136 (307)
T ss_pred HHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 34578899999999999999999999999999999999995 577777664 3468999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccc---cCCCCCcchHHHHHHHHHHHHhC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slg~~~~~~~~~ 164 (177)
+|+||+|+||++ +..+.++++|||.+...... ....++..|+|||.+. ...++.++|+||+|++++++++|
T Consensus 137 ~H~dl~p~nIl~---~~~~~~kL~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg 210 (307)
T cd06607 137 IHRDIKAGNILL---TEPGTVKLADFGSASLVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 210 (307)
T ss_pred eecCCCcccEEE---CCCCCEEEeecCcceecCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcC
Confidence 999999999999 46678999999988654322 2334677899999874 34578899999999999999999
Q ss_pred CCCCCCC
Q 030430 165 YPPFSVG 171 (177)
Q Consensus 165 ~~pf~~~ 171 (177)
+.||...
T Consensus 211 ~~p~~~~ 217 (307)
T cd06607 211 KPPLFNM 217 (307)
T ss_pred CCCCCCc
Confidence 9998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=201.85 Aligned_cols=163 Identities=35% Similarity=0.619 Sum_probs=147.4
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
...+++|+.+|+++.||.||.+.-.++..+..++|||-+.|.-|+-.+.. .+.+++...+.++.||+.||+|||.+||+
T Consensus 607 esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIv 686 (888)
T KOG4236|consen 607 ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIV 686 (888)
T ss_pred HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhccee
Confidence 47899999999999999999999999999999999999955444444432 35699999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf 168 (177)
|+|+||+|+++.+.+.-.++||||||.++.++.........||+.|+|||.+.+..|..+.|+||.|+++|.-++|-.||
T Consensus 687 HCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPF 766 (888)
T KOG4236|consen 687 HCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPF 766 (888)
T ss_pred eccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccC
Confidence 99999999999877778889999999999999888888899999999999999999999999999999999999999999
Q ss_pred CCCC
Q 030430 169 SVGE 172 (177)
Q Consensus 169 ~~~~ 172 (177)
...+
T Consensus 767 NEdE 770 (888)
T KOG4236|consen 767 NEDE 770 (888)
T ss_pred CCcc
Confidence 7653
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=197.00 Aligned_cols=168 Identities=33% Similarity=0.629 Sum_probs=153.6
Q ss_pred chhHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
+.+..++-..|.++|... +-|.++++..+++.-+++|+||||+.||+|--++..-+.+-+..+..++.+|+.+|=+||+
T Consensus 389 QdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~ 468 (683)
T KOG0696|consen 389 QDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHS 468 (683)
T ss_pred ecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhc
Confidence 666778888999999888 5678899999999999999999999999999999988999999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCC-CccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~ 163 (177)
+||++||+|.+|+++ +..+.+++.|||+++..-.. ..+.+..||+.|+|||.+...+|+.+.|-||+|+++|||+.
T Consensus 469 kgIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmla 545 (683)
T KOG0696|consen 469 KGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 545 (683)
T ss_pred CCeeeeeccccceEe---ccCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHc
Confidence 999999999999999 67889999999999775444 44567889999999999999999999999999999999999
Q ss_pred CCCCCCCCCcccC
Q 030430 164 GYPPFSVGEEHQF 176 (177)
Q Consensus 164 ~~~pf~~~~~~~~ 176 (177)
|++||.+.+++++
T Consensus 546 GQpPFdGeDE~el 558 (683)
T KOG0696|consen 546 GQPPFDGEDEDEL 558 (683)
T ss_pred CCCCCCCCCHHHH
Confidence 9999999887764
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=186.25 Aligned_cols=160 Identities=35% Similarity=0.629 Sum_probs=134.2
Q ss_pred HHHHHHHHHHHHhhC-CCCceeeEeEEEeeCC------eEEEEEecCCCCChHHHHhhc----CCCCHHHHHHHHHHHHH
Q 030430 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGA 77 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~ 77 (177)
..+.+.+|+++++++ +|+|++++++++.... .+++++||+++++|.+++... ..+++..+..++.|++.
T Consensus 45 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~ 124 (275)
T cd06608 45 EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLR 124 (275)
T ss_pred hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHH
Confidence 456789999999999 7999999999986544 589999999999999988643 46899999999999999
Q ss_pred HHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCcccccccccc-----CCCCCcchH
Q 030430 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-----QRYDEKVDM 151 (177)
Q Consensus 78 ~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~-----~~~~~~~Di 151 (177)
|+++||+.|++|+||+|+||++ +..+.++|+|||.+....... ......++..|+|||.+.. ..++.++|+
T Consensus 125 al~~lH~~~i~H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv 201 (275)
T cd06608 125 GLAYLHENKVIHRDIKGQNILL---TKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDV 201 (275)
T ss_pred HHHHHhcCCcccCCCCHHHEEE---ccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccH
Confidence 9999999999999999999999 456789999999886543322 1223446778999998643 236778999
Q ss_pred HHHHHHHHHHHhCCCCCCCC
Q 030430 152 WSVGAILFELLNGYPPFSVG 171 (177)
Q Consensus 152 ~slg~~~~~~~~~~~pf~~~ 171 (177)
||+|++++++++|..||...
T Consensus 202 ~slG~il~~l~~g~~p~~~~ 221 (275)
T cd06608 202 WSLGITAIELADGKPPLCDM 221 (275)
T ss_pred HHhHHHHHHHHhCCCCcccc
Confidence 99999999999999999754
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=191.16 Aligned_cols=158 Identities=37% Similarity=0.542 Sum_probs=132.7
Q ss_pred HHHHHHHHHhhCCCCceeeEeEEEeeC--CeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 12 CLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 12 ~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
.+.+|++++++++|+|++++.+++.+. +.+++++||+. ++|.+++... ..+++..+..++.|++.++++||+.|++
T Consensus 52 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~ 130 (309)
T cd07845 52 SSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFII 130 (309)
T ss_pred hhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 456899999999999999999998755 56899999995 5888888754 5689999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCcccccccccc-CCCCCcchHHHHHHHHHHHHhCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
|+||+|+||++ +..+.++|+|||.+........ ......+..|+|||.+.+ ..++.++|+||+|++++++++|+.
T Consensus 131 H~dl~p~nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~ 207 (309)
T cd07845 131 HRDLKVSNLLL---TDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKP 207 (309)
T ss_pred cCCCCHHHEEE---CCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCC
Confidence 99999999999 4667899999999876654321 112234677999998764 457889999999999999999999
Q ss_pred CCCCCCc
Q 030430 167 PFSVGEE 173 (177)
Q Consensus 167 pf~~~~~ 173 (177)
||.+.++
T Consensus 208 ~f~~~~~ 214 (309)
T cd07845 208 LLPGKSE 214 (309)
T ss_pred CCCCCCH
Confidence 9976543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=200.83 Aligned_cols=158 Identities=32% Similarity=0.544 Sum_probs=136.2
Q ss_pred HHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 11 SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 11 ~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
....+|..++... +|||+++..+++.++...|+|||.+.|+-+.+.+...+.+. ..+..|+.+|+.|+.|||++|++|
T Consensus 360 ~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvh 438 (612)
T KOG0603|consen 360 DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVH 438 (612)
T ss_pred cccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeee
Confidence 4456677666666 79999999999999999999999999998888887665555 677789999999999999999999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf~ 169 (177)
||++|+||++. +..+.++++|||.++..... ..+...+..|.|||.....+++.++|+||||+++|+|++|+.||.
T Consensus 439 RDLkp~NIL~~--~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~ 514 (612)
T KOG0603|consen 439 RDLKPGNILLD--GSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFA 514 (612)
T ss_pred cCCChhheeec--CCCCcEEEEEechhhhCchh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccc
Confidence 99999999994 36677999999988776555 334557888999999998899999999999999999999999997
Q ss_pred CCCc
Q 030430 170 VGEE 173 (177)
Q Consensus 170 ~~~~ 173 (177)
....
T Consensus 515 ~~P~ 518 (612)
T KOG0603|consen 515 AHPA 518 (612)
T ss_pred cCCc
Confidence 7543
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=187.32 Aligned_cols=160 Identities=35% Similarity=0.563 Sum_probs=136.7
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeC--CeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
....+.+|++++++++|+|++++.+++.+. +..++++||++ ++|.+++... ..+++..++.++.|++.|+++||+.
T Consensus 41 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~ 119 (287)
T cd07840 41 FPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN 119 (287)
T ss_pred chHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 456688999999999999999999999887 88999999996 5898888755 4699999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC--ccccccCCCcccccccccc-CCCCCcchHHHHHHHHHHHH
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~ 162 (177)
|++|+||+|+||++ +..+.++++|||.+....... ......++..|+|||.+.+ ..++.++|+||+|+++++++
T Consensus 120 ~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~ 196 (287)
T cd07840 120 GILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELF 196 (287)
T ss_pred CceeccCcHHHeEE---cCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHH
Confidence 99999999999999 467789999999987664443 1223345778999997654 35788999999999999999
Q ss_pred hCCCCCCCCC
Q 030430 163 NGYPPFSVGE 172 (177)
Q Consensus 163 ~~~~pf~~~~ 172 (177)
+|+.||...+
T Consensus 197 t~~~p~~~~~ 206 (287)
T cd07840 197 LGKPIFQGST 206 (287)
T ss_pred hCCCCCCCCC
Confidence 9999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=187.29 Aligned_cols=159 Identities=35% Similarity=0.572 Sum_probs=137.7
Q ss_pred HHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
..+.+.+|+++++++ +||+++++.+.+..+...++|+||+.+++|.+++.....+++..+..++.|++.+|++||+.|+
T Consensus 47 ~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~ 126 (288)
T cd05583 47 TAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGI 126 (288)
T ss_pred HHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 345688999999999 6999999999999999999999999999999998877779999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--cccccCCCccccccccccCC--CCCcchHHHHHHHHHHHHh
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQR--YDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~--~~~~~Di~slg~~~~~~~~ 163 (177)
+|+||+|+||++ +..+.++++|||.+........ .....++..|++||...+.. .+.++|+||+|++++++++
T Consensus 127 ~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~t 203 (288)
T cd05583 127 IYRDIKLENILL---DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLT 203 (288)
T ss_pred eccCCCHHHeEE---CCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHh
Confidence 999999999999 4567799999998866543321 12234678899999986554 6789999999999999999
Q ss_pred CCCCCCC
Q 030430 164 GYPPFSV 170 (177)
Q Consensus 164 ~~~pf~~ 170 (177)
|..||..
T Consensus 204 g~~p~~~ 210 (288)
T cd05583 204 GASPFTV 210 (288)
T ss_pred CCCCccc
Confidence 9999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=187.18 Aligned_cols=160 Identities=28% Similarity=0.495 Sum_probs=137.1
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEee--CCeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
....+.+|+++++.+.|+|++++.+++.. ....++++||+++++|.+++.... .++...+..++.|++.+|++||+.
T Consensus 49 ~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~ 128 (284)
T cd05038 49 HRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ 128 (284)
T ss_pred HHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC
Confidence 46789999999999999999999998876 557899999999999999998654 589999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc----ccccCCCccccccccccCCCCCcchHHHHHHHHHHH
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~ 161 (177)
|++|+||+|+||++. ..+.++++|||.+......... ....++..|++||...+..++.++|+||+|++++++
T Consensus 129 ~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el 205 (284)
T cd05038 129 RYIHRDLAARNILVE---SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYEL 205 (284)
T ss_pred CeecCCCCHHhEEEc---CCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhhee
Confidence 999999999999994 5678999999998766432111 112234569999998878889999999999999999
Q ss_pred HhCCCCCCCC
Q 030430 162 LNGYPPFSVG 171 (177)
Q Consensus 162 ~~~~~pf~~~ 171 (177)
++|..||...
T Consensus 206 ~tg~~p~~~~ 215 (284)
T cd05038 206 FTYGDPSQSP 215 (284)
T ss_pred eccCCCcccc
Confidence 9999998653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=188.20 Aligned_cols=160 Identities=38% Similarity=0.610 Sum_probs=138.1
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
....+.+|++++++++|++++++++++.++...++++||+++ ++.+++... ..+++..+..++.|++.++++||+.|+
T Consensus 41 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i 119 (283)
T cd05118 41 IPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119 (283)
T ss_pred hHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 456788999999999999999999999999999999999965 888877753 578999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccC-CCCCcchHHHHHHHHHHHHhCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~~~ 165 (177)
+|+||+|+||++ +.++.++++|||.+....... ......++..|.+||...+. .++.++|+||+|++++++++|+
T Consensus 120 ~H~dl~p~nili---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~ 196 (283)
T cd05118 120 LHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196 (283)
T ss_pred eecCcCHHHEEE---CCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCC
Confidence 999999999999 456789999999887665443 22223466789999988766 6789999999999999999999
Q ss_pred CCCCCCC
Q 030430 166 PPFSVGE 172 (177)
Q Consensus 166 ~pf~~~~ 172 (177)
.||.+.+
T Consensus 197 ~~~~~~~ 203 (283)
T cd05118 197 PLFPGKS 203 (283)
T ss_pred CCCCCCC
Confidence 9997655
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=193.41 Aligned_cols=162 Identities=34% Similarity=0.561 Sum_probs=140.4
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCC-----eEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (177)
....+.+.+|++++++++|+|++++.+++.... ..|++++|++ ++|.+++.....+++..+..++.|++.++++
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~ 118 (330)
T cd07834 40 LIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKY 118 (330)
T ss_pred chhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHH
Confidence 344567899999999999999999999987764 7899999995 5899988877789999999999999999999
Q ss_pred HhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC----ccccccCCCccccccccccC-CCCCcchHHHHHH
Q 030430 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGA 156 (177)
Q Consensus 82 lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~ 156 (177)
||+.|++|+||+|.||++. ..+.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||+|+
T Consensus 119 LH~~gi~H~dlkp~nili~---~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~ 195 (330)
T cd07834 119 LHSANVIHRDLKPSNILVN---SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGC 195 (330)
T ss_pred HHhCCeecCCCCHHHEEEc---CCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHH
Confidence 9999999999999999994 56789999999987765443 12234467789999998877 7899999999999
Q ss_pred HHHHHHhCCCCCCCCC
Q 030430 157 ILFELLNGYPPFSVGE 172 (177)
Q Consensus 157 ~~~~~~~~~~pf~~~~ 172 (177)
+++++++|..||.+.+
T Consensus 196 il~~l~~g~~pf~~~~ 211 (330)
T cd07834 196 IFAELLTRKPLFPGRD 211 (330)
T ss_pred HHHHHHcCCCCcCCCC
Confidence 9999999999997654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-29 Score=186.44 Aligned_cols=157 Identities=35% Similarity=0.581 Sum_probs=133.3
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
....+.+|+++++.++|||++++.+++.+....++++||+. +++.+++.. ...+++..+..++.|++.+++|||+.|+
T Consensus 64 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi 142 (313)
T cd06633 64 KWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 142 (313)
T ss_pred HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 34568889999999999999999999999999999999995 577777664 3468999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccc---cCCCCCcchHHHHHHHHHHHHhC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slg~~~~~~~~~ 164 (177)
+|+||+|+||++ +..+.++++|||.+..... .....++..|+|||.+. ...++.++|+||+|++++++++|
T Consensus 143 ~H~dl~p~nili---~~~~~~kL~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g 216 (313)
T cd06633 143 IHRDIKAGNILL---TEPGQVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 216 (313)
T ss_pred ecCCCChhhEEE---CCCCCEEEeecCCCcccCC---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhC
Confidence 999999999999 4567799999998754322 22345778899999874 34578899999999999999999
Q ss_pred CCCCCCCC
Q 030430 165 YPPFSVGE 172 (177)
Q Consensus 165 ~~pf~~~~ 172 (177)
..||...+
T Consensus 217 ~~p~~~~~ 224 (313)
T cd06633 217 KPPLFNMN 224 (313)
T ss_pred CCCCCCCC
Confidence 99986643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=186.07 Aligned_cols=160 Identities=29% Similarity=0.495 Sum_probs=133.9
Q ss_pred hHHHHHHHHHHHHhhCC-CCceeeEeEEEeeCCeEEEEEecCCCCChHHHHh-----hcCCCCHHHHHHHHHHHHHHHHH
Q 030430 8 HLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-----LHGRVPEQTARKFLQQLGAGLEI 81 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~ 81 (177)
.....+.+|+.++.++. |+||+++++++...+..++++|++ ++++.++.. ....+++..+..++.+++.+++|
T Consensus 44 ~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~-~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~ 122 (288)
T cd06616 44 KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNY 122 (288)
T ss_pred HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc-cCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Confidence 45667889999999995 999999999999888899999998 456655432 23569999999999999999999
Q ss_pred Hhh-CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccC---CCCCcchHHHHHHH
Q 030430 82 LNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ---RYDEKVDMWSVGAI 157 (177)
Q Consensus 82 lh~-~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~---~~~~~~Di~slg~~ 157 (177)
||+ .|++|+||+|+||+++ ..+.++++|||.+.............++..|+|||.+... .++.++|+||+|++
T Consensus 123 lh~~~~i~H~dlkp~Nil~~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~i 199 (288)
T cd06616 123 LKEELKIIHRDVKPSNILLD---RNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGIT 199 (288)
T ss_pred HhhcCCeeccCCCHHHEEEc---cCCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHH
Confidence 997 4999999999999994 5677999999998765444333344578889999998765 57899999999999
Q ss_pred HHHHHhCCCCCCCC
Q 030430 158 LFELLNGYPPFSVG 171 (177)
Q Consensus 158 ~~~~~~~~~pf~~~ 171 (177)
++++++|+.||...
T Consensus 200 l~el~~g~~p~~~~ 213 (288)
T cd06616 200 LYEVATGKFPYPKW 213 (288)
T ss_pred HHHHHhCCCCchhc
Confidence 99999999999653
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=185.54 Aligned_cols=160 Identities=38% Similarity=0.590 Sum_probs=134.8
Q ss_pred HHHHHHHHHHHhhC---CCCceeeEeEEEeeCCe-----EEEEEecCCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHH
Q 030430 10 KSCLDCELNFLSSV---NHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGL 79 (177)
Q Consensus 10 ~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l 79 (177)
...+.+|+.+++++ +|||++++.+++.+... .++++|++. ++|.+++.... .+++..+..++.|++.||
T Consensus 42 ~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al 120 (287)
T cd07838 42 PLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGV 120 (287)
T ss_pred hhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHH
Confidence 44566788777666 59999999999987766 899999995 58988887643 489999999999999999
Q ss_pred HHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHH
Q 030430 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (177)
Q Consensus 80 ~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~ 159 (177)
++||+.|++|+|++|+||+++ ..+.++++|||.+.............++..|+|||...+..++.++|+||+|++++
T Consensus 121 ~~LH~~~i~h~~l~~~nili~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~ 197 (287)
T cd07838 121 DFLHSHRIVHRDLKPQNILVT---SDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFA 197 (287)
T ss_pred HHHHHCCeeeccCChhhEEEc---cCCCEEEeccCcceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHH
Confidence 999999999999999999994 56789999999887654443333334677899999998888899999999999999
Q ss_pred HHHhCCCCCCCCCc
Q 030430 160 ELLNGYPPFSVGEE 173 (177)
Q Consensus 160 ~~~~~~~pf~~~~~ 173 (177)
++++|.+||.+.++
T Consensus 198 ~l~~~~~~~~~~~~ 211 (287)
T cd07838 198 ELFRRRPLFRGTSE 211 (287)
T ss_pred HHHhCCCcccCCCh
Confidence 99999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=175.40 Aligned_cols=161 Identities=30% Similarity=0.494 Sum_probs=136.4
Q ss_pred chhHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHh----hcCCCCHHHHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKFLQQLGAGLE 80 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~ 80 (177)
......++.+|+.+...- .+|.+|.+++.+.+.+..++.||.+ ..||+.+-+ +.+..++..+.+|+..++.||.
T Consensus 84 n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~ 162 (282)
T KOG0984|consen 84 NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALE 162 (282)
T ss_pred ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHH
Confidence 344455667777755544 7999999999888888999999998 779987754 3456999999999999999999
Q ss_pred HHhhC-CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccc----cCCCCCcchHHHHH
Q 030430 81 ILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ----FQRYDEKVDMWSVG 155 (177)
Q Consensus 81 ~lh~~-~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~----~~~~~~~~Di~slg 155 (177)
+||++ .++|||+||+||++ +-.+++|+||||.+-...++...+...|...|+|||.+. ...|+.++|+||||
T Consensus 163 ~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLG 239 (282)
T KOG0984|consen 163 FLHSKLSVIHRDVKPSNILI---NYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLG 239 (282)
T ss_pred HHHHHhhhhhccCCcceEEE---ccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhh
Confidence 99984 89999999999999 578899999999997777766666566888999999874 23689999999999
Q ss_pred HHHHHHHhCCCCCCC
Q 030430 156 AILFELLNGYPPFSV 170 (177)
Q Consensus 156 ~~~~~~~~~~~pf~~ 170 (177)
+++.|+++++.||..
T Consensus 240 ItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 240 ITMIEMAILRFPYES 254 (282)
T ss_pred hhhhhhhhccccccc
Confidence 999999999999965
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-29 Score=185.45 Aligned_cols=156 Identities=35% Similarity=0.578 Sum_probs=132.9
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
....+.+|++++++++|||++++.+++.++...++++||+.| ++.+.+.. ...+++.++..++.|++.++.+||+.|+
T Consensus 68 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i 146 (317)
T cd06635 68 KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146 (317)
T ss_pred HHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 345788999999999999999999999999999999999965 77777654 3458999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccc---cCCCCCcchHHHHHHHHHHHHhC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slg~~~~~~~~~ 164 (177)
+|+||+|+||++ +..+.++++|||.+...... ....++..|+|||.+. ....+.++|+||+|++++++++|
T Consensus 147 ~H~dL~p~Nil~---~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g 220 (317)
T cd06635 147 IHRDIKAGNILL---TEPGQVKLADFGSASIASPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 220 (317)
T ss_pred ccCCCCcccEEE---CCCCCEEEecCCCccccCCc---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhC
Confidence 999999999999 45678999999987543322 2334678899999873 34578899999999999999999
Q ss_pred CCCCCCC
Q 030430 165 YPPFSVG 171 (177)
Q Consensus 165 ~~pf~~~ 171 (177)
..||...
T Consensus 221 ~~p~~~~ 227 (317)
T cd06635 221 KPPLFNM 227 (317)
T ss_pred CCCCCCc
Confidence 9998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=187.24 Aligned_cols=158 Identities=28% Similarity=0.495 Sum_probs=130.6
Q ss_pred HHHHHHHHHHhhCCCCceeeEeEEEeeCC--------eEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHH
Q 030430 11 SCLDCELNFLSSVNHPNIIRLFDAFQAEN--------CIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEI 81 (177)
Q Consensus 11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~ 81 (177)
..+.+|++++++++|||++++++++.... ..++++||+. ++|.+++... ..+++..++.++.|++.|++|
T Consensus 56 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~ 134 (310)
T cd07865 56 ITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY 134 (310)
T ss_pred hHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHH
Confidence 35678999999999999999999876543 4699999994 5888877654 368999999999999999999
Q ss_pred HhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-----cccccCCCccccccccccCC-CCCcchHHHHH
Q 030430 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVG 155 (177)
Q Consensus 82 lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slg 155 (177)
||+.|++|+||+|+||++ +..+.++++|||.+........ .....++..|+|||...+.. ++.++|+||+|
T Consensus 135 lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG 211 (310)
T cd07865 135 IHRNKILHRDMKAANILI---TKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAG 211 (310)
T ss_pred HHHCCeeccCCCHHHEEE---CCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHH
Confidence 999999999999999999 4677899999998876533221 12234567899999876543 68899999999
Q ss_pred HHHHHHHhCCCCCCCCC
Q 030430 156 AILFELLNGYPPFSVGE 172 (177)
Q Consensus 156 ~~~~~~~~~~~pf~~~~ 172 (177)
++++++++|+.||.+.+
T Consensus 212 ~~l~el~t~~~~~~~~~ 228 (310)
T cd07865 212 CIMAEMWTRSPIMQGNT 228 (310)
T ss_pred HHHHHHHhCCCCCCCCC
Confidence 99999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=185.80 Aligned_cols=164 Identities=32% Similarity=0.549 Sum_probs=139.3
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEee-CCeEEEEEecCCCCChHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHH
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH-----GRVPEQTARKFLQQLGAGLEIL 82 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~l 82 (177)
.-...-+|+.+++.++|||++.+..++.. +..+++++||. .-+|...+.-+ ..++...++.+++||+.++.||
T Consensus 70 iS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYA-EhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YL 148 (438)
T KOG0666|consen 70 ISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYA-EHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYL 148 (438)
T ss_pred cCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhh-hhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHH
Confidence 34556789999999999999999998876 78899999999 55999888744 3499999999999999999999
Q ss_pred hhCCCeeecCCCCcEEEecC-CCCeeEEEeeeccccccCCCCc----cccccCCCccccccccccCC-CCCcchHHHHHH
Q 030430 83 NSHHIIHRDLKPENILLSGL-DDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGA 156 (177)
Q Consensus 83 h~~~~~H~~i~~~nil~~~~-~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slg~ 156 (177)
|+.-++|||+||.||++-.. ...+.+|+.|+|+++.+..+-. .....-|.+|.|||++.++. ++++.|+||+||
T Consensus 149 H~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGC 228 (438)
T KOG0666|consen 149 HSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGC 228 (438)
T ss_pred hhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHH
Confidence 99999999999999999532 3468899999999987765432 12344688999999988765 899999999999
Q ss_pred HHHHHHhCCCCCCCCCc
Q 030430 157 ILFELLNGYPPFSVGEE 173 (177)
Q Consensus 157 ~~~~~~~~~~pf~~~~~ 173 (177)
++.|++|.++.|.+.++
T Consensus 229 IfaElLtl~PlF~g~E~ 245 (438)
T KOG0666|consen 229 IFAELLTLEPLFKGREE 245 (438)
T ss_pred HHHHHHccCccccchhh
Confidence 99999999999988654
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=186.29 Aligned_cols=162 Identities=37% Similarity=0.687 Sum_probs=141.9
Q ss_pred hHHHHHHHHHHHHhhCC-CCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 8 HLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
...+.+.+|.++++++. ||||+++++++.+++..+++||++++++|.+++.+.+.++...+..++.|++.++++||+.|
T Consensus 43 ~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~ 122 (280)
T cd05581 43 KKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122 (280)
T ss_pred HHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 44577889999999998 99999999999999999999999999999999998878999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---------------------cccccCCCccccccccccCCC
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---------------------AEKVCGSPLYMAPEVLQFQRY 145 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---------------------~~~~~~~~~~~~pe~~~~~~~ 145 (177)
++|+|++|+||+++ ..+.++++|||.+........ .....++..|++||......+
T Consensus 123 ~~H~dl~~~ni~i~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~ 199 (280)
T cd05581 123 IIHRDLKPENILLD---KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA 199 (280)
T ss_pred eeecCCCHHHeEEC---CCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCC
Confidence 99999999999994 567799999998866543221 112235678999999887778
Q ss_pred CCcchHHHHHHHHHHHHhCCCCCCCCC
Q 030430 146 DEKVDMWSVGAILFELLNGYPPFSVGE 172 (177)
Q Consensus 146 ~~~~Di~slg~~~~~~~~~~~pf~~~~ 172 (177)
+.++|+||+|++++++++|+.||...+
T Consensus 200 ~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 200 GKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred ChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=191.40 Aligned_cols=159 Identities=33% Similarity=0.550 Sum_probs=135.0
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeC-----CeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
...+.+|+.+++.++|+|++++.+++... ...++++||+ +++|.+++.....+++..+..++.|++.++++||+
T Consensus 48 ~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 126 (337)
T cd07858 48 AKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHS 126 (337)
T ss_pred hHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCC-CCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 45677899999999999999999987643 3589999999 57999999877889999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCcccccccccc-CCCCCcchHHHHHHHHHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~ 162 (177)
.|++|+||+|+||++ +..+.++|+|||.+....... ......++..|+|||.+.. ..++.++|+||+|+++++++
T Consensus 127 ~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~ 203 (337)
T cd07858 127 ANVLHRDLKPSNLLL---NANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL 203 (337)
T ss_pred CCEecCCCCHHHEEE---cCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHH
Confidence 999999999999999 456789999999987654432 2223346778999998764 45789999999999999999
Q ss_pred hCCCCCCCCC
Q 030430 163 NGYPPFSVGE 172 (177)
Q Consensus 163 ~~~~pf~~~~ 172 (177)
+|+.||.+.+
T Consensus 204 ~g~~pf~~~~ 213 (337)
T cd07858 204 GRKPLFPGKD 213 (337)
T ss_pred cCCCCCCCCC
Confidence 9999997653
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=192.50 Aligned_cols=160 Identities=33% Similarity=0.532 Sum_probs=135.1
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEe----eCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
....+.+|+.++++++||||+++.+++. ....+++++||+ +++|.+++.....+++..+..++.|++.||++||+
T Consensus 47 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~ 125 (334)
T cd07855 47 LAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHS 125 (334)
T ss_pred chHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehh-hhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4566788999999999999999998875 335789999999 56999998877779999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-----cccccCCCcccccccccc-CCCCCcchHHHHHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAIL 158 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~ 158 (177)
.|++|+||+|+||++ +..+.++|+|||.+........ .....++..|.|||.+.+ ..++.++|+||+|+++
T Consensus 126 ~~ivH~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l 202 (334)
T cd07855 126 ANVIHRDLKPSNLLV---NEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIF 202 (334)
T ss_pred CCeecCCCCHHHEEE---cCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHH
Confidence 999999999999999 4677899999999866533221 123357788999998765 4578899999999999
Q ss_pred HHHHhCCCCCCCCC
Q 030430 159 FELLNGYPPFSVGE 172 (177)
Q Consensus 159 ~~~~~~~~pf~~~~ 172 (177)
+++++|+.||.+.+
T Consensus 203 ~el~~g~~pf~~~~ 216 (334)
T cd07855 203 AEMLGRRQLFPGKN 216 (334)
T ss_pred HHHHcCCCccCCCC
Confidence 99999999997643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=195.94 Aligned_cols=168 Identities=29% Similarity=0.507 Sum_probs=146.4
Q ss_pred cchhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHh
Q 030430 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 5 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lh 83 (177)
.+++.++.|..|+-++++++||||++++|++.+.. .++|||+++-|.|+.|+..++. ++...+..++.||..||+|||
T Consensus 430 ~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P-~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe 508 (974)
T KOG4257|consen 430 CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP-MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE 508 (974)
T ss_pred CChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc-eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH
Confidence 36678999999999999999999999999998765 6899999999999999997754 999999999999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--cccccCCCccccccccccCCCCCcchHHHHHHHHHHH
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~ 161 (177)
+..+|||||-..||+++ ...-+||.|||+++....... .+.......|++||.+....++.+||||.+|+|+||+
T Consensus 509 SkrfVHRDIAaRNiLVs---Sp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEI 585 (974)
T KOG4257|consen 509 SKRFVHRDIAARNILVS---SPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEI 585 (974)
T ss_pred hhchhhhhhhhhheeec---CcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHH
Confidence 99999999999999995 455689999999988766542 2222345679999999888999999999999999999
Q ss_pred Hh-CCCCCCCCCcccC
Q 030430 162 LN-GYPPFSVGEEHQF 176 (177)
Q Consensus 162 ~~-~~~pf~~~~~~~~ 176 (177)
+. |-.||.+-.+.+.
T Consensus 586 l~lGvkPfqgvkNsDV 601 (974)
T KOG4257|consen 586 LSLGVKPFQGVKNSDV 601 (974)
T ss_pred HHhcCCccccccccce
Confidence 88 8899988665553
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=178.85 Aligned_cols=162 Identities=27% Similarity=0.376 Sum_probs=135.3
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEe-----eCCeEEEEEecCCCCChHHHHhhc----CCCCHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ-----AENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLG 76 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~ 76 (177)
+.+..+...+|++..++++|||+.++++... .....|+++.|...|+|.+.++.. ..+++.+++.|+.++.
T Consensus 58 ~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic 137 (302)
T KOG2345|consen 58 SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGIC 137 (302)
T ss_pred chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHH
Confidence 3466788999999999999999999998643 233589999999999999999744 2499999999999999
Q ss_pred HHHHHHhhCC--CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC----------ccccccCCCccccccccc---
Q 030430 77 AGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----------YAEKVCGSPLYMAPEVLQ--- 141 (177)
Q Consensus 77 ~~l~~lh~~~--~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~----------~~~~~~~~~~~~~pe~~~--- 141 (177)
.+|+++|+.. +.|+||||+||+.+ +++.+++.|||.+....-.. .......+..|.|||.+.
T Consensus 138 ~gL~~lH~~~~~yAH~DiKP~NILls---~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~ 214 (302)
T KOG2345|consen 138 RGLEALHEKEPPYAHRDIKPANILLS---DSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKS 214 (302)
T ss_pred HHHHHHhccCCcccccCCCcceeEec---CCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheeccc
Confidence 9999999998 99999999999995 57889999999886542211 111234788899999875
Q ss_pred cCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 030430 142 FQRYDEKVDMWSVGAILFELLNGYPPFSV 170 (177)
Q Consensus 142 ~~~~~~~~Di~slg~~~~~~~~~~~pf~~ 170 (177)
+...+.+.|||||||++|.++.|..||..
T Consensus 215 ~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 215 HCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred CcccccccchhhhhHHHHHHHHcCCcchH
Confidence 34567899999999999999999999964
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=182.81 Aligned_cols=163 Identities=27% Similarity=0.509 Sum_probs=132.9
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCC------eEEEEEecCCCCChHHHHhhc------CCCCHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLH------GRVPEQTARKFLQQ 74 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~ 74 (177)
....+.+.+|++++++++|||++++++++.... ..+++++|+++++|.+++... ..++...+..++.|
T Consensus 42 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~ 121 (273)
T cd05074 42 SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMID 121 (273)
T ss_pred hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHH
Confidence 344667889999999999999999999875432 347889999999998876422 24788999999999
Q ss_pred HHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCCCcchH
Q 030430 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDM 151 (177)
Q Consensus 75 i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di 151 (177)
++.+++|||+.|++|+||+|+||++ +....++++|||.+........ .....++..|++||......++.++|+
T Consensus 122 i~~~l~~lH~~~i~H~dikp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi 198 (273)
T cd05074 122 IASGMEYLSSKNFIHRDLAARNCML---NENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDV 198 (273)
T ss_pred HHHHHHHHHhCCEeecccchhhEEE---cCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhh
Confidence 9999999999999999999999999 4567799999998876543221 112223467899999887888999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCC
Q 030430 152 WSVGAILFELLN-GYPPFSVGE 172 (177)
Q Consensus 152 ~slg~~~~~~~~-~~~pf~~~~ 172 (177)
||+|++++++++ |+.||.+.+
T Consensus 199 ~slG~il~el~~~g~~p~~~~~ 220 (273)
T cd05074 199 WAFGVTMWEIMTRGQTPYAGVE 220 (273)
T ss_pred HHHHHHHHHHhhCCCCCCCCCC
Confidence 999999999999 889987654
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-30 Score=185.47 Aligned_cols=162 Identities=36% Similarity=0.613 Sum_probs=138.8
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
+...+.+.+|++++++++|++++++.+++.+.+..++++|+++ ++|.+++.+. ..+++..+..++.|++.++++||+.
T Consensus 39 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~ 117 (282)
T cd07829 39 EGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117 (282)
T ss_pred ccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3345677889999999999999999999999999999999996 5999999876 5799999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccC-CCCCcchHHHHHHHHHHHHh
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~ 163 (177)
|++|+||+|+||++. ..+.++++|||.+........ ......+..|+|||..... .++.++|+||+|++++++++
T Consensus 118 ~i~H~~l~~~ni~~~---~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~ 194 (282)
T cd07829 118 RILHRDLKPQNILIN---RDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMIT 194 (282)
T ss_pred CcccCCCChheEEEc---CCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHh
Confidence 999999999999994 577899999998866543321 1223346679999988665 68899999999999999999
Q ss_pred CCCCCCCCC
Q 030430 164 GYPPFSVGE 172 (177)
Q Consensus 164 ~~~pf~~~~ 172 (177)
|..||.+.+
T Consensus 195 ~~~~~~~~~ 203 (282)
T cd07829 195 GKPLFPGDS 203 (282)
T ss_pred CCCCCCCcc
Confidence 999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-29 Score=184.46 Aligned_cols=153 Identities=17% Similarity=0.225 Sum_probs=124.8
Q ss_pred HHHHHHhhCCCCceeeEeEEEeeCC----eEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCeee
Q 030430 15 CELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHR 90 (177)
Q Consensus 15 ~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H~ 90 (177)
.+...+..+.|+++++++++..... ..+++++++ ..++.+.+......++..+..++.|++.+++|||+.|++||
T Consensus 72 ~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHr 150 (294)
T PHA02882 72 ALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHG 150 (294)
T ss_pred HHHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 3444566778999999998765433 447888877 55777777665557888999999999999999999999999
Q ss_pred cCCCCcEEEecCCCCeeEEEeeeccccccCCCC--------ccccccCCCccccccccccCCCCCcchHHHHHHHHHHHH
Q 030430 91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 91 ~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~ 162 (177)
||||+||++ +....++|+|||++....... ......+++.|+|||...+..++.++|+||+|+++++++
T Consensus 151 DiKp~Nill---~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~ 227 (294)
T PHA02882 151 DIKPENIMV---DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWA 227 (294)
T ss_pred CCCHHHEEE---cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 999999999 456679999999987653221 112235889999999998888999999999999999999
Q ss_pred hCCCCCCCC
Q 030430 163 NGYPPFSVG 171 (177)
Q Consensus 163 ~~~~pf~~~ 171 (177)
+|+.||.+.
T Consensus 228 ~g~~P~~~~ 236 (294)
T PHA02882 228 GIKLPWKGF 236 (294)
T ss_pred hCCCCCCcc
Confidence 999999876
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=187.66 Aligned_cols=163 Identities=30% Similarity=0.555 Sum_probs=145.3
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
-++.-+++.+|+.++++.+.|++|++++.|-....+++|||||.-|+..+.++. ++.+++..+..+++..+.+|+|||.
T Consensus 68 V~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~ 147 (502)
T KOG0574|consen 68 VDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHD 147 (502)
T ss_pred ccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHH
Confidence 455678899999999999999999999999999999999999999999999984 4679999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCC-CccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~ 163 (177)
..=+|||||..||++ +..+..+|.|||.+-..-.. ....+..|++.|+|||.+..-.|+...||||||++..||..
T Consensus 148 ~~KIHRDIKAGNILL---NT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAE 224 (502)
T KOG0574|consen 148 LKKIHRDIKAGNILL---NTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAE 224 (502)
T ss_pred HHHHHhhcccccEEE---cccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhc
Confidence 999999999999999 46778999999988554322 22345679999999999998899999999999999999999
Q ss_pred CCCCCCCC
Q 030430 164 GYPPFSVG 171 (177)
Q Consensus 164 ~~~pf~~~ 171 (177)
|++||..-
T Consensus 225 G~PPYsDI 232 (502)
T KOG0574|consen 225 GRPPYSDI 232 (502)
T ss_pred CCCCcccc
Confidence 99999764
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-29 Score=183.04 Aligned_cols=157 Identities=30% Similarity=0.520 Sum_probs=129.4
Q ss_pred HHHHHHHHHH-HhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 10 KSCLDCELNF-LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 10 ~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
...+..|... ++.++|||++++++++..++..++++||++ ++|.+++.. ...+++..++.++.|++.+++|||+
T Consensus 43 ~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 121 (283)
T cd06617 43 QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121 (283)
T ss_pred HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 3445556654 666799999999999999999999999995 688877753 2358999999999999999999999
Q ss_pred C-CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCcccccccccc----CCCCCcchHHHHHHHHH
Q 030430 85 H-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF----QRYDEKVDMWSVGAILF 159 (177)
Q Consensus 85 ~-~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~----~~~~~~~Di~slg~~~~ 159 (177)
. +++|+||+|+||++ +..+.++++|||.+.............++..|+|||.+.+ ..++.++|+||+|++++
T Consensus 122 ~~~i~h~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~ 198 (283)
T cd06617 122 KLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMI 198 (283)
T ss_pred cCCeecCCCCHHHEEE---CCCCCEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHH
Confidence 7 99999999999999 4677899999999876543332233456778999998754 34578999999999999
Q ss_pred HHHhCCCCCCC
Q 030430 160 ELLNGYPPFSV 170 (177)
Q Consensus 160 ~~~~~~~pf~~ 170 (177)
++++|+.||..
T Consensus 199 ~l~~g~~p~~~ 209 (283)
T cd06617 199 ELATGRFPYDS 209 (283)
T ss_pred HHHhCCCCCCc
Confidence 99999999964
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-29 Score=184.11 Aligned_cols=160 Identities=31% Similarity=0.498 Sum_probs=131.2
Q ss_pred HHHHHHHHHHHhhCC-CCceeeEeEEEeeCCe-----EEEEEecCCCCChHHHHhhc-----CCCCHHHHHHHHHHHHHH
Q 030430 10 KSCLDCELNFLSSVN-HPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLH-----GRVPEQTARKFLQQLGAG 78 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~ 78 (177)
...+.+|+.+++.++ |||++++++++..... .|+++||+++ +|.+++... ..+++..+..++.|++.+
T Consensus 44 ~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~ 122 (295)
T cd07837 44 PPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122 (295)
T ss_pred chHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHH
Confidence 356788999999995 6999999998876554 8999999975 888887643 347999999999999999
Q ss_pred HHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCcccccccccc-CCCCCcchHHHHHH
Q 030430 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGA 156 (177)
Q Consensus 79 l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~ 156 (177)
|+|||+.|++|+||+|+||+++ ...+.++++|||.+........ .....+++.|+|||.+.+ ..++.++|+||+|+
T Consensus 123 L~~LH~~~i~H~dl~~~nil~~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ 200 (295)
T cd07837 123 VAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGC 200 (295)
T ss_pred HHHHHHCCeeecCCChHHEEEe--cCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHH
Confidence 9999999999999999999995 2367899999998876533221 112235678999998754 34688999999999
Q ss_pred HHHHHHhCCCCCCCCC
Q 030430 157 ILFELLNGYPPFSVGE 172 (177)
Q Consensus 157 ~~~~~~~~~~pf~~~~ 172 (177)
+++++++|..||.+.+
T Consensus 201 ~l~~l~~g~~~~~~~~ 216 (295)
T cd07837 201 IFAEMSRKQPLFPGDS 216 (295)
T ss_pred HHHHHHcCCCCCCCCC
Confidence 9999999999997643
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-29 Score=186.19 Aligned_cols=158 Identities=37% Similarity=0.589 Sum_probs=133.1
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEee-CCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
.....+.+|++++++++|||++++.+++.. ....++++|++ +++|.+++. ...+++..+..++.|++.++++||+.|
T Consensus 51 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~ 128 (328)
T cd07856 51 VLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAG 128 (328)
T ss_pred chhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 345678899999999999999999998865 55789999998 679988876 346888899999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCcccccccccc-CCCCCcchHHHHHHHHHHHHhCC
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~~~~ 165 (177)
++|+||+|+|+++ +..+.++++|||.+....... ....++..|++||.+.+ ..++.++|+||+|++++++++|+
T Consensus 129 iiH~dl~p~Nili---~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~ 203 (328)
T cd07856 129 VVHRDLKPSNILI---NENCDLKICDFGLARIQDPQM--TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203 (328)
T ss_pred cccCCCCHHHEeE---CCCCCEEeCccccccccCCCc--CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCC
Confidence 9999999999999 467789999999886543222 22345778999998765 46789999999999999999999
Q ss_pred CCCCCCC
Q 030430 166 PPFSVGE 172 (177)
Q Consensus 166 ~pf~~~~ 172 (177)
.||.+.+
T Consensus 204 ~~f~~~~ 210 (328)
T cd07856 204 PLFPGKD 210 (328)
T ss_pred CCCCCCC
Confidence 9997654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-29 Score=187.36 Aligned_cols=160 Identities=33% Similarity=0.552 Sum_probs=132.1
Q ss_pred HHHHHHHHHHHHhhC-CCCceeeEeEEEee-CCeEEEEEecCCCCChHHHHhhcC-------------------------
Q 030430 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLHG------------------------- 61 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~------------------------- 61 (177)
..+.+.+|+.++.++ +|||++++++++.. +...++++||+++++|.+++....
T Consensus 53 ~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 132 (343)
T cd05103 53 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISE 132 (343)
T ss_pred HHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhh
Confidence 356788999999999 68999999997754 456889999999999999986421
Q ss_pred ------------------------------------------CCCHHHHHHHHHHHHHHHHHHhhCCCeeecCCCCcEEE
Q 030430 62 ------------------------------------------RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL 99 (177)
Q Consensus 62 ------------------------------------------~~~~~~~~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~ 99 (177)
.++...+..++.|++.|++|||+.|++|+||+|.||++
T Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~ 212 (343)
T cd05103 133 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL 212 (343)
T ss_pred hhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE
Confidence 25677888999999999999999999999999999999
Q ss_pred ecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q 030430 100 SGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSVG 171 (177)
Q Consensus 100 ~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-~~~pf~~~ 171 (177)
+ ....++++|||.+........ .....++..|+|||.+.+..++.++|+||+|++++++++ |..||...
T Consensus 213 ~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 285 (343)
T cd05103 213 S---ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 285 (343)
T ss_pred c---CCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 4 567899999998866432211 112224567999999888888999999999999999997 89999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=197.47 Aligned_cols=168 Identities=29% Similarity=0.532 Sum_probs=146.0
Q ss_pred ccccchhH--HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCC--CCHHHHHHHHHHHHH
Q 030430 2 LKKLNKHL--KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGA 77 (177)
Q Consensus 2 l~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~ 77 (177)
+|.++++. ..+|..|+.+|+.++|||+|+++++|.....+|||+||+..|+|.+|++++.. ++.-.++.++.||..
T Consensus 297 VKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsS 376 (1157)
T KOG4278|consen 297 VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISS 376 (1157)
T ss_pred hhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHH
Confidence 34454443 67899999999999999999999999999999999999999999999997743 777788899999999
Q ss_pred HHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcccc--ccCCCccccccccccCCCCCcchHHHHH
Q 030430 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVG 155 (177)
Q Consensus 78 ~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~--~~~~~~~~~pe~~~~~~~~~~~Di~slg 155 (177)
+++||..++++|||+-..|+++ +++..+|+.|||+++.+-.+..+.. ..-...|.|||.+....++.++|||++|
T Consensus 377 aMeYLEkknFIHRDLAARNCLV---gEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFG 453 (1157)
T KOG4278|consen 377 AMEYLEKKNFIHRDLAARNCLV---GENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFG 453 (1157)
T ss_pred HHHHHHHhhhhhhhhhhhhccc---cccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHH
Confidence 9999999999999999999999 4777899999999987755544322 2235679999999989999999999999
Q ss_pred HHHHHHHh-CCCCCCCCC
Q 030430 156 AILFELLN-GYPPFSVGE 172 (177)
Q Consensus 156 ~~~~~~~~-~~~pf~~~~ 172 (177)
+++||+.| |..||.+-+
T Consensus 454 VLLWEIATYGMsPYPGid 471 (1157)
T KOG4278|consen 454 VLLWEIATYGMSPYPGID 471 (1157)
T ss_pred HHHHHHHhcCCCCCCCcc
Confidence 99999999 888998754
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=188.41 Aligned_cols=158 Identities=32% Similarity=0.556 Sum_probs=131.5
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeC-----CeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (177)
...++.+|++++++++|+|++++++++... ...++++|++. ++|.+.+. ...+++..+..++.|++.+|++||
T Consensus 46 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH 123 (336)
T cd07849 46 FCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIK-TQHLSNDHIQYFLYQILRGLKYIH 123 (336)
T ss_pred hHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 456678899999999999999999886544 35799999995 58888775 457999999999999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc----cccccCCCcccccccccc-CCCCCcchHHHHHHHH
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAIL 158 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~ 158 (177)
+.|++|+||+|+||++ +..+.++++|||.+........ .....++..|+|||.+.+ ..++.++|+||+|+++
T Consensus 124 ~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil 200 (336)
T cd07849 124 SANVLHRDLKPSNLLL---NTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCIL 200 (336)
T ss_pred hCCeeccCCCHHHEEE---CCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHH
Confidence 9999999999999999 4677899999998866533221 122346788999998654 4578899999999999
Q ss_pred HHHHhCCCCCCCC
Q 030430 159 FELLNGYPPFSVG 171 (177)
Q Consensus 159 ~~~~~~~~pf~~~ 171 (177)
+++++|+.||.+.
T Consensus 201 ~el~~G~~~f~~~ 213 (336)
T cd07849 201 AEMLSNRPLFPGK 213 (336)
T ss_pred HHHHhCCCCCCCC
Confidence 9999999999764
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=184.30 Aligned_cols=158 Identities=32% Similarity=0.547 Sum_probs=136.3
Q ss_pred HHHHHHHHHHhhCC-CCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 11 SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 11 ~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
....+|++.+++++ |+|++++++++.+++..++++||+ +++|.+++.... .+++..+..++.|++.++.+||+.|+
T Consensus 42 ~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i 120 (283)
T cd07830 42 CMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGF 120 (283)
T ss_pred HHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 34567999999998 999999999999999999999999 789998887654 68999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccc-cCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
+|+||+|+||++ +..+.++|+|||.+.............++..|+|||.+. ...++.++|+||+|++++++++|+.
T Consensus 121 ~H~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~ 197 (283)
T cd07830 121 FHRDLKPENLLV---SGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRP 197 (283)
T ss_pred ccCCCChhhEEE---cCCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCC
Confidence 999999999999 467889999999987665443333344677899999874 3457899999999999999999999
Q ss_pred CCCCCC
Q 030430 167 PFSVGE 172 (177)
Q Consensus 167 pf~~~~ 172 (177)
||...+
T Consensus 198 ~~~~~~ 203 (283)
T cd07830 198 LFPGSS 203 (283)
T ss_pred ccCCCC
Confidence 997654
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=187.40 Aligned_cols=160 Identities=38% Similarity=0.590 Sum_probs=133.5
Q ss_pred hHHHHHHHHHHHHhhC-CCCceeeEeEEEee--CCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
.....+.+|+++++++ +||||+++++++.. ...+++++||++ ++|.+++... .+++..+..++.|++.+|++||+
T Consensus 48 ~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~ 125 (337)
T cd07852 48 TDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHS 125 (337)
T ss_pred hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence 3445677899999999 99999999998764 346899999996 5999988755 78888999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC------ccccccCCCcccccccccc-CCCCCcchHHHHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAI 157 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~ 157 (177)
.|++|+||+|+||++ +..+.++++|||.+....... ......++..|+|||.+.+ ...+.++|+||+|++
T Consensus 126 ~~i~H~dl~p~nill---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~ 202 (337)
T cd07852 126 GNVIHRDLKPSNILL---NSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCI 202 (337)
T ss_pred CCeecCCCCHHHEEE---cCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHH
Confidence 999999999999999 567789999999887654322 1122346778999998754 456889999999999
Q ss_pred HHHHHhCCCCCCCCC
Q 030430 158 LFELLNGYPPFSVGE 172 (177)
Q Consensus 158 ~~~~~~~~~pf~~~~ 172 (177)
++++++|+.||.+..
T Consensus 203 l~el~tg~~pf~~~~ 217 (337)
T cd07852 203 LGEMLLGKPLFPGTS 217 (337)
T ss_pred HHHHHhCCCCCCCCC
Confidence 999999999997644
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=186.80 Aligned_cols=156 Identities=33% Similarity=0.585 Sum_probs=131.1
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeC------CeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (177)
.+.+.+|++++++++||||+++.+++... ...+++++++ |++|.+++.. ..+++..+..++.|++.|++|||
T Consensus 60 ~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH 137 (345)
T cd07877 60 AKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIH 137 (345)
T ss_pred HHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH
Confidence 45678899999999999999999987543 3468888877 8899887764 46999999999999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCcccccccccc-CCCCCcchHHHHHHHHHHHH
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~ 162 (177)
+.|++|+||+|+||++ +..+.++++|||.+...... .....++..|+|||.+.+ ..++.++|+||+|+++++++
T Consensus 138 ~~~ivH~dlkp~NIll---~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~ 212 (345)
T cd07877 138 SADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 212 (345)
T ss_pred HCCeeecCCChHHEEE---cCCCCEEEeccccccccccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHH
Confidence 9999999999999999 45678999999988654322 223446788999998765 45788999999999999999
Q ss_pred hCCCCCCCCC
Q 030430 163 NGYPPFSVGE 172 (177)
Q Consensus 163 ~~~~pf~~~~ 172 (177)
+|+.||.+.+
T Consensus 213 ~g~~pf~~~~ 222 (345)
T cd07877 213 TGRTLFPGTD 222 (345)
T ss_pred hCCCCCCCCC
Confidence 9999997654
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=187.16 Aligned_cols=157 Identities=34% Similarity=0.582 Sum_probs=133.2
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCC------eEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHH
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l 82 (177)
....+.+|++++++++||||+++.+++.... .++++++++ |++|.+++. ...+++..+..++.|++.++++|
T Consensus 57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~L 134 (343)
T cd07880 57 FAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYI 134 (343)
T ss_pred HHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH
Confidence 4567889999999999999999999886543 468999998 889998876 45799999999999999999999
Q ss_pred hhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCcccccccccc-CCCCCcchHHHHHHHHHHH
Q 030430 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 83 h~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~ 161 (177)
|+.|++|+||+|+||+++ ..+.++++|||.+....... ....++..|++||.+.+ ..++.++|+||+|++++++
T Consensus 135 H~~gi~H~dlkp~Nill~---~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l 209 (343)
T cd07880 135 HAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQTDSEM--TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEM 209 (343)
T ss_pred HhCCeecCCCCHHHEEEc---CCCCEEEeecccccccccCc--cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence 999999999999999994 56779999999987653322 22346788999998865 3578899999999999999
Q ss_pred HhCCCCCCCCC
Q 030430 162 LNGYPPFSVGE 172 (177)
Q Consensus 162 ~~~~~pf~~~~ 172 (177)
++|..||.+.+
T Consensus 210 ~~g~~pf~~~~ 220 (343)
T cd07880 210 LTGKPLFKGHD 220 (343)
T ss_pred HhCCCCCCCCC
Confidence 99999997653
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=184.15 Aligned_cols=156 Identities=34% Similarity=0.586 Sum_probs=132.7
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
..+.+.+|+++++.++|+|++++.+++......++++||+. +++.+.+.. ...+++..+..++.|++.++.+||+.|+
T Consensus 58 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i 136 (308)
T cd06634 58 KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136 (308)
T ss_pred HHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 34567889999999999999999999999999999999995 578777654 3458999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccc---cCCCCCcchHHHHHHHHHHHHhC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slg~~~~~~~~~ 164 (177)
+|+||+|+||++ +..+.++++|||.+...... ....++..|+|||.+. ....+.++|+||+|++++++++|
T Consensus 137 ~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g 210 (308)
T cd06634 137 IHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 210 (308)
T ss_pred ccCCCCHHhEEE---CCCCcEEECCcccceeecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcC
Confidence 999999999999 45678999999987654332 2334677899999874 34578899999999999999999
Q ss_pred CCCCCCC
Q 030430 165 YPPFSVG 171 (177)
Q Consensus 165 ~~pf~~~ 171 (177)
..||...
T Consensus 211 ~~p~~~~ 217 (308)
T cd06634 211 KPPLFNM 217 (308)
T ss_pred CCCCccc
Confidence 9998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=182.44 Aligned_cols=159 Identities=33% Similarity=0.604 Sum_probs=136.4
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
....+.+|+++++.++|||++++++++.+....++++||+++++|.+++.. ...+++..+..++.|++.++++||+
T Consensus 45 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~ 124 (260)
T cd08222 45 ETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124 (260)
T ss_pred hHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH
Confidence 344577899999999999999999999988899999999999999988763 3458999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~ 163 (177)
.|++|+|++|+|+++. .+.++++|||.+....... ......++..|++||...+..++.++|+||+|++++++++
T Consensus 125 ~~i~h~~l~~~nili~----~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~ 200 (260)
T cd08222 125 RRILHRDLKAKNIFLK----NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCC 200 (260)
T ss_pred cCccccCCChhheEee----cCCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHh
Confidence 9999999999999994 2458999999886654332 2223446778999999887778899999999999999999
Q ss_pred CCCCCCCC
Q 030430 164 GYPPFSVG 171 (177)
Q Consensus 164 ~~~pf~~~ 171 (177)
|..||...
T Consensus 201 ~~~~~~~~ 208 (260)
T cd08222 201 LAHAFEGQ 208 (260)
T ss_pred CCCCCCCc
Confidence 99999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=187.09 Aligned_cols=159 Identities=33% Similarity=0.514 Sum_probs=132.6
Q ss_pred HHHHHHHHHHHhhC-CCCceeeEeEEEee----CCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 10 KSCLDCELNFLSSV-NHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
...+.+|+++++++ +||||+++++.... ....+++++++ +++|.+++.....+++..+..++.|++.+|++||+
T Consensus 45 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~ 123 (332)
T cd07857 45 AKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELM-EADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHS 123 (332)
T ss_pred HHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEecc-cCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 45678899999999 59999999986432 24578888988 57999998877789999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-----cccccCCCcccccccccc-CCCCCcchHHHHHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAIL 158 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~ 158 (177)
.|++|+||+|+||++ +..+.++|+|||.+........ .....++..|+|||...+ ..++.++|+||+|+++
T Consensus 124 ~givH~dlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l 200 (332)
T cd07857 124 ANVLHRDLKPGNLLV---NADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCIL 200 (332)
T ss_pred CCcccCCCCHHHeEE---cCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHH
Confidence 999999999999999 4667899999999876543221 122357788999998754 4578999999999999
Q ss_pred HHHHhCCCCCCCCC
Q 030430 159 FELLNGYPPFSVGE 172 (177)
Q Consensus 159 ~~~~~~~~pf~~~~ 172 (177)
+++++|..||.+.+
T Consensus 201 ~~l~~g~~pf~~~~ 214 (332)
T cd07857 201 AELLGRKPVFKGKD 214 (332)
T ss_pred HHHHhCCcCCCCCC
Confidence 99999999997654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=184.10 Aligned_cols=160 Identities=29% Similarity=0.480 Sum_probs=132.0
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCC----------eEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHH
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN----------CIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGA 77 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----------~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~ 77 (177)
....+.+|+++++.++|||++++++++.+.. .+++++||+++ ++.+.+... ..+++..+..++.|++.
T Consensus 49 ~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~ 127 (302)
T cd07864 49 FPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLE 127 (302)
T ss_pred chHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHH
Confidence 3456788999999999999999999886544 78999999965 777776644 46899999999999999
Q ss_pred HHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--cccccCCCccccccccccC-CCCCcchHHHH
Q 030430 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSV 154 (177)
Q Consensus 78 ~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~-~~~~~~Di~sl 154 (177)
||+|||+.|++|+||+|+||++ +..+.++++|||.+........ ......+..|++||.+.+. ..+.++|+||+
T Consensus 128 aL~~LH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~sl 204 (302)
T cd07864 128 GLNYCHKKNFLHRDIKCSNILL---NNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC 204 (302)
T ss_pred HHHHHHhCCeecCCCCHHHEEE---CCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHH
Confidence 9999999999999999999999 5677899999998876543321 1122346679999987543 46889999999
Q ss_pred HHHHHHHHhCCCCCCCCC
Q 030430 155 GAILFELLNGYPPFSVGE 172 (177)
Q Consensus 155 g~~~~~~~~~~~pf~~~~ 172 (177)
|++++++++|+.||...+
T Consensus 205 G~~~~el~~g~~~~~~~~ 222 (302)
T cd07864 205 GCILGELFTKKPIFQANQ 222 (302)
T ss_pred HHHHHHHHhCCCCCCCCC
Confidence 999999999999997643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-30 Score=184.23 Aligned_cols=163 Identities=33% Similarity=0.557 Sum_probs=148.2
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
...-..|-++|+..+||.+..+...|+...++|+||||..||.|.-++.+...++++....+-..|+.||.|||++++++
T Consensus 212 VAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivY 291 (516)
T KOG0690|consen 212 VAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVY 291 (516)
T ss_pred hhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeee
Confidence 34445577899999999999999999999999999999999999999998888999999999999999999999999999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeecccccc-CCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~~-~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf 168 (177)
||+|.+|.++ ++.+.+|+.|||+++.- ..+....+.+|++.|+|||.+....++.+.|-|.+|+++|||++|+.||
T Consensus 292 RDlKLENLlL---DkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPF 368 (516)
T KOG0690|consen 292 RDLKLENLLL---DKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPF 368 (516)
T ss_pred eechhhhhee---ccCCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcc
Confidence 9999999999 78999999999999764 3445667889999999999999999999999999999999999999999
Q ss_pred CCCCccc
Q 030430 169 SVGEEHQ 175 (177)
Q Consensus 169 ~~~~~~~ 175 (177)
...+-+.
T Consensus 369 yn~dh~k 375 (516)
T KOG0690|consen 369 YNKDHEK 375 (516)
T ss_pred cccchhH
Confidence 8876543
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=187.61 Aligned_cols=161 Identities=30% Similarity=0.617 Sum_probs=131.4
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeC--------------CeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHH
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--------------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 73 (177)
...+.+.+|++++++++|||++++++++... ...++++||++ ++|.+++.. ..+++..++.++.
T Consensus 44 ~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~ 121 (342)
T cd07854 44 QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMY 121 (342)
T ss_pred chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHH
Confidence 3456788999999999999999999876543 35789999995 589888763 4689999999999
Q ss_pred HHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC----ccccccCCCcccccccccc-CCCCCc
Q 030430 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQF-QRYDEK 148 (177)
Q Consensus 74 ~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~-~~~~~~ 148 (177)
|++.|+.|||+.|++|+||+|+||+++ ..+..++++|||.+....... ......++..|+|||.+.. ..++.+
T Consensus 122 qi~~aL~~LH~~givH~dikp~Nili~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 199 (342)
T cd07854 122 QLLRGLKYIHSANVLHRDLKPANVFIN--TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKA 199 (342)
T ss_pred HHHHHHHHHHhCCcccCCCCHHHEEEc--CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCch
Confidence 999999999999999999999999995 345678999999987653221 1122345778999997654 457889
Q ss_pred chHHHHHHHHHHHHhCCCCCCCCC
Q 030430 149 VDMWSVGAILFELLNGYPPFSVGE 172 (177)
Q Consensus 149 ~Di~slg~~~~~~~~~~~pf~~~~ 172 (177)
+|+||||++++++++|+.||.+.+
T Consensus 200 ~DiwSlGvil~el~~g~~pf~~~~ 223 (342)
T cd07854 200 IDMWAAGCIFAEMLTGKPLFAGAH 223 (342)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999997653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=177.04 Aligned_cols=158 Identities=47% Similarity=0.860 Sum_probs=142.5
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
.+.+.+|++.+++++|++++++.+.+......++++|++++++|..++.....++...+..++.+++.++.+||+.|++|
T Consensus 31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h 110 (244)
T smart00220 31 RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIH 110 (244)
T ss_pred HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeec
Confidence 57899999999999999999999999999999999999998899999987666899999999999999999999999999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf~ 169 (177)
+||+|+||++. ..+.++++|||.+.............++..|++||......++.++|+||+|++++++++|..||.
T Consensus 111 ~~i~~~ni~~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~ 187 (244)
T smart00220 111 RDLKPENILLD---EDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFP 187 (244)
T ss_pred CCcCHHHeEEC---CCCcEEEccccceeeeccccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999994 557899999999877665544444557788999999887788899999999999999999999997
Q ss_pred C
Q 030430 170 V 170 (177)
Q Consensus 170 ~ 170 (177)
.
T Consensus 188 ~ 188 (244)
T smart00220 188 G 188 (244)
T ss_pred C
Confidence 6
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=184.15 Aligned_cols=158 Identities=28% Similarity=0.519 Sum_probs=128.6
Q ss_pred HHHHHHHHHHhhCCCCceeeEeEEEeeC--------CeEEEEEecCCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHH
Q 030430 11 SCLDCELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEI 81 (177)
Q Consensus 11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~ 81 (177)
..+.+|+++++.++||||+++++++.+. ..++++++|+. +++...+.. ...+++..+..++.|++.+|++
T Consensus 52 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~ 130 (311)
T cd07866 52 ITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINY 130 (311)
T ss_pred hhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHH
Confidence 4567899999999999999999876433 35799999995 577776654 3469999999999999999999
Q ss_pred HhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc------------ccccCCCccccccccccC-CCCCc
Q 030430 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA------------EKVCGSPLYMAPEVLQFQ-RYDEK 148 (177)
Q Consensus 82 lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~------------~~~~~~~~~~~pe~~~~~-~~~~~ 148 (177)
||+.|++|+|++|+||++ +..+.++++|||.+......... ....+++.|+|||.+.+. .++.+
T Consensus 131 lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 207 (311)
T cd07866 131 LHENHILHRDIKAANILI---DNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTA 207 (311)
T ss_pred HHhCCeecCCCCHHHEEE---CCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCch
Confidence 999999999999999999 46778999999988654322111 112346779999987543 47889
Q ss_pred chHHHHHHHHHHHHhCCCCCCCCC
Q 030430 149 VDMWSVGAILFELLNGYPPFSVGE 172 (177)
Q Consensus 149 ~Di~slg~~~~~~~~~~~pf~~~~ 172 (177)
+|+||+|++++++++|.+||.+.+
T Consensus 208 ~Dv~slG~il~el~~g~~~~~~~~ 231 (311)
T cd07866 208 VDIWGIGCVFAEMFTRRPILQGKS 231 (311)
T ss_pred hHhHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999997654
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=180.41 Aligned_cols=158 Identities=30% Similarity=0.550 Sum_probs=130.4
Q ss_pred HHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhh-C
Q 030430 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNS-H 85 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~-~ 85 (177)
....+..|..++.+. +|||++++++++.+....++++||+ ++++.+++.. ...+++..+..++.|++.+++|||+ .
T Consensus 56 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ 134 (296)
T cd06618 56 ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH 134 (296)
T ss_pred HHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC
Confidence 344566677766666 5999999999999999999999998 5578777765 3468999999999999999999997 5
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCC----CCCcchHHHHHHHHHHH
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR----YDEKVDMWSVGAILFEL 161 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~----~~~~~Di~slg~~~~~~ 161 (177)
|++|+||+|+||++ +..+.++|+|||.+.............++..|+|||.+.+.. ++.++|+||+|++++++
T Consensus 135 ~i~H~dl~p~nill---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el 211 (296)
T cd06618 135 GVIHRDVKPSNILL---DASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVEL 211 (296)
T ss_pred CEecCCCcHHHEEE---cCCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHH
Confidence 99999999999999 467789999999987654333333334677899999886443 68899999999999999
Q ss_pred HhCCCCCCC
Q 030430 162 LNGYPPFSV 170 (177)
Q Consensus 162 ~~~~~pf~~ 170 (177)
++|+.||..
T Consensus 212 ~~g~~p~~~ 220 (296)
T cd06618 212 ATGQFPYKN 220 (296)
T ss_pred HhCCCCCCc
Confidence 999999976
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=186.84 Aligned_cols=157 Identities=33% Similarity=0.576 Sum_probs=133.2
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCe------EEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHH
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l 82 (177)
....+.+|+.++++++|||++++.+++..... .++++|++ +++|.+++.. ..+++..+..++.|++.++++|
T Consensus 57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~L 134 (343)
T cd07851 57 HAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYI 134 (343)
T ss_pred HHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Confidence 44667789999999999999999987765544 89999998 7799998874 4799999999999999999999
Q ss_pred hhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCcccccccccc-CCCCCcchHHHHHHHHHHH
Q 030430 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 83 h~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~ 161 (177)
|+.|++|+||+|+||+++ .++.++|+|||.+...... .....++..|+|||...+ ..++.++|+||+|++++++
T Consensus 135 H~~gi~H~dlkp~Nill~---~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~el 209 (343)
T cd07851 135 HSAGIIHRDLKPSNIAVN---EDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209 (343)
T ss_pred HHCCeecCCCCHHHeEEC---CCCCEEEcccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHH
Confidence 999999999999999994 5678999999998765333 223346778999998754 3578899999999999999
Q ss_pred HhCCCCCCCCC
Q 030430 162 LNGYPPFSVGE 172 (177)
Q Consensus 162 ~~~~~pf~~~~ 172 (177)
++|+.||.+.+
T Consensus 210 ltg~~pf~~~~ 220 (343)
T cd07851 210 LTGKTLFPGSD 220 (343)
T ss_pred HhCCCCCCCCC
Confidence 99999997654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=179.13 Aligned_cols=162 Identities=32% Similarity=0.659 Sum_probs=148.9
Q ss_pred chhHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
+.+..+-.+.|..++.+- +||.+|.+..+|+..+.+++|.||++||+|.-++.+..+++++.+..+...|..||.|||+
T Consensus 290 ddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~ 369 (593)
T KOG0695|consen 290 DDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHE 369 (593)
T ss_pred CcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhh
Confidence 344556678888889888 7999999999999999999999999999999999888899999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeecccccc-CCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~-~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~ 163 (177)
+||++||+|.+|+++ +..+.+||.|+|+++.. .+++.+++.+|++.|.|||.+.+..|+.+.|-|+||++++||+.
T Consensus 370 rgiiyrdlkldnvll---daeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemma 446 (593)
T KOG0695|consen 370 RGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMA 446 (593)
T ss_pred cCeeeeeccccceEE---ccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHc
Confidence 999999999999999 67889999999999764 55667788999999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 030430 164 GYPPFSV 170 (177)
Q Consensus 164 ~~~pf~~ 170 (177)
|+.||..
T Consensus 447 grspfdi 453 (593)
T KOG0695|consen 447 GRSPFDI 453 (593)
T ss_pred CCCCcce
Confidence 9999954
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-30 Score=194.68 Aligned_cols=152 Identities=37% Similarity=0.629 Sum_probs=134.9
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
=+.+.+|+++|++++|||.+.+.++|......++||||| -|+-.+++.-+ +++.+..+..|..+.+.+|+|||+.+.+
T Consensus 70 WqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~I 148 (948)
T KOG0577|consen 70 WQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRI 148 (948)
T ss_pred HHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHH
Confidence 356889999999999999999999999999999999999 56889988866 4599999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccc---cCCCCCcchHHHHHHHHHHHHhCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slg~~~~~~~~~~ 165 (177)
|||||..||++ .+.+.++|.|||.+....+ ..+..|||.|||||++. .+.|+.+.||||||++..++...+
T Consensus 149 HRDiKAGNILL---se~g~VKLaDFGSAsi~~P---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERk 222 (948)
T KOG0577|consen 149 HRDIKAGNILL---SEPGLVKLADFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 222 (948)
T ss_pred hhhccccceEe---cCCCeeeeccccchhhcCc---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcC
Confidence 99999999999 4788999999998866533 23456999999999874 456899999999999999999999
Q ss_pred CCC
Q 030430 166 PPF 168 (177)
Q Consensus 166 ~pf 168 (177)
+|+
T Consensus 223 PPl 225 (948)
T KOG0577|consen 223 PPL 225 (948)
T ss_pred CCc
Confidence 884
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=183.54 Aligned_cols=156 Identities=33% Similarity=0.544 Sum_probs=129.7
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeC------CeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHH
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l 82 (177)
....+.+|+++++.++||||+++.+++... ..+++++|++. .+|..+.. ..++++.+..++.|++.|+++|
T Consensus 57 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~L 133 (342)
T cd07879 57 FAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG--HPLSEDKVQYLVYQMLCGLKYI 133 (342)
T ss_pred chhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHHc--CCCCHHHHHHHHHHHHHHHHHH
Confidence 345678999999999999999999988644 35699999984 57776543 4689999999999999999999
Q ss_pred hhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCcccccccccc-CCCCCcchHHHHHHHHHHH
Q 030430 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 83 h~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~ 161 (177)
|+.|++|+||+|+||++ +..+.++|+|||.+...... .....++..|+|||.+.+ ..++.++|+||+|++++++
T Consensus 134 H~~~i~H~dlkp~NIll---~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el 208 (342)
T cd07879 134 HSAGIIHRDLKPGNLAV---NEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEM 208 (342)
T ss_pred HHCCcccCCCCHHHEEE---CCCCCEEEeeCCCCcCCCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHH
Confidence 99999999999999999 46778999999988654322 122345778999998865 4578899999999999999
Q ss_pred HhCCCCCCCCC
Q 030430 162 LNGYPPFSVGE 172 (177)
Q Consensus 162 ~~~~~pf~~~~ 172 (177)
++|+.||.+.+
T Consensus 209 ~~g~~pf~~~~ 219 (342)
T cd07879 209 LTGKTLFKGKD 219 (342)
T ss_pred HhCCCCCCCCC
Confidence 99999998754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=170.37 Aligned_cols=166 Identities=28% Similarity=0.481 Sum_probs=140.6
Q ss_pred CccccchhHHHHHHHHHHHHhhCC-CCceeeEeEEEeeC--CeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHH
Q 030430 1 MLKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGA 77 (177)
Q Consensus 1 ~l~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ 77 (177)
|+|.+++--+..+.+|+.+|+.|. +|||++++++..++ ....+++|++.+.++..+- +.++.-.+.-++.+++.
T Consensus 67 ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLk 143 (338)
T KOG0668|consen 67 VIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLK 143 (338)
T ss_pred EEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHH
Confidence 467788889999999999999996 99999999998754 5678999999888877653 46888899999999999
Q ss_pred HHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCcccccccccc-CCCCCcchHHHHHH
Q 030430 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGA 156 (177)
Q Consensus 78 ~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~ 156 (177)
||.|||+.||.|||+||.|++++ .....++|+|+|++....++..-.....+..|-.||++.. ..++.+.|+||+||
T Consensus 144 ALdyCHS~GImHRDVKPhNvmId--h~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~Gc 221 (338)
T KOG0668|consen 144 ALDYCHSMGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGC 221 (338)
T ss_pred HHhHHHhcCcccccCCcceeeec--hhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHH
Confidence 99999999999999999999996 4566799999999987765544334456777888998754 45788999999999
Q ss_pred HHHHHHhCCCCCCCC
Q 030430 157 ILFELLNGYPPFSVG 171 (177)
Q Consensus 157 ~~~~~~~~~~pf~~~ 171 (177)
++..|+..+.||-.+
T Consensus 222 mlA~miFrkepFFhG 236 (338)
T KOG0668|consen 222 MLASMIFRKEPFFHG 236 (338)
T ss_pred HHHHHHhccCcccCC
Confidence 999999998887443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-28 Score=171.27 Aligned_cols=159 Identities=45% Similarity=0.779 Sum_probs=140.5
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
..+.+.+|++.++.++|++++++.+++......++++|++++++|.+++..... +++..+..++.+++.++.++|+.++
T Consensus 40 ~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i 119 (225)
T smart00221 40 QREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGI 119 (225)
T ss_pred HHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 567899999999999999999999999998999999999999999999987666 8999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC--ccccccCCCcccccccc-ccCCCCCcchHHHHHHHHHHHHhC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pe~~-~~~~~~~~~Di~slg~~~~~~~~~ 164 (177)
+|+|++|.|++++ ....++++|||.+....... ......+...|++||.. ....++.++|+|++|++++++++|
T Consensus 120 ~h~di~~~ni~v~---~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g 196 (225)
T smart00221 120 VHRDLKPENILLG---MDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWG 196 (225)
T ss_pred ecCCCCHHHEEEc---CCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHC
Confidence 9999999999994 55789999999887765442 22334467789999988 556678899999999999999999
Q ss_pred CCCCCC
Q 030430 165 YPPFSV 170 (177)
Q Consensus 165 ~~pf~~ 170 (177)
+.||..
T Consensus 197 ~~pf~~ 202 (225)
T smart00221 197 PEPFSG 202 (225)
T ss_pred CCCccc
Confidence 999977
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=194.30 Aligned_cols=163 Identities=24% Similarity=0.397 Sum_probs=142.2
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
..+.|.+|+.+|.+|+|+|+++++++..+ ....+|+|+++.|+|.+.+++. ..|....++.++.||+.++.||..++
T Consensus 154 ~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr 232 (1039)
T KOG0199|consen 154 IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR 232 (1039)
T ss_pred hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh
Confidence 56789999999999999999999999988 5688999999999999999872 34889999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcccc----ccCCCccccccccccCCCCCcchHHHHHHHHHHHH
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK----VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~----~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~ 162 (177)
+||||+-..|+++. ....+|++|||+.+.+........ ..-...|+|||.+....++.++|+|++|+++|||+
T Consensus 233 lvHRDLAARNllla---sprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMF 309 (1039)
T KOG0199|consen 233 LVHRDLAARNLLLA---SPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMF 309 (1039)
T ss_pred hhhhhhhhhhheec---ccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhh
Confidence 99999999999994 466799999999988866554332 22344599999999999999999999999999999
Q ss_pred h-CCCCCCCCCccc
Q 030430 163 N-GYPPFSVGEEHQ 175 (177)
Q Consensus 163 ~-~~~pf~~~~~~~ 175 (177)
+ |+.||-|...-+
T Consensus 310 tyGEePW~G~~g~q 323 (1039)
T KOG0199|consen 310 TYGEEPWVGCRGIQ 323 (1039)
T ss_pred ccCCCCCCCCCHHH
Confidence 9 789998865433
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=181.91 Aligned_cols=162 Identities=34% Similarity=0.588 Sum_probs=139.5
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEe-eCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQ-AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH-- 86 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~-- 86 (177)
..-..+|.++-+.|+||.||++++++. +...+|.|.|||+|.+|..+++.+.-+++..+..|+-||+.||.||.+..
T Consensus 511 hKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpP 590 (775)
T KOG1151|consen 511 HKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPP 590 (775)
T ss_pred HHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCC
Confidence 345678999999999999999999986 55678999999999999999999989999999999999999999999975
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC--------ccccccCCCccccccccccC--C--CCCcchHHHH
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQFQ--R--YDEKVDMWSV 154 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~~~--~--~~~~~Di~sl 154 (177)
|+|-|+||.||++-.-...+.+++.|||+++...... .++.-.|+-+|+|||.+.-. + .+.+.||||+
T Consensus 591 IIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSv 670 (775)
T KOG1151|consen 591 IIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSV 670 (775)
T ss_pred eeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEee
Confidence 9999999999998654568889999999998764432 22344588899999987433 2 5778999999
Q ss_pred HHHHHHHHhCCCCCCCC
Q 030430 155 GAILFELLNGYPPFSVG 171 (177)
Q Consensus 155 g~~~~~~~~~~~pf~~~ 171 (177)
|+++|.++-|+.||..+
T Consensus 671 GVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 671 GVIFYQCLYGRKPFGHN 687 (775)
T ss_pred ehhhhhhhccCCCCCCc
Confidence 99999999999999764
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=181.43 Aligned_cols=165 Identities=27% Similarity=0.427 Sum_probs=139.9
Q ss_pred hHHHHHHHHHHHHhhCC--CC----ceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHH
Q 030430 8 HLKSCLDCELNFLSSVN--HP----NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGL 79 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~--h~----~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l 79 (177)
..++...-|+++++++. .| .++.+.+|++..++.|+|+|.+ |.|+.+++..+. +++.+.+..+++|++.++
T Consensus 127 kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv 205 (415)
T KOG0671|consen 127 KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESV 205 (415)
T ss_pred HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHH
Confidence 44667778999999993 33 3788889999999999999988 889999999764 499999999999999999
Q ss_pred HHHhhCCCeeecCCCCcEEEec-----------------CCCCeeEEEeeeccccccCCCCccccccCCCcccccccccc
Q 030430 80 EILNSHHIIHRDLKPENILLSG-----------------LDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF 142 (177)
Q Consensus 80 ~~lh~~~~~H~~i~~~nil~~~-----------------~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 142 (177)
++||+.+++|.|+||+||++-+ ..++..++++|||.+....... .....|..|.|||++.+
T Consensus 206 ~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLg 283 (415)
T KOG0671|consen 206 AFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILG 283 (415)
T ss_pred HHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheec
Confidence 9999999999999999998731 1124558999999886643332 45567899999999999
Q ss_pred CCCCCcchHHHHHHHHHHHHhCCCCCCCCCccc
Q 030430 143 QRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 175 (177)
Q Consensus 143 ~~~~~~~Di~slg~~~~~~~~~~~pf~~~~~~~ 175 (177)
-+++..+||||+||++.|+.+|...|.+.++.+
T Consensus 284 LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 284 LGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred cCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 999999999999999999999999998876543
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=191.67 Aligned_cols=161 Identities=34% Similarity=0.558 Sum_probs=138.8
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
..--+.+.-|++||...+||+|+++++.|-..+.++++.|+|.||-+...+-.- ..+.+.++.-+..|++.||.|||+.
T Consensus 70 eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~ 149 (1187)
T KOG0579|consen 70 EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ 149 (1187)
T ss_pred hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc
Confidence 344556788999999999999999999988888999999999999998877644 5699999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCC-CccccccCCCccccccccc-----cCCCCCcchHHHHHHHHH
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILF 159 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~slg~~~~ 159 (177)
+|+|||++..||++ ...+.++|.|||.+...... ....+..|++.|||||+.. ..+|+.++||||||+++.
T Consensus 150 ~iIHRDLKAGNiL~---TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLI 226 (1187)
T KOG0579|consen 150 NIIHRDLKAGNILL---TLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLI 226 (1187)
T ss_pred chhhhhccccceEE---EecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHH
Confidence 99999999999999 46788999999988654332 2333567999999999864 456899999999999999
Q ss_pred HHHhCCCCCCC
Q 030430 160 ELLNGYPPFSV 170 (177)
Q Consensus 160 ~~~~~~~pf~~ 170 (177)
+|..+.+|-..
T Consensus 227 EMAqiEPPHhe 237 (1187)
T KOG0579|consen 227 EMAQIEPPHHE 237 (1187)
T ss_pred HHhccCCCccc
Confidence 99999998644
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=179.90 Aligned_cols=159 Identities=30% Similarity=0.487 Sum_probs=134.3
Q ss_pred hHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHh-----hcCCCCHHHHHHHHHHHHHHHHH
Q 030430 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-----LHGRVPEQTARKFLQQLGAGLEI 81 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~ 81 (177)
....++..|.+...+- +.|+||+++|..-..+..++.||++ ..||..+-. +...++++.+..|..-++.||.|
T Consensus 104 keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~y 182 (361)
T KOG1006|consen 104 KEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDY 182 (361)
T ss_pred HHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHH
Confidence 4456677787755554 7999999999888888889999999 778877654 23459999999998899999999
Q ss_pred Hhh-CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccc--cCCCCCcchHHHHHHHH
Q 030430 82 LNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ--FQRYDEKVDMWSVGAIL 158 (177)
Q Consensus 82 lh~-~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~Di~slg~~~ 158 (177)
|-+ ..++|||+||+||++ +..+.+||||||.+-....+.......|-..|+|||.+. ..+++.+||+||||+++
T Consensus 183 LK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL 259 (361)
T KOG1006|consen 183 LKEELKIIHRDVKPSNILL---DRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITL 259 (361)
T ss_pred HHHHhhhhhccCChhheEE---ecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceE
Confidence 987 579999999999999 567889999999998777776666667888999999885 33589999999999999
Q ss_pred HHHHhCCCCCCC
Q 030430 159 FELLNGYPPFSV 170 (177)
Q Consensus 159 ~~~~~~~~pf~~ 170 (177)
+|++||..||++
T Consensus 260 ~EvAtG~fPyr~ 271 (361)
T KOG1006|consen 260 YEVATGNFPYRK 271 (361)
T ss_pred eeeecCCCCcch
Confidence 999999999976
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-29 Score=164.76 Aligned_cols=165 Identities=35% Similarity=0.577 Sum_probs=143.2
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
+.+-....+|+-+++.++|.|||+++++.-.+..+-+|+|+| ..+|.++.+.. +.++.+.+..++-|++.++.++|+.
T Consensus 42 egvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh 120 (292)
T KOG0662|consen 42 EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH 120 (292)
T ss_pred CCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh
Confidence 344567889999999999999999999999999999999999 66999988854 6699999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccc-cccCCCccccccccccCC-CCCcchHHHHHHHHHHHHh
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-KVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~pe~~~~~~-~~~~~Di~slg~~~~~~~~ 163 (177)
++.|||+||.|.++ +.++.+++.|||+++.++-+.... ...-+.+|.||..+.++. ++.+.|+||.||++.|+..
T Consensus 121 nvlhrdlkpqnlli---n~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelan 197 (292)
T KOG0662|consen 121 NVLHRDLKPQNLLI---NRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN 197 (292)
T ss_pred hhhhccCCcceEEe---ccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhh
Confidence 99999999999999 578889999999998886665332 344688999999988765 7999999999999999987
Q ss_pred -CCCCCCCCCccc
Q 030430 164 -GYPPFSVGEEHQ 175 (177)
Q Consensus 164 -~~~pf~~~~~~~ 175 (177)
|++.|.+.+.++
T Consensus 198 agrplfpg~dvdd 210 (292)
T KOG0662|consen 198 AGRPLFPGNDVDD 210 (292)
T ss_pred cCCCCCCCCcHHH
Confidence 677788876543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=199.96 Aligned_cols=148 Identities=28% Similarity=0.470 Sum_probs=123.6
Q ss_pred HHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCCee
Q 030430 13 LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN---SHHIIH 89 (177)
Q Consensus 13 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~~~H 89 (177)
...|++.+++++||||+++++++.+....++||||+++++|.+++. .++...+.+++.|++.|++|+| +.+++|
T Consensus 730 ~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH 806 (968)
T PLN00113 730 PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVV 806 (968)
T ss_pred cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeec
Confidence 3467899999999999999999999999999999999999999986 4788999999999999999999 669999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf~ 169 (177)
||+||+||++. .....++. ++........ ....++..|+|||...+..++.++||||+|+++||++||+.||.
T Consensus 807 ~dlkp~Nil~~---~~~~~~~~-~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~ 879 (968)
T PLN00113 807 GNLSPEKIIID---GKDEPHLR-LSLPGLLCTD---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879 (968)
T ss_pred CCCCHHhEEEC---CCCceEEE-eccccccccC---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCC
Confidence 99999999994 33344433 4433221111 12246789999999988889999999999999999999999985
Q ss_pred C
Q 030430 170 V 170 (177)
Q Consensus 170 ~ 170 (177)
.
T Consensus 880 ~ 880 (968)
T PLN00113 880 A 880 (968)
T ss_pred c
Confidence 4
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-30 Score=191.91 Aligned_cols=165 Identities=32% Similarity=0.487 Sum_probs=143.8
Q ss_pred HHHHHHHHHHHHhhCC------CCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCC---CCHHHHHHHHHHHHHHH
Q 030430 9 LKSCLDCELNFLSSVN------HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFLQQLGAGL 79 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l 79 (177)
....=..|+++|++|. --+++.++..|....++|||+|.+ ..+|.+.+++.+. +....+..+++|++.||
T Consensus 471 M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflAL 549 (752)
T KOG0670|consen 471 MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLAL 549 (752)
T ss_pred HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHH
Confidence 3444567999999995 237888888899999999999988 7899999987653 88899999999999999
Q ss_pred HHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHH
Q 030430 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (177)
Q Consensus 80 ~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~ 159 (177)
+.|-.+|++|.||||+||||. .....++|||||.+...+.+..++. .-+.+|.|||++.+.+|+...|+||.||++|
T Consensus 550 klLK~c~vlHaDIKPDNiLVN--E~k~iLKLCDfGSA~~~~eneitPY-LVSRFYRaPEIiLG~~yd~~iD~WSvgctLY 626 (752)
T KOG0670|consen 550 KLLKKCGVLHADIKPDNILVN--ESKNILKLCDFGSASFASENEITPY-LVSRFYRAPEIILGLPYDYPIDTWSVGCTLY 626 (752)
T ss_pred HHHHhcCeeecccCccceEec--cCcceeeeccCccccccccccccHH-HHHHhccCcceeecCcccCCccceeeceeeE
Confidence 999999999999999999996 4566689999999988776665533 3467899999999999999999999999999
Q ss_pred HHHhCCCCCCCCCcccCC
Q 030430 160 ELLNGYPPFSVGEEHQFM 177 (177)
Q Consensus 160 ~~~~~~~pf~~~~~~~~l 177 (177)
|++||+..|.|.+.++||
T Consensus 627 ElYtGkIlFpG~TNN~ML 644 (752)
T KOG0670|consen 627 ELYTGKILFPGRTNNQML 644 (752)
T ss_pred EeeccceecCCCCcHHHH
Confidence 999999999999988875
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-29 Score=187.73 Aligned_cols=153 Identities=31% Similarity=0.621 Sum_probs=137.1
Q ss_pred HHHHHHHHhhCC---CCceeeEeEEEeeCCeEEEEEecC-CCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 13 LDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFC-AGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 13 ~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~-~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
+..|++||..++ |+||++++++|++++++|++||-. +|.+|.++++.++.+++..+.-|++|++.+++.||++||+
T Consensus 613 Vp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~iv 692 (772)
T KOG1152|consen 613 VPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIV 692 (772)
T ss_pred cchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCce
Confidence 467999999997 999999999999999999999854 3679999999999999999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCC-CCcchHHHHHHHHHHHHhCCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slg~~~~~~~~~~~p 167 (177)
|||||-+|+.+ +.++.++|+|||.+....++... ...||.+|.|||.+.+..| +..-|||+||+++|.+.-...|
T Consensus 693 hrdikdenviv---d~~g~~klidfgsaa~~ksgpfd-~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenp 768 (772)
T KOG1152|consen 693 HRDIKDENVIV---DSNGFVKLIDFGSAAYTKSGPFD-VFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENP 768 (772)
T ss_pred ecccccccEEE---ecCCeEEEeeccchhhhcCCCcc-eeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCC
Confidence 99999999999 67889999999998766555544 3458999999999998887 5668999999999999999998
Q ss_pred CC
Q 030430 168 FS 169 (177)
Q Consensus 168 f~ 169 (177)
|.
T Consensus 769 yy 770 (772)
T KOG1152|consen 769 YY 770 (772)
T ss_pred Cc
Confidence 84
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=189.92 Aligned_cols=107 Identities=35% Similarity=0.649 Sum_probs=98.6
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
.....+..|+++++.++||||+++++++.....+|+||||+.|++|.+++...+.+++..++.++.|++.+|+|||..|+
T Consensus 46 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gI 125 (669)
T cd05610 46 NMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGI 125 (669)
T ss_pred HHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 34578899999999999999999999999999999999999999999999877789999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeecccc
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSC 117 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~ 117 (177)
+|+||||+||++. ..+.++|+|||++.
T Consensus 126 iHrDLKP~NILl~---~~g~vkL~DFGls~ 152 (669)
T cd05610 126 IHRDLKPDNMLIS---NEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCccHHHEEEc---CCCCEEEEeCCCCc
Confidence 9999999999994 56679999998764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=188.64 Aligned_cols=162 Identities=32% Similarity=0.580 Sum_probs=142.2
Q ss_pred chhHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC----------------CCCHHHH
Q 030430 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTA 68 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~ 68 (177)
+...++.+..|+++++.+ +|+|++.+++++..++.+++|.||+..|+|.++++.++ .++...+
T Consensus 341 ~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dL 420 (609)
T KOG0200|consen 341 SSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDL 420 (609)
T ss_pred CcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHH
Confidence 446788999999999999 69999999999999999999999999999999999765 2888899
Q ss_pred HHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccc--ccc--CCCccccccccccCC
Q 030430 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVC--GSPLYMAPEVLQFQR 144 (177)
Q Consensus 69 ~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~--~~~--~~~~~~~pe~~~~~~ 144 (177)
+.++.||+.+++||++..++|||+-..||+++ .+..+|++|||+++.......-. ... -...|+|||.+....
T Consensus 421 lsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~---~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ 497 (609)
T KOG0200|consen 421 LSFAYQIANGMEYLASVPCVHRDLAARNVLIT---KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRV 497 (609)
T ss_pred HHHHHHHHHHHHHHhhCCccchhhhhhhEEec---CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCc
Confidence 99999999999999999999999999999994 66789999999998654433221 111 345699999999889
Q ss_pred CCCcchHHHHHHHHHHHHh-CCCCCCC
Q 030430 145 YDEKVDMWSVGAILFELLN-GYPPFSV 170 (177)
Q Consensus 145 ~~~~~Di~slg~~~~~~~~-~~~pf~~ 170 (177)
++.++||||+|+++||+++ |..||.+
T Consensus 498 ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 498 FTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred ccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 9999999999999999999 7899986
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=190.78 Aligned_cols=169 Identities=33% Similarity=0.548 Sum_probs=142.1
Q ss_pred ccccchhHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-C---CCHHHHHHHHHHHH
Q 030430 2 LKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-R---VPEQTARKFLQQLG 76 (177)
Q Consensus 2 l~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~---~~~~~~~~~~~~i~ 76 (177)
+|++=.+..+..++|++.|+.- +||||+++++.-.++...||..|+| ..+|.++++... . .........+.|++
T Consensus 538 VKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~ 616 (903)
T KOG1027|consen 538 VKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIA 616 (903)
T ss_pred HHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHH
Confidence 4555566677889999999999 6999999999999999999999999 679999999741 1 22245577889999
Q ss_pred HHHHHHhhCCCeeecCCCCcEEEecCC--CCeeEEEeeeccccccCCCCc----cccccCCCccccccccccCCCCCcch
Q 030430 77 AGLEILNSHHIIHRDLKPENILLSGLD--DDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVD 150 (177)
Q Consensus 77 ~~l~~lh~~~~~H~~i~~~nil~~~~~--~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~D 150 (177)
.+|+.||+.+|+|||+||.||++...+ ....++|+|||++++...+.. .....|+-+|+|||++.....+.+.|
T Consensus 617 ~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avD 696 (903)
T KOG1027|consen 617 SGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVD 696 (903)
T ss_pred HHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccc
Confidence 999999999999999999999997542 346789999999998865432 23456889999999998888888999
Q ss_pred HHHHHHHHHHHHhC-CCCCCCC
Q 030430 151 MWSVGAILFELLNG-YPPFSVG 171 (177)
Q Consensus 151 i~slg~~~~~~~~~-~~pf~~~ 171 (177)
+|||||++|++++| ..||...
T Consensus 697 iFslGCvfyYvltgG~HpFGd~ 718 (903)
T KOG1027|consen 697 IFSLGCVFYYVLTGGSHPFGDS 718 (903)
T ss_pred hhhcCceEEEEecCCccCCCch
Confidence 99999999999996 8999764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=172.63 Aligned_cols=157 Identities=38% Similarity=0.536 Sum_probs=136.9
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCC------eEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (177)
-++..+|+.++..+.|+|+++++.++.-.. ..|+|||++ ..+|.+.+. -.++-+++..+..|++++++++|
T Consensus 59 akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lh 135 (369)
T KOG0665|consen 59 AKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLH 135 (369)
T ss_pred chhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHH
Confidence 356789999999999999999999986433 579999999 779998877 35788999999999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~ 163 (177)
+.||+|||+||+||++ ..+..+|++|||.+......-..+....+..|.|||.+.+..+....||||+||++.||++
T Consensus 136 s~~IihRdLkPsnivv---~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~ 212 (369)
T KOG0665|consen 136 SAGIIHRDLKPSNIVV---NSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELIL 212 (369)
T ss_pred hcceeecccCccccee---cchhheeeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhh
Confidence 9999999999999999 5677899999999987666533344556888999999998889999999999999999999
Q ss_pred CCCCCCCCC
Q 030430 164 GYPPFSVGE 172 (177)
Q Consensus 164 ~~~pf~~~~ 172 (177)
|...|.|.+
T Consensus 213 ~~Vlf~g~d 221 (369)
T KOG0665|consen 213 GTVLFPGKD 221 (369)
T ss_pred ceEEecCch
Confidence 999998754
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9e-28 Score=188.60 Aligned_cols=166 Identities=27% Similarity=0.459 Sum_probs=145.1
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
.+....++..|+-.|.+++|||++++++++..+. ..||++|+++|+|.++++.++ ++....++.|..||++++.|||+
T Consensus 738 ~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~ 816 (1177)
T KOG1025|consen 738 SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEE 816 (1177)
T ss_pred CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh
Confidence 4555788999999999999999999999998776 889999999999999999774 58899999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcccc---ccCCCccccccccccCCCCCcchHHHHHHHHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~---~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~ 161 (177)
++++||||-..|+++ .....+++.|||+++.......... ....+.|+|-|.+....++.++||||+|+++||+
T Consensus 817 qrlVHrdLaaRNVLV---ksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWEl 893 (1177)
T KOG1025|consen 817 QRLVHRDLAARNVLV---KSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWEL 893 (1177)
T ss_pred cchhhhhhhhhheee---cCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHH
Confidence 999999999999999 4666799999999988766543332 2235679999999988999999999999999999
Q ss_pred Hh-CCCCCCCCCccc
Q 030430 162 LN-GYPPFSVGEEHQ 175 (177)
Q Consensus 162 ~~-~~~pf~~~~~~~ 175 (177)
+| |..||.+...++
T Consensus 894 mTFGa~Py~gi~~~e 908 (1177)
T KOG1025|consen 894 MTFGAKPYDGIPAEE 908 (1177)
T ss_pred HhcCCCccCCCCHHH
Confidence 99 899998865443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-29 Score=175.55 Aligned_cols=161 Identities=32% Similarity=0.513 Sum_probs=137.3
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCC-----eEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (177)
...++.+|..+|..++|.|++..++...-.. .+|+++|++ ..+|.+.+-..+.++.+.++.++.||+.+|+|||
T Consensus 95 s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLH 173 (449)
T KOG0664|consen 95 SCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLH 173 (449)
T ss_pred HHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHh
Confidence 3567889999999999999999888765432 468899988 5699999988888999999999999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--cccccCCCccccccccccCC-CCCcchHHHHHHHHHH
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFE 160 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slg~~~~~ 160 (177)
+.||.||||||.|.++ +.+..+|+||||+++-...... .....-+..|.+||.+++.. ++.+.||||.||++.|
T Consensus 174 sA~ILHRDIKPGNLLV---NSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaE 250 (449)
T KOG0664|consen 174 TANILHRDIKPGNLLV---NSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAE 250 (449)
T ss_pred hcchhhccCCCccEEe---ccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHH
Confidence 9999999999999999 5778899999999976654432 22344577899999998765 8999999999999999
Q ss_pred HHhCCCCCCCCCc
Q 030430 161 LLNGYPPFSVGEE 173 (177)
Q Consensus 161 ~~~~~~pf~~~~~ 173 (177)
++..+..|.+.++
T Consensus 251 LLgRrILFQAq~P 263 (449)
T KOG0664|consen 251 LLQRKILFQAAGP 263 (449)
T ss_pred HHhhhhhhhccCh
Confidence 9999998977654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=166.10 Aligned_cols=160 Identities=27% Similarity=0.500 Sum_probs=134.6
Q ss_pred HHHHHHHHHhhCCCCceeeEeEEEe--------eCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHH
Q 030430 12 CLDCELNFLSSVNHPNIIRLFDAFQ--------AENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEIL 82 (177)
Q Consensus 12 ~~~~e~~~l~~l~h~~i~~~~~~~~--------~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~l 82 (177)
-..+|+++|..++|+|++.+++.+. +...+|+|+++| ..+|.-++... ..++...+.++++++..+|.|+
T Consensus 62 talreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~c-ehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~i 140 (376)
T KOG0669|consen 62 TALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFC-EHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYI 140 (376)
T ss_pred HHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHh-hhhHHHHhcCccccccHHHHHHHHHHHHHHHHHH
Confidence 4568999999999999999998763 344689999999 56888887754 4699999999999999999999
Q ss_pred hhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc-----ccccCCCccccccccccC-CCCCcchHHHHHH
Q 030430 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-----EKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGA 156 (177)
Q Consensus 83 h~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~ 156 (177)
|...|+|||+|+.|+++ +..+.+++.|||.++.+...... ....-|.+|.+||.+.+. .+++..|+|..||
T Consensus 141 Hr~kilHRDmKaaNvLI---t~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgC 217 (376)
T KOG0669|consen 141 HRNKILHRDMKAANVLI---TKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGC 217 (376)
T ss_pred HHhhHHhhcccHhhEEE---cCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHH
Confidence 99999999999999999 57788999999999776543221 122347889999988654 5899999999999
Q ss_pred HHHHHHhCCCCCCCCCccc
Q 030430 157 ILFELLNGYPPFSVGEEHQ 175 (177)
Q Consensus 157 ~~~~~~~~~~pf~~~~~~~ 175 (177)
++.+|+|+++.++++++.+
T Consensus 218 imaeMwtrspimqgnteqq 236 (376)
T KOG0669|consen 218 IMAEMWTRSPIMQGNTEQQ 236 (376)
T ss_pred HHHHHHccCccccCChHHH
Confidence 9999999999999987643
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=167.58 Aligned_cols=163 Identities=30% Similarity=0.496 Sum_probs=137.6
Q ss_pred ccccchhHHHHHHHHHHHHhhC--CCCceeeEeEEEeeCC----eEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHH
Q 030430 2 LKKLNKHLKSCLDCELNFLSSV--NHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75 (177)
Q Consensus 2 l~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i 75 (177)
+|......++.++.|.++++.. +|+||+++++.-+... .+++|++|.+.|+|.+|+..+ ..+....++++..+
T Consensus 238 VKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~Sm 316 (534)
T KOG3653|consen 238 VKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESM 316 (534)
T ss_pred EEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHH
Confidence 5777888999999999999987 7999999999876544 799999999999999999965 78899999999999
Q ss_pred HHHHHHHhhC---------CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccC
Q 030430 76 GAGLEILNSH---------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQ 143 (177)
Q Consensus 76 ~~~l~~lh~~---------~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~ 143 (177)
+.+|+|||+. .|+|||||..||++ ..+..+-|+|||++-++..... .....||.+|||||.+.++
T Consensus 317 arGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEga 393 (534)
T KOG3653|consen 317 ARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGA 393 (534)
T ss_pred HHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhh
Confidence 9999999984 39999999999999 4677789999999987754322 2236799999999998754
Q ss_pred C-C-----CCcchHHHHHHHHHHHHhCCCCC
Q 030430 144 R-Y-----DEKVDMWSVGAILFELLNGYPPF 168 (177)
Q Consensus 144 ~-~-----~~~~Di~slg~~~~~~~~~~~pf 168 (177)
. + -.+.||||+|.++||+++.-..+
T Consensus 394 inl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 394 INLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred cccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 3 2 23689999999999998864433
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=189.58 Aligned_cols=150 Identities=17% Similarity=0.205 Sum_probs=115.8
Q ss_pred HhhCCC-CceeeEeEEE-------eeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCeee
Q 030430 20 LSSVNH-PNIIRLFDAF-------QAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIHR 90 (177)
Q Consensus 20 l~~l~h-~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~H~ 90 (177)
.+.++| +||+++++++ .....++.++|+. +++|.++++.. ..+++..+..++.||+.||+|||++||+||
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHr 104 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVH 104 (793)
T ss_pred cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 345566 6888888877 2334577888887 77999999754 459999999999999999999999999999
Q ss_pred cCCCCcEEEecC----------------CCCeeEEEeeeccccccCCCC-----------------ccccccCCCccccc
Q 030430 91 DLKPENILLSGL----------------DDDVMLKIADFGLSCTLYPGN-----------------YAEKVCGSPLYMAP 137 (177)
Q Consensus 91 ~i~~~nil~~~~----------------~~~~~~~l~d~~~~~~~~~~~-----------------~~~~~~~~~~~~~p 137 (177)
||||+||++... +....++++|||.+....... ......+++.|+||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 999999999421 223456777777765421100 00113467889999
Q ss_pred cccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 030430 138 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 170 (177)
Q Consensus 138 e~~~~~~~~~~~Di~slg~~~~~~~~~~~pf~~ 170 (177)
|.+.+..++.++||||+||+++||+++..|+..
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 999888899999999999999999999988764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-24 Score=151.36 Aligned_cols=149 Identities=46% Similarity=0.812 Sum_probs=130.2
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
.+.+.+|++.++.++|++++++++++......++++|++.|++|.+++... ..++...+..++.+++.++++||+.|++
T Consensus 35 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~ 114 (215)
T cd00180 35 LEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII 114 (215)
T ss_pred HHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 478999999999999999999999999989999999999989999998865 4689999999999999999999999999
Q ss_pred eecCCCCcEEEecCCC-CeeEEEeeeccccccCCCC-ccccccCCCccccccccccC-CCCCcchHHHHHHHHHHH
Q 030430 89 HRDLKPENILLSGLDD-DVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 89 H~~i~~~nil~~~~~~-~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~ 161 (177)
|+|++|.||++. . ...++++||+.+....... ......+...|.+||..... ..+.+.|+|++|++++++
T Consensus 115 H~dl~~~ni~~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 115 HRDLKPENILLD---SDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred ccCCCHhhEEEe---CCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 999999999995 4 6789999999887664442 12234467789999998766 778899999999998876
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=175.51 Aligned_cols=163 Identities=32% Similarity=0.647 Sum_probs=138.6
Q ss_pred chhHHHHHHHHHHHHhhC-CCCceeeEeEEEe-----eCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQ-----AENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGA 77 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~ 77 (177)
+.+..++++.|.++++.. .|||++.+++++. .++.+++|||||.|||..++++.. ..+.++.+.-|+..++.
T Consensus 55 ~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lr 134 (953)
T KOG0587|consen 55 TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILR 134 (953)
T ss_pred CccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHH
Confidence 445567889999999999 6999999999885 345799999999999999999854 45888899999999999
Q ss_pred HHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCC-CccccccCCCccccccccccC-----CCCCcchH
Q 030430 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQ-----RYDEKVDM 151 (177)
Q Consensus 78 ~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~-----~~~~~~Di 151 (177)
++..||...++|+||+-.||+. ...+.+||+|||.+...-.. ....+-.|++.|||||++... .++.++|+
T Consensus 135 gl~HLH~nkviHRDikG~NiLL---T~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~ 211 (953)
T KOG0587|consen 135 GLAHLHNNKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDL 211 (953)
T ss_pred HHHHHhhcceeeecccCceEEE---eccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccch
Confidence 9999999999999999999999 57888999999988655332 233455689999999998643 47789999
Q ss_pred HHHHHHHHHHHhCCCCCCCC
Q 030430 152 WSVGAILFELLNGYPPFSVG 171 (177)
Q Consensus 152 ~slg~~~~~~~~~~~pf~~~ 171 (177)
||||++..||..|.+|+.+.
T Consensus 212 WsLGITaIEladG~PPl~Dm 231 (953)
T KOG0587|consen 212 WSLGITAIEMAEGAPPLCDM 231 (953)
T ss_pred hhccceeehhcCCCCCccCc
Confidence 99999999999999998653
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=162.65 Aligned_cols=158 Identities=28% Similarity=0.465 Sum_probs=127.3
Q ss_pred HHHHHHHHHHHhhC-CCCceeeEeEE-EeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 10 KSCLDCELNFLSSV-NHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 10 ~~~~~~e~~~l~~l-~h~~i~~~~~~-~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
.+.|.+|...=-.| .|.||+.-+++ |+..+.+++++||++.|+|..-+.- ..+.+....+++.|++.|+.|+|+.++
T Consensus 64 ~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknl 142 (378)
T KOG1345|consen 64 QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNL 142 (378)
T ss_pred HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccch
Confidence 45677777765566 58999988875 7778889999999999999886653 458899999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCcccccccccc---C--CCCCcchHHHHHHHHHHHH
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF---Q--RYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~---~--~~~~~~Di~slg~~~~~~~ 162 (177)
||||||.+||++...+ ..++||||||.+...+.... .......|.+||.... + ...+.+|+|++|++++.++
T Consensus 143 VHRdlK~eNiLif~~d-f~rvKlcDFG~t~k~g~tV~--~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cl 219 (378)
T KOG1345|consen 143 VHRDLKAENILIFDAD-FYRVKLCDFGLTRKVGTTVK--YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCL 219 (378)
T ss_pred hhcccccceEEEecCC-ccEEEeeecccccccCceeh--hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeee
Confidence 9999999999997533 45899999999876543322 2234566888887532 2 2568899999999999999
Q ss_pred hCCCCCCCC
Q 030430 163 NGYPPFSVG 171 (177)
Q Consensus 163 ~~~~pf~~~ 171 (177)
||..||...
T Consensus 220 tG~~PWQka 228 (378)
T KOG1345|consen 220 TGKFPWQKA 228 (378)
T ss_pred cCCCcchhh
Confidence 999999743
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=155.40 Aligned_cols=163 Identities=20% Similarity=0.307 Sum_probs=143.2
Q ss_pred HHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
.-..+..|.+..+.| ..++|+.++.+...+.+..+|+|++ |.||+++.+-++ .|+..++.-++.|++.-++++|+..
T Consensus 66 ~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~ 144 (449)
T KOG1165|consen 66 EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD 144 (449)
T ss_pred CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc
Confidence 346788899999999 5799999999889998999999998 999999999775 4999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCC--CeeEEEeeeccccccCCCCcc--------ccccCCCccccccccccCCCCCcchHHHHHH
Q 030430 87 IIHRDLKPENILLSGLDD--DVMLKIADFGLSCTLYPGNYA--------EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA 156 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~--~~~~~l~d~~~~~~~~~~~~~--------~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~ 156 (177)
+++|||||+|++|++... ...+.++|||+++....+... ....||.+||+-....+.+.+.+.|+-|||-
T Consensus 145 LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGH 224 (449)
T KOG1165|consen 145 LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGH 224 (449)
T ss_pred eeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhh
Confidence 999999999999986433 455899999999887665432 2345889999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCC
Q 030430 157 ILFELLNGYPPFSVGE 172 (177)
Q Consensus 157 ~~~~~~~~~~pf~~~~ 172 (177)
++.+.+.|+.||.|-.
T Consensus 225 vFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 225 VFMYFLRGSLPWQGLK 240 (449)
T ss_pred hhhhhccCCCcccccc
Confidence 9999999999998743
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=154.54 Aligned_cols=167 Identities=27% Similarity=0.457 Sum_probs=141.1
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEe-eCCeEEEEEecCCCCChHHHHhhcC--------CCCHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ-AENCIFLVVEFCAGGNLSSYIRLHG--------RVPEQTARKFLQQLG 76 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~i~ 76 (177)
++-....+..|.-.+.-+.|||+..+.++.. +....++++.+..-++|..++..++ .++-.++..++.|++
T Consensus 327 S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla 406 (563)
T KOG1024|consen 327 SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLA 406 (563)
T ss_pred cHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHH
Confidence 4455677888888999999999999999875 4557789999998899999998331 267778889999999
Q ss_pred HHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccc---cccCCCccccccccccCCCCCcchHHH
Q 030430 77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE---KVCGSPLYMAPEVLQFQRYDEKVDMWS 153 (177)
Q Consensus 77 ~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~---~~~~~~~~~~pe~~~~~~~~~~~Di~s 153 (177)
.|+++||+.|++|.||-..|+++ ++.-+++++|-.+++...+.+... .......||+||.+.+..++.++|+||
T Consensus 407 ~am~hlh~~~ViHkDiAaRNCvI---dd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWs 483 (563)
T KOG1024|consen 407 MAMEHLHNHGVIHKDIAARNCVI---DDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWS 483 (563)
T ss_pred HHHHHHHhcCcccchhhhhccee---hhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHH
Confidence 99999999999999999999999 677899999999998876655432 223456799999999999999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCccc
Q 030430 154 VGAILFELLN-GYPPFSVGEEHQ 175 (177)
Q Consensus 154 lg~~~~~~~~-~~~pf~~~~~~~ 175 (177)
+|+++||++| |+.||..-++.+
T Consensus 484 fGVllWELmtlg~~PyaeIDPfE 506 (563)
T KOG1024|consen 484 FGVLLWELMTLGKLPYAEIDPFE 506 (563)
T ss_pred HHHHHHHHHhcCCCCccccCHHH
Confidence 9999999999 899998766544
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=158.92 Aligned_cols=158 Identities=27% Similarity=0.436 Sum_probs=131.7
Q ss_pred ccccchhHHHHHHHHHHHHhhC--CCCceeeEeEEEeeC----CeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHH
Q 030430 2 LKKLNKHLKSCLDCELNFLSSV--NHPNIIRLFDAFQAE----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75 (177)
Q Consensus 2 l~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i 75 (177)
+|......++...+|.++++.. +|+||+.+++.-..+ ..+++|++|.+.|||.+|+.+ ..++.+.+.+++..+
T Consensus 239 VKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~ 317 (513)
T KOG2052|consen 239 VKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSI 317 (513)
T ss_pred EEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHH
Confidence 4566667788999999999987 999999999875422 268999999999999999996 579999999999999
Q ss_pred HHHHHHHhhC--------CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-----ccccccCCCcccccccccc
Q 030430 76 GAGLEILNSH--------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQF 142 (177)
Q Consensus 76 ~~~l~~lh~~--------~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~~~~~~pe~~~~ 142 (177)
+.+|++||.. .|.|||||..||+| .+++.+-+.|+|++.+..... ......||.+|||||.+..
T Consensus 318 AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV---Kkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLde 394 (513)
T KOG2052|consen 318 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDE 394 (513)
T ss_pred hhhHHHHHHHHhcCCCCchhhccccccccEEE---ccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhh
Confidence 9999999974 29999999999999 578889999999998775542 2234679999999999864
Q ss_pred CC----C--CCcchHHHHHHHHHHHHh
Q 030430 143 QR----Y--DEKVDMWSVGAILFELLN 163 (177)
Q Consensus 143 ~~----~--~~~~Di~slg~~~~~~~~ 163 (177)
.- + -...||||+|.++||++.
T Consensus 395 tin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 395 TINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred hcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 32 1 235899999999999865
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-24 Score=168.26 Aligned_cols=132 Identities=24% Similarity=0.390 Sum_probs=100.7
Q ss_pred eeCCeEEEEEecCCCCChHHHHhhcCC--------------------CCHHHHHHHHHHHHHHHHHHhhCCCeeecCCCC
Q 030430 36 QAENCIFLVVEFCAGGNLSSYIRLHGR--------------------VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPE 95 (177)
Q Consensus 36 ~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~~l~~lh~~~~~H~~i~~~ 95 (177)
.....+++++||+.+++|.+++..... .....+..++.|++.+|+|||+.|++||||||+
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~ 284 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ 284 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence 355678999999999999998864321 123446689999999999999999999999999
Q ss_pred cEEEecCCCCeeEEEeeeccccccCCC--CccccccCCCccccccccccCC----------------------CCCcchH
Q 030430 96 NILLSGLDDDVMLKIADFGLSCTLYPG--NYAEKVCGSPLYMAPEVLQFQR----------------------YDEKVDM 151 (177)
Q Consensus 96 nil~~~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~----------------------~~~~~Di 151 (177)
||+++ ...+.++|+|||.+...... .......+++.|+|||.+.... ++.++||
T Consensus 285 NILl~--~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 285 NIIFS--EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HEEEe--CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99995 34567999999999755322 1223445788999999653221 2334699
Q ss_pred HHHHHHHHHHHhCCCCCC
Q 030430 152 WSVGAILFELLNGYPPFS 169 (177)
Q Consensus 152 ~slg~~~~~~~~~~~pf~ 169 (177)
||+||++++|+++..++.
T Consensus 363 wSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred HHHHHHHHHHHhCcCCCc
Confidence 999999999998776543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=162.46 Aligned_cols=154 Identities=23% Similarity=0.345 Sum_probs=114.9
Q ss_pred HHHHHHHHhhCCCCce-----eeEeEEEee--------CCeEEEEEecCCCCChHHHHhhcC------------------
Q 030430 13 LDCELNFLSSVNHPNI-----IRLFDAFQA--------ENCIFLVVEFCAGGNLSSYIRLHG------------------ 61 (177)
Q Consensus 13 ~~~e~~~l~~l~h~~i-----~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~------------------ 61 (177)
...|+.++.+++|.++ +++++++.. .+..++|+||+++++|.+++....
T Consensus 219 ~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~ 298 (507)
T PLN03224 219 GMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIP 298 (507)
T ss_pred hHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchh
Confidence 3457777777866554 566666542 346799999999999999886321
Q ss_pred ------CCCHHHHHHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccc--cccCCCc
Q 030430 62 ------RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPL 133 (177)
Q Consensus 62 ------~~~~~~~~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~ 133 (177)
.++...+..++.|++.+++|+|+.+++|+||||+||++. ....++++|||.+.......... ....++.
T Consensus 299 ~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~---~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~ 375 (507)
T PLN03224 299 DNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVT---VDGQVKIIDFGAAVDMCTGINFNPLYGMLDPR 375 (507)
T ss_pred hhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEEC---CCCcEEEEeCcCccccccCCccCccccCCCcc
Confidence 135567889999999999999999999999999999994 56779999999986554332211 1224688
Q ss_pred cccccccccCCC----------------------CCcchHHHHHHHHHHHHhCCC-CCC
Q 030430 134 YMAPEVLQFQRY----------------------DEKVDMWSVGAILFELLNGYP-PFS 169 (177)
Q Consensus 134 ~~~pe~~~~~~~----------------------~~~~Di~slg~~~~~~~~~~~-pf~ 169 (177)
|++||.+..... ....|+||+|+++++|+++.. ||.
T Consensus 376 Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 376 YSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred eeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 999998753221 124699999999999999875 675
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-23 Score=154.61 Aligned_cols=160 Identities=27% Similarity=0.349 Sum_probs=134.3
Q ss_pred HHHHHHHHHhhCCC----CceeeEeEEE-eeCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 12 CLDCELNFLSSVNH----PNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 12 ~~~~e~~~l~~l~h----~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
.+..|..++..+.. ++++.+.+.. ......++||+.+ |.+|.++.... +.++..++..++.|++.+|+++|+
T Consensus 62 ~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~ 140 (322)
T KOG1164|consen 62 VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS 140 (322)
T ss_pred cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh
Confidence 68889999999963 6899999988 4777899999988 99999988655 359999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCC--eeEEEeeeccccccC--C-CC-------c-cccccCCCccccccccccCCCCCcchH
Q 030430 85 HHIIHRDLKPENILLSGLDDD--VMLKIADFGLSCTLY--P-GN-------Y-AEKVCGSPLYMAPEVLQFQRYDEKVDM 151 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~--~~~~l~d~~~~~~~~--~-~~-------~-~~~~~~~~~~~~pe~~~~~~~~~~~Di 151 (177)
.|++||||||.|++++..... ..+++.|||++++.. . .. . .....||.+|.+++...+.+.+++.|+
T Consensus 141 ~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDl 220 (322)
T KOG1164|consen 141 KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDL 220 (322)
T ss_pred cCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhh
Confidence 999999999999999743212 569999999998322 1 11 0 112338899999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCC
Q 030430 152 WSVGAILFELLNGYPPFSVGE 172 (177)
Q Consensus 152 ~slg~~~~~~~~~~~pf~~~~ 172 (177)
||+++++.++..|..||.+.+
T Consensus 221 es~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 221 ESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred hhHHHHHHHHhcCCCCCcccc
Confidence 999999999999999997654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.7e-24 Score=171.67 Aligned_cols=121 Identities=36% Similarity=0.652 Sum_probs=101.4
Q ss_pred eEEEEEecCCCCChHHHHhhcCCC-CHHHHHHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccc
Q 030430 40 CIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (177)
Q Consensus 40 ~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~ 118 (177)
.+||.||||+..++.++++.+... .....++++++|++||+|+|++|++||||||.||++ +....++|+|||.+..
T Consensus 670 ~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFL---d~~~~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 670 ILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFL---DSRNSVKIGDFGLATD 746 (1351)
T ss_pred EEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEE---cCCCCeeecccccchh
Confidence 579999999988888888866433 578899999999999999999999999999999999 5778899999999876
Q ss_pred cC------------------CC-CccccccCCCccccccccccCC---CCCcchHHHHHHHHHHHHh
Q 030430 119 LY------------------PG-NYAEKVCGSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 119 ~~------------------~~-~~~~~~~~~~~~~~pe~~~~~~---~~~~~Di~slg~~~~~~~~ 163 (177)
.. .+ ...++..||.-|+|||++.+.. ++.+.|+||||++++||+-
T Consensus 747 ~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 747 LKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred hhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc
Confidence 21 01 1233456888999999987554 8999999999999999974
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=145.68 Aligned_cols=161 Identities=21% Similarity=0.234 Sum_probs=138.7
Q ss_pred HHHHHHHHHHhhCC-CCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 11 SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 11 ~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
..+.-|.++.+.|+ ...|+.+..+..+..+..+|||++ |++|+++.+.+. .++-.+++-.+-|++.-++|+|.++++
T Consensus 55 pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fi 133 (341)
T KOG1163|consen 55 PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFI 133 (341)
T ss_pred cchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccc
Confidence 46778999999995 588999999999999999999998 999999998664 599999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc--------ccccCCCccccccccccCCCCCcchHHHHHHHHHH
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--------EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--------~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~ 160 (177)
||||||+|++++-.....++.++|||++++..+.... ....||.+|.+-....+.+.+.+.|+-|+|+++.+
T Consensus 134 HRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmY 213 (341)
T KOG1163|consen 134 HRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMY 213 (341)
T ss_pred cccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeee
Confidence 9999999999975455677999999999887553322 12347888988888877888999999999999999
Q ss_pred HHhCCCCCCCCC
Q 030430 161 LLNGYPPFSVGE 172 (177)
Q Consensus 161 ~~~~~~pf~~~~ 172 (177)
.-.|..||.+-.
T Consensus 214 fnrG~LPWQglk 225 (341)
T KOG1163|consen 214 FNRGSLPWQGLK 225 (341)
T ss_pred eecCCCcccccc
Confidence 999999998743
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-22 Score=151.30 Aligned_cols=94 Identities=31% Similarity=0.517 Sum_probs=81.8
Q ss_pred chhHHHHHHHHHHHHhhCC--------CCceeeEeEEEee----CCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVN--------HPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKF 71 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~ 71 (177)
-++.++....|+++|++++ ..+||++++.|.. +.++|||+|++ |.+|..++.+. +.++...++.|
T Consensus 114 AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I 192 (590)
T KOG1290|consen 114 AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEI 192 (590)
T ss_pred hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHH
Confidence 3556788899999999993 2369999998864 45899999998 99999999876 45999999999
Q ss_pred HHHHHHHHHHHhh-CCCeeecCCCCcEEEe
Q 030430 72 LQQLGAGLEILNS-HHIIHRDLKPENILLS 100 (177)
Q Consensus 72 ~~~i~~~l~~lh~-~~~~H~~i~~~nil~~ 100 (177)
++|++.+|.|||+ +||+|.||||+|||+.
T Consensus 193 ~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 193 CRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred HHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 9999999999997 6999999999999984
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=138.82 Aligned_cols=106 Identities=31% Similarity=0.392 Sum_probs=90.7
Q ss_pred CChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcccccc
Q 030430 51 GNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129 (177)
Q Consensus 51 ~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 129 (177)
|+|.+++... ..+++.+++.++.|++.||+|||+.+ ||+||++ +..+.+++ ||.+....... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~~----~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPEQ----SR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeecccc----CC
Confidence 6899999864 45999999999999999999999998 9999999 45666777 88876543322 24
Q ss_pred CCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 030430 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVG 171 (177)
Q Consensus 130 ~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf~~~ 171 (177)
+++.|+|||.+.+..++.++||||+|+++|++++|+.||...
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~ 107 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE 107 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 788999999999888999999999999999999999999654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.4e-23 Score=151.67 Aligned_cols=158 Identities=29% Similarity=0.434 Sum_probs=132.1
Q ss_pred HHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
.-.++..|+++|..+ .+.||+++.+++..++...+|++|++.....++.. .++...+..++..++.||+++|..||
T Consensus 77 ~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GI 153 (418)
T KOG1167|consen 77 SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGI 153 (418)
T ss_pred CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCc
Confidence 356799999999999 68999999999999999999999999999988766 56789999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCC----------------C------------------C----------
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP----------------G------------------N---------- 123 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~----------------~------------------~---------- 123 (177)
+||||||+|++++ .....-.|+|||++..... . .
T Consensus 154 vHRDiKpsNFL~n--~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~ 231 (418)
T KOG1167|consen 154 VHRDIKPSNFLYN--RRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRP 231 (418)
T ss_pred cccCCCccccccc--cccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCcc
Confidence 9999999999997 3445568899999862100 0 0
Q ss_pred -ccccccCCCccccccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 030430 124 -YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPFSVG 171 (177)
Q Consensus 124 -~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~~~~pf~~~ 171 (177)
......||++|.|||++... ..+++.|+||.|+++..++++..||-..
T Consensus 232 ~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 232 SERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred ceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccC
Confidence 00013489999999988654 4789999999999999999999998543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-20 Score=137.96 Aligned_cols=161 Identities=42% Similarity=0.689 Sum_probs=139.2
Q ss_pred HHHHHHHHHHHHhhCCCC-ceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhh
Q 030430 9 LKSCLDCELNFLSSVNHP-NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
....+.+|.+++..+.|+ +++++.+.+......+++++++.++++.+++.... .++......++.|++.+++++|+
T Consensus 40 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~ 119 (384)
T COG0515 40 EVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119 (384)
T ss_pred HHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 467799999999999988 79999999988878899999999999998777664 79999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCe-eEEEeeeccccccCCCC-------ccccccCCCcccccccccc---CCCCCcchHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYPGN-------YAEKVCGSPLYMAPEVLQF---QRYDEKVDMWS 153 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~-~~~l~d~~~~~~~~~~~-------~~~~~~~~~~~~~pe~~~~---~~~~~~~Di~s 153 (177)
.|++|+|++|+|+++. ... .++++|||.+....... ......++..|.+||...+ ...+...|+||
T Consensus 120 ~~~~hrd~kp~nil~~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s 196 (384)
T COG0515 120 KGIIHRDIKPENILLD---RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWS 196 (384)
T ss_pred CCeeccCCCHHHeeec---CCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHH
Confidence 9999999999999994 444 69999999987544332 2345668899999999886 56788999999
Q ss_pred HHHHHHHHHhCCCCCCCCC
Q 030430 154 VGAILFELLNGYPPFSVGE 172 (177)
Q Consensus 154 lg~~~~~~~~~~~pf~~~~ 172 (177)
+|++++++++|..||....
T Consensus 197 ~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 197 LGITLYELLTGLPPFEGEK 215 (384)
T ss_pred HHHHHHHHHhCCCCCCCCC
Confidence 9999999999999987654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-19 Score=125.20 Aligned_cols=146 Identities=18% Similarity=0.157 Sum_probs=110.2
Q ss_pred HHHHHHHHHHhhCC-CCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 11 SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 11 ~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
..+.+|+++|++|. ++++++++++ +..+++|+|+.|.+|.+.... . ...++.|++.+++++|+.|++|
T Consensus 46 ~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvH 114 (218)
T PRK12274 46 WLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAH 114 (218)
T ss_pred HHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCcc
Confidence 36899999999995 5889999886 346899999999998754321 1 2357789999999999999999
Q ss_pred ecC-CCCcEEEecCCCCeeEEEeeeccccccCCCCcc--------------ccccCCCcccccccccc-CCCC-CcchHH
Q 030430 90 RDL-KPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--------------EKVCGSPLYMAPEVLQF-QRYD-EKVDMW 152 (177)
Q Consensus 90 ~~i-~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--------------~~~~~~~~~~~pe~~~~-~~~~-~~~Di~ 152 (177)
+|| +|.||+++ ..+.++|+|||.+......... ....+++.+++|+...- ...+ ++.+-+
T Consensus 115 rDL~kp~NILv~---~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~ 191 (218)
T PRK12274 115 NDLAKEANWLVQ---EDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWF 191 (218)
T ss_pred CCCCCcceEEEc---CCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHH
Confidence 999 79999994 5567999999999755443311 11235666777764321 2333 678889
Q ss_pred HHHHHHHHHHhCCCCCCC
Q 030430 153 SVGAILFELLNGYPPFSV 170 (177)
Q Consensus 153 slg~~~~~~~~~~~pf~~ 170 (177)
+.|+-+|.++|+..+..+
T Consensus 192 ~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 192 ATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HhcchHHHHHhccCCccc
Confidence 999999999999988643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.6e-22 Score=152.21 Aligned_cols=157 Identities=32% Similarity=0.571 Sum_probs=135.2
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
+..-+++|+-+++..+||||+.+++.+..+..+++.||||.||+|.+.-.-.+.+++.++.-..+..+.+++|||+.|=+
T Consensus 55 d~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~ 134 (829)
T KOG0576|consen 55 DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKI 134 (829)
T ss_pred cccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcc
Confidence 34567889999999999999999999999999999999999999998655557799999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccc---cCCCCCcchHHHHHHHHHHHHhC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slg~~~~~~~~~ 164 (177)
|||||-.||++ .+.+.+++.|||.+..+.... ......|++.|++||... ...+...+|+|++|+...|+...
T Consensus 135 hRdiKGanill---td~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eL 211 (829)
T KOG0576|consen 135 HRDIKGANILL---TDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGEL 211 (829)
T ss_pred cccccccceee---cccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhc
Confidence 99999999999 477889999999886654432 233566999999999753 45688899999999999998887
Q ss_pred CCCC
Q 030430 165 YPPF 168 (177)
Q Consensus 165 ~~pf 168 (177)
++|-
T Consensus 212 qppl 215 (829)
T KOG0576|consen 212 QPPL 215 (829)
T ss_pred CCcc
Confidence 7763
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.8e-20 Score=137.63 Aligned_cols=121 Identities=21% Similarity=0.210 Sum_probs=92.4
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
.....+.+|++++++++|+++++.+.. .+..+++|||++|++|... . ... ...++.+++.+|++||+.|+
T Consensus 63 ~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE~~~G~~L~~~-~---~~~---~~~~~~~i~~aL~~lH~~gI 132 (365)
T PRK09188 63 LARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVRGWTEGVPLHLA-R---PHG---DPAWFRSAHRALRDLHRAGI 132 (365)
T ss_pred HHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEEEccCCCCHHHh-C---ccc---hHHHHHHHHHHHHHHHHCCC
Confidence 346779999999999999998853322 2457999999999999632 1 111 14678899999999999999
Q ss_pred eeecC-CCCcEEEecCCCCeeEEEeeeccccccCCCCcc---------ccccCCCccccccccc
Q 030430 88 IHRDL-KPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---------EKVCGSPLYMAPEVLQ 141 (177)
Q Consensus 88 ~H~~i-~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---------~~~~~~~~~~~pe~~~ 141 (177)
+|||| ||+||+++ ..+.++|+|||++......... ....+++.|.+||.+.
T Consensus 133 iHrDL~KP~NILv~---~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 133 THNDLAKPQNWLMG---PDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred eeCCCCCcceEEEc---CCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 99999 99999994 5567999999999866443211 1334566788999874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.9e-21 Score=152.96 Aligned_cols=157 Identities=36% Similarity=0.568 Sum_probs=131.2
Q ss_pred HHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCeeecC
Q 030430 13 LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDL 92 (177)
Q Consensus 13 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H~~i 92 (177)
+..|+-+-..++|+|++.......+.....-.||||++ +|..++.....+....+..+++|++.+++|+|+.|+.|+|+
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~Giahrdl 446 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDL 446 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccC
Confidence 66677777888999998877766655555555999999 99999887767889999999999999999999999999999
Q ss_pred CCCcEEEecCCCCeeEEEeeeccccccCCCC-----ccccccCCCccccccccccCCCCC-cchHHHHHHHHHHHHhCCC
Q 030430 93 KPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQFQRYDE-KVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 93 ~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~~~~~~pe~~~~~~~~~-~~Di~slg~~~~~~~~~~~ 166 (177)
|++|+++ ...+.++++|||.+.-+..+. ......|+..|+|||.+....+++ ..|+||.|++++.|.+|+.
T Consensus 447 K~enll~---~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~ 523 (601)
T KOG0590|consen 447 KLENLLV---TENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRF 523 (601)
T ss_pred ccccEEE---ecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCC
Confidence 9999999 466789999999885543322 233466888999999999888876 4899999999999999999
Q ss_pred CCCCCCc
Q 030430 167 PFSVGEE 173 (177)
Q Consensus 167 pf~~~~~ 173 (177)
||.....
T Consensus 524 ~Wk~a~~ 530 (601)
T KOG0590|consen 524 PWKVAKK 530 (601)
T ss_pred ccccccc
Confidence 9976543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=9e-20 Score=128.13 Aligned_cols=126 Identities=17% Similarity=0.252 Sum_probs=95.0
Q ss_pred HHHHHHHHhhCCCCceeeEeEEEeeC--------CeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 13 LDCELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 13 ~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
+++|++.+.++.|++++.+.+++... +..+++|||++|.+|.++.. ++++ ...+++.+++.+|+
T Consensus 82 ~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~~----~~~~i~~~l~~lH~ 153 (232)
T PRK10359 82 YENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISED----VKAKIKASIESLHQ 153 (232)
T ss_pred HHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh----ccHH----HHHHHHHHHHHHHH
Confidence 68999999999999999999886533 35789999999999988732 3332 45689999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~ 161 (177)
.|++|+|++|+|+++. ..+ ++++|||............. ......++.++|+|+||+++...
T Consensus 154 ~gi~H~Dikp~Nili~---~~g-i~liDfg~~~~~~e~~a~d~-----------~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 154 HGMVSGDPHKGNFIVS---KNG-LRIIDLSGKRCTAQRKAKDR-----------IDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred cCCccCCCChHHEEEe---CCC-EEEEECCCcccccchhhHHH-----------HHHHhHhcccccccceeEeehHH
Confidence 9999999999999995 334 99999997644321111100 12223355789999999887654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.8e-18 Score=120.80 Aligned_cols=105 Identities=21% Similarity=0.336 Sum_probs=84.0
Q ss_pred HHHHHHHHHHHHhhC-----CCCceeeEeEEEeeCC---eEE-EEEec--CCCCChHHHHhhcCCCCHHHHHHHHHHHHH
Q 030430 9 LKSCLDCELNFLSSV-----NHPNIIRLFDAFQAEN---CIF-LVVEF--CAGGNLSSYIRLHGRVPEQTARKFLQQLGA 77 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~---~~~-lv~e~--~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ 77 (177)
..+.+.+|+++++++ +||||+++++++.++. ..+ +|+|| +.+++|.+++.+. .++++ ..++.+++.
T Consensus 39 ~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~ 115 (210)
T PRK10345 39 GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLK 115 (210)
T ss_pred hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHH
Confidence 457799999999999 5799999999998764 333 78999 5579999999753 46655 356778777
Q ss_pred HH-HHHhhCCCeeecCCCCcEEEecCC-CCeeEEEeeeccc
Q 030430 78 GL-EILNSHHIIHRDLKPENILLSGLD-DDVMLKIADFGLS 116 (177)
Q Consensus 78 ~l-~~lh~~~~~H~~i~~~nil~~~~~-~~~~~~l~d~~~~ 116 (177)
++ +|||+.+|+|+||||+||++...+ ....++|+|++.+
T Consensus 116 ~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 116 KLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 77 999999999999999999996433 3457999995444
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.2e-20 Score=149.16 Aligned_cols=146 Identities=22% Similarity=0.299 Sum_probs=116.4
Q ss_pred HhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCeeecCCCCcEEE
Q 030430 20 LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL 99 (177)
Q Consensus 20 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~ 99 (177)
+...++||++++.-+.......|+|-+|+ -.+|.+.+...+-+..-..+-|+.|++.|+..+|+.|++|||||.+||++
T Consensus 75 ~~l~~~pn~lPfqk~~~t~kAAylvRqyv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILi 153 (1431)
T KOG1240|consen 75 FALMKAPNCLPFQKVLVTDKAAYLVRQYV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILI 153 (1431)
T ss_pred HHhhcCCcccchHHHHHhhHHHHHHHHHH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEE
Confidence 56669999999998888888889999999 56999988866668888888999999999999999999999999999999
Q ss_pred ecCCCCeeEEEeeeccccccCCCCccc--------cccCCCccccccccccC----------C-CCCcchHHHHHHHHHH
Q 030430 100 SGLDDDVMLKIADFGLSCTLYPGNYAE--------KVCGSPLYMAPEVLQFQ----------R-YDEKVDMWSVGAILFE 160 (177)
Q Consensus 100 ~~~~~~~~~~l~d~~~~~~~~~~~~~~--------~~~~~~~~~~pe~~~~~----------~-~~~~~Di~slg~~~~~ 160 (177)
. .=.++.|.||...++..-+...+ +......|.|||.+... . .+++.||||+||++.|
T Consensus 154 T---SWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaE 230 (1431)
T KOG1240|consen 154 T---SWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAE 230 (1431)
T ss_pred e---eechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHH
Confidence 5 44568999999775542211111 11223459999976431 2 5688999999999999
Q ss_pred HHh-CCCCCC
Q 030430 161 LLN-GYPPFS 169 (177)
Q Consensus 161 ~~~-~~~pf~ 169 (177)
+++ |++||.
T Consensus 231 Lf~Eg~PlF~ 240 (1431)
T KOG1240|consen 231 LFLEGRPLFT 240 (1431)
T ss_pred HHhcCCCccc
Confidence 988 788884
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.4e-18 Score=118.92 Aligned_cols=102 Identities=23% Similarity=0.211 Sum_probs=81.8
Q ss_pred HHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHH-hhCCCeee
Q 030430 12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL-NSHHIIHR 90 (177)
Q Consensus 12 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l-h~~~~~H~ 90 (177)
...+|++.+.++.++++.....+.... .++||||++|+++.........++...+..++.|++.+++++ |+.|++|+
T Consensus 65 ~~~~E~~~l~~l~~~~v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHr 142 (190)
T cd05147 65 WAEKEMRNLKRLVTAGIPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHA 142 (190)
T ss_pred HHHHHHHHHHHHHHCCCCCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 345699999999888775444332222 389999998887766544456799999999999999999999 79999999
Q ss_pred cCCCCcEEEecCCCCeeEEEeeecccccc
Q 030430 91 DLKPENILLSGLDDDVMLKIADFGLSCTL 119 (177)
Q Consensus 91 ~i~~~nil~~~~~~~~~~~l~d~~~~~~~ 119 (177)
||||+||+++ .+.++|+|||.+...
T Consensus 143 DlkP~NIli~----~~~v~LiDFG~a~~~ 167 (190)
T cd05147 143 DLSEYNLLYH----DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCCHHHEEEE----CCcEEEEEccccccC
Confidence 9999999995 256999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.1e-17 Score=114.39 Aligned_cols=105 Identities=19% Similarity=0.158 Sum_probs=83.5
Q ss_pred HHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-CCCee
Q 030430 11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-HHIIH 89 (177)
Q Consensus 11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~H 89 (177)
..+.+|.+.+.++.++++.....+.... .++||||++|+++.........++......++.|++.++.++|. .|++|
T Consensus 64 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givH 141 (190)
T cd05145 64 AWAEKEFRNLKRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVH 141 (190)
T ss_pred HHHHHHHHHHHHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEec
Confidence 3457899999999999875554443332 48999999887654432234568888999999999999999999 99999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeeccccccCC
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~ 121 (177)
+||+|.||+++ .+.++++|||.+.....
T Consensus 142 rDlkP~NIll~----~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 142 GDLSEYNILYH----DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCChhhEEEE----CCCEEEEEcccceecCC
Confidence 99999999994 46799999999866543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.9e-18 Score=120.49 Aligned_cols=158 Identities=24% Similarity=0.390 Sum_probs=124.5
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh 83 (177)
++...+.|..|.-.|+.+.||||+++++.+.....+.++..|++.++|.+.+..... .+..++.+++-+++.+++|||
T Consensus 227 t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflh 306 (448)
T KOG0195|consen 227 TARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLH 306 (448)
T ss_pred chhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHh
Confidence 455567788899999999999999999999999999999999999999999875544 777899999999999999999
Q ss_pred hCC--CeeecCCCCcEEEecCCCCee--EEEeeeccccccCCCCccccccCCCccccccccccCCCC---CcchHHHHHH
Q 030430 84 SHH--IIHRDLKPENILLSGLDDDVM--LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD---EKVDMWSVGA 156 (177)
Q Consensus 84 ~~~--~~H~~i~~~nil~~~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~---~~~Di~slg~ 156 (177)
+.. +.--.++..+++++ +... +...|.-.+ -......+.+.|++||.+...+-+ .++|+||+++
T Consensus 307 slep~ipr~~lns~hvmid---edltarismad~kfs------fqe~gr~y~pawmspealqrkped~n~raadmwsfai 377 (448)
T KOG0195|consen 307 SLEPMIPRFYLNSKHVMID---EDLTARISMADTKFS------FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAI 377 (448)
T ss_pred hcchhhhhhhcccceEEec---chhhhheecccceee------eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHH
Confidence 975 33346777888884 3322 333332221 112244578899999998766543 4689999999
Q ss_pred HHHHHHhCCCCCCCCC
Q 030430 157 ILFELLNGYPPFSVGE 172 (177)
Q Consensus 157 ~~~~~~~~~~pf~~~~ 172 (177)
++||+.|...||..-+
T Consensus 378 llwel~trevpfadls 393 (448)
T KOG0195|consen 378 LLWELNTREVPFADLS 393 (448)
T ss_pred HHHHhhccccccccCC
Confidence 9999999999997654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=8.5e-17 Score=118.93 Aligned_cols=145 Identities=32% Similarity=0.475 Sum_probs=111.6
Q ss_pred CCCceeeEeEEEee---------------------------CCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHH
Q 030430 24 NHPNIIRLFDAFQA---------------------------ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76 (177)
Q Consensus 24 ~h~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~ 76 (177)
+||||+.+...|.+ +..+|+||... ..+|+.++... ..+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC-CCchHHHHHHHHHHH
Confidence 69999999876521 34689999887 56999998844 566677778999999
Q ss_pred HHHHHHhhCCCeeecCCCCcEEEec-CCCCeeEEEeeeccccccCCCC-------ccccccCCCccccccccccCCCC--
Q 030430 77 AGLEILNSHHIIHRDLKPENILLSG-LDDDVMLKIADFGLSCTLYPGN-------YAEKVCGSPLYMAPEVLQFQRYD-- 146 (177)
Q Consensus 77 ~~l~~lh~~~~~H~~i~~~nil~~~-~~~~~~~~l~d~~~~~~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~-- 146 (177)
+++.+||..|+.|||+|.+||++.- .+.-.++++.|||++-.-.... ......|....++||..... ++
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~-PGp~ 430 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV-PGPN 430 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC-CCCc
Confidence 9999999999999999999999953 3456778999999874322211 11123466678999987432 22
Q ss_pred -----CcchHHHHHHHHHHHHhCCCCCCCC
Q 030430 147 -----EKVDMWSVGAILFELLNGYPPFSVG 171 (177)
Q Consensus 147 -----~~~Di~slg~~~~~~~~~~~pf~~~ 171 (177)
.+.|.|+.|.+.||+++...||..+
T Consensus 431 avvny~kAD~WA~GalaYEIfg~~NPFY~r 460 (598)
T KOG4158|consen 431 AVVNYEKADTWAAGALAYEIFGRSNPFYKR 460 (598)
T ss_pred eeeccchhhhhhhhhhHHHHhccCCccccc
Confidence 3689999999999999999999763
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=7e-17 Score=123.79 Aligned_cols=149 Identities=27% Similarity=0.446 Sum_probs=123.5
Q ss_pred HhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCC-eeecCCCCcE
Q 030430 20 LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI-IHRDLKPENI 97 (177)
Q Consensus 20 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~-~H~~i~~~ni 97 (177)
|+++.|.|+.++++...+++..++|.+||..|+|.+.+... .+++......++++++.+++|+|+-.+ .|+.++..|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 46789999999999999999999999999999999999863 458888899999999999999998654 9999999999
Q ss_pred EEecCCCCeeEEEeeeccccccCCC---CccccccCCCccccccccccCC-------CCCcchHHHHHHHHHHHHhCCCC
Q 030430 98 LLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQFQR-------YDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 98 l~~~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~-------~~~~~Di~slg~~~~~~~~~~~p 167 (177)
++ +....+|+.|||+....... ..........-|.|||.+.... .+.+.|+||+|++++|+++.+.|
T Consensus 81 lv---d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 81 LV---DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ee---eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99 67888999999987665321 1111112345589999886531 46679999999999999999999
Q ss_pred CCCC
Q 030430 168 FSVG 171 (177)
Q Consensus 168 f~~~ 171 (177)
|...
T Consensus 158 ~~~~ 161 (484)
T KOG1023|consen 158 FDLR 161 (484)
T ss_pred cccc
Confidence 9764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.3e-17 Score=128.59 Aligned_cols=151 Identities=33% Similarity=0.504 Sum_probs=134.8
Q ss_pred HHHHHHHHHhhCC-CCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCeee
Q 030430 12 CLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHR 90 (177)
Q Consensus 12 ~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H~ 90 (177)
.-..|-.++...+ ||.++++...++.++..+++.++..|+.|...+.+...+.+.....+...++.++..+|+.|++|+
T Consensus 42 ~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyr 121 (612)
T KOG0603|consen 42 HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYR 121 (612)
T ss_pred ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHh
Confidence 4556778888886 999999999999999999999999999999888877789999999999999999999999999999
Q ss_pred cCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 030430 91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 170 (177)
Q Consensus 91 ~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf~~ 170 (177)
|+|++||++ +..+.+++.|||.++..-..... +|+..|++||.+. ..+.+.|-||+|++.++++||-.||.+
T Consensus 122 d~k~enill---d~~Ghi~~tdfglske~v~~~~~---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 122 DYKLENVLL---LLEGHIKLTDFGLSKEAVKEKIA---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred cccccceee---cccCccccCCchhhhHhHhhhhc---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 999999999 67888999999998765444333 6789999999987 567889999999999999999999987
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.1e-17 Score=118.61 Aligned_cols=127 Identities=24% Similarity=0.344 Sum_probs=86.9
Q ss_pred EEEEEecCCCCChHHHHhh---cCC----CCHHHHHHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeee
Q 030430 41 IFLVVEFCAGGNLSSYIRL---HGR----VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113 (177)
Q Consensus 41 ~~lv~e~~~~~~L~~~l~~---~~~----~~~~~~~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~ 113 (177)
.+++|+-+ .++|.+++.. ... +.......+..|++..+++||..|++|+||+|+|+++ +.++.+.|+||
T Consensus 114 ~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll---~~~G~v~Lg~F 189 (288)
T PF14531_consen 114 RFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLL---DQDGGVFLGDF 189 (288)
T ss_dssp EEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE----TTS-EEE--G
T ss_pred hhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEE---cCCCCEEEcCh
Confidence 37788877 6688887652 222 2222334555789999999999999999999999999 56788999999
Q ss_pred ccccccCCCCccccccCCCcccccccccc--------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 030430 114 GLSCTLYPGNYAEKVCGSPLYMAPEVLQF--------QRYDEKVDMWSVGAILFELLNGYPPFSVGEE 173 (177)
Q Consensus 114 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Di~slg~~~~~~~~~~~pf~~~~~ 173 (177)
+...+.+..... ...+..|.|||.... ..++.+.|.|+||+++|.++++..||.....
T Consensus 190 ~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~ 255 (288)
T PF14531_consen 190 SSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSP 255 (288)
T ss_dssp GGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGG
T ss_pred HHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCc
Confidence 877665443322 334577899987643 2467789999999999999999999987643
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1e-16 Score=130.88 Aligned_cols=148 Identities=26% Similarity=0.334 Sum_probs=120.1
Q ss_pred HHHhhCC---CCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCeeecCCC
Q 030430 18 NFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKP 94 (177)
Q Consensus 18 ~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H~~i~~ 94 (177)
+++.+|+ -+.|.++...+...+.-++++||.+.|+|.++++.++.+++..+..++.|++..++.||+.+|+||||||
T Consensus 743 q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKP 822 (974)
T KOG1166|consen 743 QVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKP 822 (974)
T ss_pred HHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCc
Confidence 3444444 3455556666666777789999999999999999778899999999999999999999999999999999
Q ss_pred CcEEEecC----CCCeeEEEeeeccccccC---CCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCC
Q 030430 95 ENILLSGL----DDDVMLKIADFGLSCTLY---PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 95 ~nil~~~~----~~~~~~~l~d~~~~~~~~---~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~ 165 (177)
+|+++... ....-++|+|||.+..+. .+..-.....+-.+-.+|...+.+++...|.|.++-+++.|+.|+
T Consensus 823 DNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 823 DNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 99999642 234558999999886643 222223455677788999999999999999999999999999985
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.6e-16 Score=109.21 Aligned_cols=101 Identities=24% Similarity=0.328 Sum_probs=87.5
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
...+.+|++++..+.|++++....++.+....+++|||++|++|.+++..... ....++.+++.+++++|+.|++|
T Consensus 43 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H 118 (211)
T PRK14879 43 RERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIH 118 (211)
T ss_pred HHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCccc
Confidence 35688999999999999988777777777788999999999999998874422 77889999999999999999999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeeccccc
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCT 118 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~ 118 (177)
+|++|.||++. .+.++++|||.+..
T Consensus 119 ~Dl~p~Nil~~----~~~~~liDf~~a~~ 143 (211)
T PRK14879 119 GDLTTSNMILS----GGKIYLIDFGLAEF 143 (211)
T ss_pred CCCCcccEEEE----CCCEEEEECCcccC
Confidence 99999999995 45689999998755
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.6e-17 Score=124.77 Aligned_cols=118 Identities=36% Similarity=0.614 Sum_probs=101.5
Q ss_pred eEEEEEecCCCCChHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccc
Q 030430 40 CIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116 (177)
Q Consensus 40 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~ 116 (177)
++|+.|++|.-.+|.+|++... ..+...++.++.|++.++.| +|.+|+|++|.||+.. ...++++.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~---~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS---DDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc---cchhhhhhhhhhe
Confidence 5789999999999999997442 37777889999999999999 9999999999999984 4557999999988
Q ss_pred cccCCCC-------ccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh
Q 030430 117 CTLYPGN-------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 117 ~~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~ 163 (177)
....... ......++.+|++||.+.+..++.+.||||||.+++|++.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 6654433 3345668999999999999999999999999999999987
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.2e-15 Score=120.81 Aligned_cols=98 Identities=20% Similarity=0.279 Sum_probs=85.6
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
.+++.+|++++++++|++++....+..+....+++|||++|++|.+++. ....++.+++.+++++|+.|++|
T Consensus 380 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiH 451 (535)
T PRK09605 380 TERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVH 451 (535)
T ss_pred HHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCcc
Confidence 4678899999999999999888777777777899999999999999875 34678999999999999999999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeecccccc
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCTL 119 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~~ 119 (177)
||++|+||++. .+.++++|||.+...
T Consensus 452 rDlkp~NILl~----~~~~~liDFGla~~~ 477 (535)
T PRK09605 452 GDLTTSNFIVR----DDRLYLIDFGLGKYS 477 (535)
T ss_pred CCCChHHEEEE----CCcEEEEeCcccccC
Confidence 99999999993 456899999998654
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=8e-16 Score=107.09 Aligned_cols=99 Identities=23% Similarity=0.291 Sum_probs=82.0
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
..++.+|+++++.+.++++.....+.......+++|||++|++|.+++..... .++.+++.+++++|+.|++|
T Consensus 41 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H 113 (199)
T TIGR03724 41 RERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVH 113 (199)
T ss_pred HHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeec
Confidence 36678999999999988765555555566667899999999999998764321 78999999999999999999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeecccccc
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCTL 119 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~~ 119 (177)
+|++|.|+++. .+.++++|||.+...
T Consensus 114 ~Dl~~~Nil~~----~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 114 GDLTTSNIIVR----DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCCCcceEEEE----CCcEEEEECCCCcCC
Confidence 99999999994 567999999987553
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.63 E-value=2e-15 Score=107.69 Aligned_cols=103 Identities=20% Similarity=0.199 Sum_probs=81.5
Q ss_pred HHHHHHHHHHhhCCCCc--eeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC-C
Q 030430 11 SCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH-I 87 (177)
Q Consensus 11 ~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~-~ 87 (177)
..+.+|++.+.++.+.. +++++++ . ..++||||++|.+|.........+....+..++.|++.+++++|+.| +
T Consensus 95 ~~~~~E~~~L~~L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~i 170 (237)
T smart00090 95 LWAEKEFRNLQRLYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGEL 170 (237)
T ss_pred HHHHHHHHHHHHHHhcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCE
Confidence 45788999999997533 4444442 2 34899999999888776544445667778899999999999999999 9
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~ 121 (177)
+|+|++|+||++. .+.++++|||.+.....
T Consensus 171 iH~Dikp~NIli~----~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 171 VHGDLSEYNILVH----DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EeCCCChhhEEEE----CCCEEEEEChhhhccCC
Confidence 9999999999994 45799999998865433
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.2e-15 Score=106.21 Aligned_cols=103 Identities=19% Similarity=0.252 Sum_probs=80.6
Q ss_pred HHHHHHHHHHHHhhCCCCce--eeEeEEEeeC-Ce---EEEEEecCCC-CChHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Q 030430 9 LKSCLDCELNFLSSVNHPNI--IRLFDAFQAE-NC---IFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~-~~---~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (177)
.+.++.+|++++..+.|+++ +..+++.... +. .++|+|+++| .+|.+++.. ..+++.. +.+++.++++
T Consensus 83 ~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~ 157 (239)
T PRK01723 83 ERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIAR 157 (239)
T ss_pred hhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHH
Confidence 35678899999999988875 6666654332 22 2599999997 689888764 3455543 5689999999
Q ss_pred HhhCCCeeecCCCCcEEEecCCCCeeEEEeeecccccc
Q 030430 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119 (177)
Q Consensus 82 lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~ 119 (177)
+|+.|++|+|++|.||+++ ..+.++++|||.+...
T Consensus 158 lH~~GI~HrDlkp~NILv~---~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 158 FHDAGVYHADLNAHNILLD---PDGKFWLIDFDRGELR 192 (239)
T ss_pred HHHCCCCCCCCCchhEEEc---CCCCEEEEECCCcccC
Confidence 9999999999999999995 4457999999987654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.55 E-value=6.2e-14 Score=109.54 Aligned_cols=147 Identities=21% Similarity=0.334 Sum_probs=114.3
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh-hCCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN-SHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~~ 87 (177)
......+-++-|+.++||||+++++.++..++.|+|+|.+. .|..++++- ....+.--+.||+.||.+|| ++++
T Consensus 52 ~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l---~~~~v~~Gl~qIl~AL~FL~~d~~l 126 (690)
T KOG1243|consen 52 VTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL---GKEEVCLGLFQILAALSFLNDDCNL 126 (690)
T ss_pred hhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh---HHHHHHHHHHHHHHHHHHHhccCCe
Confidence 34567788899999999999999999999999999999984 777777743 36777778999999999997 5789
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~ 165 (177)
+|+|+..+.+++ +..+..+|++|..+........ .........|..|+.+.... -..|.|-||+++++++.|.
T Consensus 127 vHgNv~~~SVfV---n~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 127 VHGNVCKDSVFV---NESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred eeccEeeeeEEE---cCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence 999999999999 5788899999988766543332 11111223355665543222 3479999999999999983
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.50 E-value=1e-13 Score=96.55 Aligned_cols=97 Identities=23% Similarity=0.232 Sum_probs=76.9
Q ss_pred HHHHHHHHHHhhCCCCc--eeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 11 SCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 11 ~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
....+|..++..+.+++ ++..++ .+..+++|||++|++|.+... ......++.+++.++.++|+.|++
T Consensus 78 ~~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~ 147 (198)
T cd05144 78 LAAQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGII 147 (198)
T ss_pred HHHHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCC
Confidence 45788999999997774 444443 344689999999999876533 134567889999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~ 120 (177)
|+|++|.||++. ..+.++++|||.+....
T Consensus 148 H~Dl~p~Nill~---~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 148 HGDLSEFNILVD---DDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cCCCCcccEEEc---CCCcEEEEECCccccCC
Confidence 999999999994 56789999999885543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.9e-13 Score=90.45 Aligned_cols=98 Identities=22% Similarity=0.360 Sum_probs=83.7
Q ss_pred HHHHHHHHHHHhhCCC--CceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC--
Q 030430 10 KSCLDCELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH-- 85 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~-- 85 (177)
...+.+|.+.++.+.+ .++++++.+....+..++++||++|.++..+ +......++.+++.+++.+|..
T Consensus 35 ~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~ 107 (155)
T cd05120 35 GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPL 107 (155)
T ss_pred hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCc
Confidence 4578999999999976 5899999888888889999999988877654 4566677889999999999985
Q ss_pred -CCeeecCCCCcEEEecCCCCeeEEEeeecccc
Q 030430 86 -HIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117 (177)
Q Consensus 86 -~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~ 117 (177)
+++|+|++|.|+++. +...++++||+.+.
T Consensus 108 ~~i~H~Dl~~~Nil~~---~~~~~~l~Df~~~~ 137 (155)
T cd05120 108 LVLCHGDLHPGNILVD---DGKILGIIDWEYAG 137 (155)
T ss_pred eEEEecCCCcceEEEE---CCcEEEEEeccccc
Confidence 699999999999995 46779999999764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=7.7e-15 Score=116.75 Aligned_cols=158 Identities=32% Similarity=0.565 Sum_probs=131.7
Q ss_pred HHHHHHHHHHhhCC-CCceeeEeEEEeeCCeEEEEEecCCCCChHHHH-hhcC-CCCHHHHHHHHHHHHHHHHHHh-hCC
Q 030430 11 SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHG-RVPEQTARKFLQQLGAGLEILN-SHH 86 (177)
Q Consensus 11 ~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l-~~~~-~~~~~~~~~~~~~i~~~l~~lh-~~~ 86 (177)
.....|..+-+.+. |+|++.+++...+....++..++..|+++.+-+ .... ..+......++.|+..++.|+| ..+
T Consensus 65 ~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~ 144 (601)
T KOG0590|consen 65 EHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG 144 (601)
T ss_pred hhcCccccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc
Confidence 34445777777776 999999999999999999999999999999887 5444 5778888999999999999999 999
Q ss_pred CeeecCCCCcEEEecCCCCe-eEEEeeeccccccCC-CCc---cccccC-CCccccccccccC-CCCCcchHHHHHHHHH
Q 030430 87 IIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYP-GNY---AEKVCG-SPLYMAPEVLQFQ-RYDEKVDMWSVGAILF 159 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~-~~~l~d~~~~~~~~~-~~~---~~~~~~-~~~~~~pe~~~~~-~~~~~~Di~slg~~~~ 159 (177)
+.|+|++|+|.++. .++ .++..||+.+..... ... .....+ ++.|.+||...+. -..+..|+||+|+++.
T Consensus 145 ~~h~~ikP~n~~l~---~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~ 221 (601)
T KOG0590|consen 145 VTHRDIKPSNSLLD---ESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLS 221 (601)
T ss_pred cccCCCCCccchhc---cCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCccccccccccc
Confidence 99999999999984 555 799999999977665 322 223456 8889999998764 4578899999999999
Q ss_pred HHHhCCCCCCCC
Q 030430 160 ELLNGYPPFSVG 171 (177)
Q Consensus 160 ~~~~~~~pf~~~ 171 (177)
.+++|..||...
T Consensus 222 ~~~~g~~p~~~~ 233 (601)
T KOG0590|consen 222 AMLTGELPWDFP 233 (601)
T ss_pred ccccCCCCcccc
Confidence 999999998654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=6.1e-13 Score=89.57 Aligned_cols=98 Identities=21% Similarity=0.259 Sum_probs=80.1
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
+.+-.+|++++.+++.-.++...=+..+.....++|||++|..|.+.+... ...++..+-..+.-||..|++|
T Consensus 43 r~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givH 115 (204)
T COG3642 43 RERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVH 115 (204)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeec
Confidence 567788999999998777766665666666678999999999999888855 2456677778889999999999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeeccccc
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCT 118 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~ 118 (177)
||++++|++++ +..+.++|||++..
T Consensus 116 GDLTtsNiIl~----~~~i~~IDfGLg~~ 140 (204)
T COG3642 116 GDLTTSNIILS----GGRIYFIDFGLGEF 140 (204)
T ss_pred CCCccceEEEe----CCcEEEEECCcccc
Confidence 99999999995 33499999999854
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.44 E-value=6.7e-14 Score=113.91 Aligned_cols=99 Identities=40% Similarity=0.690 Sum_probs=84.5
Q ss_pred HHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC----------------ccccccCCCccccccc
Q 030430 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----------------YAEKVCGSPLYMAPEV 139 (177)
Q Consensus 76 ~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~----------------~~~~~~~~~~~~~pe~ 139 (177)
+.+++|+|+-|++|+|++|+|.++ ..-+.+++.|||+++...... ......+++.|.|||+
T Consensus 153 vla~Eylh~ygivhrdlkpdnllI---T~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV 229 (1205)
T KOG0606|consen 153 VLAVEYLHSYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV 229 (1205)
T ss_pred hHHhHhhccCCeecCCCCCCccee---eecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence 789999999999999999999999 467889999999886542211 1123468999999999
Q ss_pred cccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcccCC
Q 030430 140 LQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 177 (177)
Q Consensus 140 ~~~~~~~~~~Di~slg~~~~~~~~~~~pf~~~~~~~~l 177 (177)
+....|+...|=|+||+++|+.+-|..||.+.+.++++
T Consensus 230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf 267 (1205)
T KOG0606|consen 230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF 267 (1205)
T ss_pred hhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH
Confidence 99899999999999999999999999999998877653
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.4e-12 Score=88.78 Aligned_cols=101 Identities=15% Similarity=0.150 Sum_probs=75.1
Q ss_pred HHHHHHHHHhhCCC--CceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHH-hhCCCe
Q 030430 12 CLDCELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL-NSHHII 88 (177)
Q Consensus 12 ~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l-h~~~~~ 88 (177)
-.++|++.|+++.. -++++++++ ...+++||++.+..+....-+...++++....+..+++.+++.+ |+.|++
T Consensus 72 wa~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glV 147 (197)
T cd05146 72 WAEKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLV 147 (197)
T ss_pred HHHHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCee
Confidence 34499999999954 456666654 44689999996644422212223455667778889999999988 899999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~ 120 (177)
|||+++.||++. .+.++++||+.+....
T Consensus 148 HGDLs~~NIL~~----~~~v~iIDF~qav~~~ 175 (197)
T cd05146 148 HADLSEYNMLWH----DGKVWFIDVSQSVEPT 175 (197)
T ss_pred cCCCCHHHEEEE----CCcEEEEECCCceeCC
Confidence 999999999995 3568999999775543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=4.1e-13 Score=97.46 Aligned_cols=147 Identities=18% Similarity=0.292 Sum_probs=109.9
Q ss_pred HHHHhhCCCCceeeEeEEEeeCC-----eEEEEEecCCCCChHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhCC-
Q 030430 17 LNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQLGAGLEILNSHH- 86 (177)
Q Consensus 17 ~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lh~~~- 86 (177)
+.-|-++.|.|++++..+|.+.. ...+++||+..|++.+++++.. .+......+|+.||+.||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 34566778999999999986544 5788999999999999998543 3888899999999999999999986
Q ss_pred -CeeecCCCCcEEEecCCCCeeEEEeeeccccccCC---C--CccccccCCCccccccccccCCCCCcchHHHHHHHHHH
Q 030430 87 -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP---G--NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (177)
Q Consensus 87 -~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~---~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~ 160 (177)
++|++++.+.+++ ..++.+++..-.-...... . .......+.++|.+|+.-....-+.++|||++|.+..+
T Consensus 198 piihgnlTc~tifi---q~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFI---QHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred ccccCCcchhheee---cCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 9999999999998 4555565443221111000 0 01112335678899987665666788999999999999
Q ss_pred HHhCCC
Q 030430 161 LLNGYP 166 (177)
Q Consensus 161 ~~~~~~ 166 (177)
|.-+..
T Consensus 275 mailEi 280 (458)
T KOG1266|consen 275 MAILEI 280 (458)
T ss_pred HHHhee
Confidence 877654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.7e-12 Score=85.74 Aligned_cols=111 Identities=22% Similarity=0.269 Sum_probs=88.8
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCC-CChHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGR--VPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
.+.+-.+|++.|.++.--.|....-++.|.....+.||+++| .++.+++.+... ........+++.+-..+.-||..
T Consensus 53 tr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n 132 (229)
T KOG3087|consen 53 TRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN 132 (229)
T ss_pred HHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC
Confidence 467788999999999877776666677777777899999976 588888875532 33334478899999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeecccccc
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~ 119 (177)
+++|||++++||++.+.+....+.++|||++.-.
T Consensus 133 diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 133 DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 9999999999999986555556799999987543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.7e-11 Score=84.89 Aligned_cols=111 Identities=19% Similarity=0.217 Sum_probs=86.6
Q ss_pred HHHHHHHHHHHHhhCCCCc--eeeEeEEEeeCC----eEEEEEecCCCC-ChHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Q 030430 9 LKSCLDCELNFLSSVNHPN--IIRLFDAFQAEN----CIFLVVEFCAGG-NLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~----~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (177)
.+.+..+|.+.+..+...+ .++++.+..... ..++|+|+++|. +|.+++......+......++.+++..++-
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAK 133 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHH
Confidence 3457888999888885443 355555554322 458999999874 899998865557778888999999999999
Q ss_pred HhhCCCeeecCCCCcEEEecCCCCeeEEEeeecccccc
Q 030430 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119 (177)
Q Consensus 82 lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~ 119 (177)
||+.|++|+|+++.||++...+....+.++||+.+...
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999999999999975444567999999976543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.29 E-value=5.5e-11 Score=86.19 Aligned_cols=107 Identities=16% Similarity=0.162 Sum_probs=81.7
Q ss_pred HHHHHHHHHhhCCCCce--eeEeEEEee-----CCeEEEEEecCCCC-ChHHHHhh--cCCCCHHHHHHHHHHHHHHHHH
Q 030430 12 CLDCELNFLSSVNHPNI--IRLFDAFQA-----ENCIFLVVEFCAGG-NLSSYIRL--HGRVPEQTARKFLQQLGAGLEI 81 (177)
Q Consensus 12 ~~~~e~~~l~~l~h~~i--~~~~~~~~~-----~~~~~lv~e~~~~~-~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~ 81 (177)
.+.+|.+.+..+...+| +++..+... ....++|+|++++. +|.+++.. ....+......++.+++..++-
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~ 153 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD 153 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 47899999988854444 333444432 23468999999876 89998764 2345667778999999999999
Q ss_pred HhhCCCeeecCCCCcEEEecC----CCCeeEEEeeeccccc
Q 030430 82 LNSHHIIHRDLKPENILLSGL----DDDVMLKIADFGLSCT 118 (177)
Q Consensus 82 lh~~~~~H~~i~~~nil~~~~----~~~~~~~l~d~~~~~~ 118 (177)
||+.|++|+|++++||++... ++...+.++||+.+..
T Consensus 154 LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 154 MHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 999999999999999999631 2356799999997743
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=7e-12 Score=96.90 Aligned_cols=158 Identities=29% Similarity=0.446 Sum_probs=129.8
Q ss_pred HHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCC-CCHHHHHHHHHHHHH----HHHHHh
Q 030430 10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGA----GLEILN 83 (177)
Q Consensus 10 ~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~----~l~~lh 83 (177)
..+-.+|+...+.+ .|++.++....++.++..++-+|++ +.+|..+...... +++..++....+... |+..+|
T Consensus 161 ~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h 239 (524)
T KOG0601|consen 161 SKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH 239 (524)
T ss_pred cccccchhhcccccCccccccccCcccccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccC
Confidence 33445677777777 5899999899999999999999999 7889888876555 888899999999888 999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccc------cccCCCccccccccccCCCCCcchHHHHHHH
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE------KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAI 157 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~------~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~ 157 (177)
..+++|.+++|.|++.. .....++++||+....+....... ...+...|++||... ..++..+|+|++|.+
T Consensus 240 s~~~~~~~~kp~~i~~~--~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev 316 (524)
T KOG0601|consen 240 SNNIVHDDLKPANIFTT--SDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEV 316 (524)
T ss_pred CCcccccccchhheecc--cccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhh
Confidence 99999999999999985 222678999999988877665332 224677899999876 457889999999999
Q ss_pred HHHHHhCCCCCCCC
Q 030430 158 LFELLNGYPPFSVG 171 (177)
Q Consensus 158 ~~~~~~~~~pf~~~ 171 (177)
+.+..++..+...+
T Consensus 317 ~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 317 ILEAILGSHLPSVG 330 (524)
T ss_pred hHhhHhhcccccCC
Confidence 99999988777665
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.6e-11 Score=84.60 Aligned_cols=96 Identities=22% Similarity=0.308 Sum_probs=69.3
Q ss_pred HHHHHHHhhCCCCc--eeeEeEEEeeCCeEEEEEecCCCCChHH-HHhhcCCCCHHHHHHHHHHHHHHHHHHhh-CCCee
Q 030430 14 DCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPEQTARKFLQQLGAGLEILNS-HHIIH 89 (177)
Q Consensus 14 ~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~H 89 (177)
..|.+.+..+.+.. ++++++. ...++++||++|+++.. .+... .. .+.+..++.+++.++.++|. .|++|
T Consensus 65 ~~e~~~l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH 138 (187)
T cd05119 65 EKEFRNLKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVH 138 (187)
T ss_pred HHHHHHHHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCc
Confidence 56777777775443 4444443 23589999998844321 11111 11 16778899999999999999 99999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeecccccc
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCTL 119 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~~ 119 (177)
+|++|+||+++ .+.++++|||.+...
T Consensus 139 ~Dl~p~Nili~----~~~~~liDfg~a~~~ 164 (187)
T cd05119 139 GDLSEYNILVD----DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCCChhhEEEE----CCcEEEEECcccccc
Confidence 99999999994 567899999988554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.21 E-value=3.1e-11 Score=81.76 Aligned_cols=94 Identities=22% Similarity=0.220 Sum_probs=69.8
Q ss_pred HHHHHHHHHHhhCCCCc-eeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC--
Q 030430 11 SCLDCELNFLSSVNHPN-IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI-- 87 (177)
Q Consensus 11 ~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~-- 87 (177)
..+.+|+++++.+.+.+ +++++.+.. ...++|||+++|.++... . ......+.+++.+++.||+.++
T Consensus 37 ~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~~-----~---~~~~~~~~~l~~~l~~LH~~~~~~ 106 (170)
T cd05151 37 INRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLTE-----D---FSDPENLEKIAKLLKKLHSSPLPD 106 (170)
T ss_pred cCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccccc-----c---ccCHHHHHHHHHHHHHHhCCCCCC
Confidence 45688999999996544 455554433 234799999999888653 1 1113456789999999999985
Q ss_pred ---eeecCCCCcEEEecCCCCeeEEEeeeccccc
Q 030430 88 ---IHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (177)
Q Consensus 88 ---~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~ 118 (177)
+|+|++|.|+++. .+.++++||+.+..
T Consensus 107 ~~~~HgD~~~~Nil~~----~~~~~liDf~~a~~ 136 (170)
T cd05151 107 LVPCHNDLLPGNFLLD----DGRLWLIDWEYAGM 136 (170)
T ss_pred ceeecCCCCcCcEEEE----CCeEEEEecccccC
Confidence 9999999999995 34689999998743
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.3e-10 Score=79.96 Aligned_cols=104 Identities=20% Similarity=0.325 Sum_probs=69.5
Q ss_pred hhHHHHHHHHHHHHhhCCCC--ceeeEeEEEeeCCeEEEEEecCC--CCChHHHHhhcCCCCHHHHHHHHHHHHHHHH-H
Q 030430 7 KHLKSCLDCELNFLSSVNHP--NIIRLFDAFQAENCIFLVVEFCA--GGNLSSYIRLHGRVPEQTARKFLQQLGAGLE-I 81 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~-~ 81 (177)
...+...++|.+.|.++... ++++++++. . .++||||++ |..+..+... .++.+....++.+++..+. .
T Consensus 49 ~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~--~--~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~ 122 (188)
T PF01163_consen 49 YLIREWAKKEFRNLKRLYEAGVPVPKPYDYN--R--NVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKM 122 (188)
T ss_dssp HHHHHHHHHHHHHHHHCCCTT-SS--EEEEE--T--TEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHCCccCCcEEEEe--C--CEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHH
Confidence 34467789999999999766 466666442 2 379999998 6666554332 2224556677778888444 4
Q ss_pred HhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccC
Q 030430 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120 (177)
Q Consensus 82 lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~ 120 (177)
+|..|++|||+++.||+++ .+ .++++||+.+....
T Consensus 123 ~~~~givHGDLs~~NIlv~---~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 123 LHKAGIVHGDLSEYNILVD---DG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp HHCTTEEESS-STTSEEEE---TT-CEEE--GTTEEETT
T ss_pred HHhcCceecCCChhhEEee---cc-eEEEEecCcceecC
Confidence 6899999999999999995 23 79999999875543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.20 E-value=7.8e-11 Score=91.15 Aligned_cols=103 Identities=22% Similarity=0.251 Sum_probs=72.0
Q ss_pred HHHHHHHHhhCC-----CCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHH-HHHHHhhC
Q 030430 13 LDCELNFLSSVN-----HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGA-GLEILNSH 85 (177)
Q Consensus 13 ~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~-~l~~lh~~ 85 (177)
+.+|++.+.++. ++++.-..-+....+..+++|||++|++|.+..... ...+ ...++..++. .+..+|..
T Consensus 200 f~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 200 LRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC
Confidence 556666666652 344432232333445679999999999999876532 1222 3345556555 57889999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCC
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~ 121 (177)
|++|+|++|.||++ ...+.++++|||++.....
T Consensus 277 g~~H~D~hPgNilv---~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 GFFHADLHPGNIFV---LKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CceeCCCCcccEEE---CCCCcEEEEeCCCeeECCH
Confidence 99999999999999 4567899999999877643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=7.7e-10 Score=83.43 Aligned_cols=128 Identities=17% Similarity=0.202 Sum_probs=96.3
Q ss_pred eEEEEEecCCCC-ChHHHHh------hcCCCCHHHHHHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEee
Q 030430 40 CIFLVVEFCAGG-NLSSYIR------LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 112 (177)
Q Consensus 40 ~~~lv~e~~~~~-~L~~~l~------~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d 112 (177)
...++|..+.|. ....+.+ .....+...+.+.+..++.+.+.||+.|.+-||++++|++++ +...++|.|
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs---d~~~V~LVd 160 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS---DDSKVVLVD 160 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee---cCceEEEEc
Confidence 467788877653 2222221 123378889999999999999999999999999999999995 566788888
Q ss_pred eccccccCCCCccccccCCCccccccccc-----cCCCCCcchHHHHHHHHHHHHhC-CCCCCC
Q 030430 113 FGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFELLNG-YPPFSV 170 (177)
Q Consensus 113 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~slg~~~~~~~~~-~~pf~~ 170 (177)
-........+.......+...|.+||... +...+..+|.|.||+++++++.| +.||++
T Consensus 161 sDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 161 SDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred ccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 66443333333333455788899999764 44567889999999999998886 999987
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.94 E-value=9.6e-09 Score=79.20 Aligned_cols=136 Identities=19% Similarity=0.331 Sum_probs=100.5
Q ss_pred HHHHHHHHHHhhCCCCceeeEeEEEe----eCCeEEEEEecCCC-CChHHHHh---------------hcCCCCHHHHHH
Q 030430 11 SCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAG-GNLSSYIR---------------LHGRVPEQTARK 70 (177)
Q Consensus 11 ~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~~lv~e~~~~-~~L~~~l~---------------~~~~~~~~~~~~ 70 (177)
..-..-.++++++-|+|++++.+++. ++..+++||+|.++ ++|.++-= .+...+++.+|.
T Consensus 318 nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~ 397 (655)
T KOG3741|consen 318 NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWS 397 (655)
T ss_pred ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHH
Confidence 34455688999999999999999886 44578999999985 45554331 112378899999
Q ss_pred HHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcch
Q 030430 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVD 150 (177)
Q Consensus 71 ~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~D 150 (177)
++.|+..||.++|+.|+..+-+.+.+|++. +..++++...|...-..... .+| + +--.+-|
T Consensus 398 y~~QLtaaL~sIHssGLAck~L~~~kIlv~---G~~RIriS~C~i~Dvl~~d~-----------~~~--l---e~~Qq~D 458 (655)
T KOG3741|consen 398 YISQLTAALYSIHSSGLACKTLDLKKILVT---GKMRIRISGCGIMDVLQEDP-----------TEP--L---ESQQQND 458 (655)
T ss_pred HHHHHHHHHHHHHhcCceeecccHhHeEee---CcceEEEecccceeeecCCC-----------Ccc--h---hHHhhhh
Confidence 999999999999999999999999999994 44478877766553332222 011 0 1124578
Q ss_pred HHHHHHHHHHHHhCC
Q 030430 151 MWSVGAILFELLNGY 165 (177)
Q Consensus 151 i~slg~~~~~~~~~~ 165 (177)
.-.||.++..+.||.
T Consensus 459 ~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 459 LRDLGLLLLALATGT 473 (655)
T ss_pred HHHHHHHHHHHhhcc
Confidence 888999999998883
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=3.1e-10 Score=93.10 Aligned_cols=149 Identities=34% Similarity=0.555 Sum_probs=115.3
Q ss_pred CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCC
Q 030430 24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD 103 (177)
Q Consensus 24 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~ 103 (177)
.+|-++.....+.-....+++++|..|++|...+.+.+..+.+-....+..+..++++||...+.|+|++|.|.+..
T Consensus 862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~--- 938 (1205)
T KOG0606|consen 862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIA--- 938 (1205)
T ss_pred CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhc---
Confidence 34555544444556677899999999999999888777788888888999999999999999999999999999984
Q ss_pred CCeeEEEeeecccccc---------------------CCC-----------CccccccCCCccccccccccCCCCCcchH
Q 030430 104 DDVMLKIADFGLSCTL---------------------YPG-----------NYAEKVCGSPLYMAPEVLQFQRYDEKVDM 151 (177)
Q Consensus 104 ~~~~~~l~d~~~~~~~---------------------~~~-----------~~~~~~~~~~~~~~pe~~~~~~~~~~~Di 151 (177)
..+...+.+|+..... ... .......+++.|.+||...+.......|.
T Consensus 939 ~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~ 1018 (1205)
T KOG0606|consen 939 YDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADW 1018 (1205)
T ss_pred ccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchh
Confidence 4555666666522111 000 01123457888999999998889999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCccc
Q 030430 152 WSVGAILFELLNGYPPFSVGEEHQ 175 (177)
Q Consensus 152 ~slg~~~~~~~~~~~pf~~~~~~~ 175 (177)
|+.|+++++.++|..||......+
T Consensus 1019 ~~~g~~l~e~l~g~pp~na~tpq~ 1042 (1205)
T KOG0606|consen 1019 WSSGVCLFEVLTGIPPFNAETPQQ 1042 (1205)
T ss_pred hhhhhhhhhhhcCCCCCCCcchhh
Confidence 999999999999999998866544
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.6e-08 Score=70.29 Aligned_cols=111 Identities=13% Similarity=0.124 Sum_probs=82.8
Q ss_pred hhHHHHHHHHHHHHhhCCCCc--eeeEeEEEe---eC--CeEEEEEecCCC-CChHHHHhhc--CCCCHHHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPN--IIRLFDAFQ---AE--NCIFLVVEFCAG-GNLSSYIRLH--GRVPEQTARKFLQQLG 76 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~---~~--~~~~lv~e~~~~-~~L~~~l~~~--~~~~~~~~~~~~~~i~ 76 (177)
+.-+..+.+|++.+++|...+ ++++. ++. .+ -..+||+|-+.| .+|.+++... .+.+......++.+++
T Consensus 60 P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va 138 (216)
T PRK09902 60 PFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVA 138 (216)
T ss_pred CCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHH
Confidence 345678899999999995443 44444 222 11 135899997743 6898887653 3457777889999999
Q ss_pred HHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeecccccc
Q 030430 77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119 (177)
Q Consensus 77 ~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~ 119 (177)
.+++-||+.|+.|+|+.+.||++... +...+.++||..++..
T Consensus 139 ~~ia~LH~~Gv~Hgdly~khIll~~~-g~~~v~lIDlEk~r~~ 180 (216)
T PRK09902 139 LAFKKMHSVNRQHGCCYVRHIYVKTE-GKAEAGFLDLEKSRRR 180 (216)
T ss_pred HHHHHHHHCCCcCCCCCHhheeecCC-CCeeEEEEEhhccchh
Confidence 99999999999999999999999632 2456999999977553
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.90 E-value=7.5e-09 Score=72.90 Aligned_cols=105 Identities=17% Similarity=0.262 Sum_probs=76.0
Q ss_pred HHHHHHHHHHHhhCCCC--ceeeEeEEEeeC---CeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 10 KSCLDCELNFLSSVNHP--NIIRLFDAFQAE---NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
...+.+|.++++.+.+. .+++++.+.... +..+++||+++|.++.+.+.. ..++.++...++.+++.+++.||+
T Consensus 39 ~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~ 117 (223)
T cd05154 39 AHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHS 117 (223)
T ss_pred cccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhC
Confidence 56789999999999764 457777776654 256899999999888775431 345666666667777777666663
Q ss_pred --------------------------------------------------------CCCeeecCCCCcEEEecCCCCeeE
Q 030430 85 --------------------------------------------------------HHIIHRDLKPENILLSGLDDDVML 108 (177)
Q Consensus 85 --------------------------------------------------------~~~~H~~i~~~nil~~~~~~~~~~ 108 (177)
..++|+|+.+.|++++.. ....+
T Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~ 196 (223)
T cd05154 118 VDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVV 196 (223)
T ss_pred CChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEE
Confidence 236899999999999521 14557
Q ss_pred EEeeeccc
Q 030430 109 KIADFGLS 116 (177)
Q Consensus 109 ~l~d~~~~ 116 (177)
.++||+.+
T Consensus 197 ~iID~e~~ 204 (223)
T cd05154 197 AVLDWELA 204 (223)
T ss_pred EEEecccc
Confidence 89999866
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.2e-09 Score=86.08 Aligned_cols=78 Identities=23% Similarity=0.272 Sum_probs=53.4
Q ss_pred eCCeEEEEEecCCCCChHHHHh--hcC----CCCHHHHHHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCC-CCeeEE
Q 030430 37 AENCIFLVVEFCAGGNLSSYIR--LHG----RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD-DDVMLK 109 (177)
Q Consensus 37 ~~~~~~lv~e~~~~~~L~~~l~--~~~----~~~~~~~~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~-~~~~~~ 109 (177)
..+..++||||+.|+++.+.-. ..+ .+.+..+..++.|+ ...|++|+|++|.||++...+ ..++++
T Consensus 232 ~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f~~GffHaDpHPGNIlv~~~g~~~~~i~ 304 (537)
T PRK04750 232 YCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------FRDGFFHADMHPGNIFVSYDPPENPRYI 304 (537)
T ss_pred cCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------HhCCeeeCCCChHHeEEecCCCCCCeEE
Confidence 3556789999999999987532 222 13333334444444 468999999999999996311 124899
Q ss_pred EeeeccccccCC
Q 030430 110 IADFGLSCTLYP 121 (177)
Q Consensus 110 l~d~~~~~~~~~ 121 (177)
++|||++.....
T Consensus 305 llDFGivg~l~~ 316 (537)
T PRK04750 305 ALDFGIVGSLNK 316 (537)
T ss_pred EEecceEEECCH
Confidence 999999876643
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.4e-08 Score=72.70 Aligned_cols=101 Identities=18% Similarity=0.225 Sum_probs=77.7
Q ss_pred HHHHHHHHHHHHhhCCCC--ceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 9 LKSCLDCELNFLSSVNHP--NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
.+...++|.++|..|... .+++.+ +.+...++||+++|..|...- ++.+..-.++..|+..++..-..|
T Consensus 152 sRl~A~rEf~~L~~L~~~G~~VP~P~----~~nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~G 222 (304)
T COG0478 152 SRLAAEREFEALQRLYPEGVKVPKPI----AWNRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRG 222 (304)
T ss_pred HHHHHHHHHHHHHHhhhcCCCCCCcc----ccccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcC
Confidence 456778999999999655 777776 456678999999997776642 234555566777777777777999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCC
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~ 121 (177)
++|||+++-||+++ +++.++++||-.+.....
T Consensus 223 iVHGDlSefNIlV~---~dg~~~vIDwPQ~v~~~h 254 (304)
T COG0478 223 IVHGDLSEFNILVT---EDGDIVVIDWPQAVPISH 254 (304)
T ss_pred ccccCCchheEEEe---cCCCEEEEeCcccccCCC
Confidence 99999999999994 667799999987655433
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.3e-09 Score=84.57 Aligned_cols=154 Identities=24% Similarity=0.285 Sum_probs=113.6
Q ss_pred HHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 11 SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 11 ~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
..-..|+.+...+ .|.+.+.....|......|+--||+.++++.........+++...+++..|++.++.++|+..++|
T Consensus 310 i~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~ 389 (524)
T KOG0601|consen 310 IFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVH 389 (524)
T ss_pred hcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhc
Confidence 3344555555555 588888888777766667799999999998877765567999999999999999999999999999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCcc-ccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY-MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~-~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
.|++|+||++.. .++..++.||+...+...... .....+..| .++.......+..+.|++|||..+.+.+++...
T Consensus 390 ~d~~psni~i~~--~~~~~~~~~~~~~t~~~~~~~-~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 390 LDVKPSNILISN--DGFFSKLGDFGCWTRLAFSSG-VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred ccccccceeecc--chhhhhccccccccccceecc-cccccccccccchhhccccccccccccccccccccccccCccc
Confidence 999999999963 226678888887754211111 111123333 345555556678899999999999998888653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.67 E-value=8.5e-08 Score=67.08 Aligned_cols=68 Identities=22% Similarity=0.353 Sum_probs=52.7
Q ss_pred CCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeecccc
Q 030430 38 ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117 (177)
Q Consensus 38 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~ 117 (177)
....++++||++|..|.+... +++ .+...+..++.-+|+.|++|||.+|.|++++ ...++++|++...
T Consensus 115 ~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~----~~~i~iID~~~k~ 182 (229)
T PF06176_consen 115 TSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS----NNGIRIIDTQGKR 182 (229)
T ss_pred eeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE----CCcEEEEECcccc
Confidence 345679999999998877533 333 2445677789999999999999999999995 3348999998653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.65 E-value=8.8e-07 Score=61.51 Aligned_cols=102 Identities=27% Similarity=0.397 Sum_probs=78.0
Q ss_pred HHHHHHHHHHHhhCC------CCceeeEeEEEeeCCeEEEEEecCCC------CChHHHHhhcCCCCHHHHHHHHHHHHH
Q 030430 10 KSCLDCELNFLSSVN------HPNIIRLFDAFQAENCIFLVVEFCAG------GNLSSYIRLHGRVPEQTARKFLQQLGA 77 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~~~~~~~~~i~~ 77 (177)
.+...+|+....++. +.+|++++|+.+.+....+|+|.+.+ .+|.+++. .+.++. . +...+-.
T Consensus 55 ~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-~~~~~~-~---~~~~L~~ 129 (199)
T PF10707_consen 55 YRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLK-EGGLTE-E---LRQALDE 129 (199)
T ss_pred hHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHH-cCCccH-H---HHHHHHH
Confidence 567788888777776 88999999999999999999997763 47888875 334654 3 3344455
Q ss_pred HHHHHhhCCCeeecCCCCcEEEecCCCCe-eEEEee-eccc
Q 030430 78 GLEILNSHHIIHRDLKPENILLSGLDDDV-MLKIAD-FGLS 116 (177)
Q Consensus 78 ~l~~lh~~~~~H~~i~~~nil~~~~~~~~-~~~l~d-~~~~ 116 (177)
..++|-+.+|+.+|++|.||++...+++. .+.++| ||..
T Consensus 130 f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 130 FKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred HHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEeCCCCc
Confidence 56788888999999999999998655544 788888 6643
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.3e-08 Score=80.61 Aligned_cols=100 Identities=19% Similarity=0.327 Sum_probs=74.8
Q ss_pred HHHHHHHHHHHHHHhh-CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc----------ccccCCCccccc
Q 030430 69 RKFLQQLGAGLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----------EKVCGSPLYMAP 137 (177)
Q Consensus 69 ~~~~~~i~~~l~~lh~-~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~----------~~~~~~~~~~~p 137 (177)
..-+.+.+.++.++|. .++||++|.|++|.+ +..+..|++.|+.+.....+... ........|.+|
T Consensus 102 f~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~ap 178 (700)
T KOG2137|consen 102 FANLGNVADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAP 178 (700)
T ss_pred hhhhhcccchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccc
Confidence 3344566689999997 589999999999999 57788999999877554332111 011234569999
Q ss_pred cccccCCCCCcchHHHHHHHHHHHH-hCCCCCCCC
Q 030430 138 EVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSVG 171 (177)
Q Consensus 138 e~~~~~~~~~~~Di~slg~~~~~~~-~~~~pf~~~ 171 (177)
|.+.....++++|+||+|+++|.+. +|+..+.+.
T Consensus 179 E~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~ 213 (700)
T KOG2137|consen 179 EYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAAN 213 (700)
T ss_pred hhhccccccccccceeeeeEEEEEecCCcchhhcc
Confidence 9998877889999999999999988 566656544
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.33 E-value=4.4e-06 Score=59.99 Aligned_cols=47 Identities=13% Similarity=0.082 Sum_probs=36.5
Q ss_pred HHHHHHHHHHHhhCC-CCceeeEeEEEeeCCeEEEEEecCCCCChHHH
Q 030430 10 KSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY 56 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 56 (177)
...+.+|+++++.+. +--+++++++...++..+++|++++|.++...
T Consensus 35 ~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 35 TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 346788999999983 45567888877776678899999999887643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.5e-05 Score=56.66 Aligned_cols=43 Identities=19% Similarity=0.188 Sum_probs=34.3
Q ss_pred HHHHHHHHHHHhhCCCCc--eeeEeEEEeeCCeEEEEEecCCCCC
Q 030430 10 KSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGN 52 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~ 52 (177)
...+.+|.++++.+.... +++++++..+++...++||+++|.+
T Consensus 36 ~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 36 KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 455789999999996443 4778888888888889999998863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.15 E-value=2.8e-05 Score=65.72 Aligned_cols=158 Identities=25% Similarity=0.267 Sum_probs=111.7
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCe----EEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENC----IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
....+-|+..+.+..|+|++.+..|-..... ..+..+++...++...+..-...+.++.+.+..+..++++++|+.
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 4445667778888899999999988654322 235567888889988888778899999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEe--eeccccccCCCCccccccCCCccccccccccCCCC--CcchHHHHHHHHHHH
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIA--DFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD--EKVDMWSVGAILFEL 161 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~--d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~--~~~Di~slg~~~~~~ 161 (177)
...|.-+..+...-...+..+..... ||+.+..............+..+.+++.......+ ...|+|++|.....+
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~ 385 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQL 385 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhh
Confidence 77666666653332221333333333 77777666555544444455667788877655444 347999999999888
Q ss_pred HhCCCC
Q 030430 162 LNGYPP 167 (177)
Q Consensus 162 ~~~~~p 167 (177)
..+..+
T Consensus 386 ~~~~~i 391 (1351)
T KOG1035|consen 386 SQGEDI 391 (1351)
T ss_pred hhcCcc
Confidence 877643
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.4e-05 Score=56.94 Aligned_cols=102 Identities=19% Similarity=0.129 Sum_probs=69.1
Q ss_pred HHHHHHHHHhhCCC--CceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-CCCe
Q 030430 12 CLDCELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-HHII 88 (177)
Q Consensus 12 ~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~ 88 (177)
=..+|.+-|+++.. -.+++.+.+.. ..++||++......--.-+.-.+..+....+..+++..++-|-. .|+|
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LV 189 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLV 189 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcc
Confidence 34678888888854 44555554332 37899999433111000011123334677788889998888887 8999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~ 121 (177)
|+|++.=||++. .+.++++|++.+.....
T Consensus 190 HgDLSEyNiL~~----~~~p~iID~~QaV~~~h 218 (268)
T COG1718 190 HGDLSEYNILVH----DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred cccchhhheEEE----CCeEEEEECccccccCC
Confidence 999999999994 56789999998866543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.08 E-value=3e-05 Score=61.33 Aligned_cols=105 Identities=21% Similarity=0.265 Sum_probs=70.6
Q ss_pred HHHHHHHHhhC-----CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 13 LDCELNFLSSV-----NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 13 ~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
+.+|+..+.++ +.+++.-..-+++-.+.-.++|||+.|..+.+..... ...+...+.....++ .+..+-..|
T Consensus 208 y~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~dg 285 (517)
T COG0661 208 YRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhcC
Confidence 44555555555 3566655555566667779999999999999885322 345533333222222 234445589
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCC
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~ 122 (177)
+.|+|.+|.|+++. ..+.+.+.|||+.......
T Consensus 286 ffHaDpHpGNi~v~---~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 286 FFHADPHPGNILVR---SDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred ccccCCCccceEEe---cCCcEEEEcCcceecCCHH
Confidence 99999999999994 6688999999998766543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.04 E-value=3.9e-05 Score=52.99 Aligned_cols=98 Identities=24% Similarity=0.271 Sum_probs=74.9
Q ss_pred HHHHHHHhhCCC-CceeeEeEEEeeCCeEEEEEecCCCCChHH---HHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CC
Q 030430 14 DCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSS---YIRLHGRVPEQTARKFLQQLGAGLEILNS---HH 86 (177)
Q Consensus 14 ~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~---~l~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~ 86 (177)
..|.-+++.+.+ +++++++|++.. ++++|+...+++.. .+......+.....+++.+++..+..++. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888899965 699999998843 56889997655531 11112246788999999999999999998 34
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccc
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~ 118 (177)
+.-.|++++|+-+. .++.++++|......
T Consensus 83 ~~lcDv~~~nfgv~---~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVN---DDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEe---CCCcEEEEechhcch
Confidence 78889999999994 567799999886543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.91 E-value=3.5e-06 Score=67.03 Aligned_cols=150 Identities=24% Similarity=0.364 Sum_probs=101.5
Q ss_pred HHHHHHHHHHhhCCCCc-eeeEeEEEeeCCeEEEEEecCCCC-ChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 11 SCLDCELNFLSSVNHPN-IIRLFDAFQAENCIFLVVEFCAGG-NLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 11 ~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
-...-++++|.+.+||| .+..++-++......+.++++.++ +-....... ..+..-+.......-...++++|+..=
T Consensus 278 l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~ 357 (829)
T KOG0576|consen 278 LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYK 357 (829)
T ss_pred hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccc
Confidence 34566888999999999 555555566667888999998665 222211100 113333334444555677888887755
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
+|+| ||+. .+...+..+++....+..........+++.+++||......+....|.|+++.-..++..|-+|
T Consensus 358 ~~~d----~~l~----s~~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 358 VHRD----NILG----SEEEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred cCcc----cccc----cccccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence 6666 7774 3455778888887666555444556688999999998888888899999999766666666555
Q ss_pred C
Q 030430 168 F 168 (177)
Q Consensus 168 f 168 (177)
-
T Consensus 430 r 430 (829)
T KOG0576|consen 430 R 430 (829)
T ss_pred C
Confidence 3
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.84 E-value=9e-05 Score=52.96 Aligned_cols=46 Identities=9% Similarity=0.071 Sum_probs=31.0
Q ss_pred HHHHHHHHHHHHhhCCCC---ceeeEeEEEeeC---CeEEEEEecCCCCChH
Q 030430 9 LKSCLDCELNFLSSVNHP---NIIRLFDAFQAE---NCIFLVVEFCAGGNLS 54 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~---~~~~lv~e~~~~~~L~ 54 (177)
....+.+|.++++.+... .++++++..... +..+++|++++|.++.
T Consensus 31 ~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G~~l~ 82 (235)
T cd05155 31 YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEGETAT 82 (235)
T ss_pred hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecCCCCC
Confidence 345799999999988532 345555444332 2347899999997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.0003 Score=59.20 Aligned_cols=43 Identities=14% Similarity=0.387 Sum_probs=33.2
Q ss_pred HHHHHHHHHHhhCC-CCce--eeEeEEEeeC---CeEEEEEecCCCCCh
Q 030430 11 SCLDCELNFLSSVN-HPNI--IRLFDAFQAE---NCIFLVVEFCAGGNL 53 (177)
Q Consensus 11 ~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~---~~~~lv~e~~~~~~L 53 (177)
..+.+|+++++.+. |+++ ++++.++.+. +..|+|||+++|..+
T Consensus 83 ~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~ 131 (822)
T PLN02876 83 HAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIF 131 (822)
T ss_pred HHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCccc
Confidence 46889999999995 6665 7777777654 457899999988653
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00033 Score=55.62 Aligned_cols=90 Identities=17% Similarity=0.258 Sum_probs=59.2
Q ss_pred eeeEeEEEeeCCeEEEEEecCCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecC-CCC
Q 030430 28 IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGL-DDD 105 (177)
Q Consensus 28 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~-~~~ 105 (177)
|++++ +.-.+...++|||++|..+.+.-.- ...++...+..-+.+... +.+=..|++|+|-+|.||++... ..+
T Consensus 266 VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~GffHaDPHPGNilv~~~~~~~ 341 (538)
T KOG1235|consen 266 VPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTGFFHADPHPGNILVRPNPEGD 341 (538)
T ss_pred CCeeh--hhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcCCccCCCCCCcEEEecCCCCC
Confidence 44443 3344557899999999877665331 234666654444333322 33445689999999999999743 246
Q ss_pred eeEEEeeeccccccCC
Q 030430 106 VMLKIADFGLSCTLYP 121 (177)
Q Consensus 106 ~~~~l~d~~~~~~~~~ 121 (177)
..+.+.|||+......
T Consensus 342 ~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 342 EEIVLLDHGLYAVISH 357 (538)
T ss_pred ccEEEEcccccccccH
Confidence 7799999998866543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00052 Score=48.45 Aligned_cols=47 Identities=17% Similarity=0.238 Sum_probs=33.6
Q ss_pred HHHHHHHHHHHHhhCCCC--ceeeEeEEE---eeCCeEEEEEecCCCCChHH
Q 030430 9 LKSCLDCELNFLSSVNHP--NIIRLFDAF---QAENCIFLVVEFCAGGNLSS 55 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~--~i~~~~~~~---~~~~~~~lv~e~~~~~~L~~ 55 (177)
....+.+|..+++.+... .+++++... ......++++++++|.++..
T Consensus 33 ~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 33 AAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDD 84 (239)
T ss_dssp HHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHH
T ss_pred CHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccc
Confidence 677889999999998533 356666543 33446799999999988877
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0002 Score=53.41 Aligned_cols=97 Identities=20% Similarity=0.258 Sum_probs=69.6
Q ss_pred HHHHHHHHHHHhhCCCCc--eeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 10 KSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
+-...+|+..|+.|.... +++.+ +-+..++|||++.|-.|.+... -.+. -.+...+...+.-|...|+
T Consensus 154 Rlaa~kEfafmkaL~e~gfpVPkpi----D~~RH~Vvmelv~g~Pl~~v~~---v~d~---~~ly~~lm~~Iv~la~~Gl 223 (465)
T KOG2268|consen 154 RLAATKEFAFMKALYERGFPVPKPI----DHNRHCVVMELVDGYPLRQVRH---VEDP---PTLYDDLMGLIVRLANHGL 223 (465)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCCcc----cccceeeHHHhhcccceeeeee---cCCh---HHHHHHHHHHHHHHHHcCc
Confidence 345678899999985433 34443 4556789999999999877532 1222 2344566667778899999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeecccccc
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~ 119 (177)
+|||.+--||++. +...++++||-.....
T Consensus 224 IHgDFNEFNimv~---dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 224 IHGDFNEFNIMVK---DDDKIVVIDFPQMVST 252 (465)
T ss_pred eecccchheeEEe---cCCCEEEeechHhhcc
Confidence 9999999999994 5677999999765443
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0027 Score=46.85 Aligned_cols=114 Identities=26% Similarity=0.326 Sum_probs=62.9
Q ss_pred ccccchhHHHHHHHHHHHHhhCCCCc--eeeEeEE------EeeCCeEEEEEecCCCCChHH----HHh--------hc-
Q 030430 2 LKKLNKHLKSCLDCELNFLSSVNHPN--IIRLFDA------FQAENCIFLVVEFCAGGNLSS----YIR--------LH- 60 (177)
Q Consensus 2 l~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~------~~~~~~~~lv~e~~~~~~L~~----~l~--------~~- 60 (177)
||.........+..|+++++.+.+.+ +++++.. ....+..+.++++++|.++.. ... .+
T Consensus 42 Lr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~ 121 (296)
T cd05153 42 LTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHL 121 (296)
T ss_pred EEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHH
Confidence 34433344567888999998885433 4444431 233456789999999876532 010 00
Q ss_pred --CCCCH--------HHHHH------------HHHHHHHHHHHHhh-------CCCeeecCCCCcEEEecCCCCeeEEEe
Q 030430 61 --GRVPE--------QTARK------------FLQQLGAGLEILNS-------HHIIHRDLKPENILLSGLDDDVMLKIA 111 (177)
Q Consensus 61 --~~~~~--------~~~~~------------~~~~i~~~l~~lh~-------~~~~H~~i~~~nil~~~~~~~~~~~l~ 111 (177)
..+.. ..... ....+..++..+.+ .+++|+|+.|.|+++. +...+.++
T Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~---~~~~~~iI 198 (296)
T cd05153 122 AAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNVLFD---GDELSGVI 198 (296)
T ss_pred HhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEe---CCceEEEe
Confidence 00000 00000 01112223333332 4699999999999994 44446799
Q ss_pred eeccccc
Q 030430 112 DFGLSCT 118 (177)
Q Consensus 112 d~~~~~~ 118 (177)
||+.+..
T Consensus 199 Dfe~a~~ 205 (296)
T cd05153 199 DFYFACT 205 (296)
T ss_pred ehhhhcC
Confidence 9987643
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0017 Score=44.22 Aligned_cols=98 Identities=16% Similarity=0.134 Sum_probs=70.3
Q ss_pred chhHHHHHHHHHHHHhhCCCCce-eeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNI-IRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
.++.+..++.|+++|+.+.-.++ ++++.+..+. +.|||+.|.+|.+.... .+..++. .+++.--.|..
T Consensus 55 ~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~----i~me~i~G~~L~~~~~~---~~rk~l~----~vlE~a~~LD~ 123 (201)
T COG2112 55 RDSPRRNLEKEAKILEILAGEGVTPEVYFYGEDF----IRMEYIDGRPLGKLEIG---GDRKHLL----RVLEKAYKLDR 123 (201)
T ss_pred CCcchhhHHHHHHHHHHhhhcCCCceEEEechhh----hhhhhhcCcchhhhhhc---ccHHHHH----HHHHHHHHHHH
Confidence 56778999999999999987776 4555444332 45999999899876542 1333433 45555566778
Q ss_pred CCCeeecCCC--CcEEEecCCCCeeEEEeeeccccc
Q 030430 85 HHIIHRDLKP--ENILLSGLDDDVMLKIADFGLSCT 118 (177)
Q Consensus 85 ~~~~H~~i~~--~nil~~~~~~~~~~~l~d~~~~~~ 118 (177)
.||-|+.++- .|++++ ...+.++||..+..
T Consensus 124 ~GI~H~El~~~~k~vlv~----~~~~~iIDFd~At~ 155 (201)
T COG2112 124 LGIEHGELSRPWKNVLVN----DRDVYIIDFDSATF 155 (201)
T ss_pred hccchhhhcCCceeEEec----CCcEEEEEccchhh
Confidence 8999999986 567763 33799999998863
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.19 E-value=6e-05 Score=65.85 Aligned_cols=160 Identities=14% Similarity=0.056 Sum_probs=113.1
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEee--CCeEEEEEecCCCCChHHHHhhc----CCCCHHHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGL 79 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l 79 (177)
.+..++....|..-+++..|+++.....-.+. +..-+..++++.+|.+.+.+-+. +++.+.-+....++.+...
T Consensus 1269 sePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~ 1348 (2724)
T KOG1826|consen 1269 SEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNR 1348 (2724)
T ss_pred hhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhcc
Confidence 34445555566666677789888766554433 33457888999999999988654 3355555555555556666
Q ss_pred HHHhhC---C--CeeecCCCCcEEEecCCCCeeEEEeeecccc-ccCCCCccccccCCCccccccccccCCCCCcchHHH
Q 030430 80 EILNSH---H--IIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWS 153 (177)
Q Consensus 80 ~~lh~~---~--~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~-~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~s 153 (177)
.-+|.+ | -+|.++++.|.++ .....+++.++|+.+ ........+...+++.|+.|++...-.++.++|+|.
T Consensus 1349 ~~~ls~tnlg~T~v~~~Lkf~lpmI---Vtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr 1425 (2724)
T KOG1826|consen 1349 NVILSLTNLGNTNVSKSLKFTLPMI---VTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILR 1425 (2724)
T ss_pred chhhhcccCCccchhhhhhhhccce---ecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHH
Confidence 665553 2 7789999999998 466778999999987 333334445556777788888877677888899999
Q ss_pred HHHHHHHHHhCCCCC
Q 030430 154 VGAILFELLNGYPPF 168 (177)
Q Consensus 154 lg~~~~~~~~~~~pf 168 (177)
.|+-.+....|..+|
T Consensus 1426 ~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1426 RSLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHHHHhcccHHH
Confidence 999988887777766
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0033 Score=47.86 Aligned_cols=102 Identities=23% Similarity=0.197 Sum_probs=72.7
Q ss_pred HHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh-hCCCeee
Q 030430 12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN-SHHIIHR 90 (177)
Q Consensus 12 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~~~H~ 90 (177)
=.+.|++-|+++....|+..--....+ ..+||+++......--..+...++...+...-.+++.-++-|- .+++||.
T Consensus 212 WAEKE~RNLkRl~~aGIP~PePIlLk~--hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHA 289 (520)
T KOG2270|consen 212 WAEKEMRNLKRLNNAGIPCPEPILLKN--HVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHA 289 (520)
T ss_pred HHHHHHHHHHHHHhcCCCCCCceeeec--ceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceecc
Confidence 356799999999877776544333333 4789999843322222223345777788888888888888775 4789999
Q ss_pred cCCCCcEEEecCCCCeeEEEeeecccccc
Q 030430 91 DLKPENILLSGLDDDVMLKIADFGLSCTL 119 (177)
Q Consensus 91 ~i~~~nil~~~~~~~~~~~l~d~~~~~~~ 119 (177)
|++--|+++. .+.++++|.+.+...
T Consensus 290 DLSEfN~Lyh----dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 290 DLSEFNLLYH----DGKLYIIDVSQSVEH 314 (520)
T ss_pred chhhhhheEE----CCEEEEEEccccccC
Confidence 9999999994 567999998876543
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.0078 Score=43.55 Aligned_cols=29 Identities=21% Similarity=0.402 Sum_probs=23.1
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccc
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~ 118 (177)
.++|+|+.|.|++++ +++ +.++||..+..
T Consensus 147 ~l~H~Dl~~~Nil~~---~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVT---PQG-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEe---CCC-CEEEeccccCc
Confidence 489999999999995 222 78999987643
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.0087 Score=45.13 Aligned_cols=30 Identities=30% Similarity=0.490 Sum_probs=24.8
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccc
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~ 118 (177)
++|+|+.+.||++. ++.+.++++||..+..
T Consensus 184 ~CHnDl~~~NiL~~--~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLN--EDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEe--CCCCcEEEEcccccCC
Confidence 79999999999995 3446799999987744
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.022 Score=43.44 Aligned_cols=74 Identities=24% Similarity=0.284 Sum_probs=58.2
Q ss_pred eCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC-CCeeecCCCCcEEEecCCCCeeEEEeeecc
Q 030430 37 AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGL 115 (177)
Q Consensus 37 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~-~~~H~~i~~~nil~~~~~~~~~~~l~d~~~ 115 (177)
+..+.|+++++. |+++... ..-..+++..++++.+..+.-+... .+-|+|+.-.||++ + .+++.|+||.+
T Consensus 297 e~~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI---d-~GnvtLIDfkl 367 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI---D-EGNVTLIDFKL 367 (488)
T ss_pred CceEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee---e-cCceEEEEeee
Confidence 344678999987 7777542 2345678888999988888888764 59999999999999 4 78899999999
Q ss_pred cccc
Q 030430 116 SCTL 119 (177)
Q Consensus 116 ~~~~ 119 (177)
++..
T Consensus 368 sRl~ 371 (488)
T COG5072 368 SRLS 371 (488)
T ss_pred eecc
Confidence 8743
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.031 Score=41.54 Aligned_cols=72 Identities=13% Similarity=0.060 Sum_probs=49.7
Q ss_pred HHHHHHHHHHHHhhCCC---CceeeEeEEEee---CCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHH
Q 030430 9 LKSCLDCELNFLSSVNH---PNIIRLFDAFQA---ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l 82 (177)
....+.+|++.++.+.. -.++++++++.+ .+..++|||+++|.++.+. ..+......+..+++.+++.|
T Consensus 50 ~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~L 124 (297)
T PRK10593 50 TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAW 124 (297)
T ss_pred cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHH
Confidence 34689999999999953 368888887754 3568999999999877641 122333444555666666767
Q ss_pred hhC
Q 030430 83 NSH 85 (177)
Q Consensus 83 h~~ 85 (177)
|..
T Consensus 125 H~~ 127 (297)
T PRK10593 125 HRI 127 (297)
T ss_pred hCC
Confidence 763
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.063 Score=37.57 Aligned_cols=86 Identities=21% Similarity=0.301 Sum_probs=59.4
Q ss_pred HHHHHHHHHHHhhCC---CCce--eeEeEEEeeC------------------CeEEEEEecCCCCChHHHHhhcCCCCHH
Q 030430 10 KSCLDCELNFLSSVN---HPNI--IRLFDAFQAE------------------NCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~---h~~i--~~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 66 (177)
.+-|..|-+.+.+|+ +.++ +++++|..-. ....||-|+++... .++..
T Consensus 98 ~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~ 168 (207)
T PF13095_consen 98 ADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR 168 (207)
T ss_pred cChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh
Confidence 345778888777774 4455 9999987322 13467888775533 22223
Q ss_pred HHHHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccc
Q 030430 67 TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116 (177)
Q Consensus 67 ~~~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~ 116 (177)
-+.++..-+..+|..||+-+|+++.|..= -+|+||+.+
T Consensus 169 ----~~~~~~~dl~~~~k~gI~~~Dv~~~ny~~--------G~lvDfs~~ 206 (207)
T PF13095_consen 169 ----DIPQMLRDLKILHKLGIVPRDVKPRNYRG--------GKLVDFSSS 206 (207)
T ss_pred ----HHHHHHHHHHHHHHCCeeeccCccccccC--------CEEEecccC
Confidence 34567777888999999999999999973 278899854
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.07 Score=41.17 Aligned_cols=37 Identities=19% Similarity=0.378 Sum_probs=27.3
Q ss_pred HHHHHHHhhCCCCc-eeeEeEEEeeCCeEEEEEecCCCCChH
Q 030430 14 DCELNFLSSVNHPN-IIRLFDAFQAENCIFLVVEFCAGGNLS 54 (177)
Q Consensus 14 ~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~~L~ 54 (177)
.+|.++++.+...+ -+++++.+.. +++.||++|.+|.
T Consensus 100 ~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efIeGr~l~ 137 (383)
T PTZ00384 100 DLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWVEGNTMG 137 (383)
T ss_pred HHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEeccccCC
Confidence 67899999996554 4666666653 4899999987664
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.84 E-value=0.082 Score=42.30 Aligned_cols=50 Identities=16% Similarity=0.287 Sum_probs=40.0
Q ss_pred HHHHHHHHHHhhCCCCceeeEeEEEeeC-CeEEEEEecCCCCChHHHHhhcC
Q 030430 11 SCLDCELNFLSSVNHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLHG 61 (177)
Q Consensus 11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~ 61 (177)
..+...+++++.+.|++....+++.... .+..+|+|++ +.||.+.+....
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~ 77 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN 77 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence 3466778999999999999999877643 3577899998 889999887553
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.27 E-value=0.52 Score=36.69 Aligned_cols=41 Identities=10% Similarity=-0.044 Sum_probs=29.2
Q ss_pred HHHHHHHHHHHHhhCC---CCceeeEeEEEeeCCeEEEEEecCCCC
Q 030430 9 LKSCLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGG 51 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~ 51 (177)
..++...|.+.|+.+. ...+++++.+.. ...++|||++++.
T Consensus 73 ~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lVME~L~~~ 116 (401)
T PRK09550 73 TLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTVMEDLSDH 116 (401)
T ss_pred cHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEEEecCCCc
Confidence 4567788899888873 245777777633 4468999999763
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.11 E-value=0.042 Score=39.07 Aligned_cols=31 Identities=23% Similarity=0.381 Sum_probs=24.7
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeecccc
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~ 117 (177)
.+++|+|+.+.||+++ +....+.++||..+.
T Consensus 170 ~~l~H~Dl~~~Nil~~--~~~~~~~lIDwe~a~ 200 (235)
T cd05157 170 IVFCHNDLLSGNIIYN--EEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEEcCCCCcCcEEEe--CCCCCEEEEEcccCC
Confidence 3599999999999995 213568999998763
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.65 E-value=0.096 Score=38.90 Aligned_cols=29 Identities=31% Similarity=0.438 Sum_probs=23.6
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeecccc
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~ 117 (177)
.+++|||+.+.|+++. . +.+.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~---~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLK---D-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEe---C-CcEEEEECcccc
Confidence 4789999999999995 2 457899999653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.61 E-value=0.21 Score=37.54 Aligned_cols=30 Identities=20% Similarity=0.458 Sum_probs=23.7
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccc
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~ 118 (177)
.++|||+++.|+++. ....+-++||+.+..
T Consensus 199 ~lvHGD~~~gNlii~---~~~~~gVlDwe~~~l 228 (321)
T COG3173 199 VLVHGDYRPGNLIID---PGRPTGVLDWELATL 228 (321)
T ss_pred eeeeCCcccCCEEEe---CCCeeEEEecccccc
Confidence 389999999999996 333378899997743
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=94.58 E-value=0.076 Score=39.53 Aligned_cols=30 Identities=37% Similarity=0.751 Sum_probs=24.5
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeecccc
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~ 117 (177)
.+++|+|+++.|+++. .+....++||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~---~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFD---GDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEE---CCceEEEeeccccc
Confidence 6799999999999995 33446799999774
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.48 E-value=0.11 Score=38.78 Aligned_cols=31 Identities=32% Similarity=0.618 Sum_probs=24.4
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccc
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~ 118 (177)
.|++|+|+.+.|+++. ++...-++||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~---~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFE---GDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEE---CCceEEEEecccccC
Confidence 4799999999999995 333457999987744
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.41 E-value=0.1 Score=38.61 Aligned_cols=33 Identities=30% Similarity=0.400 Sum_probs=24.9
Q ss_pred CCeeecCCCCcEEEecC-CCCeeEEEeeeccccc
Q 030430 86 HIIHRDLKPENILLSGL-DDDVMLKIADFGLSCT 118 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~-~~~~~~~l~d~~~~~~ 118 (177)
+++|+|+.+.||++... .+...+.++||..+..
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 58999999999999511 0025689999998754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=94.18 E-value=0.12 Score=37.97 Aligned_cols=48 Identities=33% Similarity=0.412 Sum_probs=35.2
Q ss_pred HHHHHHHHHHHHHHHhhC--CCeeecCCCCcEEEecCCCCeeEEEeeeccccc
Q 030430 68 ARKFLQQLGAGLEILNSH--HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (177)
Q Consensus 68 ~~~~~~~i~~~l~~lh~~--~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~ 118 (177)
+.+.+..+-..+...+.. -++|+|+.|.|++.+ +.+.++|+||..+..
T Consensus 134 ~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t---~~~~l~LIDWEyAg~ 183 (269)
T COG0510 134 LRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLT---DKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHHhhhcCCCceeeecCCCCccceEEc---CCCcEEEEecccCCC
Confidence 334455555566666654 589999999999984 557899999997743
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=93.47 E-value=0.17 Score=38.41 Aligned_cols=31 Identities=23% Similarity=0.454 Sum_probs=25.2
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccc
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~ 118 (177)
.++|+|+++.||++. ++...+.++||..+..
T Consensus 201 ~~cH~Dl~~~Nil~~--~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 201 GFCHNDLQYGNIMID--EETRAITIIDYEYASY 231 (344)
T ss_pred eEEeCCCCcCcEEEe--CCCCcEEEEeehhccc
Confidence 589999999999995 2345799999987754
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.55 E-value=0.55 Score=35.73 Aligned_cols=39 Identities=26% Similarity=0.353 Sum_probs=26.1
Q ss_pred HHHHHHHHHHHHHHHHHHhh----CCCeeecCCCCcEEEecCC
Q 030430 65 EQTARKFLQQLGAGLEILNS----HHIIHRDLKPENILLSGLD 103 (177)
Q Consensus 65 ~~~~~~~~~~i~~~l~~lh~----~~~~H~~i~~~nil~~~~~ 103 (177)
.+-++.+.-|++...-.+-+ .+++|.||||+||++...+
T Consensus 278 ~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~ 320 (444)
T PHA03111 278 VEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSD 320 (444)
T ss_pred HHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCC
Confidence 34555666677665533322 3599999999999997433
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=92.17 E-value=0.53 Score=32.70 Aligned_cols=34 Identities=29% Similarity=0.337 Sum_probs=24.6
Q ss_pred CCCeeecCCCCcEEEecCCC--CeeEEEeeeccccc
Q 030430 85 HHIIHRDLKPENILLSGLDD--DVMLKIADFGLSCT 118 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~--~~~~~l~d~~~~~~ 118 (177)
..++|||+.+.|+++...+. ...+.++||..+..
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~ 155 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY 155 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence 35899999999999963111 12588999987643
|
subfamily of choline kinases |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=92.11 E-value=0.27 Score=36.68 Aligned_cols=30 Identities=17% Similarity=0.207 Sum_probs=24.7
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccc
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~ 118 (177)
+++|+|+.++|+++ ++++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~---~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLY---DETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEE---cCCCCEEEEEhhhccc
Confidence 69999999999999 3455688899987644
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.04 E-value=0.37 Score=36.50 Aligned_cols=28 Identities=43% Similarity=0.725 Sum_probs=22.5
Q ss_pred CeeecCCCCcEEEecCCCCe-eEEEeeecccc
Q 030430 87 IIHRDLKPENILLSGLDDDV-MLKIADFGLSC 117 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~-~~~l~d~~~~~ 117 (177)
++|+|+.|.|+++. ... ...++||+-+.
T Consensus 199 iIH~D~~~~NVl~d---~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFD---DDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEc---CCCCeeeEEEccccc
Confidence 89999999999995 333 47789998663
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.92 E-value=0.14 Score=35.37 Aligned_cols=29 Identities=21% Similarity=0.360 Sum_probs=23.0
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccc
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~ 118 (177)
..+|+|+.|.|++++ +++ ++++|++.+..
T Consensus 78 ~p~H~D~~~~N~~~~---~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHS---ASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEE---CCC-EEEEeCCcccC
Confidence 368999999999985 333 88999997743
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=91.88 E-value=1.8 Score=33.88 Aligned_cols=40 Identities=8% Similarity=0.033 Sum_probs=28.6
Q ss_pred HHHHHHHHHHHHhhCC---CCceeeEeEEEeeCCeEEEEEecCCC
Q 030430 9 LKSCLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAG 50 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~ 50 (177)
..++-..|++.|+.+. ...+++++.+..+. .+++||++++
T Consensus 77 ~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~vlvME~L~~ 119 (418)
T PLN02756 77 TKERAYFEATALREHGRLCPDHVPEVYHFDRTM--ALIGMRYLEP 119 (418)
T ss_pred CccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CEEEEeecCC
Confidence 4556666788887774 24788888877754 4678999966
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.82 E-value=0.38 Score=36.24 Aligned_cols=29 Identities=28% Similarity=0.287 Sum_probs=23.2
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccc
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~ 118 (177)
.+++|+|+.+.|+++. + .+.++||+-+..
T Consensus 196 ~~liHgD~h~~NvL~~--d---~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR--D---GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc--C---CcEEEeCCCCCC
Confidence 4699999999999993 2 367899997643
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=91.73 E-value=0.28 Score=34.32 Aligned_cols=32 Identities=34% Similarity=0.535 Sum_probs=20.4
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccc
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~ 118 (177)
..+.|+|+.+.||++. +..+.++++||..+..
T Consensus 143 ~v~cHnDl~~~Nil~~--~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILIN--NKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEET--SSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEec--cCCCeEEEecHHHHhh
Confidence 3589999999999993 3567799999998743
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=90.84 E-value=0.24 Score=36.47 Aligned_cols=31 Identities=26% Similarity=0.501 Sum_probs=23.2
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccc
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~ 118 (177)
.++|+|+++.|++++ +.....-++||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~--~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILID--EDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEe--CCCCEEEEECcHhccc
Confidence 489999999999995 2233356999997643
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=90.80 E-value=2.3 Score=32.60 Aligned_cols=75 Identities=19% Similarity=0.184 Sum_probs=53.3
Q ss_pred EEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh-hCCCeeecCCCCcEEEecCCCCeeEEEeeecccccc
Q 030430 41 IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN-SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119 (177)
Q Consensus 41 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~ 119 (177)
..+||.++...-+.--.-+.-.++.+.+...-.|+..++..|. ++-+||.|++--|+++. .+.+.++|...+...
T Consensus 358 hvLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec~LVHADlSEyN~Lw~----~gKvw~IDVsQsvep 433 (531)
T KOG2269|consen 358 HVLVMSFIGDQGLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKECLLVHADLSEYNLLWT----PGKVWVIDVSQSVEP 433 (531)
T ss_pred ceEEEEeecCCCCCCccccccccChHHHHHHHHHHHHHHHHHHHhhheeecchhhhhheec----CCceEEEechhccCC
Confidence 4678888744333322223345888888888888888887764 56799999999999994 347889998766443
|
|
| >PRK14559 putative protein serine/threonine phosphatase; Provisional | Back alignment and domain information |
|---|
Probab=90.68 E-value=0.93 Score=37.51 Aligned_cols=75 Identities=17% Similarity=0.188 Sum_probs=58.3
Q ss_pred CCceeeEeEEEeeCCeEEEEEecCCC-CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCeeecCCCCcEEEe
Q 030430 25 HPNIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS 100 (177)
Q Consensus 25 h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~ 100 (177)
..+|++++++|..+..-.+++|+... .+|.+... ....+.-+...|+.||+....-|...|+...=+.++|+.+.
T Consensus 179 ~~~iP~v~~~~~~~~~~i~Lle~~~~~~~l~~~w~-~~~~~~l~~l~Wl~q~~~LW~~l~~~~~~~sll~~~nlrv~ 254 (645)
T PRK14559 179 PTEIPKIHDAWQDGDLQVILLEDRSHWQPLLDLWQ-DQTLPTLQILYWLNQMTQLWKALEPWGCCQSLLELENLRVD 254 (645)
T ss_pred cccCcchheeecCCCCcEEEeCCCCCCchHHHHhh-hcCCcHHHHHHHHHHHHHHHHHHHhcCeehhccchhheeeC
Confidence 35599999999887777788887532 23333333 22356778889999999999999999999999999999993
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=90.60 E-value=0.48 Score=41.22 Aligned_cols=34 Identities=24% Similarity=0.265 Sum_probs=24.2
Q ss_pred hCCCeeecCCCCcEEEecCCCC--eeEEEeeecccc
Q 030430 84 SHHIIHRDLKPENILLSGLDDD--VMLKIADFGLSC 117 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~--~~~~l~d~~~~~ 117 (177)
..|++|+|+++.|+++...... ...-++|||-+.
T Consensus 207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~ 242 (972)
T PRK06149 207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV 242 (972)
T ss_pred cccccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence 3579999999999999632111 224689999664
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 177 | ||||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-34 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-33 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-33 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-33 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-33 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-33 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-33 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-32 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-32 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-32 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-32 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-31 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-31 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-31 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-31 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-31 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-30 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-30 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-30 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-30 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-30 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-30 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-30 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-30 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-30 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-30 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-30 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-30 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-30 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-30 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-30 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-29 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-29 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-29 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-29 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-29 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-29 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-29 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-29 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-29 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-29 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-29 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-29 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-29 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-29 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-29 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-28 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-28 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-28 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-28 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-27 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-27 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-27 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-27 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-27 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-27 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-27 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-26 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-26 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-26 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-26 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-26 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-26 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-26 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-26 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-26 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-26 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-26 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-26 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-26 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-26 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-26 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-26 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-26 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-26 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-26 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-26 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-26 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-26 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-26 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-26 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-26 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-26 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-25 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-25 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-25 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-25 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-25 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-25 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-25 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-25 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-25 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-25 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-25 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-25 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-25 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-25 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-25 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-25 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-25 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-25 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-25 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-25 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-25 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-25 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-25 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-25 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-25 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-25 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-25 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-25 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-25 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-25 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-25 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-25 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-25 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-25 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-25 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-25 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-25 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-25 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-25 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-25 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-25 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-25 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-25 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-25 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-25 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-25 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-25 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-25 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-25 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-25 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-25 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-25 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-25 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-25 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-25 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-25 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-25 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-25 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-25 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-25 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-25 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-25 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-25 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-25 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-25 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-25 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-25 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-25 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-25 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-25 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-25 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-25 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-25 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-25 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-25 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-25 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-25 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-25 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-25 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-25 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-25 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-25 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-25 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-25 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-25 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-25 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-25 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-25 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-25 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-25 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-25 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-25 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-25 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-25 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-25 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-25 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-25 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-25 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-25 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 8e-25 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-25 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-25 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-25 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-25 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-24 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-24 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-24 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-24 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-24 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-24 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-24 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-24 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-24 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-24 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-24 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-24 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-24 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-24 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-24 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-24 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-24 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-24 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-24 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-24 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-24 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-24 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-24 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-24 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-24 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-24 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-24 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-24 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-24 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-24 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-24 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-24 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-24 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-23 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-23 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-23 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-23 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-23 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-23 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-23 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-23 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-23 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-23 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-23 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-23 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-23 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-23 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-23 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-23 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-23 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-23 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-23 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-23 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-23 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-23 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-23 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-23 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-23 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-23 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-23 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-23 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-23 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-23 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-23 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-23 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-23 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-23 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-23 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-23 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-23 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 9e-23 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 9e-23 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-22 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-22 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-22 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-22 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-22 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-22 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-22 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-22 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-22 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-22 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-22 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-22 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-22 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-22 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-22 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-21 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-21 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-21 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-21 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-21 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-21 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-21 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-21 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-21 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-21 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-21 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-21 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-21 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-21 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-21 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-21 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-21 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-21 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-21 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-21 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-21 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-21 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 9e-21 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-21 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-20 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-20 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-20 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-20 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-20 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-20 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-20 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-20 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-20 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-20 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-20 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-20 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-19 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-19 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-19 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-19 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-19 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-19 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-19 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-19 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-19 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-19 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-19 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-19 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-19 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-19 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-19 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-19 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-19 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-18 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-18 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-18 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-18 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-18 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-18 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-18 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-18 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-18 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-18 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-18 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-18 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-18 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-18 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-18 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-18 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-18 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-18 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-18 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-18 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-18 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-18 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-18 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-18 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 5e-18 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-18 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-18 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-18 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-18 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-18 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-18 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-18 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-18 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-18 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-18 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-18 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-18 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-18 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-18 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-18 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-18 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-18 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-18 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-18 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-17 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-17 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-17 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-17 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-17 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-17 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-17 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-17 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-17 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-17 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-17 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-17 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-17 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-17 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-17 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-17 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-17 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-17 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-17 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-17 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-17 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-17 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-17 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-17 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-17 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-17 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-17 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-17 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-17 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-17 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-17 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-17 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-17 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-17 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-17 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-17 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-17 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-17 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-17 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-17 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-17 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-17 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-17 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-17 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-17 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-17 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-17 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-17 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-17 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-17 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-17 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-17 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-17 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-17 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 9e-17 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-16 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-16 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-16 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-16 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-16 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-16 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-16 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-16 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-16 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-16 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-16 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-16 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-16 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-16 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-16 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-16 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-16 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-16 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-16 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-16 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-16 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-16 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-16 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-16 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-16 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-16 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-16 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-16 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-16 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-16 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-16 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-16 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-16 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-16 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-16 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-16 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-16 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-16 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-16 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-16 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-16 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-16 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-16 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-16 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-16 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-16 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-16 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-16 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-16 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-16 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-16 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-16 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-16 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-16 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-16 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-16 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-16 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-16 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-16 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-16 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-16 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-16 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-16 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-16 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-16 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-16 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-16 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-16 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-16 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-16 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-16 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-16 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-16 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-16 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-16 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-16 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 9e-16 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-15 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-15 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-15 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-15 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-15 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-15 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-15 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-15 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-15 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-15 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-15 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-15 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-15 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-15 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-15 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-15 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-15 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-15 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-15 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-15 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-15 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-15 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-15 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-15 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-15 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-15 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-15 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-15 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-15 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-15 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-14 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-14 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-14 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-14 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-14 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-14 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-14 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-14 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-14 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-14 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-14 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-14 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-13 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-13 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-13 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-13 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-13 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-13 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-13 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-13 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-12 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-12 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-12 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-12 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-12 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-12 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-12 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-12 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-12 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-12 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-12 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-12 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-12 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-12 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-12 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 8e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-12 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-12 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 9e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-11 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-11 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-11 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-11 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-11 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-11 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-11 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-11 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-11 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-11 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-11 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 5e-11 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 5e-11 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 5e-11 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 5e-11 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 5e-11 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 5e-11 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-11 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 5e-11 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-11 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 6e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-11 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 6e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-11 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 8e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-11 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-11 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-11 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 9e-11 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 9e-11 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 9e-11 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 9e-11 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 9e-11 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 9e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 9e-11 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 9e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-10 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-10 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-10 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-10 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-10 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-10 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-10 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-10 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-10 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-10 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-10 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-10 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-10 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-10 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-10 |
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 8e-69
Identities = 53/182 (29%), Positives = 88/182 (48%), Gaps = 9/182 (4%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCI------FLVVEFCAGGNLSSY 56
++L+ + E+ + +NHPN++ + + L +E+C GG+L Y
Sbjct: 49 QELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKY 108
Query: 57 IRLHGR---VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
+ + E R L + + L L+ + IIHRDLKPENI+L ++ KI D
Sbjct: 109 LNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168
Query: 114 GLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 173
G + L G + G+ Y+APE+L+ ++Y VD WS G + FE + G+ PF +
Sbjct: 169 GYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228
Query: 174 HQ 175
Sbjct: 229 PV 230
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 208 bits (530), Expect = 1e-67
Identities = 45/180 (25%), Positives = 79/180 (43%), Gaps = 15/180 (8%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLH 60
+ + E L +NH NI++LF + L++EFC G+L + +
Sbjct: 45 ISFLRPVDV-QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP 103
Query: 61 GR---VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS-GLDDDVMLKIADFGLS 116
+PE L+ + G+ L + I+HR++KP NI+ G D + K+ DFG +
Sbjct: 104 SNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163
Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQF--------QRYDEKVDMWSVGAILFELLNGYPPF 168
L + G+ Y+ P++ + ++Y VD+WS+G + G PF
Sbjct: 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 6e-66
Identities = 56/165 (33%), Positives = 91/165 (55%), Gaps = 8/165 (4%)
Query: 4 KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV 63
+ L+ E+ S + HPNI+RL+ F ++L++E+ G + ++ +
Sbjct: 51 GVEHQLRR----EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF 106
Query: 64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
EQ ++ +L L +S +IHRD+KPEN+L L LKIADFG S P +
Sbjct: 107 DEQRTATYITELANALSYCHSKRVIHRDIKPENLL---LGSAGELKIADFGWS-VHAPSS 162
Query: 124 YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
+CG+ Y+ PE+++ + +DEKVD+WS+G + +E L G PPF
Sbjct: 163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 207
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-65
Identities = 67/163 (41%), Positives = 98/163 (60%), Gaps = 5/163 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ L +NHP II++ + F AE+ ++V+E GG L + + R+ E T + + Q+
Sbjct: 65 EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
++ L+ + IIHRDLKPEN+LLS ++D ++KI DFG S L + +CG+P Y+
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 183
Query: 136 APEVLQ---FQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 175
APEVL Y+ VD WS+G ILF L+GYPPFS Q
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS-EHRTQ 225
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 2e-65
Identities = 45/167 (26%), Positives = 77/167 (46%), Gaps = 14/167 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLHGR---VPEQTARK 70
E L +NH NI++LF + L++EFC G+L + + +PE
Sbjct: 57 EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLS-GLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
L+ + G+ L + I+HR++KP NI+ G D + K+ DFG + L +
Sbjct: 117 VLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY 176
Query: 130 GSPLYMAPEVLQF--------QRYDEKVDMWSVGAILFELLNGYPPF 168
G+ Y+ P++ + ++Y VD+WS+G + G PF
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 2e-65
Identities = 66/157 (42%), Positives = 97/157 (61%), Gaps = 4/157 (2%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ L +NHP II++ + F AE+ ++V+E GG L + + R+ E T + + Q+
Sbjct: 190 EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 248
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
++ L+ + IIHRDLKPEN+LLS ++D ++KI DFG S L + +CG+P Y+
Sbjct: 249 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 308
Query: 136 APEVLQ---FQRYDEKVDMWSVGAILFELLNGYPPFS 169
APEVL Y+ VD WS+G ILF L+GYPPFS
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 345
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 2e-65
Identities = 59/165 (35%), Positives = 92/165 (55%), Gaps = 8/165 (4%)
Query: 4 KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV 63
+ L+ E+ S + HPNI+R+++ F I+L++EF G L ++ HGR
Sbjct: 56 GVEHQLRR----EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRF 111
Query: 64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
EQ + F+++L L + +IHRD+KPEN+L + LKIADFG S P
Sbjct: 112 DEQRSATFMEELADALHYCHERKVIHRDIKPENLL---MGYKGELKIADFGWS-VHAPSL 167
Query: 124 YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
+CG+ Y+ PE+++ + +DEKVD+W G + +E L G PPF
Sbjct: 168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF 212
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 4e-65
Identities = 54/154 (35%), Positives = 93/154 (60%), Gaps = 4/154 (2%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E++ S+ H +++ F+ + +F+V+E C +L + + E AR +L+Q+
Sbjct: 91 EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 150
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLY 134
G + L+ + +IHRDLK N+ L++D+ +KI DFGL+ + Y G + +CG+P Y
Sbjct: 151 VLGCQYLHRNRVIHRDLKLGNLF---LNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNY 207
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
+APEVL + + +VD+WS+G I++ LL G PPF
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 241
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 7e-65
Identities = 54/154 (35%), Positives = 93/154 (60%), Gaps = 4/154 (2%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E++ S+ H +++ F+ + +F+V+E C +L + + E AR +L+Q+
Sbjct: 65 EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 124
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLY 134
G + L+ + +IHRDLK N+ L++D+ +KI DFGL+ + Y G + +CG+P Y
Sbjct: 125 VLGCQYLHRNRVIHRDLKLGNLF---LNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNY 181
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
+APEVL + + +VD+WS+G I++ LL G PPF
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 215
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 7e-65
Identities = 56/153 (36%), Positives = 86/153 (56%), Gaps = 1/153 (0%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ + S++HPNIIRL++ F+ I+LV+E C GG L + E A + ++ +
Sbjct: 56 EIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDV 115
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
+ + + ++ HRDLKPEN L D LK+ DFGL+ PG G+P Y+
Sbjct: 116 LSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYV 175
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
+P+VL+ Y + D WS G +++ LL GYPPF
Sbjct: 176 SPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPF 207
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 198 bits (507), Expect = 1e-64
Identities = 62/166 (37%), Positives = 91/166 (54%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
KKL+ L+ E + HPNI+RL D+ Q E+ +LV + GG L I
Sbjct: 42 KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 101
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
E A +QQ+ + +S+ I+HR+LKPEN+LL+ +K+ADFGL+ +
Sbjct: 102 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
G+P Y++PEVL+ Y + VD+W+ G IL+ LL GYPPF
Sbjct: 162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 5e-64
Identities = 62/166 (37%), Positives = 91/166 (54%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
KKL+ L+ E + HPNI+RL D+ Q E+ +LV + GG L I
Sbjct: 65 KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 124
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
E A +QQ+ + +S+ I+HR+LKPEN+LL+ +K+ADFGL+ +
Sbjct: 125 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
G+P Y++PEVL+ Y + VD+W+ G IL+ LL GYPPF
Sbjct: 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 230
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 7e-64
Identities = 64/166 (38%), Positives = 94/166 (56%), Gaps = 1/166 (0%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
S + E+ L ++HPNI++LF+ + + ++V E GG L I R
Sbjct: 58 ASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR 117
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
E A + ++Q+ +G+ ++ H+I+HRDLKPENILL + D +KI DFGLS
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
+ G+ Y+APEVL+ YDEK D+WS G IL+ LL+G PPF
Sbjct: 178 TKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPF 222
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 4e-63
Identities = 56/170 (32%), Positives = 92/170 (54%), Gaps = 5/170 (2%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI----R 58
K ++ ++ E+ L S++HPNII++F+ F+ + +++V+E C GG L I
Sbjct: 57 KDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQA 116
Query: 59 LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
+ E + ++Q+ L +S H++H+DLKPENIL +KI DFGL+
Sbjct: 117 RGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176
Query: 119 LYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
++ G+ LYMAPEV + + K D+WS G +++ LL G PF
Sbjct: 177 FKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPF 225
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 3e-62
Identities = 63/168 (37%), Positives = 96/168 (57%), Gaps = 1/168 (0%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+KK S L+ E+ L + H NI+ L D +++ +LV++ +GG L I
Sbjct: 41 CIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER 100
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
G E+ A +QQ+ + ++ L+ + I+HRDLKPEN+L +++ + I DFGLS
Sbjct: 101 GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160
Query: 121 PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
G + CG+P Y+APEVL + Y + VD WS+G I + LL GYPPF
Sbjct: 161 NGIMST-ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPF 207
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 5e-62
Identities = 64/166 (38%), Positives = 94/166 (56%), Gaps = 1/166 (0%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
S + E+ L ++HPNI++LF+ + + ++V E GG L I R
Sbjct: 58 ASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR 117
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
E A + ++Q+ +G+ ++ H+I+HRDLKPENILL + D +KI DFGLS
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
+ G+ Y+APEVL+ YDEK D+WS G IL+ LL+G PPF
Sbjct: 178 TKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPF 222
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 9e-62
Identities = 68/162 (41%), Positives = 93/162 (57%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ L ++HPNII+L + F+ I LV+E GG L I G E+ A ++Q+
Sbjct: 98 EIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI 157
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
+ L+ + I+HRDLKPEN+L + D LKIADFGLS + + VCG+P Y
Sbjct: 158 LEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYC 217
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 177
APE+L+ Y +VDMWSVG I + LL G+ PF QFM
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM 259
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 1e-61
Identities = 61/153 (39%), Positives = 90/153 (58%), Gaps = 1/153 (0%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ L ++HPNI++L++ F+ + +LV E GG L I R E A + ++Q+
Sbjct: 76 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQV 135
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
+G+ ++ + I+HRDLKPEN+LL D ++I DFGLS + G+ Y+
Sbjct: 136 LSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYI 195
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
APEVL YDEK D+WS G IL+ LL+G PPF
Sbjct: 196 APEVLH-GTYDEKCDVWSTGVILYILLSGCPPF 227
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 2e-61
Identities = 66/153 (43%), Positives = 96/153 (62%), Gaps = 1/153 (0%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E++ L S++HPNII+LFD F+ + +LV EF GG L I + E A ++Q+
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
+G+ L+ H+I+HRD+KPENILL + + +KI DFGLS G+ Y+
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYI 215
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
APEVL+ ++Y+EK D+WS G I++ LL GYPPF
Sbjct: 216 APEVLK-KKYNEKCDVWSCGVIMYILLCGYPPF 247
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-61
Identities = 55/155 (35%), Positives = 90/155 (58%), Gaps = 5/155 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E+ + HP+I+ L++ F+ N ++LV+E C G ++ Y++ E AR F+ Q
Sbjct: 61 EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ 120
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPL 133
+ G+ L+SH I+HRDL N+LL ++ +KIADFGL+ L P +CG+P
Sbjct: 121 IITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKMPHEKHYTLCGTPN 177
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
Y++PE+ + + D+WS+G + + LL G PPF
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPF 212
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 2e-61
Identities = 68/166 (40%), Positives = 102/166 (61%), Gaps = 1/166 (0%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
++ S L E+ L ++HPNI++L+D F+ + +LV+E GG L I +
Sbjct: 73 TSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK 132
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
E A ++Q+ +G+ L+ H+I+HRDLKPEN+LL + D ++KI DFGLS
Sbjct: 133 FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
++ G+ Y+APEVL+ ++YDEK D+WS+G ILF LL GYPPF
Sbjct: 193 KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPF 237
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 7e-61
Identities = 57/169 (33%), Positives = 94/169 (55%), Gaps = 2/169 (1%)
Query: 2 LKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+K ++K +++ E+ L HPNI++L + F + FLV+E GG L I+
Sbjct: 41 VKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK 100
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
E A +++L + + ++ ++HRDLKPEN+L + +D++ +KI DFG +
Sbjct: 101 KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160
Query: 121 PGNYA-EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
P N + C + Y APE+L YDE D+WS+G IL+ +L+G PF
Sbjct: 161 PDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPF 209
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 1e-60
Identities = 67/161 (41%), Positives = 96/161 (59%), Gaps = 10/161 (6%)
Query: 16 ELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
E++ L V+ HPNII+L D ++ FLV + G L Y+ + E+ RK ++
Sbjct: 73 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
L + L+ +I+HRDLKPENIL LDDD+ +K+ DFG SC L PG +VCG+P Y
Sbjct: 133 LLEVICALHKLNIVHRDLKPENIL---LDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSY 189
Query: 135 MAPEVLQ------FQRYDEKVDMWSVGAILFELLNGYPPFS 169
+APE+++ Y ++VDMWS G I++ LL G PPF
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW 230
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 2e-60
Identities = 46/184 (25%), Positives = 87/184 (47%), Gaps = 21/184 (11%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
L++ + E+ +L+ + + IIRL+D + I++V+E C +L+S+++
Sbjct: 43 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK 101
Query: 60 HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
+ + + + + + ++ H I+H DLKP N L+ D MLK+ DFG++ +
Sbjct: 102 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQM 157
Query: 120 YPG---NYAEKVCGSPLYMAPEVLQFQ-----------RYDEKVDMWSVGAILFELLNGY 165
P + G+ YM PE ++ + K D+WS+G IL+ + G
Sbjct: 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
Query: 166 PPFS 169
PF
Sbjct: 218 TPFQ 221
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 2e-60
Identities = 46/184 (25%), Positives = 87/184 (47%), Gaps = 21/184 (11%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
L++ + E+ +L+ + + IIRL+D + I++V+E C +L+S+++
Sbjct: 62 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK 120
Query: 60 HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
+ + + + + + ++ H I+H DLKP N L+ D MLK+ DFG++ +
Sbjct: 121 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQM 176
Query: 120 YPG---NYAEKVCGSPLYMAPEVLQFQ-----------RYDEKVDMWSVGAILFELLNGY 165
P + G+ YM PE ++ + K D+WS+G IL+ + G
Sbjct: 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
Query: 166 PPFS 169
PF
Sbjct: 237 TPFQ 240
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-60
Identities = 60/151 (39%), Positives = 95/151 (62%), Gaps = 9/151 (5%)
Query: 24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
HP+II L D++++ + +FLV + G L Y+ + E+ R ++ L + L+
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLH 217
Query: 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-- 141
+++I+HRDLKPENIL LDD++ ++++DFG SC L PG ++CG+P Y+APE+L+
Sbjct: 218 ANNIVHRDLKPENIL---LDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCS 274
Query: 142 ----FQRYDEKVDMWSVGAILFELLNGYPPF 168
Y ++VD+W+ G ILF LL G PPF
Sbjct: 275 MDETHPGYGKEVDLWACGVILFTLLAGSPPF 305
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 3e-60
Identities = 56/154 (36%), Positives = 92/154 (59%), Gaps = 1/154 (0%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+N L + HPNII L D F+ + + L++E +GG L ++ + E A +FL+Q+
Sbjct: 58 EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 117
Query: 76 GAGLEILNSHHIIHRDLKPENILL-SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
G+ L+S I H DLKPENI+L + +K+ DFG++ + GN + + G+P +
Sbjct: 118 LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEF 177
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
+APE++ ++ + DMWS+G I + LL+G PF
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 211
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 3e-60
Identities = 55/176 (31%), Positives = 96/176 (54%), Gaps = 4/176 (2%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI--RL 59
++ + ++ + E+ L P +I L + ++ + I L++E+ AGG + S L
Sbjct: 65 RRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPEL 124
Query: 60 HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
V E + ++Q+ G+ L+ ++I+H DLKP+NILLS + +KI DFG+S +
Sbjct: 125 AEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184
Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 175
++ G+P Y+APE+L + DMW++G I + LL PF VGE++Q
Sbjct: 185 GHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPF-VGEDNQ 239
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 4e-60
Identities = 59/167 (35%), Positives = 88/167 (52%), Gaps = 1/167 (0%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
KKL+ L+ E + HPNI+RL D+ E +L+ + GG L I
Sbjct: 47 KKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY 106
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
E A +QQ+ + + ++HR+LKPEN+LL+ +K+ADFGL+ +
Sbjct: 107 YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166
Query: 123 NYA-EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
A G+P Y++PEVL+ Y + VD+W+ G IL+ LL GYPPF
Sbjct: 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPF 213
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 4e-60
Identities = 51/154 (33%), Positives = 88/154 (57%), Gaps = 1/154 (0%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E++ L V H N+I L D ++ + L++E +GG L ++ + E+ A F++Q+
Sbjct: 65 EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 76 GAGLEILNSHHIIHRDLKPENILL-SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
G+ L++ I H DLKPENI+L +K+ DFGL+ + G + + G+P +
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
+APE++ ++ + DMWS+G I + LL+G PF
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 5e-60
Identities = 55/154 (35%), Positives = 92/154 (59%), Gaps = 1/154 (0%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E++ L + HPN+I L + ++ + + L++E AGG L ++ + E+ A +FL+Q+
Sbjct: 64 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 76 GAGLEILNSHHIIHRDLKPENILL-SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
G+ L+S I H DLKPENI+L +KI DFGL+ + GN + + G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
+APE++ ++ + DMWS+G I + LL+G PF
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 8e-60
Identities = 53/154 (34%), Positives = 89/154 (57%), Gaps = 1/154 (0%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E++ L V HPNII L D ++ + L++E +GG L ++ + E+ A F++Q+
Sbjct: 65 EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 76 GAGLEILNSHHIIHRDLKPENILL-SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
G+ L++ I H DLKPENI+L +K+ DFGL+ + G + + G+P +
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
+APE++ ++ + DMWS+G I + LL+G PF
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 9e-60
Identities = 50/158 (31%), Positives = 86/158 (54%), Gaps = 5/158 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----EQTARKF 71
E + + HP+I+ L + + ++ +++V EF G +L I E A +
Sbjct: 76 EASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY 135
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCG 130
++Q+ L + ++IIHRD+KP +LL+ ++ +K+ FG++ L G A G
Sbjct: 136 MRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVG 195
Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
+P +MAPEV++ + Y + VD+W G ILF LL+G PF
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 1e-59
Identities = 65/167 (38%), Positives = 104/167 (62%), Gaps = 4/167 (2%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
+LN L E+ + +NHPNI++LF+ + E ++L++E+ +GG + Y+ HGR
Sbjct: 51 TQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR 110
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
+ E+ AR +Q+ + ++ + I+HRDLK EN+L LD D+ +KIADFG S G
Sbjct: 111 MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLL---LDADMNIKIADFGFSNEFTVG 167
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 168
+ CG+P Y APE+ Q ++YD +VD+WS+G IL+ L++G PF
Sbjct: 168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 214
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 1e-59
Identities = 46/184 (25%), Positives = 87/184 (47%), Gaps = 21/184 (11%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
L++ + E+ +L+ + + IIRL+D + I++V+E C +L+S+++
Sbjct: 90 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK 148
Query: 60 HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
+ + + + + + ++ H I+H DLKP N L+ D MLK+ DFG++ +
Sbjct: 149 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQM 204
Query: 120 YPG---NYAEKVCGSPLYMAPEVLQFQ-----------RYDEKVDMWSVGAILFELLNGY 165
P + G+ YM PE ++ + K D+WS+G IL+ + G
Sbjct: 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
Query: 166 PPFS 169
PF
Sbjct: 265 TPFQ 268
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 2e-59
Identities = 53/153 (34%), Positives = 79/153 (51%), Gaps = 2/153 (1%)
Query: 23 VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82
HPNII L D + +++V E GG L I E+ A L + +E L
Sbjct: 73 GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYL 132
Query: 83 NSHHIIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYPGNYA-EKVCGSPLYMAPEVL 140
++ ++HRDLKP NIL + ++I DFG + L N C + ++APEVL
Sbjct: 133 HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL 192
Query: 141 QFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 173
+ Q YD D+WS+G +L+ +L GY PF+ G +
Sbjct: 193 ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD 225
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 5e-59
Identities = 67/154 (43%), Positives = 92/154 (59%), Gaps = 4/154 (2%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ L HP+II+L+ F+V+E+ +GG L YI HGRV E AR+ QQ+
Sbjct: 61 EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI 120
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
+ ++ + H ++HRDLKPEN+L LD + KIADFGLS + G + CGSP Y
Sbjct: 121 LSAVDYCHRHMVVHRDLKPENVL---LDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYA 177
Query: 136 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 168
APEV+ + Y +VD+WS G IL+ LL G PF
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGTLPF 211
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 4e-58
Identities = 33/164 (20%), Positives = 70/164 (42%), Gaps = 15/164 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--------RVPEQT 67
EL ++ + + + + ++++ E+ ++ + +P Q
Sbjct: 93 ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152
Query: 68 ARKFLQQLGAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
+ ++ + +++ +I HRD+KP NIL +D + +K++DFG S +
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL---MDKNGRVKLSDFGES-EYMVDKKIK 208
Query: 127 KVCGSPLYMAPEVLQFQR--YDEKVDMWSVGAILFELLNGYPPF 168
G+ +M PE + KVD+WS+G L+ + PF
Sbjct: 209 GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 4e-58
Identities = 58/157 (36%), Positives = 90/157 (57%), Gaps = 7/157 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ +NH N+++ + + N +L +E+C+GG L I +PE A++F QL
Sbjct: 55 EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSP 132
AG+ L+ I HRD+KPEN+L LD+ LKI+DFGL+ N K+CG+
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLL---LDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 133 LYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 168
Y+APE+L+ + + E VD+WS G +L +L G P+
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 8e-58
Identities = 44/170 (25%), Positives = 90/170 (52%), Gaps = 6/170 (3%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
+ +++ + E+ L+++ HPNI++ ++F+ +++V+++C GG+L I
Sbjct: 59 ISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQK 118
Query: 61 -GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
E + Q+ L+ ++ I+HRD+K +NI L D +++ DFG++ L
Sbjct: 119 GVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVL 175
Query: 120 YPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
A G+P Y++PE+ + + Y+ K D+W++G +L+EL F
Sbjct: 176 NSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAF 225
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 9e-58
Identities = 56/151 (37%), Positives = 88/151 (58%), Gaps = 6/151 (3%)
Query: 24 NHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQQLGA 77
P+I+R+ D ++ C+ +V+E GG L S I R E+ A + ++ +G
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAP 137
++ L+S +I HRD+KPEN+L + + +LK+ DFG + N C +P Y+AP
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232
Query: 138 EVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
EVL ++YD+ DMWS+G I++ LL GYPPF
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 263
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-57
Identities = 58/157 (36%), Positives = 90/157 (57%), Gaps = 7/157 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ +NH N+++ + + N +L +E+C+GG L I +PE A++F QL
Sbjct: 55 EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSP 132
AG+ L+ I HRD+KPEN+L LD+ LKI+DFGL+ N K+CG+
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLL---LDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 133 LYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 168
Y+APE+L+ + + E VD+WS G +L +L G P+
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 3e-57
Identities = 57/154 (37%), Positives = 90/154 (58%), Gaps = 2/154 (1%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQ 74
E++ ++ ++H N+I+L+DAF+++N I LV+E+ GG L I + E F++Q
Sbjct: 136 EISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQ 195
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
+ G+ ++ +I+H DLKPENIL D +KI DFGL+ P + G+P +
Sbjct: 196 ICEGIRHMHQMYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLKVNFGTPEF 254
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
+APEV+ + DMWSVG I + LL+G PF
Sbjct: 255 LAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPF 288
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 3e-57
Identities = 48/154 (31%), Positives = 83/154 (53%), Gaps = 2/154 (1%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
E++ ++ ++HP +I L DAF+ + + L++EF +GG L I E +++Q
Sbjct: 98 EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQ 157
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
GL+ ++ H I+H D+KPENI+ +KI DFGL+ L P + + +
Sbjct: 158 ACEGLKHMHEHSIVHLDIKPENIMCETKKAS-SVKIIDFGLATKLNPDEIVKVTTATAEF 216
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
APE++ + DMW++G + + LL+G PF
Sbjct: 217 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF 250
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 4e-57
Identities = 57/158 (36%), Positives = 84/158 (53%), Gaps = 13/158 (8%)
Query: 24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
H N++ L + F+ E+ +LV E GG++ S+I E A +Q + + L+ L+
Sbjct: 69 GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH 128
Query: 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV--------CGSPLYM 135
+ I HRDLKPENIL + +KI DF L + + CGS YM
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 136 APEVL-----QFQRYDEKVDMWSVGAILFELLNGYPPF 168
APEV+ + YD++ D+WS+G IL+ LL+GYPPF
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 4e-57
Identities = 52/154 (33%), Positives = 89/154 (57%), Gaps = 2/154 (1%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQ 74
E+ +S + HP ++ L DAF+ +N + ++ EF +GG L + H ++ E A ++++Q
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ 263
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
+ GL ++ ++ +H DLKPENI+ + + LK+ DFGL+ L P + G+ +
Sbjct: 264 VCKGLCHMHENNYVHLDLKPENIMFTTKRSN-ELKLIDFGLTAHLDPKQSVKVTTGTAEF 322
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
APEV + + DMWSVG + + LL+G PF
Sbjct: 323 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 356
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 5e-57
Identities = 61/154 (39%), Positives = 83/154 (53%), Gaps = 2/154 (1%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ S+ HPNI+R + + +++E+ +GG L I GR E AR F QQL
Sbjct: 66 EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL 125
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
+G+ +S I HRDLK EN LL G LKI DFG S + + + G+P Y+
Sbjct: 126 LSGVSYCHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 184
Query: 136 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 168
APEVL Q YD + D+WS G L+ +L G PF
Sbjct: 185 APEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF 218
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 5e-57
Identities = 56/155 (36%), Positives = 84/155 (54%), Gaps = 5/155 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEF-CAGGNLSSYIRLHGRVPEQTARKFLQQ 74
E+ LS V H NII++ D F+ + LV+E +G +L ++I H R+ E A +Q
Sbjct: 79 EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
L + + L IIHRD+K ENI+ + +D +K+ DFG + L G CG+ Y
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIV---IAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEY 195
Query: 135 MAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 168
APEVL Y +++MWS+G L+ L+ PF
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF 230
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 6e-57
Identities = 51/185 (27%), Positives = 91/185 (49%), Gaps = 22/185 (11%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE----------------NCIFLVV 45
+K++ + + E+ L+ ++H NI+ + C+F+ +
Sbjct: 41 IKRVKYNNEKAER-EVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQM 99
Query: 46 EFCAGGNLSSYI--RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD 103
EFC G L +I R ++ + A + +Q+ G++ ++S +I+RDLKP NI L
Sbjct: 100 EFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL---V 156
Query: 104 DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
D +KI DFGL +L + G+ YM+PE + Q Y ++VD++++G IL ELL+
Sbjct: 157 DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH 216
Query: 164 GYPPF 168
Sbjct: 217 VCDTA 221
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 8e-57
Identities = 66/154 (42%), Positives = 96/154 (62%), Gaps = 4/154 (2%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ L HP+II+L+ + IF+V+E+ +GG L YI +GR+ E+ +R+ QQ+
Sbjct: 66 EIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI 125
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
+G++ + H ++HRDLKPEN+L LD + KIADFGLS + G + CGSP Y
Sbjct: 126 LSGVDYCHRHMVVHRDLKPENVL---LDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYA 182
Query: 136 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 168
APEV+ + Y +VD+WS G IL+ LL G PF
Sbjct: 183 APEVISGRLYAGPEVDIWSSGVILYALLCGTLPF 216
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 2e-56
Identities = 48/154 (31%), Positives = 84/154 (54%), Gaps = 2/154 (1%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQ 74
E++ L+ H NI+ L ++F++ + ++ EF +G ++ I + E+ ++ Q
Sbjct: 51 EISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQ 110
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
+ L+ L+SH+I H D++PENI+ +KI +FG + L PG+ + +P Y
Sbjct: 111 VCEALQFLHSHNIGHFDIRPENIIYQTRRSS-TIKIIEFGQARQLKPGDNFRLLFTAPEY 169
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
APEV Q DMWS+G +++ LL+G PF
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPF 203
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 2e-56
Identities = 68/154 (44%), Positives = 98/154 (63%), Gaps = 5/154 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+++L + HP+II+L+D I +V+E+ AGG L YI R+ E R+F QQ+
Sbjct: 59 EISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQI 117
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
+E + H I+HRDLKPEN+L LDD++ +KIADFGLS + GN+ + CGSP Y
Sbjct: 118 ICAIEYCHRHKIVHRDLKPENLL---LDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYA 174
Query: 136 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 168
APEV+ + Y +VD+WS G +L+ +L G PF
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF 208
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 3e-56
Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 48/214 (22%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
++++N + E+ + ++HPNI RL++ ++ E I LV+E C GG+L + +
Sbjct: 64 IRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFI 123
Query: 62 RVP----------------------------------------EQTARKFLQQLGAGLEI 81
E+ ++Q+ + L
Sbjct: 124 DDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183
Query: 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-----KVCGSPLYMA 136
L++ I HRD+KPEN L S + +K+ DFGLS Y N E G+P ++A
Sbjct: 184 LHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242
Query: 137 PEVLQF--QRYDEKVDMWSVGAILFELLNGYPPF 168
PEVL + Y K D WS G +L LL G PF
Sbjct: 243 PEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPF 276
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 5e-56
Identities = 55/151 (36%), Positives = 91/151 (60%), Gaps = 7/151 (4%)
Query: 24 NHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQQLGA 77
P+I+ + D ++ + C+ +++E GG L S I R E+ A + ++ +G
Sbjct: 80 GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGT 139
Query: 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAP 137
++ L+SH+I HRD+KPEN+L + + D +LK+ DFG + N + C +P Y+AP
Sbjct: 140 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA-KETTQNALQTPCYTPYYVAP 198
Query: 138 EVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
EVL ++YD+ DMWS+G I++ LL G+PPF
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIMYILLCGFPPF 229
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 1e-55
Identities = 52/183 (28%), Positives = 78/183 (42%), Gaps = 12/183 (6%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
+K+ + D E+ V HP +RL A++ ++L E C G +L
Sbjct: 87 VKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQ 145
Query: 56 YIRLHG-RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
+ G +PE +L+ L L+S ++H D+KP NI L K+ DFG
Sbjct: 146 HCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIF---LGPRGRCKLGDFG 202
Query: 115 LSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 174
L L E G P YMAPE+LQ Y D++S+G + E+ GE
Sbjct: 203 LLVELGTAGAGEVQEGDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNMELPHGGEGW 261
Query: 175 QFM 177
Q +
Sbjct: 262 QQL 264
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 8e-55
Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 9/158 (5%)
Query: 16 ELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFL 72
E+ L V+ +IRL D F+ + L++E +L +I G + E+ AR F
Sbjct: 96 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 155
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVM-LKIADFGLSCTLYPGNYAEKVCGS 131
Q+ + ++ ++HRD+K ENIL +D + LK+ DFG L G+
Sbjct: 156 WQVLEAVRHCHNCGVLHRDIKDENIL---IDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 211
Query: 132 PLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF 168
+Y PE +++ RY +WS+G +L++++ G PF
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 249
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 1e-54
Identities = 59/179 (32%), Positives = 94/179 (52%), Gaps = 15/179 (8%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRL 59
+ + K L E+N L + HPNI+R +D +++V+E+C GG+L+S I
Sbjct: 41 YGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK 100
Query: 60 HGR----VPEQTARKFLQQLGAGLEIL-----NSHHIIHRDLKPENILLSGLDDDVMLKI 110
+ + E+ + + QL L+ H ++HRDLKP N+ L D +K+
Sbjct: 101 GTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKL 157
Query: 111 ADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
DFGL+ L +A+ G+P YM+PE + Y+EK D+WS+G +L+EL PPF
Sbjct: 158 GDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 216
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-54
Identities = 53/192 (27%), Positives = 86/192 (44%), Gaps = 36/192 (18%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAEN-------------CIFLVVEFCAGGNLSSYIRLHGR 62
E+ L+S+NH ++R + A+ +F+ +E+C G L I
Sbjct: 52 EVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL 111
Query: 63 -VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-- 119
+ +Q+ L ++S IIHRDLKP NI +D+ +KI DFGL+ +
Sbjct: 112 NQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIF---IDESRNVKIGDFGLAKNVHR 168
Query: 120 -------------YPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGY 165
+ G+ +Y+A EVL Y+EK+DM+S+G I FE++ Y
Sbjct: 169 SLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--Y 226
Query: 166 PPFSVGEEHQFM 177
P + G E +
Sbjct: 227 PFST-GMERVNI 237
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 3e-54
Identities = 50/159 (31%), Positives = 83/159 (52%), Gaps = 10/159 (6%)
Query: 16 ELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73
E+ L ++HPN+++L + E+ +++V E G + + E AR + Q
Sbjct: 86 EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQ 144
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSP 132
L G+E L+ IIHRD+KP N+L + +D +KIADFG+S + G+P
Sbjct: 145 DLIKGIEYLHYQKIIHRDIKPSNLL---VGEDGHIKIADFGVSNEFKGSDALLSNTVGTP 201
Query: 133 LYMAPEVLQFQR--YD-EKVDMWSVGAILFELLNGYPPF 168
+MAPE L R + + +D+W++G L+ + G PF
Sbjct: 202 AFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 8e-54
Identities = 45/150 (30%), Positives = 73/150 (48%), Gaps = 5/150 (3%)
Query: 21 SSVNHPNIIRLFDAFQAENCIFLVVEF-CAGGNLSSYIRLHGRVPEQTARKFLQQLGAGL 79
+ HP +IRL D F+ + LV+E +L YI G + E +R F Q+ A +
Sbjct: 93 AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAI 152
Query: 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 139
+ +S ++HRD+K ENIL+ K+ DFG L G+ +Y PE
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCA--KLIDFGSG-ALLHDEPYTDFDGTRVYSPPEW 209
Query: 140 LQFQRYD-EKVDMWSVGAILFELLNGYPPF 168
+ +Y +WS+G +L++++ G PF
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCGDIPF 239
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 3e-53
Identities = 51/158 (32%), Positives = 89/158 (56%), Gaps = 8/158 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----VPEQTARKF 71
E++ L +NHPN+I+ + +F +N + +V+E G+LS I+ + +PE+T K+
Sbjct: 82 EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY 141
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCG 130
QL + LE ++S ++HRD+KP N+ + ++K+ D GL A + G
Sbjct: 142 FVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVG 198
Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
+P YM+PE + Y+ K D+WS+G +L+E+ PF
Sbjct: 199 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 9e-53
Identities = 51/162 (31%), Positives = 79/162 (48%), Gaps = 13/162 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGN--LSSYIRLHGRVPEQTARKF 71
E+ L + H N+I+L D E +++V+E+C G + + R P A +
Sbjct: 56 EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGY 114
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP---GNYAEKV 128
QL GLE L+S I+H+D+KP N+L L LKI+ G++ L+P +
Sbjct: 115 FCQLIDGLEYLHSQGIVHKDIKPGNLL---LTTGGTLKISALGVAEALHPFAADDTCRTS 171
Query: 129 CGSPLYMAPEVLQFQR-YD-EKVDMWSVGAILFELLNGYPPF 168
GSP + PE+ + KVD+WS G L+ + G PF
Sbjct: 172 QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF 213
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 8e-52
Identities = 52/156 (33%), Positives = 90/156 (57%), Gaps = 6/156 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E + +S ++HP ++L+ FQ + ++ + + G L YIR G E R + ++
Sbjct: 80 ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSP 132
+ LE L+ IIHRDLKPENIL L++D+ ++I DFG + L P + + G+
Sbjct: 140 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 196
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
Y++PE+L + + D+W++G I+++L+ G PPF
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 1e-51
Identities = 55/187 (29%), Positives = 85/187 (45%), Gaps = 13/187 (6%)
Query: 3 KKLNKHLKSCLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
K++ S D E+ L S HPN+IR F + ++ +E C L Y+
Sbjct: 54 KRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKD 112
Query: 62 RV-PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS--GLDDDVMLKIADFGLSCT 118
LQQ +GL L+S +I+HRDLKP NIL+S + I+DFGL
Sbjct: 113 FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172
Query: 119 LYPGNYAEK----VCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELL-NGYPPFSV 170
L G ++ V G+ ++APE+L + VD++S G + + ++ G PF
Sbjct: 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK 232
Query: 171 GEEHQFM 177
+ Q
Sbjct: 233 SLQRQAN 239
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 2e-51
Identities = 53/156 (33%), Positives = 87/156 (55%), Gaps = 6/156 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
EL + + HP ++ L+ +FQ E +F+VV+ GG+L +++ + E+T + F+ +L
Sbjct: 65 ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICEL 124
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
L+ L + IIHRD+KP+NIL LD+ + I DF ++ L + G+ YM
Sbjct: 125 VMALDYLQNQRIIHRDMKPDNIL---LDEHGHVHITDFNIAAMLPRETQITTMAGTKPYM 181
Query: 136 APEVLQFQR---YDEKVDMWSVGAILFELLNGYPPF 168
APE+ ++ Y VD WS+G +ELL G P+
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 8e-51
Identities = 51/198 (25%), Positives = 91/198 (45%), Gaps = 32/198 (16%)
Query: 3 KKLNKHLKSCLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
K++ E+ L+ S +HPN+IR + + + +++ +E C NL +
Sbjct: 45 KRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKN 103
Query: 62 -------RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS----------GLDD 104
E L+Q+ +G+ L+S IIHRDLKP+NIL+S +
Sbjct: 104 VSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAE 163
Query: 105 DVMLKIADFGLSCTLYPGNYAEK-----VCGSPLYMAPEVLQ-------FQRYDEKVDMW 152
++ + I+DFGL L G + + G+ + APE+L+ +R +D++
Sbjct: 164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIF 223
Query: 153 SVGAILFELL-NGYPPFS 169
S+G + + +L G PF
Sbjct: 224 SMGCVFYYILSKGKHPFG 241
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 6e-50
Identities = 53/202 (26%), Positives = 85/202 (42%), Gaps = 35/202 (17%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC------------IFLVVEFCA 49
L + + E+ L+ + HP I+R F+A+ +N +++ ++ C
Sbjct: 40 LPNRELAREKVMR-EVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCR 98
Query: 50 GGNLSSYIRLHGRV---PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV 106
NL ++ + Q+ +E L+S ++HRDLKP NI D
Sbjct: 99 KENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDD 155
Query: 107 MLKIADFGLSCTL-------------YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWS 153
++K+ DFGL + G+ LYM+PE + Y KVD++S
Sbjct: 156 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFS 215
Query: 154 VGAILFELLNGYPPFSVGEEHQ 175
+G ILFELL PFS E
Sbjct: 216 LGLILFELLY---PFSTQMERV 234
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-49
Identities = 38/193 (19%), Positives = 72/193 (37%), Gaps = 16/193 (8%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+ K N + L ++ + A +N LV E + G L + I L+
Sbjct: 102 VQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLY 161
Query: 61 GR-----VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL--------SGLDDDVM 107
+P+ F ++ +E ++ IIH D+KP+N +L D
Sbjct: 162 KNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221
Query: 108 LKIADFGLSCTLY---PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164
L + D G S + G C + + E+L + ++ ++D + V A ++ +L G
Sbjct: 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281
Query: 165 YPPFSVGEEHQFM 177
E +
Sbjct: 282 TYMKVKNEGGECK 294
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-49
Identities = 52/167 (31%), Positives = 86/167 (51%), Gaps = 8/167 (4%)
Query: 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
L+ EL + ++ P I+ L+ A + + + +E GG+L I+ G +PE A
Sbjct: 93 LEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRA 152
Query: 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK- 127
+L Q GLE L++ I+H D+K +N+LLS D + DFG + L P +
Sbjct: 153 LYYLGQALEGLEYLHTRRILHGDVKADNVLLS--SDGSRAALCDFGHALCLQPDGLGKSL 210
Query: 128 -----VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
+ G+ +MAPEV+ + D KVD+WS ++ +LNG P++
Sbjct: 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWT 257
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 5e-49
Identities = 49/191 (25%), Positives = 80/191 (41%), Gaps = 27/191 (14%)
Query: 2 LKKLNKHLKSCLDC---ELNFLSSVNHPNIIRLFDAFQAE----NCIFLVVEFCAGGNLS 54
LK++ H + + E + NHPNI+RL E + +L++ F G L
Sbjct: 59 LKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLW 118
Query: 55 SYI----RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
+ I + E L + GLE +++ HRDLKP NIL L D+ +
Sbjct: 119 NEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNIL---LGDEGQPVL 175
Query: 111 ADFGLSCTL--YPGNYAE--------KVCGSPLYMAPEVLQFQRY---DEKVDMWSVGAI 157
D G + + + Y APE+ Q + DE+ D+WS+G +
Sbjct: 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCV 235
Query: 158 LFELLNGYPPF 168
L+ ++ G P+
Sbjct: 236 LYAMMFGEGPY 246
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-48
Identities = 64/160 (40%), Positives = 92/160 (57%), Gaps = 19/160 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E LS V HP IIR++ FQ IF+++++ GG L S +R R P A+ + ++
Sbjct: 56 ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV 115
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-------CTLYPGNYAEKV 128
LE L+S II+RDLKPENIL LD + +KI DFG + TL
Sbjct: 116 CLALEYLHSKDIIYRDLKPENIL---LDKNGHIKITDFGFAKYVPDVTYTL--------- 163
Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
CG+P Y+APEV+ + Y++ +D WS G +++E+L GY PF
Sbjct: 164 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 203
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 2e-48
Identities = 57/177 (32%), Positives = 101/177 (57%), Gaps = 19/177 (10%)
Query: 2 LKKLNK----------HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGG 51
+K L+K H + E L +VN P +++L +F+ + +++V+E+ AGG
Sbjct: 71 MKILDKQKVVKLKQIEHTLN----EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 52 NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
+ S++R GR E AR + Q+ E L+S +I+RDLKPEN+L +D +++
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVT 183
Query: 112 DFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
DFG + + +CG+P +APE++ + Y++ VD W++G +++E+ GYPPF
Sbjct: 184 DFGFAKRV--KGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-47
Identities = 61/167 (36%), Positives = 93/167 (55%), Gaps = 5/167 (2%)
Query: 12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
E N L V HP I+ L AFQ ++L++E+ +GG L + G E TA +
Sbjct: 67 HTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY 126
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCG 130
L ++ L L+ II+RDLKPENI+ L+ +K+ DFGL +++ G CG
Sbjct: 127 LAEISMALGHLHQKGIIYRDLKPENIM---LNHQGHVKLTDFGLCKESIHDGTVTHTFCG 183
Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 177
+ YMAPE+L ++ VD WS+GA+++++L G PPF+ GE +
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFT-GENRKKT 229
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-47
Identities = 57/180 (31%), Positives = 96/180 (53%), Gaps = 8/180 (4%)
Query: 2 LKK---LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR 58
L+K + K + E L + HP + L AFQ + + V+E+ GG L ++
Sbjct: 38 LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS 97
Query: 59 LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-C 117
E+ AR + ++ + LE L+S +++RD+K EN++ LD D +KI DFGL
Sbjct: 98 RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGLCKE 154
Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 177
+ G + CG+P Y+APEVL+ Y VD W +G +++E++ G PF ++H+ +
Sbjct: 155 GISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY-NQDHERL 213
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 8e-47
Identities = 59/174 (33%), Positives = 97/174 (55%), Gaps = 10/174 (5%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF----QAENCIFLVVEFCAGGNLSSYI 57
+KL K + E L + HPNI+R +D++ + + CI LV E G L +Y+
Sbjct: 61 DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL 120
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGL 115
+ + + R + +Q+ GL+ L++ IIHRDLK +NI ++G V KI D GL
Sbjct: 121 KRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSV--KIGDLGL 178
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
TL ++A+ V G+P +MAPE+ + ++YDE VD+++ G + E+ P+S
Sbjct: 179 -ATLKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYS 230
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 8e-47
Identities = 62/163 (38%), Positives = 97/163 (59%), Gaps = 5/163 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E + L VNHP I++L AFQ E ++L+++F GG+L + + E+ + +L +L
Sbjct: 76 ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL 135
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCGSPLY 134
L+ L+S II+RDLKPENIL LD++ +K+ DFGLS ++ A CG+ Y
Sbjct: 136 ALALDHLHSLGIIYRDLKPENIL---LDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 192
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 177
MAPEV+ + + + D WS G ++FE+L G PF G++ +
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ-GKDRKET 234
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-46
Identities = 60/175 (34%), Positives = 94/175 (53%), Gaps = 11/175 (6%)
Query: 2 LKKLNK-HLKS-----CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
KKL K +K E L VN ++ L A++ ++ + LV+ GG+L
Sbjct: 214 CKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKF 273
Query: 56 YIRLHGRV--PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
+I G+ PE A + ++ GLE L+ I++RDLKPENILL DD ++I+D
Sbjct: 274 HIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDL 330
Query: 114 GLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
GL+ + G + G+ YMAPEV++ +RY D W++G +L+E++ G PF
Sbjct: 331 GLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 385
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 8e-46
Identities = 57/182 (31%), Positives = 96/182 (52%), Gaps = 9/182 (4%)
Query: 1 MLKK---LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
+LKK + K + E L + HP + L +FQ + + V+E+ GG L ++
Sbjct: 180 ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL 239
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHH-IIHRDLKPENILLSGLDDDVMLKIADFGLS 116
E AR + ++ + L+ L+S +++RDLK EN++L D D +KI DFGL
Sbjct: 240 SRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLC 296
Query: 117 -CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 175
+ G + CG+P Y+APEVL+ Y VD W +G +++E++ G PF ++H+
Sbjct: 297 KEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY-NQDHE 355
Query: 176 FM 177
+
Sbjct: 356 KL 357
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-45
Identities = 42/180 (23%), Positives = 80/180 (44%), Gaps = 25/180 (13%)
Query: 16 ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----PEQTARK 70
E+ + + H +++R F A+ ++ + + E+C GG+L+ I + R+ E +
Sbjct: 60 EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 119
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLS----------------GLDDDVMLKIADFG 114
L Q+G GL ++S ++H D+KP NI +S + VM KI D G
Sbjct: 120 LLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179
Query: 115 LSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYPPFSVGEE 173
+ + + G ++A EVLQ + K D++++ + P G++
Sbjct: 180 HVTRI---SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-45
Identities = 49/151 (32%), Positives = 78/151 (51%), Gaps = 27/151 (17%)
Query: 24 NHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQQLGA 77
P+I+R+ D ++ C+ +V+E GG L S I R E+ A + ++ +G
Sbjct: 69 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAP 137
++ L+S +I HRD+KPEN+L + + +LK+ DFG A
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------AK 168
Query: 138 EVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
E ++YD+ DMWS+G I++ LL GYPPF
Sbjct: 169 ETTG-EKYDKSCDMWSLGVIMYILLCGYPPF 198
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-45
Identities = 62/181 (34%), Positives = 96/181 (53%), Gaps = 9/181 (4%)
Query: 2 LKK---LNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
LKK L C E + HP + +F FQ + +F V+E+ GG+L +I
Sbjct: 50 LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI 109
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS- 116
+ + A + ++ GL+ L+S I++RDLK +NIL LD D +KIADFG+
Sbjct: 110 QSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNIL---LDKDGHIKIADFGMCK 166
Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQF 176
+ CG+P Y+APE+L Q+Y+ VD WS G +L+E+L G PF G++ +
Sbjct: 167 ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH-GQDEEE 225
Query: 177 M 177
+
Sbjct: 226 L 226
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 8e-45
Identities = 63/172 (36%), Positives = 97/172 (56%), Gaps = 8/172 (4%)
Query: 2 LKK---LNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
L+K L K + + E N L +V HP ++ L +FQ + ++ V+++ GG L ++
Sbjct: 71 LQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHL 130
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS- 116
+ E AR + ++ + L L+S +I++RDLKPENIL LD + + DFGL
Sbjct: 131 QRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENIL---LDSQGHIVLTDFGLCK 187
Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
+ + CG+P Y+APEVL Q YD VD W +GA+L+E+L G PPF
Sbjct: 188 ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 239
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-44
Identities = 46/160 (28%), Positives = 80/160 (50%), Gaps = 9/160 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFL 72
E+ + + HPNI+ A + +V E+ + G+L + G + E+
Sbjct: 84 EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143
Query: 73 QQLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVC 129
+ G+ L++ + I+HR+LK N+L+ D +K+ DFGLS ++
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLSRLKASTFLSSKSAA 200
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
G+P +MAPEVL+ + +EK D++S G IL+EL P+
Sbjct: 201 GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-44
Identities = 62/182 (34%), Positives = 99/182 (54%), Gaps = 11/182 (6%)
Query: 2 LKK---LNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
LKK + C E L+ P + +L FQ + ++ V+E+ GG+L +I
Sbjct: 53 LKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI 112
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
+ GR E A + ++ GL L S II+RDLK +N++ LD + +KIADFG+ C
Sbjct: 113 QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM---LDSEGHIKIADFGM-C 168
Query: 118 --TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 175
++ G + CG+P Y+APE++ +Q Y + VD W+ G +L+E+L G PF GE+
Sbjct: 169 KENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE-GEDED 227
Query: 176 FM 177
+
Sbjct: 228 EL 229
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-44
Identities = 56/163 (34%), Positives = 81/163 (49%), Gaps = 12/163 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E + + HPNII L E + LV+EF GG L+ L G+ +P + Q
Sbjct: 56 EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRV--LSGKRIPPDILVNWAVQ 113
Query: 75 LGAGLEILNSHH---IIHRDLKPENILLS-----GLDDDVMLKIADFGLSCTLYPGNYAE 126
+ G+ L+ IIHRDLK NIL+ G + +LKI DFGL+ +
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH-RTTKM 172
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
G+ +MAPEV++ + + D+WS G +L+ELL G PF
Sbjct: 173 SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR 215
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-44
Identities = 60/179 (33%), Positives = 99/179 (55%), Gaps = 16/179 (8%)
Query: 2 LKKLNKH--LK----SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
+K L+K +K + E + ++ N P +++LF AFQ + +++V+E+ GG+L +
Sbjct: 99 MKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN 158
Query: 56 YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
+ + VPE+ AR + ++ L+ ++S IHRD+KP+N+L LD LK+ADFG
Sbjct: 159 LMS-NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML---LDKSGHLKLADFGT 214
Query: 116 S--CTLYPGNYAEKVCGSPLYMAPEVLQFQ----RYDEKVDMWSVGAILFELLNGYPPF 168
+ G+P Y++PEVL+ Q Y + D WSVG L+E+L G PF
Sbjct: 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 6e-44
Identities = 54/158 (34%), Positives = 93/158 (58%), Gaps = 4/158 (2%)
Query: 19 FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
F + NHP ++ L FQ E+ +F V+E+ GG+L +++ ++PE+ AR + ++
Sbjct: 63 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 122
Query: 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCGSPLYMAP 137
L L+ II+RDLK +N+L LD + +K+ D+G+ L PG+ CG+P Y+AP
Sbjct: 123 LNYLHERGIIYRDLKLDNVL---LDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAP 179
Query: 138 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 175
E+L+ + Y VD W++G ++FE++ G PF +
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 217
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 6e-44
Identities = 55/175 (31%), Positives = 89/175 (50%), Gaps = 11/175 (6%)
Query: 2 LKK---LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI- 57
L K + E L+ V+ I+ L AF+ + + LV+ GG++ +I
Sbjct: 218 LNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIY 277
Query: 58 ---RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
+ E A + Q+ +GLE L+ +II+RDLKPEN+LL DDD ++I+D G
Sbjct: 278 NVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLG 334
Query: 115 LSC-TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
L+ + G+P +MAPE+L + YD VD +++G L+E++ PF
Sbjct: 335 LAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 7e-44
Identities = 66/181 (36%), Positives = 96/181 (53%), Gaps = 9/181 (4%)
Query: 2 LKK---LNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
LKK L C E LS NHP + +LF FQ + +F V+EF GG+L +I
Sbjct: 56 LKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI 115
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS- 116
+ R E AR + ++ + L L+ II+RDLK +N+L LD + K+ADFG+
Sbjct: 116 QKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVL---LDHEGHCKLADFGMCK 172
Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQF 176
+ G CG+P Y+APE+LQ Y VD W++G +L+E+L G+ PF E
Sbjct: 173 EGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE-AENEDD 231
Query: 177 M 177
+
Sbjct: 232 L 232
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 7e-44
Identities = 60/160 (37%), Positives = 86/160 (53%), Gaps = 12/160 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR---KFL 72
EL LS VNHPNI++L+ A C+ V+E+ GG+L + + +P TA +
Sbjct: 51 ELRQLSRVNHPNIVKLYGACLNPVCL--VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWC 108
Query: 73 QQLGAGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
Q G+ L+S +IHRDLKP N+LL +LKI DFG +C + +
Sbjct: 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLV--AGGTVLKICDFGTACDIQ--THMTNNK 164
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
GS +MAPEV + Y EK D++S G IL+E++ PF
Sbjct: 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD 204
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-43
Identities = 59/182 (32%), Positives = 102/182 (56%), Gaps = 19/182 (10%)
Query: 2 LKKLNKH--LK----SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
+K LNK LK +C E + L + + I L AFQ +N ++LV+++ GG+L +
Sbjct: 104 MKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLT 163
Query: 56 YI-RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
+ + R+PE+ AR +L ++ ++ ++ H +HRD+KP+NIL +D + +++ADFG
Sbjct: 164 LLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL---MDMNGHIRLADFG 220
Query: 115 LSCTLYPGNYAEK---VCGSPLYMAPEVLQFQ-----RYDEKVDMWSVGAILFELLNGYP 166
C + + G+P Y++PE+LQ RY + D WS+G ++E+L G
Sbjct: 221 S-CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279
Query: 167 PF 168
PF
Sbjct: 280 PF 281
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-43
Identities = 54/158 (34%), Positives = 93/158 (58%), Gaps = 4/158 (2%)
Query: 19 FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
F + NHP ++ L FQ E+ +F V+E+ GG+L +++ ++PE+ AR + ++
Sbjct: 106 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 165
Query: 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCGSPLYMAP 137
L L+ II+RDLK +N+L LD + +K+ D+G+ L PG+ CG+P Y+AP
Sbjct: 166 LNYLHERGIIYRDLKLDNVL---LDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAP 222
Query: 138 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 175
E+L+ + Y VD W++G ++FE++ G PF +
Sbjct: 223 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-43
Identities = 54/165 (32%), Positives = 88/165 (53%), Gaps = 8/165 (4%)
Query: 16 ELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
E L + P ++ L AFQ E + L++++ GG L +++ R E + ++ +
Sbjct: 108 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE 167
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS--CTLYPGNYAEKVCGSP 132
+ LE L+ II+RD+K ENIL LD + + + DFGLS A CG+
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENIL---LDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 224
Query: 133 LYMAPEVLQFQR--YDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 175
YMAP++++ +D+ VD WS+G +++ELL G PF+V E
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 269
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-43
Identities = 40/182 (21%), Positives = 70/182 (38%), Gaps = 19/182 (10%)
Query: 4 KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLH 60
+ ++ + + N + + +++ ++ C NL ++
Sbjct: 99 LSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL- 119
Q+ +E L+S ++HRDLKP NI D ++K+ DFGL +
Sbjct: 159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMD 215
Query: 120 ------------YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167
G+ LYM+PE + Y KVD++S+G ILFELL +
Sbjct: 216 QDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST 275
Query: 168 FS 169
Sbjct: 276 QM 277
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 3e-43
Identities = 58/177 (32%), Positives = 92/177 (51%), Gaps = 14/177 (7%)
Query: 2 LKKLNK-HLKS-----CLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGN 52
+K L+K +K E LS V+ P I+ + AF + + +++ GG+
Sbjct: 219 MKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGD 278
Query: 53 LSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 112
L ++ HG E R + ++ GLE +++ +++RDLKP NIL LD+ ++I+D
Sbjct: 279 LHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISD 335
Query: 113 FGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPF 168
GL+C G+ YMAPEVLQ YD D +S+G +LF+LL G+ PF
Sbjct: 336 LGLACDF-SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 7e-43
Identities = 49/161 (30%), Positives = 80/161 (49%), Gaps = 11/161 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E+ +S++NHPNI++L+ + V+EF G+L + + + +
Sbjct: 73 EVFIMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLD 130
Query: 75 LGAGLEILNSHH--IIHRDLKPENILLSGLD--DDVMLKIADFGLSCTLYPGNYAEKVCG 130
+ G+E + + + I+HRDL+ NI L LD V K+ADFGLS + + G
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSVSGLLG 188
Query: 131 SPLYMAPEVLQFQ--RYDEKVDMWSVGAILFELLNGYPPFS 169
+ +MAPE + + Y EK D +S IL+ +L G PF
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-42
Identities = 52/163 (31%), Positives = 86/163 (52%), Gaps = 8/163 (4%)
Query: 13 LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVP--EQTAR 69
L E+ + H NI++ +F I + +E GG+LS+ +R G + EQT
Sbjct: 66 LHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG 125
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-V 128
+ +Q+ GL+ L+ + I+HRD+K +N+L++ + KI+DFG S L N +
Sbjct: 126 FYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVL--KISDFGTSKRLAGINPCTETF 183
Query: 129 CGSPLYMAPEVLQFQR--YDEKVDMWSVGAILFELLNGYPPFS 169
G+ YMAPE++ Y + D+WS+G + E+ G PPF
Sbjct: 184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 226
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-42
Identities = 55/155 (35%), Positives = 81/155 (52%), Gaps = 5/155 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
EL L N P I+ + AF ++ I + +E GG+L ++ GR+PEQ K +
Sbjct: 81 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 140
Query: 76 GAGLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
GL L H I+HRD+KP NIL++ + +K+ DFG+S L + A G+ Y
Sbjct: 141 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 196
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
M+PE LQ Y + D+WS+G L E+ G P
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 231
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-42
Identities = 55/183 (30%), Positives = 95/183 (51%), Gaps = 19/183 (10%)
Query: 2 LKKLNKHL---KSCLDC---ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
+K +NK + + C E + L + + I +L AFQ EN ++LV+E+ GG+L +
Sbjct: 91 MKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLT 150
Query: 56 YIRLHG-RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
+ G R+P + AR +L ++ ++ ++ +HRD+KP+NIL LD +++ADFG
Sbjct: 151 LLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNIL---LDRCGHIRLADFG 207
Query: 115 LSCTLYPGNY--AEKVCGSPLYMAPEVLQFQ-------RYDEKVDMWSVGAILFELLNGY 165
L + G+P Y++PE+LQ Y + D W++G +E+ G
Sbjct: 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
Query: 166 PPF 168
PF
Sbjct: 268 TPF 270
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-42
Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 13/162 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQ 73
E+ L H NI+ A I V ++C G +L ++ + + +
Sbjct: 70 EVGVLRKTRHVNILLFMGYSTAPQLAI--VTQWCEGSSLYHHLHASETKFEMKKLIDIAR 127
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC---TLYPGNYAEKVCG 130
Q G++ L++ IIHRDLK NI L +D +KI DFGL+ + E++ G
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIF---LHEDNTVKIGDFGLATEKSRWSGSHQFEQLSG 184
Query: 131 SPLYMAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPPFS 169
S L+MAPEV++ Q Y + D+++ G +L+EL+ G P+S
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS 226
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 5e-42
Identities = 62/182 (34%), Positives = 99/182 (54%), Gaps = 11/182 (6%)
Query: 2 LKK---LNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
LKK + C E L+ P + +L FQ + ++ V+E+ GG+L +I
Sbjct: 374 LKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI 433
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
+ GR E A + ++ GL L S II+RDLK +N++ LD + +KIADFG+ C
Sbjct: 434 QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM---LDSEGHIKIADFGM-C 489
Query: 118 --TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 175
++ G + CG+P Y+APE++ +Q Y + VD W+ G +L+E+L G PF GE+
Sbjct: 490 KENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE-GEDED 548
Query: 176 FM 177
+
Sbjct: 549 EL 550
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 6e-42
Identities = 48/199 (24%), Positives = 79/199 (39%), Gaps = 35/199 (17%)
Query: 2 LKKLNKHLKSCLDC---ELNFLSSV-NHPNIIRLFDAF-------QAENCIFLVVEFCAG 50
LK+L + + E+ F+ + HPNI++ A FL++
Sbjct: 58 LKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK 117
Query: 51 GNLSSYI---RLHGRVPEQTARKFLQQLGAGLEILNSHH--IIHRDLKPENILLSGLDDD 105
G L ++ G + T K Q ++ ++ IIHRDLK EN+LL +
Sbjct: 118 GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQ 174
Query: 106 VMLKIADFGLSCTLYPGNYAEK-------------VCGSPLYMAPEVLQFQR---YDEKV 149
+K+ DFG + T+ +P+Y PE++ EK
Sbjct: 175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQ 234
Query: 150 DMWSVGAILFELLNGYPPF 168
D+W++G IL+ L PF
Sbjct: 235 DIWALGCILYLLCFRQHPF 253
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-41
Identities = 44/169 (26%), Positives = 79/169 (46%), Gaps = 19/169 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E+ + + HPN+++ + + + E+ GG L I+ P F +
Sbjct: 57 EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD 116
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------- 127
+ +G+ L+S +IIHRDL N L+ ++ + +ADFGL+ + +
Sbjct: 117 IASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173
Query: 128 --------VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
V G+P +MAPE++ + YDEKVD++S G +L E++
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD 222
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-41
Identities = 37/170 (21%), Positives = 70/170 (41%), Gaps = 20/170 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
E+ H N++ A + + ++ C G L S +R V R+ Q+
Sbjct: 79 EVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQE 138
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------V 128
+ G+ L++ I+H+DLK +N+ D+ + I DFGL +
Sbjct: 139 IVKGMGYLHAKGILHKDLKSKNVFY----DNGKVVITDFGLFSISGVLQAGRREDKLRIQ 194
Query: 129 CGSPLYMAPEVLQFQR---------YDEKVDMWSVGAILFELLNGYPPFS 169
G ++APE+++ + + D++++G I +EL PF
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK 244
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-41
Identities = 24/172 (13%), Positives = 52/172 (30%), Gaps = 25/172 (14%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENC--IFLVVEFCA------GGNLSSYIRLHGRVPEQT 67
+ + +IR+ + F + G L S+ H +
Sbjct: 148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHA 207
Query: 68 ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 127
+ Q+ L L+ + ++H L+P +I+ LD + + F
Sbjct: 208 RLQLTLQVIRLLASLHHYGLVHTYLRPVDIV---LDQRGGVFLTGFEHLV---RDGARVV 261
Query: 128 VCGSPLYMAPEVLQFQ-----------RYDEKVDMWSVGAILFELLNGYPPF 168
S + PE+ + D W++G +++ + P
Sbjct: 262 SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI 313
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-40
Identities = 23/162 (14%), Positives = 43/162 (26%), Gaps = 15/162 (9%)
Query: 24 NHPNIIRLFDAFQAENC--IFLVVEFCAG------GNLSSYIRLHGRVPEQTARKFLQQL 75
+ P +L L++ + L G QL
Sbjct: 144 SQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQL 203
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
L S ++H P+N+ + D L + D G Y
Sbjct: 204 IRLAANLQSKGLVHGHFTPDNLF---IMPDGRLMLGDVSAL--WKVGTRGPASSVPVTYA 258
Query: 136 APEVLQFQR--YDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 175
E L + ++ W +G ++ + + PF +
Sbjct: 259 PREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-40
Identities = 57/157 (36%), Positives = 90/157 (57%), Gaps = 12/157 (7%)
Query: 21 SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE 80
S ++H NI+ + D + ++C +LV+E+ G LS YI HG + TA F Q+ G++
Sbjct: 66 SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK 125
Query: 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-----SCTLYPGNYAEKVCGSPLYM 135
+ I+HRD+KP+NIL +D + LKI DFG+ +L V G+ Y
Sbjct: 126 HAHDMRIVHRDIKPQNIL---IDSNKTLKIFDFGIAKALSETSL---TQTNHVLGTVQYF 179
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGE 172
+PE + + DE D++S+G +L+E+L G PPF+ GE
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN-GE 215
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 5e-40
Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 25/167 (14%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E++ L + H NII L + + L+ E+ +L Y+ + V + + FL QL
Sbjct: 83 EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQL 141
Query: 76 GAGLEILNSHHIIHRDLKPENILLS--GLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
G+ +S +HRDLKP+N+LLS + +LKI DFGL+ + G P+
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA----------RAFGIPI 191
Query: 134 -----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
Y PE+L + Y VD+WS+ I E+L P F
Sbjct: 192 RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF 238
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 134 bits (341), Expect = 2e-39
Identities = 55/166 (33%), Positives = 86/166 (51%), Gaps = 27/166 (16%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
E++ L ++HPNI+ L D +E C+ LV EF +L + + + + +L Q
Sbjct: 69 EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQ 127
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
L G+ + H I+HRDLKP+N+L ++ D LK+ADFGL+ + G P+
Sbjct: 128 LLRGVAHCHQHRILHRDLKPQNLL---INSDGALKLADFGLA----------RAFGIPVR 174
Query: 134 ----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
Y AP+VL ++Y VD+WS+G I E++ G P F
Sbjct: 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF 220
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-39
Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 27/166 (16%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E+ L + HPN++ L + F+ + + LV E+C + + + R VPE + Q
Sbjct: 52 EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQ 110
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
+ + H+ IHRD+KPENIL + ++K+ DFG + ++ P
Sbjct: 111 TLQAVNFCHKHNCIHRDVKPENIL---ITKHSVIKLCDFGFA----------RLLTGPSD 157
Query: 134 ----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
Y +PE+L +Y VD+W++G + ELL+G P +
Sbjct: 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLW 203
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-39
Identities = 53/166 (31%), Positives = 84/166 (50%), Gaps = 27/166 (16%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
E++ L + H NI++L+D + + LV E +L + + TA+ FL Q
Sbjct: 50 EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
L G+ + ++HRDLKP+N+L ++ + LKIADFGL+ + G P+
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLL---INREGELKIADFGLA----------RAFGIPVR 155
Query: 134 ----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
Y AP+VL ++Y +D+WSVG I E++NG P F
Sbjct: 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF 201
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-39
Identities = 49/161 (30%), Positives = 74/161 (45%), Gaps = 10/161 (6%)
Query: 16 ELNFL-SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
+L+ + S + P I++ F F +F+ +E R+ G +PE+ K
Sbjct: 73 DLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVA 132
Query: 75 LGAGLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
+ L L H +IHRD+KP NILL +K+ DFG+S L ++ G
Sbjct: 133 IVKALYYLKEKHGVIHRDVKPSNILLDERGQ---IKLCDFGISGRLVDDKAKDRSAGCAA 189
Query: 134 YMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPFS 169
YMAPE + YD + D+WS+G L EL G P+
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYK 230
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-39
Identities = 63/166 (37%), Positives = 86/166 (51%), Gaps = 27/166 (16%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
E+ L ++HPNII L DAF ++ I LV +F +L I+ + V + ++
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
GLE L+ H I+HRDLKP N+L LD++ +LK+ADFGL+ K GSP
Sbjct: 121 TLQGLEYLHQHWILHRDLKPNNLL---LDENGVLKLADFGLA----------KSFGSPNR 167
Query: 134 ----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
Y APE+L + Y VDMW+VG IL ELL P
Sbjct: 168 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL 213
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 6e-39
Identities = 37/163 (22%), Positives = 70/163 (42%), Gaps = 16/163 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKF 71
E L +HPN++ + A Q+ L+ + G+L + + V + A KF
Sbjct: 57 ECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKF 116
Query: 72 LQQLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
+ G+ L++ I L ++++ D+D+ +I+ + +
Sbjct: 117 ALDMARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADVKFSFQSPG----RM 169
Query: 130 GSPLYMAPEVLQFQRYD---EKVDMWSVGAILFELLNGYPPFS 169
+P ++APE LQ + D DMWS +L+EL+ PF+
Sbjct: 170 YAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA 212
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-38
Identities = 51/161 (31%), Positives = 87/161 (54%), Gaps = 7/161 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E++ + + P++++ + ++ +++V+E+C G++S IRL + E LQ
Sbjct: 74 EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQS 133
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPL 133
GLE L+ IHRD+K NILL+ + K+ADFG++ L V G+P
Sbjct: 134 TLKGLEYLHFMRKIHRDIKAGNILLN-TEGHA--KLADFGVAGQLTDTMAKRNTVIGTPF 190
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 174
+MAPEV+Q Y+ D+WS+G E+ G PP++ + H
Sbjct: 191 WMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYA--DIH 229
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-38
Identities = 45/160 (28%), Positives = 88/160 (55%), Gaps = 7/160 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ + H N++ ++ ++ +++++EF GG L+ + R+ E+ + +
Sbjct: 92 EVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-QVRLNEEQIATVCEAV 150
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 134
L L++ +IHRD+K ++ILL+ LD V K++DFG + K + G+P +
Sbjct: 151 LQALAYLHAQGVIHRDIKSDSILLT-LDGRV--KLSDFGFCAQISKDVPKRKSLVGTPYW 207
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 174
MAPEV+ Y +VD+WS+G ++ E+++G PP+ +
Sbjct: 208 MAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYF--SDS 245
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-38
Identities = 51/160 (31%), Positives = 89/160 (55%), Gaps = 7/160 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ + +PNI+ D++ + +++V+E+ AGG+L+ + + E ++
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCREC 125
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 134
LE L+S+ +IHRD+K +NILL +D V K+ DFG + P + G+P +
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLG-MDGSV--KLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 174
MAPEV+ + Y KVD+WS+G + E++ G PP+ E+
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL--NEN 220
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-38
Identities = 49/155 (31%), Positives = 84/155 (54%), Gaps = 5/155 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ LS + P + + + ++ + +++++E+ GG+ + G + E L+++
Sbjct: 70 EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREI 128
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLY 134
GL+ L+S IHRD+K N+LLS + +K+ADFG++ L G+P +
Sbjct: 129 LKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFW 185
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
MAPEV++ YD K D+WS+G EL G PP S
Sbjct: 186 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS 220
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-38
Identities = 47/166 (28%), Positives = 81/166 (48%), Gaps = 27/166 (16%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E+ L + H N++ L + + + +LV EF + + L + Q +K+L Q
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQ 132
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
+ G+ +SH+IIHRD+KPENIL + ++K+ DFG + + +P
Sbjct: 133 IINGIGFCHSHNIIHRDIKPENIL---VSQSGVVKLCDFGFA----------RTLAAPGE 179
Query: 134 ----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
Y APE+L +Y + VD+W++G ++ E+ G P F
Sbjct: 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF 225
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-38
Identities = 53/166 (31%), Positives = 79/166 (47%), Gaps = 27/166 (16%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
E+ L + H NI+RL D ++ + LV EFC +L Y + + FL Q
Sbjct: 51 EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQ 109
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
L GL +S +++HRDLKP+N+L ++ + LK+A+FGL+ + G P+
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLL---INRNGELKLANFGLA----------RAFGIPVR 156
Query: 134 ----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
Y P+VL + Y +DMWS G I EL N P
Sbjct: 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-37
Identities = 55/166 (33%), Positives = 80/166 (48%), Gaps = 31/166 (18%)
Query: 20 LSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFL 72
L + HPN++RLFD E + LV E +L++Y+ P +T + +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
QL GL+ L+SH ++HRDLKP+NIL + +K+ADFGL+ ++
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNIL---VTSSGQIKLADFGLA----------RIYSFQ 173
Query: 133 L----------YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
+ Y APEVL Y VD+WSVG I E+ P F
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 219
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-37
Identities = 50/166 (30%), Positives = 77/166 (46%), Gaps = 27/166 (16%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
E++ L + H NI+ L D E + LV E+ +L Y+ G + + FL Q
Sbjct: 50 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQ 108
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
L GL + ++HRDLKP+N+L +++ LK+ADFGL+ + P
Sbjct: 109 LLRGLAYCHRQKVLHRDLKPQNLL---INERGELKLADFGLA----------RAKSIPTK 155
Query: 134 ----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
Y P++L Y ++DMW VG I +E+ G P F
Sbjct: 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF 201
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-37
Identities = 54/169 (31%), Positives = 78/169 (46%), Gaps = 31/169 (18%)
Query: 17 LNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHGRV--PEQTAR 69
L L + HPN++RL D + LV E +L +Y+ P +T +
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
++Q GL+ L+++ I+HRDLKPENIL + +K+ADFGL+ ++
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENIL---VTSGGTVKLADFGLA----------RIY 170
Query: 130 GSPL----------YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
+ Y APEVL Y VDMWSVG I E+ P F
Sbjct: 171 SYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 219
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-37
Identities = 44/160 (27%), Positives = 82/160 (51%), Gaps = 12/160 (7%)
Query: 21 SSVNHPNIIRLFD----AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76
+++NHP I+ ++D A ++V+E+ G L + G + + A + +
Sbjct: 67 AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 126
Query: 77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL----SCTLYPGNYAEKVCGSP 132
L + + IIHRD+KP NI++S +K+ DFG+ + + V G+
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGE 172
Y++PE + D + D++S+G +L+E+L G PPF+ G+
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT-GD 222
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-37
Identities = 53/171 (30%), Positives = 80/171 (46%), Gaps = 32/171 (18%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV------PEQTAR 69
E++ + + H NI+RL+D EN + LV EF +L Y+ +
Sbjct: 53 EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVK 111
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
F QL GL + + I+HRDLKP+N+L ++ LK+ DFGL+ +
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLL---INKRGQLKLGDFGLA----------RAF 158
Query: 130 GSPL-----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
G P+ Y AP+VL + Y +D+WS G IL E++ G P F
Sbjct: 159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLF 209
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-37
Identities = 55/162 (33%), Positives = 77/162 (47%), Gaps = 11/162 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ FL + HPN I+ + E+ +LV+E+C G + E
Sbjct: 104 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGA 163
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
GL L+SH++IHRD+K NILLS V K+ DFG + + P N G+P +M
Sbjct: 164 LQGLAYLHSHNMIHRDVKAGNILLS-EPGLV--KLGDFGSASIMAPAN---SFVGTPYWM 217
Query: 136 APEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFSVGEEH 174
APEV+ YD KVD+WS+G EL PP +
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF--NMN 257
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-37
Identities = 54/168 (32%), Positives = 91/168 (54%), Gaps = 16/168 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
E+ L++ +HP I++L A+ + +++++EFC GG + + + R E + +Q
Sbjct: 66 EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQ 125
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGS 131
+ L L+S IIHRDLK N+L++ L+ D+ ++ADFG+S +K G+
Sbjct: 126 MLEALNFLHSKRIIHRDLKAGNVLMT-LEGDI--RLADFGVSAKN--LKTLQKRDSFIGT 180
Query: 132 PLYMAPEV-----LQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 174
P +MAPEV ++ YD K D+WS+G L E+ PP E +
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH--ELN 226
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-37
Identities = 39/153 (25%), Positives = 75/153 (49%), Gaps = 11/153 (7%)
Query: 22 SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81
+ P+++ + D + + +++ + G +L++ +R G + A ++Q+G+ L+
Sbjct: 90 RLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDA 149
Query: 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-----SCTLYPGNYAEKVCGSPLYMA 136
++ HRD+KPENIL+S DD + DFG+ L G+ YMA
Sbjct: 150 AHAAGATHRDVKPENILVSA-DDFA--YLVDFGIASATTDEKL---TQLGNTVGTLYYMA 203
Query: 137 PEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
PE + D++++ +L+E L G PP+
Sbjct: 204 PERFSESHATYRADIYALTCVLYECLTGSPPYQ 236
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-37
Identities = 55/169 (32%), Positives = 89/169 (52%), Gaps = 18/169 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF---- 71
E+ +S +HPNI+ + +F ++ ++LV++ +GG++ I+ E +
Sbjct: 63 EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122
Query: 72 ----LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 127
L+++ GLE L+ + IHRD+K NIL L +D ++IADFG+S L G +
Sbjct: 123 IATILREVLEGLEYLHKNGQIHRDVKAGNIL---LGEDGSVQIADFGVSAFLATGGDITR 179
Query: 128 ------VCGSPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFS 169
G+P +MAPEV+ Q + YD K D+WS G EL G P+
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH 228
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 8e-37
Identities = 48/166 (28%), Positives = 77/166 (46%), Gaps = 15/166 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
EL+ NHPNI+ F A+N +++V F A G+ I H + E LQ
Sbjct: 76 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ 135
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC---- 129
+ L+ ++ +HR +K +IL+S D V ++ + ++ ++V
Sbjct: 136 GVLKALDYIHHMGYVHRSVKASHILISV-DGKV--YLSGLRSNLSMISHGQRQRVVHDFP 192
Query: 130 ----GSPLYMAPEVLQ--FQRYDEKVDMWSVGAILFELLNGYPPFS 169
+++PEVLQ Q YD K D++SVG EL NG+ PF
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 238
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-36
Identities = 55/179 (30%), Positives = 87/179 (48%), Gaps = 17/179 (9%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF------QAENCIFLVVEFCAGGNLSS 55
+KK+ + + EL + ++H NI+RL F + E + LV+++ +
Sbjct: 84 IKKVLQDKRFKNR-ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYR 141
Query: 56 YIRLHGR----VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
R + R +P + ++ QL L ++S I HRD+KP+N+LL D +LK+
Sbjct: 142 VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLC 199
Query: 112 DFGLSCTLYPGN-YAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
DFG + L G +C S Y APE+ Y +D+WS G +L ELL G P F
Sbjct: 200 DFGSAKQLVRGEPNVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-36
Identities = 51/181 (28%), Positives = 84/181 (46%), Gaps = 38/181 (20%)
Query: 15 CELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGR---------V 63
E+ L + HPN+I L F A+ ++L+ ++ +L I+ H +
Sbjct: 67 REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQL 125
Query: 64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYPG 122
P + L Q+ G+ L+++ ++HRDLKP NIL+ G + +KIAD G +
Sbjct: 126 PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA------ 179
Query: 123 NYAEKVCGSPL--------------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPP 167
++ SPL Y APE+L + Y + +D+W++G I ELL P
Sbjct: 180 ----RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 235
Query: 168 F 168
F
Sbjct: 236 F 236
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-36
Identities = 46/163 (28%), Positives = 73/163 (44%), Gaps = 12/163 (7%)
Query: 16 ELNF-LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY---IRLHGRVPEQTARKF 71
+L+ + +V+ P + + A E +++ +E Y I +PE K
Sbjct: 55 DLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKI 114
Query: 72 LQQLGAGLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG 130
+ LE L+S +IHRD+KP N+L++ V K+ DFG+S L + G
Sbjct: 115 AVSIVKALEHLHSKLSVIHRDVKPSNVLIN-ALGQV--KMCDFGISGYLVDDVAKDIDAG 171
Query: 131 SPLYMAPEV----LQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
YMAPE L + Y K D+WS+G + EL P+
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-35
Identities = 40/156 (25%), Positives = 79/156 (50%), Gaps = 15/156 (9%)
Query: 19 FLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73
FL+ V HP+I+++F+ + + ++V+E+ G +L ++P A +L
Sbjct: 132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLL 189
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
++ L L+S +++ DLKPENI+L+ ++ + K+ D G + N + G+P
Sbjct: 190 EILPALSYLHSIGLVYNDLKPENIMLT--EEQL--KLIDLGAVSRI---NSFGYLYGTPG 242
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
+ APE+++ D+++VG L L P +
Sbjct: 243 FQAPEIVR-TGPTVATDIYTVGRTLAALTLDLPTRN 277
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-35
Identities = 43/183 (23%), Positives = 77/183 (42%), Gaps = 27/183 (14%)
Query: 16 ELNFLSSVNHPNIIRLFDA----FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
EL + H NI+ + + ++L+ + G+L Y++L + + +
Sbjct: 52 ELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRI 110
Query: 72 LQQLGAGLEILNSHH--------IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
+ + +GL L+ I HRDLK +NIL+ + IAD GL+
Sbjct: 111 VLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQST 167
Query: 124 YAEKV-----CGSPLYMAPEVL------QFQRYDEKVDMWSVGAILFELLNGYPPFSVGE 172
V G+ YMAPEVL ++VD+W+ G +L+E+ + E
Sbjct: 168 NQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227
Query: 173 EHQ 175
+++
Sbjct: 228 DYK 230
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-35
Identities = 24/168 (14%), Positives = 53/168 (31%), Gaps = 18/168 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCI--FLVVEFCAG------GNLSSYIRLHGRVPEQT 67
+ + +IR+ + + F + L S+ H +
Sbjct: 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHA 212
Query: 68 ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE- 126
+ Q+ L L+ + ++H L+P +I+ LD + + F +
Sbjct: 213 RLQLTLQVIRLLASLHHYGLVHTYLRPVDIV---LDQRGGVFLTGFEHLVRDGASAVSPI 269
Query: 127 -KVCGSPLYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPF 168
+ P A +L F + D W++G ++ + P
Sbjct: 270 GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN 317
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-35
Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 16/165 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAF------QAENCIFLVVEFCAGGNLSSYIRLHGR----VPE 65
EL + V HPN++ L F + E + LV+E+ + R + + +P
Sbjct: 82 ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPM 140
Query: 66 QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-Y 124
+ ++ QL L ++S I HRD+KP+N+LL +LK+ DFG + L G
Sbjct: 141 LLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG--VLKLIDFGSAKILIAGEPN 198
Query: 125 AEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
+C S Y APE+ Y +D+WS G ++ EL+ G P F
Sbjct: 199 VSYIC-SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF 242
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-35
Identities = 48/164 (29%), Positives = 73/164 (44%), Gaps = 13/164 (7%)
Query: 16 ELNF-LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARK 70
+L+ + S + P I++ + A E ++ +E + Y L +PE+ K
Sbjct: 70 DLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGK 129
Query: 71 FLQQLGAGLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
L L IIHRD+KP NILL ++ K+ DFG+S L +
Sbjct: 130 ITLATVKALNHLKENLKIIHRDIKPSNILLD-RSGNI--KLCDFGISGQLVDSIAKTRDA 186
Query: 130 GSPLYMAPEVLQFQR----YDEKVDMWSVGAILFELLNGYPPFS 169
G YMAPE + YD + D+WS+G L+EL G P+
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYP 230
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-34
Identities = 42/185 (22%), Positives = 74/185 (40%), Gaps = 27/185 (14%)
Query: 16 ELNFLSSVNHPNIIRLFDA----FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
E+ + H NI+ A ++LV ++ G+L Y+ + V + K
Sbjct: 86 EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKL 144
Query: 72 LQQLGAGLEILNSHH--------IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
+GL L+ I HRDLK +NIL+ + IAD GL+
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSAT 201
Query: 124 YAEKV-----CGSPLYMAPEVL------QFQRYDEKVDMWSVGAILFELLNGYPPFSVGE 172
+ G+ YMAPEVL + ++ D++++G + +E+ + E
Sbjct: 202 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261
Query: 173 EHQFM 177
++Q
Sbjct: 262 DYQLP 266
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-34
Identities = 45/184 (24%), Positives = 75/184 (40%), Gaps = 27/184 (14%)
Query: 16 ELNFLSSVNHPNIIRLFDA----FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
E+ + H NI+ A + ++L+ ++ G+L Y++ + ++ K
Sbjct: 81 EIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKL 139
Query: 72 LQQLGAGL-----EILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
+GL EI ++ I HRDLK +NIL+ + IAD GL+
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDT 196
Query: 124 YAEKV-----CGSPLYMAPEVL------QFQRYDEKVDMWSVGAILFELLNGYPPFSVGE 172
+ G+ YM PEVL + DM+S G IL+E+ + E
Sbjct: 197 NEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256
Query: 173 EHQF 176
E+Q
Sbjct: 257 EYQL 260
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-33
Identities = 53/169 (31%), Positives = 86/169 (50%), Gaps = 18/169 (10%)
Query: 16 ELNFLSSV-NHPNIIRLFDAF------QAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQ 66
E+N L +H NI + AF ++ ++LV+EFC G+++ I+ + E+
Sbjct: 70 EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 129
Query: 67 TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
+++ GL L+ H +IHRD+K +N+LL+ + +V K+ DFG+S L
Sbjct: 130 WIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT-ENAEV--KLVDFGVSAQLDRTVGRR 186
Query: 127 K-VCGSPLYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPFS 169
G+P +MAPEV+ YD K D+WS+G E+ G PP
Sbjct: 187 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 235
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-33
Identities = 59/178 (33%), Positives = 88/178 (49%), Gaps = 17/178 (9%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
+KKL++ ++ EL + VNH NII L + F + +++V+E
Sbjct: 55 IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MD 113
Query: 51 GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
NL I++ + + L Q+ G++ L+S IIHRDLKP NI++ D LKI
Sbjct: 114 ANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKI 168
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
DFGL+ T + Y APEV+ Y E VD+WSVG I+ E++ G F
Sbjct: 169 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 226
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-33
Identities = 59/178 (33%), Positives = 86/178 (48%), Gaps = 17/178 (9%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
+KKL++ ++ EL + VNH NII L + F + ++LV+E
Sbjct: 92 IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-MD 150
Query: 51 GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
NL I+ + + L Q+ G++ L+S IIHRDLKP NI++ D LKI
Sbjct: 151 ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKI 205
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
DFGL+ T + Y APEV+ Y E VD+WSVG I+ E++ F
Sbjct: 206 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 263
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-33
Identities = 60/187 (32%), Positives = 92/187 (49%), Gaps = 35/187 (18%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
+KKL + +S L EL L + H N+I L D F + +LV+ F G
Sbjct: 55 IKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF-MG 113
Query: 51 GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
+L ++ H ++ E + + Q+ GL +++ IIHRDLKP N+ + ++D LKI
Sbjct: 114 TDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKI 169
Query: 111 ADFGLSCTLYPGNYAEKVCGSPL--------YMAPEV-LQFQRYDEKVDMWSVGAILFEL 161
DFGL+ + S + Y APEV L + RY + VD+WSVG I+ E+
Sbjct: 170 LDFGLA----------RQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEM 219
Query: 162 LNGYPPF 168
+ G F
Sbjct: 220 ITGKTLF 226
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-32
Identities = 56/179 (31%), Positives = 90/179 (50%), Gaps = 20/179 (11%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
+KKL++ +S + EL L + H N+I L D F + +LV+ F
Sbjct: 54 IKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPF-MQ 112
Query: 51 GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
+L + + E+ + + Q+ GL+ ++S ++HRDLKP N+ + ++D LKI
Sbjct: 113 TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKI 167
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
DFGL+ V + Y APEV L + Y++ VD+WSVG I+ E+L G F
Sbjct: 168 LDFGLARHADA-EMTGYV-VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-32
Identities = 48/189 (25%), Positives = 81/189 (42%), Gaps = 28/189 (14%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
+KK+ L E+ L H NII +F+ + ++ ++++ E
Sbjct: 41 IKKIEP-FDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQEL-MQT 98
Query: 52 NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
+L I + + + F+ Q +++L+ ++IHRDLKP N+L+ + + LK+
Sbjct: 99 DLHRVIS-TQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVC 154
Query: 112 DFGLSCTLYPGNYAEKVCGSPL-----------YMAPEV-LQFQRYDEKVDMWSVGAILF 159
DFGL+ + Y APEV L +Y +D+WS G IL
Sbjct: 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILA 214
Query: 160 ELLNGYPPF 168
EL P F
Sbjct: 215 ELFLRRPIF 223
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-32
Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 10/155 (6%)
Query: 24 NHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81
PNII L D + LV E + + + + R ++ ++ L+
Sbjct: 89 GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDY 145
Query: 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVL 140
+S I+HRD+KP N+++ L++ D+GL+ +PG Y +V S + PE+L
Sbjct: 146 CHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNVRV-ASRYFKGPELL 202
Query: 141 -QFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 174
+Q YD +DMWS+G +L ++ PF G ++
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 237
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-31
Identities = 53/168 (31%), Positives = 80/168 (47%), Gaps = 19/168 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQA-------ENCIFLVVEFCAGGNLSSYIRLHGR----VP 64
+ L+ ++HPNI++L F + + +V+E+ L R + R P
Sbjct: 69 IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPP 127
Query: 65 EQTARKFLQQLGAGLEIL--NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
+ FL QL + L S ++ HRD+KP N+L++ D LK+ DFG + L P
Sbjct: 128 PILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT--LKLCDFGSAKKLSPS 185
Query: 123 N-YAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
+C S Y APE+ Q Y VD+WSVG I E++ G P F
Sbjct: 186 EPNVAYIC-SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF 232
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-31
Identities = 50/162 (30%), Positives = 82/162 (50%), Gaps = 11/162 (6%)
Query: 15 CELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVP-EQTARKFL 72
E + +HPN++ L ++E +V+ + G+L ++IR P + F
Sbjct: 75 TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 134
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCG 130
Q+ G++ L S +HRDL N +L + + K+ADFGL+ +Y Y G
Sbjct: 135 LQVAKGMKYLASKKFVHRDLAARNCMLD--EKFTV-KVADFGLARDMYDKEYYSVHNKTG 191
Query: 131 SPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
+ L +MA E LQ Q++ K D+WS G +L+EL+ G PP+
Sbjct: 192 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 233
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-31
Identities = 42/171 (24%), Positives = 79/171 (46%), Gaps = 25/171 (14%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCAGGNLSSYI-RLHGRVPEQ 66
E+ L + H N++ L + + + I+LV +FC +L+ + + +
Sbjct: 66 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS 124
Query: 67 TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
++ +Q L GL ++ + I+HRD+K N+L + D +LK+ADFGL+ + + A+
Sbjct: 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVL---ITRDGVLKLADFGLA-RAF--SLAK 178
Query: 127 KVCGSPL--------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168
+ Y PE+L + Y +D+W G I+ E+ P
Sbjct: 179 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 229
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-31
Identities = 56/187 (29%), Positives = 92/187 (49%), Gaps = 35/187 (18%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
+KKL++ +S + EL L + H N+I L D F ++LV G
Sbjct: 59 VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-MG 117
Query: 51 GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
+L++ ++ ++ + + + Q+ GL+ ++S IIHRDLKP N+ +++D LKI
Sbjct: 118 ADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLA---VNEDCELKI 173
Query: 111 ADFGLSCTLYPGNYAEKVCGSPL--------YMAPEV-LQFQRYDEKVDMWSVGAILFEL 161
DFGL+ + + Y APE+ L + Y++ VD+WSVG I+ EL
Sbjct: 174 LDFGLA----------RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223
Query: 162 LNGYPPF 168
L G F
Sbjct: 224 LTGRTLF 230
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-31
Identities = 49/161 (30%), Positives = 82/161 (50%), Gaps = 11/161 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVP-EQTARKFLQ 73
E + +HPN++ L ++E +V+ + G+L ++IR P + F
Sbjct: 140 EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL 199
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGS 131
Q+ G++ L S +HRDL N +L + + K+ADFGL+ +Y + G+
Sbjct: 200 QVAKGMKFLASKKFVHRDLAARNCMLD--EKFTV-KVADFGLARDMYDKEFDSVHNKTGA 256
Query: 132 PL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
L +MA E LQ Q++ K D+WS G +L+EL+ G PP+
Sbjct: 257 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 297
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-31
Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 9/158 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E ++SV++P++ RL + + L+ + G L Y+R H + Q + Q
Sbjct: 67 EAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--P 132
+ G+ L ++HRDL N+L+ +KI DFGL+ L G P
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
+ +MA E + + Y + D+WS G ++EL+ G P+
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-31
Identities = 54/200 (27%), Positives = 86/200 (43%), Gaps = 38/200 (19%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
+KK+N+ + +DC E+ L+ + IIRL+D ++ +++V+E A
Sbjct: 56 IKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEI-ADS 114
Query: 52 NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
+L + + E+ + L L G ++ IIHRDLKP N L L+ D +K+
Sbjct: 115 DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCL---LNQDCSVKVC 171
Query: 112 DFGLSCTLYPGNYAEKVCGSPL-----------------------YMAPEV-LQFQRYDE 147
DFGL+ T+ V Y APE+ L + Y +
Sbjct: 172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTK 231
Query: 148 KVDMWSVGAILFELLNGYPP 167
+D+WS G I ELLN
Sbjct: 232 SIDIWSTGCIFAELLNMLQS 251
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-31
Identities = 54/186 (29%), Positives = 87/186 (46%), Gaps = 29/186 (15%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
+KK++ + C E+ L H NII + D +A +++V +
Sbjct: 57 IKKISP-FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL-MET 114
Query: 52 NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
+L ++ + FL Q+ GL+ ++S +++HRDLKP N+LL + LKI
Sbjct: 115 DLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKIC 170
Query: 112 DFGLSCTLYPGNYAEKVCGSPL--------YMAPEV-LQFQRYDEKVDMWSVGAILFELL 162
DFGL+ P + L Y APE+ L + Y + +D+WSVG IL E+L
Sbjct: 171 DFGLARVADP----DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226
Query: 163 NGYPPF 168
+ P F
Sbjct: 227 SNRPIF 232
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-31
Identities = 45/176 (25%), Positives = 79/176 (44%), Gaps = 26/176 (14%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
E+ L + H NI++ A + + +L+ F G+LS +++ + V
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHI 126
Query: 72 LQQLGAGLEILNSH----------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
+ + GL L+ I HRD+K +N+L L +++ IADFGL+
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVL---LKNNLTACIADFGLALKFEA 183
Query: 122 GNYAEK---VCGSPLYMAPEVLQF-----QRYDEKVDMWSVGAILFELLNGYPPFS 169
G A G+ YMAPEVL+ + ++DM+++G +L+EL +
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-31
Identities = 48/176 (27%), Positives = 87/176 (49%), Gaps = 31/176 (17%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENC--------------IFLVVEFCAGGNLSSYIRLHG 61
E+ + ++H NI+++F+ +++V E+ +L++ + G
Sbjct: 58 EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-METDLANVLE-QG 115
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
+ E+ AR F+ QL GL+ ++S +++HRDLKP N+ ++ +D++LKI DFGL+ + P
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--EDLVLKIGDFGLARIMDP 173
Query: 122 GNYAEKVCGSPL--------YMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
L Y +P + L Y + +DMW+ G I E+L G F
Sbjct: 174 ----HYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-31
Identities = 49/161 (30%), Positives = 78/161 (48%), Gaps = 11/161 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVP-EQTARKFLQ 73
E + +NHPN++ L E +++ + G+L +IR R P + F
Sbjct: 72 EGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL 131
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGS 131
Q+ G+E L +HRDL N +L + +K+ADFGL+ + Y ++ +
Sbjct: 132 QVARGMEYLAEQKFVHRDLAARNCMLD---ESFTVKVADFGLARDILDREYYSVQQHRHA 188
Query: 132 PL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
L + A E LQ R+ K D+WS G +L+ELL G PP+
Sbjct: 189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY 229
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-31
Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 36/198 (18%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVN-HPNIIRLFDAFQAENC--IFLVVEFCAGGNL 53
+KK+ ++ D E+ L+ ++ H NI+ L + +A+N ++LV ++ +L
Sbjct: 39 VKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDY-METDL 97
Query: 54 SSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
+ IR + + + QL ++ L+S ++HRD+KP NILL + + +K+ADF
Sbjct: 98 HAVIR-ANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADF 153
Query: 114 GLSCTLYPGNYAEKVCGSPL----------------------YMAPEV-LQFQRYDEKVD 150
GLS + + Y APE+ L +Y + +D
Sbjct: 154 GLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGID 213
Query: 151 MWSVGAILFELLNGYPPF 168
MWS+G IL E+L G P F
Sbjct: 214 MWSLGCILGEILCGKPIF 231
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-31
Identities = 50/205 (24%), Positives = 88/205 (42%), Gaps = 43/205 (20%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
+KK+ + + +DC E+ L+ +NH +++++ D ++ +++V+E A
Sbjct: 83 IKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEI-ADS 141
Query: 52 NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
+ R + E + L L G++ ++S I+HRDLKP N L ++ D +K+
Sbjct: 142 DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCL---VNQDCSVKVC 198
Query: 112 DFGLSCTLYPGNYAEKVCGSPL----------------------------YMAPEV-LQF 142
DFGL+ T+ Y APE+ L
Sbjct: 199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ 258
Query: 143 QRYDEKVDMWSVGAILFELLNGYPP 167
+ Y E +D+WS+G I ELLN
Sbjct: 259 ENYTEAIDVWSIGCIFAELLNMIKE 283
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-31
Identities = 50/185 (27%), Positives = 88/185 (47%), Gaps = 20/185 (10%)
Query: 1 MLKKLNKHLKSCLD--CELNFLSSVNHPNIIRLF-----DAFQAENCIFLVVEFCAGGNL 53
+K N + + E + +HPN+IRL + Q +++ F G+L
Sbjct: 69 TMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDL 128
Query: 54 SSYIRLH------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVM 107
+Y+ +P QT KF+ + G+E L++ + +HRDL N +L DD +
Sbjct: 129 HTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR--DDMTV 186
Query: 108 LKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163
+ADFGLS +Y G+Y + + + ++A E L + Y K D+W+ G ++E+
Sbjct: 187 -CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 245
Query: 164 GYPPF 168
G P+
Sbjct: 246 GMTPY 250
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 7e-31
Identities = 45/170 (26%), Positives = 82/170 (48%), Gaps = 21/170 (12%)
Query: 16 ELNFLSSVNHPNIIRLF------DAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
E + +HP++ +L A +++ F G+L +++ R+ E
Sbjct: 75 EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS-RIGENPFN 133
Query: 70 -------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
+F+ + G+E L+S + IHRDL N +L+ +D+ + +ADFGLS +Y G
Sbjct: 134 LPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA---EDMTVCVADFGLSRKIYSG 190
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
+Y + C S L ++A E L Y D+W+ G ++E++ G P+
Sbjct: 191 DYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY 240
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-31
Identities = 49/161 (30%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHGRVP--EQTA 68
E+ L+ +HPNI+ L D F ++LV E +L+ I R+ Q
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTEL-MRTDLAQVIH-DQRIVISPQHI 136
Query: 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
+ F+ + GL +L+ ++HRDL P NILL D+ + I DF L+
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNNDITICDFNLAREDTADANKTHY 193
Query: 129 CGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
Y APE+ +QF+ + + VDMWS G ++ E+ N F
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-30
Identities = 48/179 (26%), Positives = 84/179 (46%), Gaps = 20/179 (11%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC----IFLVVEFCAGGNLSSY 56
+L+++N + D +I++L D F + + +V E G NL +
Sbjct: 68 LLQRVNDADNTKEDSM-------GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLAL 119
Query: 57 IRL--HGRVPEQTARKFLQQLGAGLEILNSH-HIIHRDLKPENILLSGLDD---DVMLKI 110
I+ H +P ++ +QL GL+ ++ IIH D+KPEN+L+ +D + +KI
Sbjct: 120 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKI 179
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
AD G +C + + + Y +PEVL + D+WS ++FEL+ G F
Sbjct: 180 ADLGNAC--WYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-30
Identities = 52/211 (24%), Positives = 88/211 (41%), Gaps = 49/211 (23%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA------------------------ 37
LKK+ + + EL+ + ++H NII+L D F
Sbjct: 37 LKKVLQDPRYKNR-ELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNG 95
Query: 38 --------------ENCIFLVVEFCAGGNLSSYIRLHGR----VPEQTARKFLQQLGAGL 79
+ +++E+ L ++ R +P ++ QL +
Sbjct: 96 VNNHHKSVIVNPSQNKYLNVIMEYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154
Query: 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPE 138
++S I HRD+KP+N+L++ D+ LK+ DFG + L P +C S Y APE
Sbjct: 155 GFIHSLGICHRDIKPQNLLVNSKDNT--LKLCDFGSAKKLIPSEPSVAYIC-SRFYRAPE 211
Query: 139 V-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
+ L Y +D+WS+G + EL+ G P F
Sbjct: 212 LMLGATEYTPSIDLWSIGCVFGELILGKPLF 242
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-30
Identities = 42/158 (26%), Positives = 79/158 (50%), Gaps = 9/158 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
+ + S++H +I+RL + + LV ++ G+L ++R H G + Q + Q
Sbjct: 65 HMLAIGSLDHAHIVRLL-GLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ 123
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
+ G+ L H ++HR+L N+LL +++ADFG++ L P + +
Sbjct: 124 IAKGMYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
+MA E + F +Y + D+WS G ++EL+ G P+
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY 218
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-30
Identities = 43/151 (28%), Positives = 81/151 (53%), Gaps = 10/151 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFL 72
E + ++ + H N+++L + + +++V E+ A G+L Y+R GR KF
Sbjct: 64 EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 123
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
+ +E L ++ +HRDL N+L+S +D + K++DFGL+ K+ P
Sbjct: 124 LDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL---P 177
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
+ + APE L+ +++ K D+WS G +L+E+
Sbjct: 178 VKWTAPEALREKKFSTKSDVWSFGILLWEIY 208
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-30
Identities = 42/158 (26%), Positives = 73/158 (46%), Gaps = 9/158 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E ++SV++P++ RL + + L+ + G L Y+R H + Q + Q
Sbjct: 67 EAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
+ G+ L ++HRDL N+L+ +KI DFGL+ L G +
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
+MA E + + Y + D+WS G ++EL+ G P+
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-30
Identities = 39/167 (23%), Positives = 74/167 (44%), Gaps = 17/167 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR------ 69
E + + N +++RL +++E G+L SY+R
Sbjct: 78 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 70 ----KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 125
+ ++ G+ LN++ +HRDL N +++ +D +KI DFG++ +Y +Y
Sbjct: 138 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYY 194
Query: 126 EKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
K L +M+PE L+ + D+WS G +L+E+ P+
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 241
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-30
Identities = 46/156 (29%), Positives = 72/156 (46%), Gaps = 10/156 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR------ 69
E +S NH NI+R F+++E AGG+L S++R P Q +
Sbjct: 83 EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142
Query: 70 -KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
+ + G + L +H IHRD+ N LL+ + KI DFG++ +Y +Y K
Sbjct: 143 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 202
Query: 129 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
+ L +M PE + K D WS G +L+E+
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-30
Identities = 60/177 (33%), Positives = 78/177 (44%), Gaps = 18/177 (10%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+L+ L K K N N+I + + F N I + E NL I+ +
Sbjct: 146 ILEHLRKQDKD------------NTMNVIHMLENFTFRNHICMTFE-LLSMNLYELIKKN 192
Query: 61 G--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
RKF + L+ L+ + IIH DLKPENILL +K+ DFG SC
Sbjct: 193 KFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQ-QGRSGIKVIDFGSSC- 250
Query: 119 LYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 175
Y S Y APEV+ RY +DMWS+G IL ELL GYP +E
Sbjct: 251 -YEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD 306
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-30
Identities = 43/151 (28%), Positives = 82/151 (54%), Gaps = 10/151 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFL 72
E + ++ + H N+++L + + +++V E+ A G+L Y+R GR + KF
Sbjct: 236 EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 295
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
+ +E L ++ +HRDL N+L+S +D + K++DFGL+ K+ P
Sbjct: 296 LDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL---P 349
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
+ + APE L+ +++ K D+WS G +L+E+
Sbjct: 350 VKWTAPEALREKKFSTKSDVWSFGILLWEIY 380
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-30
Identities = 49/164 (29%), Positives = 75/164 (45%), Gaps = 11/164 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR------ 69
E +S NH NI+R F+++E AGG+L S++R P Q +
Sbjct: 124 EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 183
Query: 70 -KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
+ + G + L +H IHRD+ N LL+ + KI DFG++ +Y Y K
Sbjct: 184 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKG 243
Query: 129 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPF 168
+ L +M PE + K D WS G +L+E+ GY P+
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 287
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-29
Identities = 44/152 (28%), Positives = 74/152 (48%), Gaps = 9/152 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
E + + HPN+++L E +++ EF GNL Y+R R
Sbjct: 59 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
Q+ + +E L + IHRDL N L+ ++ ++K+ADFGLS L G+ G+
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLS-RLMTGDTYTAHAGAKF 174
Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
+ APE L + ++ K D+W+ G +L+E+
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 206
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-29
Identities = 50/150 (33%), Positives = 79/150 (52%), Gaps = 8/150 (5%)
Query: 24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGAGLEIL 82
+HPNI+RL + I++V+E GG+ +++R G + +T + + AG+E L
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL 229
Query: 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEV 139
S IHRDL N L++ + +LKI+DFG+S G YA + + APE
Sbjct: 230 ESKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEA 286
Query: 140 LQFQRYDEKVDMWSVGAILFELL-NGYPPF 168
L + RY + D+WS G +L+E G P+
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPY 316
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-29
Identities = 52/180 (28%), Positives = 84/180 (46%), Gaps = 25/180 (13%)
Query: 16 ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ-------- 66
EL +S + H NI+ L A + ++ E+C G+L +++R RV E
Sbjct: 99 ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 67 ---TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
+ R L Q+ G+ L S + IHRD+ N+LL+ + + KI DFGL+ +
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLARDIM 215
Query: 121 PGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL----LNGYPPFSVGEE 173
+ + L +MAPE + Y + D+WS G +L+E+ LN YP V +
Sbjct: 216 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-29
Identities = 47/190 (24%), Positives = 73/190 (38%), Gaps = 34/190 (17%)
Query: 15 CELNFLSSVNHPNIIRLFDA-----FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
+ + + H NI R LV+E+ G+L Y+ LH ++
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSC 114
Query: 70 KFLQQLGAGL-----EILNSHH----IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
+ + GL E+ H I HRDL N+L + +D I+DFGLS L
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVL---VKNDGTCVISDFGLSMRLT 171
Query: 121 PGNYAEK---------VCGSPLYMAPEVLQ-------FQRYDEKVDMWSVGAILFELLNG 164
G+ YMAPEVL+ + ++VDM+++G I +E+
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
Query: 165 YPPFSVGEEH 174
GE
Sbjct: 232 CTDLFPGESV 241
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-29
Identities = 62/179 (34%), Positives = 76/179 (42%), Gaps = 20/179 (11%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+L+ +NKH I+ L F N + LV E NL +R
Sbjct: 103 LLELMNKHDTE------------MKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNT 149
Query: 61 GRVP--EQTARKFLQQLGAGLEILNSH--HIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
RKF QQ+ L L + IIH DLKPENILL +KI DFG S
Sbjct: 150 NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSAIKIVDFGSS 208
Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 175
C G + S Y +PEVL YD +DMWS+G IL E+ G P FS E
Sbjct: 209 C--QLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVD 265
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-29
Identities = 46/159 (28%), Positives = 78/159 (49%), Gaps = 10/159 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
E + + HPN+++L E +++ EF GNL Y+R R V
Sbjct: 266 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 325
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
Q+ + +E L + IHR+L N L+ ++ ++K+ADFGLS L G+ G+
Sbjct: 326 QISSAMEYLEKKNFIHRNLAARNCLVG---ENHLVKVADFGLS-RLMTGDTYTAHAGAKF 381
Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPF 168
+ APE L + ++ K D+W+ G +L+E+ G P+
Sbjct: 382 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-29
Identities = 40/158 (25%), Positives = 79/158 (50%), Gaps = 9/158 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
E + + H +++L+ E I++V E+ + G+L +++ + +
Sbjct: 312 EAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 370
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-P 132
Q+ +G+ + + +HRDL+ NIL+ ++++ K+ADFGL+ + Y + P
Sbjct: 371 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 427
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
+ + APE + R+ K D+WS G +L EL G P+
Sbjct: 428 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 465
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-28
Identities = 44/157 (28%), Positives = 82/157 (52%), Gaps = 7/157 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E + ++HP +++ + E I++V E+ + G L +Y+R HG+ + +
Sbjct: 53 EAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYD 112
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-PL 133
+ G+ L SH IHRDL N L+ D+ +K++DFG++ + Y V P+
Sbjct: 113 VCEGMAFLESHQFIHRDLAARNCLVD---RDLCVKVSDFGMTRYVLDDQYVSSVGTKFPV 169
Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
+ APEV + +Y K D+W+ G +++E+ + G P+
Sbjct: 170 KWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY 206
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-28
Identities = 45/157 (28%), Positives = 78/157 (49%), Gaps = 7/157 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + ++HP +++L+ + I LV EF G LS Y+R G +T
Sbjct: 53 EAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 112
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-PL 133
+ G+ L +IHRDL N L+ ++ ++K++DFG++ + Y P+
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 169
Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
+ +PEV F RY K D+WS G +++E+ + G P+
Sbjct: 170 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 206
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-28
Identities = 45/180 (25%), Positives = 83/180 (46%), Gaps = 21/180 (11%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
LK+ ++ + E L+ + H +I+R F + +V E+ G+L+ ++R H
Sbjct: 78 ALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSH 137
Query: 61 GRVPEQTAR---------------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDD 105
G + A Q+ AG+ L H +HRDL N L+
Sbjct: 138 GPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---QG 194
Query: 106 VMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
+++KI DFG+S +Y +Y + L +M PE + ++++ + D+WS G +L+E+
Sbjct: 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-28
Identities = 56/183 (30%), Positives = 86/183 (46%), Gaps = 28/183 (15%)
Query: 16 ELNFLSSV-NHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLH------------- 60
EL L + +H N++ L A + + ++VEFC GNLS+Y+R
Sbjct: 80 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 61 GRVPEQTARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
T + Q+ G+E L S IHRDL NILLS + ++KI DFGL+
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLAR 196
Query: 118 TLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELL----NGYPPFSV 170
+Y + + L +MAPE + + Y + D+WS G +L+E+ + YP +
Sbjct: 197 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256
Query: 171 GEE 173
EE
Sbjct: 257 DEE 259
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-28
Identities = 46/155 (29%), Positives = 75/155 (48%), Gaps = 10/155 (6%)
Query: 15 CELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKF 71
E+ L ++ H NI++ N I L++EF G+L Y+ + ++ + K+
Sbjct: 72 KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY 131
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVC 129
Q+ G++ L S +HRDL N+L+ + +KI DFGL+ + Y K
Sbjct: 132 AVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTKAIETDKEYYTVKDD 188
Query: 130 G-SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
SP+ + APE L ++ D+WS G L ELL
Sbjct: 189 RDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 223
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-28
Identities = 44/182 (24%), Positives = 86/182 (47%), Gaps = 23/182 (12%)
Query: 1 MLKK-LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
LK L+ E + + HPN++ L + + ++ +C+ G+L ++ +
Sbjct: 46 TLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVM 105
Query: 60 HGRVPEQTAR----------------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD 103
+ + + Q+ AG+E L+SHH++H+DL N+L+
Sbjct: 106 RSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY--- 162
Query: 104 DDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFE 160
D + +KI+D GL +Y +Y + + S L +MAPE + + ++ D+WS G +L+E
Sbjct: 163 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWE 222
Query: 161 LL 162
+
Sbjct: 223 VF 224
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-28
Identities = 40/158 (25%), Positives = 79/158 (50%), Gaps = 9/158 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
E + + H +++L+ E I++V E+ + G+L +++ + +
Sbjct: 229 EAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-P 132
Q+ +G+ + + +HRDL+ NIL+ ++++ K+ADFGL+ + Y + P
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
+ + APE + R+ K D+WS G +L EL G P+
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-28
Identities = 43/181 (23%), Positives = 82/181 (45%), Gaps = 22/181 (12%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
LK + E L+++ H +I++ + + + +V E+ G+L+ ++R H
Sbjct: 52 ALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAH 111
Query: 61 GRVPEQTAR----------------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDD 104
G Q+ +G+ L S H +HRDL N L+
Sbjct: 112 GPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---A 168
Query: 105 DVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
++++KI DFG+S +Y +Y + L +M PE + ++++ + D+WS G IL+E+
Sbjct: 169 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 228
Query: 162 L 162
Sbjct: 229 F 229
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-28
Identities = 49/154 (31%), Positives = 80/154 (51%), Gaps = 10/154 (6%)
Query: 15 CELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
E++ L ++ H +II+ + LV+E+ G+L Y+ H + F
Sbjct: 82 QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFA 140
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG-- 130
QQ+ G+ L++ H IHRDL N+LL +D ++KI DFGL+ + G+ +V
Sbjct: 141 QQICEGMAYLHAQHYIHRDLAARNVLLD---NDRLVKIGDFGLAKAVPEGHEYYRVREDG 197
Query: 131 -SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
SP+ + APE L+ ++ D+WS G L+ELL
Sbjct: 198 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 231
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-28
Identities = 43/159 (27%), Positives = 79/159 (49%), Gaps = 11/159 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
E N + + H ++RL+ A + I+++ E+ G+L +++ + +
Sbjct: 58 EANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
Q+ G+ + + IHRDL+ NIL+S D + KIADFGL+ + Y + G+
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTARE-GAKF 172
Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
+ APE + + + K D+WS G +L E++ G P+
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-27
Identities = 44/157 (28%), Positives = 79/157 (50%), Gaps = 8/157 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + +HP+I++L +++++E C G L S++++ + + + Q
Sbjct: 441 EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 499
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG-SPL 133
L L L S +HRD+ N+L+S + +K+ DFGLS + Y + G P+
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 556
Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
+MAPE + F+R+ D+W G ++E+L G PF
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 593
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-27
Identities = 46/172 (26%), Positives = 86/172 (50%), Gaps = 13/172 (7%)
Query: 7 KHLKSCLDCELNFLS------SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
K +K E F+ +++H +++L+ + IF++ E+ A G L +Y+R
Sbjct: 54 KMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM 113
Query: 61 -GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
R Q + + + +E L S +HRDL N L++ D ++K++DFGLS +
Sbjct: 114 RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRYV 170
Query: 120 YPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
Y V P+ + PEVL + ++ K D+W+ G +++E+ + G P+
Sbjct: 171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 222
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-27
Identities = 46/158 (29%), Positives = 83/158 (52%), Gaps = 9/158 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E N + +++P I+R+ +AE+ LV+E G L+ Y++ + V ++ + + Q+
Sbjct: 68 EANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 126
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGS--P 132
G++ L + +HRDL N+LL KI+DFGLS L NY + P
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKAQTHGKWP 183
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
+ + APE + + ++ K D+WS G +++E + G P+
Sbjct: 184 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 221
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-27
Identities = 57/201 (28%), Positives = 83/201 (41%), Gaps = 32/201 (15%)
Query: 1 MLKKLNKHLKSCLD--CELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
MLK + HL EL LS + NH NI+ L A ++ E+C G+L +++
Sbjct: 60 MLKP-SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 118
Query: 58 R---------------LHGRVPEQTARKFLQ---QLGAGLEILNSHHIIHRDLKPENILL 99
R + L Q+ G+ L S + IHRDL NILL
Sbjct: 119 RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178
Query: 100 SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGA 156
+ + KI DFGL+ + + + L +MAPE + Y + D+WS G
Sbjct: 179 T--HGRIT-KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 235
Query: 157 ILFEL--LNG--YPPFSVGEE 173
L+EL L YP V +
Sbjct: 236 FLWELFSLGSSPYPGMPVDSK 256
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-27
Identities = 47/170 (27%), Positives = 76/170 (44%), Gaps = 11/170 (6%)
Query: 16 ELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFL 72
E+ L +++ I++ + LV+E+ G L +++ H R+ +
Sbjct: 74 EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 133
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCG- 130
Q+ G+E L S +HRDL NIL+ + +KIADFGL+ L +Y
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLAKLLPLDKDYYVVREPG 190
Query: 131 -SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSVGEEHQFM 177
SP+ + APE L + + D+WS G +L+EL S E M
Sbjct: 191 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM 240
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-27
Identities = 49/173 (28%), Positives = 80/173 (46%), Gaps = 30/173 (17%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
E N L VNHP++I+L+ A + + L+VE+ G+L ++R +V
Sbjct: 76 EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 67 ------------TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
T + Q+ G++ L ++HRDL NIL++ + M KI+
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA--EGRKM-KIS 192
Query: 112 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
DFGLS +Y + K + +MA E L Y + D+WS G +L+E+
Sbjct: 193 DFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-27
Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 9/159 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + + +HPNIIRL +V E+ G+L +++R H G+ L+
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRG 159
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--- 131
+GAG+ L+ +HRDL N+L+ +++ K++DFGLS L A
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNVLVD---SNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI 216
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
P+ + APE + F+ + D+WS G +++E+L G P+
Sbjct: 217 PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY 255
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-27
Identities = 47/163 (28%), Positives = 76/163 (46%), Gaps = 15/163 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E+N + S++H N+IRL+ + +V E G+L +R H G T ++ Q
Sbjct: 71 EVNAMHSLDHRNLIRLY-GVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPL 133
+ G+ L S IHRDL N+LL+ ++KI DFGL L ++ +
Sbjct: 130 VAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186
Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 173
+ APE L+ + + D W G L+E+ F+ G+E
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEM------FTYGQE 223
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-27
Identities = 47/155 (30%), Positives = 77/155 (49%), Gaps = 10/155 (6%)
Query: 15 CELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKF 71
E+ L S+ H NI++ + L++E+ G+L Y++ H R+ ++
Sbjct: 60 REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 119
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVC 129
Q+ G+E L + IHRDL NIL+ ++ +KI DFGL+ L + K
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTKVLPQDKEFFKVKEP 176
Query: 130 G-SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
G SP+ + APE L ++ D+WS G +L+EL
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 211
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-27
Identities = 48/155 (30%), Positives = 77/155 (49%), Gaps = 10/155 (6%)
Query: 15 CELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKF 71
E+ L S+ H NI++ + L++E+ G+L Y++ H R+ ++
Sbjct: 91 REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 150
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVC 129
Q+ G+E L + IHRDL NIL+ ++ +KI DFGL+ L Y K
Sbjct: 151 TSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTKVLPQDKEYYKVKEP 207
Query: 130 G-SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
G SP+ + APE L ++ D+WS G +L+EL
Sbjct: 208 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 242
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-27
Identities = 43/151 (28%), Positives = 78/151 (51%), Gaps = 8/151 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
E N + ++ H +++L A + I+++ EF A G+L +++ + + F
Sbjct: 233 EANVMKTLQHDKLVKLH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 291
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-P 132
Q+ G+ + + IHRDL+ NIL+S ++ KIADFGL+ + Y + P
Sbjct: 292 QIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIEDNEYTAREGAKFP 348
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
+ + APE + F + K D+WS G +L E++
Sbjct: 349 IKWTAPEAINFGSFTIKSDVWSFGILLMEIV 379
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-27
Identities = 44/157 (28%), Positives = 79/157 (50%), Gaps = 8/157 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + +HP+I++L +++++E C G L S++++ + + + Q
Sbjct: 66 EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 124
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG-SPL 133
L L L S +HRD+ N+L+S + +K+ DFGLS + Y + G P+
Sbjct: 125 LSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 181
Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
+MAPE + F+R+ D+W G ++E+L G PF
Sbjct: 182 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 218
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-27
Identities = 44/193 (22%), Positives = 76/193 (39%), Gaps = 33/193 (17%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+LKK+ + K N + + D F + + E G N +++ +
Sbjct: 69 VLKKIKEKDKE------------NKFLCVLMSDWFNFHGHMCIAFE-LLGKNTFEFLKEN 115
Query: 61 GRV--PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVM----------- 107
P R QL L L+ + + H DLKPENIL + + +
Sbjct: 116 NFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175
Query: 108 -----LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
+++ADFG + + + + + Y PEV+ + + D+WS+G ILFE
Sbjct: 176 VKNTSIRVADFGSAT--FDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYY 233
Query: 163 NGYPPFSVGEEHQ 175
G+ F E +
Sbjct: 234 RGFTLFQTHENRE 246
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-26
Identities = 43/160 (26%), Positives = 82/160 (51%), Gaps = 9/160 (5%)
Query: 15 CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
E + + +HPNIIRL + +V E+ G+L S++R H + L+
Sbjct: 95 GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSP 132
+ +G++ L+ +HRDL NIL++ +++ K++DFGL L A G
Sbjct: 155 GIASGMKYLSDMGYVHRDLAARNILIN---SNLVCKVSDFGLGRVLEDDPEAAYTTRGGK 211
Query: 133 L---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
+ + +PE + ++++ D+WS G +L+E+++ G P+
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-26
Identities = 44/159 (27%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + +++P I+RL + LV+E GG L ++ +P + L Q
Sbjct: 60 EAQIMHQLDNPYIVRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPL 133
+ G++ L + +HRDL N+LL + KI+DFGLS L +Y
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKW 175
Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
+ APE + F+++ + D+WS G ++E L+ G P+
Sbjct: 176 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 214
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-26
Identities = 52/190 (27%), Positives = 80/190 (42%), Gaps = 34/190 (17%)
Query: 15 CELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH------------- 60
EL ++ + +H NI+ L A I+L+ E+C G+L +Y+R
Sbjct: 97 SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156
Query: 61 -------GRVPEQTARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
+ T L Q+ G+E L +HRDL N+L++ V+ KI
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT--HGKVV-KI 213
Query: 111 ADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNG- 164
DFGL+ + + + L +MAPE L Y K D+WS G +L+E+ L
Sbjct: 214 CDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273
Query: 165 -YPPFSVGEE 173
YP V
Sbjct: 274 PYPGIPVDAN 283
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-26
Identities = 42/159 (26%), Positives = 78/159 (49%), Gaps = 9/159 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + +H NIIRL + ++ E+ G L ++R G L+
Sbjct: 96 EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 155
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC-GSPL 133
+ AG++ L + + +HRDL NIL++ +++ K++DFGLS L A G +
Sbjct: 156 IAAGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 212
Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
+ APE + ++++ D+WS G +++E++ G P+
Sbjct: 213 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 251
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-26
Identities = 41/158 (25%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + +++HP+I++L + E ++++E G L Y+ + + T + Q
Sbjct: 63 EAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ 121
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
+ + L S + +HRD+ NIL++ +K+ DFGLS + +Y K + L
Sbjct: 122 ICKAMAYLESINCVHRDIAVRNILVA---SPECVKLGDFGLSRYIEDEDY-YKASVTRLP 177
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
+M+PE + F+R+ D+W ++E+L+ G PF
Sbjct: 178 IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 215
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-26
Identities = 43/186 (23%), Positives = 76/186 (40%), Gaps = 33/186 (17%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+L+ LN + + +++ + F+ I +V E G + +I+ +
Sbjct: 64 VLEHLNTTDPN------------STFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKEN 110
Query: 61 GRV--PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL----------------SGL 102
G + RK Q+ + L+S+ + H DLKPENIL
Sbjct: 111 GFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170
Query: 103 DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
+ +K+ DFG + Y + + + Y APEV+ + + D+WS+G IL E
Sbjct: 171 LINPDIKVVDFGSAT--YDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYY 228
Query: 163 NGYPPF 168
G+ F
Sbjct: 229 LGFTVF 234
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-26
Identities = 29/150 (19%), Positives = 48/150 (32%), Gaps = 31/150 (20%)
Query: 20 LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGL 79
LS ++ P + R+ D +V E+ GG+L P R +Q L A
Sbjct: 85 LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD-TSPSPVGAIR-AMQSLAAAA 142
Query: 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 139
+ + + P + +S D DV +A M
Sbjct: 143 DAAHRAGVALSIDHPSRVRVSI-DGDV--VLAYPA-------------------TMPDA- 179
Query: 140 LQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
+ + D+ +GA L+ LL P
Sbjct: 180 ------NPQDDIRGIGASLYALLVNRWPLP 203
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-26
Identities = 45/190 (23%), Positives = 86/190 (45%), Gaps = 31/190 (16%)
Query: 1 MLKK-LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
MLK+ + +++ E ++ ++PNI++L + L+ E+ A G+L+ ++R
Sbjct: 84 MLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRS 143
Query: 60 HGRVPEQTAR------------------------KFLQQLGAGLEILNSHHIIHRDLKPE 95
+ +Q+ AG+ L+ +HRDL
Sbjct: 144 MSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 203
Query: 96 NILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMW 152
N L+ ++ V+ KIADFGLS +Y +Y + + +M PE + + RY + D+W
Sbjct: 204 NCLVG--ENMVV-KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVW 260
Query: 153 SVGAILFELL 162
+ G +L+E+
Sbjct: 261 AYGVVLWEIF 270
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-26
Identities = 49/167 (29%), Positives = 73/167 (43%), Gaps = 26/167 (15%)
Query: 15 CELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR---- 69
EL L + +HPNII L A + ++L +E+ GNL ++R + A
Sbjct: 74 GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133
Query: 70 ------------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
F + G++ L+ IHRDL NIL+ ++ + KIADFGLS
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSR 190
Query: 118 TLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
K L +MA E L + Y D+WS G +L+E+
Sbjct: 191 G---QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 234
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-26
Identities = 43/182 (23%), Positives = 69/182 (37%), Gaps = 32/182 (17%)
Query: 16 ELNFLSSVNH-----PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTA 68
E + L + + NI++ F + + L+ E G +L I + +
Sbjct: 81 EADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDI 139
Query: 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILL----------------------SGLDDDV 106
+ + ++ L L + H DLKPENILL
Sbjct: 140 KLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
Query: 107 MLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166
+K+ DFG + + +Y + + Y APEV+ +D DMWS G +L EL G
Sbjct: 200 GIKLIDFGCAT--FKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257
Query: 167 PF 168
F
Sbjct: 258 LF 259
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-25
Identities = 43/159 (27%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + +++P I+RL + LV+E GG L ++ +P + L Q
Sbjct: 386 EAQIMHQLDNPYIVRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 444
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPL 133
+ G++ L + +HR+L N+LL + KI+DFGLS L +Y
Sbjct: 445 VSMGMKYLEEKNFVHRNLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKW 501
Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
+ APE + F+++ + D+WS G ++E L+ G P+
Sbjct: 502 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 540
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-25
Identities = 49/166 (29%), Positives = 83/166 (50%), Gaps = 23/166 (13%)
Query: 16 ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ-------- 66
E+ + + H NII L A + ++++VE+ + GNL Y+R +
Sbjct: 90 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 67 -----TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
T + + QL G+E L S IHRDL N+L++ ++ ++KIADFGL+
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARD 206
Query: 119 LYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
+ +Y +K L +MAPE L + Y + D+WS G +++E+
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-25
Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 23/166 (13%)
Query: 16 ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR----- 69
E+ + + H NII L A + ++++VE+ + GNL Y+R + +
Sbjct: 136 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 195
Query: 70 -----------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
QL G+E L S IHRDL N+L++ +++VM KIADFGL+
Sbjct: 196 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT--ENNVM-KIADFGLARD 252
Query: 119 LYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
+ +Y +K L +MAPE L + Y + D+WS G +++E+
Sbjct: 253 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-25
Identities = 48/166 (28%), Positives = 85/166 (51%), Gaps = 23/166 (13%)
Query: 16 ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ-------- 66
E+ + + H NII L A + ++++VE+ + GNL Y++ +
Sbjct: 124 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183
Query: 67 -----TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
+++ + Q+ G+E L S IHRDL N+L++ +D ++KIADFGL+
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARD 240
Query: 119 LYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
++ +Y +K L +MAPE L + Y + D+WS G +L+E+
Sbjct: 241 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 286
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-25
Identities = 37/177 (20%), Positives = 83/177 (46%), Gaps = 13/177 (7%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+L K +++ + +S ++H +++ + + LV EF G+L +Y++ +
Sbjct: 47 VLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN 106
Query: 61 -GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD-----DDVMLKIADFG 114
+ + +QL A + L + +IH ++ +NILL + + +K++D G
Sbjct: 107 KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG 166
Query: 115 LSCTLYPGNYAEKVCGSPL-YMAPEVLQ-FQRYDEKVDMWSVGAILFELL-NGYPPF 168
+S T+ P + ++ + ++ PE ++ + + D WS G L+E+ G P
Sbjct: 167 ISITVLPKDILQE----RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 3e-23
Identities = 52/162 (32%), Positives = 78/162 (48%), Gaps = 16/162 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ LS HP+++ L N + L+ ++ GNL + L+G + + Q+L
Sbjct: 85 EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH--LYGSDLPTMSMSWEQRL 142
Query: 76 ----GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--- 126
GA GL L++ IIHRD+K NIL LD++ + KI DFG+S
Sbjct: 143 EICIGAARGLHYLHTRAIIHRDVKSINIL---LDENFVPKITDFGIS-KKGTELDQTHLS 198
Query: 127 -KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167
V G+ Y+ PE R EK D++S G +LFE+L
Sbjct: 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-19
Identities = 49/176 (27%), Positives = 73/176 (41%), Gaps = 30/176 (17%)
Query: 16 ELNFLSSVNHPNIIRL--FDAFQAENCI-----FLVVEFCAGGNLSSYIRLHGRVPEQT- 67
E+ ++ H N++ L F LV + G+L RL
Sbjct: 80 EIKVMAKCQHENLVELLGF-------SSDGDDLCLVYVYMPNGSLLD--RLSCLDGTPPL 130
Query: 68 --ARKFLQQLGA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
+ GA G+ L+ +H IHRD+K NIL LD+ KI+DFGL+
Sbjct: 131 SWHMRCKIAQGAANGINFLHENHHIHRDIKSANIL---LDEAFTAKISDFGLA-RASEKF 186
Query: 124 YAE----KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 175
++ G+ YMAPE L+ K D++S G +L E++ G P E Q
Sbjct: 187 AQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 2e-19
Identities = 57/233 (24%), Positives = 88/233 (37%), Gaps = 70/233 (30%)
Query: 2 LK--KLNKHLKSCLDCELNFLSSV-----NHPN---IIRLFDAFQAEN------CIFLVV 45
+K K +H E+ L SV N PN +++L D F+ C +V
Sbjct: 67 MKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHIC--MVF 124
Query: 46 EFCAGGNLSSYIRL--HGRVPEQTARKFLQQLGAGLEILNSH-HIIHRDLKPENILLSGL 102
E G +L +I + +P +K +QQ+ GL+ L++ IIH D+KPENILLS
Sbjct: 125 EV-LGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVN 183
Query: 103 DDDVM----------------------------------------------LKIADFGLS 116
+ + +KIAD G +
Sbjct: 184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA 243
Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
C + + + + Y + EVL Y+ D+WS + FEL G F
Sbjct: 244 C--WVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFE 294
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-19
Identities = 51/167 (30%), Positives = 75/167 (44%), Gaps = 22/167 (13%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA----RKF 71
E+ +S H N++RL LV + A G+++S L R Q ++
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVAS--CLRERPESQPPLDWPKRQ 134
Query: 72 LQQLGA--GLEILNSH-----HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 124
LG+ GL L H IIHRD+K NIL LD++ + DFGL+ L
Sbjct: 135 RIALGSARGLAYL--HDHCDPKIIHRDVKAANIL---LDEEFEAVVGDFGLA-KLMDYKD 188
Query: 125 AE---KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
V G+ ++APE L + EK D++ G +L EL+ G F
Sbjct: 189 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 3e-18
Identities = 38/111 (34%), Positives = 58/111 (52%), Gaps = 10/111 (9%)
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
+ Q+ G+E L S IHRDL NILLS + ++KI DFGL+ +Y +
Sbjct: 197 CYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDYVRKG 253
Query: 130 GSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELL----NGYPPFSVGEE 173
+ L +MAPE + + Y + D+WS G +L+E+ + YP + EE
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 304
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 39.9 bits (93), Expect = 2e-04
Identities = 28/136 (20%), Positives = 47/136 (34%), Gaps = 7/136 (5%)
Query: 1 MLKK-LNKHLKSCLDCELNFLSSV-NHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
MLK+ L EL L + +H N++ L A + + ++VEFC GNLS+Y+
Sbjct: 59 MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 118
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
R K + + + I DLK ++ +
Sbjct: 119 RSKRNEFVPYKTKGARF----RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174
Query: 118 TLYPGNYAEKVCGSPL 133
+ E + L
Sbjct: 175 DVEEEEAPEDLYKDFL 190
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 7e-11
Identities = 26/117 (22%), Positives = 50/117 (42%), Gaps = 3/117 (2%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRL-FDAFQAENCIFLVVEFCAGGNLSSYIRL 59
+++ K E L + P F+ + F+V+E G +L
Sbjct: 86 FYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ 144
Query: 60 HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
+G + T + ++ LE ++ + +H D+K N+LL G + + +AD+GLS
Sbjct: 145 NGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLL-GYKNPDQVYLADYGLS 200
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 3e-10
Identities = 32/192 (16%), Positives = 68/192 (35%), Gaps = 30/192 (15%)
Query: 4 KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCI-------------------FLV 44
K+ L EL F P I+ + + + F++
Sbjct: 71 KVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMI 130
Query: 45 VEFCAGGNLSSYIRLHGRV-PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD 103
++ G +L + + +T + ++ LE ++ H +H D+K N+LL
Sbjct: 131 MDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLL-NYK 188
Query: 104 DDVMLKIADFGLSCTLYPGN------YAEKVC--GSPLYMAPEVLQFQRYDEKVDMWSVG 155
+ + + D+GL+ P K C G+ + + + + D+ +G
Sbjct: 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILG 248
Query: 156 AILFELLNGYPP 167
+ + L G+ P
Sbjct: 249 YCMIQWLTGHLP 260
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 8e-10
Identities = 35/154 (22%), Positives = 59/154 (38%), Gaps = 16/154 (10%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGAGLEILNS 84
I + + +V+E G +L R +T Q+ + +E ++S
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 123
Query: 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------YAEK--VCGSPLYMA 136
+ IHRD+KP+N L+ ++ I DFGL+ Y E + G+ Y +
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183
Query: 137 PEVLQFQ---RYDEKVDMWSVGAILFELLNGYPP 167
R D D+ S+G +L G P
Sbjct: 184 INTHLGIEQSRRD---DLESLGYVLMYFNLGSLP 214
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.8 bits (134), Expect = 9e-10
Identities = 35/156 (22%), Positives = 58/156 (37%), Gaps = 16/156 (10%)
Query: 24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQLGAGLEIL 82
I + + LV++ G +L R +T Q+ +E +
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
Query: 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------YAEK--VCGSPLY 134
+S +HRD+KP+N L+ + I DFGL+ + Y E + G+ Y
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
Query: 135 MAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPP 167
+ R D D+ S+G +L L G P
Sbjct: 180 ASVNTHLGIEQSRRD---DLESLGYVLMYFLRGSLP 212
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-08
Identities = 34/153 (22%), Positives = 66/153 (43%), Gaps = 12/153 (7%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQLGAGLEILNS 84
I ++ Q LV++ G +L + L GR +T +Q+ A ++ ++
Sbjct: 66 TGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 124
Query: 85 HHIIHRDLKPENILL--SGLDDDVMLKIADFGLS------CTLYPGNYAEK--VCGSPLY 134
+++RD+KP+N L+ + M+ + DFG+ T Y EK + G+ Y
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167
M+ + + D+ ++G + L G P
Sbjct: 185 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 3e-08
Identities = 18/77 (23%), Positives = 39/77 (50%), Gaps = 4/77 (5%)
Query: 42 FLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL 99
FLV+ G +L S + + + + E++ + +L LE L+ + +H ++ ENI +
Sbjct: 134 FLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192
Query: 100 SGLDDDVMLKIADFGLS 116
+D + +A +G +
Sbjct: 193 -DPEDQSQVTLAGYGFA 208
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-08
Identities = 39/157 (24%), Positives = 66/157 (42%), Gaps = 20/157 (12%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQLGAGLEILNS 84
I +++ +V+E G +L L R +T QL + +E ++S
Sbjct: 65 DGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS 123
Query: 85 HHIIHRDLKPENILL--SGLDDDVMLKIADFGLSCTLY--PGN-----YAEK--VCGSPL 133
++I+RD+KPEN L+ G ++ I DF L+ Y P Y E + G+
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA-KEYIDPETKKHIPYREHKSLTGTAR 182
Query: 134 YMAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPP 167
YM+ + R D D+ ++G + L G P
Sbjct: 183 YMSINTHLGKEQSRRD---DLEALGHMFMYFLRGSLP 216
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 1e-06
Identities = 22/88 (25%), Positives = 35/88 (39%), Gaps = 5/88 (5%)
Query: 38 ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL-NSHHIIHRDLKPEN 96
++ +F+V+EF GG +R A+ L QL A L + S HRDL N
Sbjct: 134 DDQLFIVLEFEFGGIDLEQMRTKLSSLAT-AKSILHQLTASLAVAEASLRFEHRDLHWGN 192
Query: 97 ILLSGLDDDVMLKIADFGLSCTLYPGNY 124
+L L + K+ + +
Sbjct: 193 VL---LKKTSLKKLHYTLNGKSSTIPSC 217
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 177 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.78 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.62 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.38 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.09 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.0 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.93 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.69 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.66 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.48 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.07 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.96 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.59 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.16 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.93 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 96.92 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.34 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.29 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.09 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.75 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.56 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 94.81 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 94.79 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 92.16 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 91.8 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 91.28 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 89.09 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 85.41 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 83.09 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 82.39 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 81.55 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=285.10 Aligned_cols=163 Identities=34% Similarity=0.662 Sum_probs=149.7
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
..+.+.+|++++++++||||+++++++.+.+.+|+||||++||+|.+++.+.+.+++..+..++.|++.||+|||++||+
T Consensus 75 ~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~Ii 154 (311)
T 4aw0_A 75 KVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGII 154 (311)
T ss_dssp CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 45679999999999999999999999999999999999999999999999888999999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCC---CccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~ 165 (177)
||||||+||++ +.++.+||+|||+++..... ....+..||+.|+|||.+.+..++.++|+||+||++|+|++|+
T Consensus 155 HRDlKPeNILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~ 231 (311)
T 4aw0_A 155 HRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 231 (311)
T ss_dssp CSCCSGGGEEE---CTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSS
T ss_pred cCCCCHHHeEE---cCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 99999999999 56788999999999876433 2334567999999999999889999999999999999999999
Q ss_pred CCCCCCCcc
Q 030430 166 PPFSVGEEH 174 (177)
Q Consensus 166 ~pf~~~~~~ 174 (177)
.||.+.+..
T Consensus 232 ~PF~~~~~~ 240 (311)
T 4aw0_A 232 PPFRAGNEG 240 (311)
T ss_dssp CSSCCSSHH
T ss_pred CCCCCCCHH
Confidence 999887654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=285.29 Aligned_cols=166 Identities=27% Similarity=0.589 Sum_probs=149.0
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh 83 (177)
+....+.+.+|++++++++||||+++++++.+++.+|+||||++||+|.+++...+ .+++..++.++.|++.||+|||
T Consensus 63 ~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH 142 (350)
T 4b9d_A 63 SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142 (350)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 45567889999999999999999999999999999999999999999999997543 4789999999999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccCCCCCcchHHHHHHHHHHHH
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~ 162 (177)
++||+||||||+|||+ +..+.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 143 ~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyeml 219 (350)
T 4b9d_A 143 DRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELC 219 (350)
T ss_dssp HTTCEETTCCGGGEEE---CTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred HCCeeeccCCHHHEEE---CCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999999999 567789999999997764432 233456999999999999889999999999999999999
Q ss_pred hCCCCCCCCCcc
Q 030430 163 NGYPPFSVGEEH 174 (177)
Q Consensus 163 ~~~~pf~~~~~~ 174 (177)
+|+.||.+.+..
T Consensus 220 tG~~PF~~~~~~ 231 (350)
T 4b9d_A 220 TLKHAFEAGSMK 231 (350)
T ss_dssp HSSCSCCCSSHH
T ss_pred HCCCCCCCcCHH
Confidence 999999887654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=283.43 Aligned_cols=163 Identities=26% Similarity=0.570 Sum_probs=148.2
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
....+.+.+|+++|++++||||+++++++.+++.+|+||||++||+|.+++.+ ..++++.+..++.|++.||+|||++|
T Consensus 112 ~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~ 190 (346)
T 4fih_A 112 QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG 190 (346)
T ss_dssp CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34467789999999999999999999999999999999999999999999875 57999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCC-CccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCC
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~ 165 (177)
|+||||||+|||+ +..+.+||+|||++...... ....+..||+.|+|||.+.+..++.++||||+||++|+|++|+
T Consensus 191 IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~ 267 (346)
T 4fih_A 191 VIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 267 (346)
T ss_dssp EECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred cccccCCHHHEEE---CCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 9999999999999 56778999999999876544 3345667999999999999889999999999999999999999
Q ss_pred CCCCCCCc
Q 030430 166 PPFSVGEE 173 (177)
Q Consensus 166 ~pf~~~~~ 173 (177)
.||.+.+.
T Consensus 268 ~PF~~~~~ 275 (346)
T 4fih_A 268 PPYFNEPP 275 (346)
T ss_dssp CTTTTSCH
T ss_pred CCCCCcCH
Confidence 99987654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=272.07 Aligned_cols=163 Identities=33% Similarity=0.637 Sum_probs=144.3
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEee----CCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (177)
++...+++.+|++++++++|||||++++++.+ ...+|+||||++||+|.+++.+.+.+++..+..++.|++.||+|
T Consensus 65 ~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~y 144 (290)
T 3fpq_A 65 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF 144 (290)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Confidence 45567889999999999999999999999865 35689999999999999999988899999999999999999999
Q ss_pred HhhCC--CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHH
Q 030430 82 LNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (177)
Q Consensus 82 lh~~~--~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~ 159 (177)
||++| |+||||||+||++. +..+.+||+|||+++... .....+..||+.|+|||.+. ..++.++||||+||++|
T Consensus 145 lH~~~~~IiHRDlKp~NILl~--~~~g~vKl~DFGla~~~~-~~~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvily 220 (290)
T 3fpq_A 145 LHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCML 220 (290)
T ss_dssp HHTSSSCCCCCCCCGGGEEES--STTSCEEECCTTGGGGCC-TTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHH
T ss_pred HHHCCCCEEecccChhheeEE--CCCCCEEEEeCcCCEeCC-CCccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHH
Confidence 99998 99999999999994 246789999999996543 33344567999999999886 46999999999999999
Q ss_pred HHHhCCCCCCCCC
Q 030430 160 ELLNGYPPFSVGE 172 (177)
Q Consensus 160 ~~~~~~~pf~~~~ 172 (177)
+|+||+.||.+.+
T Consensus 221 elltg~~Pf~~~~ 233 (290)
T 3fpq_A 221 EMATSEYPYSECQ 233 (290)
T ss_dssp HHHHSSCTTTTCS
T ss_pred HHHHCCCCCCCCC
Confidence 9999999997654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=273.44 Aligned_cols=163 Identities=40% Similarity=0.759 Sum_probs=137.6
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
....++.+|++++++++||||+++++++.+.+.+|+||||+ +|+|.+++.+.+.+++..+..++.|++.||+|||++|+
T Consensus 55 ~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~I 133 (275)
T 3hyh_A 55 DMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 133 (275)
T ss_dssp -CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 44667999999999999999999999999999999999999 78999999988899999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCC-CCcchHHHHHHHHHHHHhCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slg~~~~~~~~~~~ 166 (177)
+||||||+||++ +..+.++|+|||++..........+..||+.|+|||.+.+..+ +.++|+||+||++|+|++|+.
T Consensus 134 iHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~ 210 (275)
T 3hyh_A 134 VHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRL 210 (275)
T ss_dssp CCCCCCTTTEEE---CTTCCEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccccCChHHeEE---CCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCC
Confidence 999999999999 5677899999999987666555556779999999999987776 579999999999999999999
Q ss_pred CCCCCCcc
Q 030430 167 PFSVGEEH 174 (177)
Q Consensus 167 pf~~~~~~ 174 (177)
||.+.+..
T Consensus 211 PF~~~~~~ 218 (275)
T 3hyh_A 211 PFDDESIP 218 (275)
T ss_dssp SSCCSSHH
T ss_pred CCCCCCHH
Confidence 99886543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-48 Score=281.84 Aligned_cols=164 Identities=37% Similarity=0.611 Sum_probs=142.4
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
...++.+|++++++++||||+++++++.+++.+|+||||++||+|.+++.+.+.+++..+..++.|++.||+|||++|++
T Consensus 69 ~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~Ii 148 (304)
T 3ubd_A 69 DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 148 (304)
T ss_dssp ECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 34578899999999999999999999999999999999999999999999888999999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCC-CccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
||||||+||++ +..+.+||+|||+++..... ....+..||+.|+|||.+.+..++.++|+||+||++|+|++|+.|
T Consensus 149 HRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~P 225 (304)
T 3ubd_A 149 YRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225 (304)
T ss_dssp CSSCCGGGEEE---CTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCCCHHHeEE---cCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCC
Confidence 99999999999 56778999999999765433 334456799999999999989999999999999999999999999
Q ss_pred CCCCCccc
Q 030430 168 FSVGEEHQ 175 (177)
Q Consensus 168 f~~~~~~~ 175 (177)
|.+.+..+
T Consensus 226 F~~~~~~~ 233 (304)
T 3ubd_A 226 FQGKDRKE 233 (304)
T ss_dssp SCCSSHHH
T ss_pred CCCcCHHH
Confidence 98876543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=277.96 Aligned_cols=161 Identities=32% Similarity=0.514 Sum_probs=142.2
Q ss_pred HHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCeeecC
Q 030430 13 LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDL 92 (177)
Q Consensus 13 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H~~i 92 (177)
..+|++++++++|||||++++++.+++.+|+||||++||+|.+++.+.+.+++..+..++.|++.||+|||++||+||||
T Consensus 97 ~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDl 176 (336)
T 4g3f_A 97 RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 176 (336)
T ss_dssp CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCC
T ss_pred HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccc
Confidence 35799999999999999999999999999999999999999999998889999999999999999999999999999999
Q ss_pred CCCcEEEecCCCCeeEEEeeeccccccCCCCc------cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 93 KPENILLSGLDDDVMLKIADFGLSCTLYPGNY------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 93 ~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~------~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
||+|||++ .++..+||+|||+++....... .....||+.|+|||++.+..++.++||||+||++|+|++|+.
T Consensus 177 Kp~NILl~--~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~ 254 (336)
T 4g3f_A 177 KADNVLLS--SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254 (336)
T ss_dssp CGGGEEEC--TTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CHHHEEEe--CCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcC
Confidence 99999995 2234699999999987644321 123469999999999999999999999999999999999999
Q ss_pred CCCCCCccc
Q 030430 167 PFSVGEEHQ 175 (177)
Q Consensus 167 pf~~~~~~~ 175 (177)
||.+.+..+
T Consensus 255 Pf~~~~~~~ 263 (336)
T 4g3f_A 255 PWTQYFRGP 263 (336)
T ss_dssp SSTTTCCSC
T ss_pred CCCCCCHHH
Confidence 998866544
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=276.30 Aligned_cols=167 Identities=25% Similarity=0.587 Sum_probs=148.5
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-------------CCCCHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-------------GRVPEQTARKFL 72 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~~ 72 (177)
+...++.+.+|++++++++|||||++++++.+++.+++||||++||+|.+++..+ ..+++.++..++
T Consensus 55 ~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 134 (299)
T 4asz_A 55 SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIA 134 (299)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHH
Confidence 4566788999999999999999999999999999999999999999999999754 259999999999
Q ss_pred HHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCCCcc
Q 030430 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKV 149 (177)
Q Consensus 73 ~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~ 149 (177)
.|++.||+|||+.+++||||||+||++ +.++.+||+|||+++....... .....+++.|+|||.+.+..++.++
T Consensus 135 ~qia~gl~yLH~~~iiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~ 211 (299)
T 4asz_A 135 QQIAAGMVYLASQHFVHRDLATRNCLV---GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES 211 (299)
T ss_dssp HHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHH
T ss_pred HHHHHHHHHHHhCCcccCccCHhhEEE---CCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchh
Confidence 999999999999999999999999999 5678899999999976544332 2234578999999999989999999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCCccc
Q 030430 150 DMWSVGAILFELLN-GYPPFSVGEEHQ 175 (177)
Q Consensus 150 Di~slg~~~~~~~~-~~~pf~~~~~~~ 175 (177)
||||+|+++|||+| |+.||.+.+..+
T Consensus 212 DVwS~Gvvl~Ellt~G~~Pf~~~~~~~ 238 (299)
T 4asz_A 212 DVWSLGVVLWEIFTYGKQPWYQLSNNE 238 (299)
T ss_dssp HHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred hHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 99999999999999 899998866543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=284.62 Aligned_cols=163 Identities=26% Similarity=0.570 Sum_probs=148.1
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
...++.+.+|+++|++++||||+++++++.+++.+|+||||++||+|.+++.. ..+++..+..++.|++.||+|||++|
T Consensus 189 ~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~ 267 (423)
T 4fie_A 189 QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG 267 (423)
T ss_dssp CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 44567799999999999999999999999999999999999999999999874 57999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCC-CccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCC
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~ 165 (177)
|+||||||+|||+ +..+.+||+|||++...... ....+..||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus 268 IiHRDiKp~NILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~ 344 (423)
T 4fie_A 268 VIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 344 (423)
T ss_dssp EECCCCSTTTEEE---CTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred eecccCCHHHEEE---cCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 9999999999999 56778999999999876543 3345667999999999999889999999999999999999999
Q ss_pred CCCCCCCc
Q 030430 166 PPFSVGEE 173 (177)
Q Consensus 166 ~pf~~~~~ 173 (177)
.||.+.+.
T Consensus 345 ~PF~~~~~ 352 (423)
T 4fie_A 345 PPYFNEPP 352 (423)
T ss_dssp CTTTTSCH
T ss_pred CCCCCcCH
Confidence 99987654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=273.15 Aligned_cols=167 Identities=25% Similarity=0.531 Sum_probs=141.7
Q ss_pred cchhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc---------------CCCCHHHHH
Q 030430 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---------------GRVPEQTAR 69 (177)
Q Consensus 5 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~ 69 (177)
.++..++.|.+|++++++++|||||++++++.+++.+++||||+++|+|.+++.+. ..+++.++.
T Consensus 82 ~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~ 161 (329)
T 4aoj_A 82 ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 161 (329)
T ss_dssp CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHH
T ss_pred CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHH
Confidence 35666788999999999999999999999999999999999999999999999754 248999999
Q ss_pred HHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC---ccccccCCCccccccccccCCCC
Q 030430 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYD 146 (177)
Q Consensus 70 ~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~ 146 (177)
.++.|++.||+|||+.+++||||||+||+++ ....+||+|||+++...... ......+++.|+|||.+.+..++
T Consensus 162 ~i~~qia~gl~yLH~~~iiHRDLKp~NILl~---~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~ 238 (329)
T 4aoj_A 162 AVASQVAAGMVYLAGLHFVHRDLATRNCLVG---QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT 238 (329)
T ss_dssp HHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCC
T ss_pred HHHHHHHHHHHHHhcCCeecccccHhhEEEC---CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCC
Confidence 9999999999999999999999999999994 67889999999997664432 22345688999999999999999
Q ss_pred CcchHHHHHHHHHHHHh-CCCCCCCCCcc
Q 030430 147 EKVDMWSVGAILFELLN-GYPPFSVGEEH 174 (177)
Q Consensus 147 ~~~Di~slg~~~~~~~~-~~~pf~~~~~~ 174 (177)
.++||||+|+++|||+| |+.||.+.+..
T Consensus 239 ~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~ 267 (329)
T 4aoj_A 239 TESDVWSFGVVLWEIFTYGKQPWYQLSNT 267 (329)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTCSSCHH
T ss_pred ccccccchHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999999999999 89999876544
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=266.17 Aligned_cols=164 Identities=27% Similarity=0.501 Sum_probs=139.5
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
++...+.+.+|++++++++||||+++++++.+ +.+++||||++||+|.+++... ..+++.++..++.|++.||+|||+
T Consensus 72 ~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~ 150 (307)
T 3omv_A 72 TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA 150 (307)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 45667889999999999999999999998865 4579999999999999999754 469999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCC---CccccccCCCcccccccccc---CCCCCcchHHHHHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQF---QRYDEKVDMWSVGAIL 158 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~---~~~~~~~Di~slg~~~ 158 (177)
.|++||||||+|||+ +.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++||||+|+++
T Consensus 151 ~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl 227 (307)
T 3omv_A 151 KNIIHRDMKSNNIFL---HEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVL 227 (307)
T ss_dssp TTCBCSCCCSSSEEE---ETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHH
T ss_pred CCccCCccCHHHEEE---CCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHH
Confidence 999999999999999 46788999999999765432 22334569999999999853 3588999999999999
Q ss_pred HHHHhCCCCCCCCCc
Q 030430 159 FELLNGYPPFSVGEE 173 (177)
Q Consensus 159 ~~~~~~~~pf~~~~~ 173 (177)
|||+||+.||.+.+.
T Consensus 228 ~Elltg~~Pf~~~~~ 242 (307)
T 3omv_A 228 YELMTGELPYSHINN 242 (307)
T ss_dssp HHHHHSSCTTTTCCC
T ss_pred HHHHHCCCCCCCCCh
Confidence 999999999987543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=268.06 Aligned_cols=166 Identities=25% Similarity=0.553 Sum_probs=146.1
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc----------------CCCCHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTARK 70 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~ 70 (177)
...++.|.+|++++++++||||+++++++.+++.+++||||+++|+|.+++... ..+++..+..
T Consensus 70 ~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 149 (308)
T 4gt4_A 70 GPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 149 (308)
T ss_dssp C-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHH
Confidence 344678999999999999999999999999999999999999999999999642 3489999999
Q ss_pred HHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC---ccccccCCCccccccccccCCCCC
Q 030430 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDE 147 (177)
Q Consensus 71 ~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~ 147 (177)
++.|++.||+|||+.+++||||||+||++ +..+.+||+|||+++...... ......+++.|+|||.+.+..++.
T Consensus 150 i~~qia~gl~yLH~~~iiHRDLK~~NILl---~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ 226 (308)
T 4gt4_A 150 LVAQIAAGMEYLSSHHVVHKDLATRNVLV---YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSI 226 (308)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHHhCCCCCCCccccceEE---CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCc
Confidence 99999999999999999999999999999 567889999999997654332 233456889999999999899999
Q ss_pred cchHHHHHHHHHHHHh-CCCCCCCCCccc
Q 030430 148 KVDMWSVGAILFELLN-GYPPFSVGEEHQ 175 (177)
Q Consensus 148 ~~Di~slg~~~~~~~~-~~~pf~~~~~~~ 175 (177)
++||||+|+++|||+| |..||.+.+..+
T Consensus 227 ksDVwSfGvvl~El~t~g~~Pf~~~~~~~ 255 (308)
T 4gt4_A 227 DSDIWSYGVVLWEVFSYGLQPYCGYSNQD 255 (308)
T ss_dssp HHHHHHHHHHHHHHHTTTCCTTTTCCHHH
T ss_pred cchhhhHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999998 899998866543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=251.73 Aligned_cols=159 Identities=32% Similarity=0.596 Sum_probs=130.7
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCC------------eEEEEEecCCCCChHHHHhhcCC---CCHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------------CIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKF 71 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------------~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~ 71 (177)
+...+.+.+|++++++++||||+++++++.+.+ .+|++|||++|++|.+++..... .+...+..+
T Consensus 44 ~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i 123 (299)
T 4g31_A 44 ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123 (299)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHH
Confidence 455678999999999999999999999986543 47999999999999999986644 455678899
Q ss_pred HHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-------------cccccCCCcccccc
Q 030430 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-------------AEKVCGSPLYMAPE 138 (177)
Q Consensus 72 ~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-------------~~~~~~~~~~~~pe 138 (177)
+.|++.||+|||++|++||||||+||++ +.++.+||+|||+++....... .....||+.|+|||
T Consensus 124 ~~qi~~al~ylH~~~IiHRDlKp~NILl---~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE 200 (299)
T 4g31_A 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPE 200 (299)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCCCC--------------------------CCCTTSCHH
T ss_pred HHHHHHHHHHHHHCcCccccCcHHHeEE---CCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHH
Confidence 9999999999999999999999999999 4677899999999977643321 12346999999999
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 030430 139 VLQFQRYDEKVDMWSVGAILFELLNGYPPFSVG 171 (177)
Q Consensus 139 ~~~~~~~~~~~Di~slg~~~~~~~~~~~pf~~~ 171 (177)
.+.+..++.++||||+||++|+|++ ||.+.
T Consensus 201 ~~~~~~y~~~~DiwSlGvilyell~---Pf~~~ 230 (299)
T 4g31_A 201 QIHGNSYSHKVDIFSLGLILFELLY---PFSTQ 230 (299)
T ss_dssp HHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred HHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence 9998899999999999999999996 77653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=259.46 Aligned_cols=164 Identities=32% Similarity=0.531 Sum_probs=142.6
Q ss_pred hhHHHHHHHHHHHHhhCCC-CceeeEeEEEee-CCeEEEEEecCCCCChHHHHhhc----------------CCCCHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNH-PNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTA 68 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~ 68 (177)
....+.+.+|++++.+++| ||||++++++.. ++.+++||||+++|+|.++++.. ..+++..+
T Consensus 108 ~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~ 187 (353)
T 4ase_A 108 HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 187 (353)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHH
T ss_pred hHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHH
Confidence 3456789999999999965 899999999865 45789999999999999999753 23889999
Q ss_pred HHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC---ccccccCCCccccccccccCCC
Q 030430 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRY 145 (177)
Q Consensus 69 ~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~ 145 (177)
..++.|++.||+|||+++++||||||+||++ +.++.+||+|||+++...... ......+++.|+|||.+.+..+
T Consensus 188 ~~~~~qia~gl~yLH~~~iiHRDLK~~NILl---~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y 264 (353)
T 4ase_A 188 ICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 264 (353)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHhHhhCCeecCccCccceee---CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCC
Confidence 9999999999999999999999999999999 567889999999998764432 2234557899999999998999
Q ss_pred CCcchHHHHHHHHHHHHh-CCCCCCCCCc
Q 030430 146 DEKVDMWSVGAILFELLN-GYPPFSVGEE 173 (177)
Q Consensus 146 ~~~~Di~slg~~~~~~~~-~~~pf~~~~~ 173 (177)
+.++||||+|+++|||+| |+.||.+.+.
T Consensus 265 ~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 265 TIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp CHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred CCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999998 8999987543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=272.39 Aligned_cols=168 Identities=32% Similarity=0.574 Sum_probs=151.7
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
....++.+.+|+++|++++||||+++++++.+++.+|++|||++||+|.+++.. ...+++..+..++.||+.||+|||+
T Consensus 194 ~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~ 273 (573)
T 3uto_A 194 HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 273 (573)
T ss_dssp SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHH
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 455677899999999999999999999999999999999999999999999864 3569999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhC
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~ 164 (177)
+|++||||||+||++.. +..+.++|+|||++.............||+.|+|||.+.+..++.++|+||+||++|+|++|
T Consensus 274 ~~iiHRDlKp~Nill~~-~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G 352 (573)
T 3uto_A 274 NNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352 (573)
T ss_dssp TTEECCCCCGGGEEESS-SSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred CCeeeccCChhhccccC-CCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 99999999999999952 23467999999999888766666667799999999999998999999999999999999999
Q ss_pred CCCCCCCCcc
Q 030430 165 YPPFSVGEEH 174 (177)
Q Consensus 165 ~~pf~~~~~~ 174 (177)
..||.+.+..
T Consensus 353 ~~Pf~~~~~~ 362 (573)
T 3uto_A 353 LSPFGGENDD 362 (573)
T ss_dssp CCSSCCSSHH
T ss_pred CCCCCCcCHH
Confidence 9999887654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=259.77 Aligned_cols=164 Identities=30% Similarity=0.489 Sum_probs=142.1
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEee------CCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE 80 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~ 80 (177)
....+++.+|+++|++++||||+++++++.. .+.+|+||||++ |+|.+++.+.+.+++..+..++.|++.||+
T Consensus 94 ~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ 172 (398)
T 4b99_A 94 VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLK 172 (398)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Confidence 3456778899999999999999999998753 357899999994 689999998888999999999999999999
Q ss_pred HHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCC-----CccccccCCCccccccccccC-CCCCcchHHHH
Q 030430 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-----NYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSV 154 (177)
Q Consensus 81 ~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~sl 154 (177)
|||++|++||||||+||++ +..+.++++|||+++..... ....+..||+.|+|||++.+. .++.++|+||+
T Consensus 173 ylH~~~iiHRDlKP~NIl~---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSl 249 (398)
T 4b99_A 173 YMHSAQVIHRDLKPSNLLV---NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSV 249 (398)
T ss_dssp HHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHH
T ss_pred HHHHCcCcCCCcCcccccc---CCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehh
Confidence 9999999999999999999 56788999999999765432 223356799999999998765 46899999999
Q ss_pred HHHHHHHHhCCCCCCCCCcc
Q 030430 155 GAILFELLNGYPPFSVGEEH 174 (177)
Q Consensus 155 g~~~~~~~~~~~pf~~~~~~ 174 (177)
||++|+|++|++||.+.+..
T Consensus 250 G~il~ell~G~~pF~g~~~~ 269 (398)
T 4b99_A 250 GCIFGEMLARRQLFPGKNYV 269 (398)
T ss_dssp HHHHHHHHHTSCSSCCSSHH
T ss_pred HHHHHHHHHCCCCCCCCCHH
Confidence 99999999999999887643
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=268.29 Aligned_cols=156 Identities=33% Similarity=0.584 Sum_probs=140.3
Q ss_pred HHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCeeecCC
Q 030430 14 DCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLK 93 (177)
Q Consensus 14 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H~~i~ 93 (177)
..++++++.++||||+++++++.+.+.+|+||||++||+|.+++.+.+.+++..+..++.||+.||+|||++||+|||||
T Consensus 240 ~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLK 319 (689)
T 3v5w_A 240 RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLK 319 (689)
T ss_dssp HHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCS
T ss_pred HHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCc
Confidence 33466777889999999999999999999999999999999999988899999999999999999999999999999999
Q ss_pred CCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccc-cCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 030430 94 PENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPFSVGE 172 (177)
Q Consensus 94 ~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Di~slg~~~~~~~~~~~pf~~~~ 172 (177)
|+||++ +..+.++|+|||++....... ..+..||+.|+|||++. +..++.++|+|||||++|+|++|+.||.+.+
T Consensus 320 PeNILl---d~~G~vKL~DFGlA~~~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~ 395 (689)
T 3v5w_A 320 PANILL---DEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 395 (689)
T ss_dssp GGGEEE---CTTSCEEECCCTTCEECSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGG
T ss_pred hHHeEE---eCCCCEEecccceeeecCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999 577889999999998765443 33567999999999986 4578999999999999999999999998754
Q ss_pred c
Q 030430 173 E 173 (177)
Q Consensus 173 ~ 173 (177)
.
T Consensus 396 ~ 396 (689)
T 3v5w_A 396 T 396 (689)
T ss_dssp C
T ss_pred h
Confidence 3
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=254.26 Aligned_cols=159 Identities=25% Similarity=0.420 Sum_probs=137.6
Q ss_pred HHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...++.+|+++++.+ +||||+++++++.+.+.+|+||||++|++|.++++ .+++..+..++.|++.||+|||++||
T Consensus 62 ~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gI 138 (361)
T 4f9c_A 62 HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGI 138 (361)
T ss_dssp CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 356788999999999 69999999999999999999999999999999885 69999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-----------------------------ccccccCCCcccccc
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----------------------------YAEKVCGSPLYMAPE 138 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~pe 138 (177)
+||||||+||+++ ...+.++|+|||+++...... ......||+.|+|||
T Consensus 139 iHRDiKPeNiLl~--~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE 216 (361)
T 4f9c_A 139 VHRDVKPSNFLYN--RRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPE 216 (361)
T ss_dssp ECSCCSGGGEEEE--TTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHH
T ss_pred EeCcCCHHHeEEe--CCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHH
Confidence 9999999999996 344689999999997543221 112346899999999
Q ss_pred ccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 030430 139 VLQFQ-RYDEKVDMWSVGAILFELLNGYPPFSVGE 172 (177)
Q Consensus 139 ~~~~~-~~~~~~Di~slg~~~~~~~~~~~pf~~~~ 172 (177)
.+.+. .++.++|+||+||++|+|++|+.||...+
T Consensus 217 ~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 217 VLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp HHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred HHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 98765 48999999999999999999999996554
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=246.27 Aligned_cols=166 Identities=25% Similarity=0.364 Sum_probs=133.2
Q ss_pred ccccchhHHHHHH--HHHHHHhhCCCCceeeEeEEEeeCC----eEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHH
Q 030430 2 LKKLNKHLKSCLD--CELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75 (177)
Q Consensus 2 l~~~~~~~~~~~~--~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i 75 (177)
+|.++....+.+. .|+..+.+++||||+++++++.+++ .+++||||++||+|.+++.. ..++.+.+.+++.|+
T Consensus 31 vK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~i 109 (303)
T 3hmm_A 31 VKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALST 109 (303)
T ss_dssp EEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHH
T ss_pred EEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHH
Confidence 4555444444444 4555567889999999999987543 68999999999999999985 468999999999999
Q ss_pred HHHHHHHhhC--------CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-----cccccCCCcccccccccc
Q 030430 76 GAGLEILNSH--------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQF 142 (177)
Q Consensus 76 ~~~l~~lh~~--------~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~~pe~~~~ 142 (177)
+.||+|||+. +++||||||+|||+ +.++.+||+|||+++....... .....||+.|+|||.+.+
T Consensus 110 a~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~ 186 (303)
T 3hmm_A 110 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186 (303)
T ss_dssp HHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTT
T ss_pred HHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcc
Confidence 9999999987 89999999999999 5778899999999876544321 223468999999999864
Q ss_pred C------CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 030430 143 Q------RYDEKVDMWSVGAILFELLNGYPPFSVG 171 (177)
Q Consensus 143 ~------~~~~~~Di~slg~~~~~~~~~~~pf~~~ 171 (177)
. .++.++||||+|+++|||+||..||...
T Consensus 187 ~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~ 221 (303)
T 3hmm_A 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp CSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred cccccCCccChhHhhhhHHHHHHHHHHCCCCCCcc
Confidence 3 3567899999999999999998776543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=240.45 Aligned_cols=165 Identities=39% Similarity=0.737 Sum_probs=149.8
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
++...+++.+|++++++++||||+++++++.+.+.+++||||++|++|.+++...+.+++..+..++.|++.||+|||+.
T Consensus 54 ~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~ 133 (328)
T 3fe3_A 54 NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK 133 (328)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 44566788999999999999999999999999999999999999999999998888899999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCC-CcchHHHHHHHHHHHHhC
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNG 164 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Di~slg~~~~~~~~~ 164 (177)
|++||||||+||++ +..+.++|+|||.+.............+++.|+|||.+.+..++ .++|+||+|+++++|++|
T Consensus 134 ~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 210 (328)
T 3fe3_A 134 RIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210 (328)
T ss_dssp TCCCSCCCGGGEEE---CTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHS
T ss_pred CEeccCCCHHHEEE---cCCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhC
Confidence 99999999999999 56778999999999877665555566789999999999877764 789999999999999999
Q ss_pred CCCCCCCCc
Q 030430 165 YPPFSVGEE 173 (177)
Q Consensus 165 ~~pf~~~~~ 173 (177)
+.||.+.+.
T Consensus 211 ~~pf~~~~~ 219 (328)
T 3fe3_A 211 SLPFDGQNL 219 (328)
T ss_dssp SCSSCCSSH
T ss_pred CCCCCCCCH
Confidence 999987654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=242.30 Aligned_cols=168 Identities=35% Similarity=0.594 Sum_probs=150.9
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
.....+.+.+|++++++++||||+++++++.+.+..++||||++|++|.+++.....+++..+..++.|++.||+|||+.
T Consensus 68 ~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~ 147 (362)
T 2bdw_A 68 SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147 (362)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34556789999999999999999999999999999999999999999999998777899999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCC
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~ 165 (177)
|++|+||+|+||++...+....++|+|||.+.............+++.|+|||.+.+..++.++|+||+|+++|+|++|.
T Consensus 148 ~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~ 227 (362)
T 2bdw_A 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY 227 (362)
T ss_dssp TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCC
Confidence 99999999999999644445679999999998776555444567899999999998888999999999999999999999
Q ss_pred CCCCCCCc
Q 030430 166 PPFSVGEE 173 (177)
Q Consensus 166 ~pf~~~~~ 173 (177)
.||.+.+.
T Consensus 228 ~Pf~~~~~ 235 (362)
T 2bdw_A 228 PPFWDEDQ 235 (362)
T ss_dssp CSSCCSSH
T ss_pred CCCCCCCH
Confidence 99987654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=245.28 Aligned_cols=168 Identities=33% Similarity=0.549 Sum_probs=150.7
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
.....+.+.+|++++++++||||+++++++.+.+..++||||+.|++|.+.+.....+++..+..++.|++.||+|||+.
T Consensus 50 ~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~ 129 (444)
T 3soa_A 50 SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129 (444)
T ss_dssp HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 44566789999999999999999999999999999999999999999999999888899999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhC
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~ 164 (177)
|++|+||||+||++......+.++|+|||.+........ .....+++.|+|||.+.+..++.++|+||+|+++|+|++|
T Consensus 130 givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G 209 (444)
T 3soa_A 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209 (444)
T ss_dssp TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhC
Confidence 999999999999996544567899999999977654332 2345689999999999888899999999999999999999
Q ss_pred CCCCCCCCc
Q 030430 165 YPPFSVGEE 173 (177)
Q Consensus 165 ~~pf~~~~~ 173 (177)
..||.+.+.
T Consensus 210 ~~Pf~~~~~ 218 (444)
T 3soa_A 210 YPPFWDEDQ 218 (444)
T ss_dssp SCSCCCSSH
T ss_pred CCCCCCccH
Confidence 999987654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=240.68 Aligned_cols=165 Identities=32% Similarity=0.615 Sum_probs=147.9
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
.+.+.+|++++++++||||+++++++.+...+++||||++|++|.+++.....+++..+..++.|++.||+|||+.|++|
T Consensus 59 ~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH 138 (361)
T 2yab_A 59 REEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH 138 (361)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 56799999999999999999999999999999999999999999999988888999999999999999999999999999
Q ss_pred ecCCCCcEEEecCCC-CeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 030430 90 RDLKPENILLSGLDD-DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (177)
Q Consensus 90 ~~i~~~nil~~~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf 168 (177)
+||+|+||++...+. ...++|+|||.+.............+++.|+|||.+.+..++.++|+||+|+++|+|++|..||
T Consensus 139 rDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf 218 (361)
T 2yab_A 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218 (361)
T ss_dssp CCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred CCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence 999999999952111 2279999999998776655455567899999999998888999999999999999999999999
Q ss_pred CCCCcc
Q 030430 169 SVGEEH 174 (177)
Q Consensus 169 ~~~~~~ 174 (177)
.+.+..
T Consensus 219 ~~~~~~ 224 (361)
T 2yab_A 219 LGDTKQ 224 (361)
T ss_dssp CCSSHH
T ss_pred CCCCHH
Confidence 876543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=237.38 Aligned_cols=162 Identities=33% Similarity=0.556 Sum_probs=146.6
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
....+.+|.++++.++||||+++++++.+.+.+++||||++|++|.+++.+...+++..+..++.|++.||+|||+.|++
T Consensus 48 ~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv 127 (337)
T 1o6l_A 48 EVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 127 (337)
T ss_dssp CHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred HHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 35678899999999999999999999999999999999999999999999888899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCC-CCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
||||||+||++ +..+.++|+|||.+..... ........+++.|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus 128 HrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P 204 (337)
T 1o6l_A 128 YRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204 (337)
T ss_dssp CCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred cCcCCHHHEEE---CCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCC
Confidence 99999999999 5677899999999876433 2334456689999999999888899999999999999999999999
Q ss_pred CCCCCc
Q 030430 168 FSVGEE 173 (177)
Q Consensus 168 f~~~~~ 173 (177)
|.+.+.
T Consensus 205 f~~~~~ 210 (337)
T 1o6l_A 205 FYNQDH 210 (337)
T ss_dssp SCCSSH
T ss_pred CCCCCH
Confidence 987654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=238.69 Aligned_cols=160 Identities=33% Similarity=0.603 Sum_probs=146.2
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
.+.+.+|+++++.++||||+++++++.+.+.+|+|+||+.|++|.+++.....+++..+..++.|++.||+|||+.|++|
T Consensus 59 ~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH 138 (384)
T 4fr4_A 59 VRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIH 138 (384)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence 46788999999999999999999999999999999999999999999998888999999999999999999999999999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCcccccccccc---CCCCCcchHHHHHHHHHHHHhCCC
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF---QRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~---~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
|||||+||++ +..+.++|+|||.+.............+++.|+|||.+.. ..++.++|+||||+++|+|++|+.
T Consensus 139 rDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~ 215 (384)
T 4fr4_A 139 RDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215 (384)
T ss_dssp CCCSGGGEEE---CTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred ccCcHHHeEE---CCCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCC
Confidence 9999999999 5677899999999987766555566779999999999863 457899999999999999999999
Q ss_pred CCCCCC
Q 030430 167 PFSVGE 172 (177)
Q Consensus 167 pf~~~~ 172 (177)
||.+..
T Consensus 216 Pf~~~~ 221 (384)
T 4fr4_A 216 PYHIRS 221 (384)
T ss_dssp SSCCCT
T ss_pred CCCCCC
Confidence 997643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=239.29 Aligned_cols=164 Identities=37% Similarity=0.606 Sum_probs=143.8
Q ss_pred hHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
...+.+.+|.++++.+ +||||+++++++.+.+.+|+||||++|++|.+++.+...+++..+..++.|++.||+|||+.|
T Consensus 65 ~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g 144 (353)
T 3txo_A 65 DDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG 144 (353)
T ss_dssp TTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3456788999999998 799999999999999999999999999999999998888999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCC-CccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCC
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~ 165 (177)
++||||||+||++ +..+.++|+|||++...... .......+++.|+|||.+.+..++.++|+||||+++|+|++|+
T Consensus 145 ivHrDlkp~NILl---~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~ 221 (353)
T 3txo_A 145 IIYRDLKLDNVLL---DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221 (353)
T ss_dssp CBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSS
T ss_pred CcccCCCHHHEEE---CCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCC
Confidence 9999999999999 56778999999998764332 3334566899999999998888999999999999999999999
Q ss_pred CCCCCCCcc
Q 030430 166 PPFSVGEEH 174 (177)
Q Consensus 166 ~pf~~~~~~ 174 (177)
.||.+.+..
T Consensus 222 ~Pf~~~~~~ 230 (353)
T 3txo_A 222 APFEAENED 230 (353)
T ss_dssp CSSCCSSHH
T ss_pred CCCCCCCHH
Confidence 999887654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=231.47 Aligned_cols=165 Identities=34% Similarity=0.606 Sum_probs=143.8
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
+....+.+.+|++++++++||||+++++++.+++.++++|||++|++|.+++...+.+++..+..++.|++.+|+|||+.
T Consensus 51 ~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 130 (294)
T 4eqm_A 51 KEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130 (294)
T ss_dssp CHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34566789999999999999999999999999999999999999999999999888899999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC--ccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~ 163 (177)
|++|+||+|+||++ +..+.++|+|||.+....... ......+++.|+|||.+.+..++.++|+||+|++++++++
T Consensus 131 ~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~ 207 (294)
T 4eqm_A 131 RIVHRDIKPQNILI---DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLV 207 (294)
T ss_dssp TCCCCCCCGGGEEE---CTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHH
T ss_pred CcccCCCCHHHEEE---CCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHh
Confidence 99999999999999 466789999999987654432 2223458999999999988889999999999999999999
Q ss_pred CCCCCCCCCc
Q 030430 164 GYPPFSVGEE 173 (177)
Q Consensus 164 ~~~pf~~~~~ 173 (177)
|+.||.+.+.
T Consensus 208 g~~pf~~~~~ 217 (294)
T 4eqm_A 208 GEPPFNGETA 217 (294)
T ss_dssp SSCSSCSSCH
T ss_pred CCCCCCCCCh
Confidence 9999987653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=234.33 Aligned_cols=171 Identities=33% Similarity=0.611 Sum_probs=133.1
Q ss_pred ccccchhHHHHHHHHHHHHhhCC-CCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHH
Q 030430 2 LKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE 80 (177)
Q Consensus 2 l~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~ 80 (177)
+|.+.+.....+.+|+++++.+. ||||+++++++.+....++||||++|++|.+++.....+++..+..++.|++.+|+
T Consensus 41 vK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~ 120 (325)
T 3kn6_A 41 VKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVS 120 (325)
T ss_dssp EEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHH
T ss_pred EEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Confidence 56667777788999999999996 99999999999999999999999999999999998888999999999999999999
Q ss_pred HHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccCCCCCcchHHHHHHHHH
Q 030430 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (177)
Q Consensus 81 ~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~ 159 (177)
|||+.|++|+||+|+||++...+....++|+|||.+....... ......+++.|+|||.+.+..++.++|+||+|++++
T Consensus 121 ~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ 200 (325)
T 3kn6_A 121 HMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILY 200 (325)
T ss_dssp HHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHH
T ss_pred HHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHH
Confidence 9999999999999999999743344579999999997654432 233455789999999998888999999999999999
Q ss_pred HHHhCCCCCCCCC
Q 030430 160 ELLNGYPPFSVGE 172 (177)
Q Consensus 160 ~~~~~~~pf~~~~ 172 (177)
++++|..||.+.+
T Consensus 201 ~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 201 TMLSGQVPFQSHD 213 (325)
T ss_dssp HHHHSSCTTC---
T ss_pred HHHhCCCCCCCCc
Confidence 9999999998754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=234.14 Aligned_cols=165 Identities=33% Similarity=0.630 Sum_probs=147.5
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
..+.+.+|++++++++||||+++++++.+....++||||++|++|.+++.....+++..+..++.|++.+|+|||+.|++
T Consensus 57 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iv 136 (326)
T 2y0a_A 57 SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIA 136 (326)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 35779999999999999999999999999999999999999999999998878899999999999999999999999999
Q ss_pred eecCCCCcEEEecCC-CCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 89 HRDLKPENILLSGLD-DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 89 H~~i~~~nil~~~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
|+||+|+||++...+ ....++|+|||.+.............+++.|+|||.+.+..++.++|+||+|++++++++|..|
T Consensus 137 H~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p 216 (326)
T 2y0a_A 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216 (326)
T ss_dssp CCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCS
T ss_pred cCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCC
Confidence 999999999995322 1237999999999877555444456689999999999888899999999999999999999999
Q ss_pred CCCCCc
Q 030430 168 FSVGEE 173 (177)
Q Consensus 168 f~~~~~ 173 (177)
|.+...
T Consensus 217 f~~~~~ 222 (326)
T 2y0a_A 217 FLGDTK 222 (326)
T ss_dssp SCCSSH
T ss_pred CCCCCH
Confidence 987653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=234.67 Aligned_cols=167 Identities=29% Similarity=0.524 Sum_probs=148.7
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
......+.+|+++++.++||||+++++++.+.+.++++|||++|++|.+++.... .+++..+..++.|++.+|+|||+.
T Consensus 42 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~ 121 (321)
T 1tki_A 42 GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121 (321)
T ss_dssp THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4456778999999999999999999999999999999999999999999997653 699999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCC
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~ 165 (177)
|++|+||+|+||++.. +..+.++|+|||.+.............+++.|+|||.+.+..++.++|+||+|++++++++|.
T Consensus 122 givH~Dlkp~NIl~~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~ 200 (321)
T 1tki_A 122 NIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI 200 (321)
T ss_dssp TEECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSS
T ss_pred CCCcCCCCHHHEEEcc-CCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999952 126789999999998776655555566899999999998877899999999999999999999
Q ss_pred CCCCCCCcc
Q 030430 166 PPFSVGEEH 174 (177)
Q Consensus 166 ~pf~~~~~~ 174 (177)
.||.+.+..
T Consensus 201 ~pf~~~~~~ 209 (321)
T 1tki_A 201 NPFLAETNQ 209 (321)
T ss_dssp CTTCCSSHH
T ss_pred CCCcCCCHH
Confidence 999876543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=238.71 Aligned_cols=160 Identities=33% Similarity=0.678 Sum_probs=144.2
Q ss_pred hHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
...+.+.+|..+++++ +||||+++++++.+.+.+++||||++|++|..++.+...+++..+..++.|++.||+|||+.|
T Consensus 94 ~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g 173 (396)
T 4dc2_A 94 EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 173 (396)
T ss_dssp --CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3456688999999887 899999999999999999999999999999999998888999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeecccccc-CCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCC
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~-~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~ 165 (177)
++||||||+||++ +..+.++|+|||++... ..........|++.|+|||.+.+..++.++|+||||+++|+|++|+
T Consensus 174 ivHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~ 250 (396)
T 4dc2_A 174 IIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250 (396)
T ss_dssp CBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred EEeccCCHHHEEE---CCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCC
Confidence 9999999999999 56778999999999763 3333445567899999999999888999999999999999999999
Q ss_pred CCCCC
Q 030430 166 PPFSV 170 (177)
Q Consensus 166 ~pf~~ 170 (177)
.||.+
T Consensus 251 ~Pf~~ 255 (396)
T 4dc2_A 251 SPFDI 255 (396)
T ss_dssp CSSTT
T ss_pred CCCcc
Confidence 99964
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=232.55 Aligned_cols=161 Identities=33% Similarity=0.678 Sum_probs=145.4
Q ss_pred hhHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
....+.+.+|.++++++ +||||+++++++.+.+.+|+||||++|++|.+++.+...+++..++.++.|++.||+|||+.
T Consensus 50 ~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~ 129 (345)
T 3a8x_A 50 DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 129 (345)
T ss_dssp HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34567789999999998 89999999999999999999999999999999999888899999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccC-CCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhC
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~ 164 (177)
|++||||||+||++ +..+.++|+|||.+.... .........+++.|+|||.+.+..++.++|+||||+++|+|++|
T Consensus 130 ~ivHrDlkp~NIll---~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 206 (345)
T 3a8x_A 130 GIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 206 (345)
T ss_dssp TCBCCCCCGGGEEE---CTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred CceecCCCHHHEEE---CCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhC
Confidence 99999999999999 567789999999987643 23334456789999999999888899999999999999999999
Q ss_pred CCCCCC
Q 030430 165 YPPFSV 170 (177)
Q Consensus 165 ~~pf~~ 170 (177)
+.||..
T Consensus 207 ~~pf~~ 212 (345)
T 3a8x_A 207 RSPFDI 212 (345)
T ss_dssp SCTTTT
T ss_pred CCCcCC
Confidence 999965
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=230.79 Aligned_cols=159 Identities=39% Similarity=0.701 Sum_probs=145.1
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
.+.+.+|..+++.++||||+++++++.+...+|+||||++|++|.+++.....+++..+..++.|++.||+|||+.|++|
T Consensus 50 ~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH 129 (318)
T 1fot_A 50 VEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIY 129 (318)
T ss_dssp HHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred HHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 46688899999999999999999999999999999999999999999998888999999999999999999999999999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf~ 169 (177)
|||+|+||++ +..+.++|+|||.+...... .....+++.|+|||.+.+..++.++|+||||+++++|++|+.||.
T Consensus 130 rDlkp~NIll---~~~g~~kL~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 204 (318)
T 1fot_A 130 RDLKPENILL---DKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY 204 (318)
T ss_dssp CCCCGGGEEE---CTTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred cCCChheEEE---cCCCCEEEeecCcceecCCc--cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence 9999999999 56778999999999765433 234568999999999988889999999999999999999999998
Q ss_pred CCCc
Q 030430 170 VGEE 173 (177)
Q Consensus 170 ~~~~ 173 (177)
+.+.
T Consensus 205 ~~~~ 208 (318)
T 1fot_A 205 DSNT 208 (318)
T ss_dssp CSSH
T ss_pred CCCH
Confidence 7653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=233.32 Aligned_cols=161 Identities=42% Similarity=0.757 Sum_probs=145.7
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
...+.+|+++++.++||||+++++++.+.+..++||||+ +++|.+++...+.+++..+..++.|++.|++|||+.|++|
T Consensus 53 ~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH 131 (336)
T 3h4j_B 53 HMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVH 131 (336)
T ss_dssp SHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCC
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 457899999999999999999999999999999999999 7899999988888999999999999999999999999999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCC-CCcchHHHHHHHHHHHHhCCCCC
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPF 168 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slg~~~~~~~~~~~pf 168 (177)
+||+|+||++ +..+.++|+|||.+.............+++.|+|||.+.+..+ ++++|+||+|++++++++|+.||
T Consensus 132 ~Dlkp~NIll---~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf 208 (336)
T 3h4j_B 132 RDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF 208 (336)
T ss_dssp CCCSTTTEEE---CTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred cCCchhhEEE---cCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCC
Confidence 9999999999 5677899999999987766555556678999999999987665 78999999999999999999999
Q ss_pred CCCCcc
Q 030430 169 SVGEEH 174 (177)
Q Consensus 169 ~~~~~~ 174 (177)
.+....
T Consensus 209 ~~~~~~ 214 (336)
T 3h4j_B 209 DDEFIP 214 (336)
T ss_dssp BCSSST
T ss_pred CCccHH
Confidence 876443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=234.43 Aligned_cols=163 Identities=35% Similarity=0.628 Sum_probs=146.6
Q ss_pred HHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
..+.+..|.+++..+ +||+|+++++++.+.+.+|+||||++|++|.+++...+.+++..+..++.|++.||+|||+.|+
T Consensus 63 ~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gi 142 (353)
T 2i0e_A 63 DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGI 142 (353)
T ss_dssp CHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 356788999999988 8999999999999999999999999999999999988889999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCC-CCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
+||||||+||++ +..+.++|+|||.+..... ........|++.|+|||.+.+..++.++|+||||+++|+|++|+.
T Consensus 143 vHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~ 219 (353)
T 2i0e_A 143 IYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 219 (353)
T ss_dssp BCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSC
T ss_pred EeccCCHHHEEE---cCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCC
Confidence 999999999999 5677899999999876432 233445668999999999988889999999999999999999999
Q ss_pred CCCCCCcc
Q 030430 167 PFSVGEEH 174 (177)
Q Consensus 167 pf~~~~~~ 174 (177)
||.+.+..
T Consensus 220 Pf~~~~~~ 227 (353)
T 2i0e_A 220 PFEGEDED 227 (353)
T ss_dssp SSCCSSHH
T ss_pred CCCCCCHH
Confidence 99876543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=227.37 Aligned_cols=164 Identities=27% Similarity=0.503 Sum_probs=145.1
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
+....+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+
T Consensus 47 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~ 126 (310)
T 3s95_A 47 DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS 126 (310)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 567788899999999999999999999999999999999999999999999987 4569999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc---------------ccccCCCccccccccccCCCCCcc
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---------------EKVCGSPLYMAPEVLQFQRYDEKV 149 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---------------~~~~~~~~~~~pe~~~~~~~~~~~ 149 (177)
.|++|+||+|+||++ +..+.++|+|||.+......... ....+++.|+|||.+.+..++.++
T Consensus 127 ~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 203 (310)
T 3s95_A 127 MNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKV 203 (310)
T ss_dssp TTEECSCCSTTSEEE---CTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHH
T ss_pred CCccCCCCCcCeEEE---CCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHH
Confidence 999999999999999 56778999999998765433211 134588899999999988899999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCC
Q 030430 150 DMWSVGAILFELLNGYPPFSVGE 172 (177)
Q Consensus 150 Di~slg~~~~~~~~~~~pf~~~~ 172 (177)
|+||+|++++++++|..||....
T Consensus 204 Di~slG~~l~el~~g~~~~~~~~ 226 (310)
T 3s95_A 204 DVFSFGIVLCEIIGRVNADPDYL 226 (310)
T ss_dssp HHHHHHHHHHHHHHTCCSSTTTS
T ss_pred HHHHHHHHHHHHhcCCCCCcchh
Confidence 99999999999999999987643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=234.11 Aligned_cols=163 Identities=37% Similarity=0.617 Sum_probs=146.1
Q ss_pred HHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
..+.+..|.+++..+ +||||+++++++.+.+.+|+||||++|++|.+++.....+++..+..++.|++.||+|||+.|+
T Consensus 60 ~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i 139 (345)
T 1xjd_A 60 DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGI 139 (345)
T ss_dssp CHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred hHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 356788899999887 9999999999999999999999999999999999988889999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCC-CCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
+||||||+||++ +..+.++|+|||.+..... ........|++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 140 vHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 216 (345)
T 1xjd_A 140 VYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 216 (345)
T ss_dssp BCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred EeCCCChhhEEE---CCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCC
Confidence 999999999999 4677899999999876433 223445668999999999988889999999999999999999999
Q ss_pred CCCCCCcc
Q 030430 167 PFSVGEEH 174 (177)
Q Consensus 167 pf~~~~~~ 174 (177)
||.+.+..
T Consensus 217 Pf~~~~~~ 224 (345)
T 1xjd_A 217 PFHGQDEE 224 (345)
T ss_dssp SSCCSSHH
T ss_pred CCCCCCHH
Confidence 99876543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=228.12 Aligned_cols=161 Identities=31% Similarity=0.592 Sum_probs=144.7
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+.+.+|+.++++++||||+++++++..++.+++||||++|++|.+++... .+++..+..++.|++.+|+|||+.|+
T Consensus 59 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i 137 (297)
T 3fxz_A 59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQV 137 (297)
T ss_dssp SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 34677899999999999999999999999999999999999999999998854 69999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
+|+||+|+||++ +..+.++|+|||.+....... ......+++.|+|||.+.+..++.++|+||+|++++++++|..
T Consensus 138 ~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 214 (297)
T 3fxz_A 138 IHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214 (297)
T ss_dssp ECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred eeCCCCHHHEEE---CCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999999999999 466789999999987665433 2334568999999999988889999999999999999999999
Q ss_pred CCCCCC
Q 030430 167 PFSVGE 172 (177)
Q Consensus 167 pf~~~~ 172 (177)
||.+.+
T Consensus 215 pf~~~~ 220 (297)
T 3fxz_A 215 PYLNEN 220 (297)
T ss_dssp TTTTSC
T ss_pred CCCCCC
Confidence 997754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=234.53 Aligned_cols=159 Identities=33% Similarity=0.637 Sum_probs=145.5
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
.+.+.+|+++++.++||||+++++++.+.+.+|+||||++|++|.+++...+.+++..+..++.|++.||+|||+.|++|
T Consensus 85 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH 164 (350)
T 1rdq_E 85 IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 164 (350)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 46788999999999999999999999999999999999999999999998888999999999999999999999999999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf~ 169 (177)
|||||+||++ +..+.++|+|||.+....... ....+++.|+|||.+.+..++.++|+||||+++++|++|..||.
T Consensus 165 rDlkp~NIll---~~~g~~kL~DFg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 239 (350)
T 1rdq_E 165 RDLKPENLLI---DQQGYIQVTDFGFAKRVKGRT--WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239 (350)
T ss_dssp CCCSGGGEEE---CTTSCEEECCCTTCEECSSCB--CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccCccceEEE---CCCCCEEEcccccceeccCCc--ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCC
Confidence 9999999999 567789999999997764432 34568999999999988889999999999999999999999998
Q ss_pred CCCc
Q 030430 170 VGEE 173 (177)
Q Consensus 170 ~~~~ 173 (177)
+.+.
T Consensus 240 ~~~~ 243 (350)
T 1rdq_E 240 ADQP 243 (350)
T ss_dssp CSSH
T ss_pred CCCH
Confidence 7654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=226.13 Aligned_cols=165 Identities=35% Similarity=0.670 Sum_probs=148.6
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+.+.+|++++++++||||+++++++.++...+++|||+++++|.+++.....+++..+..++.|++.++++||+.|+
T Consensus 48 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i 127 (277)
T 3f3z_A 48 EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 127 (277)
T ss_dssp SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 34678999999999999999999999999999999999999999999999888889999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
+|+||+|+||++...+..+.++|+|||.+.............+++.|+|||.+.+ .++.++|+||+|++++++++|+.|
T Consensus 128 ~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p 206 (277)
T 3f3z_A 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPP 206 (277)
T ss_dssp ECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred cCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCC
Confidence 9999999999995445677899999999987766555556678999999998864 489999999999999999999999
Q ss_pred CCCCCc
Q 030430 168 FSVGEE 173 (177)
Q Consensus 168 f~~~~~ 173 (177)
|.+.++
T Consensus 207 ~~~~~~ 212 (277)
T 3f3z_A 207 FSAPTD 212 (277)
T ss_dssp SCCSSH
T ss_pred CCCCCH
Confidence 987654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=234.47 Aligned_cols=164 Identities=30% Similarity=0.559 Sum_probs=144.5
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
..+.+.+|++++++++||||+++++++.+.+.+++||||++|++|.+++... ..+++..+..++.|++.+|+|||+
T Consensus 69 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~ 148 (351)
T 3c0i_A 69 STEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148 (351)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3577999999999999999999999999999999999999999998877643 248999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~ 163 (177)
.|++|+||||+||++...+....++|+|||.+........ .....+++.|+|||.+.+..++.++|+||+|++++++++
T Consensus 149 ~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~ 228 (351)
T 3c0i_A 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLS 228 (351)
T ss_dssp TTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred CCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHH
Confidence 9999999999999996444455699999999977655432 334568999999999988889999999999999999999
Q ss_pred CCCCCCCCC
Q 030430 164 GYPPFSVGE 172 (177)
Q Consensus 164 ~~~pf~~~~ 172 (177)
|..||.+..
T Consensus 229 g~~pf~~~~ 237 (351)
T 3c0i_A 229 GCLPFYGTK 237 (351)
T ss_dssp SSCSSCSSH
T ss_pred CCCCCCCcH
Confidence 999998753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=239.88 Aligned_cols=160 Identities=33% Similarity=0.642 Sum_probs=143.0
Q ss_pred HHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
..+.+|..++..++||||+++++++.+.+.+|+||||++|++|.+++.. ...+++..+..++.|++.||+|||+.|++|
T Consensus 119 ~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiH 198 (437)
T 4aw2_A 119 ACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVH 198 (437)
T ss_dssp CCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEe
Confidence 4488999999999999999999999999999999999999999999986 467999999999999999999999999999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--cccccCCCccccccccc-----cCCCCCcchHHHHHHHHHHHH
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~slg~~~~~~~ 162 (177)
|||||+||++ +..+.++|+|||++........ .....|++.|+|||.+. ...++.++|+||+|+++|+|+
T Consensus 199 rDLKp~NILl---~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~ell 275 (437)
T 4aw2_A 199 RDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEML 275 (437)
T ss_dssp CCCSGGGEEE---CTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHH
T ss_pred cccCHHHeeE---cCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHH
Confidence 9999999999 5677899999999976644332 22356899999999986 456889999999999999999
Q ss_pred hCCCCCCCCCc
Q 030430 163 NGYPPFSVGEE 173 (177)
Q Consensus 163 ~~~~pf~~~~~ 173 (177)
+|+.||.+.+.
T Consensus 276 tG~~Pf~~~~~ 286 (437)
T 4aw2_A 276 YGETPFYAESL 286 (437)
T ss_dssp HSSCTTCCSSH
T ss_pred hCCCCCCCCCh
Confidence 99999987654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=235.66 Aligned_cols=165 Identities=40% Similarity=0.614 Sum_probs=132.4
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
..+.+.+|++++++++||||+++++++.+.+..+++|||++|++|.+++...+.+++..+..++.|++.+|+|||+.|++
T Consensus 91 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iv 170 (349)
T 2w4o_A 91 DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIV 170 (349)
T ss_dssp --------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 45678899999999999999999999999999999999999999999998877899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf 168 (177)
|+||+|+||++...+..+.++|+|||.+.............+++.|+|||.+.+..++.++|+||||++++++++|..||
T Consensus 171 H~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 250 (349)
T 2w4o_A 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPF 250 (349)
T ss_dssp CCCCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ecCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCC
Confidence 99999999999643457789999999987765544444556899999999998888999999999999999999999999
Q ss_pred CCCCc
Q 030430 169 SVGEE 173 (177)
Q Consensus 169 ~~~~~ 173 (177)
.....
T Consensus 251 ~~~~~ 255 (349)
T 2w4o_A 251 YDERG 255 (349)
T ss_dssp CCTTC
T ss_pred CCCcc
Confidence 76543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=225.53 Aligned_cols=168 Identities=35% Similarity=0.594 Sum_probs=150.7
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
.....+.+.+|++++++++||||+++++++.+.+..++++||++|++|.+.+.....+++..+..++.|++.++++||+.
T Consensus 45 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 124 (284)
T 3kk8_A 45 SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124 (284)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34456788999999999999999999999999999999999999999999998888899999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCC
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~ 165 (177)
|++|+||+|+||+++..+....++|+|||.+.............+++.|+|||.+.+..++.++|+||+|++++++++|.
T Consensus 125 ~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 204 (284)
T 3kk8_A 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY 204 (284)
T ss_dssp TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCC
Confidence 99999999999999654445669999999997776655545566899999999998888999999999999999999999
Q ss_pred CCCCCCCc
Q 030430 166 PPFSVGEE 173 (177)
Q Consensus 166 ~pf~~~~~ 173 (177)
.||.+.+.
T Consensus 205 ~pf~~~~~ 212 (284)
T 3kk8_A 205 PPFWDEDQ 212 (284)
T ss_dssp CSSCCSSH
T ss_pred CCCCCCch
Confidence 99977653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=237.38 Aligned_cols=166 Identities=30% Similarity=0.570 Sum_probs=147.9
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
......+.+|++++++++||||+++++++.+....++||||+.|++|.+++.... .+++..+..++.|++.||+|||+.
T Consensus 89 ~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 168 (387)
T 1kob_A 89 PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168 (387)
T ss_dssp HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3456689999999999999999999999999999999999999999999987553 699999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCC
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~ 165 (177)
|++|+||+|+||++.. +..+.++|+|||.+.............+++.|+|||.+.+..++.++|+||||+++++|++|.
T Consensus 169 givHrDlkp~NIll~~-~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~ 247 (387)
T 1kob_A 169 SIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 247 (387)
T ss_dssp TEECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSC
T ss_pred CeeecccchHHeEEec-CCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCC
Confidence 9999999999999952 234679999999998776655555566899999999998888999999999999999999999
Q ss_pred CCCCCCCc
Q 030430 166 PPFSVGEE 173 (177)
Q Consensus 166 ~pf~~~~~ 173 (177)
.||.+.+.
T Consensus 248 ~Pf~~~~~ 255 (387)
T 1kob_A 248 SPFAGEDD 255 (387)
T ss_dssp CSSCCSSH
T ss_pred CCCCCCCH
Confidence 99987653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=235.43 Aligned_cols=165 Identities=35% Similarity=0.594 Sum_probs=147.6
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
...+.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++... ..+++..+..++.|++.+|+|||+.|
T Consensus 128 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 207 (373)
T 2x4f_A 128 KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY 207 (373)
T ss_dssp HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 56778999999999999999999999999999999999999999999988654 45999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
++|+||+|+||++.. +..+.++|+|||.+.............+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 208 ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 286 (373)
T 2x4f_A 208 ILHLDLKPENILCVN-RDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLS 286 (373)
T ss_dssp EECCCCCGGGEEEEE-TTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cccccCCHHHEEEec-CCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCC
Confidence 999999999999852 3456799999999987766555555568999999999988888999999999999999999999
Q ss_pred CCCCCCc
Q 030430 167 PFSVGEE 173 (177)
Q Consensus 167 pf~~~~~ 173 (177)
||.+.++
T Consensus 287 pf~~~~~ 293 (373)
T 2x4f_A 287 PFLGDND 293 (373)
T ss_dssp TTCCSSH
T ss_pred CCCCCCH
Confidence 9987654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=230.91 Aligned_cols=162 Identities=36% Similarity=0.612 Sum_probs=137.0
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
....+.+|++++++++||||+++++++.+.+.+++||||++|++|.+++.....+++..+..++.|++.||+|||+.|++
T Consensus 64 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~iv 143 (327)
T 3a62_A 64 DTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGII 143 (327)
T ss_dssp -------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence 45668899999999999999999999999999999999999999999999888899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCC-CccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
|+||+|+||++ +..+.++|+|||.+...... .......+++.|+|||.+.+..++.++|+||||+++++|++|..|
T Consensus 144 H~Dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p 220 (327)
T 3a62_A 144 YRDLKPENIML---NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220 (327)
T ss_dssp CCCCCTTTEEE---CTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccCCHHHeEE---CCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCC
Confidence 99999999999 46778999999998654332 223345689999999999888899999999999999999999999
Q ss_pred CCCCCc
Q 030430 168 FSVGEE 173 (177)
Q Consensus 168 f~~~~~ 173 (177)
|.+.+.
T Consensus 221 f~~~~~ 226 (327)
T 3a62_A 221 FTGENR 226 (327)
T ss_dssp CCCSSH
T ss_pred CCCCCH
Confidence 987654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=236.00 Aligned_cols=170 Identities=21% Similarity=0.283 Sum_probs=146.5
Q ss_pred ccccchhHHHHHHHHHHHHhhCC---CCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh-----cCCCCHHHHHHHHH
Q 030430 2 LKKLNKHLKSCLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-----HGRVPEQTARKFLQ 73 (177)
Q Consensus 2 l~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~ 73 (177)
+|...+.....+.+|.++++.++ |+|++++++++...+..++||||++|++|.+++.. ...+++..+..++.
T Consensus 100 vK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~ 179 (365)
T 3e7e_A 100 LKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179 (365)
T ss_dssp EEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHH
T ss_pred EEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHH
Confidence 56666667778999999999997 89999999999999999999999999999999974 34699999999999
Q ss_pred HHHHHHHHHhhCCCeeecCCCCcEEEec--------CCCCeeEEEeeeccccccC---CCCccccccCCCcccccccccc
Q 030430 74 QLGAGLEILNSHHIIHRDLKPENILLSG--------LDDDVMLKIADFGLSCTLY---PGNYAEKVCGSPLYMAPEVLQF 142 (177)
Q Consensus 74 ~i~~~l~~lh~~~~~H~~i~~~nil~~~--------~~~~~~~~l~d~~~~~~~~---~~~~~~~~~~~~~~~~pe~~~~ 142 (177)
|++.||+|||+.|++||||||+||+++. .+..+.++|+|||.+.... .........++..|+|||.+.+
T Consensus 180 qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 259 (365)
T 3e7e_A 180 RMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN 259 (365)
T ss_dssp HHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT
T ss_pred HHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC
Confidence 9999999999999999999999999953 1116789999999996543 2223334568999999999998
Q ss_pred CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 030430 143 QRYDEKVDMWSVGAILFELLNGYPPFSVG 171 (177)
Q Consensus 143 ~~~~~~~Di~slg~~~~~~~~~~~pf~~~ 171 (177)
..++.++|+||||+++++|++|+.||...
T Consensus 260 ~~~~~~~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 260 KPWNYQIDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp CCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred CCCCccccHHHHHHHHHHHHhCCCccccC
Confidence 88999999999999999999999999654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=238.96 Aligned_cols=160 Identities=35% Similarity=0.631 Sum_probs=142.7
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
.+.+.+|.++++.++||||+++++++.+...+|+||||++|++|.+++.. ..+++..+..++.|++.||+|||+.|++|
T Consensus 113 ~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givH 191 (410)
T 3v8s_A 113 SAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIH 191 (410)
T ss_dssp CSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 34588999999999999999999999999999999999999999999874 47999999999999999999999999999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--cccccCCCccccccccccCC----CCCcchHHHHHHHHHHHHh
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQR----YDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~----~~~~~Di~slg~~~~~~~~ 163 (177)
|||||+||++ +..+.++|+|||.+........ .....|++.|+|||.+.+.. ++.++|+||||+++|+|++
T Consensus 192 rDLKp~NILl---~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~ 268 (410)
T 3v8s_A 192 RDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268 (410)
T ss_dssp CCCSGGGEEE---CTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHH
T ss_pred ccCCHHHeeE---CCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHh
Confidence 9999999999 5677899999999977654432 23556899999999987654 6789999999999999999
Q ss_pred CCCCCCCCCc
Q 030430 164 GYPPFSVGEE 173 (177)
Q Consensus 164 ~~~pf~~~~~ 173 (177)
|+.||.+.+.
T Consensus 269 G~~Pf~~~~~ 278 (410)
T 3v8s_A 269 GDTPFYADSL 278 (410)
T ss_dssp SSCTTCCSSH
T ss_pred CCCCCCCCCh
Confidence 9999987654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=232.88 Aligned_cols=164 Identities=39% Similarity=0.599 Sum_probs=133.3
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
..+.+.+|+.++++++||||+++++++.+.+.+++||||+.|++|.+++...+.+++..+..++.|++.||+|||+.|++
T Consensus 59 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~iv 138 (361)
T 3uc3_A 59 IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQIC 138 (361)
T ss_dssp SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 34678899999999999999999999999999999999999999999998888899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCc-chHHHHHHHHHHHHhCCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEK-VDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Di~slg~~~~~~~~~~~p 167 (177)
||||||+||+++. +....++|+|||.+.............+++.|+|||.+.+..++.+ +|+||+|++++++++|+.|
T Consensus 139 H~Dlkp~Nill~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~P 217 (361)
T 3uc3_A 139 HRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217 (361)
T ss_dssp SCCCCGGGEEECS-SSSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCCCHHHEEEcC-CCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCC
Confidence 9999999999952 1233599999999875544444445568999999999987777655 8999999999999999999
Q ss_pred CCCCCc
Q 030430 168 FSVGEE 173 (177)
Q Consensus 168 f~~~~~ 173 (177)
|.+...
T Consensus 218 f~~~~~ 223 (361)
T 3uc3_A 218 FEDPEE 223 (361)
T ss_dssp CC----
T ss_pred CCCCcc
Confidence 987543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=240.21 Aligned_cols=165 Identities=39% Similarity=0.684 Sum_probs=146.6
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
....+.+|++++++++||||+++++++.+...+++|+||+.|++|.+.+.....+++..+..++.|++.||+|||+.|++
T Consensus 64 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~iv 143 (486)
T 3mwu_A 64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIV 143 (486)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 45678999999999999999999999999999999999999999999998888899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf 168 (177)
|+||||+||++...+....++|+|||.+.............+++.|+|||.+.+ .++.++|+||+|+++|++++|..||
T Consensus 144 H~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf 222 (486)
T 3mwu_A 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPF 222 (486)
T ss_dssp CSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred eccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999996545567799999999977665555555668999999999874 5899999999999999999999999
Q ss_pred CCCCcc
Q 030430 169 SVGEEH 174 (177)
Q Consensus 169 ~~~~~~ 174 (177)
.+.+..
T Consensus 223 ~~~~~~ 228 (486)
T 3mwu_A 223 YGKNEY 228 (486)
T ss_dssp CCSSHH
T ss_pred CCCCHH
Confidence 876543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=228.39 Aligned_cols=165 Identities=31% Similarity=0.589 Sum_probs=146.9
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
..+.+.+|++++++++||||+++++++.+....++++||++|++|.+++.....+++..+..++.|++.||+|||+.|++
T Consensus 58 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iv 137 (321)
T 2a2a_A 58 SREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIA 137 (321)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 35779999999999999999999999999999999999999999999999877899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCC-CeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 89 HRDLKPENILLSGLDD-DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 89 H~~i~~~nil~~~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
|+||+|+||++...+. ...++|+|||.+.............+++.|+|||.+.+..++.++|+||||++++++++|..|
T Consensus 138 H~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 217 (321)
T 2a2a_A 138 HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217 (321)
T ss_dssp CCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCS
T ss_pred cCCCChHHEEEecCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCC
Confidence 9999999999952111 127999999999877655444455689999999999888899999999999999999999999
Q ss_pred CCCCCc
Q 030430 168 FSVGEE 173 (177)
Q Consensus 168 f~~~~~ 173 (177)
|.+.+.
T Consensus 218 f~~~~~ 223 (321)
T 2a2a_A 218 FLGDTK 223 (321)
T ss_dssp SCCSSH
T ss_pred CCCCCH
Confidence 987653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=241.34 Aligned_cols=166 Identities=41% Similarity=0.715 Sum_probs=149.0
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
.....+.+|+++++.++||||+++++++.+...+++||||++|++|.+++.....+++..+..++.|++.||+|||+.|+
T Consensus 78 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 157 (494)
T 3lij_A 78 SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNI 157 (494)
T ss_dssp CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 34677899999999999999999999999999999999999999999999888889999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
+||||||+||++...+....++|+|||.+.............+++.|+|||.+. ..++.++|+||+|+++|++++|..|
T Consensus 158 vH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~p 236 (494)
T 3lij_A 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPP 236 (494)
T ss_dssp ECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred eeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCC
Confidence 999999999999644445679999999998776655555667899999999876 5689999999999999999999999
Q ss_pred CCCCCcc
Q 030430 168 FSVGEEH 174 (177)
Q Consensus 168 f~~~~~~ 174 (177)
|.+.+..
T Consensus 237 f~~~~~~ 243 (494)
T 3lij_A 237 FGGQTDQ 243 (494)
T ss_dssp SCCSSHH
T ss_pred CCCCCHH
Confidence 9886543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=236.00 Aligned_cols=163 Identities=33% Similarity=0.602 Sum_probs=144.3
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
..+.+.+|.+++..++||+|+++++++.+.+.+|+||||++|++|.+++.+.+ .+++..++.++.|++.||+|||+.|+
T Consensus 104 ~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~gi 183 (412)
T 2vd5_A 104 EVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGY 183 (412)
T ss_dssp GGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 34568899999999999999999999999999999999999999999998754 69999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--cccccCCCccccccccc-------cCCCCCcchHHHHHHHH
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQ-------FQRYDEKVDMWSVGAIL 158 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~-------~~~~~~~~Di~slg~~~ 158 (177)
+||||||+||++ +..+.++|+|||++........ .....|++.|+|||.+. ...++.++|+||||+++
T Consensus 184 iHrDLKp~NILl---d~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvil 260 (412)
T 2vd5_A 184 VHRDIKPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFA 260 (412)
T ss_dssp ECCCCSGGGEEE---CTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHH
T ss_pred eecccCHHHeee---cCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHH
Confidence 999999999999 5677899999999977654432 22356899999999986 34678999999999999
Q ss_pred HHHHhCCCCCCCCCcc
Q 030430 159 FELLNGYPPFSVGEEH 174 (177)
Q Consensus 159 ~~~~~~~~pf~~~~~~ 174 (177)
|+|++|+.||.+.+..
T Consensus 261 yelltG~~Pf~~~~~~ 276 (412)
T 2vd5_A 261 YEMFYGQTPFYADSTA 276 (412)
T ss_dssp HHHHHSSCTTCCSSHH
T ss_pred HHHHhCCCCCCCCCHH
Confidence 9999999999876543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=233.68 Aligned_cols=162 Identities=36% Similarity=0.645 Sum_probs=137.9
Q ss_pred HHHHHHHHHH-HhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 10 KSCLDCELNF-LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 10 ~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
...+.+|..+ ++.++||||+++++++.+.+.+|+||||++|++|.+++.+...+++..++.++.|++.||+|||+.|++
T Consensus 82 ~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~giv 161 (373)
T 2r5t_A 82 EKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIV 161 (373)
T ss_dssp ---------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence 4556667766 577899999999999999999999999999999999999888899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCC-CCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
||||||+||++ +..+.++|+|||.+..... ........+++.|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus 162 HrDlkp~NIll---~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~P 238 (373)
T 2r5t_A 162 YRDLKPENILL---DSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238 (373)
T ss_dssp CCCCCGGGEEE---CTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred ecCCCHHHEEE---CCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCC
Confidence 99999999999 5677899999999876432 3334456789999999999988899999999999999999999999
Q ss_pred CCCCCcc
Q 030430 168 FSVGEEH 174 (177)
Q Consensus 168 f~~~~~~ 174 (177)
|.+.+..
T Consensus 239 f~~~~~~ 245 (373)
T 2r5t_A 239 FYSRNTA 245 (373)
T ss_dssp TCCSBHH
T ss_pred CCCCCHH
Confidence 9876543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=240.51 Aligned_cols=166 Identities=40% Similarity=0.724 Sum_probs=148.6
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+.+.+|++++++++||||+++++++.+...+++||||++|++|.+++.....+++..+..++.|++.||+|||+.|+
T Consensus 88 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 167 (504)
T 3q5i_A 88 KFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNI 167 (504)
T ss_dssp CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 34578999999999999999999999999999999999999999999999888889999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
+|+||+|+||++...+....++|+|||.+.............+++.|+|||.+. ..++.++|+||+|++++++++|..|
T Consensus 168 vH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~p 246 (504)
T 3q5i_A 168 VHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP 246 (504)
T ss_dssp ECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred EeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCC
Confidence 999999999999643334479999999998776655555667899999999986 4689999999999999999999999
Q ss_pred CCCCCcc
Q 030430 168 FSVGEEH 174 (177)
Q Consensus 168 f~~~~~~ 174 (177)
|.+.+..
T Consensus 247 f~~~~~~ 253 (504)
T 3q5i_A 247 FGGQNDQ 253 (504)
T ss_dssp SCCSSHH
T ss_pred CCCCCHH
Confidence 9886644
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=241.92 Aligned_cols=167 Identities=39% Similarity=0.679 Sum_probs=150.4
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
....+.+.+|++++++++||||+++++++.+.+.+++|+||+.|++|.+++.....+++..+..++.|++.||+|||+.|
T Consensus 67 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 146 (484)
T 3nyv_A 67 KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146 (484)
T ss_dssp SSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred chHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34567899999999999999999999999999999999999999999999988888999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
++|+||||+||++...+..+.++|+|||.+.............+++.|+|||.+.+ .++.++|+||+|+++|++++|..
T Consensus 147 ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~ 225 (484)
T 3nyv_A 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCP 225 (484)
T ss_dssp CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCC
Confidence 99999999999996545667899999999987766555555678999999999865 68999999999999999999999
Q ss_pred CCCCCCcc
Q 030430 167 PFSVGEEH 174 (177)
Q Consensus 167 pf~~~~~~ 174 (177)
||.+.+..
T Consensus 226 pf~~~~~~ 233 (484)
T 3nyv_A 226 PFNGANEY 233 (484)
T ss_dssp SSCCSSHH
T ss_pred CCCCCCHH
Confidence 99876543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=226.89 Aligned_cols=165 Identities=28% Similarity=0.463 Sum_probs=138.0
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCC---CCHHHHHHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFLQQLGAGLEIL 82 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~l 82 (177)
.....+.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++..... +++..+..++.|++.+|+||
T Consensus 74 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~L 153 (309)
T 3p86_A 74 HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL 153 (309)
T ss_dssp SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 345567899999999999999999999999999999999999999999999986543 99999999999999999999
Q ss_pred hhCC--CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccCCCCCcchHHHHHHHHH
Q 030430 83 NSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (177)
Q Consensus 83 h~~~--~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~ 159 (177)
|+.| ++|+||||+||++ +..+.++|+|||.+....... ......+++.|+|||.+.+..++.++|+||||++++
T Consensus 154 H~~~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 230 (309)
T 3p86_A 154 HNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILW 230 (309)
T ss_dssp HTSSSCCCCTTCCGGGEEE---CTTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred HcCCCCEECCCCChhhEEE---eCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHH
Confidence 9999 9999999999999 567789999999986544332 223456889999999999888999999999999999
Q ss_pred HHHhCCCCCCCCCc
Q 030430 160 ELLNGYPPFSVGEE 173 (177)
Q Consensus 160 ~~~~~~~pf~~~~~ 173 (177)
++++|+.||.+.+.
T Consensus 231 elltg~~Pf~~~~~ 244 (309)
T 3p86_A 231 ELATLQQPWGNLNP 244 (309)
T ss_dssp HHHHCCCTTTTSCH
T ss_pred HHHhCCCCCCCCCH
Confidence 99999999987654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=230.39 Aligned_cols=165 Identities=28% Similarity=0.409 Sum_probs=144.0
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
....+.+.+|++++++++||||+++++++.+.+.+++||||+++++|.+++... ..+++..+..++.|++.||+|||+
T Consensus 67 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~ 146 (389)
T 3gni_B 67 NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 146 (389)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 456788999999999999999999999999999999999999999999999865 569999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCC--------CccccccCCCcccccccccc--CCCCCcchHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--------NYAEKVCGSPLYMAPEVLQF--QRYDEKVDMWSV 154 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~--------~~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~sl 154 (177)
.|++||||||+||++ +..+.++|+|||.+...... .......++..|+|||.+.+ ..++.++|+||+
T Consensus 147 ~~ivHrDlkp~NIll---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 223 (389)
T 3gni_B 147 MGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 223 (389)
T ss_dssp TTEECCCCSGGGEEE---CTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHH
T ss_pred CCeecCCCCHHHEEE---cCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHH
Confidence 999999999999999 46778999999987544221 11122357888999999876 568999999999
Q ss_pred HHHHHHHHhCCCCCCCCCcc
Q 030430 155 GAILFELLNGYPPFSVGEEH 174 (177)
Q Consensus 155 g~~~~~~~~~~~pf~~~~~~ 174 (177)
|+++++|++|+.||.+.+..
T Consensus 224 G~il~el~~g~~pf~~~~~~ 243 (389)
T 3gni_B 224 GITACELANGHVPFKDMPAT 243 (389)
T ss_dssp HHHHHHHHHSSCTTTTCCST
T ss_pred HHHHHHHHHCCCCCCCCCHH
Confidence 99999999999999875543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=238.75 Aligned_cols=161 Identities=41% Similarity=0.746 Sum_probs=146.7
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
...+.+|+++++.++||||+++++++.+.+.+++|+||++|++|.+++...+.+++..+..++.|++.||+|||+.|++|
T Consensus 60 ~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH 139 (476)
T 2y94_A 60 VGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVH 139 (476)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCc
Confidence 46789999999999999999999999999999999999999999999988888999999999999999999999999999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCC-CCcchHHHHHHHHHHHHhCCCCC
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPF 168 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slg~~~~~~~~~~~pf 168 (177)
+||||+||++ +..+.++|+|||.+.............+++.|+|||.+.+..+ +.++|+||+|++++++++|..||
T Consensus 140 rDLkp~NIll---~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf 216 (476)
T 2y94_A 140 RDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF 216 (476)
T ss_dssp SCCSGGGEEE---CTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSS
T ss_pred ccccHHHEEE---ecCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCC
Confidence 9999999999 4677899999999987766555556678999999999987654 68999999999999999999999
Q ss_pred CCCCc
Q 030430 169 SVGEE 173 (177)
Q Consensus 169 ~~~~~ 173 (177)
.+.+.
T Consensus 217 ~~~~~ 221 (476)
T 2y94_A 217 DDDHV 221 (476)
T ss_dssp CCSSS
T ss_pred CCCCH
Confidence 87643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=240.83 Aligned_cols=160 Identities=34% Similarity=0.581 Sum_probs=145.7
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+.+|++++++++||||+++++++.+.+.+|+||||++|++|.+++...+. +++..+..++.|++.||+|||+.|+
T Consensus 228 ~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gI 307 (576)
T 2acx_A 228 EAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERI 307 (576)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 45688999999999999999999999999999999999999999999986543 9999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
+||||||+||++ +..+.++|+|||.+.............|++.|+|||.+.+..++.++|+||+|+++|+|++|+.|
T Consensus 308 vHrDLKPeNILl---d~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~P 384 (576)
T 2acx_A 308 VYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384 (576)
T ss_dssp ECCCCCGGGEEE---CTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCS
T ss_pred eccCCchheEEE---eCCCCeEEEecccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCC
Confidence 999999999999 56778999999999877655544456789999999999888899999999999999999999999
Q ss_pred CCCCC
Q 030430 168 FSVGE 172 (177)
Q Consensus 168 f~~~~ 172 (177)
|.+..
T Consensus 385 F~~~~ 389 (576)
T 2acx_A 385 FQQRK 389 (576)
T ss_dssp SSCSS
T ss_pred Ccccc
Confidence 98754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=222.44 Aligned_cols=164 Identities=34% Similarity=0.635 Sum_probs=139.7
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
..+.+.+|++++++++||||+++++++.+....++|+||+++++|.+++... ..+++..++.++.|++.+|++||+
T Consensus 63 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~ 142 (285)
T 3is5_A 63 PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS 142 (285)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3578999999999999999999999999999999999999999999988543 569999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhC
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~ 164 (177)
.|++|+||+|+||++...+..+.++|+|||.+.............+++.|+|||.+. ..++.++|+||+|++++++++|
T Consensus 143 ~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g 221 (285)
T 3is5_A 143 QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTG 221 (285)
T ss_dssp TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHS
T ss_pred CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhC
Confidence 999999999999999644456789999999997765555445566899999999875 5688999999999999999999
Q ss_pred CCCCCCCCc
Q 030430 165 YPPFSVGEE 173 (177)
Q Consensus 165 ~~pf~~~~~ 173 (177)
..||.+.+.
T Consensus 222 ~~pf~~~~~ 230 (285)
T 3is5_A 222 CLPFTGTSL 230 (285)
T ss_dssp SCSSCCSSH
T ss_pred CCCCCCCCH
Confidence 999987643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=225.22 Aligned_cols=163 Identities=27% Similarity=0.496 Sum_probs=141.8
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCC--eEEEEEecCCCCChHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHh
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lh 83 (177)
..+.+.+|++++++++||||+++++++.... ..++||||+++++|.+++..... +++..+..++.|++.+|+|||
T Consensus 50 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH 129 (319)
T 4euu_A 50 PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129 (319)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 3567889999999999999999999987655 78999999999999999986533 999999999999999999999
Q ss_pred hCCCeeecCCCCcEEEec-CCCCeeEEEeeeccccccCCCCccccccCCCccccccccc--------cCCCCCcchHHHH
Q 030430 84 SHHIIHRDLKPENILLSG-LDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ--------FQRYDEKVDMWSV 154 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~-~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--------~~~~~~~~Di~sl 154 (177)
+.|++|+||||+||++.. .+....++|+|||.+.............+++.|+|||.+. +..++.++|+||+
T Consensus 130 ~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Diwsl 209 (319)
T 4euu_A 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSI 209 (319)
T ss_dssp HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHH
T ss_pred HCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHH
Confidence 999999999999999732 2456779999999998776655555566899999999875 4567899999999
Q ss_pred HHHHHHHHhCCCCCCCC
Q 030430 155 GAILFELLNGYPPFSVG 171 (177)
Q Consensus 155 g~~~~~~~~~~~pf~~~ 171 (177)
|++++++++|+.||...
T Consensus 210 G~il~el~~g~~pf~~~ 226 (319)
T 4euu_A 210 GVTFYHAATGSLPFRPF 226 (319)
T ss_dssp HHHHHHHHHSSCSEECT
T ss_pred HHHHHHHHhCCCCCCCC
Confidence 99999999999999753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=238.11 Aligned_cols=163 Identities=31% Similarity=0.530 Sum_probs=137.4
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-CCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-HHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~ 87 (177)
....+.+|+++++.++||||+++++++.+.+.+++||||++|++|.+++.....+++..+..++.|++.||+|||+ .|+
T Consensus 191 ~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~gi 270 (446)
T 4ejn_A 191 EVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV 270 (446)
T ss_dssp ----------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCC
T ss_pred HHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCE
Confidence 3466788999999999999999999999999999999999999999999988889999999999999999999998 999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCC-CccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
+||||||+||++ +..+.++|+|||++...... .......+++.|+|||.+.+..++.++|+||+|+++++|++|+.
T Consensus 271 iHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 347 (446)
T 4ejn_A 271 VYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 347 (446)
T ss_dssp CCCCCCGGGEEE---CSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EECCCCHHHEEE---CCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCC
Confidence 999999999999 46678999999998764332 23345668999999999988889999999999999999999999
Q ss_pred CCCCCCcc
Q 030430 167 PFSVGEEH 174 (177)
Q Consensus 167 pf~~~~~~ 174 (177)
||.+.+..
T Consensus 348 Pf~~~~~~ 355 (446)
T 4ejn_A 348 PFYNQDHE 355 (446)
T ss_dssp SSCCSSHH
T ss_pred CCCCCCHH
Confidence 99876543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=232.48 Aligned_cols=163 Identities=35% Similarity=0.679 Sum_probs=134.4
Q ss_pred HHHHHHHHHHh-hCCCCceeeEeEEEee----CCeEEEEEecCCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh
Q 030430 11 SCLDCELNFLS-SVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 11 ~~~~~e~~~l~-~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh 83 (177)
..+.+|++++. ..+||||+++++++.. ...+|+||||++|++|.+++.... .+++..+..++.|++.+|+|||
T Consensus 99 ~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH 178 (400)
T 1nxk_A 99 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 178 (400)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 45778888874 4589999999999875 567899999999999999998653 4999999999999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~ 163 (177)
+.|++|+||||+||+++..+..+.++|+|||.+.............+++.|+|||.+.+..++.++|+||+|+++|+|++
T Consensus 179 ~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 258 (400)
T 1nxk_A 179 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 258 (400)
T ss_dssp HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHH
T ss_pred HCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHh
Confidence 99999999999999996433367899999999987655544455668999999999988889999999999999999999
Q ss_pred CCCCCCCCCc
Q 030430 164 GYPPFSVGEE 173 (177)
Q Consensus 164 ~~~pf~~~~~ 173 (177)
|+.||.+...
T Consensus 259 g~~pf~~~~~ 268 (400)
T 1nxk_A 259 GYPPFYSNHG 268 (400)
T ss_dssp SSCSCCCCTT
T ss_pred CCCCCCCCcc
Confidence 9999976543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=228.91 Aligned_cols=165 Identities=30% Similarity=0.521 Sum_probs=144.1
Q ss_pred hhHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC----------------CCCHHHHH
Q 030430 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTAR 69 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~ 69 (177)
....+.+.+|+++++++ +||||+++++++.+.+.+|+||||+++++|.+++.... .++...+.
T Consensus 127 ~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (370)
T 2psq_A 127 EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206 (370)
T ss_dssp HHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHH
Confidence 44567899999999999 89999999999999999999999999999999998653 37899999
Q ss_pred HHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCC
Q 030430 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYD 146 (177)
Q Consensus 70 ~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~ 146 (177)
.++.|++.||+|||+.|++|+||||+||++ +..+.++|+|||.+........ .....+++.|+|||.+.+..++
T Consensus 207 ~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 283 (370)
T 2psq_A 207 SCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT 283 (370)
T ss_dssp HHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCC
T ss_pred HHHHHHHHHHHHHHhCCeeccccchhhEEE---CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCC
Confidence 999999999999999999999999999999 4677899999999976544321 2223456789999999888899
Q ss_pred CcchHHHHHHHHHHHHh-CCCCCCCCCcc
Q 030430 147 EKVDMWSVGAILFELLN-GYPPFSVGEEH 174 (177)
Q Consensus 147 ~~~Di~slg~~~~~~~~-~~~pf~~~~~~ 174 (177)
.++|+||||+++|+|++ |..||.+....
T Consensus 284 ~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 284 HQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred cHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999999999999 99999876544
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=227.28 Aligned_cols=162 Identities=21% Similarity=0.278 Sum_probs=143.0
Q ss_pred HHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
..+.+.+|+++++++ +||||+++++++......++||||+ +++|.+++... ..+++..+..++.|++.||+|||+.|
T Consensus 47 ~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ 125 (330)
T 2izr_A 47 RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN 125 (330)
T ss_dssp SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 345789999999999 9999999999999999999999999 99999999864 56999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCee-----EEEeeeccccccCCCCc--------cccccCCCccccccccccCCCCCcchHHH
Q 030430 87 IIHRDLKPENILLSGLDDDVM-----LKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVDMWS 153 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~-----~~l~d~~~~~~~~~~~~--------~~~~~~~~~~~~pe~~~~~~~~~~~Di~s 153 (177)
++|+||||+||+++ ..+. ++|+|||.+........ .....+++.|+|||.+.+..++.++|+||
T Consensus 126 iiHrDlkp~Nill~---~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s 202 (330)
T 2izr_A 126 LIYRDVKPENFLIG---RPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEA 202 (330)
T ss_dssp EECCCCCGGGEEEC---CGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHH
T ss_pred eeccCCCHHHeeec---cCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHH
Confidence 99999999999995 4444 99999999976543322 13456899999999999888999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcc
Q 030430 154 VGAILFELLNGYPPFSVGEEH 174 (177)
Q Consensus 154 lg~~~~~~~~~~~pf~~~~~~ 174 (177)
||++++++++|..||.+.+.+
T Consensus 203 lG~il~ell~g~~Pf~~~~~~ 223 (330)
T 2izr_A 203 LGHMFMYFLRGSLPWQGLKAD 223 (330)
T ss_dssp HHHHHHHHHHSSCTTTTCCCS
T ss_pred HHHHHHHHhcCCCCccccccc
Confidence 999999999999999875443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=219.75 Aligned_cols=165 Identities=34% Similarity=0.653 Sum_probs=143.0
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
..+.+.+|++++++++||||+++++++.+....++++|++++++|.+++.....+++..+..++.|++.+|++||+.|++
T Consensus 51 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 130 (283)
T 3bhy_A 51 SREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIA 130 (283)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 36789999999999999999999999999999999999999999999998888899999999999999999999999999
Q ss_pred eecCCCCcEEEecCC-CCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 89 HRDLKPENILLSGLD-DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 89 H~~i~~~nil~~~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
|+||+|+||++...+ ....++|+|||.+.............+++.|+|||.+.+..++.++|+||+|++++++++|..|
T Consensus 131 H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 210 (283)
T 3bhy_A 131 HFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210 (283)
T ss_dssp CSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred CCCCChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCC
Confidence 999999999995321 1237999999999876554444455688999999999888899999999999999999999999
Q ss_pred CCCCCc
Q 030430 168 FSVGEE 173 (177)
Q Consensus 168 f~~~~~ 173 (177)
|.+.+.
T Consensus 211 ~~~~~~ 216 (283)
T 3bhy_A 211 FLGETK 216 (283)
T ss_dssp TCCSSH
T ss_pred CCCcch
Confidence 987643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=227.92 Aligned_cols=162 Identities=36% Similarity=0.647 Sum_probs=141.8
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
..+.+.+|++++++++||||+++++++.+++..+++|||++|++|.+++.....+++..+..++.|++.+|+|||+.|++
T Consensus 48 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~giv 127 (323)
T 3tki_A 48 CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT 127 (323)
T ss_dssp ---CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 34678999999999999999999999999999999999999999999998777899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCC---ccccccCCCccccccccccCCC-CCcchHHHHHHHHHHHHhC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slg~~~~~~~~~ 164 (177)
|+||+|+||++ +..+.++|+|||.+....... ......+++.|+|||.+.+..+ +.++|+||+|+++++|++|
T Consensus 128 H~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 204 (323)
T 3tki_A 128 HRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204 (323)
T ss_dssp CSCCSGGGEEE---CTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred ccccchHHEEE---eCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhC
Confidence 99999999999 466789999999987653222 2234568899999999876665 6789999999999999999
Q ss_pred CCCCCCCCc
Q 030430 165 YPPFSVGEE 173 (177)
Q Consensus 165 ~~pf~~~~~ 173 (177)
+.||....+
T Consensus 205 ~~pf~~~~~ 213 (323)
T 3tki_A 205 ELPWDQPSD 213 (323)
T ss_dssp SCSCSSSCT
T ss_pred CCCCCCCch
Confidence 999977544
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=236.42 Aligned_cols=160 Identities=34% Similarity=0.515 Sum_probs=144.2
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
.+.+.+|.+++++++||||+++++++.+.+.+|+||||++|++|.+++... ..+++..+..++.|++.||+|||+.
T Consensus 229 ~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~ 308 (543)
T 3c4z_A 229 YQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308 (543)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc
Confidence 456889999999999999999999999999999999999999999998754 3599999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhC
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~ 164 (177)
|++||||||+||++ +..+.++|+|||++........ .....|++.|+|||.+.+..++.++|+||||+++|+|++|
T Consensus 309 gIvHrDLKP~NILl---~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG 385 (543)
T 3c4z_A 309 NIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAA 385 (543)
T ss_dssp TEECCCCCGGGEEE---CTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred CCcccCCChHHEEE---eCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhC
Confidence 99999999999999 5677899999999987654433 2344789999999999988899999999999999999999
Q ss_pred CCCCCCCC
Q 030430 165 YPPFSVGE 172 (177)
Q Consensus 165 ~~pf~~~~ 172 (177)
+.||.+..
T Consensus 386 ~~PF~~~~ 393 (543)
T 3c4z_A 386 RGPFRARG 393 (543)
T ss_dssp SCSSCCTT
T ss_pred CCCCCCCc
Confidence 99998754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=228.53 Aligned_cols=164 Identities=27% Similarity=0.516 Sum_probs=137.4
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCC----eEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l 82 (177)
+.....+.+|++++++++||||+++++++.... ..++||||++|++|.+++...+.+++..+..++.|++.+|+||
T Consensus 53 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~l 132 (311)
T 3ork_A 53 PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132 (311)
T ss_dssp HHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Confidence 345668899999999999999999999987543 3599999999999999999888899999999999999999999
Q ss_pred hhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC----ccccccCCCccccccccccCCCCCcchHHHHHHHH
Q 030430 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (177)
Q Consensus 83 h~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~ 158 (177)
|+.|++|+||+|+||+++ ..+.++|+|||.+....... ......+++.|+|||.+.+..++.++|+||||+++
T Consensus 133 H~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l 209 (311)
T 3ork_A 133 HQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVL 209 (311)
T ss_dssp HHTTCCCCCCCGGGEEEE---TTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHH
T ss_pred HHCCCCcCCCCHHHEEEc---CCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHH
Confidence 999999999999999995 56779999999987654332 12234578999999999888899999999999999
Q ss_pred HHHHhCCCCCCCCCc
Q 030430 159 FELLNGYPPFSVGEE 173 (177)
Q Consensus 159 ~~~~~~~~pf~~~~~ 173 (177)
+++++|+.||.+.+.
T Consensus 210 ~~ll~g~~pf~~~~~ 224 (311)
T 3ork_A 210 YEVLTGEPPFTGDSP 224 (311)
T ss_dssp HHHHHSSCSCCCSSH
T ss_pred HHHHhCCCCCCCCCh
Confidence 999999999987654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=228.21 Aligned_cols=160 Identities=35% Similarity=0.565 Sum_probs=144.5
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCC-ChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGG-NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
..+.+.+|++++++++||||+++++++.+.+.+++++|++.++ +|.+++.....+++..+..++.|++.+|+|||+.|+
T Consensus 72 ~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i 151 (335)
T 3dls_A 72 KLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDI 151 (335)
T ss_dssp TTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 4456788999999999999999999999999999999998666 999999988889999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCC-CCcchHHHHHHHHHHHHhCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slg~~~~~~~~~~~ 166 (177)
+|+||||+||++ +..+.++|+|||.+.............+++.|+|||.+.+..+ +.++|+||||++++++++|..
T Consensus 152 vH~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~ 228 (335)
T 3dls_A 152 IHRDIKDENIVI---AEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEEN 228 (335)
T ss_dssp ECSCCSGGGEEE---CTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSC
T ss_pred EEeccCHHHEEE---cCCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCC
Confidence 999999999999 4677899999999987766655556678999999999887766 789999999999999999999
Q ss_pred CCCCC
Q 030430 167 PFSVG 171 (177)
Q Consensus 167 pf~~~ 171 (177)
||...
T Consensus 229 pf~~~ 233 (335)
T 3dls_A 229 PFCEL 233 (335)
T ss_dssp SCSSG
T ss_pred chhhH
Confidence 99764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=223.59 Aligned_cols=161 Identities=27% Similarity=0.556 Sum_probs=143.9
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+.+.+|++++++++||||+++++++...+..+++|||++|++|.+++.. ..+++..+..++.|++.||+|||+.|+
T Consensus 84 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~i 162 (321)
T 2c30_A 84 QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGV 162 (321)
T ss_dssp CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 3456788999999999999999999999999999999999999999998874 479999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
+|+||+|+||++ +..+.++|+|||.+....... ......+++.|+|||.+.+..++.++|+||+|++++++++|+.
T Consensus 163 vH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~ 239 (321)
T 2c30_A 163 IHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEP 239 (321)
T ss_dssp ECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred ecCCCCHHHEEE---CCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999 466789999999987664432 2334568999999999988889999999999999999999999
Q ss_pred CCCCCC
Q 030430 167 PFSVGE 172 (177)
Q Consensus 167 pf~~~~ 172 (177)
||.+.+
T Consensus 240 pf~~~~ 245 (321)
T 2c30_A 240 PYFSDS 245 (321)
T ss_dssp TTTTSC
T ss_pred CCCCCC
Confidence 997654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=218.73 Aligned_cols=163 Identities=33% Similarity=0.632 Sum_probs=146.8
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
+...+.+.+|++++++++||||+++++++.+.+..++++||+++++|.+++.....+++..+..++.|++.++++||+.|
T Consensus 56 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 135 (294)
T 2rku_A 56 PHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR 135 (294)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 45678899999999999999999999999999999999999999999999988888999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCC
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~ 165 (177)
++|+||+|+||++ +..+.++|+|||.+....... ......+++.|+|||.+.+..++.++|+||+|++++++++|+
T Consensus 136 i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 212 (294)
T 2rku_A 136 VIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212 (294)
T ss_dssp EECCCCCGGGEEE---CTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred ccccCCChHhEEE---cCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999 467789999999987654332 233455788999999998888899999999999999999999
Q ss_pred CCCCCCC
Q 030430 166 PPFSVGE 172 (177)
Q Consensus 166 ~pf~~~~ 172 (177)
.||....
T Consensus 213 ~p~~~~~ 219 (294)
T 2rku_A 213 PPFETSC 219 (294)
T ss_dssp CTTCCSS
T ss_pred CCCCCCC
Confidence 9998754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=226.51 Aligned_cols=165 Identities=28% Similarity=0.513 Sum_probs=142.5
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
....++.+.+|++++++++||||+++++++.+++..++||||++|++|.+++... ..+++..+..++.|++.+|+|||+
T Consensus 90 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~ 169 (325)
T 3kul_A 90 TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD 169 (325)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4556778999999999999999999999999999999999999999999999755 569999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc----cccccCCCccccccccccCCCCCcchHHHHHHHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~ 160 (177)
.|++|+||+|+||++ +..+.++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|+++++
T Consensus 170 ~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~e 246 (325)
T 3kul_A 170 LGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWE 246 (325)
T ss_dssp TTEECSCCSGGGEEE---CTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHH
T ss_pred CCeeCCCCCcceEEE---CCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHH
Confidence 999999999999999 5677899999999977644321 112234667999999988889999999999999999
Q ss_pred HHh-CCCCCCCCCc
Q 030430 161 LLN-GYPPFSVGEE 173 (177)
Q Consensus 161 ~~~-~~~pf~~~~~ 173 (177)
+++ |..||.+...
T Consensus 247 ll~~g~~p~~~~~~ 260 (325)
T 3kul_A 247 VLAYGERPYWNMTN 260 (325)
T ss_dssp HHTTSCCTTTTSCH
T ss_pred HHcCCCCCcccCCH
Confidence 999 9999977554
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=231.39 Aligned_cols=169 Identities=26% Similarity=0.441 Sum_probs=145.4
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-------CCCHHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------RVPEQTARKFLQQLGAG 78 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~~ 78 (177)
.......+.+|+.++++++||||+++++++.+....++||||++|++|.+++.... .++...++.++.|++.|
T Consensus 114 ~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~a 193 (367)
T 3l9p_A 114 SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193 (367)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHH
T ss_pred ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHH
Confidence 45556678999999999999999999999999999999999999999999998653 48999999999999999
Q ss_pred HHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCC---CCccccccCCCccccccccccCCCCCcchHHHHH
Q 030430 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP---GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVG 155 (177)
Q Consensus 79 l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~---~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg 155 (177)
|+|||+.|++||||||+||+++..+....++|+|||.+..... ........+++.|+|||.+.+..++.++|+||||
T Consensus 194 L~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG 273 (367)
T 3l9p_A 194 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 273 (367)
T ss_dssp HHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHH
Confidence 9999999999999999999996434455699999999865422 1222334578899999999888899999999999
Q ss_pred HHHHHHHh-CCCCCCCCCcc
Q 030430 156 AILFELLN-GYPPFSVGEEH 174 (177)
Q Consensus 156 ~~~~~~~~-~~~pf~~~~~~ 174 (177)
+++++|++ |..||.+.+..
T Consensus 274 ~il~ellt~g~~pf~~~~~~ 293 (367)
T 3l9p_A 274 VLLWEIFSLGYMPYPSKSNQ 293 (367)
T ss_dssp HHHHHHHTTSCCSSTTCCHH
T ss_pred HHHHHHHhCCCCCCCCCCHH
Confidence 99999998 99999876543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=222.22 Aligned_cols=162 Identities=33% Similarity=0.578 Sum_probs=140.0
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
..+.+.+|++++++++||||+++++++.+....++||||+++ +|.+++... ..+++..+..++.|++.||+|||+.|+
T Consensus 62 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i 140 (311)
T 3niz_A 62 IPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRI 140 (311)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 456788999999999999999999999999999999999964 888877755 349999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCcccccccccc-CCCCCcchHHHHHHHHHHHHhCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~~~~ 165 (177)
+|+||||+||++ +..+.++|+|||.+....... ......+++.|+|||.+.+ ..++.++|+||+|++++++++|+
T Consensus 141 vH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 217 (311)
T 3niz_A 141 LHRDLKPQNLLI---NSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217 (311)
T ss_dssp ECCCCCGGGEEE---CTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred ccCCCchHhEEE---CCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCC
Confidence 999999999999 466789999999997764332 2234457899999999865 45799999999999999999999
Q ss_pred CCCCCCCcc
Q 030430 166 PPFSVGEEH 174 (177)
Q Consensus 166 ~pf~~~~~~ 174 (177)
.||.+..+.
T Consensus 218 ~pf~~~~~~ 226 (311)
T 3niz_A 218 PLFPGVTDD 226 (311)
T ss_dssp CSCCCSSTT
T ss_pred CCCCCCChH
Confidence 999876554
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=223.11 Aligned_cols=163 Identities=33% Similarity=0.632 Sum_probs=147.1
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
...++.+.+|++++++++||||+++++++.+.+..+++|||+.+++|.+++.....+++..+..++.|++.+|+|||+.|
T Consensus 82 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 161 (335)
T 2owb_A 82 PHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR 161 (335)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 45678899999999999999999999999999999999999999999999988788999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCC
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~ 165 (177)
++|+||+|+||++ +..+.++|+|||.+....... ......++..|+|||.+.+..++.++|+||||++++++++|+
T Consensus 162 ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 238 (335)
T 2owb_A 162 VIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238 (335)
T ss_dssp EECSCCCGGGEEE---CTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred CEecCCCchhEEE---cCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCc
Confidence 9999999999999 466789999999997764332 233455889999999998888899999999999999999999
Q ss_pred CCCCCCC
Q 030430 166 PPFSVGE 172 (177)
Q Consensus 166 ~pf~~~~ 172 (177)
.||....
T Consensus 239 ~pf~~~~ 245 (335)
T 2owb_A 239 PPFETSC 245 (335)
T ss_dssp CTTCCSS
T ss_pred CCCCCCC
Confidence 9998754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=218.97 Aligned_cols=161 Identities=34% Similarity=0.643 Sum_probs=141.9
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
..+.+.+|++++++++||||+++++++.+.+..+++|||+++++|.+++.....+++..+..++.|++.+++|||+.|++
T Consensus 52 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~ 131 (279)
T 3fdn_A 52 VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 131 (279)
T ss_dssp CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCE
T ss_pred HHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 35678999999999999999999999999999999999999999999999888899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf 168 (177)
|+||+|+||++ +..+.++|+|||.+....... .....+++.|+|||.+.+..++.++|+||+|++++++++|..||
T Consensus 132 H~dlkp~Nili---~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 207 (279)
T 3fdn_A 132 HRDIKPENLLL---GSAGELKIADFGWSVHAPSSR-RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 207 (279)
T ss_dssp ECCCCGGGEEE---CTTSCEEECSCCEESCC---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred cccCChHhEEE---cCCCCEEEEeccccccCCccc-ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCC
Confidence 99999999999 467789999999885543332 23445789999999998888899999999999999999999999
Q ss_pred CCCCc
Q 030430 169 SVGEE 173 (177)
Q Consensus 169 ~~~~~ 173 (177)
...+.
T Consensus 208 ~~~~~ 212 (279)
T 3fdn_A 208 EANTY 212 (279)
T ss_dssp CCSSH
T ss_pred CCCcH
Confidence 87653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=224.41 Aligned_cols=165 Identities=28% Similarity=0.401 Sum_probs=144.1
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC----CCCHHHHHHHHHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQLGAGLEIL 82 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~l 82 (177)
....+.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++.... .+++..+..++.|++.+|+||
T Consensus 76 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l 155 (321)
T 2qkw_B 76 SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL 155 (321)
T ss_dssp SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHh
Confidence 3456789999999999999999999999999999999999999999999987543 489999999999999999999
Q ss_pred hhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC---ccccccCCCccccccccccCCCCCcchHHHHHHHHH
Q 030430 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (177)
Q Consensus 83 h~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~ 159 (177)
|+.|++|+||+|+||++ +..+.++|+|||.+....... ......+++.|+|||.+.+..++.++|+||+|++++
T Consensus 156 H~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 232 (321)
T 2qkw_B 156 HTRAIIHRDVKSINILL---DENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLF 232 (321)
T ss_dssp HHTTEECSCCCSTTEEE---CTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHH
T ss_pred cCCCeecCCCCHHHEEE---CCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHH
Confidence 99999999999999999 567789999999987643322 122344788999999998888999999999999999
Q ss_pred HHHhCCCCCCCCCcc
Q 030430 160 ELLNGYPPFSVGEEH 174 (177)
Q Consensus 160 ~~~~~~~pf~~~~~~ 174 (177)
++++|+.||.+..+.
T Consensus 233 ell~g~~p~~~~~~~ 247 (321)
T 2qkw_B 233 EVLCARSAIVQSLPR 247 (321)
T ss_dssp HHHHCCTTCSCSSSS
T ss_pred HHHhCCCcccccCcH
Confidence 999999999765443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=222.22 Aligned_cols=165 Identities=30% Similarity=0.563 Sum_probs=140.6
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
++...+.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++.....+++..+..++.|++.||+|||+.
T Consensus 42 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~ 121 (311)
T 4agu_A 42 DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121 (311)
T ss_dssp -HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34556788899999999999999999999999999999999999999999988777899999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCcccccccccc-CCCCCcchHHHHHHHHHHHHh
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~~ 163 (177)
|++|+||+|+||++ +..+.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||+|++++++++
T Consensus 122 ~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 198 (311)
T 4agu_A 122 NCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLS 198 (311)
T ss_dssp TEECCCCSGGGEEE---CTTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred CCcCCCCChhhEEE---cCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHh
Confidence 99999999999999 467789999999997765332 2334557889999999875 567999999999999999999
Q ss_pred CCCCCCCCCc
Q 030430 164 GYPPFSVGEE 173 (177)
Q Consensus 164 ~~~pf~~~~~ 173 (177)
|..||.+.+.
T Consensus 199 g~~p~~~~~~ 208 (311)
T 4agu_A 199 GVPLWPGKSD 208 (311)
T ss_dssp SSCSCCCSSH
T ss_pred CCCCCCCCCH
Confidence 9999987654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=223.68 Aligned_cols=166 Identities=37% Similarity=0.606 Sum_probs=139.1
Q ss_pred hHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
...+.+.+|+++++++ +||||+++++++.+.+.+++||||++|++|.+++.....+++..+..++.|++.+|+|||+.|
T Consensus 52 ~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 131 (316)
T 2ac3_A 52 HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG 131 (316)
T ss_dssp CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3467899999999995 799999999999999999999999999999999998888999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC--------ccccccCCCcccccccccc-----CCCCCcchHHH
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQF-----QRYDEKVDMWS 153 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~~-----~~~~~~~Di~s 153 (177)
++|+||+|+||+++..+....++|+|||.+....... ......+++.|+|||.+.. ..++.++|+||
T Consensus 132 ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diws 211 (316)
T 2ac3_A 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWS 211 (316)
T ss_dssp CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHH
T ss_pred ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHh
Confidence 9999999999999643333459999999886553211 1123348899999999864 45788999999
Q ss_pred HHHHHHHHHhCCCCCCCCCc
Q 030430 154 VGAILFELLNGYPPFSVGEE 173 (177)
Q Consensus 154 lg~~~~~~~~~~~pf~~~~~ 173 (177)
+|+++++|++|+.||.+...
T Consensus 212 lG~il~~l~~g~~pf~~~~~ 231 (316)
T 2ac3_A 212 LGVILYILLSGYPPFVGRCG 231 (316)
T ss_dssp HHHHHHHHHHSSCSCCCCCC
T ss_pred HHHHHHHHHHCCCCCccccc
Confidence 99999999999999987643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=218.19 Aligned_cols=161 Identities=34% Similarity=0.679 Sum_probs=124.0
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
.+.+.+|++++++++||||+++++++.+.+..++++||+++++|.+++... ..+++..+..++.|++.++++||+.|++
T Consensus 55 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 134 (278)
T 3cok_A 55 VQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGIL 134 (278)
T ss_dssp HHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 467899999999999999999999999999999999999999999999865 5699999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
|+||+|+||++ +..+.++|+|||.+....... ......+++.|+|||.+.+..++.++|+||+|++++++++|..|
T Consensus 135 H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 211 (278)
T 3cok_A 135 HRDLTLSNLLL---TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211 (278)
T ss_dssp CSSCCGGGEEE---CTTCCEEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCS
T ss_pred cCCCCHHHEEE---cCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999 466789999999987654332 22234578899999999888889999999999999999999999
Q ss_pred CCCCCc
Q 030430 168 FSVGEE 173 (177)
Q Consensus 168 f~~~~~ 173 (177)
|.....
T Consensus 212 ~~~~~~ 217 (278)
T 3cok_A 212 FDTDTV 217 (278)
T ss_dssp SCCCSC
T ss_pred CCChhH
Confidence 987543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=232.73 Aligned_cols=162 Identities=40% Similarity=0.711 Sum_probs=134.8
Q ss_pred HHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCeee
Q 030430 11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHR 90 (177)
Q Consensus 11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H~ 90 (177)
..+.+|++++++++||||+++++++.. +..++||||+++++|.+++.....+++..+..++.|++.||+|||+.|++|+
T Consensus 185 ~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHr 263 (419)
T 3i6u_A 185 LNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHR 263 (419)
T ss_dssp CCHHHHHHHHHHCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 468899999999999999999999854 4578999999999999999888889999999999999999999999999999
Q ss_pred cCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCcccccccccc---CCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF---QRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 91 ~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~---~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
||||+||+++..+....++|+|||.+.............+++.|+|||.+.+ ..++.++|+||+|+++++|++|+.|
T Consensus 264 Dlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~p 343 (419)
T 3i6u_A 264 DLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343 (419)
T ss_dssp CCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 9999999996444456799999999987765555555678999999998753 4577899999999999999999999
Q ss_pred CCCCCc
Q 030430 168 FSVGEE 173 (177)
Q Consensus 168 f~~~~~ 173 (177)
|.....
T Consensus 344 f~~~~~ 349 (419)
T 3i6u_A 344 FSEHRT 349 (419)
T ss_dssp SCCCSS
T ss_pred CCCCcc
Confidence 976543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=221.94 Aligned_cols=164 Identities=38% Similarity=0.653 Sum_probs=144.3
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
..+.+.+|++++++++||||+++++++.+.+..++++||++|++|.+++...+.+++..+..++.|++.+|++||+.|++
T Consensus 49 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 128 (304)
T 2jam_A 49 RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIV 128 (304)
T ss_dssp ---HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 45678899999999999999999999999999999999999999999998888899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf 168 (177)
|+||+|+||++...+..+.++|+|||.+...... ......+++.|+|||.+.+..++.++|+||||++++++++|..||
T Consensus 129 H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 207 (304)
T 2jam_A 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPF 207 (304)
T ss_dssp CCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 9999999999954446778999999988654332 223445889999999998888999999999999999999999999
Q ss_pred CCCCc
Q 030430 169 SVGEE 173 (177)
Q Consensus 169 ~~~~~ 173 (177)
...+.
T Consensus 208 ~~~~~ 212 (304)
T 2jam_A 208 YEETE 212 (304)
T ss_dssp TTSCH
T ss_pred CCCCH
Confidence 77543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=226.07 Aligned_cols=165 Identities=25% Similarity=0.527 Sum_probs=143.7
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc------------------------C
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH------------------------G 61 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------------------------~ 61 (177)
.....+.+.+|++++++++||||+++++++.+.+..+++|||+++++|.+++... .
T Consensus 90 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (343)
T 1luf_A 90 SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169 (343)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------C
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCC
Confidence 3455778999999999999999999999999999999999999999999999864 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC---ccccccCCCcccccc
Q 030430 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPE 138 (177)
Q Consensus 62 ~~~~~~~~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pe 138 (177)
.+++..++.++.|++.+|+|||+.|++|+||+|+||++ +..+.++|+|||.+....... ......++..|+|||
T Consensus 170 ~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE 246 (343)
T 1luf_A 170 PLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE 246 (343)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---CCCCeEEEeecCCCcccccCccccccCCCcccceecChh
Confidence 68999999999999999999999999999999999999 467789999999987654322 122344678899999
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCc
Q 030430 139 VLQFQRYDEKVDMWSVGAILFELLN-GYPPFSVGEE 173 (177)
Q Consensus 139 ~~~~~~~~~~~Di~slg~~~~~~~~-~~~pf~~~~~ 173 (177)
.+.+..++.++|+||+|++++++++ |..||.+.+.
T Consensus 247 ~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 282 (343)
T 1luf_A 247 SIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282 (343)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred hhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence 9988889999999999999999999 9999987654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=228.29 Aligned_cols=160 Identities=34% Similarity=0.598 Sum_probs=140.5
Q ss_pred HHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCeee
Q 030430 12 CLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHR 90 (177)
Q Consensus 12 ~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H~ 90 (177)
...+|++++.++ +||||+++++++.++...|+||||++|++|.+++...+.+++..+..++.|++.||+|||+.|++|+
T Consensus 61 ~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHr 140 (342)
T 2qr7_A 61 DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHR 140 (342)
T ss_dssp CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Confidence 456788888888 7999999999999999999999999999999999888889999999999999999999999999999
Q ss_pred cCCCCcEEEecCC-CCeeEEEeeeccccccCCC-CccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 030430 91 DLKPENILLSGLD-DDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (177)
Q Consensus 91 ~i~~~nil~~~~~-~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf 168 (177)
||||+||++...+ ....++|+|||.+...... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus 141 Dlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf 220 (342)
T 2qr7_A 141 DLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPF 220 (342)
T ss_dssp CCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred cCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCC
Confidence 9999999985322 2345999999999765443 2334556899999999998777889999999999999999999999
Q ss_pred CCC
Q 030430 169 SVG 171 (177)
Q Consensus 169 ~~~ 171 (177)
.+.
T Consensus 221 ~~~ 223 (342)
T 2qr7_A 221 ANG 223 (342)
T ss_dssp CSS
T ss_pred CCC
Confidence 864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=218.22 Aligned_cols=160 Identities=36% Similarity=0.685 Sum_probs=144.4
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
.+.+.+|++++++++||||+++++++.+.+..++++||+++++|.+++.....+++..+..++.|++.++++||+.|++|
T Consensus 58 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H 137 (284)
T 2vgo_A 58 EHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIH 137 (284)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred HHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence 56789999999999999999999999999999999999999999999998888999999999999999999999999999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf~ 169 (177)
+||+|+||++ +..+.++|+|||.+....... .....+++.|+|||.+.+..++.++|+||+|++++++++|..||.
T Consensus 138 ~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 213 (284)
T 2vgo_A 138 RDIKPENLLM---GYKGELKIADFGWSVHAPSLR-RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213 (284)
T ss_dssp CCCSGGGEEE---CTTCCEEECCCTTCEECSSSC-BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred cCCCHHHEEE---cCCCCEEEecccccccCcccc-cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCC
Confidence 9999999999 466789999999886654332 234457899999999988888999999999999999999999998
Q ss_pred CCCc
Q 030430 170 VGEE 173 (177)
Q Consensus 170 ~~~~ 173 (177)
..+.
T Consensus 214 ~~~~ 217 (284)
T 2vgo_A 214 SPSH 217 (284)
T ss_dssp CSSH
T ss_pred CCCH
Confidence 7543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=242.01 Aligned_cols=163 Identities=35% Similarity=0.628 Sum_probs=147.3
Q ss_pred HHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
..+.+..|.+++..+ +||+|+++++++.+.+.+|+||||++|++|.+++...+.+++..+..++.|++.||+|||+.|+
T Consensus 384 ~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gI 463 (674)
T 3pfq_A 384 DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGI 463 (674)
T ss_dssp TTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSE
T ss_pred HHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 456788899999988 7999999999999999999999999999999999988889999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCC-CCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
+||||||+||++ +..+.++|+|||++..... ........|++.|+|||.+.+..++.++|+||||+++|+|++|+.
T Consensus 464 iHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~ 540 (674)
T 3pfq_A 464 IYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 540 (674)
T ss_dssp ECCCCCSTTEEE---CSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSC
T ss_pred EeccCChhhEEE---cCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCC
Confidence 999999999999 5677899999999976432 333445678999999999998899999999999999999999999
Q ss_pred CCCCCCcc
Q 030430 167 PFSVGEEH 174 (177)
Q Consensus 167 pf~~~~~~ 174 (177)
||.+.+..
T Consensus 541 Pf~~~~~~ 548 (674)
T 3pfq_A 541 PFEGEDED 548 (674)
T ss_dssp SSCCSSHH
T ss_pred CCCCCCHH
Confidence 99887654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=222.08 Aligned_cols=165 Identities=30% Similarity=0.500 Sum_probs=144.1
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCC------------------------
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR------------------------ 62 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------ 62 (177)
....+.+.+|++++++++||||+++++++.+.+..++++||+++++|.+++.....
T Consensus 67 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (314)
T 2ivs_A 67 PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146 (314)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CE
T ss_pred HHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccC
Confidence 45567899999999999999999999999999999999999999999999986543
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccc
Q 030430 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEV 139 (177)
Q Consensus 63 ~~~~~~~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~ 139 (177)
+++..+..++.|++.+|+|||+.|++|+||+|+||+++ ..+.++|+|||.+........ .....+++.|+|||.
T Consensus 147 ~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 223 (314)
T 2ivs_A 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA---EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIES 223 (314)
T ss_dssp ECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEc---CCCCEEEccccccccccccccceeccCCCCcccccChhh
Confidence 88999999999999999999999999999999999995 567899999999876544322 122335678999999
Q ss_pred cccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcc
Q 030430 140 LQFQRYDEKVDMWSVGAILFELLN-GYPPFSVGEEH 174 (177)
Q Consensus 140 ~~~~~~~~~~Di~slg~~~~~~~~-~~~pf~~~~~~ 174 (177)
+.+..++.++|+||+|++++++++ |..||.+...+
T Consensus 224 ~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 259 (314)
T 2ivs_A 224 LFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259 (314)
T ss_dssp HHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred hcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 988888999999999999999999 99999876544
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=225.81 Aligned_cols=161 Identities=39% Similarity=0.800 Sum_probs=145.3
Q ss_pred HHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
..+.+.+|+.+++++ +||||+++++++...+..++||||++|++|.+++.....+++..+..++.|++.+|+|||+.|+
T Consensus 142 ~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi 221 (365)
T 2y7j_A 142 VREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNI 221 (365)
T ss_dssp HHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 367789999999999 8999999999999999999999999999999999887889999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCcccccccccc------CCCCCcchHHHHHHHHHHH
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF------QRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~------~~~~~~~Di~slg~~~~~~ 161 (177)
+|+||+|+||++ +..+.++++|||.+.............+++.|+|||.+.+ ..++.++|+||||+++++|
T Consensus 222 ~H~Dlkp~NIl~---~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el 298 (365)
T 2y7j_A 222 VHRDLKPENILL---DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTL 298 (365)
T ss_dssp ECSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEE---CCCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHH
Confidence 999999999999 5677899999999987765555555678999999998753 2478899999999999999
Q ss_pred HhCCCCCCCCC
Q 030430 162 LNGYPPFSVGE 172 (177)
Q Consensus 162 ~~~~~pf~~~~ 172 (177)
++|..||.+.+
T Consensus 299 l~g~~pf~~~~ 309 (365)
T 2y7j_A 299 LAGSPPFWHRR 309 (365)
T ss_dssp HHSSCSSCCSS
T ss_pred HHCCCCCCCCC
Confidence 99999997754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=219.11 Aligned_cols=162 Identities=27% Similarity=0.511 Sum_probs=142.0
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
..+.+.+|++++++++||||+++++++.+.+..+++|||+++++|.+++... ..+++..+..++.|++.++++||+.|+
T Consensus 48 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i 127 (269)
T 4hcu_A 48 SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 127 (269)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 3567999999999999999999999999999999999999999999999754 458999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC--ccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-C
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-~ 164 (177)
+|+||+|+||++ +..+.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|++++++++ |
T Consensus 128 ~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g 204 (269)
T 4hcu_A 128 IHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 204 (269)
T ss_dssp CCSCCCGGGEEE---CGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred ecCCcchheEEE---cCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCC
Confidence 999999999999 466789999999987654332 1122335667999999988889999999999999999999 9
Q ss_pred CCCCCCCCc
Q 030430 165 YPPFSVGEE 173 (177)
Q Consensus 165 ~~pf~~~~~ 173 (177)
..||...+.
T Consensus 205 ~~p~~~~~~ 213 (269)
T 4hcu_A 205 KIPYENRSN 213 (269)
T ss_dssp CCTTTTCCH
T ss_pred CCCCCCCCH
Confidence 999987654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=234.00 Aligned_cols=162 Identities=35% Similarity=0.499 Sum_probs=135.8
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeC------CeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGL 79 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l 79 (177)
+....+++.+|+++++.++||||+++++++... ..+|+||||+.+ +|.+.+. ..+++..+..++.|++.||
T Consensus 101 ~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL 177 (464)
T 3ttj_A 101 NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGI 177 (464)
T ss_dssp SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHH
Confidence 445577889999999999999999999998654 467999999955 6766665 3599999999999999999
Q ss_pred HHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHH
Q 030430 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (177)
Q Consensus 80 ~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~ 159 (177)
+|||+.|++||||||+||++ +..+.++|+|||.+.............+++.|+|||.+.+..++.++|+||+|++++
T Consensus 178 ~~lH~~~iiHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 254 (464)
T 3ttj_A 178 KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254 (464)
T ss_dssp HHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred HHHHHCCcccCCCChHhEEE---eCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHH
Confidence 99999999999999999999 467789999999998776555555567899999999999889999999999999999
Q ss_pred HHHhCCCCCCCCCc
Q 030430 160 ELLNGYPPFSVGEE 173 (177)
Q Consensus 160 ~~~~~~~pf~~~~~ 173 (177)
+|++|+.||.+.+.
T Consensus 255 ell~g~~pF~g~~~ 268 (464)
T 3ttj_A 255 EMVRHKILFPGRDY 268 (464)
T ss_dssp HHHHSSCSSCCSSH
T ss_pred HHHhCCCCCCCCCH
Confidence 99999999988653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=217.85 Aligned_cols=162 Identities=27% Similarity=0.553 Sum_probs=142.6
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
..+.+.+|++++++++||||+++++++.+....+++|||+++++|.+++.... .+++..+..++.|++.++++||+.|+
T Consensus 46 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 125 (268)
T 3sxs_A 46 SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF 125 (268)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 45678999999999999999999999999999999999999999999998654 49999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc--ccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-C
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-~ 164 (177)
+|+||+|+||++ +..+.++|+|||.+......... ....++..|+|||.+.+..++.++|+||+|++++++++ |
T Consensus 126 ~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g 202 (268)
T 3sxs_A 126 IHRDLAARNCLV---DRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLG 202 (268)
T ss_dssp EESSCSGGGEEE---CTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTT
T ss_pred ecCCcCcceEEE---CCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCC
Confidence 999999999999 56778999999998766544322 12334567999999988888999999999999999999 9
Q ss_pred CCCCCCCCc
Q 030430 165 YPPFSVGEE 173 (177)
Q Consensus 165 ~~pf~~~~~ 173 (177)
..||...+.
T Consensus 203 ~~p~~~~~~ 211 (268)
T 3sxs_A 203 KMPYDLYTN 211 (268)
T ss_dssp CCTTTTSCH
T ss_pred CCCccccCh
Confidence 999976543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=220.81 Aligned_cols=161 Identities=32% Similarity=0.528 Sum_probs=140.5
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc------CCCCHHHHHHHHHHHHHHHHHH
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH------GRVPEQTARKFLQQLGAGLEIL 82 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~l 82 (177)
..+.+.+|++++++++||||+++++++.+.+..++||||++ ++|.+++... ..+++..+..++.|++.||+||
T Consensus 46 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~l 124 (317)
T 2pmi_A 46 TPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124 (317)
T ss_dssp SCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHH
Confidence 34678899999999999999999999999999999999996 5999988754 3489999999999999999999
Q ss_pred hhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccC-CCCCcchHHHHHHHHHH
Q 030430 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFE 160 (177)
Q Consensus 83 h~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~ 160 (177)
|+.|++|+||||+||++ +..+.++|+|||.+....... ......+++.|+|||.+.+. .++.++|+||||+++++
T Consensus 125 H~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 201 (317)
T 2pmi_A 125 HENKILHRDLKPQNLLI---NKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAE 201 (317)
T ss_dssp HHTTEECCCCCGGGEEE---CTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred HHCCeeeCCCChHHeEE---cCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHH
Confidence 99999999999999999 467789999999997764332 22345578999999998754 57999999999999999
Q ss_pred HHhCCCCCCCCCc
Q 030430 161 LLNGYPPFSVGEE 173 (177)
Q Consensus 161 ~~~~~~pf~~~~~ 173 (177)
|++|+.||.+.++
T Consensus 202 l~~g~~pf~~~~~ 214 (317)
T 2pmi_A 202 MITGKPLFPGTND 214 (317)
T ss_dssp HHHSSCSCCCSSH
T ss_pred HHhCCCCCCCCCh
Confidence 9999999987654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=217.69 Aligned_cols=158 Identities=34% Similarity=0.567 Sum_probs=136.3
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
....+.+.+|++++++++||||+++++++.+++.+++||||+.+ ++.+.+.. .+.+++..+..++.|++.||+|||+.
T Consensus 42 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~ 120 (292)
T 3o0g_A 42 EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120 (292)
T ss_dssp TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 44557888999999999999999999999999999999999965 55555544 56799999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccCC-CCCcchHHHHHHHHHHHHh
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slg~~~~~~~~ 163 (177)
|++|+||||+||++ +..+.++|+|||.+....... ......+++.|+|||.+.+.. ++.++|+||+|++++++++
T Consensus 121 ~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~ 197 (292)
T 3o0g_A 121 NVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN 197 (292)
T ss_dssp TEECCCCSGGGEEE---CTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTT
T ss_pred CeecCCCCHHHEEE---cCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHH
Confidence 99999999999999 467789999999997764332 233455788999999987665 7999999999999999999
Q ss_pred CCCCC
Q 030430 164 GYPPF 168 (177)
Q Consensus 164 ~~~pf 168 (177)
|..||
T Consensus 198 ~~~p~ 202 (292)
T 3o0g_A 198 AGRPL 202 (292)
T ss_dssp TSCCS
T ss_pred cCCCC
Confidence 88775
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=217.29 Aligned_cols=160 Identities=42% Similarity=0.748 Sum_probs=135.8
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
.+.+.+|++++++++||||+++++++.+.+..++++|++++++|.+++.....+++..+..++.|++.+|++||+.|++|
T Consensus 55 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H 134 (276)
T 2h6d_A 55 VGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVH 134 (276)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSC
T ss_pred HHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 45789999999999999999999999999999999999999999999988888999999999999999999999999999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCC-CCcchHHHHHHHHHHHHhCCCCC
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPF 168 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slg~~~~~~~~~~~pf 168 (177)
+||+|+||++ +..+.++|+|||.+.............+++.|+|||.+.+..+ +.++|+||||++++++++|..||
T Consensus 135 ~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 211 (276)
T 2h6d_A 135 RDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPF 211 (276)
T ss_dssp CCCCGGGEEE---CTTSCEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCCChhhEEE---CCCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCC
Confidence 9999999999 4667899999999877655544445567889999999886654 67999999999999999999999
Q ss_pred CCCC
Q 030430 169 SVGE 172 (177)
Q Consensus 169 ~~~~ 172 (177)
....
T Consensus 212 ~~~~ 215 (276)
T 2h6d_A 212 DDEH 215 (276)
T ss_dssp CCSS
T ss_pred CCCc
Confidence 7754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=224.06 Aligned_cols=164 Identities=30% Similarity=0.497 Sum_probs=140.2
Q ss_pred hhHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC----------------CCCHHHHH
Q 030430 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTAR 69 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~ 69 (177)
+...+.+.+|+++++++ +||||+++++++.+.+..+++|||+++++|.+++.... .+++..++
T Consensus 66 ~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (327)
T 1fvr_A 66 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145 (327)
T ss_dssp ----CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHH
T ss_pred hHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHH
Confidence 44567799999999999 99999999999999999999999999999999998654 69999999
Q ss_pred HHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcc
Q 030430 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149 (177)
Q Consensus 70 ~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~ 149 (177)
.++.|++.+|++||+.|++|+||+|+||++ +..+.++|+|||.+.............++..|+|||.+.+..++.++
T Consensus 146 ~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 222 (327)
T 1fvr_A 146 HFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNS 222 (327)
T ss_dssp HHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHH
T ss_pred HHHHHHHHHHHHHHhCCccCCCCccceEEE---cCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchh
Confidence 999999999999999999999999999999 46678999999998654333333334467789999999888889999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCCc
Q 030430 150 DMWSVGAILFELLN-GYPPFSVGEE 173 (177)
Q Consensus 150 Di~slg~~~~~~~~-~~~pf~~~~~ 173 (177)
|+||||++++++++ |..||.+.+.
T Consensus 223 Di~slG~il~ellt~g~~pf~~~~~ 247 (327)
T 1fvr_A 223 DVWSYGVLLWEIVSLGGTPYCGMTC 247 (327)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred cchHHHHHHHHHHcCCCCCCCCCcH
Confidence 99999999999998 9999977643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=214.52 Aligned_cols=162 Identities=33% Similarity=0.619 Sum_probs=142.4
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEee----CCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (177)
++...+.+.+|++++++++||||+++++++.. ...+++|+||+++++|.+++.....+++..+..++.|++.+|+|
T Consensus 65 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~ 144 (290)
T 1t4h_A 65 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF 144 (290)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHH
Confidence 45667889999999999999999999998865 45689999999999999999988889999999999999999999
Q ss_pred HhhCC--CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHH
Q 030430 82 LNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (177)
Q Consensus 82 lh~~~--~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~ 159 (177)
||+.| ++|+||+|+||++. +..+.++|+|||.+....... .....+++.|+|||.+. ..++.++|+||||++++
T Consensus 145 lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Dfg~~~~~~~~~-~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~ 220 (290)
T 1t4h_A 145 LHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKRASF-AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCML 220 (290)
T ss_dssp HHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGGGCCTTS-BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHH
T ss_pred HHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeCCCcccccccc-cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHH
Confidence 99999 99999999999994 356789999999986544332 33445889999999876 45899999999999999
Q ss_pred HHHhCCCCCCCC
Q 030430 160 ELLNGYPPFSVG 171 (177)
Q Consensus 160 ~~~~~~~pf~~~ 171 (177)
++++|..||...
T Consensus 221 ~l~~g~~pf~~~ 232 (290)
T 1t4h_A 221 EMATSEYPYSEC 232 (290)
T ss_dssp HHHHSSCTTTTC
T ss_pred HHHhCCCCCCCc
Confidence 999999999764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=218.86 Aligned_cols=163 Identities=23% Similarity=0.458 Sum_probs=135.9
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
+...+.+.+|++++++++||||+++++++.+.+..++++|+++|++|.+++.....+++..+..++.|++.+|++||+.|
T Consensus 75 ~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 154 (309)
T 2h34_A 75 PVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG 154 (309)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence 34467899999999999999999999999999999999999999999999998888999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC--ccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhC
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~ 164 (177)
++|+||+|+||++ +..+.++|+|||.+....... ......+++.|+|||.+.+..++.++|+||||++++++++|
T Consensus 155 i~H~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 231 (309)
T 2h34_A 155 ATHRDVKPENILV---SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTG 231 (309)
T ss_dssp CCCSCCCGGGEEE---CTTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHS
T ss_pred CCcCCCChHHEEE---cCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHC
Confidence 9999999999999 456789999999987654432 12234578899999999888889999999999999999999
Q ss_pred CCCCCCCC
Q 030430 165 YPPFSVGE 172 (177)
Q Consensus 165 ~~pf~~~~ 172 (177)
..||.+..
T Consensus 232 ~~pf~~~~ 239 (309)
T 2h34_A 232 SPPYQGDQ 239 (309)
T ss_dssp SCSSCSCH
T ss_pred CCCCCCch
Confidence 99998754
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=219.61 Aligned_cols=161 Identities=34% Similarity=0.556 Sum_probs=137.6
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
..+.+.+|++++++++||||+++++++.+.+..+++||++++ +|.+++... +.+++..+..++.|++.||+|||+.|+
T Consensus 43 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 121 (288)
T 1ob3_A 43 IPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121 (288)
T ss_dssp CCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred cchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 346788999999999999999999999999999999999965 999988865 569999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccC-CCCCcchHHHHHHHHHHHHhCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~~~ 165 (177)
+|+||+|+||++ +..+.++|+|||.+....... ......+++.|+|||.+.+. .++.++|+||+|++++++++|.
T Consensus 122 ~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~ 198 (288)
T 1ob3_A 122 LHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198 (288)
T ss_dssp CCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred ecCCCCHHHEEE---cCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 999999999999 467789999999987654332 22334578999999998654 5799999999999999999999
Q ss_pred CCCCCCCc
Q 030430 166 PPFSVGEE 173 (177)
Q Consensus 166 ~pf~~~~~ 173 (177)
.||.+.++
T Consensus 199 ~pf~~~~~ 206 (288)
T 1ob3_A 199 PLFPGVSE 206 (288)
T ss_dssp CSCCCSSH
T ss_pred CCCCCCCH
Confidence 99987543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=223.24 Aligned_cols=164 Identities=27% Similarity=0.390 Sum_probs=143.5
Q ss_pred hhHHHHHHHHHHHHhhCC-----CCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVN-----HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGL 79 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l 79 (177)
....+.+..|+++++.+. ||||+++++++...+..++|||++ +++|.+++.... .+++..+..++.|++.||
T Consensus 72 ~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL 150 (360)
T 3llt_A 72 KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKAL 150 (360)
T ss_dssp HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHH
Confidence 455677889999999996 999999999999999999999999 999999998664 499999999999999999
Q ss_pred HHHhhCCCeeecCCCCcEEEecC----------------------CCCeeEEEeeeccccccCCCCccccccCCCccccc
Q 030430 80 EILNSHHIIHRDLKPENILLSGL----------------------DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAP 137 (177)
Q Consensus 80 ~~lh~~~~~H~~i~~~nil~~~~----------------------~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~p 137 (177)
+|||+.|++|+||||+||+++.. .....++|+|||.+...... .....+++.|+||
T Consensus 151 ~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aP 228 (360)
T 3llt_A 151 NYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAP 228 (360)
T ss_dssp HHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCH
T ss_pred HHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCc
Confidence 99999999999999999999521 12567999999998764432 2345588999999
Q ss_pred cccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 030430 138 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 173 (177)
Q Consensus 138 e~~~~~~~~~~~Di~slg~~~~~~~~~~~pf~~~~~ 173 (177)
|.+.+..++.++|+||+|+++++|++|+.||.+.+.
T Consensus 229 E~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 264 (360)
T 3llt_A 229 EVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEH 264 (360)
T ss_dssp HHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred HHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcH
Confidence 999988899999999999999999999999987654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=218.90 Aligned_cols=162 Identities=25% Similarity=0.503 Sum_probs=142.4
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
..+.+.+|++++++++||||+++++++.+.+..+++|||+++++|.+++.. ...+++..+..++.|++.+|++||+.|+
T Consensus 62 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 141 (283)
T 3gen_A 62 SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 141 (283)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 356789999999999999999999999999999999999999999999986 3569999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-C
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-~ 164 (177)
+|+||+|+||++ +..+.++|+|||.+........ .....+++.|+|||.+.+..++.++|+||+|++++++++ |
T Consensus 142 ~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g 218 (283)
T 3gen_A 142 LHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG 218 (283)
T ss_dssp CCSSCSGGGEEE---CTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTT
T ss_pred cCCCCccceEEE---cCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 999999999999 4677899999999876543321 112335677999999988889999999999999999998 9
Q ss_pred CCCCCCCCc
Q 030430 165 YPPFSVGEE 173 (177)
Q Consensus 165 ~~pf~~~~~ 173 (177)
..||...+.
T Consensus 219 ~~p~~~~~~ 227 (283)
T 3gen_A 219 KMPYERFTN 227 (283)
T ss_dssp CCTTTTSCH
T ss_pred CCCccccCh
Confidence 999987543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=219.66 Aligned_cols=160 Identities=35% Similarity=0.555 Sum_probs=140.0
Q ss_pred HHHHHHHHHHhhCC---CCceeeEeEEEeeCC-----eEEEEEecCCCCChHHHHhhcCC--CCHHHHHHHHHHHHHHHH
Q 030430 11 SCLDCELNFLSSVN---HPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLE 80 (177)
Q Consensus 11 ~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~ 80 (177)
..+.+|+++++.++ ||||+++++++.... ..++++|++. ++|.+++..... +++..+..++.|++.||+
T Consensus 56 ~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~ 134 (308)
T 3g33_A 56 ISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 134 (308)
T ss_dssp HHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHH
Confidence 46677888777774 999999999987655 5899999995 699999987654 999999999999999999
Q ss_pred HHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHH
Q 030430 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (177)
Q Consensus 81 ~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~ 160 (177)
|||+.|++|+||||+||++ +..+.++|+|||.+.............+++.|+|||.+.+..++.++|+||||+++++
T Consensus 135 ~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ 211 (308)
T 3g33_A 135 FLHANCIVHRDLKPENILV---TSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAE 211 (308)
T ss_dssp HHHHTTCCCSCCCTTTEEE---CTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHH
T ss_pred HHHHCCcccCCCCHHHEEE---cCCCCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHH
Confidence 9999999999999999999 4677899999999987665555556678999999999988889999999999999999
Q ss_pred HHhCCCCCCCCCcc
Q 030430 161 LLNGYPPFSVGEEH 174 (177)
Q Consensus 161 ~~~~~~pf~~~~~~ 174 (177)
+++|..||.+.++.
T Consensus 212 l~~g~~pf~~~~~~ 225 (308)
T 3g33_A 212 MFRRKPLFCGNSEA 225 (308)
T ss_dssp TTTSSCSCCCSSHH
T ss_pred HHhCCCCCCCCCHH
Confidence 99999999876543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=226.01 Aligned_cols=164 Identities=30% Similarity=0.506 Sum_probs=144.1
Q ss_pred hhHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC----------------CCCHHHHH
Q 030430 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTAR 69 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~ 69 (177)
+...+.+.+|+++++++ +||||+++++++.+.+..++||||+++++|.+++.... .+++..++
T Consensus 115 ~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 194 (382)
T 3tt0_A 115 EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194 (382)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHH
Confidence 44567899999999999 99999999999999999999999999999999998653 49999999
Q ss_pred HHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC---ccccccCCCccccccccccCCCC
Q 030430 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYD 146 (177)
Q Consensus 70 ~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~ 146 (177)
.++.|++.||+|||+.|++|+||||+||++ +..+.++|+|||.+....... ......++..|+|||.+.+..++
T Consensus 195 ~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 271 (382)
T 3tt0_A 195 SCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 271 (382)
T ss_dssp HHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCC
T ss_pred HHHHHHHHHHHHHHhCCEecCCCCcceEEE---cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCC
Confidence 999999999999999999999999999999 466789999999997664432 12233456789999999888899
Q ss_pred CcchHHHHHHHHHHHHh-CCCCCCCCCc
Q 030430 147 EKVDMWSVGAILFELLN-GYPPFSVGEE 173 (177)
Q Consensus 147 ~~~Di~slg~~~~~~~~-~~~pf~~~~~ 173 (177)
.++|+||||++++++++ |..||.+.+.
T Consensus 272 ~~~DiwslG~il~ellt~g~~p~~~~~~ 299 (382)
T 3tt0_A 272 HQSDVWSFGVLLWEIFTLGGSPYPGVPV 299 (382)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred chhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999 9999987654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=222.54 Aligned_cols=163 Identities=27% Similarity=0.433 Sum_probs=138.1
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCC----eEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (177)
.......+|+.++++++||||+++++++.+.. .+++||||+++++|.+++.. ..+++..+..++.|++.||+|||
T Consensus 60 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH 138 (322)
T 3soc_A 60 KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLH 138 (322)
T ss_dssp HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHH
Confidence 34455677888999999999999999988643 47999999999999999975 46999999999999999999999
Q ss_pred hC----------CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccC-----CC
Q 030430 84 SH----------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQ-----RY 145 (177)
Q Consensus 84 ~~----------~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~-----~~ 145 (177)
+. |++|+||||+||++ +..+.++|+|||.+........ .....+++.|+|||.+.+. .+
T Consensus 139 ~~~~~l~~~~~~~ivH~Dlkp~Nill---~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 215 (322)
T 3soc_A 139 EDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDA 215 (322)
T ss_dssp CCEEEETTEEECEEECSCCSGGGEEE---CTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHH
T ss_pred hhccccccccCCCEEeCCCChHhEEE---CCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCC
Confidence 99 99999999999999 4677899999999976544322 2234588999999998753 45
Q ss_pred CCcchHHHHHHHHHHHHhCCCCCCCCCcc
Q 030430 146 DEKVDMWSVGAILFELLNGYPPFSVGEEH 174 (177)
Q Consensus 146 ~~~~Di~slg~~~~~~~~~~~pf~~~~~~ 174 (177)
+.++|+||+|+++|++++|+.||.+..+.
T Consensus 216 ~~~~DiwslG~il~el~tg~~pf~~~~~~ 244 (322)
T 3soc_A 216 FLRIDMYAMGLVLWELASRCTAADGPVDE 244 (322)
T ss_dssp HHHHHHHHHHHHHHHHHTTBTTSSSCCCC
T ss_pred CccchhHHHHHHHHHHHhCCCCCCCCcch
Confidence 56789999999999999999999876543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=221.46 Aligned_cols=163 Identities=40% Similarity=0.723 Sum_probs=140.9
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
...+.+|++++++++||||+++++++.... .++|+||+++++|.+++.....+++..+..++.|++.+|+|||+.|++|
T Consensus 59 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH 137 (322)
T 2ycf_A 59 ALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIH 137 (322)
T ss_dssp --CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 456889999999999999999999987665 8999999999999999988888999999999999999999999999999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccc---cCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
+||+|+||+++..+....++|+|||.+.............+++.|+|||.+. ...++.++|+||||++++++++|..
T Consensus 138 ~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 217 (322)
T 2ycf_A 138 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217 (322)
T ss_dssp CCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSC
T ss_pred cCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999643344569999999997765544334456899999999863 4567899999999999999999999
Q ss_pred CCCCCCc
Q 030430 167 PFSVGEE 173 (177)
Q Consensus 167 pf~~~~~ 173 (177)
||.....
T Consensus 218 pf~~~~~ 224 (322)
T 2ycf_A 218 PFSEHRT 224 (322)
T ss_dssp SSCSTTC
T ss_pred CCcccch
Confidence 9976543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=217.77 Aligned_cols=159 Identities=31% Similarity=0.585 Sum_probs=137.8
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEee--CCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
.+.+.+|++++++++||||+++++++.+ ....+++|||+++++|.+++. ...+++..+..++.|++.||+|||+.|+
T Consensus 80 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i 158 (298)
T 2zv2_A 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKI 158 (298)
T ss_dssp -CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 4678999999999999999999999986 568999999999999988654 4579999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccCC---CCCcchHHHHHHHHHHHHh
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~---~~~~~Di~slg~~~~~~~~ 163 (177)
+|+||+|+||++ +..+.++|+|||.+....... ......+++.|+|||.+.+.. .+.++|+||||++++++++
T Consensus 159 vH~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~ 235 (298)
T 2zv2_A 159 IHRDIKPSNLLV---GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235 (298)
T ss_dssp ECCCCCGGGEEE---CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHH
T ss_pred eccCCCHHHEEE---CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHH
Confidence 999999999999 466789999999997765433 223456899999999987554 3678999999999999999
Q ss_pred CCCCCCCCC
Q 030430 164 GYPPFSVGE 172 (177)
Q Consensus 164 ~~~pf~~~~ 172 (177)
|..||.+..
T Consensus 236 g~~pf~~~~ 244 (298)
T 2zv2_A 236 GQCPFMDER 244 (298)
T ss_dssp SSCSSCCSS
T ss_pred CCCCCCCcc
Confidence 999997654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=230.11 Aligned_cols=161 Identities=27% Similarity=0.508 Sum_probs=139.6
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCC-eEEEEEecCCCCChHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
..+.+.+|++++++++||||+++++++.+.. ..++||||+++++|.+++...+. ++...+..++.|++.+|+|||+.
T Consensus 229 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~ 308 (450)
T 1k9a_A 229 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308 (450)
T ss_dssp TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4678999999999999999999999976654 79999999999999999987644 79999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-C
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-~ 164 (177)
|++|+||+|+||++ +..+.++|+|||++........ ...++..|+|||.+.+..++.++|+||+|++++++++ |
T Consensus 309 ~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g 383 (450)
T 1k9a_A 309 NFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 383 (450)
T ss_dssp TEECSCCCGGGEEE---CTTSCEEECCCTTCEECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTT
T ss_pred CeeCCCCCHhhEEE---CCCCCEEEeeCCCccccccccc--CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 99999999999999 4677899999999875433222 2246788999999988889999999999999999998 9
Q ss_pred CCCCCCCCcc
Q 030430 165 YPPFSVGEEH 174 (177)
Q Consensus 165 ~~pf~~~~~~ 174 (177)
..||.+.+..
T Consensus 384 ~~P~~~~~~~ 393 (450)
T 1k9a_A 384 RVPYPRIPLK 393 (450)
T ss_dssp CCSSTTSCTT
T ss_pred CCCCCCCCHH
Confidence 9999876544
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=220.45 Aligned_cols=165 Identities=30% Similarity=0.535 Sum_probs=140.7
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
+....+.+.+|++++++++||||+++++++.+.+..++||||+++++|.++......+++..+..++.|++.+|++||+.
T Consensus 64 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~ 143 (331)
T 4aaa_A 64 DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH 143 (331)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34456778899999999999999999999999999999999999999998877777899999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccC-CCCCcchHHHHHHHHHHHHh
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~ 163 (177)
|++|+||+|+||++ +..+.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||||++++++++
T Consensus 144 ~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 220 (331)
T 4aaa_A 144 NIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFM 220 (331)
T ss_dssp TCCCCCCCGGGEEE---CTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHH
T ss_pred CEEccCcChheEEE---cCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHh
Confidence 99999999999999 466789999999987654332 22345578899999998765 67899999999999999999
Q ss_pred CCCCCCCCCc
Q 030430 164 GYPPFSVGEE 173 (177)
Q Consensus 164 ~~~pf~~~~~ 173 (177)
|+.||.+.++
T Consensus 221 g~~pf~~~~~ 230 (331)
T 4aaa_A 221 GEPLFPGDSD 230 (331)
T ss_dssp SSCSCCCSSH
T ss_pred CCCCCCCCCc
Confidence 9999987654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=226.22 Aligned_cols=165 Identities=25% Similarity=0.491 Sum_probs=134.4
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
.+..++.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++.... .+++..+..++.|++.||+|||+
T Consensus 86 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~ 165 (373)
T 2qol_A 86 TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165 (373)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34567789999999999999999999999999999999999999999999998654 59999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc----ccccCCCccccccccccCCCCCcchHHHHHHHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~ 160 (177)
.|++|+||+|+||++ +..+.++|+|||.+......... ....++..|+|||.+.+..++.++|+||+|+++++
T Consensus 166 ~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~e 242 (373)
T 2qol_A 166 MGYVHRDLAARNILI---NSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE 242 (373)
T ss_dssp TTCCCSCCCGGGEEE---CTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred CCeeCCCCCcceEEE---cCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHH
Confidence 999999999999999 56778999999998765433211 11224567999999988889999999999999999
Q ss_pred HHh-CCCCCCCCCc
Q 030430 161 LLN-GYPPFSVGEE 173 (177)
Q Consensus 161 ~~~-~~~pf~~~~~ 173 (177)
+++ |..||...+.
T Consensus 243 llt~g~~P~~~~~~ 256 (373)
T 2qol_A 243 VMSYGERPYWEMSN 256 (373)
T ss_dssp HHTTC-CTTTTCCH
T ss_pred HHhCCCCCCCCCCH
Confidence 998 9999976543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=216.56 Aligned_cols=164 Identities=19% Similarity=0.267 Sum_probs=142.4
Q ss_pred hHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
...+.+.+|+++++++ +|++++++++++.+....++++||+ +++|.+++...+ .+++..+..++.|++.||+|||+.
T Consensus 47 ~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 125 (298)
T 1csn_A 47 SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 125 (298)
T ss_dssp TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3456789999999999 8999999999999999999999999 999999998754 599999999999999999999999
Q ss_pred CCeeecCCCCcEEEecC--CCCeeEEEeeeccccccCCCCc--------cccccCCCccccccccccCCCCCcchHHHHH
Q 030430 86 HIIHRDLKPENILLSGL--DDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVG 155 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~--~~~~~~~l~d~~~~~~~~~~~~--------~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg 155 (177)
|++|+||+|+||+++.. .....++|+|||.+........ .....+++.|+|||.+.+..++.++|+||||
T Consensus 126 ~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 205 (298)
T 1csn_A 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALG 205 (298)
T ss_dssp TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHH
Confidence 99999999999999532 1233499999999976644321 2344588999999999888899999999999
Q ss_pred HHHHHHHhCCCCCCCCC
Q 030430 156 AILFELLNGYPPFSVGE 172 (177)
Q Consensus 156 ~~~~~~~~~~~pf~~~~ 172 (177)
++++++++|+.||.+.+
T Consensus 206 ~il~el~~g~~pf~~~~ 222 (298)
T 1csn_A 206 HVFMYFLRGSLPWQGLK 222 (298)
T ss_dssp HHHHHHHHSSCTTSSCC
T ss_pred HHHHHHHcCCCCcchhh
Confidence 99999999999998743
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=225.81 Aligned_cols=164 Identities=33% Similarity=0.552 Sum_probs=145.1
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
++...+.+.+|++++++++||||+++++++.+++..++||||++|++|.+++.....+++..+..++.|++.+++|||+.
T Consensus 71 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 150 (360)
T 3eqc_A 71 KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150 (360)
T ss_dssp CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 45667889999999999999999999999999999999999999999999999888899999999999999999999996
Q ss_pred -CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhC
Q 030430 86 -HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 86 -~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~ 164 (177)
|++|+||+|+||++ +..+.++|+|||.+....... .....+++.|+|||.+.+..++.++|+||+|++++++++|
T Consensus 151 ~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 226 (360)
T 3eqc_A 151 HKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226 (360)
T ss_dssp HCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHHHHC-----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHT
T ss_pred CCEEcCCccHHHEEE---CCCCCEEEEECCCCccccccc-ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999999 466789999999886543222 2234578999999999888899999999999999999999
Q ss_pred CCCCCCCCc
Q 030430 165 YPPFSVGEE 173 (177)
Q Consensus 165 ~~pf~~~~~ 173 (177)
..||...+.
T Consensus 227 ~~pf~~~~~ 235 (360)
T 3eqc_A 227 RYPIPPPDA 235 (360)
T ss_dssp SCCSSCCCH
T ss_pred CCCCCCCCH
Confidence 999977543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=216.24 Aligned_cols=163 Identities=42% Similarity=0.789 Sum_probs=145.5
Q ss_pred hHHHHHHHHHHHHhhCC-CCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 8 HLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
..++.+.+|+++++++. ||||+++++++.+++..++|+||+++++|.+++.....+++..+..++.|++.+|++||+.|
T Consensus 65 ~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 144 (298)
T 1phk_A 65 ELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 144 (298)
T ss_dssp HHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 44678899999999995 99999999999999999999999999999999998888999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccc------cCCCCCcchHHHHHHHHHH
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ------FQRYDEKVDMWSVGAILFE 160 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~------~~~~~~~~Di~slg~~~~~ 160 (177)
++|+||+|+||++ +..+.++|+|||.+.............+++.|+|||.+. ...++.++|+||||+++++
T Consensus 145 i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~ 221 (298)
T 1phk_A 145 IVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYT 221 (298)
T ss_dssp EECSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHH
T ss_pred cccCCCCcceEEE---cCCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHH
Confidence 9999999999999 466789999999998766555445566889999999874 3457889999999999999
Q ss_pred HHhCCCCCCCCCc
Q 030430 161 LLNGYPPFSVGEE 173 (177)
Q Consensus 161 ~~~~~~pf~~~~~ 173 (177)
+++|..||...+.
T Consensus 222 l~~g~~p~~~~~~ 234 (298)
T 1phk_A 222 LLAGSPPFWHRKQ 234 (298)
T ss_dssp HHHSSCSSCCSSH
T ss_pred HHHCCCCCcCccH
Confidence 9999999977543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=219.11 Aligned_cols=159 Identities=30% Similarity=0.561 Sum_probs=136.2
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCC-----------------------------------------------
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN----------------------------------------------- 39 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----------------------------------------------- 39 (177)
+...+.+.+|++++++++||||+++++++.+..
T Consensus 45 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 124 (332)
T 3qd2_B 45 ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124 (332)
T ss_dssp TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-------------------------------------
T ss_pred hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCccccc
Confidence 446788999999999999999999999885433
Q ss_pred ----------eEEEEEecCCCCChHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCe
Q 030430 40 ----------CIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV 106 (177)
Q Consensus 40 ----------~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~ 106 (177)
..+++|||++|++|.+++..... .+...++.++.|++.||+|||+.|++|+||||+||++ +..+
T Consensus 125 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~ 201 (332)
T 3qd2_B 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDD 201 (332)
T ss_dssp -------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTC
T ss_pred ccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCC
Confidence 38999999999999999986543 5666789999999999999999999999999999999 4667
Q ss_pred eEEEeeeccccccCCCC-------------ccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 030430 107 MLKIADFGLSCTLYPGN-------------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (177)
Q Consensus 107 ~~~l~d~~~~~~~~~~~-------------~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf 168 (177)
.++|+|||.+....... ......+++.|+|||.+.+..++.++|+||+|++++++++|..|+
T Consensus 202 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~ 276 (332)
T 3qd2_B 202 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276 (332)
T ss_dssp CEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred CEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh
Confidence 89999999997765432 122345889999999998888999999999999999999998776
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=219.43 Aligned_cols=165 Identities=28% Similarity=0.466 Sum_probs=144.3
Q ss_pred ccccchhHHHHHHHHHHHHhhCC-CCceeeEeEEEee--CCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHH
Q 030430 2 LKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78 (177)
Q Consensus 2 l~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~ 78 (177)
+|.+++...+.+.+|++++++++ ||||+++++++.+ ....+++|||+.+++|.+++. .+++..+..++.|++.+
T Consensus 66 vK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~ 142 (330)
T 3nsz_A 66 VKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKA 142 (330)
T ss_dssp EEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHH
T ss_pred EEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHH
Confidence 55666666788999999999997 9999999999987 667899999999999999875 48899999999999999
Q ss_pred HHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCcccccccccc-CCCCCcchHHHHHHH
Q 030430 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAI 157 (177)
Q Consensus 79 l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~ 157 (177)
|+|||+.|++|+||+|+||+++ .....++|+|||.+.............++..|+|||.+.+ ..++.++|+||||++
T Consensus 143 l~~lH~~~ivH~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i 220 (330)
T 3nsz_A 143 LDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCM 220 (330)
T ss_dssp HHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHH
T ss_pred HHHHHhCCeeeCCCCHHHEEEc--CCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHH
Confidence 9999999999999999999996 3444899999999987665555555668889999999876 568999999999999
Q ss_pred HHHHHhCCCCCCCC
Q 030430 158 LFELLNGYPPFSVG 171 (177)
Q Consensus 158 ~~~~~~~~~pf~~~ 171 (177)
+++|++|..||...
T Consensus 221 l~~ll~g~~p~~~~ 234 (330)
T 3nsz_A 221 LASMIFRKEPFFHG 234 (330)
T ss_dssp HHHHHHTCSSSSCC
T ss_pred HHHHHhCCCCcccC
Confidence 99999999999543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=225.45 Aligned_cols=163 Identities=32% Similarity=0.509 Sum_probs=138.3
Q ss_pred chhHHHHHHHHHHHHhhCC-CCceeeEeEEEeeCC--eEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l 82 (177)
......++.+|+.+++++. ||||+++++++...+ .+|+||||++ ++|.+++.. ..+++..+..++.|++.||+||
T Consensus 48 ~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~L 125 (388)
T 3oz6_A 48 NSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYL 125 (388)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH
Confidence 3455677889999999997 999999999987543 7899999995 699998875 5799999999999999999999
Q ss_pred hhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCC----------------------CccccccCCCcccccccc
Q 030430 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----------------------NYAEKVCGSPLYMAPEVL 140 (177)
Q Consensus 83 h~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~----------------------~~~~~~~~~~~~~~pe~~ 140 (177)
|+.|++||||||+||++ +..+.++|+|||++...... .......+++.|+|||.+
T Consensus 126 H~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 202 (388)
T 3oz6_A 126 HSGGLLHRDMKPSNILL---NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEIL 202 (388)
T ss_dssp HHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHH
T ss_pred HhCCEEeCCCCHHHeEE---cCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHh
Confidence 99999999999999999 56778999999998765321 112234688999999998
Q ss_pred cc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 030430 141 QF-QRYDEKVDMWSVGAILFELLNGYPPFSVGEE 173 (177)
Q Consensus 141 ~~-~~~~~~~Di~slg~~~~~~~~~~~pf~~~~~ 173 (177)
.+ ..++.++|+||+|+++++|++|+.||.+.+.
T Consensus 203 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 203 LGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp TTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 75 5689999999999999999999999988654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=221.75 Aligned_cols=165 Identities=30% Similarity=0.462 Sum_probs=135.4
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+.+.+|++++++++||||+++++++.++..+++||||++ ++|.+++.....+++..+..++.|++.+|+|||+.|+
T Consensus 75 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~i 153 (329)
T 3gbz_A 75 GVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRC 153 (329)
T ss_dssp -----CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred ccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 345667899999999999999999999999999999999996 5999999988889999999999999999999999999
Q ss_pred eeecCCCCcEEEecC--CCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccC-CCCCcchHHHHHHHHHHHHh
Q 030430 88 IHRDLKPENILLSGL--DDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 88 ~H~~i~~~nil~~~~--~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~ 163 (177)
+|+||||+||+++.. +....++|+|||.+....... ......+++.|+|||.+.+. .++.++|+||||++++++++
T Consensus 154 vH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 233 (329)
T 3gbz_A 154 LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM 233 (329)
T ss_dssp CCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH
T ss_pred ECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHH
Confidence 999999999999632 234569999999997664332 22334578999999998764 47999999999999999999
Q ss_pred CCCCCCCCCc
Q 030430 164 GYPPFSVGEE 173 (177)
Q Consensus 164 ~~~pf~~~~~ 173 (177)
|..||.+.++
T Consensus 234 g~~pf~~~~~ 243 (329)
T 3gbz_A 234 KTPLFPGDSE 243 (329)
T ss_dssp SSCSSCCSSH
T ss_pred CCCCcCCCCH
Confidence 9999987654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=223.73 Aligned_cols=166 Identities=34% Similarity=0.608 Sum_probs=137.5
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc--------------------------
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-------------------------- 60 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------------------------- 60 (177)
+...+.+.+|++++++++||||+++++++.+.+..++||||++|++|.+++...
T Consensus 69 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (345)
T 3hko_A 69 PKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148 (345)
T ss_dssp -CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccc
Confidence 345678999999999999999999999999999999999999999999988521
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC---
Q 030430 61 --------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--- 123 (177)
Q Consensus 61 --------------~~~~~~~~~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--- 123 (177)
..+++..++.++.|++.+|+|||+.|++|+||+|+||++.. +....++|+|||.+.......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~Dfg~a~~~~~~~~~~ 227 (345)
T 3hko_A 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGE 227 (345)
T ss_dssp HHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESC-SSSCCEEECCCTTCEEGGGTTCC-
T ss_pred ccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEec-CCCceEEEeeccccccccccCccc
Confidence 11467788899999999999999999999999999999952 223479999999987653321
Q ss_pred --ccccccCCCcccccccccc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 030430 124 --YAEKVCGSPLYMAPEVLQF--QRYDEKVDMWSVGAILFELLNGYPPFSVGEE 173 (177)
Q Consensus 124 --~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slg~~~~~~~~~~~pf~~~~~ 173 (177)
......+++.|+|||.+.+ ..++.++|+||||++++++++|+.||.+.+.
T Consensus 228 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 281 (345)
T 3hko_A 228 YYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVND 281 (345)
T ss_dssp -------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCh
Confidence 1234558899999999864 5688999999999999999999999987654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-36 Score=217.12 Aligned_cols=164 Identities=40% Similarity=0.692 Sum_probs=145.5
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
..+.+.+|++++++++||||+++++++.+.+..++++|++++++|.+++.....+++..+..++.|++.+|++||+.|++
T Consensus 64 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~ 143 (287)
T 2wei_A 64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIV 143 (287)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 46788999999999999999999999999999999999999999999998778899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf 168 (177)
|+||+|+||++...+....++|+|||.+.............+++.|+|||.+.+ .++.++|+||||++++++++|..||
T Consensus 144 H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~ 222 (287)
T 2wei_A 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPF 222 (287)
T ss_dssp CSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ccCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCC
Confidence 999999999996444456799999999877655544444557888999998864 4889999999999999999999999
Q ss_pred CCCCc
Q 030430 169 SVGEE 173 (177)
Q Consensus 169 ~~~~~ 173 (177)
.+.+.
T Consensus 223 ~~~~~ 227 (287)
T 2wei_A 223 YGKNE 227 (287)
T ss_dssp CCSSH
T ss_pred CCCCH
Confidence 87653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=217.16 Aligned_cols=164 Identities=27% Similarity=0.530 Sum_probs=132.1
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
+...+.+.+|++++++++||||+++++++.+ +..++||||+++++|.+++.... .+++..+..++.|++.+|++||+.
T Consensus 57 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 135 (281)
T 1mp8_A 57 DSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK 135 (281)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhCCCCccceEEEEEcc-CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4567789999999999999999999999854 56789999999999999998654 599999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~ 163 (177)
|++|+||+|+||+++ ..+.++|+|||.+........ .....+++.|+|||.+.+..++.++|+||||++++++++
T Consensus 136 ~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~ 212 (281)
T 1mp8_A 136 RFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 212 (281)
T ss_dssp TCCCSCCSGGGEEEE---ETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHT
T ss_pred CeecccccHHHEEEC---CCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHh
Confidence 999999999999995 466899999999876644322 122335678999999988889999999999999999997
Q ss_pred -CCCCCCCCCcc
Q 030430 164 -GYPPFSVGEEH 174 (177)
Q Consensus 164 -~~~pf~~~~~~ 174 (177)
|..||.+....
T Consensus 213 ~g~~pf~~~~~~ 224 (281)
T 1mp8_A 213 HGVKPFQGVKNN 224 (281)
T ss_dssp TSCCTTTTCCGG
T ss_pred cCCCCCCcCCHH
Confidence 99999876543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=220.20 Aligned_cols=166 Identities=30% Similarity=0.538 Sum_probs=142.0
Q ss_pred hHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
.....+.+|+++++++ .||||+++++++.+.+..++||||++|++|.+++... ..+++..+..++.|++.+|++||+
T Consensus 70 ~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~ 149 (327)
T 3lm5_A 70 DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ 149 (327)
T ss_dssp ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3467889999999999 5699999999999999999999999999999998643 569999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhC
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~ 164 (177)
.|++|+||+|+||+++.....+.++|+|||.+.............+++.|+|||.+.+..++.++|+||||+++++|++|
T Consensus 150 ~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g 229 (327)
T 3lm5_A 150 NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229 (327)
T ss_dssp TTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred CCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999999964334678999999999877655444456689999999999888899999999999999999999
Q ss_pred CCCCCCCCc
Q 030430 165 YPPFSVGEE 173 (177)
Q Consensus 165 ~~pf~~~~~ 173 (177)
..||.+.+.
T Consensus 230 ~~pf~~~~~ 238 (327)
T 3lm5_A 230 TSPFVGEDN 238 (327)
T ss_dssp SCSSCCSSH
T ss_pred CCCCCCCCc
Confidence 999977654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=228.70 Aligned_cols=164 Identities=34% Similarity=0.581 Sum_probs=142.5
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
+...+.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++...+ .++...+..++.|++.||+|||+.
T Consensus 153 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~ 232 (377)
T 3cbl_A 153 PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232 (377)
T ss_dssp HHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4556788999999999999999999999999999999999999999999998654 599999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc---ccccCCCccccccccccCCCCCcchHHHHHHHHHHHH
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~ 162 (177)
|++|+||+|+||++ +..+.++|+|||.+......... ....++..|+|||.+.+..++.++|+||+|+++++++
T Consensus 233 ~ivHrDlkp~Nil~---~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~ 309 (377)
T 3cbl_A 233 CCIHRDLAARNCLV---TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETF 309 (377)
T ss_dssp TEECSCCSGGGEEE---CTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred CcCCcccCHHHEEE---cCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHH
Confidence 99999999999999 46678999999998765433211 1122456799999998888899999999999999999
Q ss_pred h-CCCCCCCCCc
Q 030430 163 N-GYPPFSVGEE 173 (177)
Q Consensus 163 ~-~~~pf~~~~~ 173 (177)
+ |..||.+.+.
T Consensus 310 t~g~~p~~~~~~ 321 (377)
T 3cbl_A 310 SLGASPYPNLSN 321 (377)
T ss_dssp TTSCCSSTTSCH
T ss_pred hCCCCCCCCCCH
Confidence 8 9999987543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=225.56 Aligned_cols=157 Identities=15% Similarity=0.220 Sum_probs=133.7
Q ss_pred HHHHHHHHhhCCCCceeeEeEEEeeC----CeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 13 LDCELNFLSSVNHPNIIRLFDAFQAE----NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 13 ~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...|+..++.++||||+++++++... ...++||||+ |++|.+++... ..+++..+..++.|++.+|+|||+.|+
T Consensus 95 ~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i 173 (364)
T 3op5_A 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEY 173 (364)
T ss_dssp HHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 34455667778899999999998754 4689999999 99999999876 569999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--------cccccCCCccccccccccCCCCCcchHHHHHHHHH
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--------~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~ 159 (177)
+||||||+||+++. +..+.++|+|||.+........ .....+++.|+|||.+.+..++.++||||||++++
T Consensus 174 iHrDlkp~Nill~~-~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~ 252 (364)
T 3op5_A 174 VHGDIKASNLLLNY-KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMI 252 (364)
T ss_dssp ECCCCCGGGEEEES-SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred EEecCCHHHEEEec-CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHH
Confidence 99999999999962 2467899999999976543221 12334889999999999888999999999999999
Q ss_pred HHHhCCCCCCCC
Q 030430 160 ELLNGYPPFSVG 171 (177)
Q Consensus 160 ~~~~~~~pf~~~ 171 (177)
+|++|+.||.+.
T Consensus 253 el~~g~~Pf~~~ 264 (364)
T 3op5_A 253 QWLTGHLPWEDN 264 (364)
T ss_dssp HHHHSCCTTGGG
T ss_pred HHHhCCCCcccc
Confidence 999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=221.14 Aligned_cols=163 Identities=26% Similarity=0.419 Sum_probs=140.2
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
...+.+.+|++++++++||||+++++++.++. .+++++++.+++|.+++... ..+++..+..++.|++.+|+|||+.|
T Consensus 59 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ 137 (327)
T 3poz_A 59 KANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137 (327)
T ss_dssp -CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 44578999999999999999999999998765 67899999999999999864 46999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc---ccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~ 163 (177)
++|+||||+||+++ ..+.++|+|||.+......... ....++..|+|||.+.+..++.++|+||+|++++++++
T Consensus 138 ivH~Dikp~NIll~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 214 (327)
T 3poz_A 138 LVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214 (327)
T ss_dssp CCCSCCCGGGEEEE---ETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred eeCCCCChheEEEC---CCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHh
Confidence 99999999999995 5667999999999766443322 22335678999999998889999999999999999999
Q ss_pred -CCCCCCCCCcc
Q 030430 164 -GYPPFSVGEEH 174 (177)
Q Consensus 164 -~~~pf~~~~~~ 174 (177)
|..||.+....
T Consensus 215 ~g~~p~~~~~~~ 226 (327)
T 3poz_A 215 FGSKPYDGIPAS 226 (327)
T ss_dssp TSCCTTTTCCGG
T ss_pred cCCCCccCCCHH
Confidence 99999876544
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=223.12 Aligned_cols=164 Identities=29% Similarity=0.508 Sum_probs=141.5
Q ss_pred hhHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-----------------------C
Q 030430 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----------------------R 62 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------------------~ 62 (177)
....+.+.+|+++++++ +||||+++++++...+..+++|||+++++|.+++.... .
T Consensus 89 ~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (344)
T 1rjb_A 89 SSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168 (344)
T ss_dssp ---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------
T ss_pred HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhccccccccccc
Confidence 34567899999999999 99999999999999999999999999999999998643 2
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccc
Q 030430 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEV 139 (177)
Q Consensus 63 ~~~~~~~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~ 139 (177)
+++..++.++.|++.||+|||+.|++|+||+|+||+++ ..+.++|+|||.+........ .....+++.|+|||.
T Consensus 169 l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~ 245 (344)
T 1rjb_A 169 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPES 245 (344)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEE---TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEc---CCCcEEeCCCccCcccccCccceeccCccCccCccCHHH
Confidence 78999999999999999999999999999999999995 567899999999976543322 223345778999999
Q ss_pred cccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCc
Q 030430 140 LQFQRYDEKVDMWSVGAILFELLN-GYPPFSVGEE 173 (177)
Q Consensus 140 ~~~~~~~~~~Di~slg~~~~~~~~-~~~pf~~~~~ 173 (177)
+.+..++.++|+||||++++++++ |..||.+...
T Consensus 246 ~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 246 LFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 988889999999999999999998 9999987543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=223.85 Aligned_cols=164 Identities=32% Similarity=0.538 Sum_probs=140.9
Q ss_pred hhHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCC-eEEEEEecCCCCChHHHHhhcCC----------------------
Q 030430 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHGR---------------------- 62 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~---------------------- 62 (177)
....+.+.+|+++++++ +||||+++++++.+.+ .++++|||++|++|.+++.....
T Consensus 66 ~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (359)
T 3vhe_A 66 HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145 (359)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------
T ss_pred HHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhccccccccc
Confidence 34457799999999999 7899999999988754 48999999999999999986532
Q ss_pred --------------------------------------------CCHHHHHHHHHHHHHHHHHHhhCCCeeecCCCCcEE
Q 030430 63 --------------------------------------------VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENIL 98 (177)
Q Consensus 63 --------------------------------------------~~~~~~~~~~~~i~~~l~~lh~~~~~H~~i~~~nil 98 (177)
+++..+..++.|++.+|+|||+.|++|+||||+||+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIl 225 (359)
T 3vhe_A 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 225 (359)
T ss_dssp --------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred chhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEE
Confidence 889999999999999999999999999999999999
Q ss_pred EecCCCCeeEEEeeeccccccCCCC---ccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCc
Q 030430 99 LSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSVGEE 173 (177)
Q Consensus 99 ~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-~~~pf~~~~~ 173 (177)
+ +..+.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|++++++++ |..||.+...
T Consensus 226 l---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 301 (359)
T 3vhe_A 226 L---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 301 (359)
T ss_dssp E---CGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred E---cCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch
Confidence 9 467789999999997654332 2223456788999999988889999999999999999998 9999987653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=213.31 Aligned_cols=163 Identities=36% Similarity=0.644 Sum_probs=143.3
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+.+.+|++++++++||||+++++++.+++..++++||+++++|.+++.....+++..+..++.|++.+|++||+.|+
T Consensus 47 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i 126 (276)
T 2yex_A 47 DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126 (276)
T ss_dssp THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 34578999999999999999999999999999999999999999999999877789999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC---ccccccCCCccccccccccCCC-CCcchHHHHHHHHHHHHh
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLN 163 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slg~~~~~~~~ 163 (177)
+|+||+|+||++ +..+.++|+|||.+....... ......++..|+|||.+.+..+ +.++|+||+|++++++++
T Consensus 127 ~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 203 (276)
T 2yex_A 127 THRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 203 (276)
T ss_dssp ECSCCSGGGEEE---CTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHH
T ss_pred eccCCChHHEEE---ccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHh
Confidence 999999999999 466789999999987653222 1233457889999999876664 678999999999999999
Q ss_pred CCCCCCCCCc
Q 030430 164 GYPPFSVGEE 173 (177)
Q Consensus 164 ~~~pf~~~~~ 173 (177)
|..||.....
T Consensus 204 g~~p~~~~~~ 213 (276)
T 2yex_A 204 GELPWDQPSD 213 (276)
T ss_dssp SSCCCSCSCT
T ss_pred CCCCCCCCch
Confidence 9999987553
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=218.39 Aligned_cols=163 Identities=31% Similarity=0.482 Sum_probs=143.5
Q ss_pred hHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC------------------CCCHHHH
Q 030430 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG------------------RVPEQTA 68 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~ 68 (177)
...+.+.+|+++++++ +||||+++++++.+.+..++++||+++++|.+++.... .+++..+
T Consensus 68 ~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (313)
T 1t46_A 68 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147 (313)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHH
T ss_pred HHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHH
Confidence 4568899999999999 99999999999999999999999999999999998653 3899999
Q ss_pred HHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCC
Q 030430 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRY 145 (177)
Q Consensus 69 ~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~ 145 (177)
..++.|++.+|++||+.|++|+||+|+||+++ ..+.++|+|||.+........ .....++..|+|||.+.+..+
T Consensus 148 ~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 224 (313)
T 1t46_A 148 LSFSYQVAKGMAFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY 224 (313)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHCCeecCCCccceEEEc---CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCC
Confidence 99999999999999999999999999999995 567899999999877654432 223345678999999988889
Q ss_pred CCcchHHHHHHHHHHHHh-CCCCCCCCCc
Q 030430 146 DEKVDMWSVGAILFELLN-GYPPFSVGEE 173 (177)
Q Consensus 146 ~~~~Di~slg~~~~~~~~-~~~pf~~~~~ 173 (177)
+.++|+||+|++++++++ |..||.+...
T Consensus 225 ~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 225 TFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 999999999999999999 9999987543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=219.75 Aligned_cols=165 Identities=26% Similarity=0.480 Sum_probs=134.3
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeE------EEEEecCCCCChHHHHhhcC------CCCHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCI------FLVVEFCAGGNLSSYIRLHG------RVPEQTARKFLQQ 74 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~ 74 (177)
....+.+.+|++++++++||||+++++++...... ++++||+.+++|.+++.... .+++..+..++.|
T Consensus 66 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~q 145 (323)
T 3qup_A 66 SSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145 (323)
T ss_dssp CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHH
Confidence 34567899999999999999999999999876654 99999999999999986442 5999999999999
Q ss_pred HHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc---ccccCCCccccccccccCCCCCcchH
Q 030430 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDM 151 (177)
Q Consensus 75 i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~Di 151 (177)
++.||+|||+.|++|+||||+||++ +..+.++|+|||.+......... ....+++.|+|||.+.+..++.++|+
T Consensus 146 i~~al~~LH~~~ivH~Dikp~NIli---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 222 (323)
T 3qup_A 146 IACGMEYLSSRNFIHRDLAARNCML---AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDV 222 (323)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHcCCcccCCCCcceEEE---cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccch
Confidence 9999999999999999999999999 46678999999999765443221 12335678999999988889999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCcc
Q 030430 152 WSVGAILFELLN-GYPPFSVGEEH 174 (177)
Q Consensus 152 ~slg~~~~~~~~-~~~pf~~~~~~ 174 (177)
||+|++++++++ |..||.+.+..
T Consensus 223 ~slG~il~ell~~g~~p~~~~~~~ 246 (323)
T 3qup_A 223 WAFGVTMWEIMTRGQTPYAGIENA 246 (323)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred hhHHHHHHHHHhCCCCCccccChH
Confidence 999999999999 99999876543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=215.15 Aligned_cols=164 Identities=29% Similarity=0.477 Sum_probs=143.0
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHh
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---GRVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lh 83 (177)
+...+.+.+|++++++++||||+++++++.+.+..+++|||+++++|.+++... ..+++..++.++.|++.+|+|||
T Consensus 71 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH 150 (307)
T 2nru_A 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH 150 (307)
T ss_dssp TTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh
Confidence 455788999999999999999999999999999999999999999999998743 45999999999999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCCCcchHHHHHHHHHH
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~ 160 (177)
+.|++|+||+|+||++ +..+.++|+|||.+........ .....+++.|+|||.+.+ .++.++|+||||+++++
T Consensus 151 ~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~ 226 (307)
T 2nru_A 151 ENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLE 226 (307)
T ss_dssp HTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHH
T ss_pred cCCeecCCCCHHHEEE---cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHH
Confidence 9999999999999999 4677899999999876543221 223457899999998764 57899999999999999
Q ss_pred HHhCCCCCCCCCcc
Q 030430 161 LLNGYPPFSVGEEH 174 (177)
Q Consensus 161 ~~~~~~pf~~~~~~ 174 (177)
+++|..||......
T Consensus 227 l~~g~~p~~~~~~~ 240 (307)
T 2nru_A 227 IITGLPAVDEHREP 240 (307)
T ss_dssp HHHCCCSBCTTBSS
T ss_pred HHHCCCCcccCcch
Confidence 99999999876543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=227.51 Aligned_cols=162 Identities=28% Similarity=0.466 Sum_probs=134.5
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEee-----CCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (177)
....+++.+|+++++.++||||+++++++.. ...+|+|+|++ +++|.+++.....+++..+..++.|++.||+|
T Consensus 93 ~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~ 171 (458)
T 3rp9_A 93 LIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKY 171 (458)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHH
Confidence 4456788999999999999999999999843 35789999998 67999999887789999999999999999999
Q ss_pred HhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC----------------------------ccccccCCCc
Q 030430 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----------------------------YAEKVCGSPL 133 (177)
Q Consensus 82 lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~----------------------------~~~~~~~~~~ 133 (177)
||+.|++||||||+||++ +..+.++|+|||++....... ......+|+.
T Consensus 172 LH~~~iiHrDlKp~NILl---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 248 (458)
T 3rp9_A 172 VHSAGILHRDLKPANCLV---NQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRW 248 (458)
T ss_dssp HHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCT
T ss_pred HHhCCcCCCCCChhhEEE---CCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCccccc
Confidence 999999999999999999 567789999999997654221 1223457899
Q ss_pred ccccccc-ccCCCCCcchHHHHHHHHHHHHh-----------CCCCCCCCC
Q 030430 134 YMAPEVL-QFQRYDEKVDMWSVGAILFELLN-----------GYPPFSVGE 172 (177)
Q Consensus 134 ~~~pe~~-~~~~~~~~~Di~slg~~~~~~~~-----------~~~pf~~~~ 172 (177)
|+|||.+ ....++.++|+||+||++++|++ |.++|.+.+
T Consensus 249 Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 249 YRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSS 299 (458)
T ss_dssp TCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC---
T ss_pred ccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCc
Confidence 9999976 45668999999999999999998 677776643
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-36 Score=220.48 Aligned_cols=156 Identities=29% Similarity=0.441 Sum_probs=139.7
Q ss_pred HHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhC-
Q 030430 11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQLGAGLEILNSH- 85 (177)
Q Consensus 11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lh~~- 85 (177)
..+.+|++++++++||||+++++++.+.+..++++||+.+++|.+++.... .+++..+..++.|++.+|+|||+.
T Consensus 72 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ 151 (326)
T 3uim_A 72 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC 151 (326)
T ss_dssp CHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSS
T ss_pred HHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 368999999999999999999999999999999999999999999998543 399999999999999999999999
Q ss_pred --CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--cccccCCCccccccccccCCCCCcchHHHHHHHHHHH
Q 030430 86 --HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 86 --~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~ 161 (177)
|++|+||+|+||++ +..+.++|+|||.+........ .....+++.|+|||.+.+..++.++|+||+|++++++
T Consensus 152 ~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 228 (326)
T 3uim_A 152 DPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 228 (326)
T ss_dssp SSCEECCCCSGGGEEE---CTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHH
T ss_pred CCCeEeCCCchhhEEE---CCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHH
Confidence 99999999999999 4677899999999976643322 2334488999999999888889999999999999999
Q ss_pred HhCCCCCC
Q 030430 162 LNGYPPFS 169 (177)
Q Consensus 162 ~~~~~pf~ 169 (177)
++|+.||.
T Consensus 229 ~~g~~pf~ 236 (326)
T 3uim_A 229 ITGQRAFD 236 (326)
T ss_dssp HHCCCSBC
T ss_pred HhCCCccc
Confidence 99999995
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=227.91 Aligned_cols=163 Identities=27% Similarity=0.494 Sum_probs=140.5
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCC--eEEEEEecCCCCChHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHh
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lh 83 (177)
..+.+.+|++++++++||||+++++++.+.. ..++||||++|++|.+++..... +++..++.++.|++.||+|||
T Consensus 50 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 129 (396)
T 4eut_A 50 PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129 (396)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence 3567889999999999999999999988655 78999999999999999985433 999999999999999999999
Q ss_pred hCCCeeecCCCCcEEEec-CCCCeeEEEeeeccccccCCCCccccccCCCcccccccccc--------CCCCCcchHHHH
Q 030430 84 SHHIIHRDLKPENILLSG-LDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF--------QRYDEKVDMWSV 154 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~-~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Di~sl 154 (177)
+.|++|+||||+||++.. .+....++|+|||.+.............+++.|+|||.+.+ ..++.++|+||+
T Consensus 130 ~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSl 209 (396)
T 4eut_A 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSI 209 (396)
T ss_dssp HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHH
T ss_pred HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHH
Confidence 999999999999999732 24566799999999987655554445668999999998764 456788999999
Q ss_pred HHHHHHHHhCCCCCCCC
Q 030430 155 GAILFELLNGYPPFSVG 171 (177)
Q Consensus 155 g~~~~~~~~~~~pf~~~ 171 (177)
|+++|++++|+.||...
T Consensus 210 G~il~el~tg~~Pf~~~ 226 (396)
T 4eut_A 210 GVTFYHAATGSLPFRPF 226 (396)
T ss_dssp HHHHHHHHHSSCSEECT
T ss_pred HHHHHHHHHCCCCCCCC
Confidence 99999999999999653
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=223.09 Aligned_cols=161 Identities=32% Similarity=0.554 Sum_probs=140.6
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCC------eEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGL 79 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l 79 (177)
+....+++.+|++++++++||||+++++++.... .+|++||++ +++|.+++.. ..+++..+..++.|++.||
T Consensus 64 ~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L 141 (367)
T 1cm8_A 64 SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGL 141 (367)
T ss_dssp SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHH
Confidence 3445678899999999999999999999987653 469999999 8899999875 5799999999999999999
Q ss_pred HHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCcccccccccc-CCCCCcchHHHHHHHH
Q 030430 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAIL 158 (177)
Q Consensus 80 ~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~ 158 (177)
+|||+.|++|+||||+||++ +..+.++|+|||.+...... .....+++.|+|||.+.+ ..++.++|+||+|+++
T Consensus 142 ~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 216 (367)
T 1cm8_A 142 RYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIM 216 (367)
T ss_dssp HHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHH
T ss_pred HHHHHCCccccCcCHHHEEE---cCCCCEEEEeeecccccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHH
Confidence 99999999999999999999 46778999999999765432 233457899999999876 5789999999999999
Q ss_pred HHHHhCCCCCCCCCc
Q 030430 159 FELLNGYPPFSVGEE 173 (177)
Q Consensus 159 ~~~~~~~~pf~~~~~ 173 (177)
++|++|+.||.+.+.
T Consensus 217 ~ell~g~~pf~~~~~ 231 (367)
T 1cm8_A 217 AEMITGKTLFKGSDH 231 (367)
T ss_dssp HHHHHSSCSSCCSSH
T ss_pred HHHHhCCCCCCCCCH
Confidence 999999999987654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=216.35 Aligned_cols=163 Identities=23% Similarity=0.397 Sum_probs=137.9
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHhh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
.....+.+.+|++++++++||||+++++++.+++..++||||++|++|.+++..... +++..+..++.|++.+|+|||+
T Consensus 52 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~ 131 (289)
T 4fvq_A 52 HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE 131 (289)
T ss_dssp GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 345567899999999999999999999999999999999999999999999987654 9999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCC-----CeeEEEeeeccccccCCCCccccccCCCcccccccccc-CCCCCcchHHHHHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDD-----DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAIL 158 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~-----~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~ 158 (177)
.|++|+||+|+||+++.... ...++++|||.+...... ....++..|+|||.+.+ ..++.++|+||+|+++
T Consensus 132 ~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il 208 (289)
T 4fvq_A 132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTL 208 (289)
T ss_dssp TTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHH
T ss_pred CCeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHH
Confidence 99999999999999963221 122999999988654332 22346788999999876 6689999999999999
Q ss_pred HHHHhC-CCCCCCC
Q 030430 159 FELLNG-YPPFSVG 171 (177)
Q Consensus 159 ~~~~~~-~~pf~~~ 171 (177)
+++++| .+||...
T Consensus 209 ~el~~g~~~~~~~~ 222 (289)
T 4fvq_A 209 WEICSGGDKPLSAL 222 (289)
T ss_dssp HHHHTTTCCTTTTS
T ss_pred HHHHcCCCCCcccc
Confidence 999995 4555543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-36 Score=217.63 Aligned_cols=162 Identities=27% Similarity=0.462 Sum_probs=136.2
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEee--CCeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEIL 82 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~l 82 (177)
+....+.+.+|++++++++||||+++++++.. ...+++||||+++++|.+++.... .+++..+..++.|++.+|+||
T Consensus 51 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l 130 (295)
T 3ugc_A 51 TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 130 (295)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHH
Confidence 44556789999999999999999999999854 456899999999999999998654 499999999999999999999
Q ss_pred hhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc----cccccCCCccccccccccCCCCCcchHHHHHHHH
Q 030430 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (177)
Q Consensus 83 h~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~ 158 (177)
|+.|++|+||+|+||+++ ..+.++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|+++
T Consensus 131 H~~~ivH~Dikp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 207 (295)
T 3ugc_A 131 GTKRYIHRDLATRNILVE---NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 207 (295)
T ss_dssp HHTTCCCSCCSGGGEEEE---ETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred hcCCcccCCCCHhhEEEc---CCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHH
Confidence 999999999999999995 567899999999976543321 1223356679999999888899999999999999
Q ss_pred HHHHhCCCCCCC
Q 030430 159 FELLNGYPPFSV 170 (177)
Q Consensus 159 ~~~~~~~~pf~~ 170 (177)
+++++|..||..
T Consensus 208 ~~l~~g~~~~~~ 219 (295)
T 3ugc_A 208 YELFTYIEKSKS 219 (295)
T ss_dssp HHHHHTTCTTCS
T ss_pred HHHHhcccccCC
Confidence 999999998865
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=220.63 Aligned_cols=161 Identities=35% Similarity=0.514 Sum_probs=131.6
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCC------eEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE 80 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~ 80 (177)
....+.+.+|+++++.++||||+++++++...+ ..++||||+. ++|.+.+. ..+++..+..++.|++.||+
T Consensus 65 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~ 141 (371)
T 2xrw_A 65 QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIK 141 (371)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHH
Confidence 455677899999999999999999999987654 7899999995 58888776 46899999999999999999
Q ss_pred HHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHH
Q 030430 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (177)
Q Consensus 81 ~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~ 160 (177)
|||+.|++|+||||+||++ +..+.++|+|||.+.............+++.|+|||.+.+..++.++|+||+|+++++
T Consensus 142 ~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 218 (371)
T 2xrw_A 142 HLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 218 (371)
T ss_dssp HHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred HHHHCCeecccCCHHHEEE---cCCCCEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHH
Confidence 9999999999999999999 4667899999999977655444445568899999999988889999999999999999
Q ss_pred HHhCCCCCCCCCc
Q 030430 161 LLNGYPPFSVGEE 173 (177)
Q Consensus 161 ~~~~~~pf~~~~~ 173 (177)
+++|..||.+.+.
T Consensus 219 l~~g~~pf~~~~~ 231 (371)
T 2xrw_A 219 MIKGGVLFPGTDH 231 (371)
T ss_dssp HHHSSCSSCCSSH
T ss_pred HHhCCCCCCCCCH
Confidence 9999999987653
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=213.76 Aligned_cols=162 Identities=27% Similarity=0.530 Sum_probs=141.8
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
..+.+.+|++++++++||||+++++++.+.+..++++|++++++|.+++... ..+++..+..++.|++.+|++||+.|+
T Consensus 46 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i 125 (267)
T 3t9t_A 46 SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 125 (267)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 3567999999999999999999999999999999999999999999999865 458999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-C
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-~ 164 (177)
+|+||+|+||++ +..+.++|+|||.+........ .....++..|+|||...+..++.++|+||+|++++++++ |
T Consensus 126 ~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g 202 (267)
T 3t9t_A 126 IHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 202 (267)
T ss_dssp CCSSCCGGGEEE---CGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred ccCCCchheEEE---CCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccC
Confidence 999999999999 4677899999999876543211 122335678999999988889999999999999999999 8
Q ss_pred CCCCCCCCc
Q 030430 165 YPPFSVGEE 173 (177)
Q Consensus 165 ~~pf~~~~~ 173 (177)
..||...+.
T Consensus 203 ~~p~~~~~~ 211 (267)
T 3t9t_A 203 KIPYENRSN 211 (267)
T ss_dssp CCTTTTCCH
T ss_pred CCCCCCCCH
Confidence 999987543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=216.91 Aligned_cols=162 Identities=27% Similarity=0.506 Sum_probs=140.9
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+.+.+|++++++++||||+++++++ ..+..++++|++++++|.+++.....+++..+..++.|++.+|++||+.|+
T Consensus 60 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i 138 (291)
T 1xbb_A 60 ALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 138 (291)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 4467899999999999999999999999 556789999999999999999988889999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc----ccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~ 163 (177)
+|+||+|+||++. ..+.++|+|||.+......... ....++..|+|||.+.+..++.++|+||||++++++++
T Consensus 139 ~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 215 (291)
T 1xbb_A 139 VHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215 (291)
T ss_dssp ECSCCSGGGEEEE---ETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred EcCCCCcceEEEe---CCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHh
Confidence 9999999999995 4568999999998766443221 12234577999999987788999999999999999999
Q ss_pred -CCCCCCCCCc
Q 030430 164 -GYPPFSVGEE 173 (177)
Q Consensus 164 -~~~pf~~~~~ 173 (177)
|..||.+.+.
T Consensus 216 ~g~~p~~~~~~ 226 (291)
T 1xbb_A 216 YGQKPYRGMKG 226 (291)
T ss_dssp TTCCSSTTCCH
T ss_pred cCCCCCCCCCH
Confidence 9999987554
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=215.13 Aligned_cols=165 Identities=27% Similarity=0.487 Sum_probs=144.3
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhh
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
....+.+.+|++++++++||||+++++++.+.+..++|+|+++|++|.+++.... .+++..+..++.|++.+|++||+
T Consensus 50 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~ 129 (288)
T 3kfa_A 50 TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129 (288)
T ss_dssp STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999999999999999999999999999998643 49999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc--ccccCCCccccccccccCCCCCcchHHHHHHHHHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~ 162 (177)
.|++|+||+|+||++ +..+.++|+|||.+......... ....++..|+|||.+.+..++.++|+||||+++++++
T Consensus 130 ~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll 206 (288)
T 3kfa_A 130 KNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 206 (288)
T ss_dssp HTCCCSCCSGGGEEE---CGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred CCccCCCCCcceEEE---cCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHH
Confidence 999999999999999 46678999999998766543322 2234567899999998888999999999999999999
Q ss_pred h-CCCCCCCCCcc
Q 030430 163 N-GYPPFSVGEEH 174 (177)
Q Consensus 163 ~-~~~pf~~~~~~ 174 (177)
+ |..||.+.+..
T Consensus 207 ~~g~~p~~~~~~~ 219 (288)
T 3kfa_A 207 TYGMSPYPGIDLS 219 (288)
T ss_dssp TTSCCSSTTCCGG
T ss_pred hCCCCCCCCCCHH
Confidence 9 99999876543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=223.09 Aligned_cols=158 Identities=18% Similarity=0.203 Sum_probs=137.8
Q ss_pred HHHHHHHHHHhhCCCCceeeEeEEEee----CCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 11 SCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
..+.+|+..++.++||||+++++++.. ....+++|||+ |++|.+++...+.+++..+..++.|++.||+|||+.|
T Consensus 93 ~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ 171 (345)
T 2v62_A 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE 171 (345)
T ss_dssp HHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hHHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 346788899999999999999999887 77899999999 9999999987778999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC--------ccccccCCCccccccccccCCCCCcchHHHHHHHH
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~ 158 (177)
++|+||+|+||+++. +....++|+|||.+....... ......++..|+|||.+.+..++.++|+||||+++
T Consensus 172 ivH~Dlkp~NIll~~-~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 250 (345)
T 2v62_A 172 YVHGDIKAANLLLGY-KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCM 250 (345)
T ss_dssp EECSCCSGGGEEEES-SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHH
T ss_pred eeCCCcCHHHEEEcc-CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHH
Confidence 999999999999963 122389999999997653221 11334588999999999888899999999999999
Q ss_pred HHHHhCCCCCCC
Q 030430 159 FELLNGYPPFSV 170 (177)
Q Consensus 159 ~~~~~~~~pf~~ 170 (177)
+++++|+.||.+
T Consensus 251 ~ell~g~~pf~~ 262 (345)
T 2v62_A 251 LRWLCGKLPWEQ 262 (345)
T ss_dssp HHHHHSSCTTGG
T ss_pred HHHHhCCCCccc
Confidence 999999999965
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=231.10 Aligned_cols=163 Identities=26% Similarity=0.488 Sum_probs=143.0
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
..+.+.+|++++++++||||+++++++.+...+++||||+++++|.+++... ..++...+..++.|++.+|+|||+.|
T Consensus 259 ~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ 338 (495)
T 1opk_A 259 EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338 (495)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4677999999999999999999999999999999999999999999999864 34899999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc--ccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~- 163 (177)
++|+||+|+||++ +..+.++|+|||++......... ....++..|+|||.+....++.++|+||||+++++|++
T Consensus 339 ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~ 415 (495)
T 1opk_A 339 FIHRNLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 415 (495)
T ss_dssp EECSCCSGGGEEE---CGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred cccCCCChhhEEE---CCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhC
Confidence 9999999999999 46778999999999776443221 12334678999999988889999999999999999999
Q ss_pred CCCCCCCCCcc
Q 030430 164 GYPPFSVGEEH 174 (177)
Q Consensus 164 ~~~pf~~~~~~ 174 (177)
|..||.+.+..
T Consensus 416 g~~p~~~~~~~ 426 (495)
T 1opk_A 416 GMSPYPGIDLS 426 (495)
T ss_dssp SCCSSTTCCGG
T ss_pred CCCCCCCCCHH
Confidence 99999876543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=213.73 Aligned_cols=162 Identities=33% Similarity=0.542 Sum_probs=134.2
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH--- 86 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--- 86 (177)
.+.+.+|++++++++||||+++++++.+++..+++|||+++++|.+++. ...+++..+..++.|++.++++||+.|
T Consensus 50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~ 128 (271)
T 3dtc_A 50 IENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVP 128 (271)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSC
T ss_pred HHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Confidence 4678999999999999999999999999999999999999999999886 457999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCC-----CCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHH
Q 030430 87 IIHRDLKPENILLSGLD-----DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~-----~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~ 161 (177)
++|+||+|+||++.... ..+.++|+|||.+......... ...+++.|+|||.+.+..++.++|+||+|++++++
T Consensus 129 i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l 207 (271)
T 3dtc_A 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM-SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWEL 207 (271)
T ss_dssp CCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHH
T ss_pred eeecCCchHHEEEecccccccccCcceEEccCCccccccccccc-CCCCccceeCHHHhccCCCCchhhHHHHHHHHHHH
Confidence 89999999999996311 2567999999998765443322 34588999999999888899999999999999999
Q ss_pred HhCCCCCCCCCc
Q 030430 162 LNGYPPFSVGEE 173 (177)
Q Consensus 162 ~~~~~pf~~~~~ 173 (177)
++|+.||.+.+.
T Consensus 208 ~~g~~p~~~~~~ 219 (271)
T 3dtc_A 208 LTGEVPFRGIDG 219 (271)
T ss_dssp HHCCCTTTTSCH
T ss_pred HhCCCCCCCCCH
Confidence 999999987543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=219.17 Aligned_cols=164 Identities=24% Similarity=0.463 Sum_probs=137.9
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
...+..+.+|++++++++||||+++++++.+.+..++||||+++++|.+++... ..+++..+..++.|++.+|++||+.
T Consensus 87 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 166 (333)
T 1mqb_A 87 EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM 166 (333)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 445677999999999999999999999999999999999999999999999865 5699999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc----cccccCCCccccccccccCCCCCcchHHHHHHHHHHH
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~ 161 (177)
|++|+||+|+||++ +..+.++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|++++++
T Consensus 167 ~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 243 (333)
T 1mqb_A 167 NYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEV 243 (333)
T ss_dssp TCCCSCCCGGGEEE---CTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHH
T ss_pred CeeCCCCChheEEE---CCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHH
Confidence 99999999999999 4677899999999876543321 1122346689999999888899999999999999999
Q ss_pred Hh-CCCCCCCCCc
Q 030430 162 LN-GYPPFSVGEE 173 (177)
Q Consensus 162 ~~-~~~pf~~~~~ 173 (177)
++ |..||.+.+.
T Consensus 244 lt~g~~pf~~~~~ 256 (333)
T 1mqb_A 244 MTYGERPYWELSN 256 (333)
T ss_dssp HTTSCCTTTTCCH
T ss_pred HcCCCCCcccCCH
Confidence 99 9999976543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=214.60 Aligned_cols=161 Identities=31% Similarity=0.566 Sum_probs=143.1
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
..+.+.+|++++++++||||+++++++...+..++++||+++++|.+++.. ...+++..+..++.|++.+|++||+.|+
T Consensus 67 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i 146 (314)
T 3com_A 67 DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK 146 (314)
T ss_dssp CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Confidence 356789999999999999999999999999999999999999999999873 4579999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
+|+||+|+||++ +..+.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|++++++++|..
T Consensus 147 ~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 223 (314)
T 3com_A 147 IHRDIKAGNILL---NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKP 223 (314)
T ss_dssp ECCCCSGGGEEE---CTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred cCCCcCHHHEEE---CCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCC
Confidence 999999999999 466789999999987654432 2234457889999999988888999999999999999999999
Q ss_pred CCCCCC
Q 030430 167 PFSVGE 172 (177)
Q Consensus 167 pf~~~~ 172 (177)
||....
T Consensus 224 p~~~~~ 229 (314)
T 3com_A 224 PYADIH 229 (314)
T ss_dssp TTTTSC
T ss_pred CCCCCC
Confidence 997653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=214.08 Aligned_cols=156 Identities=31% Similarity=0.579 Sum_probs=138.6
Q ss_pred HHHHHHHHHHhhCCCCceeeEeEEEee----------------CCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHH
Q 030430 11 SCLDCELNFLSSVNHPNIIRLFDAFQA----------------ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFL 72 (177)
Q Consensus 11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~ 72 (177)
+.+.+|++++++++||||+++++++.. ...++++|||+++++|.+++... ..+++..+..++
T Consensus 49 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~ 128 (284)
T 2a19_B 49 EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128 (284)
T ss_dssp GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHH
Confidence 467899999999999999999998854 45689999999999999999754 569999999999
Q ss_pred HHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHH
Q 030430 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMW 152 (177)
Q Consensus 73 ~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~ 152 (177)
.|++.+|++||+.|++|+||+|+||++. ..+.++|+|||.+.............+++.|+|||.+.+..++.++|+|
T Consensus 129 ~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 205 (284)
T 2a19_B 129 EQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLY 205 (284)
T ss_dssp HHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHH
T ss_pred HHHHHHHHHHHhCCeeeccCCHHHEEEc---CCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhH
Confidence 9999999999999999999999999995 5667999999998877655544455689999999999888899999999
Q ss_pred HHHHHHHHHHhCCCCCC
Q 030430 153 SVGAILFELLNGYPPFS 169 (177)
Q Consensus 153 slg~~~~~~~~~~~pf~ 169 (177)
|+|++++++++|..||.
T Consensus 206 slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 206 ALGLILAELLHVCDTAF 222 (284)
T ss_dssp HHHHHHHHHHSCCSSHH
T ss_pred HHHHHHHHHHhcCCcch
Confidence 99999999999998874
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=221.70 Aligned_cols=161 Identities=33% Similarity=0.570 Sum_probs=140.4
Q ss_pred HHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
..+.+.+|+++++++ .||||+++++++...+.+++||||+++++|.+++.....+++..+..++.|++.+|+|||+.|+
T Consensus 101 ~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i 180 (355)
T 1vzo_A 101 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGI 180 (355)
T ss_dssp SGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 356678899999999 6999999999999999999999999999999999988889999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC--ccccccCCCcccccccccc--CCCCCcchHHHHHHHHHHHHh
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQF--QRYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slg~~~~~~~~ 163 (177)
+|+||||+||++ +..+.++|+|||.+....... ......+++.|+|||.+.+ ..++.++|+||||++++++++
T Consensus 181 vH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~ 257 (355)
T 1vzo_A 181 IYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 257 (355)
T ss_dssp CCCCCCGGGEEE---CTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHH
T ss_pred ccCCCCHHHEEE---CCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHH
Confidence 999999999999 467789999999987654322 2223468999999999875 346889999999999999999
Q ss_pred CCCCCCCCC
Q 030430 164 GYPPFSVGE 172 (177)
Q Consensus 164 ~~~pf~~~~ 172 (177)
|..||....
T Consensus 258 g~~pf~~~~ 266 (355)
T 1vzo_A 258 GASPFTVDG 266 (355)
T ss_dssp SSCTTSCTT
T ss_pred CCCCCccCC
Confidence 999997643
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=222.12 Aligned_cols=159 Identities=30% Similarity=0.525 Sum_probs=136.4
Q ss_pred HHHHHHHHHhhCCCCceeeEeEEEee--------------------------------------CCeEEEEEecCCCCCh
Q 030430 12 CLDCELNFLSSVNHPNIIRLFDAFQA--------------------------------------ENCIFLVVEFCAGGNL 53 (177)
Q Consensus 12 ~~~~e~~~l~~l~h~~i~~~~~~~~~--------------------------------------~~~~~lv~e~~~~~~L 53 (177)
...+|+++++.++||||+++++++.. ...+++||||++ ++|
T Consensus 46 ~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L 124 (383)
T 3eb0_A 46 YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTL 124 (383)
T ss_dssp SCCHHHHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCS-EEH
T ss_pred hHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccH
Confidence 34579999999999999999999843 345899999996 577
Q ss_pred HHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcccccc
Q 030430 54 SSYIR----LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129 (177)
Q Consensus 54 ~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 129 (177)
.+.+. ....+++..++.++.|++.||+|||+.|++|+||||+||+++ ...+.++|+|||.+.............
T Consensus 125 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 202 (383)
T 3eb0_A 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN--SKDNTLKLCDFGSAKKLIPSEPSVAYI 202 (383)
T ss_dssp HHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEE--TTTTEEEECCCTTCEECCTTSCCCCCC
T ss_pred HHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEc--CCCCcEEEEECCCCcccCCCCCCcCcc
Confidence 76665 346799999999999999999999999999999999999995 356789999999998776655555666
Q ss_pred CCCccccccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 030430 130 GSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPFSVGEE 173 (177)
Q Consensus 130 ~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~~~~pf~~~~~ 173 (177)
+++.|+|||.+.+. .++.++|+||+|+++++|++|+.||.+.+.
T Consensus 203 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 247 (383)
T 3eb0_A 203 CSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETS 247 (383)
T ss_dssp CCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCh
Confidence 89999999988764 489999999999999999999999988654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=219.35 Aligned_cols=168 Identities=26% Similarity=0.451 Sum_probs=144.1
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-------CCCHHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------RVPEQTARKFLQQLGAG 78 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~~ 78 (177)
.......+.+|++++++++||||+++++++.+....+++|||++|++|.+++.... .++...++.++.|++.|
T Consensus 73 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~a 152 (327)
T 2yfx_A 73 SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152 (327)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHH
T ss_pred chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHH
Confidence 34566789999999999999999999999999999999999999999999998653 38899999999999999
Q ss_pred HHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC---ccccccCCCccccccccccCCCCCcchHHHHH
Q 030430 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVG 155 (177)
Q Consensus 79 l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg 155 (177)
|+|||+.|++|+||+|+||++...+....++|+|||.+....... ......+++.|+|||.+.+..++.++|+||||
T Consensus 153 l~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 232 (327)
T 2yfx_A 153 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 232 (327)
T ss_dssp HHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHH
Confidence 999999999999999999999643455679999999986543222 22234567889999999888899999999999
Q ss_pred HHHHHHHh-CCCCCCCCCc
Q 030430 156 AILFELLN-GYPPFSVGEE 173 (177)
Q Consensus 156 ~~~~~~~~-~~~pf~~~~~ 173 (177)
++++++++ |..||.....
T Consensus 233 ~il~ellt~g~~p~~~~~~ 251 (327)
T 2yfx_A 233 VLLWEIFSLGYMPYPSKSN 251 (327)
T ss_dssp HHHHHHHTTSCCSSTTCCH
T ss_pred HHHHHHHcCCCCCCCCcCH
Confidence 99999998 9999987543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-35 Score=223.35 Aligned_cols=158 Identities=29% Similarity=0.477 Sum_probs=133.5
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeC-----CeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (177)
....+++.+|++++++++||||+++++++... ...|+|||++ +++|.+++.....+++..++.++.|++.||+|
T Consensus 66 ~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~ 144 (432)
T 3n9x_A 66 LIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGENF 144 (432)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecC-CcCHHHHHhccCCCCHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999998766 5789999998 56999999987789999999999999999999
Q ss_pred HhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-----------------------ccccccCCCcccccc
Q 030430 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----------------------YAEKVCGSPLYMAPE 138 (177)
Q Consensus 82 lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-----------------------~~~~~~~~~~~~~pe 138 (177)
||+.|++||||||+||++ +..+.++|+|||.+....... ......+++.|+|||
T Consensus 145 LH~~givHrDlkp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 221 (432)
T 3n9x_A 145 IHESGIIHRDLKPANCLL---NQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPE 221 (432)
T ss_dssp HHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHH
T ss_pred HHHCCCCCCCCCHHHeEE---CCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHH
Confidence 999999999999999999 567789999999997654322 123456899999999
Q ss_pred cc-ccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 030430 139 VL-QFQRYDEKVDMWSVGAILFELLNGYPPF 168 (177)
Q Consensus 139 ~~-~~~~~~~~~Di~slg~~~~~~~~~~~pf 168 (177)
.+ ....++.++|+||+||++++|++|..||
T Consensus 222 ~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 222 LILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp HHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred HHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 86 4566899999999999999999854443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=217.82 Aligned_cols=161 Identities=27% Similarity=0.547 Sum_probs=136.6
Q ss_pred chhHHHHHHHHHHHHhhCCC--CceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh
Q 030430 6 NKHLKSCLDCELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (177)
+....+.+.+|++++++++| |||+++++++.+....++|||+ .+++|.+++.....+++..+..++.|++.||+|||
T Consensus 47 ~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH 125 (343)
T 3dbq_A 47 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 125 (343)
T ss_dssp CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34556789999999999976 9999999999999999999995 48899999998888999999999999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCcccccccccc-----------CCCCCcc
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQF-----------QRYDEKV 149 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~-----------~~~~~~~ 149 (177)
+.|++|+||||+||++. .+.++|+|||.+........ .....+++.|+|||.+.+ ..++.++
T Consensus 126 ~~~iiHrDikp~NIll~----~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 201 (343)
T 3dbq_A 126 QHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 201 (343)
T ss_dssp HTTCCCCCCCGGGEEEE----TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHH
T ss_pred hCCeecCCCCcceEEEE----CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchh
Confidence 99999999999999994 35699999999977644322 234568999999999854 5678899
Q ss_pred hHHHHHHHHHHHHhCCCCCCCC
Q 030430 150 DMWSVGAILFELLNGYPPFSVG 171 (177)
Q Consensus 150 Di~slg~~~~~~~~~~~pf~~~ 171 (177)
|+||+|+++++|++|+.||...
T Consensus 202 DiwslG~il~ell~g~~pf~~~ 223 (343)
T 3dbq_A 202 DVWSLGCILYYMTYGKTPFQQI 223 (343)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTC
T ss_pred hHHHHHHHHHHHHhCCCcchhh
Confidence 9999999999999999999763
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=218.12 Aligned_cols=164 Identities=30% Similarity=0.523 Sum_probs=143.0
Q ss_pred hhHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC----------------CCCHHHHH
Q 030430 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTAR 69 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~ 69 (177)
....+.+.+|+++++++ +||||+++++++.+.+..++|+||+++++|.+++.... .++...+.
T Consensus 81 ~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (334)
T 2pvf_A 81 EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160 (334)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHH
Confidence 34567799999999999 89999999999999999999999999999999998653 38899999
Q ss_pred HHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCC
Q 030430 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYD 146 (177)
Q Consensus 70 ~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~ 146 (177)
.++.|++.||+|||+.|++|+||+|+||++ +..+.++|+|||.+........ .....+++.|+|||.+.+..++
T Consensus 161 ~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 237 (334)
T 2pvf_A 161 SCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT 237 (334)
T ss_dssp HHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEEC
T ss_pred HHHHHHHHHHHHHHhCCeeCCCCccceEEE---cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcC
Confidence 999999999999999999999999999999 4677899999999876654321 1223356789999999888889
Q ss_pred CcchHHHHHHHHHHHHh-CCCCCCCCCc
Q 030430 147 EKVDMWSVGAILFELLN-GYPPFSVGEE 173 (177)
Q Consensus 147 ~~~Di~slg~~~~~~~~-~~~pf~~~~~ 173 (177)
.++|+||+|++++++++ |..||.+...
T Consensus 238 ~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 238 HQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred hHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 99999999999999999 9999987643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=211.73 Aligned_cols=163 Identities=26% Similarity=0.463 Sum_probs=138.4
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
....+.+.+|++++++++||||+++++++.++. .++++|++++++|.+++.... .+++..+..++.|++.+|++||+.
T Consensus 54 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 132 (281)
T 3cc6_A 54 LDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI 132 (281)
T ss_dssp HHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred chHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC-CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC
Confidence 346788999999999999999999999987654 589999999999999998654 499999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~ 163 (177)
|++|+||+|+||+++ ..+.++|+|||.+........ .....++..|+|||.+.+..++.++|+||||++++++++
T Consensus 133 ~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt 209 (281)
T 3cc6_A 133 NCVHRDIAVRNILVA---SPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 209 (281)
T ss_dssp TCCCCCCSGGGEEEE---ETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred CcccCCCccceEEEC---CCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHh
Confidence 999999999999995 456899999999876544322 122345678999999988889999999999999999998
Q ss_pred -CCCCCCCCCc
Q 030430 164 -GYPPFSVGEE 173 (177)
Q Consensus 164 -~~~pf~~~~~ 173 (177)
|..||.....
T Consensus 210 ~g~~p~~~~~~ 220 (281)
T 3cc6_A 210 FGKQPFFWLEN 220 (281)
T ss_dssp TTCCTTTTSCG
T ss_pred CCCCCcccCCh
Confidence 9999976544
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=216.84 Aligned_cols=159 Identities=34% Similarity=0.585 Sum_probs=138.6
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
....+.+.+|++++++++||||+++++++.+++..++||||+. ++|.+++.. ...+++..+..++.|++.||+|||+.
T Consensus 95 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 173 (348)
T 1u5q_A 95 NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173 (348)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3445678999999999999999999999999999999999996 588887754 45699999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccc---cCCCCCcchHHHHHHHHHHHH
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slg~~~~~~~ 162 (177)
|++|+||+|+||+++ ..+.++|+|||.+...... ....+++.|+|||.+. ...++.++|+||+|+++++|+
T Consensus 174 ~ivH~Dlkp~NIll~---~~~~~kL~DfG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell 247 (348)
T 1u5q_A 174 NMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 247 (348)
T ss_dssp TCBCCCCSGGGEEEE---TTTEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHH
T ss_pred CeeeCCCCHHHEEEC---CCCCEEEeeccCceecCCC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHH
Confidence 999999999999995 5678999999998765432 2345889999999874 456789999999999999999
Q ss_pred hCCCCCCCCC
Q 030430 163 NGYPPFSVGE 172 (177)
Q Consensus 163 ~~~~pf~~~~ 172 (177)
+|..||.+.+
T Consensus 248 ~g~~p~~~~~ 257 (348)
T 1u5q_A 248 ERKPPLFNMN 257 (348)
T ss_dssp HSSCTTTTSC
T ss_pred hCCCCCCCCC
Confidence 9999997654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=216.90 Aligned_cols=160 Identities=26% Similarity=0.471 Sum_probs=137.7
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
...+.+|+.++++++||||+++++++.+ +..++|+||+.+++|.+++... ..+++..+..++.|++.||+|||+.|++
T Consensus 59 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv 137 (325)
T 3kex_A 59 FQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMV 137 (325)
T ss_dssp BCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 4567889999999999999999999874 4588999999999999999865 4699999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-C
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-~ 164 (177)
|+||||+||++ +..+.++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|++++++++ |
T Consensus 138 H~Dikp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g 214 (325)
T 3kex_A 138 HRNLAARNVLL---KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFG 214 (325)
T ss_dssp CSCCSSTTEEE---SSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred CCccchheEEE---CCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCC
Confidence 99999999999 4677899999999987644322 223446778999999988889999999999999999999 9
Q ss_pred CCCCCCCCc
Q 030430 165 YPPFSVGEE 173 (177)
Q Consensus 165 ~~pf~~~~~ 173 (177)
..||.+...
T Consensus 215 ~~p~~~~~~ 223 (325)
T 3kex_A 215 AEPYAGLRL 223 (325)
T ss_dssp CCTTTTSCT
T ss_pred CCCccccCH
Confidence 999987653
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=213.46 Aligned_cols=164 Identities=27% Similarity=0.513 Sum_probs=141.4
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
.+...+.+.+|++++++++||||+++++++ ..+..++++|++++++|.+++... ..+++..+..++.|++.+|++||+
T Consensus 50 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 128 (287)
T 1u59_A 50 EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 128 (287)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHH
Confidence 345678899999999999999999999999 455689999999999999998754 459999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc----cccccCCCccccccccccCCCCCcchHHHHHHHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~ 160 (177)
.|++|+||+|+||+++ ..+.++|+|||.+........ .....+++.|+|||.+.+..++.++|+||+|+++++
T Consensus 129 ~~i~H~dlkp~Nili~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 205 (287)
T 1u59_A 129 KNFVHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWE 205 (287)
T ss_dssp TTEECCCCSGGGEEEE---ETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHH
T ss_pred CCEeeCCCchheEEEc---CCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHH
Confidence 9999999999999995 566899999999977644322 112335678999999987888999999999999999
Q ss_pred HHh-CCCCCCCCCc
Q 030430 161 LLN-GYPPFSVGEE 173 (177)
Q Consensus 161 ~~~-~~~pf~~~~~ 173 (177)
+++ |+.||.....
T Consensus 206 llt~g~~p~~~~~~ 219 (287)
T 1u59_A 206 ALSYGQKPYKKMKG 219 (287)
T ss_dssp HHTTSCCTTTTCCT
T ss_pred HHcCCCCCcccCCH
Confidence 998 9999987554
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=220.97 Aligned_cols=158 Identities=31% Similarity=0.541 Sum_probs=133.3
Q ss_pred HHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCCCeee
Q 030430 12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHIIHR 90 (177)
Q Consensus 12 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~~H~ 90 (177)
.+.+|++++++++||||+++++++.+.+..++||||++ ++|.+++.... .+++..+..++.|++.||+|||+.|++|+
T Consensus 46 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~ 124 (324)
T 3mtl_A 46 TAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHR 124 (324)
T ss_dssp CCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred hHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCC
Confidence 45579999999999999999999999999999999996 59998888654 49999999999999999999999999999
Q ss_pred cCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCcccccccccc-CCCCCcchHHHHHHHHHHHHhCCCCC
Q 030430 91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYPPF 168 (177)
Q Consensus 91 ~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~~~~~pf 168 (177)
||+|+||++ +..+.++|+|||.+....... ......+++.|+|||.+.+ ..++.++|+||+|+++++|++|+.||
T Consensus 125 Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf 201 (324)
T 3mtl_A 125 DLKPQNLLI---NERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF 201 (324)
T ss_dssp SCCGGGEEE---CTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred CcCHHHEEE---CCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999 466789999999987654332 2233457899999999875 45799999999999999999999999
Q ss_pred CCCCc
Q 030430 169 SVGEE 173 (177)
Q Consensus 169 ~~~~~ 173 (177)
.+.+.
T Consensus 202 ~~~~~ 206 (324)
T 3mtl_A 202 PGSTV 206 (324)
T ss_dssp CCSSH
T ss_pred CCCCH
Confidence 87654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=224.95 Aligned_cols=163 Identities=30% Similarity=0.540 Sum_probs=131.4
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEee--CCeEEEEEecCCCCChHHHHhhc---------CCCCHHHHHHHHHHHHHH
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLH---------GRVPEQTARKFLQQLGAG 78 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~i~~~ 78 (177)
...+.+|++++++++||||+++++++.. ...+++||||+. ++|.+++... ..+++..++.++.|++.|
T Consensus 62 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 140 (405)
T 3rgf_A 62 SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140 (405)
T ss_dssp CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHH
Confidence 4578899999999999999999999954 678999999995 5888877632 149999999999999999
Q ss_pred HHHHhhCCCeeecCCCCcEEEecC-CCCeeEEEeeeccccccCCCC----ccccccCCCccccccccccC-CCCCcchHH
Q 030430 79 LEILNSHHIIHRDLKPENILLSGL-DDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMW 152 (177)
Q Consensus 79 l~~lh~~~~~H~~i~~~nil~~~~-~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~ 152 (177)
|+|||+.|++|+||||+||++... +..+.++|+|||.+....... ......+++.|+|||.+.+. .++.++|||
T Consensus 141 l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw 220 (405)
T 3rgf_A 141 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW 220 (405)
T ss_dssp HHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHH
T ss_pred HHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhH
Confidence 999999999999999999999533 346789999999997664321 22345679999999998764 489999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCc
Q 030430 153 SVGAILFELLNGYPPFSVGEE 173 (177)
Q Consensus 153 slg~~~~~~~~~~~pf~~~~~ 173 (177)
|+|+++++|++|+.||.+..+
T Consensus 221 SlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 221 AIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp HHHHHHHHHHHSSCTTCCCC-
T ss_pred HHHHHHHHHHhCCCCCCCccc
Confidence 999999999999999977553
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-35 Score=220.25 Aligned_cols=161 Identities=27% Similarity=0.545 Sum_probs=137.7
Q ss_pred chhHHHHHHHHHHHHhhCC--CCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh
Q 030430 6 NKHLKSCLDCELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (177)
+....+.+.+|+++++++. ||||+++++++...+.+++|||+ .+++|.+++.....+++..+..++.|++.+|+|||
T Consensus 94 ~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH 172 (390)
T 2zmd_A 94 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172 (390)
T ss_dssp CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEEC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEec-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4556788999999999996 59999999999999999999994 58899999998888999999999999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC---ccccccCCCcccccccccc-----------CCCCCcc
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQF-----------QRYDEKV 149 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~-----------~~~~~~~ 149 (177)
+.|++||||||+||++. .+.++|+|||++....... ......+++.|+|||.+.+ ..++.++
T Consensus 173 ~~~ivHrDlkp~NIll~----~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 248 (390)
T 2zmd_A 173 QHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKS 248 (390)
T ss_dssp TTTCCCCCCCGGGEEES----SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHH
T ss_pred HCCeeecCCCHHHEEEE----CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChh
Confidence 99999999999999993 3679999999997764332 1234568999999999864 3578899
Q ss_pred hHHHHHHHHHHHHhCCCCCCCC
Q 030430 150 DMWSVGAILFELLNGYPPFSVG 171 (177)
Q Consensus 150 Di~slg~~~~~~~~~~~pf~~~ 171 (177)
||||||+++++|++|+.||...
T Consensus 249 DiwSlGvil~ell~G~~Pf~~~ 270 (390)
T 2zmd_A 249 DVWSLGCILYYMTYGKTPFQQI 270 (390)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTC
T ss_pred hHHHHHHHHHHHHHCCCcchhh
Confidence 9999999999999999999764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=216.14 Aligned_cols=163 Identities=23% Similarity=0.446 Sum_probs=141.4
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc----------CCCCHHHHHHHHHHHHH
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------GRVPEQTARKFLQQLGA 77 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~i~~ 77 (177)
.....+.+|++++++++||||+++++++.+.+..+++|||+++++|.+++... ..++...+..++.|++.
T Consensus 70 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 149 (322)
T 1p4o_A 70 RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149 (322)
T ss_dssp HHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHH
Confidence 44567899999999999999999999999999999999999999999998753 34789999999999999
Q ss_pred HHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCCCcchHHHH
Q 030430 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSV 154 (177)
Q Consensus 78 ~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~sl 154 (177)
+|++||+.|++|+||+|+||++ +..+.++|+|||.+........ .....+++.|+|||.+.+..++.++|+||+
T Consensus 150 ~l~~lH~~~i~H~dikp~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 226 (322)
T 1p4o_A 150 GMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 226 (322)
T ss_dssp HHHHHHHTTCBCSCCSGGGEEE---CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHCCCccCCCccceEEE---cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHH
Confidence 9999999999999999999999 4667899999999876543321 122335778999999988889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCc
Q 030430 155 GAILFELLN-GYPPFSVGEE 173 (177)
Q Consensus 155 g~~~~~~~~-~~~pf~~~~~ 173 (177)
|++++++++ |..||.+.+.
T Consensus 227 G~il~el~~~g~~p~~~~~~ 246 (322)
T 1p4o_A 227 GVVLWEIATLAEQPYQGLSN 246 (322)
T ss_dssp HHHHHHHHHTSCCTTTTSCH
T ss_pred HHHHHHHHhcCCCccccCCH
Confidence 999999999 8999987643
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=235.45 Aligned_cols=163 Identities=28% Similarity=0.520 Sum_probs=140.0
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+.+.+|++++++++||||+++++++.+. ..++||||+++++|.+++.....+++..+..++.|++.+|+|||+.|+
T Consensus 412 ~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~i 490 (635)
T 4fl3_A 412 ALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 490 (635)
T ss_dssp GGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 4467899999999999999999999999754 578999999999999999988889999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc----cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~ 163 (177)
+|+||||+||+++ ..+.++|+|||++........ .....++..|+|||.+.+..++.++||||+|+++++|++
T Consensus 491 iHrDLkp~NILl~---~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt 567 (635)
T 4fl3_A 491 VHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567 (635)
T ss_dssp CCSCCSGGGEEEE---ETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred eCCCCChHhEEEe---CCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHh
Confidence 9999999999995 566899999999976643321 112335678999999988889999999999999999998
Q ss_pred -CCCCCCCCCcc
Q 030430 164 -GYPPFSVGEEH 174 (177)
Q Consensus 164 -~~~pf~~~~~~ 174 (177)
|+.||.+.+..
T Consensus 568 ~G~~Pf~~~~~~ 579 (635)
T 4fl3_A 568 YGQKPYRGMKGS 579 (635)
T ss_dssp TTCCSSTTCCHH
T ss_pred CCCCCCCCCCHH
Confidence 99999876543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=213.70 Aligned_cols=163 Identities=29% Similarity=0.493 Sum_probs=130.6
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
.....+.+.+|++++++++||||++++++. .....++++||+++++|.+++... ..+++..+..++.|++.+|++||+
T Consensus 60 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~ 138 (289)
T 3og7_A 60 TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138 (289)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 455678899999999999999999999965 455688999999999999998644 459999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCC---CccccccCCCccccccccc---cCCCCCcchHHHHHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAIL 158 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~---~~~~~~~~Di~slg~~~ 158 (177)
.|++|+||+|+||+++ ..+.++|+|||.+...... .......+++.|+|||.+. +..++.++|+||||+++
T Consensus 139 ~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il 215 (289)
T 3og7_A 139 KSIIHRDLKSNNIFLH---EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVL 215 (289)
T ss_dssp TTCCCSCCCGGGEEEE---TTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHH
T ss_pred CCcccccCccceEEEC---CCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHH
Confidence 9999999999999995 5678999999998755432 1222345789999999886 55678899999999999
Q ss_pred HHHHhCCCCCCCCC
Q 030430 159 FELLNGYPPFSVGE 172 (177)
Q Consensus 159 ~~~~~~~~pf~~~~ 172 (177)
+++++|+.||....
T Consensus 216 ~el~~g~~p~~~~~ 229 (289)
T 3og7_A 216 YELMTGQLPYSNIN 229 (289)
T ss_dssp HHHHHSSCTTSSCC
T ss_pred HHHHHCCCCccccc
Confidence 99999999997744
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-35 Score=213.82 Aligned_cols=165 Identities=29% Similarity=0.535 Sum_probs=134.8
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCC-----eEEEEEecCCCCChHHHHhh------cCCCCHHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRL------HGRVPEQTARKFLQQL 75 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~~~~~~i 75 (177)
....+.+.+|++++++++||||+++++++.+.+ ..++++||+++++|.+++.. ...+++..++.++.|+
T Consensus 77 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi 156 (313)
T 3brb_A 77 QREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156 (313)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHH
Confidence 445677999999999999999999999987654 35999999999999999842 2459999999999999
Q ss_pred HHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCCCcchHH
Q 030430 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMW 152 (177)
Q Consensus 76 ~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~ 152 (177)
+.||+|||+.|++|+||+|+||++ +..+.++|+|||.+........ .....+++.|+|||.+.+..++.++|+|
T Consensus 157 ~~aL~~LH~~~ivH~dikp~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 233 (313)
T 3brb_A 157 ALGMEYLSNRNFLHRDLAARNCML---RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVW 233 (313)
T ss_dssp HHHHHHHHTTTCCCCCCSGGGEEE---CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHH
T ss_pred HHHHHHHHhCCcccCCCCcceEEE---cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhH
Confidence 999999999999999999999999 4667899999999876544321 1223457789999999888899999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCcc
Q 030430 153 SVGAILFELLN-GYPPFSVGEEH 174 (177)
Q Consensus 153 slg~~~~~~~~-~~~pf~~~~~~ 174 (177)
|||++++++++ |..||.+....
T Consensus 234 slG~il~el~~~g~~p~~~~~~~ 256 (313)
T 3brb_A 234 AFGVTMWEIATRGMTPYPGVQNH 256 (313)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCGG
T ss_pred HHHHHHHHHHhcCCCCCccCCHH
Confidence 99999999999 89999876544
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=212.23 Aligned_cols=161 Identities=30% Similarity=0.578 Sum_probs=143.6
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+.+.+|++++++++||||+++++++.+....++++||+++++|.+++.. ..+++..+..++.|++.+|++||+.|+
T Consensus 62 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i 140 (303)
T 3a7i_A 62 DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKK 140 (303)
T ss_dssp TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3457899999999999999999999999999999999999999999999874 579999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
+|+||+|+||++ +..+.++|+|||.+....... ......+++.|+|||.+.+..++.++|+||||++++++++|..
T Consensus 141 ~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 217 (303)
T 3a7i_A 141 IHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEP 217 (303)
T ss_dssp ECCCCSGGGEEE---CTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccCCCChheEEE---CCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCC
Confidence 999999999999 466789999999987664433 2234457889999999988888999999999999999999999
Q ss_pred CCCCCC
Q 030430 167 PFSVGE 172 (177)
Q Consensus 167 pf~~~~ 172 (177)
||....
T Consensus 218 p~~~~~ 223 (303)
T 3a7i_A 218 PHSELH 223 (303)
T ss_dssp TTTTSC
T ss_pred CCCCcC
Confidence 997654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=218.89 Aligned_cols=163 Identities=28% Similarity=0.506 Sum_probs=142.1
Q ss_pred hhHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc--------------CCCCHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------------GRVPEQTARKF 71 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------------~~~~~~~~~~~ 71 (177)
....+.+.+|+++++++ +||||+++++++.+++..++||||+++++|.+++... ..+++..+..+
T Consensus 90 ~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (333)
T 2i1m_A 90 ADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169 (333)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHH
Confidence 34567899999999999 8999999999999999999999999999999999753 34799999999
Q ss_pred HHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCCCc
Q 030430 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEK 148 (177)
Q Consensus 72 ~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~ 148 (177)
+.|++.+|+|||+.|++|+||+|+||+++ ..+.++|+|||.+........ .....++..|+|||.+.+..++.+
T Consensus 170 ~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 246 (333)
T 2i1m_A 170 SSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQ 246 (333)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGCEEE---GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHhcCCcccCCcccceEEEC---CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChH
Confidence 99999999999999999999999999995 567899999999976543321 223345678999999988889999
Q ss_pred chHHHHHHHHHHHHh-CCCCCCCCC
Q 030430 149 VDMWSVGAILFELLN-GYPPFSVGE 172 (177)
Q Consensus 149 ~Di~slg~~~~~~~~-~~~pf~~~~ 172 (177)
+|+||||++++++++ |..||.+..
T Consensus 247 ~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 247 SDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp HHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred HHHHHHHHHHHHHHcCCCCCCcccc
Confidence 999999999999998 999998754
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=218.00 Aligned_cols=159 Identities=22% Similarity=0.438 Sum_probs=141.0
Q ss_pred HHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHH------Hhh--cCCCCHHHHHHHHHHHHHHHHHH
Q 030430 11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY------IRL--HGRVPEQTARKFLQQLGAGLEIL 82 (177)
Q Consensus 11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~--~~~~~~~~~~~~~~~i~~~l~~l 82 (177)
+.+.+|++++++++||||+++++++.+.+..++||||+++++|.++ +.. ...+++..++.++.|++.||++|
T Consensus 88 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l 167 (348)
T 2pml_X 88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYI 167 (348)
T ss_dssp HHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHH
Confidence 7899999999999999999999999999999999999999999998 665 45699999999999999999999
Q ss_pred hh-CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccC-CCCC-cchHHHHHHHHH
Q 030430 83 NS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDE-KVDMWSVGAILF 159 (177)
Q Consensus 83 h~-~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~-~~Di~slg~~~~ 159 (177)
|+ .|++|+||+|+||++ +..+.++|+|||.+...... ......++..|+|||.+.+. .++. ++|+||+|++++
T Consensus 168 H~~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~ 243 (348)
T 2pml_X 168 HNEKNICHRDVKPSNILM---DKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLY 243 (348)
T ss_dssp HHTSCEECCCCCGGGEEE---CTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHH
T ss_pred hccCCEeecCCChHhEEE---cCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHH
Confidence 99 999999999999999 46678999999998765443 23345578899999998866 4555 899999999999
Q ss_pred HHHhCCCCCCCCCc
Q 030430 160 ELLNGYPPFSVGEE 173 (177)
Q Consensus 160 ~~~~~~~pf~~~~~ 173 (177)
++++|..||.....
T Consensus 244 ~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 244 VMFYNVVPFSLKIS 257 (348)
T ss_dssp HHHHSSCSSCCSSC
T ss_pred HHHhCCCCCCCCCc
Confidence 99999999987654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-35 Score=214.08 Aligned_cols=164 Identities=36% Similarity=0.585 Sum_probs=134.1
Q ss_pred cccc-chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC---CCCHHHHHHHHHHHHH
Q 030430 2 LKKL-NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQLGA 77 (177)
Q Consensus 2 l~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~ 77 (177)
+|.+ .+...+.+.+|++++++++||||+++++++.+. .++||||++|++|.+++.... .++...+..++.|++.
T Consensus 36 vK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~ 113 (307)
T 2eva_A 36 IKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 113 (307)
T ss_dssp EEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTTT--TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHH
T ss_pred EEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHH
Confidence 3443 345567899999999999999999999987744 689999999999999998654 3788999999999999
Q ss_pred HHHHHhh---CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHH
Q 030430 78 GLEILNS---HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSV 154 (177)
Q Consensus 78 ~l~~lh~---~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~sl 154 (177)
+|+|||+ .|++|+||+|+||++. .....++|+|||.+....... ....+++.|+|||.+.+..++.++|+||+
T Consensus 114 ~l~~LH~~~~~~ivH~dlkp~NIll~--~~~~~~kl~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 189 (307)
T 2eva_A 114 GVAYLHSMQPKALIHRDLKPPNLLLV--AGGTVLKICDFGTACDIQTHM--TNNKGSAAWMAPEVFEGSNYSEKCDVFSW 189 (307)
T ss_dssp HHHHHHTCSSSCCCCCCCSGGGEEEE--TTTTEEEECCCCC--------------CCTTSSCHHHHTCCCCCTHHHHHHH
T ss_pred HHHHHHhCCCCCeecCCCChhHEEEe--CCCCEEEEccccccccccccc--ccCCCCCceEChhhhCCCCCCcHHHHHHH
Confidence 9999999 8999999999999996 333458999999987654332 23348899999999988889999999999
Q ss_pred HHHHHHHHhCCCCCCCC
Q 030430 155 GAILFELLNGYPPFSVG 171 (177)
Q Consensus 155 g~~~~~~~~~~~pf~~~ 171 (177)
|++++++++|+.||...
T Consensus 190 G~il~el~~g~~p~~~~ 206 (307)
T 2eva_A 190 GIILWEVITRRKPFDEI 206 (307)
T ss_dssp HHHHHHHHHTCCTTTTT
T ss_pred HHHHHHHHHCCCCchhh
Confidence 99999999999999754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=221.70 Aligned_cols=158 Identities=31% Similarity=0.501 Sum_probs=133.6
Q ss_pred HHHHHHHHhhCCCCceeeEeEEEeeCC------eEEEEEecCCCCChHHHHh----hcCCCCHHHHHHHHHHHHHHHHHH
Q 030430 13 LDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKFLQQLGAGLEIL 82 (177)
Q Consensus 13 ~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~l 82 (177)
..+|+++++.++||||+++++++...+ .+++||||++++ +.+.+. ....+++..++.++.|++.||+||
T Consensus 79 ~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~L 157 (394)
T 4e7w_A 79 KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI 157 (394)
T ss_dssp CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH
Confidence 457999999999999999999985433 488999999764 433332 245699999999999999999999
Q ss_pred hhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccC-CCCCcchHHHHHHHHHHH
Q 030430 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 83 h~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~ 161 (177)
|+.|++||||||+||+++ ...+.++|+|||.+.............+++.|+|||.+.+. .++.++|+||+|+++++|
T Consensus 158 H~~~ivHrDlkp~Nill~--~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 235 (394)
T 4e7w_A 158 HSIGICHRDIKPQNLLLD--PPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAEL 235 (394)
T ss_dssp HHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred HHCCccCCCCCHHHEEEc--CCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHH
Confidence 999999999999999995 35678999999999876555555556689999999998654 589999999999999999
Q ss_pred HhCCCCCCCCCc
Q 030430 162 LNGYPPFSVGEE 173 (177)
Q Consensus 162 ~~~~~pf~~~~~ 173 (177)
++|+.||.+.+.
T Consensus 236 l~g~~pf~~~~~ 247 (394)
T 4e7w_A 236 MQGQPLFPGESG 247 (394)
T ss_dssp HHSSCSSCCSSH
T ss_pred HhCCCCCCCCCH
Confidence 999999988654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=215.42 Aligned_cols=163 Identities=35% Similarity=0.592 Sum_probs=130.1
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh--------cCCCCHHHHHHHHHHHHHHH
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQQLGAGL 79 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~~i~~~l 79 (177)
...+.+.+|++++++++||||+++++++...+..++++||++|++|.+++.. ...+++..+..++.|++.||
T Consensus 55 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 134 (303)
T 2vwi_A 55 TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134 (303)
T ss_dssp -----------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999999999999999999999999999874 34599999999999999999
Q ss_pred HHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC------ccccccCCCcccccccccc-CCCCCcchHH
Q 030430 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------YAEKVCGSPLYMAPEVLQF-QRYDEKVDMW 152 (177)
Q Consensus 80 ~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~ 152 (177)
++||+.|++|+||+|+||++ +..+.++|+|||.+....... ......+++.|+|||.+.. ..++.++|+|
T Consensus 135 ~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~ 211 (303)
T 2vwi_A 135 EYLHKNGQIHRDVKAGNILL---GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIW 211 (303)
T ss_dssp HHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHH
T ss_pred HHHHhCCCCCCCCChhhEEE---cCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHH
Confidence 99999999999999999999 466789999999886654321 1223457889999998865 4578999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCc
Q 030430 153 SVGAILFELLNGYPPFSVGEE 173 (177)
Q Consensus 153 slg~~~~~~~~~~~pf~~~~~ 173 (177)
|||++++++++|..||.....
T Consensus 212 slG~il~~l~~g~~pf~~~~~ 232 (303)
T 2vwi_A 212 SFGITAIELATGAAPYHKYPP 232 (303)
T ss_dssp HHHHHHHHHHHSSCTTTTSCG
T ss_pred HHHHHHHHHHhCCCCCccCch
Confidence 999999999999999987543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=218.09 Aligned_cols=161 Identities=27% Similarity=0.484 Sum_probs=136.0
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEee--------CCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHH
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA--------ENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGL 79 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l 79 (177)
....+.+|++++++++||||+++++++.. .+..++||||+++ +|.+.+... ..+++..+..++.|++.||
T Consensus 59 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l 137 (351)
T 3mi9_A 59 FPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGL 137 (351)
T ss_dssp SCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999876 4468999999965 777766644 5699999999999999999
Q ss_pred HHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCC-----CccccccCCCcccccccccc-CCCCCcchHHH
Q 030430 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-----NYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWS 153 (177)
Q Consensus 80 ~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~s 153 (177)
+|||+.|++|+||||+||++ +..+.++|+|||.+...... .......+++.|+|||.+.+ ..++.++|+||
T Consensus 138 ~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws 214 (351)
T 3mi9_A 138 YYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWG 214 (351)
T ss_dssp HHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHH
T ss_pred HHHHHCCeeCCCCCHHHEEE---cCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHH
Confidence 99999999999999999999 46678999999998765422 12233457889999998865 45799999999
Q ss_pred HHHHHHHHHhCCCCCCCCCc
Q 030430 154 VGAILFELLNGYPPFSVGEE 173 (177)
Q Consensus 154 lg~~~~~~~~~~~pf~~~~~ 173 (177)
+|++++++++|..||.+.++
T Consensus 215 lG~il~ell~g~~pf~~~~~ 234 (351)
T 3mi9_A 215 AGCIMAEMWTRSPIMQGNTE 234 (351)
T ss_dssp HHHHHHHHHHSSCSCCCSSH
T ss_pred HHHHHHHHHhCCCCCCCCCh
Confidence 99999999999999988654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=214.50 Aligned_cols=166 Identities=26% Similarity=0.436 Sum_probs=138.4
Q ss_pred ccccchhHHHHHHHHHHHHhh--CCCCceeeEeEEEee----CCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHH
Q 030430 2 LKKLNKHLKSCLDCELNFLSS--VNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75 (177)
Q Consensus 2 l~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i 75 (177)
+|.+.......+.+|.+++.. ++||||+++++++.+ ....++++||+++++|.++++ ...+++..+..++.|+
T Consensus 36 vK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i 114 (301)
T 3q4u_A 36 VKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSI 114 (301)
T ss_dssp EEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHH
T ss_pred EEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHH
Confidence 566666667777888888877 799999999998643 346899999999999999996 4579999999999999
Q ss_pred HHHHHHHh--------hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-----cccccCCCcccccccccc
Q 030430 76 GAGLEILN--------SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQF 142 (177)
Q Consensus 76 ~~~l~~lh--------~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~~pe~~~~ 142 (177)
+.||+||| +.|++|+||||+||++ +..+.++|+|||.+........ .....+++.|+|||.+.+
T Consensus 115 ~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 191 (301)
T 3q4u_A 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDE 191 (301)
T ss_dssp HHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTT
T ss_pred HHHHHHHHHhhhhccCCCCeecCCCChHhEEE---cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcC
Confidence 99999999 9999999999999999 4677899999999866543322 122358899999999876
Q ss_pred C------CCCCcchHHHHHHHHHHHHhC----------CCCCCCC
Q 030430 143 Q------RYDEKVDMWSVGAILFELLNG----------YPPFSVG 171 (177)
Q Consensus 143 ~------~~~~~~Di~slg~~~~~~~~~----------~~pf~~~ 171 (177)
. .++.++|+||+|++++++++| ..||...
T Consensus 192 ~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 192 TIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred cCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 5 345689999999999999999 8888654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=210.99 Aligned_cols=163 Identities=31% Similarity=0.612 Sum_probs=134.1
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEI 81 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~ 81 (177)
+....+.+.+|++++++++||||+++++++...+..++++|++++++|.+++.. ...+++..++.++.|++.+|++
T Consensus 72 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 151 (310)
T 2wqm_A 72 DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151 (310)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHH
Confidence 355678899999999999999999999999999999999999999999999874 3459999999999999999999
Q ss_pred HhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccCCCCCcchHHHHHHHHHH
Q 030430 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (177)
Q Consensus 82 lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~ 160 (177)
||+.|++|+||+|+||++ +..+.++|+|||.+........ .....++..|+|||.+.+..++.++|+||||+++++
T Consensus 152 LH~~~i~H~dl~p~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~ 228 (310)
T 2wqm_A 152 MHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE 228 (310)
T ss_dssp HHHTTCCCCCCCGGGEEE---CTTSCEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred HhhCCeeCCCCcHHHEEE---cCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHH
Confidence 999999999999999999 4667899999999876544322 223457889999999988889999999999999999
Q ss_pred HHhCCCCCCCC
Q 030430 161 LLNGYPPFSVG 171 (177)
Q Consensus 161 ~~~~~~pf~~~ 171 (177)
+++|..||.+.
T Consensus 229 l~~g~~p~~~~ 239 (310)
T 2wqm_A 229 MAALQSPFYGD 239 (310)
T ss_dssp HHHSSCTTC--
T ss_pred HHhCCCCCccc
Confidence 99999999764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=221.74 Aligned_cols=165 Identities=29% Similarity=0.496 Sum_probs=133.1
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEe-eCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQ-AENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
....+.+.+|++++++++||||+++++++. ..+..++||||+++++|.+++... ..++...+..++.|++.+|+|||+
T Consensus 131 ~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~ 210 (373)
T 3c1x_A 131 IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 210 (373)
T ss_dssp SHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 455678999999999999999999999864 456789999999999999999865 358899999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-----cccccCCCccccccccccCCCCCcchHHHHHHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~ 159 (177)
.|++|+||+|+||++ +..+.++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|+++|
T Consensus 211 ~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ 287 (373)
T 3c1x_A 211 KKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 287 (373)
T ss_dssp TTCCCSCCCGGGEEE---CTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred CCEecCccchheEEE---CCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHH
Confidence 999999999999999 4677899999999976543221 12234567899999998888999999999999999
Q ss_pred HHHh-CCCCCCCCCcc
Q 030430 160 ELLN-GYPPFSVGEEH 174 (177)
Q Consensus 160 ~~~~-~~~pf~~~~~~ 174 (177)
++++ |.+||.+.+..
T Consensus 288 ellt~~~~p~~~~~~~ 303 (373)
T 3c1x_A 288 ELMTRGAPPYPDVNTF 303 (373)
T ss_dssp HHHTTSCCSCTTSCSS
T ss_pred HHHhCcCCCCCCCCHH
Confidence 9999 67888765543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=219.93 Aligned_cols=162 Identities=29% Similarity=0.451 Sum_probs=130.8
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEee-----CCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHH
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEI 81 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~ 81 (177)
...+.+.+|++++++++||||+++++++.. ...+++||||+. ++|.+++... ..+++..+..++.|++.+|+|
T Consensus 71 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~ 149 (362)
T 3pg1_A 71 FLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHV 149 (362)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHH
Confidence 345789999999999999999999999843 347899999996 5888877644 359999999999999999999
Q ss_pred HhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCcccccccccc-CCCCCcchHHHHHHHHHH
Q 030430 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFE 160 (177)
Q Consensus 82 lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~ 160 (177)
||+.|++|+||+|+||++ +..+.++|+|||.+.............+++.|+|||.+.+ ..++.++|+||+|+++++
T Consensus 150 lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ 226 (362)
T 3pg1_A 150 LHEAGVVHRDLHPGNILL---ADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAE 226 (362)
T ss_dssp HHHTTCCCCCCCGGGEEE---CTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHH
T ss_pred HHHCcCEecCCChHHEEE---cCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHH
Confidence 999999999999999999 4677899999999976555544445568889999998876 568999999999999999
Q ss_pred HHhCCCCCCCCCc
Q 030430 161 LLNGYPPFSVGEE 173 (177)
Q Consensus 161 ~~~~~~pf~~~~~ 173 (177)
+++|+.||.+.+.
T Consensus 227 l~~g~~pf~~~~~ 239 (362)
T 3pg1_A 227 MFNRKALFRGSTF 239 (362)
T ss_dssp HHHSSCSCCCSSH
T ss_pred HHhCCCCCCCCCH
Confidence 9999999987653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=210.25 Aligned_cols=161 Identities=23% Similarity=0.364 Sum_probs=137.7
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeC--CeEEEEEecCCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEI 81 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~ 81 (177)
+....+.+.+|++++++++||||+++++++.+. ...++++||+++++|.+++.... .+++..+..++.|++.+|+|
T Consensus 47 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~ 126 (271)
T 3kmu_A 47 STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126 (271)
T ss_dssp CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHH
Confidence 345567899999999999999999999999876 78899999999999999998765 38999999999999999999
Q ss_pred HhhCC--CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCC---cchHHHHHH
Q 030430 82 LNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDE---KVDMWSVGA 156 (177)
Q Consensus 82 lh~~~--~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~---~~Di~slg~ 156 (177)
||+.| ++|+||+|+||++ +..+.++++||+.+...... ...+++.|+|||.+.+...+. ++|+||+|+
T Consensus 127 lH~~~~~i~H~dikp~Nil~---~~~~~~~l~~~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~ 199 (271)
T 3kmu_A 127 LHTLEPLIPRHALNSRSVMI---DEDMTARISMADVKFSFQSP----GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAV 199 (271)
T ss_dssp HTTSSSCCTTCCCSGGGEEE---CTTSCEEEEGGGSCCTTSCT----TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHH
T ss_pred HhcCCCceecCCCccceEEE---cCCcceeEEeccceeeeccc----CccCCccccChhhhccCCCCCCCchhhHHHHHH
Confidence 99999 9999999999999 45667888887766443222 334788999999987655444 799999999
Q ss_pred HHHHHHhCCCCCCCCCc
Q 030430 157 ILFELLNGYPPFSVGEE 173 (177)
Q Consensus 157 ~~~~~~~~~~pf~~~~~ 173 (177)
+++++++|+.||.+.+.
T Consensus 200 il~el~~g~~p~~~~~~ 216 (271)
T 3kmu_A 200 LLWELVTREVPFADLSN 216 (271)
T ss_dssp HHHHHHHCSCTTTTSCH
T ss_pred HHHHHHhCCCCccccCh
Confidence 99999999999987543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=214.44 Aligned_cols=158 Identities=28% Similarity=0.460 Sum_probs=137.3
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeC--CeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
..+.+.+|++++++++||||+++++++.+. ..++++|||+++++|.+++... ..+++..+..++.|++.+|++||+.
T Consensus 66 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 145 (302)
T 4e5w_A 66 HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR 145 (302)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC
Confidence 347789999999999999999999998866 6789999999999999999544 5699999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc----cccccCCCccccccccccCCCCCcchHHHHHHHHHHH
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~ 161 (177)
|++|+||+|+||+++ ..+.++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|++++++
T Consensus 146 ~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 222 (302)
T 4e5w_A 146 QYVHRDLAARNVLVE---SEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHEL 222 (302)
T ss_dssp TEECSCCSGGGEEEE---ETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHH
T ss_pred CcccCCCchheEEEc---CCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHH
Confidence 999999999999995 556899999999977654432 2234467779999999888889999999999999999
Q ss_pred HhCCCCCC
Q 030430 162 LNGYPPFS 169 (177)
Q Consensus 162 ~~~~~pf~ 169 (177)
++|..|+.
T Consensus 223 ~~g~~p~~ 230 (302)
T 4e5w_A 223 LTYCDSDS 230 (302)
T ss_dssp HTTTCGGG
T ss_pred HHccCCCc
Confidence 99998764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=212.15 Aligned_cols=165 Identities=30% Similarity=0.509 Sum_probs=139.5
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEE-eeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh 83 (177)
+....+.+.+|++++++++||||+++++++ ...+..++++||+++++|.+++... ..++...+..++.|++.+|++||
T Consensus 66 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH 145 (298)
T 3f66_A 66 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 145 (298)
T ss_dssp SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence 345567899999999999999999999985 4566789999999999999999754 45899999999999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-----cccccCCCccccccccccCCCCCcchHHHHHHHH
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~ 158 (177)
+.|++|+||+|+||++ +..+.++|+|||.+........ .....+++.|+|||.+.+..++.++|+||+|+++
T Consensus 146 ~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 222 (298)
T 3f66_A 146 SKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 222 (298)
T ss_dssp HTTCCCSCCSGGGEEE---CTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred hCCccCCCCchheEEE---CCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHH
Confidence 9999999999999999 5677899999999976543321 1223456789999999888899999999999999
Q ss_pred HHHHh-CCCCCCCCCc
Q 030430 159 FELLN-GYPPFSVGEE 173 (177)
Q Consensus 159 ~~~~~-~~~pf~~~~~ 173 (177)
+++++ +.+||.+.+.
T Consensus 223 ~~l~~~~~~~~~~~~~ 238 (298)
T 3f66_A 223 WELMTRGAPPYPDVNT 238 (298)
T ss_dssp HHHHTTSCCSSTTSCT
T ss_pred HHHHhCCCCCCccCCH
Confidence 99999 5677766544
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=216.31 Aligned_cols=163 Identities=26% Similarity=0.417 Sum_probs=141.1
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEe--eCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEIL 82 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~l 82 (177)
.....+.+.+|++++++++||||+++++++. +....++||||+++++|.+++... ..+++..+..++.|++.+|++|
T Consensus 64 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l 143 (327)
T 3lxl_A 64 GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL 143 (327)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH
Confidence 4556677999999999999999999999876 556789999999999999999864 4599999999999999999999
Q ss_pred hhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc----cccccCCCccccccccccCCCCCcchHHHHHHHH
Q 030430 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (177)
Q Consensus 83 h~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~ 158 (177)
|+.|++|+||+|+||+++ ..+.++|+|||.+........ .....++..|+|||.+.+..++.++|+||||+++
T Consensus 144 H~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 220 (327)
T 3lxl_A 144 GSRRCVHRDLAARNILVE---SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVL 220 (327)
T ss_dssp HHTTEECSCCSGGGEEEE---ETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHH
T ss_pred HhCCccCCCCChhhEEEC---CCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHH
Confidence 999999999999999995 567799999999976644321 1223467779999999888889999999999999
Q ss_pred HHHHhCCCCCCCC
Q 030430 159 FELLNGYPPFSVG 171 (177)
Q Consensus 159 ~~~~~~~~pf~~~ 171 (177)
+++++|..||...
T Consensus 221 ~~ll~g~~p~~~~ 233 (327)
T 3lxl_A 221 YELFTYCDKSCSP 233 (327)
T ss_dssp HHHHTTTCGGGSH
T ss_pred HHHHhCCCCCccc
Confidence 9999999998654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=222.90 Aligned_cols=160 Identities=32% Similarity=0.494 Sum_probs=134.2
Q ss_pred HHHHHHHHHHhhCCCCceeeEeEEEee------CCeEEEEEecCCCCChHHHHh----hcCCCCHHHHHHHHHHHHHHHH
Q 030430 11 SCLDCELNFLSSVNHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKFLQQLGAGLE 80 (177)
Q Consensus 11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~ 80 (177)
+...+|++++++++||||+++++++.. ...+++|+||+++ ++.+.+. ....+++..++.++.|++.||+
T Consensus 92 ~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~ 170 (420)
T 1j1b_A 92 RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170 (420)
T ss_dssp TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHH
Confidence 345579999999999999999998743 2247799999965 6666554 2456999999999999999999
Q ss_pred HHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccC-CCCCcchHHHHHHHHH
Q 030430 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILF 159 (177)
Q Consensus 81 ~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~ 159 (177)
|||+.|++||||||+||+++ .+...++|+|||.+.............+++.|+|||.+.+. .++.++|+||+||+++
T Consensus 171 ~LH~~~ivHrDlkp~NILl~--~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ 248 (420)
T 1j1b_A 171 YIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 248 (420)
T ss_dssp HHHTTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred HHHHCCccccCCChhhEEEe--CCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHH
Confidence 99999999999999999996 34567899999999876555444456689999999998654 6899999999999999
Q ss_pred HHHhCCCCCCCCCc
Q 030430 160 ELLNGYPPFSVGEE 173 (177)
Q Consensus 160 ~~~~~~~pf~~~~~ 173 (177)
+|++|+.||.+.+.
T Consensus 249 ell~G~~pf~~~~~ 262 (420)
T 1j1b_A 249 ELLLGQPIFPGDSG 262 (420)
T ss_dssp HHHHSSCSSCCSSH
T ss_pred HHHhCCCCCCCCCH
Confidence 99999999988653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=216.90 Aligned_cols=164 Identities=26% Similarity=0.416 Sum_probs=136.2
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
....+.+.+|++++++++||||+++++++..+. .+++++++.+++|.+++... ..+++..+..++.|++.+|+|||+.
T Consensus 58 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 136 (327)
T 3lzb_A 58 PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136 (327)
T ss_dssp CCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 345678999999999999999999999998765 77899999999999999864 4699999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc---ccccCCCccccccccccCCCCCcchHHHHHHHHHHHH
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~ 162 (177)
|++|+||||+||+++ ..+.++|+|||.+......... ....++..|+|||.+.+..++.++|+||||+++++++
T Consensus 137 ~ivH~Dikp~NIl~~---~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell 213 (327)
T 3lzb_A 137 RLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213 (327)
T ss_dssp TCCCSCCCGGGEEEE---ETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred CCcCCCCCHHHEEEc---CCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHH
Confidence 999999999999995 5667999999999765433221 2233566899999998888999999999999999999
Q ss_pred h-CCCCCCCCCcc
Q 030430 163 N-GYPPFSVGEEH 174 (177)
Q Consensus 163 ~-~~~pf~~~~~~ 174 (177)
+ |..||.+....
T Consensus 214 ~~g~~p~~~~~~~ 226 (327)
T 3lzb_A 214 TFGSKPYDGIPAS 226 (327)
T ss_dssp TTSCCTTTTCCGG
T ss_pred HCCCCCCCCCCHH
Confidence 9 99999876544
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=214.41 Aligned_cols=161 Identities=30% Similarity=0.495 Sum_probs=140.4
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEee--CCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
+...+.+.+|++++++++||||+++++++.+ ...++++|||+++++|.+++... .+++..+..++.|++.+|++||+
T Consensus 74 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~ 152 (318)
T 3lxp_A 74 PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHA 152 (318)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence 4557789999999999999999999999987 46789999999999999998754 59999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc----cccccCCCccccccccccCCCCCcchHHHHHHHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~ 160 (177)
.|++|+||+|+||++ +..+.++|+|||.+........ .....++..|+|||.+.+..++.++|+||||+++++
T Consensus 153 ~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 229 (318)
T 3lxp_A 153 QHYIHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYE 229 (318)
T ss_dssp TTEECSCCSGGGEEE---CTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHH
T ss_pred CCccCCCCchheEEE---cCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHH
Confidence 999999999999999 4677899999999977654332 223346777999999988888999999999999999
Q ss_pred HHhCCCCCCCC
Q 030430 161 LLNGYPPFSVG 171 (177)
Q Consensus 161 ~~~~~~pf~~~ 171 (177)
+++|..||...
T Consensus 230 ll~g~~p~~~~ 240 (318)
T 3lxp_A 230 LLTHCDSSQSP 240 (318)
T ss_dssp HHTTTCGGGSH
T ss_pred HHhCCCccccc
Confidence 99999998653
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=214.00 Aligned_cols=165 Identities=35% Similarity=0.670 Sum_probs=140.5
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEe--eCCeEEEEEecCCCCChHHHHhhc----CCCCHHHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGL 79 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l 79 (177)
++..++.+.+|++++++++||||+++++++. .+...+++|||+++++|.+++... ..+++..++.++.|++.+|
T Consensus 45 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l 124 (279)
T 2w5a_A 45 TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124 (279)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHH
Confidence 4566788999999999999999999999874 467899999999999999999754 2399999999999999999
Q ss_pred HHHhhCC-----CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccCCCCCcchHHH
Q 030430 80 EILNSHH-----IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWS 153 (177)
Q Consensus 80 ~~lh~~~-----~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Di~s 153 (177)
++||+.| ++|+||+|+||++ +..+.++|+|||.+........ .....++..|+|||.+.+..++.++|+||
T Consensus 125 ~~lH~~~~~~~~ivH~dl~p~NIl~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 201 (279)
T 2w5a_A 125 KECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWS 201 (279)
T ss_dssp HHHHHHC------CCCCCSGGGEEE---CSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHH
T ss_pred HHHhcccCCCCeeEEeccchhhEEE---cCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHH
Confidence 9999999 9999999999999 4677899999999876544322 22345788999999998888899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCc
Q 030430 154 VGAILFELLNGYPPFSVGEE 173 (177)
Q Consensus 154 lg~~~~~~~~~~~pf~~~~~ 173 (177)
||++++++++|..||...+.
T Consensus 202 lG~il~~l~~g~~p~~~~~~ 221 (279)
T 2w5a_A 202 LGCLLYELCALMPPFTAFSQ 221 (279)
T ss_dssp HHHHHHHHHHSSCSSCCSSH
T ss_pred HHHHHHHHHHCCCCCcccCH
Confidence 99999999999999987653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=226.36 Aligned_cols=161 Identities=27% Similarity=0.535 Sum_probs=139.7
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
..+.+.+|++++++++||||+++++++. ....++||||+.+++|.+++... ..++...+..++.|++.||+|||+.|
T Consensus 226 ~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ 304 (454)
T 1qcf_A 226 SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304 (454)
T ss_dssp CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4678999999999999999999999987 55689999999999999999854 36889999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~- 163 (177)
++||||+|+||++ +..+.++|+|||++........ .....++..|+|||.+....++.++|+||+|++++++++
T Consensus 305 ivHrDlkp~Nill---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~ 381 (454)
T 1qcf_A 305 YIHRDLRAANILV---SASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTY 381 (454)
T ss_dssp CCCSSCSGGGEEE---CTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred ccCCCCCHHHEEE---CCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhC
Confidence 9999999999999 4677899999999976543221 122335678999999988889999999999999999999
Q ss_pred CCCCCCCCCc
Q 030430 164 GYPPFSVGEE 173 (177)
Q Consensus 164 ~~~pf~~~~~ 173 (177)
|+.||.+.+.
T Consensus 382 g~~P~~~~~~ 391 (454)
T 1qcf_A 382 GRIPYPGMSN 391 (454)
T ss_dssp SCCSSTTCCH
T ss_pred CCCCCCCCCH
Confidence 9999987654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=213.65 Aligned_cols=162 Identities=26% Similarity=0.498 Sum_probs=132.7
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEee-CCeEEEEEecCCCCChHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhh
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
...+.+.+|++++++++||||+++++++.+ .+..++++||+++++|.+++..... +++..+..++.|++.++++||+
T Consensus 56 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 135 (278)
T 1byg_A 56 ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135 (278)
T ss_dssp C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh
Confidence 356779999999999999999999998654 4578999999999999999986543 8999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~- 163 (177)
.|++|+||+|+||++ +..+.++|+|||.+........ ...++..|+|||.+.+..++.++|+||||++++++++
T Consensus 136 ~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~ 210 (278)
T 1byg_A 136 NNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSF 210 (278)
T ss_dssp TTCCCSCCSGGGEEE---CTTSCEEECCCCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CCccccCCCcceEEE---eCCCcEEEeecccccccccccc--CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhC
Confidence 999999999999999 4667899999998876543322 2346788999999988889999999999999999998
Q ss_pred CCCCCCCCCcc
Q 030430 164 GYPPFSVGEEH 174 (177)
Q Consensus 164 ~~~pf~~~~~~ 174 (177)
|..||......
T Consensus 211 g~~p~~~~~~~ 221 (278)
T 1byg_A 211 GRVPYPRIPLK 221 (278)
T ss_dssp SCCSCTTSCGG
T ss_pred CCCCCCCCCHH
Confidence 99999876543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=212.44 Aligned_cols=161 Identities=26% Similarity=0.527 Sum_probs=139.6
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
..+.+.+|++++++++||||+++++++.++ ..++++|++++++|.+++.... .+++..+..++.|++.+|++||+.|
T Consensus 51 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 129 (279)
T 1qpc_A 51 SPDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129 (279)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cHHHHHHHHHHHHhCCCcCcceEEEEEcCC-CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 457899999999999999999999998754 5789999999999999987543 6999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc--ccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~- 163 (177)
++|+||+|+||++ +..+.++|+|||.+......... ....++..|+|||...+..++.++|+||||++++++++
T Consensus 130 i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 206 (279)
T 1qpc_A 130 YIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH 206 (279)
T ss_dssp EECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred eeccCCCHhhEEE---cCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhC
Confidence 9999999999999 46778999999998776543321 22335678999999987888999999999999999999
Q ss_pred CCCCCCCCCc
Q 030430 164 GYPPFSVGEE 173 (177)
Q Consensus 164 ~~~pf~~~~~ 173 (177)
|..||.+.+.
T Consensus 207 g~~p~~~~~~ 216 (279)
T 1qpc_A 207 GRIPYPGMTN 216 (279)
T ss_dssp TCCSSTTCCH
T ss_pred CCCCCcccCH
Confidence 8999987543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=218.46 Aligned_cols=160 Identities=37% Similarity=0.554 Sum_probs=139.5
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
.+.+.+|++++++++||||+++++++.+.+..++|+||+++ +|.+++.... .+++..+..++.|++.+|+|||+.|++
T Consensus 56 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv 134 (346)
T 1ua2_A 56 NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 134 (346)
T ss_dssp CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCC
T ss_pred hHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 35788999999999999999999999999999999999965 8988887553 589999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccC-CCCCcchHHHHHHHHHHHHhCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
|+||+|+||++ +..+.++|+|||.+....... ......+++.|+|||.+.+. .++.++|+||+|++++++++|.+
T Consensus 135 H~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 211 (346)
T 1ua2_A 135 HRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 211 (346)
T ss_dssp CCCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred CCCCCHHHEEE---cCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 99999999999 466789999999997764432 23345678999999998654 47889999999999999999999
Q ss_pred CCCCCCc
Q 030430 167 PFSVGEE 173 (177)
Q Consensus 167 pf~~~~~ 173 (177)
||.+.++
T Consensus 212 ~~~~~~~ 218 (346)
T 1ua2_A 212 FLPGDSD 218 (346)
T ss_dssp SSCCSSH
T ss_pred CCCCCCH
Confidence 9987654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=208.76 Aligned_cols=162 Identities=25% Similarity=0.413 Sum_probs=138.3
Q ss_pred hhHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc----CCCCHHHHHHHHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEI 81 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~ 81 (177)
......+.+|+..+.++ +||||+++++++.+.+..++++||++|++|.+++... ..+++..+..++.|++.||+|
T Consensus 51 ~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~ 130 (289)
T 1x8b_A 51 SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130 (289)
T ss_dssp SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHH
Confidence 34567888999999999 9999999999999999999999999999999999865 569999999999999999999
Q ss_pred HhhCCCeeecCCCCcEEEecCC----------------CCeeEEEeeeccccccCCCCccccccCCCccccccccccC-C
Q 030430 82 LNSHHIIHRDLKPENILLSGLD----------------DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-R 144 (177)
Q Consensus 82 lh~~~~~H~~i~~~nil~~~~~----------------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~ 144 (177)
||+.|++|+||+|+||++...+ ....++++|||.+....... ...+++.|+|||.+.+. .
T Consensus 131 lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~ 207 (289)
T 1x8b_A 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYT 207 (289)
T ss_dssp HHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCT
T ss_pred HHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCC
Confidence 9999999999999999995322 34468999999987764433 23478899999998755 4
Q ss_pred CCCcchHHHHHHHHHHHHhCCCCCCCC
Q 030430 145 YDEKVDMWSVGAILFELLNGYPPFSVG 171 (177)
Q Consensus 145 ~~~~~Di~slg~~~~~~~~~~~pf~~~ 171 (177)
++.++|+||+|++++++++|.+|+...
T Consensus 208 ~~~~~Di~slG~il~~l~~~~~~~~~~ 234 (289)
T 1x8b_A 208 HLPKADIFALALTVVCAAGAEPLPRNG 234 (289)
T ss_dssp THHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred CCchhhHHHHHHHHHHHhcCCCCCcch
Confidence 567999999999999999999876543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=210.35 Aligned_cols=158 Identities=30% Similarity=0.442 Sum_probs=131.6
Q ss_pred hHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
........|+..+.++ +||||+++++++.+++..++|||++ +++|.+++.... .+++..++.++.|++.||+|||+.
T Consensus 98 ~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 176 (311)
T 3p1a_A 98 KDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176 (311)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3344455555555554 9999999999999999999999999 779998887654 599999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCC
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~ 165 (177)
|++|+||||+||++ +..+.++|+|||.+.............+++.|+|||.+.+ .++.++|+||+|++++++++|.
T Consensus 177 ~ivH~Dikp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~ 252 (311)
T 3p1a_A 177 GLVHLDVKPANIFL---GPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNM 252 (311)
T ss_dssp TEECCCCSGGGEEE---CGGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTC
T ss_pred CEecCCCCHHHEEE---CCCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999999 5677899999999877765555555668999999998875 7899999999999999999997
Q ss_pred CCCCC
Q 030430 166 PPFSV 170 (177)
Q Consensus 166 ~pf~~ 170 (177)
.||.+
T Consensus 253 ~~~~~ 257 (311)
T 3p1a_A 253 ELPHG 257 (311)
T ss_dssp CCCSS
T ss_pred CCCCC
Confidence 76654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=211.57 Aligned_cols=163 Identities=33% Similarity=0.546 Sum_probs=138.4
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHh
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lh 83 (177)
....+.+.+|++++++++||||+++++++.+.+..++++|++++++|.+++.... .+++..+..++.|++.+|++||
T Consensus 60 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH 139 (295)
T 2clq_A 60 SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH 139 (295)
T ss_dssp C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999999999999999999999999999998652 4678899999999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccCC--CCCcchHHHHHHHHHH
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR--YDEKVDMWSVGAILFE 160 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~--~~~~~Di~slg~~~~~ 160 (177)
+.|++|+||+|+||+++ ...+.++|+|||.+....... ......++..|+|||.+.+.. ++.++|+||+|+++++
T Consensus 140 ~~~i~H~dl~p~Nil~~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~ 217 (295)
T 2clq_A 140 DNQIVHRDIKGDNVLIN--TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIE 217 (295)
T ss_dssp HTTEECCCCSGGGEEEE--TTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHH
T ss_pred hCCEEccCCChhhEEEE--CCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHH
Confidence 99999999999999996 336789999999987654332 223445788999999986543 7889999999999999
Q ss_pred HHhCCCCCCCC
Q 030430 161 LLNGYPPFSVG 171 (177)
Q Consensus 161 ~~~~~~pf~~~ 171 (177)
+++|..||...
T Consensus 218 l~~g~~pf~~~ 228 (295)
T 2clq_A 218 MATGKPPFYEL 228 (295)
T ss_dssp HHHTSCTTGGG
T ss_pred HHHCCCCccCC
Confidence 99999999653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=219.96 Aligned_cols=158 Identities=19% Similarity=0.292 Sum_probs=137.6
Q ss_pred HHHHHHHHHHhhCCCCceee---------------EeEEEee-CCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHH
Q 030430 11 SCLDCELNFLSSVNHPNIIR---------------LFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFL 72 (177)
Q Consensus 11 ~~~~~e~~~l~~l~h~~i~~---------------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~ 72 (177)
+.+.+|++++++++||||++ +++++.. ++..++||||+ +++|.+++... ..+++..+..++
T Consensus 87 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~ 165 (352)
T 2jii_A 87 GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVA 165 (352)
T ss_dssp STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHH
T ss_pred chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHH
Confidence 56889999999999999887 6677765 77899999999 99999999876 679999999999
Q ss_pred HHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCe--eEEEeeeccccccCCCC--------ccccccCCCcccccccccc
Q 030430 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV--MLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQF 142 (177)
Q Consensus 73 ~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~--~~~l~d~~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~~ 142 (177)
.|++.||+|||+.|++|+||+|+||+++ ..+ .++|+|||.+....... ......+++.|+|||.+.+
T Consensus 166 ~qi~~~L~~LH~~~ivH~Dikp~NIl~~---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 242 (352)
T 2jii_A 166 CRLLDALEFLHENEYVHGNVTAENIFVD---PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG 242 (352)
T ss_dssp HHHHHHHHHHHHTTCBCSCCCGGGEEEE---TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT
T ss_pred HHHHHHHHHHHhCCccCCCCCHHHEEEc---CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc
Confidence 9999999999999999999999999995 444 89999999997654321 1123468889999999988
Q ss_pred CCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 030430 143 QRYDEKVDMWSVGAILFELLNGYPPFSVGE 172 (177)
Q Consensus 143 ~~~~~~~Di~slg~~~~~~~~~~~pf~~~~ 172 (177)
..++.++|+||||++++++++|+.||....
T Consensus 243 ~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 243 CGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 889999999999999999999999998753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=225.02 Aligned_cols=161 Identities=14% Similarity=0.178 Sum_probs=130.5
Q ss_pred hhHHHHHHHHH---HHHhhCCCCceeeEe-------EEEeeCC-----------------eEEEEEecCCCCChHHHHhh
Q 030430 7 KHLKSCLDCEL---NFLSSVNHPNIIRLF-------DAFQAEN-----------------CIFLVVEFCAGGNLSSYIRL 59 (177)
Q Consensus 7 ~~~~~~~~~e~---~~l~~l~h~~i~~~~-------~~~~~~~-----------------~~~lv~e~~~~~~L~~~l~~ 59 (177)
....+.+.+|+ +.+++++||||++++ +++.+.+ ..+++|||+ +|+|.+++..
T Consensus 114 ~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~ 192 (377)
T 3byv_A 114 SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEV 192 (377)
T ss_dssp TTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHh
Confidence 44568899999 555566899999998 6666553 279999999 6799999987
Q ss_pred cCCCCH-------HHHHHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCC
Q 030430 60 HGRVPE-------QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132 (177)
Q Consensus 60 ~~~~~~-------~~~~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 132 (177)
.+.+++ ..+..++.|++.||+|||+.|++|+||||+||++ +..+.++|+|||++..... ......+ +
T Consensus 193 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DFG~a~~~~~--~~~~~~g-~ 266 (377)
T 3byv_A 193 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGFEHLVRDGA--RVVSSVS-R 266 (377)
T ss_dssp HHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCGGGCEETTC--EEECCCC-T
T ss_pred ccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEEechhheecCC--cccCCCC-c
Confidence 655555 7888899999999999999999999999999999 4667899999999876433 2234456 8
Q ss_pred ccccccccccC-----------CCCCcchHHHHHHHHHHHHhCCCCCCCCCcc
Q 030430 133 LYMAPEVLQFQ-----------RYDEKVDMWSVGAILFELLNGYPPFSVGEEH 174 (177)
Q Consensus 133 ~~~~pe~~~~~-----------~~~~~~Di~slg~~~~~~~~~~~pf~~~~~~ 174 (177)
.|+|||.+.+. .++.++|+||||+++++|++|+.||.+....
T Consensus 267 ~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~ 319 (377)
T 3byv_A 267 GFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAAL 319 (377)
T ss_dssp TCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred CccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccc
Confidence 99999999877 7899999999999999999999999876543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=210.03 Aligned_cols=164 Identities=27% Similarity=0.451 Sum_probs=138.8
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeE-EEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCI-FLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
....+.+.+|++++++++||||+++++++.+.+.. ++++||+.+++|.+++... ..+++..+..++.|++.+|++||+
T Consensus 63 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~ 142 (298)
T 3pls_A 63 MQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE 142 (298)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34567889999999999999999999999766554 8999999999999999863 458999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-----ccccccCCCccccccccccCCCCCcchHHHHHHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~ 159 (177)
.|++|+||+|+||++ +..+.++|+|||.+....... ......++..|+|||...+..++.++|+||+|++++
T Consensus 143 ~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 219 (298)
T 3pls_A 143 QKFVHRDLAARNCML---DESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLW 219 (298)
T ss_dssp TTCCCSCCSGGGEEE---CTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred CCcccCCCCcceEEE---cCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHH
Confidence 999999999999999 467789999999987553321 122344677899999998888999999999999999
Q ss_pred HHHhCC-CCCCCCCc
Q 030430 160 ELLNGY-PPFSVGEE 173 (177)
Q Consensus 160 ~~~~~~-~pf~~~~~ 173 (177)
++++|. +||...+.
T Consensus 220 ~l~~g~~~~~~~~~~ 234 (298)
T 3pls_A 220 ELLTRGAPPYRHIDP 234 (298)
T ss_dssp HHHHTSCCTTTTSCG
T ss_pred HHhhCCCCCCccCCH
Confidence 999954 55555443
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-35 Score=214.19 Aligned_cols=163 Identities=32% Similarity=0.544 Sum_probs=140.9
Q ss_pred hhHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCC-eEEEEEecCCCCChHHHHhhcCC----------------CCHHHH
Q 030430 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHGR----------------VPEQTA 68 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~----------------~~~~~~ 68 (177)
....+.+.+|+++++++ +||||+++++++...+ .+++++||+++++|.+++..... +++..+
T Consensus 71 ~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (316)
T 2xir_A 71 HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150 (316)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHH
T ss_pred cHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHH
Confidence 34566799999999999 7899999999987654 58999999999999999986543 889999
Q ss_pred HHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCC
Q 030430 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRY 145 (177)
Q Consensus 69 ~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~ 145 (177)
..++.|++.+|+|||+.|++|+||+|+||++ +..+.++|+|||.+........ .....+++.|+|||.+.+..+
T Consensus 151 ~~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 227 (316)
T 2xir_A 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 227 (316)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHhCCcccccCccceEEE---CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccc
Confidence 9999999999999999999999999999999 4667899999999976544322 223446778999999988889
Q ss_pred CCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 030430 146 DEKVDMWSVGAILFELLN-GYPPFSVGE 172 (177)
Q Consensus 146 ~~~~Di~slg~~~~~~~~-~~~pf~~~~ 172 (177)
+.++|+||+|++++++++ |..||.+..
T Consensus 228 ~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 228 TIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 999999999999999998 999997754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=210.71 Aligned_cols=163 Identities=20% Similarity=0.240 Sum_probs=138.0
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeE-EEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
..+.+.+|+++++.++|++++..+. +.......++++||+ +++|.+++... ..+++..+..++.|++.||+|||+.|
T Consensus 47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 125 (296)
T 3uzp_A 47 KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 125 (296)
T ss_dssp SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3467899999999998877655555 446778889999999 99999999843 56999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--------cccccCCCccccccccccCCCCCcchHHHHHHHH
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--------~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~ 158 (177)
++|+||+|+||+++..+..+.++|+|||.+........ .....+++.|+|||.+.+..++.++|+||+|+++
T Consensus 126 ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 205 (296)
T 3uzp_A 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVL 205 (296)
T ss_dssp EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHH
Confidence 99999999999995333567799999999876544322 2344688999999999988899999999999999
Q ss_pred HHHHhCCCCCCCCC
Q 030430 159 FELLNGYPPFSVGE 172 (177)
Q Consensus 159 ~~~~~~~~pf~~~~ 172 (177)
+++++|+.||.+..
T Consensus 206 ~~l~~g~~pf~~~~ 219 (296)
T 3uzp_A 206 MYFNLGSLPWQGLK 219 (296)
T ss_dssp HHHHHSSCTTSSCC
T ss_pred HHHHhCCCCCCCcC
Confidence 99999999998743
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=225.08 Aligned_cols=161 Identities=24% Similarity=0.455 Sum_probs=135.6
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
..+.+.+|++++++++||||+++++++.+ +..++||||+++++|.+++... ..++...+..++.|++.||+|||+.|
T Consensus 222 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ 300 (452)
T 1fmk_A 222 SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300 (452)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 35679999999999999999999999876 5689999999999999999743 45999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~- 163 (177)
++|+||+|+||++ +..+.++|+|||.+........ .....++..|+|||.+....++.++|+||+|++++++++
T Consensus 301 ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~ 377 (452)
T 1fmk_A 301 YVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 377 (452)
T ss_dssp CCCSCCSGGGEEE---CGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred eeCCCCChhhEEE---CCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhC
Confidence 9999999999999 4677899999999976543322 122335678999999988889999999999999999999
Q ss_pred CCCCCCCCCc
Q 030430 164 GYPPFSVGEE 173 (177)
Q Consensus 164 ~~~pf~~~~~ 173 (177)
|..||.+...
T Consensus 378 g~~P~~~~~~ 387 (452)
T 1fmk_A 378 GRVPYPGMVN 387 (452)
T ss_dssp TCCSSTTCCH
T ss_pred CCCCCCCCCH
Confidence 9999987543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=219.07 Aligned_cols=160 Identities=33% Similarity=0.560 Sum_probs=126.8
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeC------CeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE 80 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~ 80 (177)
....+++.+|++++++++||||+++++++... ...++++|++ +++|.+++.. ..+++..+..++.|++.||+
T Consensus 69 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~ 146 (367)
T 2fst_X 69 IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLK 146 (367)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHH
Confidence 34567888999999999999999999998654 5679999999 8899998874 57999999999999999999
Q ss_pred HHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCcccccccccc-CCCCCcchHHHHHHHHH
Q 030430 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILF 159 (177)
Q Consensus 81 ~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~ 159 (177)
|||+.|++|+||||+||++ +..+.++|+|||.+...... .....+++.|+|||.+.+ ..++.++|+||+|++++
T Consensus 147 ~LH~~givH~Dlkp~NIll---~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 221 (367)
T 2fst_X 147 YIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 221 (367)
T ss_dssp HHHHTTCCCCCCCGGGEEE---CTTCCEEECC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHH
T ss_pred HHHHCCeeeCCCCHhhEEE---CCCCCEEEeecccccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999 46778999999998765432 223458899999999876 56899999999999999
Q ss_pred HHHhCCCCCCCCCc
Q 030430 160 ELLNGYPPFSVGEE 173 (177)
Q Consensus 160 ~~~~~~~pf~~~~~ 173 (177)
+|++|+.||.+.+.
T Consensus 222 ell~g~~pf~~~~~ 235 (367)
T 2fst_X 222 ELLTGRTLFPGTDH 235 (367)
T ss_dssp HHHHSSCSCCCSSH
T ss_pred HHHhCCCCCCCCCH
Confidence 99999999987654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=220.46 Aligned_cols=162 Identities=36% Similarity=0.532 Sum_probs=139.9
Q ss_pred hhHHHHHHHHHHHHhhC------CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC--CCCHHHHHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAG 78 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~ 78 (177)
....+.+.+|+++++.+ +|+||+++++++.....+++++|++ +++|.+++.... .+++..+..++.|++.|
T Consensus 134 ~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~a 212 (429)
T 3kvw_A 134 KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212 (429)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHH
Confidence 34457788899988887 5679999999999999999999999 569999988654 49999999999999999
Q ss_pred HHHHhhCCCeeecCCCCcEEEecCCCCe--eEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHH
Q 030430 79 LEILNSHHIIHRDLKPENILLSGLDDDV--MLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA 156 (177)
Q Consensus 79 l~~lh~~~~~H~~i~~~nil~~~~~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~ 156 (177)
|+|||+.|++|+||||+||+++ ..+ .++|+|||.+...... .....+++.|+|||.+.+..++.++||||||+
T Consensus 213 L~~LH~~~ivHrDlKp~NILl~---~~~~~~vkL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 287 (429)
T 3kvw_A 213 LDALHKNRIIHCDLKPENILLK---QQGRSGIKVIDFGSSCYEHQR--VYTYIQSRFYRAPEVILGARYGMPIDMWSLGC 287 (429)
T ss_dssp HHHHHHHTEECSCCSGGGEEES---STTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHH
T ss_pred HHHHHHCCeecCCCCHHHeEEc---cCCCcceEEeecccceecCCc--ccccCCCCCccChHHHhCCCCCchHHHHhHHH
Confidence 9999999999999999999995 333 3999999998665433 22445889999999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCCcc
Q 030430 157 ILFELLNGYPPFSVGEEH 174 (177)
Q Consensus 157 ~~~~~~~~~~pf~~~~~~ 174 (177)
++++|++|+.||.+.++.
T Consensus 288 il~elltG~~pf~~~~~~ 305 (429)
T 3kvw_A 288 ILAELLTGYPLLPGEDEG 305 (429)
T ss_dssp HHHHHHHSSCSSCCSSHH
T ss_pred HHHHHHhCCCCCCCCCHH
Confidence 999999999999887643
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=207.69 Aligned_cols=159 Identities=31% Similarity=0.518 Sum_probs=134.5
Q ss_pred HHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC--C
Q 030430 11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH--I 87 (177)
Q Consensus 11 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~--~ 87 (177)
+.+.+|++++++++||||+++++++.+.. +++|||+++++|.+++... ..+++..+..++.|++.+++|||+.| +
T Consensus 68 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i 145 (287)
T 4f0f_A 68 QEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPI 145 (287)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCC
T ss_pred HHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCe
Confidence 67899999999999999999999997776 6899999999998888644 46999999999999999999999999 9
Q ss_pred eeecCCCCcEEEecCC--CCeeEEEeeeccccccCCCCccccccCCCccccccccc--cCCCCCcchHHHHHHHHHHHHh
Q 030430 88 IHRDLKPENILLSGLD--DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ--FQRYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~--~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~Di~slg~~~~~~~~ 163 (177)
+|+||+|+||+++..+ ....++|+|||.+...... .....+++.|+|||.+. ...++.++|+||+|++++++++
T Consensus 146 vH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~ 223 (287)
T 4f0f_A 146 VHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILT 223 (287)
T ss_dssp BCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSC--EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCcceEEEeccCCCCceeEEeCCCCcccccccc--ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHc
Confidence 9999999999995321 1223899999998754332 23455889999999983 4456889999999999999999
Q ss_pred CCCCCCCCCc
Q 030430 164 GYPPFSVGEE 173 (177)
Q Consensus 164 ~~~pf~~~~~ 173 (177)
|+.||.....
T Consensus 224 g~~pf~~~~~ 233 (287)
T 4f0f_A 224 GEGPFDEYSY 233 (287)
T ss_dssp SSCTTTTCCC
T ss_pred CCCCCccccc
Confidence 9999976543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=215.49 Aligned_cols=163 Identities=30% Similarity=0.497 Sum_probs=139.2
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeC-----CeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (177)
....+.+.+|++++++++||||+++++++... ...++++|++. ++|.+++.. ..+++..+..++.|++.+|+|
T Consensus 66 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~ 143 (364)
T 3qyz_A 66 QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKY 143 (364)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHH
Confidence 44557889999999999999999999998654 36899999995 599998874 579999999999999999999
Q ss_pred HhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc----cccccCCCcccccccccc-CCCCCcchHHHHHH
Q 030430 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGA 156 (177)
Q Consensus 82 lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~ 156 (177)
||+.|++|+||+|+||++ +..+.++|+|||.+........ .....+++.|+|||.+.+ ..++.++|+||+|+
T Consensus 144 LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ 220 (364)
T 3qyz_A 144 IHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGC 220 (364)
T ss_dssp HHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHH
T ss_pred HHHCCeecCCCChHhEEE---CCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHH
Confidence 999999999999999999 4677899999999876543221 233468899999998654 45799999999999
Q ss_pred HHHHHHhCCCCCCCCCcc
Q 030430 157 ILFELLNGYPPFSVGEEH 174 (177)
Q Consensus 157 ~~~~~~~~~~pf~~~~~~ 174 (177)
+++++++|+.||.+.+..
T Consensus 221 il~ell~g~~pf~~~~~~ 238 (364)
T 3qyz_A 221 ILAEMLSNRPIFPGKHYL 238 (364)
T ss_dssp HHHHHHHSSCSSCCSSGG
T ss_pred HHHHHHHCCCCCCCCChH
Confidence 999999999999887544
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=231.06 Aligned_cols=163 Identities=27% Similarity=0.511 Sum_probs=138.3
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
...+.+.+|++++++++||||+++++++.+ +.+++||||+++++|.+++... ..+++..+..++.|++.||+|||+.|
T Consensus 378 ~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ 456 (613)
T 2ozo_A 378 ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 456 (613)
T ss_dssp TTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 456789999999999999999999999976 4589999999999999998754 45999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc----cccccCCCccccccccccCCCCCcchHHHHHHHHHHHH
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~ 162 (177)
++|+||+|+||+++ ..+.++|+|||++........ .....++..|+|||.+.+..++.++||||+|+++++|+
T Consensus 457 iiHrDlkp~NILl~---~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ell 533 (613)
T 2ozo_A 457 FVHRNLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 533 (613)
T ss_dssp CCCSCCSGGGEEEE---ETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred EEcCcCCHHHEEEc---CCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHH
Confidence 99999999999995 566899999999976543321 11223457899999998888999999999999999999
Q ss_pred h-CCCCCCCCCcc
Q 030430 163 N-GYPPFSVGEEH 174 (177)
Q Consensus 163 ~-~~~pf~~~~~~ 174 (177)
+ |+.||.+.+..
T Consensus 534 t~G~~Pf~~~~~~ 546 (613)
T 2ozo_A 534 SYGQKPYKKMKGP 546 (613)
T ss_dssp TTSCCTTTTCCSH
T ss_pred HCCCCCCCCCCHH
Confidence 8 99999876543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-35 Score=222.81 Aligned_cols=169 Identities=32% Similarity=0.518 Sum_probs=136.3
Q ss_pred ccccchhHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHH
Q 030430 2 LKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGL 79 (177)
Q Consensus 2 l~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l 79 (177)
+|.+.+.....+.+|+++++++ +||||+++++++.+....+++||++. ++|.+++.... ...+..+..++.|++.||
T Consensus 53 vK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL 131 (432)
T 3p23_A 53 VKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGL 131 (432)
T ss_dssp EEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHH
T ss_pred EEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHH
Confidence 4555555556678999999999 89999999999999999999999995 69999998653 355667788999999999
Q ss_pred HHHhhCCCeeecCCCCcEEEecC--CCCeeEEEeeeccccccCCCC----ccccccCCCccccccccc---cCCCCCcch
Q 030430 80 EILNSHHIIHRDLKPENILLSGL--DDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQ---FQRYDEKVD 150 (177)
Q Consensus 80 ~~lh~~~~~H~~i~~~nil~~~~--~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~---~~~~~~~~D 150 (177)
+|||+.|++||||||+||+++.. +....++|+|||.+....... ......+++.|+|||.+. ...++.++|
T Consensus 132 ~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~D 211 (432)
T 3p23_A 132 AHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVD 211 (432)
T ss_dssp HHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHH
T ss_pred HHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHH
Confidence 99999999999999999999532 234458899999997764332 223456899999999987 355778999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCC
Q 030430 151 MWSVGAILFELLN-GYPPFSVG 171 (177)
Q Consensus 151 i~slg~~~~~~~~-~~~pf~~~ 171 (177)
+||+|++++++++ |..||...
T Consensus 212 iwSlG~il~ellt~g~~pf~~~ 233 (432)
T 3p23_A 212 IFSAGCVFYYVISEGSHPFGKS 233 (432)
T ss_dssp HHHHHHHHHHHHTTSCBTTBST
T ss_pred HHHHHHHHHHHHcCCCCCcchh
Confidence 9999999999999 89999654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=209.13 Aligned_cols=166 Identities=20% Similarity=0.241 Sum_probs=138.4
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeE-EEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
....+.+.+|+++++.++|++++..+. ++......+++||++ +++|.+++... ..+++..+..++.|++.||+|||+
T Consensus 45 ~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~ 123 (296)
T 4hgt_A 45 KTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 123 (296)
T ss_dssp ---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 344567899999999998877665555 456778899999999 99999999853 569999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--------cccccCCCccccccccccCCCCCcchHHHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA 156 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--------~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~ 156 (177)
.|++|+||+|+||+++..+..+.++|+|||.+........ .....+++.|+|||.+.+..++.++|+||+|+
T Consensus 124 ~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 203 (296)
T 4hgt_A 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGY 203 (296)
T ss_dssp TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHH
T ss_pred CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHH
Confidence 9999999999999995334567799999999976544322 22445789999999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCCc
Q 030430 157 ILFELLNGYPPFSVGEE 173 (177)
Q Consensus 157 ~~~~~~~~~~pf~~~~~ 173 (177)
+++++++|+.||.+.+.
T Consensus 204 il~~l~~g~~pf~~~~~ 220 (296)
T 4hgt_A 204 VLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp HHHHHHHSSCTTSSCCC
T ss_pred HHHHHhcCCCCCcccch
Confidence 99999999999987543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=227.31 Aligned_cols=166 Identities=31% Similarity=0.612 Sum_probs=146.8
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEee------CCeEEEEEecCCCCChHHHHhhcC---CCCHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQLG 76 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~ 76 (177)
.....+.+.+|++++++++||||+++++++.. ++..++||||++|++|.+++.... .+++..++.++.|++
T Consensus 52 ~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl 131 (676)
T 3qa8_A 52 SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131 (676)
T ss_dssp CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHH
Confidence 45667889999999999999999999998765 667899999999999999998654 599999999999999
Q ss_pred HHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHH
Q 030430 77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA 156 (177)
Q Consensus 77 ~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~ 156 (177)
.||+|||+.|++|+||+|+||+++..+....++|+|||.+.............+++.|+|||.+.+..++.++|+||+|+
T Consensus 132 ~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGv 211 (676)
T 3qa8_A 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGT 211 (676)
T ss_dssp HHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHH
T ss_pred HHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHH
Confidence 99999999999999999999999754445568999999998876655555567899999999998888999999999999
Q ss_pred HHHHHHhCCCCCCCC
Q 030430 157 ILFELLNGYPPFSVG 171 (177)
Q Consensus 157 ~~~~~~~~~~pf~~~ 171 (177)
+++++++|..||.+.
T Consensus 212 iLyeLltG~~Pf~~~ 226 (676)
T 3qa8_A 212 LAFECITGFRPFLPN 226 (676)
T ss_dssp HHHHHHSSCSSCCSS
T ss_pred HHHHHHHCCCCCCcc
Confidence 999999999999653
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-35 Score=211.62 Aligned_cols=162 Identities=29% Similarity=0.456 Sum_probs=138.9
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
...+.+.+|++++++++||||+++++++.+.. .++++|++++++|.+++... ..+++..+..++.|++.+|++||+.|
T Consensus 63 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 141 (291)
T 1u46_A 63 EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 141 (291)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC
Confidence 45678999999999999999999999998765 78999999999999999865 46999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc----cccccCCCccccccccccCCCCCcchHHHHHHHHHHHH
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~ 162 (177)
++|+||+|+||+++ ..+.++|+|||.+........ .....++..|+|||...+..++.++|+||||+++++++
T Consensus 142 i~H~dikp~Nili~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 218 (291)
T 1u46_A 142 FIHRDLAARNLLLA---TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 218 (291)
T ss_dssp EECSCCCGGGEEEE---ETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred cccCCCchheEEEc---CCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHH
Confidence 99999999999995 556899999999877644332 12234567899999998778899999999999999999
Q ss_pred h-CCCCCCCCCc
Q 030430 163 N-GYPPFSVGEE 173 (177)
Q Consensus 163 ~-~~~pf~~~~~ 173 (177)
+ |+.||.+.+.
T Consensus 219 ~~g~~p~~~~~~ 230 (291)
T 1u46_A 219 TYGQEPWIGLNG 230 (291)
T ss_dssp TTSCCTTTTCCH
T ss_pred hCCCCCcccCCH
Confidence 9 9999987543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-34 Score=208.59 Aligned_cols=164 Identities=30% Similarity=0.576 Sum_probs=137.8
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEe--------------eCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--------------AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 71 (177)
++...+.+.+|++++++++||||+++++++. +....++++||++ ++|.+++.. +.+++..+..+
T Consensus 48 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~ 125 (320)
T 2i6l_A 48 DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLF 125 (320)
T ss_dssp SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHH
Confidence 4556778999999999999999999999873 3467899999996 699998874 57999999999
Q ss_pred HHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCC----CccccccCCCcccccccccc-CCCC
Q 030430 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----NYAEKVCGSPLYMAPEVLQF-QRYD 146 (177)
Q Consensus 72 ~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~-~~~~ 146 (177)
+.|++.+|++||+.|++|+||+|+||+++ ..+..++|+|||.+...... .......++..|+|||.+.+ ..++
T Consensus 126 ~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 203 (320)
T 2i6l_A 126 MYQLLRGLKYIHSANVLHRDLKPANLFIN--TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYT 203 (320)
T ss_dssp HHHHHHHHHHHHHTTCBCCCCSGGGEEEE--TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCC
T ss_pred HHHHHHHHHHHHhCCEecCCCCHHHEEEc--CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCC
Confidence 99999999999999999999999999996 34568999999998765432 12223446888999998764 5688
Q ss_pred CcchHHHHHHHHHHHHhCCCCCCCCCc
Q 030430 147 EKVDMWSVGAILFELLNGYPPFSVGEE 173 (177)
Q Consensus 147 ~~~Di~slg~~~~~~~~~~~pf~~~~~ 173 (177)
.++|+||||++++++++|+.||.+.+.
T Consensus 204 ~~~Di~slG~il~el~~g~~pf~~~~~ 230 (320)
T 2i6l_A 204 KAIDMWAAGCIFAEMLTGKTLFAGAHE 230 (320)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred chhhhHhHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999999999987653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=210.64 Aligned_cols=160 Identities=36% Similarity=0.570 Sum_probs=138.0
Q ss_pred HHHHHHHHHHHhhC---CCCceeeEeEEEe-----eCCeEEEEEecCCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHH
Q 030430 10 KSCLDCELNFLSSV---NHPNIIRLFDAFQ-----AENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGL 79 (177)
Q Consensus 10 ~~~~~~e~~~l~~l---~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l 79 (177)
...+.+|+++++.+ +||||+++++++. .....++++|++. ++|.+++.... .+++..+..++.|++.+|
T Consensus 55 ~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l 133 (326)
T 1blx_A 55 PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133 (326)
T ss_dssp BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHH
T ss_pred CchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHH
Confidence 34567788877766 8999999999987 4567899999996 69999998653 399999999999999999
Q ss_pred HHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHH
Q 030430 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (177)
Q Consensus 80 ~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~ 159 (177)
++||+.|++|+||+|+||++ +..+.++|+|||.+.............++..|+|||.+.+..++.++|+||||++++
T Consensus 134 ~~lH~~gi~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 210 (326)
T 1blx_A 134 DFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 210 (326)
T ss_dssp HHHHHTTCCCCCCCGGGEEE---CTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred HHHHHCCceeccCCHHHeEE---cCCCCEEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHH
Confidence 99999999999999999999 466789999999987665444344456789999999998888999999999999999
Q ss_pred HHHhCCCCCCCCCc
Q 030430 160 ELLNGYPPFSVGEE 173 (177)
Q Consensus 160 ~~~~~~~pf~~~~~ 173 (177)
++++|+.||.+.++
T Consensus 211 ~l~~g~~pf~~~~~ 224 (326)
T 1blx_A 211 EMFRRKPLFRGSSD 224 (326)
T ss_dssp HHHHSSCSCCCSSH
T ss_pred HHHcCCCCCCCCCH
Confidence 99999999987653
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=212.79 Aligned_cols=166 Identities=26% Similarity=0.378 Sum_probs=141.4
Q ss_pred ccccchhHHHHHHHHHHHHhh--CCCCceeeEeEEEeeCC----eEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHH
Q 030430 2 LKKLNKHLKSCLDCELNFLSS--VNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75 (177)
Q Consensus 2 l~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i 75 (177)
+|.......+.+.+|.++++. ++||||+++++++.... ..++++||+++++|.+++.. ..+++..++.++.|+
T Consensus 70 vK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i 148 (342)
T 1b6c_B 70 VKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALST 148 (342)
T ss_dssp EEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHH
T ss_pred EEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHH
Confidence 566666677888999999988 79999999999998765 78999999999999999975 479999999999999
Q ss_pred HHHHHHHh--------hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-----cccccCCCcccccccccc
Q 030430 76 GAGLEILN--------SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQF 142 (177)
Q Consensus 76 ~~~l~~lh--------~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~~pe~~~~ 142 (177)
+.+|+||| +.|++|+||+|+||++ +..+.++|+|||.+........ .....+++.|+|||.+.+
T Consensus 149 ~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 225 (342)
T 1b6c_B 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 225 (342)
T ss_dssp HHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE---CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTS
T ss_pred HHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE---CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcc
Confidence 99999999 8999999999999999 4667899999999876544331 233458899999999875
Q ss_pred CC------CCCcchHHHHHHHHHHHHhC----------CCCCCCC
Q 030430 143 QR------YDEKVDMWSVGAILFELLNG----------YPPFSVG 171 (177)
Q Consensus 143 ~~------~~~~~Di~slg~~~~~~~~~----------~~pf~~~ 171 (177)
.. ++.++|+||||++++++++| +.||...
T Consensus 226 ~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 226 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp CCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred cccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence 42 33689999999999999999 7888664
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=208.94 Aligned_cols=166 Identities=27% Similarity=0.396 Sum_probs=136.3
Q ss_pred ccccchhHHHHHHHHHHHHhhC--CCCceeeEeEEEeeC----CeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHH
Q 030430 2 LKKLNKHLKSCLDCELNFLSSV--NHPNIIRLFDAFQAE----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75 (177)
Q Consensus 2 l~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i 75 (177)
+|.+.........+|.+++..+ +||||+++++++.+. ...+++|||+++++|.+++.. ..+++..+..++.|+
T Consensus 65 vK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i 143 (337)
T 3mdy_A 65 VKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSS 143 (337)
T ss_dssp EEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHH
T ss_pred EEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHH
Confidence 4555555556666777777665 899999999998877 789999999999999999975 479999999999999
Q ss_pred HHHHHHHhhC--------CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc-----ccccCCCcccccccccc
Q 030430 76 GAGLEILNSH--------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-----EKVCGSPLYMAPEVLQF 142 (177)
Q Consensus 76 ~~~l~~lh~~--------~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~pe~~~~ 142 (177)
+.+|+|||+. |++|+||||+||++ +..+.++|+|||.+......... ....+++.|+|||.+.+
T Consensus 144 ~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 220 (337)
T 3mdy_A 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE 220 (337)
T ss_dssp HHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTT
T ss_pred HHHHHHHHHhhhhhccCCCEEecccchHHEEE---CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccc
Confidence 9999999998 99999999999999 46678999999998765433221 23468899999999876
Q ss_pred CCCCCc------chHHHHHHHHHHHHhC----------CCCCCCC
Q 030430 143 QRYDEK------VDMWSVGAILFELLNG----------YPPFSVG 171 (177)
Q Consensus 143 ~~~~~~------~Di~slg~~~~~~~~~----------~~pf~~~ 171 (177)
...+.. +|+||+|+++|+|++| +.||...
T Consensus 221 ~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 221 SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 665554 9999999999999999 6777553
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=210.18 Aligned_cols=162 Identities=28% Similarity=0.427 Sum_probs=137.3
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEe----eCCeEEEEEecCCCCChHHHHhh----cCCCCHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGA 77 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~ 77 (177)
+....+.+.+|++++++++||||+++++++. .....++++||+++++|.+++.. ...+++..++.++.|++.
T Consensus 66 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~ 145 (317)
T 2buj_A 66 EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145 (317)
T ss_dssp SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence 4566788999999999999999999999886 23478999999999999999875 356999999999999999
Q ss_pred HHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc----------ccccCCCccccccccccCC---
Q 030430 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----------EKVCGSPLYMAPEVLQFQR--- 144 (177)
Q Consensus 78 ~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~----------~~~~~~~~~~~pe~~~~~~--- 144 (177)
+|+|||+.|++|+||+|+||++ +..+.++|+|||.+......... ....+++.|+|||.+....
T Consensus 146 ~L~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 222 (317)
T 2buj_A 146 GLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCV 222 (317)
T ss_dssp HHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEE
T ss_pred HHHHHHhCCcccCCCCHHHEEE---cCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcC
Confidence 9999999999999999999999 46678999999987654321110 1234688999999986443
Q ss_pred CCCcchHHHHHHHHHHHHhCCCCCCC
Q 030430 145 YDEKVDMWSVGAILFELLNGYPPFSV 170 (177)
Q Consensus 145 ~~~~~Di~slg~~~~~~~~~~~pf~~ 170 (177)
++.++|+||||++++++++|+.||..
T Consensus 223 ~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 223 IDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp ECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred CCchhhHHHHHHHHHHHHhCCCChhh
Confidence 68899999999999999999999954
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=219.63 Aligned_cols=169 Identities=30% Similarity=0.550 Sum_probs=134.1
Q ss_pred ccccchhHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCC-------CHHHHHHHHH
Q 030430 2 LKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-------PEQTARKFLQ 73 (177)
Q Consensus 2 l~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~ 73 (177)
+|.+.....+.+.+|+++++++ +||||+++++++.+.+..++++||+. ++|.+++...... ++..+..++.
T Consensus 44 vK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~ 122 (434)
T 2rio_A 44 VKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLR 122 (434)
T ss_dssp EEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHH
T ss_pred EEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHH
Confidence 5666566667789999999986 89999999999999999999999995 6999999865432 2234567999
Q ss_pred HHHHHHHHHhhCCCeeecCCCCcEEEecC----------CCCeeEEEeeeccccccCCCCc-----cccccCCCcccccc
Q 030430 74 QLGAGLEILNSHHIIHRDLKPENILLSGL----------DDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPE 138 (177)
Q Consensus 74 ~i~~~l~~lh~~~~~H~~i~~~nil~~~~----------~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~~pe 138 (177)
|++.||+|||+.|++|+||||+||+++.. +....++|+|||.+........ .....+++.|+|||
T Consensus 123 qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE 202 (434)
T 2rio_A 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPE 202 (434)
T ss_dssp HHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHH
T ss_pred HHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHH
Confidence 99999999999999999999999999632 2345799999999977654321 12346899999999
Q ss_pred cccc-------CCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q 030430 139 VLQF-------QRYDEKVDMWSVGAILFELLN-GYPPFSVG 171 (177)
Q Consensus 139 ~~~~-------~~~~~~~Di~slg~~~~~~~~-~~~pf~~~ 171 (177)
.+.+ ..++.++|+||+|++++++++ |..||...
T Consensus 203 ~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 203 LLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp HHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred HhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 9865 567899999999999999999 99999764
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=211.12 Aligned_cols=162 Identities=32% Similarity=0.592 Sum_probs=133.7
Q ss_pred hHHHHHHHHHHHHhhC-CCCceeeEeEEEee------CCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHH
Q 030430 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAG 78 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~ 78 (177)
...+.+.+|+++++++ +||||+++++++.. ....+++|||+++++|.+++... ..+++..+..++.|++.+
T Consensus 62 ~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~ 141 (326)
T 2x7f_A 62 DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141 (326)
T ss_dssp STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHH
Confidence 3457889999999999 89999999999876 56889999999999999999864 469999999999999999
Q ss_pred HHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccc-----cCCCCCcchHH
Q 030430 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMW 152 (177)
Q Consensus 79 l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~ 152 (177)
|+|||+.|++|+||+|+||++ +..+.++|+|||.+....... ......+++.|+|||.+. +..++.++|+|
T Consensus 142 l~~lH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~ 218 (326)
T 2x7f_A 142 LSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLW 218 (326)
T ss_dssp HHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHH
T ss_pred HHHHHHCCccccCCcHHHEEE---cCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHH
Confidence 999999999999999999999 467789999999987654322 223345788999999986 45688999999
Q ss_pred HHHHHHHHHHhCCCCCCCCC
Q 030430 153 SVGAILFELLNGYPPFSVGE 172 (177)
Q Consensus 153 slg~~~~~~~~~~~pf~~~~ 172 (177)
|||++++++++|..||.+..
T Consensus 219 slG~il~~l~~g~~p~~~~~ 238 (326)
T 2x7f_A 219 SLGITAIEMAEGAPPLCDMH 238 (326)
T ss_dssp HHHHHHHHHHHSSCTTTTSC
T ss_pred HHHHHHHHHHhCCCCCCCCc
Confidence 99999999999999997654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-34 Score=210.52 Aligned_cols=164 Identities=26% Similarity=0.454 Sum_probs=141.1
Q ss_pred hhHHHHHHHHHHHHhhCCCCc------eeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC--CCCHHHHHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPN------IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAG 78 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~ 78 (177)
....+.+.+|+++++.++|++ ++++++++.+.+..+++|||+ +++|.+++.... .+++..+..++.|++.|
T Consensus 52 ~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~ 130 (339)
T 1z57_A 52 DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKS 130 (339)
T ss_dssp HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHH
T ss_pred CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHH
Confidence 345678899999999997654 999999999999999999999 889999998765 58999999999999999
Q ss_pred HHHHhhCCCeeecCCCCcEEEecCCC----------------CeeEEEeeeccccccCCCCccccccCCCcccccccccc
Q 030430 79 LEILNSHHIIHRDLKPENILLSGLDD----------------DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF 142 (177)
Q Consensus 79 l~~lh~~~~~H~~i~~~nil~~~~~~----------------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 142 (177)
|+|||+.|++|+||+|+||++...+. .+.++|+|||.+...... .....+++.|+|||.+.+
T Consensus 131 l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~ 208 (339)
T 1z57_A 131 VNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILA 208 (339)
T ss_dssp HHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTT
T ss_pred HHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhC
Confidence 99999999999999999999953111 456999999998764332 234457899999999988
Q ss_pred CCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 030430 143 QRYDEKVDMWSVGAILFELLNGYPPFSVGEE 173 (177)
Q Consensus 143 ~~~~~~~Di~slg~~~~~~~~~~~pf~~~~~ 173 (177)
..++.++|+||||++++++++|..||...+.
T Consensus 209 ~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 209 LGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred CCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 8899999999999999999999999987654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=214.69 Aligned_cols=163 Identities=31% Similarity=0.467 Sum_probs=136.5
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCC-------eEEEEEecCCCCChHHHHh----hcCCCCHHHHHHHHHHHH
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-------CIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKFLQQLG 76 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~ 76 (177)
.......+|++.+..++||||+++++++...+ ..+++|||+++ +|.+.+. ....+++..+..++.|++
T Consensus 61 ~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~ 139 (360)
T 3e3p_A 61 RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLI 139 (360)
T ss_dssp TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHH
T ss_pred cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHH
Confidence 34556778888899999999999999986533 38899999965 5544433 445699999999999999
Q ss_pred HHHHHHh--hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCC-CCCcchHHH
Q 030430 77 AGLEILN--SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWS 153 (177)
Q Consensus 77 ~~l~~lh--~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~s 153 (177)
.+++||| +.|++|+||||+||+++ ...+.++|+|||.+.............+++.|+|||.+.+.. ++.++|+||
T Consensus 140 ~al~~lH~~~~~ivH~Dlkp~NIll~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~s 217 (360)
T 3e3p_A 140 RSIGCLHLPSVNVCHRDIKPHNVLVN--EADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWS 217 (360)
T ss_dssp HHHHHHTSTTTCCBCSCCCGGGEEEE--TTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHH
T ss_pred HHHHHHhCCCCCeecCcCCHHHEEEe--CCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHH
Confidence 9999999 99999999999999996 336789999999998776655555566899999999986544 799999999
Q ss_pred HHHHHHHHHhCCCCCCCCCc
Q 030430 154 VGAILFELLNGYPPFSVGEE 173 (177)
Q Consensus 154 lg~~~~~~~~~~~pf~~~~~ 173 (177)
+|++++++++|+.||.+.+.
T Consensus 218 lG~il~ell~g~~pf~~~~~ 237 (360)
T 3e3p_A 218 VGCIFAEMMLGEPIFRGDNS 237 (360)
T ss_dssp HHHHHHHHHHSSCSSCCSSH
T ss_pred HHHHHHHHHhCCCCcCCCCh
Confidence 99999999999999988654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=211.54 Aligned_cols=164 Identities=29% Similarity=0.512 Sum_probs=123.2
Q ss_pred chhHHHHHHHHHHHHhhCC-CCceeeEeEEEe--------eCCeEEEEEecCCCCChHHHHhh---cCCCCHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQ--------AENCIFLVVEFCAGGNLSSYIRL---HGRVPEQTARKFLQ 73 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--------~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ 73 (177)
.....+.+.+|+.+++++. ||||+++++++. ....+++++||+ +++|.+++.. ...+++..++.++.
T Consensus 65 ~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~ 143 (337)
T 3ll6_A 65 EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFY 143 (337)
T ss_dssp SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHH
Confidence 4455678899999999995 999999999983 445689999999 5799888864 35699999999999
Q ss_pred HHHHHHHHHhhCC--CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc-------------ccccCCCcccccc
Q 030430 74 QLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-------------EKVCGSPLYMAPE 138 (177)
Q Consensus 74 ~i~~~l~~lh~~~--~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~-------------~~~~~~~~~~~pe 138 (177)
|++.+|+|||+.| ++|+||+|+||++ +..+.++|+|||.+......... ....+++.|+|||
T Consensus 144 qi~~~l~~LH~~~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE 220 (337)
T 3ll6_A 144 QTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPE 220 (337)
T ss_dssp HHHHHHHHHHTSSSCCBCCCCCGGGCEE---CTTSCEEBCCCTTCBCCSSCC----------------------------
T ss_pred HHHHHHHHHHhCCCCEEEccCCcccEEE---CCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChh
Confidence 9999999999999 9999999999999 46678999999998766443211 1334788899999
Q ss_pred cc---ccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 030430 139 VL---QFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 173 (177)
Q Consensus 139 ~~---~~~~~~~~~Di~slg~~~~~~~~~~~pf~~~~~ 173 (177)
.+ .+..++.++|+||||++++++++|..||.....
T Consensus 221 ~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 221 IIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp ---CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred hhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 88 456678899999999999999999999976543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=210.19 Aligned_cols=162 Identities=30% Similarity=0.548 Sum_probs=136.8
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
...+.+.+|+++++.++||||+++++++.+.+..++++||+++++|.+++.. ...+++..+..++.|++.+|++||+.|
T Consensus 58 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 137 (302)
T 2j7t_A 58 EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137 (302)
T ss_dssp CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 3457788999999999999999999999999999999999999999998875 356999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCC-CccccccCCCccccccccc-----cCCCCCcchHHHHHHHHHH
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFE 160 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~slg~~~~~ 160 (177)
++|+||+|+||++ +..+.++|+|||.+...... .......++..|+|||.+. ...++.++|+||+|+++++
T Consensus 138 i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~ 214 (302)
T 2j7t_A 138 IIHRDLKAGNVLM---TLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE 214 (302)
T ss_dssp CCCCCCSGGGEEE---CTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHH
T ss_pred cccCCCCHHHEEE---CCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHH
Confidence 9999999999999 46678999999987543211 1122345788999999873 5567899999999999999
Q ss_pred HHhCCCCCCCCC
Q 030430 161 LLNGYPPFSVGE 172 (177)
Q Consensus 161 ~~~~~~pf~~~~ 172 (177)
+++|..||...+
T Consensus 215 l~~g~~p~~~~~ 226 (302)
T 2j7t_A 215 MAQIEPPHHELN 226 (302)
T ss_dssp HHHSSCTTTTSC
T ss_pred HhcCCCCCccCC
Confidence 999999998754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-34 Score=214.40 Aligned_cols=165 Identities=32% Similarity=0.475 Sum_probs=137.8
Q ss_pred hhHHHHHHHHHHHHhhCC--------CCceeeEeEEEe----eCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVN--------HPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFL 72 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~ 72 (177)
....+.+.+|++++++++ |+||+++++++. +...+++|||++ +++|.+++... ..+++..+..++
T Consensus 74 ~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~ 152 (397)
T 1wak_A 74 EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKII 152 (397)
T ss_dssp HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHH
T ss_pred CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHH
Confidence 445678899999999995 788999999987 456889999999 66777666544 459999999999
Q ss_pred HHHHHHHHHHhhC-CCeeecCCCCcEEEecCC----------------------------------------------CC
Q 030430 73 QQLGAGLEILNSH-HIIHRDLKPENILLSGLD----------------------------------------------DD 105 (177)
Q Consensus 73 ~~i~~~l~~lh~~-~~~H~~i~~~nil~~~~~----------------------------------------------~~ 105 (177)
.|++.||+|||+. |++|+||||+||+++..+ ..
T Consensus 153 ~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (397)
T 1wak_A 153 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEK 232 (397)
T ss_dssp HHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGG
T ss_pred HHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccc
Confidence 9999999999998 999999999999995211 11
Q ss_pred eeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcc
Q 030430 106 VMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 174 (177)
Q Consensus 106 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf~~~~~~ 174 (177)
..++|+|||.+...... .....+++.|+|||.+.+..++.++|+||||+++++|++|+.||.+.+..
T Consensus 233 ~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 299 (397)
T 1wak_A 233 LKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGE 299 (397)
T ss_dssp CCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCS
T ss_pred cceEecccccccccccc--CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCccc
Confidence 37999999998766443 22345789999999999888999999999999999999999999876543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-34 Score=206.74 Aligned_cols=158 Identities=28% Similarity=0.429 Sum_probs=124.5
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
..+.+..+...++.++||||+++++++.+.+..+++|||++ ++|.+++.. ...+++..++.++.|++.+++|||+
T Consensus 49 ~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 127 (290)
T 3fme_A 49 QKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127 (290)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 34445555666888899999999999999999999999996 588777653 4579999999999999999999999
Q ss_pred C-CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCcccccccc----ccCCCCCcchHHHHHHHHH
Q 030430 85 H-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL----QFQRYDEKVDMWSVGAILF 159 (177)
Q Consensus 85 ~-~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~----~~~~~~~~~Di~slg~~~~ 159 (177)
. |++|+||+|+||++ +..+.++|+|||.+.............+++.|+|||.+ .+..++.++|+||+|++++
T Consensus 128 ~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~ 204 (290)
T 3fme_A 128 KLSVIHRDVKPSNVLI---NALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMI 204 (290)
T ss_dssp HSCCCCCCCSGGGCEE---CTTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHH
T ss_pred cCCeecCCCCHHHEEE---CCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHH
Confidence 8 99999999999999 46678999999999776555544455688999999996 4556888999999999999
Q ss_pred HHHhCCCCCCC
Q 030430 160 ELLNGYPPFSV 170 (177)
Q Consensus 160 ~~~~~~~pf~~ 170 (177)
++++|..||..
T Consensus 205 ~l~~g~~p~~~ 215 (290)
T 3fme_A 205 ELAILRFPYDS 215 (290)
T ss_dssp HHHHTSCSSCC
T ss_pred HHHHCCCCccc
Confidence 99999999975
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=211.61 Aligned_cols=162 Identities=27% Similarity=0.461 Sum_probs=138.4
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCC--eEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEIL 82 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~l 82 (177)
+....+.+.+|++++++++||||+++++++...+ ..++|+|++++++|.+++.... .+++..+..++.|++.+|++|
T Consensus 82 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L 161 (326)
T 2w1i_A 82 TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 161 (326)
T ss_dssp CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH
Confidence 3455678999999999999999999999886543 6899999999999999998763 599999999999999999999
Q ss_pred hhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc----cccccCCCccccccccccCCCCCcchHHHHHHHH
Q 030430 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (177)
Q Consensus 83 h~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~ 158 (177)
|+.|++|+||+|+||+++ ..+.++|+|||.+........ .....++..|+|||.+.+..++.++|+||||+++
T Consensus 162 H~~~ivH~dikp~NIli~---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 238 (326)
T 2w1i_A 162 GTKRYIHRDLATRNILVE---NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 238 (326)
T ss_dssp HHTTEECSCCCGGGEEEE---ETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHH
T ss_pred HhCCEeccCCCcceEEEc---CCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHH
Confidence 999999999999999995 566899999999877644322 1123356679999999888889999999999999
Q ss_pred HHHHhCCCCCCC
Q 030430 159 FELLNGYPPFSV 170 (177)
Q Consensus 159 ~~~~~~~~pf~~ 170 (177)
+++++|..||..
T Consensus 239 ~el~tg~~~~~~ 250 (326)
T 2w1i_A 239 YELFTYIEKSKS 250 (326)
T ss_dssp HHHHHTTCGGGS
T ss_pred HHHHhcCCCCCC
Confidence 999999998864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=226.71 Aligned_cols=160 Identities=24% Similarity=0.462 Sum_probs=139.0
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
.+.+.+|++++++++||||+++++++.+ ...++||||+.+++|.+++... ..+++..+..++.|++.+|+|||+.|+
T Consensus 306 ~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i 384 (535)
T 2h8h_A 306 PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 384 (535)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 5679999999999999999999999876 5689999999999999999743 459999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh-C
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~-~ 164 (177)
+|+||+|+||++ +..+.++|+|||++........ .....++..|+|||.+....++.++||||||+++++|++ |
T Consensus 385 vHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g 461 (535)
T 2h8h_A 385 VHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 461 (535)
T ss_dssp CCSCCSGGGEEE---CGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTT
T ss_pred eCCCCCHhhEEE---cCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 999999999999 4667899999999876543221 112335678999999988889999999999999999999 8
Q ss_pred CCCCCCCCc
Q 030430 165 YPPFSVGEE 173 (177)
Q Consensus 165 ~~pf~~~~~ 173 (177)
..||.+...
T Consensus 462 ~~P~~~~~~ 470 (535)
T 2h8h_A 462 RVPYPGMVN 470 (535)
T ss_dssp CCSSTTCCH
T ss_pred CCCCCCCCH
Confidence 999987543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=206.67 Aligned_cols=162 Identities=31% Similarity=0.553 Sum_probs=134.8
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEE--eeCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHh
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh 83 (177)
...+.+.+|++++++++||||+++++++ .+....+++|||+.++ |.+++... ..+++..+..++.|++.+|++||
T Consensus 48 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH 126 (305)
T 2wtk_C 48 NGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH 126 (305)
T ss_dssp THHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH
Confidence 3467899999999999999999999998 4556889999999765 77777653 45999999999999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCC---CccccccCCCccccccccccCC--CCCcchHHHHHHHH
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQFQR--YDEKVDMWSVGAIL 158 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~--~~~~~Di~slg~~~ 158 (177)
+.|++|+||+|+||++ +..+.++++|||.+...... .......++..|+|||...+.. .+.++|+||||+++
T Consensus 127 ~~~i~H~dlkp~NIl~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il 203 (305)
T 2wtk_C 127 SQGIVHKDIKPGNLLL---TTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203 (305)
T ss_dssp HTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHH
T ss_pred HCCeeecCCCcccEEE---cCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHH
Confidence 9999999999999999 46778999999998765432 2223445788999999987543 37789999999999
Q ss_pred HHHHhCCCCCCCCCc
Q 030430 159 FELLNGYPPFSVGEE 173 (177)
Q Consensus 159 ~~~~~~~~pf~~~~~ 173 (177)
+++++|..||.+.+.
T Consensus 204 ~~l~~g~~p~~~~~~ 218 (305)
T 2wtk_C 204 YNITTGLYPFEGDNI 218 (305)
T ss_dssp HHHHHSSCSCCCSSH
T ss_pred HHHHhCCCCCCCchH
Confidence 999999999987543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=212.72 Aligned_cols=157 Identities=34% Similarity=0.723 Sum_probs=115.3
Q ss_pred HHHHHhhCCCCceeeEeEEEee----CCeEEEEEecCCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 16 ELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 16 e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
....++.++|||++++++++.. ...+++||||++|++|.+++.... .+++..++.++.|++.+|+|||+.|++|
T Consensus 72 ~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH 151 (336)
T 3fhr_A 72 VDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAH 151 (336)
T ss_dssp HHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 3345677799999999999876 456899999999999999998654 5999999999999999999999999999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf~ 169 (177)
+||+|+||+++..+..+.++|+|||.+....... .....+++.|+|||.+.+..++.++|+||+|++++++++|..||.
T Consensus 152 ~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 230 (336)
T 3fhr_A 152 RDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFY 230 (336)
T ss_dssp SCCSGGGEEESCSSTTCCEEECCCTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred CCCCHHHEEEEecCCCceEEEeccccceeccccc-cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 9999999999654446679999999987654332 224457899999999987788899999999999999999999997
Q ss_pred CCCc
Q 030430 170 VGEE 173 (177)
Q Consensus 170 ~~~~ 173 (177)
....
T Consensus 231 ~~~~ 234 (336)
T 3fhr_A 231 SNTG 234 (336)
T ss_dssp ----
T ss_pred Cccc
Confidence 6543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=210.59 Aligned_cols=164 Identities=26% Similarity=0.463 Sum_probs=140.1
Q ss_pred hhHHHHHHHHHHHHhhCCCCc------eeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC--CCCHHHHHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPN------IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAG 78 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~ 78 (177)
....+.+.+|++++++++|++ ++.+.+++...+..+++||++ ++++.+++.... .+++..+..++.|++.|
T Consensus 57 ~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~ 135 (355)
T 2eu9_A 57 GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135 (355)
T ss_dssp HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHH
T ss_pred ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHH
Confidence 355678899999999997665 899999999999999999999 667777776553 59999999999999999
Q ss_pred HHHHhhCCCeeecCCCCcEEEecC----------------CCCeeEEEeeeccccccCCCCccccccCCCcccccccccc
Q 030430 79 LEILNSHHIIHRDLKPENILLSGL----------------DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF 142 (177)
Q Consensus 79 l~~lh~~~~~H~~i~~~nil~~~~----------------~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 142 (177)
|+|||+.|++|+||||+||++... +..+.++|+|||.+....... ....+++.|+|||.+.+
T Consensus 136 L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~ 213 (355)
T 2eu9_A 136 LRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH--TTIVATRHYRPPEVILE 213 (355)
T ss_dssp HHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC--CSSCSCGGGCCHHHHTT
T ss_pred HHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccccc--cCCcCCCcccCCeeeec
Confidence 999999999999999999999421 245679999999987643332 33458899999999988
Q ss_pred CCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 030430 143 QRYDEKVDMWSVGAILFELLNGYPPFSVGEE 173 (177)
Q Consensus 143 ~~~~~~~Di~slg~~~~~~~~~~~pf~~~~~ 173 (177)
..++.++|+||||+++++|++|..||.+.+.
T Consensus 214 ~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 214 LGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 8899999999999999999999999987654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=218.12 Aligned_cols=164 Identities=20% Similarity=0.234 Sum_probs=140.2
Q ss_pred HHHHHHHHHHHHhhCCC-CceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 9 LKSCLDCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
....+.+|+++++.+.| ++++.+..+.......+++|||+ +++|.+++.. ...+++..++.++.|++.+|+|||+.|
T Consensus 45 ~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g 123 (483)
T 3sv0_A 45 KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123 (483)
T ss_dssp SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34568899999999976 66677777778888999999999 9999999985 356999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--------cccccCCCccccccccccCCCCCcchHHHHHHHH
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--------~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~ 158 (177)
++|+||||+||+++..+..+.++|+|||++........ .....++..|+|||.+.+..++.++||||||+++
T Consensus 124 IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil 203 (483)
T 3sv0_A 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVL 203 (483)
T ss_dssp EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHH
Confidence 99999999999995333567899999999977654322 1245588999999999988899999999999999
Q ss_pred HHHHhCCCCCCCCCc
Q 030430 159 FELLNGYPPFSVGEE 173 (177)
Q Consensus 159 ~~~~~~~~pf~~~~~ 173 (177)
|+|++|+.||.+...
T Consensus 204 ~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 204 MYFLRGSLPWQGLKA 218 (483)
T ss_dssp HHHHHSSCTTSSCCC
T ss_pred HHHHhCCCCCccccc
Confidence 999999999987543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=209.42 Aligned_cols=161 Identities=28% Similarity=0.495 Sum_probs=136.5
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeC-----CeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (177)
+.....+.+|++++++++||||+++++++... ...++++|++. ++|.+++.. ..+++..+..++.|++.||++
T Consensus 50 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~ 127 (353)
T 2b9h_A 50 PLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKV 127 (353)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHH
Confidence 44567788999999999999999999987654 67899999995 699998875 579999999999999999999
Q ss_pred HhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-----------cccccCCCcccccccccc-CCCCCcc
Q 030430 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----------AEKVCGSPLYMAPEVLQF-QRYDEKV 149 (177)
Q Consensus 82 lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-----------~~~~~~~~~~~~pe~~~~-~~~~~~~ 149 (177)
||+.|++|+||+|+||++ +..+.++|+|||.+........ .....+++.|+|||.+.. ..++.++
T Consensus 128 LH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 204 (353)
T 2b9h_A 128 LHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM 204 (353)
T ss_dssp HHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHH
T ss_pred HHHCCeecCCCCHHHeEE---cCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchh
Confidence 999999999999999999 4677899999999876543211 112357889999998754 6688999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCC
Q 030430 150 DMWSVGAILFELLNGYPPFSVGE 172 (177)
Q Consensus 150 Di~slg~~~~~~~~~~~pf~~~~ 172 (177)
|+||||++++++++|..||.+.+
T Consensus 205 Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 205 DVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999998765
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-34 Score=213.96 Aligned_cols=160 Identities=31% Similarity=0.521 Sum_probs=134.5
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeE------EEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCI------FLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGL 79 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l 79 (177)
++.....+.+|+++++.++||||+++++++...+.. ++++||+. ++|.+++. ..+++..+..++.|++.||
T Consensus 81 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL 157 (371)
T 4exu_A 81 SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGL 157 (371)
T ss_dssp SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHH
Confidence 344567889999999999999999999999876654 99999995 68888764 3599999999999999999
Q ss_pred HHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCcccccccccc-CCCCCcchHHHHHHHH
Q 030430 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAIL 158 (177)
Q Consensus 80 ~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~ 158 (177)
+|||+.|++|+||+|+||++ +..+.++|+|||.+...... .....+++.|+|||.+.+ ..++.++|+||||+++
T Consensus 158 ~~LH~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (371)
T 4exu_A 158 KYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIM 232 (371)
T ss_dssp HHHHHTTCCCSCCCGGGEEE---CTTCCEEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHH
T ss_pred HHHHHCCCcCCCcCHHHeEE---CCCCCEEEEecCcccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHH
Confidence 99999999999999999999 46778999999998765433 223457899999999876 6789999999999999
Q ss_pred HHHHhCCCCCCCCCc
Q 030430 159 FELLNGYPPFSVGEE 173 (177)
Q Consensus 159 ~~~~~~~~pf~~~~~ 173 (177)
+++++|+.||.+.+.
T Consensus 233 ~el~~g~~pf~~~~~ 247 (371)
T 4exu_A 233 AEMLTGKTLFKGKDY 247 (371)
T ss_dssp HHHHHSSCSCCCSSH
T ss_pred HHHHhCCCCCCCCCh
Confidence 999999999987653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=211.66 Aligned_cols=164 Identities=29% Similarity=0.423 Sum_probs=131.3
Q ss_pred ccccchhHHHHHHHHHHHHh--hCCCCceeeEeEEEe-----eCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHH
Q 030430 2 LKKLNKHLKSCLDCELNFLS--SVNHPNIIRLFDAFQ-----AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74 (177)
Q Consensus 2 l~~~~~~~~~~~~~e~~~l~--~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 74 (177)
+|.+.......+..|.+++. .++||||+++++.+. ....+++||||+++++|.+++... ..+...+..++.|
T Consensus 41 vK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~q 119 (336)
T 3g2f_A 41 VKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHS 119 (336)
T ss_dssp EEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHH
T ss_pred EEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHH
Confidence 45555555566666666644 589999999997553 233678999999999999999754 5688999999999
Q ss_pred HHHHHHHHhhC---------CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC---------ccccccCCCcccc
Q 030430 75 LGAGLEILNSH---------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---------YAEKVCGSPLYMA 136 (177)
Q Consensus 75 i~~~l~~lh~~---------~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---------~~~~~~~~~~~~~ 136 (177)
++.||+|||+. |++|+||||+||++ +..+.++|+|||.+....... ......+++.|+|
T Consensus 120 i~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 196 (336)
T 3g2f_A 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMA 196 (336)
T ss_dssp HHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE---CTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCC
T ss_pred HHHHHHHHHhhhccccccccceeecccccceEEE---cCCCcEEEeeccceeecccccccCccccccccccCCCccceeC
Confidence 99999999999 99999999999999 466789999999997654321 1123458899999
Q ss_pred cccccc-------CCCCCcchHHHHHHHHHHHHhCCCCCC
Q 030430 137 PEVLQF-------QRYDEKVDMWSVGAILFELLNGYPPFS 169 (177)
Q Consensus 137 pe~~~~-------~~~~~~~Di~slg~~~~~~~~~~~pf~ 169 (177)
||.+.+ ..++.++|+||+|+++++|++|..||.
T Consensus 197 PE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 197 PEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp HHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred chhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence 999875 345678999999999999999976653
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=226.24 Aligned_cols=164 Identities=27% Similarity=0.530 Sum_probs=138.8
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
.....+.+.+|+.++++++||||+++++++.+ +..++||||+++++|.+++.... .+++..+..++.|++.||+|||+
T Consensus 431 ~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 509 (656)
T 2j0j_A 431 SDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 509 (656)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34556789999999999999999999999854 45899999999999999998654 59999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--cccccCCCccccccccccCCCCCcchHHHHHHHHHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~ 162 (177)
.|++||||+|+||+++ ..+.++|+|||.+........ .....+++.|+|||.+.+..++.++|+||+|+++++++
T Consensus 510 ~givHrDikp~NILl~---~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 586 (656)
T 2j0j_A 510 KRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586 (656)
T ss_dssp TTCCCSCCSGGGEEEE---ETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred CCccccccchHhEEEe---CCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHH
Confidence 9999999999999995 566899999999977644322 12233567899999998888999999999999999999
Q ss_pred h-CCCCCCCCCc
Q 030430 163 N-GYPPFSVGEE 173 (177)
Q Consensus 163 ~-~~~pf~~~~~ 173 (177)
+ |..||.+...
T Consensus 587 t~g~~Pf~~~~~ 598 (656)
T 2j0j_A 587 MHGVKPFQGVKN 598 (656)
T ss_dssp TTSCCTTTTCCH
T ss_pred HcCCCCCCCCCH
Confidence 7 9999987654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=213.40 Aligned_cols=161 Identities=22% Similarity=0.351 Sum_probs=135.4
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
..+.+.+|++++++++||||+++++++.+....++++||++|++|.+++.... .+++..+..++.|++.||++||+.|+
T Consensus 72 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i 151 (319)
T 2y4i_B 72 QLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151 (319)
T ss_dssp CCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 34667889999999999999999999999999999999999999999998654 59999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCC------CccccccCCCcccccccccc---------CCCCCcchHH
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG------NYAEKVCGSPLYMAPEVLQF---------QRYDEKVDMW 152 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~------~~~~~~~~~~~~~~pe~~~~---------~~~~~~~Di~ 152 (177)
+|+||+|+||+++ .+.++|+|||.+...... .......++..|+|||.+.. ..++.++|+|
T Consensus 152 ~H~dlkp~NIl~~----~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~ 227 (319)
T 2y4i_B 152 LHKDLKSKNVFYD----NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVF 227 (319)
T ss_dssp CCCCCCSTTEEEC------CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHH
T ss_pred cccCCChhhEEEe----CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHH
Confidence 9999999999994 457999999987654221 11223347788999998864 3468899999
Q ss_pred HHHHHHHHHHhCCCCCCCCCc
Q 030430 153 SVGAILFELLNGYPPFSVGEE 173 (177)
Q Consensus 153 slg~~~~~~~~~~~pf~~~~~ 173 (177)
|||++++++++|..||.....
T Consensus 228 slG~il~el~~g~~p~~~~~~ 248 (319)
T 2y4i_B 228 ALGTIWYELHAREWPFKTQPA 248 (319)
T ss_dssp HHHHHHHHHHHSSCSSSSCCH
T ss_pred HHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999987543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=206.09 Aligned_cols=160 Identities=30% Similarity=0.511 Sum_probs=118.3
Q ss_pred hHHHHHHHHHH-HHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh-----cCCCCHHHHHHHHHHHHHHHHH
Q 030430 8 HLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-----HGRVPEQTARKFLQQLGAGLEI 81 (177)
Q Consensus 8 ~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~ 81 (177)
.....+..|.. +++.++||||+++++++.+.+..+++|||+.+ +|.+++.. ...+++..+..++.|++.++++
T Consensus 62 ~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~ 140 (327)
T 3aln_A 62 KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140 (327)
T ss_dssp HHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHH
Confidence 34445556665 77788999999999999999999999999965 88887763 4569999999999999999999
Q ss_pred HhhC-CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCcccccccc----ccCCCCCcchHHHHHH
Q 030430 82 LNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL----QFQRYDEKVDMWSVGA 156 (177)
Q Consensus 82 lh~~-~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~----~~~~~~~~~Di~slg~ 156 (177)
||+. |++|+||+|+||+++ ..+.++|+|||.+.............+++.|+|||.+ .+..++.++|+||||+
T Consensus 141 lH~~~~ivH~dlkp~NIll~---~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~ 217 (327)
T 3aln_A 141 LKENLKIIHRDIKPSNILLD---RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGI 217 (327)
T ss_dssp HHHHHSCCCSCCCGGGEEEE---TTTEEEECCCSSSCC------------------------------CCSHHHHHHHHH
T ss_pred HhccCCEeECCCCHHHEEEc---CCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHH
Confidence 9998 999999999999995 5678999999999776554444444688999999998 4556889999999999
Q ss_pred HHHHHHhCCCCCCCC
Q 030430 157 ILFELLNGYPPFSVG 171 (177)
Q Consensus 157 ~~~~~~~~~~pf~~~ 171 (177)
+++++++|..||.+.
T Consensus 218 il~~l~~g~~pf~~~ 232 (327)
T 3aln_A 218 TLYELATGRFPYPKW 232 (327)
T ss_dssp HHHHHHHSCCCSSCC
T ss_pred HHHHHHHCCCCCCCc
Confidence 999999999999764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-34 Score=213.49 Aligned_cols=159 Identities=15% Similarity=0.158 Sum_probs=119.7
Q ss_pred hHHHHHHHHHHHHhhC--CCCceeeEe-------EEEeeC-----------------CeEEEEEecCCCCChHHHHhhc-
Q 030430 8 HLKSCLDCELNFLSSV--NHPNIIRLF-------DAFQAE-----------------NCIFLVVEFCAGGNLSSYIRLH- 60 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l--~h~~i~~~~-------~~~~~~-----------------~~~~lv~e~~~~~~L~~~l~~~- 60 (177)
...+.+.+|+++++.+ +|||+++++ +++... ..+++||||++ ++|.+++...
T Consensus 104 ~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~ 182 (371)
T 3q60_A 104 SELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD 182 (371)
T ss_dssp HHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc
Confidence 4566778885544444 699987755 444433 34899999997 8999999864
Q ss_pred CCCCHHHH------HHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCcc
Q 030430 61 GRVPEQTA------RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134 (177)
Q Consensus 61 ~~~~~~~~------~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 134 (177)
..+..... ..++.|++.||+|||+.|++||||||+||++ +..+.++|+|||.+........ ...+++.|
T Consensus 183 ~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DFG~a~~~~~~~~--~~~~t~~y 257 (371)
T 3q60_A 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI---MPDGRLMLGDVSALWKVGTRGP--ASSVPVTY 257 (371)
T ss_dssp HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEE---CTTSCEEECCGGGEEETTCEEE--GGGSCGGG
T ss_pred cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEE---CCCCCEEEEecceeeecCCCcc--CccCCcCC
Confidence 23455555 6777999999999999999999999999999 4667899999999976643221 34466899
Q ss_pred cccccccc--CCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 030430 135 MAPEVLQF--QRYDEKVDMWSVGAILFELLNGYPPFSVGE 172 (177)
Q Consensus 135 ~~pe~~~~--~~~~~~~Di~slg~~~~~~~~~~~pf~~~~ 172 (177)
+|||.+.+ ..++.++|+||+|+++++|++|+.||.+..
T Consensus 258 ~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 297 (371)
T 3q60_A 258 APREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297 (371)
T ss_dssp CCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred cChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence 99999976 678999999999999999999999998763
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-33 Score=210.24 Aligned_cols=164 Identities=39% Similarity=0.526 Sum_probs=140.1
Q ss_pred hhHHHHHHHHHHHHhhCC-CC-----ceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVN-HP-----NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAG 78 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~ 78 (177)
....+.+.+|+++++.++ |+ +++++.+++...+..++|||++. ++|.+++... ..+++..+..++.|++.|
T Consensus 91 ~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~a 169 (382)
T 2vx3_A 91 KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169 (382)
T ss_dssp HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHH
Confidence 345677888999999885 55 49999999999999999999995 5999999865 359999999999999999
Q ss_pred HHHHh--hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHH
Q 030430 79 LEILN--SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA 156 (177)
Q Consensus 79 l~~lh--~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~ 156 (177)
|+||| +.|++|+||||+||++.. +..+.++|+|||.+...... .....+++.|+|||.+.+..++.++|+||+|+
T Consensus 170 l~~lH~~~~~ivHrDlkp~NIll~~-~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~ 246 (382)
T 2vx3_A 170 LLFLATPELSIIHCDLKPENILLCN-PKRSAIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGC 246 (382)
T ss_dssp HHHHTSTTTCEECCCCSGGGEEESS-TTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHH
T ss_pred HHHhccCCCCEEcCCCCcccEEEec-CCCCcEEEEeccCceecccc--cccccCCccccChHHHcCCCCCcHHHHHHHHH
Confidence 99999 579999999999999952 23567999999999776433 22445789999999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCCcc
Q 030430 157 ILFELLNGYPPFSVGEEH 174 (177)
Q Consensus 157 ~~~~~~~~~~pf~~~~~~ 174 (177)
++++|++|+.||.+.+..
T Consensus 247 il~elltg~~pf~~~~~~ 264 (382)
T 2vx3_A 247 ILVEMHTGEPLFSGANEV 264 (382)
T ss_dssp HHHHHHHSSCSSCCSSHH
T ss_pred HHHHHHhCCCCCCCCCHH
Confidence 999999999999886543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=208.86 Aligned_cols=159 Identities=29% Similarity=0.528 Sum_probs=139.3
Q ss_pred HHHHHHHHHHHhhCC--CCceeeEeEEEeeCCeEEEEEecCCC-CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 10 KSCLDCELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
.+.+.+|++++++++ |+|++++++++...+..++++|++.+ ++|.+++.....+++..+..++.|++.+|+|||+.|
T Consensus 90 ~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ 169 (320)
T 3a99_A 90 GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 169 (320)
T ss_dssp CCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 356778999999996 59999999999999999999999976 899999998888999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCC-CCcchHHHHHHHHHHHHhCC
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slg~~~~~~~~~~ 165 (177)
++|+||+|+||+++ ...+.++|+|||.+........ ....+++.|+|||.+.+..+ +.++|+||||++++++++|+
T Consensus 170 ivH~Dlkp~NIll~--~~~~~~kL~Dfg~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~ 246 (320)
T 3a99_A 170 VLHRDIKDENILID--LNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246 (320)
T ss_dssp EECCCCSGGGEEEE--TTTTEEEECCCTTCEECCSSCB-CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSS
T ss_pred cEeCCCCHHHEEEe--CCCCCEEEeeCccccccccccc-cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCC
Confidence 99999999999995 3567899999999877654332 23458899999999876655 67899999999999999999
Q ss_pred CCCCCC
Q 030430 166 PPFSVG 171 (177)
Q Consensus 166 ~pf~~~ 171 (177)
.||...
T Consensus 247 ~pf~~~ 252 (320)
T 3a99_A 247 IPFEHD 252 (320)
T ss_dssp CSCCSH
T ss_pred CCCCCh
Confidence 999753
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-33 Score=204.38 Aligned_cols=161 Identities=27% Similarity=0.544 Sum_probs=135.6
Q ss_pred chhHHHHHHHHHHHHhhCC--CCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh
Q 030430 6 NKHLKSCLDCELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (177)
+....+.+.+|++++++++ ||||+++++++.+.+..+++||+ .+++|.+++.....+++..+..++.|++.||+|||
T Consensus 66 ~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH 144 (313)
T 3cek_A 66 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 144 (313)
T ss_dssp CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEec-CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4556788999999999997 59999999999999999999995 58899999998888999999999999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCcccccccccc-----------CCCCCcc
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQF-----------QRYDEKV 149 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~-----------~~~~~~~ 149 (177)
+.|++|+||+|+||++. .+.++|+|||.+........ .....+++.|+|||.+.+ ..++.++
T Consensus 145 ~~~ivH~dlkp~NIl~~----~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 220 (313)
T 3cek_A 145 QHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 220 (313)
T ss_dssp HTTCCCCCCCGGGEEEE----TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHH
T ss_pred HCCceecCCCcccEEEE----CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchH
Confidence 99999999999999994 36799999999876543321 223457899999999864 3578899
Q ss_pred hHHHHHHHHHHHHhCCCCCCCC
Q 030430 150 DMWSVGAILFELLNGYPPFSVG 171 (177)
Q Consensus 150 Di~slg~~~~~~~~~~~pf~~~ 171 (177)
|+||||++++++++|..||...
T Consensus 221 Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 221 DVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTC
T ss_pred HHHHHHHHHHHHHhCCCchhhH
Confidence 9999999999999999999764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=210.71 Aligned_cols=159 Identities=31% Similarity=0.529 Sum_probs=133.9
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCe------EEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGL 79 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l 79 (177)
++...+.+.+|++++++++||||+++++++...+. ++++||++. ++|.+++. ..+++..+..++.|++.||
T Consensus 63 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al 139 (353)
T 3coi_A 63 SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGL 139 (353)
T ss_dssp SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHH
Confidence 34456788999999999999999999999987653 599999995 68888765 3599999999999999999
Q ss_pred HHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCcccccccccc-CCCCCcchHHHHHHHH
Q 030430 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAIL 158 (177)
Q Consensus 80 ~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~ 158 (177)
+|||+.|++|+||+|+||++ +..+.++|+|||.+...... .....+++.|+|||.+.+ ..++.++|+||+|+++
T Consensus 140 ~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il 214 (353)
T 3coi_A 140 KYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIM 214 (353)
T ss_dssp HHHHHTTCCCSSCCGGGEEE---CTTCCEEECSTTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHH
T ss_pred HHHHHCCcccCCCCHHHEeE---CCCCcEEEeecccccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHH
Confidence 99999999999999999999 46778999999998765332 223457899999998876 5688999999999999
Q ss_pred HHHHhCCCCCCCCC
Q 030430 159 FELLNGYPPFSVGE 172 (177)
Q Consensus 159 ~~~~~~~~pf~~~~ 172 (177)
+++++|..||.+.+
T Consensus 215 ~el~~g~~pf~~~~ 228 (353)
T 3coi_A 215 AEMLTGKTLFKGKD 228 (353)
T ss_dssp HHHHHSSCSSBSSC
T ss_pred HHHHhCCCCCCCCC
Confidence 99999999998765
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-33 Score=208.69 Aligned_cols=163 Identities=30% Similarity=0.494 Sum_probs=137.2
Q ss_pred hhHHHHHHHHHHHHhhCC-----------CCceeeEeEEEeeCC----eEEEEEecCCCCChHHHHhhc--CCCCHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVN-----------HPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLH--GRVPEQTAR 69 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~ 69 (177)
....+.+.+|++++++++ ||||+++++++...+ .+++++|++ +++|.+++... ..+++..+.
T Consensus 56 ~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~ 134 (373)
T 1q8y_A 56 KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVK 134 (373)
T ss_dssp HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHH
T ss_pred ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHH
Confidence 345677899999999886 789999999987644 789999999 89999999864 349999999
Q ss_pred HHHHHHHHHHHHHhhC-CCeeecCCCCcEEEecC---CCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCC
Q 030430 70 KFLQQLGAGLEILNSH-HIIHRDLKPENILLSGL---DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145 (177)
Q Consensus 70 ~~~~~i~~~l~~lh~~-~~~H~~i~~~nil~~~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~ 145 (177)
.++.|++.||+|||+. |++|+||||+||++... +....++|+|||.+....... ....+++.|+|||.+.+..+
T Consensus 135 ~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~ 212 (373)
T 1q8y_A 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY--TNSIQTREYRSPEVLLGAPW 212 (373)
T ss_dssp HHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC--CSCCSCGGGCCHHHHHTCCC
T ss_pred HHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCCC--CCCCCCccccCcHHHhCCCC
Confidence 9999999999999998 99999999999999532 234579999999987664332 23457899999999988889
Q ss_pred CCcchHHHHHHHHHHHHhCCCCCCCCC
Q 030430 146 DEKVDMWSVGAILFELLNGYPPFSVGE 172 (177)
Q Consensus 146 ~~~~Di~slg~~~~~~~~~~~pf~~~~ 172 (177)
+.++|+||||++++++++|+.||.+.+
T Consensus 213 ~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 213 GCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred CchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 999999999999999999999998654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-32 Score=199.93 Aligned_cols=155 Identities=32% Similarity=0.601 Sum_probs=128.3
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEee-------------CCeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-------------ENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKF 71 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~ 71 (177)
+....+.+.+|++++++++||||+++++++.+ .+..++++||+++++|.+++.... .+++..++.+
T Consensus 42 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i 121 (303)
T 1zy4_A 42 TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121 (303)
T ss_dssp EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHH
T ss_pred cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHH
Confidence 34556789999999999999999999998754 457899999999999999998543 4888999999
Q ss_pred HHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCC---------------CccccccCCCcccc
Q 030430 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---------------NYAEKVCGSPLYMA 136 (177)
Q Consensus 72 ~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~---------------~~~~~~~~~~~~~~ 136 (177)
+.|++.||++||+.|++|+||+|+||++ +..+.++|+|||.+...... .......+++.|+|
T Consensus 122 ~~qi~~~l~~LH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~a 198 (303)
T 1zy4_A 122 FRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVA 198 (303)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCCCSCTTC-------------------------CTTSC
T ss_pred HHHHHHHHHHHHhCCeecccCCHHhEEE---cCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccC
Confidence 9999999999999999999999999999 46678999999998765321 11223457889999
Q ss_pred ccccccC-CCCCcchHHHHHHHHHHHHh
Q 030430 137 PEVLQFQ-RYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 137 pe~~~~~-~~~~~~Di~slg~~~~~~~~ 163 (177)
||.+.+. .++.++|+||+|++++++++
T Consensus 199 PE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 199 TEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp HHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred cccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 9998754 58899999999999999998
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=224.34 Aligned_cols=156 Identities=26% Similarity=0.437 Sum_probs=133.4
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCe-----EEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE 80 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~ 80 (177)
+......+.+|++++++++||||+++++++...+. .|+||||++|++|.+++.. .+++..+..++.|++.+|+
T Consensus 119 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~ 196 (681)
T 2pzi_A 119 DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALS 196 (681)
T ss_dssp CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHH
Confidence 34566788999999999999999999999987654 7999999999999987664 7999999999999999999
Q ss_pred HHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHH
Q 030430 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (177)
Q Consensus 81 ~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~ 160 (177)
|||+.|++|+||||+||+++ . ..++|+|||.+...... ....+++.|+|||.+.+. ++.++||||+|+++++
T Consensus 197 ~lH~~giiHrDlkp~NIll~---~-~~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~ 268 (681)
T 2pzi_A 197 YLHSIGLVYNDLKPENIMLT---E-EQLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAA 268 (681)
T ss_dssp HHHHTTEECCCCSGGGEEEC---S-SCEEECCCTTCEETTCC---SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHH
T ss_pred HHHHCCCeecccChHHeEEe---C-CcEEEEecccchhcccC---CccCCCccccCHHHHcCC-CCCceehhhhHHHHHH
Confidence 99999999999999999995 3 37999999998776443 344589999999998654 4889999999999999
Q ss_pred HHhCCCCCCCC
Q 030430 161 LLNGYPPFSVG 171 (177)
Q Consensus 161 ~~~~~~pf~~~ 171 (177)
|++|..||.+.
T Consensus 269 l~~g~~~~~~~ 279 (681)
T 2pzi_A 269 LTLDLPTRNGR 279 (681)
T ss_dssp HHSCCCEETTE
T ss_pred HHhCCCCCccc
Confidence 99999998764
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=226.26 Aligned_cols=151 Identities=20% Similarity=0.204 Sum_probs=115.9
Q ss_pred hhHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
+...+++.+|+++|+++ .|+||+++++++++++.+||||||++|++|.+.+...+.+++. +|+.||+.||+|+|++
T Consensus 282 ~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~ 358 (569)
T 4azs_A 282 QRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQ 358 (569)
T ss_dssp HHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHC
Confidence 45567899999999999 7999999999999999999999999999999999988888765 4789999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCC-CccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhC
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~ 164 (177)
||+||||||+|||+ +.++.+||+|||+++..... ....+..||+.|++||++.+ .+...+|+||+|++.+.+.++
T Consensus 359 GIIHRDIKPeNILL---~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~ 434 (569)
T 4azs_A 359 GFWHDDVRPWNVMV---DARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQP 434 (569)
T ss_dssp TCEESCCCGGGEEE---CTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTT
T ss_pred CceeccCchHhEEE---CCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccc
Confidence 99999999999999 56778999999999776543 23445678999999999874 456789999999887655443
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-32 Score=201.26 Aligned_cols=159 Identities=32% Similarity=0.515 Sum_probs=125.4
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhC-C
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSH-H 86 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~-~ 86 (177)
..+.+..+..+++.++||||+++++++.+++..+++|||+ ++.+..+... ...+++..+..++.|++.+|+|||+. |
T Consensus 67 ~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 145 (318)
T 2dyl_A 67 NKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG 145 (318)
T ss_dssp HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC
Confidence 3445556666788889999999999999999999999999 6666666554 45699999999999999999999995 9
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccc-----cCCCCCcchHHHHHHHHHHH
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~slg~~~~~~ 161 (177)
++|+||+|+||++ +..+.++|+|||.+.............+++.|+|||.+. ...++.++|+||+|++++++
T Consensus 146 i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l 222 (318)
T 2dyl_A 146 VIHRDVKPSNILL---DERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222 (318)
T ss_dssp CCCCCCCGGGEEE---CTTSCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHH
T ss_pred EEeCCCCHHHEEE---CCCCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHH
Confidence 9999999999999 466789999999987665544444556889999999984 45678899999999999999
Q ss_pred HhCCCCCCCC
Q 030430 162 LNGYPPFSVG 171 (177)
Q Consensus 162 ~~~~~pf~~~ 171 (177)
++|+.||...
T Consensus 223 ~~g~~pf~~~ 232 (318)
T 2dyl_A 223 ATGQFPYKNC 232 (318)
T ss_dssp HHSSCTTTTC
T ss_pred HhCCCCCCCC
Confidence 9999999763
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=206.90 Aligned_cols=160 Identities=31% Similarity=0.512 Sum_probs=134.2
Q ss_pred HHHHHHHHHHHHhhC----CCCceeeEeEEEeeCCeEEEEEec-CCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh
Q 030430 9 LKSCLDCELNFLSSV----NHPNIIRLFDAFQAENCIFLVVEF-CAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l----~h~~i~~~~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (177)
....+.+|+++++++ +||||+++++++.+.+..++++|+ +.+++|.+++.....+++..+..++.|++.+|++||
T Consensus 77 ~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH 156 (312)
T 2iwi_A 77 DSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH 156 (312)
T ss_dssp --CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345667899999999 899999999999999999999999 789999999998888999999999999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCC-CCcchHHHHHHHHHHHH
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELL 162 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slg~~~~~~~ 162 (177)
+.|++|+||+|+||+++ ...+.++|+|||.+........ ....++..|+|||.+.+..+ +.++|+||||+++++++
T Consensus 157 ~~~i~H~dlkp~Nil~~--~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 233 (312)
T 2iwi_A 157 SRGVVHRDIKDENILID--LRRGCAKLIDFGSGALLHDEPY-TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMV 233 (312)
T ss_dssp HHTEECCCCSGGGEEEE--TTTTEEEECCCSSCEECCSSCB-CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHH
T ss_pred HCCeeecCCChhhEEEe--CCCCeEEEEEcchhhhcccCcc-cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHH
Confidence 99999999999999995 2567899999999877654332 34457889999998876655 45899999999999999
Q ss_pred hCCCCCCCC
Q 030430 163 NGYPPFSVG 171 (177)
Q Consensus 163 ~~~~pf~~~ 171 (177)
+|+.||...
T Consensus 234 ~g~~pf~~~ 242 (312)
T 2iwi_A 234 CGDIPFERD 242 (312)
T ss_dssp HSSCSCCSH
T ss_pred HCCCCCCCh
Confidence 999999753
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-31 Score=192.44 Aligned_cols=141 Identities=34% Similarity=0.687 Sum_probs=121.0
Q ss_pred HHHHHHHHHH-hhCCCCceeeEeEEEee----CCeEEEEEecCCCCChHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh
Q 030430 11 SCLDCELNFL-SSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 11 ~~~~~e~~~l-~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh 83 (177)
..+.+|++++ +..+||||+++++++.. ...+++||||++|++|.+++.... .+++..+..++.|++.||+|||
T Consensus 55 ~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH 134 (299)
T 3m2w_A 55 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134 (299)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 5677899888 66699999999999876 678999999999999999998764 5999999999999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~ 163 (177)
+.|++|+||+|+||+++..+..+.++|+|||.+.... +..++.++|+||+|++++++++
T Consensus 135 ~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~---------------------~~~~~~~~DiwslG~il~el~t 193 (299)
T 3m2w_A 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---------------------GEKYDKSCDMWSLGVIMYILLC 193 (299)
T ss_dssp HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---------------------TCGGGGHHHHHHHHHHHHHHHH
T ss_pred hCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc---------------------cccCCchhhHHHHHHHHHHHHH
Confidence 9999999999999999643336789999999875432 1345778999999999999999
Q ss_pred CCCCCCCCC
Q 030430 164 GYPPFSVGE 172 (177)
Q Consensus 164 ~~~pf~~~~ 172 (177)
|..||.+..
T Consensus 194 g~~pf~~~~ 202 (299)
T 3m2w_A 194 GYPPFYSNH 202 (299)
T ss_dssp SSCSCCC--
T ss_pred CCCCCCCCc
Confidence 999997654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.6e-31 Score=191.22 Aligned_cols=137 Identities=19% Similarity=0.204 Sum_probs=118.5
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
+...+.+.+|++.+.+++||||+++++++.+++..|+||||++|++|.++++.. .....+..++.|++.+|+|||+.|
T Consensus 72 ~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~g 149 (286)
T 3uqc_A 72 DDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG 149 (286)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCC
Confidence 445578999999999999999999999999999999999999999999998643 456678899999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
++|+||||+||+++ ..+.+++++++ |++ .++.++|+||||+++|+|++|+.
T Consensus 150 ivH~Dikp~NIll~---~~g~~kl~~~~-------------------~~~-------~~~~~~Di~slG~il~elltg~~ 200 (286)
T 3uqc_A 150 VALSIDHPSRVRVS---IDGDVVLAYPA-------------------TMP-------DANPQDDIRGIGASLYALLVNRW 200 (286)
T ss_dssp CCCCCCSGGGEEEE---TTSCEEECSCC-------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEE
T ss_pred CccCCCCcccEEEc---CCCCEEEEecc-------------------ccC-------CCCchhHHHHHHHHHHHHHHCCC
Confidence 99999999999995 55667776332 222 36889999999999999999999
Q ss_pred CCCCCCcc
Q 030430 167 PFSVGEEH 174 (177)
Q Consensus 167 pf~~~~~~ 174 (177)
||.+.+..
T Consensus 201 Pf~~~~~~ 208 (286)
T 3uqc_A 201 PLPEAGVR 208 (286)
T ss_dssp CSCCCSBC
T ss_pred CCCcCCcc
Confidence 99886553
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.5e-33 Score=205.81 Aligned_cols=155 Identities=24% Similarity=0.261 Sum_probs=126.1
Q ss_pred HHHHHHHHHHHhhCC---------CCceeeEeEEE-----------------e-------------eCCeEEEEEecCCC
Q 030430 10 KSCLDCELNFLSSVN---------HPNIIRLFDAF-----------------Q-------------AENCIFLVVEFCAG 50 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~---------h~~i~~~~~~~-----------------~-------------~~~~~~lv~e~~~~ 50 (177)
.+.+.+|++++++++ |||++++.+++ . +.+.+++||||+++
T Consensus 67 ~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~ 146 (336)
T 2vuw_A 67 FEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146 (336)
T ss_dssp HHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECC
T ss_pred HHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCC
Confidence 377889999999886 77777776653 2 26789999999999
Q ss_pred CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh-hCCCeeecCCCCcEEEecCC-----------------CCeeEEEee
Q 030430 51 GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN-SHHIIHRDLKPENILLSGLD-----------------DDVMLKIAD 112 (177)
Q Consensus 51 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~~~H~~i~~~nil~~~~~-----------------~~~~~~l~d 112 (177)
|++.+.+.+ ..+++..++.++.|++.||+||| +.|++||||||+||++...+ ....++|+|
T Consensus 147 g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~D 225 (336)
T 2vuw_A 147 GIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIID 225 (336)
T ss_dssp CEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECC
T ss_pred CccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEee
Confidence 976666643 56899999999999999999999 99999999999999997422 123899999
Q ss_pred eccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHH-HHHHHhCCCCCCC
Q 030430 113 FGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAI-LFELLNGYPPFSV 170 (177)
Q Consensus 113 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~-~~~~~~~~~pf~~ 170 (177)
||++...... ...+++.|+|||.+.+.. +.++||||++.+ .+++++|..||..
T Consensus 226 FG~a~~~~~~----~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 226 YTLSRLERDG----IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp CTTCBEEETT----EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred ccccEecCCC----cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 9999766433 345889999999998665 889999998766 6778889999853
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=192.69 Aligned_cols=158 Identities=16% Similarity=0.151 Sum_probs=120.8
Q ss_pred HHHHHHHHHHHhhCCC-Cce---------------------eeEeEEEee-----CCeEEEEEecCCCCChHHHHhh---
Q 030430 10 KSCLDCELNFLSSVNH-PNI---------------------IRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRL--- 59 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h-~~i---------------------~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~--- 59 (177)
.+.+.+|+.+++.++| ++. ..+..+... ...++++++.. +++|.++++.
T Consensus 122 ~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~ 200 (413)
T 3dzo_A 122 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLS 200 (413)
T ss_dssp CHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhc
Confidence 5678999999999987 211 111111111 12467777766 7899998852
Q ss_pred ----cCCCCHHHHHHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccc
Q 030430 60 ----HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135 (177)
Q Consensus 60 ----~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 135 (177)
...+++..+..++.|++.||+|||+.|++||||||+||++ +..+.++|+|||.+...... .....+ +.|+
T Consensus 201 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl---~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~ 274 (413)
T 3dzo_A 201 HSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFA 274 (413)
T ss_dssp HTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCGGGCEETTEE--ECCCCC-TTTC
T ss_pred ccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEE---ecCCeEEEEeccceeecCCc--cccCCC-Ccee
Confidence 1237788899999999999999999999999999999999 46677999999998765433 233456 8999
Q ss_pred ccccc----------ccCCCCCcchHHHHHHHHHHHHhCCCCCCCCCcc
Q 030430 136 APEVL----------QFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 174 (177)
Q Consensus 136 ~pe~~----------~~~~~~~~~Di~slg~~~~~~~~~~~pf~~~~~~ 174 (177)
|||.+ ....++.++|+||||+++|+|++|+.||.+.+..
T Consensus 275 aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~ 323 (413)
T 3dzo_A 275 PPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAAL 323 (413)
T ss_dssp CHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGG
T ss_pred CchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchh
Confidence 99998 4555788999999999999999999999876544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-26 Score=182.33 Aligned_cols=147 Identities=18% Similarity=0.193 Sum_probs=123.4
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
++++.+|++++++++||||+++..+..+....++||||++|++|.+++.. +..++.|++.+|+|||++|++|
T Consensus 383 ~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiH 454 (540)
T 3en9_A 383 KSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIH 454 (540)
T ss_dssp HHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCcc
Confidence 56789999999999999999666665667777999999999999999875 5689999999999999999999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--------cccccCCCcccccccccc--CCCCCcchHHHHHHHHH
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQF--QRYDEKVDMWSVGAILF 159 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--------~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slg~~~~ 159 (177)
+||||+||+++ . .++|+|||+++....... .....+++.|+|||.+.. ..++...|.|+..+-..
T Consensus 455 rDiKp~NILl~---~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l 529 (540)
T 3en9_A 455 NDLTTSNFIFD---K--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELM 529 (540)
T ss_dssp TTCCTTSEEES---S--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHH
T ss_pred CCCCHHHEEEC---C--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHH
Confidence 99999999994 3 899999999987754322 124568999999999875 45777889999888877
Q ss_pred HHHhCCCCCC
Q 030430 160 ELLNGYPPFS 169 (177)
Q Consensus 160 ~~~~~~~pf~ 169 (177)
+-..++.+|.
T Consensus 530 ~~v~~r~rY~ 539 (540)
T 3en9_A 530 KDVERRARYV 539 (540)
T ss_dssp HHHHTCSCCC
T ss_pred HHHHhccccC
Confidence 7777777664
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1e-19 Score=132.16 Aligned_cols=95 Identities=18% Similarity=0.230 Sum_probs=78.7
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
.+..+.+|++++++++ | +++.+++.. +..++||||++|++|.+ +. ......++.|++.++++||+.|++
T Consensus 147 ~~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~gii 215 (282)
T 1zar_A 147 AIRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIV 215 (282)
T ss_dssp HHHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCE
Confidence 4667999999999999 4 556665544 44699999999999988 43 123457999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccc
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~ 118 (177)
|+||||+||+++ .+.++|+|||.+..
T Consensus 216 HrDlkp~NILl~----~~~vkl~DFG~a~~ 241 (282)
T 1zar_A 216 HGDLSQYNVLVS----EEGIWIIDFPQSVE 241 (282)
T ss_dssp CSCCSTTSEEEE----TTEEEECCCTTCEE
T ss_pred eCCCCHHHEEEE----CCcEEEEECCCCeE
Confidence 999999999994 66899999998854
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=3.7e-16 Score=112.05 Aligned_cols=97 Identities=20% Similarity=0.254 Sum_probs=76.4
Q ss_pred HHHHHHHHHHhhCCCCce--eeEeEEEeeCCeEEEEEecCCC-C----ChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh
Q 030430 11 SCLDCELNFLSSVNHPNI--IRLFDAFQAENCIFLVVEFCAG-G----NLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 11 ~~~~~e~~~l~~l~h~~i--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (177)
..+.+|+++++.+.|+++ +.++++ ...++||||+.+ | +|.+.... .++..+..++.|++.++++||
T Consensus 115 ~~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH 187 (258)
T 1zth_A 115 IWTEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLY 187 (258)
T ss_dssp HHHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHH
Confidence 478999999999988764 444432 245899999942 3 67765432 235567889999999999999
Q ss_pred -hCCCeeecCCCCcEEEecCCCCeeEEEeeecccccc
Q 030430 84 -SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119 (177)
Q Consensus 84 -~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~ 119 (177)
+.|++|+||+|.||+++ . .++|+|||.+...
T Consensus 188 ~~~givHrDlkp~NILl~---~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 188 QEAELVHADLSEYNIMYI---D--KVYFIDMGQAVTL 219 (258)
T ss_dssp HTSCEECSSCSTTSEEES---S--SEEECCCTTCEET
T ss_pred HHCCEEeCCCCHHHEEEc---C--cEEEEECcccccC
Confidence 99999999999999994 3 7999999998665
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.38 E-value=3.5e-13 Score=101.24 Aligned_cols=100 Identities=17% Similarity=0.133 Sum_probs=71.6
Q ss_pred HHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCeeecC
Q 030430 13 LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDL 92 (177)
Q Consensus 13 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H~~i 92 (177)
..+|.+.|.++.+.++.....+.... .++||||++|.+|.++.. .+....++.|++.+++++|+.|++||||
T Consensus 160 A~kE~~nL~rL~~~gv~vp~p~~~~~--~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDL 231 (397)
T 4gyi_A 160 AIKEFAFMKALYEEGFPVPEPIAQSR--HTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDF 231 (397)
T ss_dssp HHHHHHHHHHHHHTTCSCCCEEEEET--TEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHHHHHHHHHHHhcCCCCCeeeeccC--ceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCC
Confidence 45688888888665554332222222 379999999988876532 1234568899999999999999999999
Q ss_pred CCCcEEEecCCC-------CeeEEEeeeccccccC
Q 030430 93 KPENILLSGLDD-------DVMLKIADFGLSCTLY 120 (177)
Q Consensus 93 ~~~nil~~~~~~-------~~~~~l~d~~~~~~~~ 120 (177)
||.|||++..++ ...++++||+.+....
T Consensus 232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp STTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CHHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 999999963211 1248899999775543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=6.9e-12 Score=89.71 Aligned_cols=100 Identities=17% Similarity=0.198 Sum_probs=80.4
Q ss_pred HHHHHHHHHHHHhhCC-CCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---
Q 030430 9 LKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS--- 84 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~--- 84 (177)
....+.+|+++++.+. +..+++++++..+.+..|++||+++|.+|.+.+. +......++.++..+++.||+
T Consensus 52 ~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~ 126 (263)
T 3tm0_A 52 TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDI 126 (263)
T ss_dssp STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCC
T ss_pred CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCc
Confidence 3457999999999994 6778899999999999999999999999987532 122334677889999999998
Q ss_pred --------------------------------------------------------CCCeeecCCCCcEEEecCCCCeeE
Q 030430 85 --------------------------------------------------------HHIIHRDLKPENILLSGLDDDVML 108 (177)
Q Consensus 85 --------------------------------------------------------~~~~H~~i~~~nil~~~~~~~~~~ 108 (177)
.+++|+|+++.||++. ....+
T Consensus 127 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~ 203 (263)
T 3tm0_A 127 SDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVS 203 (263)
T ss_dssp TTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEE
T ss_pred ccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEE
Confidence 4489999999999995 34456
Q ss_pred EEeeeccc
Q 030430 109 KIADFGLS 116 (177)
Q Consensus 109 ~l~d~~~~ 116 (177)
.++||+.+
T Consensus 204 ~lIDwe~a 211 (263)
T 3tm0_A 204 GFIDLGRS 211 (263)
T ss_dssp EECCCTTC
T ss_pred EEEEchhc
Confidence 69999866
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.09 E-value=1.7e-10 Score=82.04 Aligned_cols=98 Identities=15% Similarity=0.159 Sum_probs=73.4
Q ss_pred HHHHHHHHHHHhhCCCCc--eeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC-
Q 030430 10 KSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH- 86 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~- 86 (177)
...+.+|+++++.+.+.+ +++++++..+++..+++||+++|.++. .. ..+. ..++.+++..++.||+..
T Consensus 57 ~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~---~~~~---~~~~~~l~~~l~~lh~~~~ 128 (264)
T 1nd4_A 57 LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS---HLAP---AEKVSIMADAMRRLHTLDP 128 (264)
T ss_dssp TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS---CCCH---HHHHHHHHHHHHHHTTSCG
T ss_pred chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC---cCCH---hHHHHHHHHHHHHHhCCCC
Confidence 356889999999995444 567888888888899999999998884 21 1222 245667777777777643
Q ss_pred ---------------------------------------------------------CeeecCCCCcEEEecCCCCeeEE
Q 030430 87 ---------------------------------------------------------IIHRDLKPENILLSGLDDDVMLK 109 (177)
Q Consensus 87 ---------------------------------------------------------~~H~~i~~~nil~~~~~~~~~~~ 109 (177)
++|+|++|.||++. .+..+.
T Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~ 205 (264)
T 1nd4_A 129 ATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE---NGRFSG 205 (264)
T ss_dssp GGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE---TTEEEE
T ss_pred CCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE---CCcEEE
Confidence 99999999999995 344566
Q ss_pred Eeeeccccc
Q 030430 110 IADFGLSCT 118 (177)
Q Consensus 110 l~d~~~~~~ 118 (177)
++||+.+..
T Consensus 206 liD~~~a~~ 214 (264)
T 1nd4_A 206 FIDCGRLGV 214 (264)
T ss_dssp ECCCTTCEE
T ss_pred EEcchhccc
Confidence 999997643
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.00 E-value=8.8e-10 Score=82.26 Aligned_cols=105 Identities=14% Similarity=0.327 Sum_probs=81.6
Q ss_pred HHHHHHHHHHHhhCC--CCceeeEeEEEeeC---CeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 10 KSCLDCELNFLSSVN--HPNIIRLFDAFQAE---NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
...+.+|+++++.+. +..+++++.++.+. +..++|||+++|.++.+. ....++......++.+++..|+.||+
T Consensus 80 ~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~ 157 (359)
T 3dxp_A 80 AHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHT 157 (359)
T ss_dssp --CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhC
Confidence 457889999999996 44578888888766 457899999999888542 12357788888999999999999997
Q ss_pred ----------------------------------------------------------CCCeeecCCCCcEEEecCCCC-
Q 030430 85 ----------------------------------------------------------HHIIHRDLKPENILLSGLDDD- 105 (177)
Q Consensus 85 ----------------------------------------------------------~~~~H~~i~~~nil~~~~~~~- 105 (177)
.+++|+|+++.||++.. +.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~--~~~ 235 (359)
T 3dxp_A 158 VDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHP--TEP 235 (359)
T ss_dssp SCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECS--SSS
T ss_pred CCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeC--CCC
Confidence 35899999999999952 22
Q ss_pred eeEEEeeeccccc
Q 030430 106 VMLKIADFGLSCT 118 (177)
Q Consensus 106 ~~~~l~d~~~~~~ 118 (177)
..+.++||+.+..
T Consensus 236 ~v~~viDwe~a~~ 248 (359)
T 3dxp_A 236 RVLAVLDWELSTL 248 (359)
T ss_dssp CEEEECCCTTCEE
T ss_pred cEEEEECcccccc
Confidence 3368999997643
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.93 E-value=1e-09 Score=80.08 Aligned_cols=156 Identities=21% Similarity=0.271 Sum_probs=98.9
Q ss_pred HHHHHHHHHHHHhhC-CCCc--eeeEeEEEeeCC---eEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHH
Q 030430 9 LKSCLDCELNFLSSV-NHPN--IIRLFDAFQAEN---CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l-~h~~--i~~~~~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l 82 (177)
....+.+|+++++.+ .+.. +++++....... ..|+||++++|.++..... ..++.++...++.+++..++.|
T Consensus 53 ~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~L 130 (304)
T 3sg8_A 53 GSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSEL 130 (304)
T ss_dssp HHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHH
Confidence 467899999999888 4433 445554443333 3478999999998875332 3567777788888888888888
Q ss_pred hh----------------------------------------------------------CCCeeecCCCCcEEEecCCC
Q 030430 83 NS----------------------------------------------------------HHIIHRDLKPENILLSGLDD 104 (177)
Q Consensus 83 h~----------------------------------------------------------~~~~H~~i~~~nil~~~~~~ 104 (177)
|+ ..++|+|++|.|+++... .
T Consensus 131 H~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-~ 209 (304)
T 3sg8_A 131 HSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE-K 209 (304)
T ss_dssp HHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-T
T ss_pred HcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC-C
Confidence 85 136999999999999621 1
Q ss_pred CeeEEEeeeccccccCCCC-ccccccCCCccccccccc----c-CCC---------CCcchHHHHHHHHHHHHhCCCCC
Q 030430 105 DVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ----F-QRY---------DEKVDMWSVGAILFELLNGYPPF 168 (177)
Q Consensus 105 ~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~----~-~~~---------~~~~Di~slg~~~~~~~~~~~pf 168 (177)
...+.++||+.+....... .......... .+|+... . ... ....+.|+++.+++.+.+|..+|
T Consensus 210 ~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~-~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 210 NTICGIIDFGDAAISDPDNDFISLMEDDEE-YGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TEEEEECCCTTCEEECTTHHHHTTCCTTTS-CCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCEEEEEeCCCCccCChHHHHHHHHhhccc-cCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 5567899999875431110 0000000000 1222110 0 001 11258999999999999998876
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.69 E-value=1.9e-07 Score=66.78 Aligned_cols=109 Identities=14% Similarity=0.164 Sum_probs=75.1
Q ss_pred ccccchhHHHHHHHHHHHHhhCC-CCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHH
Q 030430 2 LKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE 80 (177)
Q Consensus 2 l~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~ 80 (177)
||.-.......+.+|.+.|+.+. +--+++++.+..+.+..++|||+++|.++.+...... .....+..++...++
T Consensus 55 lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~~----~~~~~~~~~l~~~L~ 130 (272)
T 4gkh_A 55 LKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYP----DSGENIVDALAVFLR 130 (272)
T ss_dssp EEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHCG----GGHHHHHHHHHHHHH
T ss_pred EEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCCH----HHHHHHHHHHHHHHH
Confidence 44444555677899999999884 3347888888899999999999999988877544221 112223334444444
Q ss_pred HHhhC----------------------------------------------------------CCeeecCCCCcEEEecC
Q 030430 81 ILNSH----------------------------------------------------------HIIHRDLKPENILLSGL 102 (177)
Q Consensus 81 ~lh~~----------------------------------------------------------~~~H~~i~~~nil~~~~ 102 (177)
.||.. .++|+|+.+.|+++.
T Consensus 131 ~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~-- 208 (272)
T 4gkh_A 131 RLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFD-- 208 (272)
T ss_dssp HHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEE--
T ss_pred HhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEE--
Confidence 33321 278999999999995
Q ss_pred CCCeeEEEeeecccc
Q 030430 103 DDDVMLKIADFGLSC 117 (177)
Q Consensus 103 ~~~~~~~l~d~~~~~ 117 (177)
....+-|+||+.+.
T Consensus 209 -~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 209 -EGKLIGCIDVGRVG 222 (272)
T ss_dssp -TTEEEEECCCTTCE
T ss_pred -CCeEEEEEECcccc
Confidence 44556799998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=1.7e-06 Score=63.15 Aligned_cols=109 Identities=20% Similarity=0.215 Sum_probs=71.6
Q ss_pred hHHHHHHHHHHHHhhCCCC---ceeeEeEEEe-eCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh
Q 030430 8 HLKSCLDCELNFLSSVNHP---NIIRLFDAFQ-AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (177)
.....+.+|+++++.+.+. .+++++.+.. ..+..+++|++++|.++....- ..++......++.++...++.||
T Consensus 51 ~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH 128 (306)
T 3tdw_A 51 QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELS 128 (306)
T ss_dssp HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHh
Confidence 4567899999999999642 3567766664 4456789999999988876311 12344444444444444444444
Q ss_pred hC------------------------------------------------------------CCeeecCCCCcEEEecCC
Q 030430 84 SH------------------------------------------------------------HIIHRDLKPENILLSGLD 103 (177)
Q Consensus 84 ~~------------------------------------------------------------~~~H~~i~~~nil~~~~~ 103 (177)
+. .++|+|+++.|+++...+
T Consensus 129 ~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~ 208 (306)
T 3tdw_A 129 AFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNS 208 (306)
T ss_dssp HSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTC
T ss_pred cCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCC
Confidence 32 369999999999995211
Q ss_pred CCee-EEEeeeccccc
Q 030430 104 DDVM-LKIADFGLSCT 118 (177)
Q Consensus 104 ~~~~-~~l~d~~~~~~ 118 (177)
..+. +.++||+.+..
T Consensus 209 ~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 209 RQTPLTGIIDFGDAAI 224 (306)
T ss_dssp SSCCEEEECCCTTCEE
T ss_pred CCCceEEEEehhhcCC
Confidence 1334 57999987644
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.96 E-value=1.4e-05 Score=59.35 Aligned_cols=44 Identities=14% Similarity=0.139 Sum_probs=32.9
Q ss_pred HHHHHHHHHHhhCC-C--CceeeEeEEEeeC---CeEEEEEecCCCCChH
Q 030430 11 SCLDCELNFLSSVN-H--PNIIRLFDAFQAE---NCIFLVVEFCAGGNLS 54 (177)
Q Consensus 11 ~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~ 54 (177)
..+.+|+++++.+. + -.+++++.+..+. +..+++||+++|.++.
T Consensus 72 ~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 72 YRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp CCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred hHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChh
Confidence 56788999999884 2 3577788777655 3568899999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00024 Score=52.12 Aligned_cols=31 Identities=19% Similarity=0.322 Sum_probs=25.5
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccc
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~ 118 (177)
.+++|+|+++.|+++. ....+.++||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~---~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLG---ENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEEC---GGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEe---CCCcEEEEehhhccc
Confidence 6799999999999993 345689999997643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0008 Score=49.36 Aligned_cols=34 Identities=21% Similarity=0.273 Sum_probs=25.4
Q ss_pred CCCeeecCCCCcEEEecCCC-CeeEEEeeeccccc
Q 030430 85 HHIIHRDLKPENILLSGLDD-DVMLKIADFGLSCT 118 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~-~~~~~l~d~~~~~~ 118 (177)
..++|||+.+.|+++..... ...+.++||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 46999999999999952111 25689999987654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0014 Score=47.36 Aligned_cols=29 Identities=28% Similarity=0.160 Sum_probs=22.9
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccc
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~ 118 (177)
.++|+|+.+.|++. ..+.+.++||..+..
T Consensus 174 ~l~HgDl~~~Nil~----~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFLD----TGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEEE----CSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEEE----CCCCEEEEecccccC
Confidence 38999999999995 234579999987643
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0017 Score=48.78 Aligned_cols=31 Identities=26% Similarity=0.355 Sum_probs=24.1
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccc
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~ 118 (177)
...++|||+.+.||+++ . ..+.++||..+..
T Consensus 226 ~~~L~HGDl~~~Nil~~---~-~~~~lID~e~a~~ 256 (397)
T 2olc_A 226 AETLIHGDLHTGSIFAS---E-HETKVIDPEFAFY 256 (397)
T ss_dssp CCEEECSCCSGGGEEEC---S-SCEEECCCTTCEE
T ss_pred CCceeeCCCCcCcEEEe---C-CCeEEEeCccccc
Confidence 35699999999999994 2 2488999976643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.34 E-value=0.0062 Score=45.74 Aligned_cols=104 Identities=21% Similarity=0.295 Sum_probs=60.1
Q ss_pred HHHHHHHHHHhhCC-CCceeeEeEEEeeCCeEEEEEecCCCCChHHH--------------Hh-hcC-------CCC--H
Q 030430 11 SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY--------------IR-LHG-------RVP--E 65 (177)
Q Consensus 11 ~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~--------------l~-~~~-------~~~--~ 65 (177)
....+|.++++.+. +.-.+++++.+.+ .+|+|+++|.+|..- +. .+. ... .
T Consensus 98 ~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~ 173 (379)
T 3feg_A 98 DSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLF 173 (379)
T ss_dssp HHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHH
Confidence 44568999998884 3334666665543 289999998655311 00 010 011 2
Q ss_pred HHHHHHHHHHHH-------------------HHH----HHhh----CCCeeecCCCCcEEEecC-CCCeeEEEeeecccc
Q 030430 66 QTARKFLQQLGA-------------------GLE----ILNS----HHIIHRDLKPENILLSGL-DDDVMLKIADFGLSC 117 (177)
Q Consensus 66 ~~~~~~~~~i~~-------------------~l~----~lh~----~~~~H~~i~~~nil~~~~-~~~~~~~l~d~~~~~ 117 (177)
.++.++..++-. .+. .|.. ..++|+|+.+.||++... +....+.++||..+.
T Consensus 174 ~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 174 GTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 445555544321 112 2222 248999999999999632 113568999998764
Q ss_pred c
Q 030430 118 T 118 (177)
Q Consensus 118 ~ 118 (177)
.
T Consensus 254 ~ 254 (379)
T 3feg_A 254 Y 254 (379)
T ss_dssp E
T ss_pred c
Confidence 3
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.29 E-value=0.036 Score=38.35 Aligned_cols=101 Identities=20% Similarity=0.166 Sum_probs=57.8
Q ss_pred CChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhh-CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccc
Q 030430 51 GNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128 (177)
Q Consensus 51 ~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 128 (177)
.+|.+.++. ..+++++++|.++.|.+.+|...-. +.-...=+.|..+++. ..+.+.+.+ . .. .
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~---~dG~V~f~~-~-------~s----~ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVW---RDGAVTLAP-A-------AD----D 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEE---TTSCEEECC-C--------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEe---cCCceeccc-c-------cc----c
Confidence 478888874 4679999999999999999887732 1111222344666664 333343221 0 00 0
Q ss_pred cCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 129 ~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
.....+.|||... ...+.+.=|||||+++|..+--..|
T Consensus 98 ~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ---------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1223456787653 2345667799999999988765443
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.09 E-value=0.015 Score=42.44 Aligned_cols=71 Identities=13% Similarity=0.155 Sum_probs=53.4
Q ss_pred ccccchhHHHHHHHHHHHHhhCC---CCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHH
Q 030430 2 LKKLNKHLKSCLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78 (177)
Q Consensus 2 l~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~ 78 (177)
||.........+.+|++.|+.|. ...+++++.+....+..+++||+++|.++.. ....++...
T Consensus 64 lK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~~~--------------~~~~~lG~~ 129 (312)
T 3jr1_A 64 VKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKNKQ--------------SSFTIFAEK 129 (312)
T ss_dssp EEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCCCT--------------THHHHHHHH
T ss_pred EEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCCCc--------------hhHHHHHHH
Confidence 44444455678899999999883 3568888888888888999999999876521 234577888
Q ss_pred HHHHhhCC
Q 030430 79 LEILNSHH 86 (177)
Q Consensus 79 l~~lh~~~ 86 (177)
|+.||..+
T Consensus 130 LA~LH~~~ 137 (312)
T 3jr1_A 130 IAQLHQIQ 137 (312)
T ss_dssp HHHHHHCC
T ss_pred HHHHHcCC
Confidence 88999864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.56 E-value=0.012 Score=44.82 Aligned_cols=39 Identities=18% Similarity=0.254 Sum_probs=25.9
Q ss_pred HHHHHHHHHHhhCCCCce-eeEeEEEeeCCeEEEEEecCCCCCh
Q 030430 11 SCLDCELNFLSSVNHPNI-IRLFDAFQAENCIFLVVEFCAGGNL 53 (177)
Q Consensus 11 ~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L 53 (177)
..+.+|.++++.+...++ +++++.+.+ .+++||++|.++
T Consensus 120 ~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~l 159 (429)
T 1nw1_A 120 SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 159 (429)
T ss_dssp HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred HHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCccc
Confidence 455679999998843333 666665442 278999987444
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=94.81 E-value=0.028 Score=42.61 Aligned_cols=32 Identities=22% Similarity=0.428 Sum_probs=25.7
Q ss_pred hhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccc
Q 030430 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (177)
Q Consensus 83 h~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~ 118 (177)
+...++|||+++.||+++ ... +.++||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~---~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVT---QDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEEC---SSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEe---CCC-CEEEeCccccc
Confidence 456799999999999995 333 89999987644
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=92.16 E-value=0.15 Score=37.02 Aligned_cols=29 Identities=24% Similarity=0.192 Sum_probs=23.5
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccc
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~ 118 (177)
..++|||+++.||++. + .+.++||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~----~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR----D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES----S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc----C-CCEEEECCCCCc
Confidence 4589999999999994 2 688999986643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=91.80 E-value=0.053 Score=39.25 Aligned_cols=31 Identities=29% Similarity=0.584 Sum_probs=24.1
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccc
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~ 118 (177)
.+++|+|+++.|+++. .+..+.++||+.+..
T Consensus 187 ~~liHgDl~~~Nil~~---~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFL---GDELSGLIDFYFACN 217 (322)
T ss_dssp EEEECSCCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred cccCCCCCCccCEEEe---CCceEEEecchhccC
Confidence 3699999999999995 344457999987643
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=91.28 E-value=0.18 Score=37.06 Aligned_cols=31 Identities=19% Similarity=0.359 Sum_probs=24.8
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccc
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~ 118 (177)
.+++|+|+.+.|+++. ..+.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~---~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVG---NEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEEC---GGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEe---CCCeEEEEECCCCee
Confidence 4599999999999994 445689999986643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=89.09 E-value=0.4 Score=35.41 Aligned_cols=28 Identities=32% Similarity=0.516 Sum_probs=22.3
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeecccc
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~ 117 (177)
+++|+|+.+.||++. . ..+.++||..+.
T Consensus 213 ~l~HgDl~~~Nil~~---~-~~~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINT---N-KCLRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEEC---C--CEEECCCTTCE
T ss_pred EEEeCCCCcccEEec---C-CcEEEEEecCCC
Confidence 599999999999984 2 337899998664
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=85.41 E-value=0.9 Score=34.93 Aligned_cols=36 Identities=25% Similarity=0.331 Sum_probs=25.0
Q ss_pred HHHHHHHhhCCCCce-eeEeEEEeeCCeEEEEEecCCCCCh
Q 030430 14 DCELNFLSSVNHPNI-IRLFDAFQAENCIFLVVEFCAGGNL 53 (177)
Q Consensus 14 ~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L 53 (177)
.+|.++++.|...++ +++++.+. +. .++||++|.+|
T Consensus 152 ~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~G~~l 188 (458)
T 2qg7_A 152 EREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMDGYAL 188 (458)
T ss_dssp HHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCCSEEC
T ss_pred HHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeCCccC
Confidence 589999999965444 66666653 32 49999987444
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=83.09 E-value=9.1 Score=26.29 Aligned_cols=81 Identities=14% Similarity=0.115 Sum_probs=56.0
Q ss_pred CCCceeeEeEEEeeCCeEEEEEecCCC-CChHHHHhhcCCCCHHHHHHHHHHHHHHHH-HHhhCCCeeecCCCCcEEEec
Q 030430 24 NHPNIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLE-ILNSHHIIHRDLKPENILLSG 101 (177)
Q Consensus 24 ~h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~-~lh~~~~~H~~i~~~nil~~~ 101 (177)
.||++ -...-.+.+.+.+.++.-++ -++.. + ..++....++++.+++.... ++ ..-+|--++|+|+++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i---~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f-- 117 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-I---RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMF-- 117 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-H---HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEE--
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-H---HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEE--
Confidence 57888 44455677777777775422 23433 2 35778999999999888655 33 446788899999999
Q ss_pred CCCCeeEEEeeecc
Q 030430 102 LDDDVMLKIADFGL 115 (177)
Q Consensus 102 ~~~~~~~~l~d~~~ 115 (177)
+.+..+++.=.|.
T Consensus 118 -~~~~~p~i~hRGi 130 (219)
T 4ano_A 118 -NRALEPFFLHVGV 130 (219)
T ss_dssp -CTTCCEEESCCEE
T ss_pred -eCCCcEEEEEcCC
Confidence 5677777765554
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=82.39 E-value=0.62 Score=35.01 Aligned_cols=32 Identities=31% Similarity=0.364 Sum_probs=25.1
Q ss_pred CeeecCCCCcEEEecC---CCCeeEEEeeeccccc
Q 030430 87 IIHRDLKPENILLSGL---DDDVMLKIADFGLSCT 118 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~---~~~~~~~l~d~~~~~~ 118 (177)
++|+|+.+.||++... ++...+.++||..+..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999531 3456699999987744
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 177 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-54 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-53 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-51 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-51 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-49 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-48 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-48 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-48 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-48 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-47 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-44 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-43 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-43 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-43 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-42 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-41 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-41 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-40 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-40 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-40 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-39 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-39 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-39 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-38 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-38 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-38 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-38 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-37 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-37 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-37 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-36 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-36 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-35 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-35 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-34 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-34 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-34 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-33 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-33 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-29 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-15 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 9e-54
Identities = 55/176 (31%), Positives = 89/176 (50%), Gaps = 5/176 (2%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+ ++ +++ + EL L N P I+ + AF ++ I + +E GG+L ++
Sbjct: 39 IHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA 98
Query: 61 GRVPEQTARKFLQQLGAGLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
GR+PEQ K + GL L H I+HRD+KP NIL ++ +K+ DFG+S L
Sbjct: 99 GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNIL---VNSRGEIKLCDFGVSGQL 155
Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 175
+ A G+ YM+PE LQ Y + D+WS+G L E+ G P + +
Sbjct: 156 -IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-53
Identities = 60/174 (34%), Positives = 95/174 (54%), Gaps = 10/174 (5%)
Query: 2 LKKLNKH------LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
LK L K ++ L E+ S + HPNI+RL+ F ++L++E+ G +
Sbjct: 36 LKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR 95
Query: 56 YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
++ + EQ ++ +L L +S +IHRD+KPEN+L L LKIADFG
Sbjct: 96 ELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLL---LGSAGELKIADFGW 152
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
S P + +CG+ Y+ PE+++ + +DEKVD+WS+G + +E L G PPF
Sbjct: 153 SVHA-PSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 205
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (431), Expect = 2e-53
Identities = 64/180 (35%), Positives = 102/180 (56%), Gaps = 4/180 (2%)
Query: 2 LKKLNKHL----KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
+K + K + ++ E+ L + HPNI+ L D +++ ++L+++ +GG L I
Sbjct: 39 IKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI 98
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
G E+ A + + Q+ ++ L+ I+HRDLKPEN+L LD+D + I+DFGLS
Sbjct: 99 VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158
Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 177
PG+ CG+P Y+APEVL + Y + VD WS+G I + LL GYPPF + +
Sbjct: 159 MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF 218
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 170 bits (431), Expect = 4e-53
Identities = 53/178 (29%), Positives = 96/178 (53%), Gaps = 2/178 (1%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RL 59
+ ++ K + E+ +S + HP ++ L DAF+ +N + ++ EF +GG L +
Sbjct: 58 FVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE 117
Query: 60 HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
H ++ E A ++++Q+ GL ++ ++ +H DLKPENI+ + LK+ DFGL+ L
Sbjct: 118 HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFT-TKRSNELKLIDFGLTAHL 176
Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 177
P + G+ + APEV + + DMWSVG + + LL+G PF + + +
Sbjct: 177 DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL 234
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 8e-52
Identities = 57/173 (32%), Positives = 98/173 (56%), Gaps = 10/173 (5%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIR 58
+KL K + E L + HPNI+R +D++++ + CI LV E G L +Y++
Sbjct: 45 RKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK 104
Query: 59 LHGRVPEQTARKFLQQLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLS 116
+ + R + +Q+ GL+ L++ IIHRDLK +NI ++ +KI D GL+
Sbjct: 105 RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLA 162
Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
TL ++A+ V G+P +MAPE+ + ++YDE VD+++ G + E+ P+S
Sbjct: 163 -TLKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYS 213
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 1e-51
Identities = 58/185 (31%), Positives = 98/185 (52%), Gaps = 12/185 (6%)
Query: 2 LKKLNKHL------KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
+K L K + E + +S ++HP ++L+ FQ + ++ + + G L
Sbjct: 38 IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 97
Query: 56 YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
YIR G E R + ++ + LE L+ IIHRDLKPENIL L++D+ ++I DFG
Sbjct: 98 YIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGT 154
Query: 116 SCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGE 172
+ L P + A G+ Y++PE+L + + D+W++G I+++L+ G PPF G
Sbjct: 155 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 214
Query: 173 EHQFM 177
E+
Sbjct: 215 EYLIF 219
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 166 bits (422), Expect = 1e-51
Identities = 51/180 (28%), Positives = 95/180 (52%), Gaps = 5/180 (2%)
Query: 2 LKKLNKHL---KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR 58
K +N K + E++ ++ ++HP +I L DAF+ + + L++EF +GG L I
Sbjct: 59 AKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA 118
Query: 59 LHG-RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
++ E +++Q GL+ ++ H I+H D+KPENI+ +KI DFGL+
Sbjct: 119 AEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLAT 177
Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 177
L P + + + APE++ + DMW++G + + LL+G PF+ ++ + +
Sbjct: 178 KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL 237
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 5e-51
Identities = 61/186 (32%), Positives = 97/186 (52%), Gaps = 13/186 (6%)
Query: 2 LKKLNKHLKSCLDC---ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI- 57
K ++ + L+ E++ L+S +HPNI++L DAF EN +++++EFCAGG + + +
Sbjct: 42 AKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML 101
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
L + E + +Q L L+ + IIHRDLK NIL D +K+ADFG+S
Sbjct: 102 ELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNIL---FTLDGDIKLADFGVSA 158
Query: 118 TLY-PGNYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFELLNGYPPFSVG 171
+ G+P +MAPEV+ + YD K D+WS+G L E+ PP
Sbjct: 159 KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 218
Query: 172 EEHQFM 177
+ +
Sbjct: 219 NPMRVL 224
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 8e-50
Identities = 47/175 (26%), Positives = 84/175 (48%), Gaps = 11/175 (6%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LH 60
+ E+ L H NI+ + + +V ++C G +L ++ +
Sbjct: 40 VTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIE 98
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
+ +Q G++ L++ IIHRDLK NI L +D+ +KI DFGL+
Sbjct: 99 TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIF---LHEDLTVKIGDFGLATVKS 155
Query: 121 PGNYAEK---VCGSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFS 169
+ + + + GS L+MAPEV++ Q Y + D+++ G +L+EL+ G P+S
Sbjct: 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 210
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (404), Expect = 2e-49
Identities = 56/185 (30%), Positives = 86/185 (46%), Gaps = 15/185 (8%)
Query: 2 LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
+KK++ K + E+ FL + HPN I+ + E+ +LV+E+C G
Sbjct: 45 IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDL 104
Query: 56 YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
+ E GL L+SH++IHRD+K NIL L + ++K+ DFG
Sbjct: 105 LEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNIL---LSEPGLVKLGDFGS 161
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNGYPPFSVGE 172
+ + P N G+P +MAPEV+ +YD KVD+WS+G EL PP
Sbjct: 162 ASIMAPANS---FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218
Query: 173 EHQFM 177
+
Sbjct: 219 AMSAL 223
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-48
Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 4/179 (2%)
Query: 2 LKKLNKHLKS--CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
K + + E++ L+ H NI+ L ++F++ + ++ EF +G ++ I
Sbjct: 35 AKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT 94
Query: 60 HG-RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
+ E+ ++ Q+ L+ L+SH+I H D++PENI+ +KI +FG +
Sbjct: 95 SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQ 153
Query: 119 LYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 177
L PG+ + +P Y APEV Q DMWS+G +++ LL+G PF Q +
Sbjct: 154 LKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII 212
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 1e-48
Identities = 49/170 (28%), Positives = 90/170 (52%), Gaps = 5/170 (2%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+ + K + E+ + +PNI+ D++ + +++V+E+ AGG+L+ +
Sbjct: 52 QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-E 110
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL- 119
+ E ++ LE L+S+ +IHRD+K +NILL D +K+ DFG +
Sbjct: 111 TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQIT 167
Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
+ + G+P +MAPEV+ + Y KVD+WS+G + E++ G PP+
Sbjct: 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL 217
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (394), Expect = 3e-48
Identities = 59/181 (32%), Positives = 94/181 (51%), Gaps = 7/181 (3%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+ K + E+ +NH N+++ + + N +L +E+C+GG L I
Sbjct: 38 VDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD 97
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
+PE A++F QL AG+ L+ I HRD+KPEN+L LD+ LKI+DFGL+
Sbjct: 98 IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLL---LDERDNLKISDFGLATVFR 154
Query: 121 PGNYAE---KVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFSVGEEHQF 176
N K+CG+ Y+APE+L+ + + E VD+WS G +L +L G P+ +
Sbjct: 155 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 214
Query: 177 M 177
Sbjct: 215 E 215
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 4e-48
Identities = 59/188 (31%), Positives = 98/188 (52%), Gaps = 15/188 (7%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYI-- 57
+ + K L E+N L + HPNI+R +D + +++V+E+C GG+L+S I
Sbjct: 39 YGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK 98
Query: 58 --RLHGRVPEQTARKFLQQLGAGLEIL-----NSHHIIHRDLKPENILLSGLDDDVMLKI 110
+ + E+ + + QL L+ H ++HRDLKP N+ L D +K+
Sbjct: 99 GTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKL 155
Query: 111 ADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
DFGL+ L +A+ G+P YM+PE + Y+EK D+WS+G +L+EL PPF+
Sbjct: 156 GDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 215
Query: 170 VGEEHQFM 177
+ +
Sbjct: 216 AFSQKELA 223
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 152 bits (384), Expect = 7e-47
Identities = 68/182 (37%), Positives = 103/182 (56%), Gaps = 10/182 (5%)
Query: 3 KKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
+ + L+ E++ L V+ HPNII+L D ++ FLV + G L Y+
Sbjct: 46 AEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV 105
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
+ E+ RK ++ L + L+ +I+HRDLKPENIL LDDD+ +K+ DFG SC L P
Sbjct: 106 TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENIL---LDDDMNIKLTDFGFSCQLDP 162
Query: 122 GNYAEKVCGSPLYMAPEVLQ------FQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 175
G +VCG+P Y+APE+++ Y ++VDMWS G I++ LL G PPF ++
Sbjct: 163 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 222
Query: 176 FM 177
+
Sbjct: 223 ML 224
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 3e-46
Identities = 62/173 (35%), Positives = 98/173 (56%), Gaps = 7/173 (4%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYI 57
LK L K+ + EL + P+I+R+ D ++ C+ +V+E GG L S I
Sbjct: 42 LKMLQDCPKARREVEL-HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 100
Query: 58 RLHG--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
+ G E+ A + ++ +G ++ L+S +I HRD+KPEN+L + + +LK+ DFG
Sbjct: 101 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
+ N C +P Y+APEVL ++YD+ DMWS+G I++ LL GYPPF
Sbjct: 161 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 213
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 3e-44
Identities = 61/184 (33%), Positives = 96/184 (52%), Gaps = 11/184 (5%)
Query: 2 LKKLNKHLKSCLDCELNFL-------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLS 54
+K L K + D + + HP + +F FQ + +F V+E+ GG+L
Sbjct: 32 IKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLM 91
Query: 55 SYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
+I+ + A + ++ GL+ L+S I++RDLK +NIL LD D +KIADFG
Sbjct: 92 YHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNIL---LDKDGHIKIADFG 148
Query: 115 LSCTLYPGNYAEK-VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 173
+ G+ CG+P Y+APE+L Q+Y+ VD WS G +L+E+L G PF +E
Sbjct: 149 MCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 208
Query: 174 HQFM 177
+
Sbjct: 209 EELF 212
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-43
Identities = 55/154 (35%), Positives = 93/154 (60%), Gaps = 1/154 (0%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E++ L + HPN+I L + ++ + + L++E AGG L ++ + E+ A +FL+Q+
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 122
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDD-DVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
G+ L+S I H DLKPENI+L + +KI DFGL+ + GN + + G+P +
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
+APE++ ++ + DMWS+G I + LL+G PF
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 216
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 144 bits (363), Expect = 3e-43
Identities = 67/182 (36%), Positives = 100/182 (54%), Gaps = 11/182 (6%)
Query: 2 LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
+K L K + L E LS V HP IIR++ FQ IF+++++ GG L S
Sbjct: 34 MKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFS 93
Query: 56 YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
+R R P A+ + ++ LE L+S II+RDLKPENIL LD + +KI DFG
Sbjct: 94 LLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENIL---LDKNGHIKITDFGF 150
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 175
+ + Y +CG+P Y+APEV+ + Y++ +D WS G +++E+L GY PF +
Sbjct: 151 AKYVPDVTY--TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 208
Query: 176 FM 177
Sbjct: 209 TY 210
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 4e-43
Identities = 43/181 (23%), Positives = 85/181 (46%), Gaps = 10/181 (5%)
Query: 2 LKKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRL 59
+K + E + ++ + H N+++L + + +++V E+ A G+L Y+R
Sbjct: 35 VKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS 94
Query: 60 HGR--VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
GR + KF + +E L ++ +HRDL N+L+ +D + K++DFGL+
Sbjct: 95 RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTK 151
Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSVGEEHQF 176
+ + APE L+ +++ K D+WS G +L+E+ G P+
Sbjct: 152 EASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 209
Query: 177 M 177
+
Sbjct: 210 V 210
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 142 bits (359), Expect = 5e-43
Identities = 46/179 (25%), Positives = 84/179 (46%), Gaps = 11/179 (6%)
Query: 2 LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGG 51
+K L L E +++NHP I+ ++D +AE ++V+E+ G
Sbjct: 37 VKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGV 96
Query: 52 NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDD-DVMLKI 110
L + G + + A + + L + + IIHRD+KP NI++S + VM
Sbjct: 97 TLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFG 156
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
++ + V G+ Y++PE + D + D++S+G +L+E+L G PPF+
Sbjct: 157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 215
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 4e-42
Identities = 44/179 (24%), Positives = 78/179 (43%), Gaps = 8/179 (4%)
Query: 2 LKKLNKHLKSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY-IR 58
+K + + S D E + ++HP +++L+ + I LV EF G LS Y
Sbjct: 34 IKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT 93
Query: 59 LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
G +T + G+ L +IHRDL N L+ ++ ++K++DFG++
Sbjct: 94 QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRF 150
Query: 119 LYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 175
+ Y + +PEV F RY K D+WS G +++E+ + +
Sbjct: 151 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 209
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 1e-41
Identities = 47/172 (27%), Positives = 84/172 (48%), Gaps = 9/172 (5%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
+ + LK L E N + +++P I+R+ +AE+ LV+E G L+ Y++ +
Sbjct: 45 EANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH 103
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
V ++ + + Q+ G++ L + +HRDL N+L L KI+DFGLS L
Sbjct: 104 VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVL---LVTQHYAKISDFGLSKALRAD 160
Query: 123 NYAEK----VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFS 169
K + APE + + ++ K D+WS G +++E + G P+
Sbjct: 161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 212
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 140 bits (354), Expect = 2e-41
Identities = 52/154 (33%), Positives = 87/154 (56%), Gaps = 5/154 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
L+ +S+ + P I+ + AF + + +++ GG+L ++ HG E R + ++
Sbjct: 57 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI 116
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
GLE +++ +++RDLKP NIL LD+ ++I+D GL+C + G+ YM
Sbjct: 117 ILGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYM 172
Query: 136 APEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPF 168
APEVLQ YD D +S+G +LF+LL G+ PF
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 206
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 2e-41
Identities = 43/174 (24%), Positives = 84/174 (48%), Gaps = 9/174 (5%)
Query: 2 LKKLNKHLKSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
+K + + S + E + +++H +++L+ + IF++ E+ A G L +Y+R
Sbjct: 33 IKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE 92
Query: 60 -HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
R Q + + + +E L S +HRDL N L ++D ++K++DFGLS
Sbjct: 93 MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRY 149
Query: 119 LYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFS 169
+ Y + PEVL + ++ K D+W+ G +++E+ G P+
Sbjct: 150 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 203
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 2e-40
Identities = 43/183 (23%), Positives = 82/183 (44%), Gaps = 11/183 (6%)
Query: 2 LKKLNKHLKSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
+K L + S E N + + H ++RL+ + I+++ E+ G+L +++
Sbjct: 42 VKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKT 100
Query: 60 HGRVP--EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
+ Q+ G+ + + IHRDL+ NIL + D + KIADFGL+
Sbjct: 101 PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL---VSDTLSCKIADFGLAR 157
Query: 118 TLYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSVGEEH 174
+ Y + + APE + + + K D+WS G +L E++ +G P+
Sbjct: 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 217
Query: 175 QFM 177
+ +
Sbjct: 218 EVI 220
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 136 bits (343), Expect = 2e-40
Identities = 42/185 (22%), Positives = 85/185 (45%), Gaps = 11/185 (5%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+ + + E + + +HPN+I L + ++ EF G+L S++R +
Sbjct: 62 LKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN 121
Query: 61 -GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
G+ L+ + AG++ L + +HRDL NIL ++ +++ K++DFGLS L
Sbjct: 122 DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNIL---VNSNLVCKVSDFGLSRFL 178
Query: 120 YPGNYAEKV------CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSVGE 172
+ APE +Q++++ D+WS G +++E+++ G P+
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238
Query: 173 EHQFM 177
+
Sbjct: 239 NQDVI 243
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-40
Identities = 47/162 (29%), Positives = 80/162 (49%), Gaps = 7/162 (4%)
Query: 16 ELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAGG-NLSSYIRLHGRVPEQTARKFL 72
E+ L V+ +IRL D F+ + L++E +L +I G + E+ AR F
Sbjct: 57 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 116
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
Q+ + ++ ++HRD+K ENIL+ + LK+ DFG L G+
Sbjct: 117 WQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGA-LLKDTVYTDFDGTR 173
Query: 133 LYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFSVGEE 173
+Y PE +++ RY +WS+G +L++++ G PF EE
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 215
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 3e-40
Identities = 48/183 (26%), Positives = 84/183 (45%), Gaps = 10/183 (5%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+ + K + E + +++P I+RL QAE + LV+E GG L ++
Sbjct: 44 LKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGK 102
Query: 61 -GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
+P + L Q+ G++ L + +HRDL N+L L + KI+DFGLS L
Sbjct: 103 REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVL---LVNRHYAKISDFGLSKAL 159
Query: 120 YPGNYAEK----VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSVGEEH 174
+ + APE + F+++ + D+WS G ++E L+ G P+ +
Sbjct: 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 219
Query: 175 QFM 177
+ M
Sbjct: 220 EVM 222
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 7e-40
Identities = 57/183 (31%), Positives = 92/183 (50%), Gaps = 10/183 (5%)
Query: 2 LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
+K L K + D E L + HP + L AFQ + + V+E+ GG L
Sbjct: 35 MKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFF 94
Query: 56 YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
++ E+ AR + ++ + LE L+S +++RD+K EN++ LD D +KI DFGL
Sbjct: 95 HLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGL 151
Query: 116 SCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEH 174
G + CG+P Y+APEVL+ Y VD W +G +++E++ G PF +
Sbjct: 152 CKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211
Query: 175 QFM 177
+
Sbjct: 212 RLF 214
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 3e-39
Identities = 61/186 (32%), Positives = 89/186 (47%), Gaps = 13/186 (6%)
Query: 2 LKKLNKHLKSCLD--------CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNL 53
+KK+ +S E+ L ++HPNII L DAF ++ I LV +F
Sbjct: 28 IKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLE 87
Query: 54 SSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
+ + ++ GLE L+ H I+HRDLKP N+L LD++ +LK+ADF
Sbjct: 88 VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLL---LDENGVLKLADF 144
Query: 114 GLSCTLYPGNYAEK-VCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPFSVG 171
GL+ + N A + Y APE+L + Y VDMW+VG IL ELL P
Sbjct: 145 GLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 204
Query: 172 EEHQFM 177
+ +
Sbjct: 205 SDLDQL 210
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 133 bits (336), Expect = 3e-39
Identities = 45/178 (25%), Positives = 83/178 (46%), Gaps = 9/178 (5%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIR 58
+K L K + E+ L ++ PNII L D + LV E + +
Sbjct: 65 VKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ 124
Query: 59 LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
+ + R ++ ++ L+ +S I+HRD+KP N+++ + L++ D+GL+
Sbjct: 125 ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEF 179
Query: 119 LYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 175
+PG S + PE+ + +Q YD +DMWS+G +L ++ PF G ++
Sbjct: 180 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 237
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 5e-39
Identities = 54/186 (29%), Positives = 84/186 (45%), Gaps = 13/186 (6%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF------QAENCIFLVVEFCAGGNLSS 55
+KK+ + K + EL + ++H NI+RL F + E + LV+++
Sbjct: 50 IKKVLQD-KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 108
Query: 56 ---YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 112
Y R +P + ++ QL L ++S I HRD+KP+N+LL D +LK+ D
Sbjct: 109 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCD 166
Query: 113 FGLSCTLYPGNYAEKVCGSPLYMAP-EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVG 171
FG + L G S Y AP + Y +D+WS G +L ELL G P F
Sbjct: 167 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226
Query: 172 EEHQFM 177
+
Sbjct: 227 SGVDQL 232
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 7e-39
Identities = 50/192 (26%), Positives = 78/192 (40%), Gaps = 20/192 (10%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
M + +K EL L + +HPNII L A + ++L +E+ GNL ++R
Sbjct: 45 MKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK 104
Query: 60 H----------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD 103
+ Q F + G++ L+ IHRDL NIL+
Sbjct: 105 SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---G 161
Query: 104 DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
++ + KIADFGLS +MA E L + Y D+WS G +L+E+++
Sbjct: 162 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 221
Query: 164 GYPPFSVGEEHQ 175
G
Sbjct: 222 LGGTPYCGMTCA 233
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 1e-38
Identities = 51/188 (27%), Positives = 79/188 (42%), Gaps = 16/188 (8%)
Query: 2 LKKLNKHLKS------CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
+K L + S E+N + S++H N+IRL+ + +V E G+L
Sbjct: 41 VKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLD 99
Query: 56 YIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
+R H G T ++ Q+ G+ L S IHRDL N+L L ++KI DFG
Sbjct: 100 RLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLL---LATRDLVKIGDFG 156
Query: 115 LSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFS 169
L L + E + APE L+ + + D W G L+E+ G P+
Sbjct: 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 216
Query: 170 VGEEHQFM 177
Q +
Sbjct: 217 GLNGSQIL 224
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 2e-38
Identities = 41/180 (22%), Positives = 79/180 (43%), Gaps = 10/180 (5%)
Query: 2 LKKLNKHLKS--CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
+K L S E + + H +++L+ E I++V E+ + G+L +++
Sbjct: 46 IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKG 104
Query: 60 HGRVP--EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
Q+ +G+ + + +HRDL+ NIL+ ++++ K+ADFGL+
Sbjct: 105 ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLAR 161
Query: 118 TLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 175
+ Y + + APE + R+ K D+WS G +L EL G ++
Sbjct: 162 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 221
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (326), Expect = 4e-38
Identities = 46/180 (25%), Positives = 79/180 (43%), Gaps = 9/180 (5%)
Query: 2 LKKLNKHLKSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
+K L + + E + + HPN+++L E +++ EF GNL Y+R
Sbjct: 47 VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE 106
Query: 60 HGR--VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
R V Q+ + +E L + IHRDL N L + ++ ++K+ADFGLS
Sbjct: 107 CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL---VGENHLVKVADFGLSR 163
Query: 118 TLYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 175
+ Y + APE L + ++ K D+W+ G +L+E+ G +
Sbjct: 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 223
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 7e-38
Identities = 49/197 (24%), Positives = 83/197 (42%), Gaps = 31/197 (15%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
+ +K + + L EL ++ + +H NI+ L A I+L+ E+C G+L +Y+R
Sbjct: 75 LKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRS 134
Query: 60 H-----------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPEN 96
+ + F Q+ G+E L +HRDL N
Sbjct: 135 KREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194
Query: 97 ILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSPLYMAPEVLQFQRYDEKVDMWS 153
+L + ++KI DFGL+ + + +MAPE L Y K D+WS
Sbjct: 195 VL---VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWS 251
Query: 154 VGAILFELLN-GYPPFS 169
G +L+E+ + G P+
Sbjct: 252 YGILLWEIFSLGVNPYP 268
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 8e-38
Identities = 45/166 (27%), Positives = 80/166 (48%), Gaps = 8/166 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQ 74
E + +HP+I++L EN +++++E C G L S++ + + + Q
Sbjct: 58 EALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 116
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSP 132
L L L S +HRD+ N+L + + +K+ DFGLS + Y A K
Sbjct: 117 LSTALAYLESKRFVHRDIAARNVL---VSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 173
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSVGEEHQFM 177
+MAPE + F+R+ D+W G ++E+L +G PF + + +
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 219
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 9e-38
Identities = 39/166 (23%), Positives = 66/166 (39%), Gaps = 7/166 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E ++SV++P++ RL + G L + Q + Q+
Sbjct: 61 EAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSP 132
G+ L ++HRDL N+L + +KI DFGL+ L AE
Sbjct: 121 AKGMNYLEDRRLVHRDLAARNVL---VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSVGEEHQFM 177
+MA E + + Y + D+WS G ++EL+ G P+ +
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 223
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 2e-37
Identities = 56/168 (33%), Positives = 80/168 (47%), Gaps = 9/168 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTAR 69
L L + HPN++RLFD E + LV E + ++ VP +T +
Sbjct: 60 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 119
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
+ QL GL+ L+SH ++HRDLKP+NIL+ +K+ADFGL+ V
Sbjct: 120 DMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVV 176
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 177
+ Y APEVL Y VD+WSVG I E+ P F + +
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL 224
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 2e-37
Identities = 41/200 (20%), Positives = 75/200 (37%), Gaps = 27/200 (13%)
Query: 2 LKKLNKHLKS--CLDCELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSS 55
+K + + + E+ + H NI+ A +N ++LV ++ G+L
Sbjct: 31 VKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD 90
Query: 56 YIRLHGRVPEQTARKFLQQLGA-------GLEILNSHHIIHRDLKPENILLSGLDDDVML 108
Y+ + E + L + I HRDLK +NIL+ +
Sbjct: 91 YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTC 147
Query: 109 KIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQ------FQRYDEKVDMWSVGAI 157
IAD GL+ G+ YMAPEVL ++ D++++G +
Sbjct: 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 207
Query: 158 LFELLNGYPPFSVGEEHQFM 177
+E+ + E++Q
Sbjct: 208 FWEIARRCSIGGIHEDYQLP 227
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 4e-37
Identities = 42/182 (23%), Positives = 76/182 (41%), Gaps = 17/182 (9%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--------AENCIFLVVEFCAGGNL 53
++ + E+ L + H N++ L + + + I+LV +FC
Sbjct: 45 MENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA 104
Query: 54 SSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
+ + ++ +Q L GL ++ + I+HRD+K N+L + D +LK+ADF
Sbjct: 105 GLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVL---ITRDGVLKLADF 161
Query: 114 GLSCTLYPG-----NYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPP 167
GL+ N + Y PE+L +R Y +D+W G I+ E+ P
Sbjct: 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221
Query: 168 FS 169
Sbjct: 222 MQ 223
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 5e-37
Identities = 50/185 (27%), Positives = 83/185 (44%), Gaps = 14/185 (7%)
Query: 2 LKKLNKHLK----SCLDCELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSY 56
+K LN+ S E + +HPN++ L ++E +V+ + G+L ++
Sbjct: 60 VKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF 119
Query: 57 IRLHGRVP-EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
IR P + F Q+ G++ L S +HRDL N +L D+ +K+ADFGL
Sbjct: 120 IRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGL 176
Query: 116 SCTLYPGNYAEK-----VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSV 170
+ +Y + +MA E LQ Q++ K D+WS G +L+EL+ P
Sbjct: 177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236
Query: 171 GEEHQ 175
Sbjct: 237 DVNTF 241
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 126 bits (317), Expect = 9e-37
Identities = 56/178 (31%), Positives = 89/178 (50%), Gaps = 5/178 (2%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L+K ++ + S E++ L + H NI++L+D + + LV E G
Sbjct: 36 LEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG 95
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY- 120
+ TA+ FL QL G+ + ++HRDLKP+N+L ++ + LKIADFGL+
Sbjct: 96 GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLL---INREGELKIADFGLARAFGI 152
Query: 121 PGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 177
P + Y AP+VL ++Y +D+WSVG I E++NG P F E +
Sbjct: 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL 210
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 2e-36
Identities = 55/179 (30%), Positives = 86/179 (48%), Gaps = 6/179 (3%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY-IRLH 60
L + + S E++ L +NHPNI++L D EN ++LV EF
Sbjct: 37 LDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAL 96
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
+P + +L QL GL +SH ++HRDLKP+N+L ++ + +K+ADFGL+
Sbjct: 97 TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFG 153
Query: 121 -PGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 177
P + Y APE+L +Y VD+WS+G I E++ F E +
Sbjct: 154 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 125 bits (315), Expect = 6e-36
Identities = 58/182 (31%), Positives = 103/182 (56%), Gaps = 11/182 (6%)
Query: 2 LKKLNKHLKSCLD------CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
+K L+K L E L +VN P +++L +F+ + +++V+E+ AGG + S
Sbjct: 71 MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130
Query: 56 YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
++R GR E AR + Q+ E L+S +I+RDLKPEN+L +D +++ DFG
Sbjct: 131 HLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGF 187
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 175
+ + + +CG+P +APE++ + Y++ VD W++G +++E+ GYPPF + Q
Sbjct: 188 AKRVKGRTW--TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245
Query: 176 FM 177
Sbjct: 246 IY 247
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 124 bits (312), Expect = 8e-36
Identities = 45/205 (21%), Positives = 88/205 (42%), Gaps = 34/205 (16%)
Query: 2 LKKLNKHLKSCLDC----ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
+K L + + + E ++ ++PNI++L + L+ E+ A G+L+ ++
Sbjct: 48 VKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFL 107
Query: 58 RLHGR------------------------VPEQTARKFLQQLGAGLEILNSHHIIHRDLK 93
R + +Q+ AG+ L+ +HRDL
Sbjct: 108 RSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 167
Query: 94 PENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSPLYMAPEVLQFQRYDEKVD 150
N L + +++++KIADFGLS +Y +Y + +M PE + + RY + D
Sbjct: 168 TRNCL---VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESD 224
Query: 151 MWSVGAILFELLNGYPPFSVGEEHQ 175
+W+ G +L+E+ + G H+
Sbjct: 225 VWAYGVVLWEIFSYGLQPYYGMAHE 249
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 2e-35
Identities = 44/186 (23%), Positives = 81/186 (43%), Gaps = 13/186 (6%)
Query: 2 LKKLNKHL----KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY- 56
+K L + E + +H NIIRL + ++ E+ G L +
Sbjct: 41 IKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL 100
Query: 57 IRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
G L+ + AG++ L + + +HRDL NIL+ + +++ K++DFGLS
Sbjct: 101 REKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLS 157
Query: 117 CTLYPGNYAEKV----CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSVG 171
L A + APE + ++++ D+WS G +++E++ G P+
Sbjct: 158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 217
Query: 172 EEHQFM 177
H+ M
Sbjct: 218 SNHEVM 223
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 121 bits (305), Expect = 8e-35
Identities = 34/186 (18%), Positives = 64/186 (34%), Gaps = 10/186 (5%)
Query: 2 LKKLNKHLKSC-LDCELNFLSSVNHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRL 59
+K K L E + I AE + +V+E +
Sbjct: 37 IKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC 96
Query: 60 HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
+ +T Q+ + +E ++S + IHRD+KP+N L+ ++ I DFGL+
Sbjct: 97 SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156
Query: 120 YPGN--------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVG 171
+ + G+ Y + + D+ S+G +L G P+
Sbjct: 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 216
Query: 172 EEHQFM 177
+
Sbjct: 217 KAATKR 222
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 1e-34
Identities = 50/162 (30%), Positives = 80/162 (49%), Gaps = 13/162 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
E+ L H NII + D +A +V G +L ++ + F
Sbjct: 56 EIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYF 114
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEK 127
L Q+ GL+ ++S +++HRDLKP N+L L+ LKI DFGL+ P + + +
Sbjct: 115 LYQILRGLKYIHSANVLHRDLKPSNLL---LNTTCDLKICDFGLARVADPDHDHTGFLTE 171
Query: 128 VCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPF 168
+ Y APE++ + Y + +D+WSVG IL E+L+ P F
Sbjct: 172 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 213
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 2e-34
Identities = 40/191 (20%), Positives = 79/191 (41%), Gaps = 20/191 (10%)
Query: 2 LKKLNKHL----KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
+K +N+ + E + + N +++RL +++E G+L SY+
Sbjct: 55 IKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 114
Query: 58 RLHGRV----------PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVM 107
R + ++ G+ LN++ +HRDL N + + +D
Sbjct: 115 RSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM---VAEDFT 171
Query: 108 LKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164
+KI DFG++ +Y +Y K +M+PE L+ + D+WS G +L+E+
Sbjct: 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 231
Query: 165 YPPFSVGEEHQ 175
G ++
Sbjct: 232 AEQPYQGLSNE 242
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 120 bits (301), Expect = 2e-34
Identities = 28/179 (15%), Positives = 65/179 (36%), Gaps = 12/179 (6%)
Query: 2 LKKLNKHLKS-CLDCELNFLSSVNHPNII-RLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
+K + + L E + I ++ Q LV++
Sbjct: 35 IKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLC 94
Query: 60 HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS--GLDDDVMLKIADFGLSC 117
+ +T +Q+ A ++ ++ +++RD+KP+N L+ + M+ + DFG+
Sbjct: 95 GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154
Query: 118 TLYPG--------NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
+ + G+ YM+ + + D+ ++G + L G P+
Sbjct: 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 213
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 4e-34
Identities = 54/167 (32%), Positives = 88/167 (52%), Gaps = 8/167 (4%)
Query: 16 ELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
E L + P ++ L AFQ E + L++++ GG L +++ R E + ++ +
Sbjct: 78 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE 137
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL--YPGNYAEKVCGSP 132
+ LE L+ II+RD+K ENIL LD + + + DFGLS A CG+
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENIL---LDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 194
Query: 133 LYMAPEVLQFQR--YDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 177
YMAP++++ +D+ VD WS+G +++ELL G PF+V E
Sbjct: 195 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ 241
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 4e-33
Identities = 53/193 (27%), Positives = 89/193 (46%), Gaps = 28/193 (14%)
Query: 2 LKKLNKHL----KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY 56
+K L S L E+ + + H NII L A + ++++VE+ + GNL Y
Sbjct: 50 VKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 109
Query: 57 IRLHG----------------RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS 100
++ ++ + Q+ G+E L S IHRDL N+L
Sbjct: 110 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL-- 167
Query: 101 GLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSPLYMAPEVLQFQRYDEKVDMWSVGAI 157
+ +D ++KIADFGL+ ++ +Y +K +MAPE L + Y + D+WS G +
Sbjct: 168 -VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 226
Query: 158 LFELLN-GYPPFS 169
L+E+ G P+
Sbjct: 227 LWEIFTLGGSPYP 239
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 4e-33
Identities = 54/176 (30%), Positives = 85/176 (48%), Gaps = 5/176 (2%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L ++ + S E+ L + H NI+RL D ++ + LV EFC + +G
Sbjct: 37 LDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG 96
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY- 120
+ + + FL QL GL +S +++HRDLKP+N+L ++ + LK+A+FGL+
Sbjct: 97 DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLL---INRNGELKLANFGLARAFGI 153
Query: 121 PGNYAEKVCGSPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQ 175
P + Y P+VL + Y +DMWS G I EL N P G +
Sbjct: 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 7e-33
Identities = 48/182 (26%), Positives = 72/182 (39%), Gaps = 25/182 (13%)
Query: 16 ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR---------------- 58
EL LS + NH NI+ L A ++ E+C G+L +++R
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 59 --LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
+ + F Q+ G+ L S + IHRDL NIL L + KI DFGL+
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL---LTHGRITKICDFGLA 192
Query: 117 CTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEE 173
+ + +MAPE + Y + D+WS G L+EL + G
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252
Query: 174 HQ 175
Sbjct: 253 VD 254
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 2e-32
Identities = 58/186 (31%), Positives = 89/186 (47%), Gaps = 19/186 (10%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
+KKL + +S L EL L + H N+I L D F + +LV+ F
Sbjct: 48 IKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-- 105
Query: 51 GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
G + H ++ E + + Q+ GL +++ IIHRDLKP N+ +++D LKI
Sbjct: 106 GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLA---VNEDCELKI 162
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
DFGL+ + + Y APEV L + RY + VD+WSVG I+ E++ G F
Sbjct: 163 LDFGLARQ--ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 220
Query: 170 VGEEHQ 175
+
Sbjct: 221 GSDHLD 226
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 7e-31
Identities = 56/178 (31%), Positives = 82/178 (46%), Gaps = 17/178 (9%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
+KKL++ ++ EL + VNH NII L + F + ++LV+E
Sbjct: 47 IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA 106
Query: 51 GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
+ + + L Q+ G++ L+S IIHRDLKP NI + D LKI
Sbjct: 107 NLCQ---VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI---VVKSDCTLKI 160
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
DFGL+ T + Y APEV+ Y E VD+WSVG I+ E++ F
Sbjct: 161 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 218
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 2e-29
Identities = 56/178 (31%), Positives = 92/178 (51%), Gaps = 17/178 (9%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGG 51
+KKL++ +S + EL L + H N+I L D F E +V G
Sbjct: 48 VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA 107
Query: 52 NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
+L++ ++ ++ + + + Q+ GL+ ++S IIHRDLKP N+ + ++D LKI
Sbjct: 108 DLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKIL 163
Query: 112 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF 168
DFGL+ + + + Y APE+ L + Y++ VD+WSVG I+ ELL G F
Sbjct: 164 DFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 1e-28
Identities = 49/197 (24%), Positives = 85/197 (43%), Gaps = 28/197 (14%)
Query: 2 LKKLNKH-----LKSCLDCELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSS 55
+K L + ++ + + +H N++ L A + + ++VEFC GNLS+
Sbjct: 48 VKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 107
Query: 56 YIRLHGR----------------VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL 99
Y+R + + + Q+ G+E L S IHRDL NIL
Sbjct: 108 YLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL- 166
Query: 100 SGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSPLYMAPEVLQFQRYDEKVDMWSVGA 156
L + ++KI DFGL+ +Y + +MAPE + + Y + D+WS G
Sbjct: 167 --LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 224
Query: 157 ILFELLNGYPPFSVGEE 173
+L+E+ + G +
Sbjct: 225 LLWEIFSLGASPYPGVK 241
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 98.2 bits (243), Expect = 2e-25
Identities = 49/180 (27%), Positives = 81/180 (45%), Gaps = 11/180 (6%)
Query: 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGN---LSSYIRLHG 61
K L+ D + S+ +I++L D F N + +V+ F G H
Sbjct: 61 KLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHR 120
Query: 62 RVPEQTARKFLQQLGAGLEILNSHH-IIHRDLKPENILLSGLD---DDVMLKIADFGLSC 117
+P ++ +QL GL+ ++ IIH D+KPEN+L+ +D + + +KIAD G +C
Sbjct: 121 GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 180
Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSVGEEHQFM 177
+ Y +PEVL + D+WS ++FEL+ G F E H +
Sbjct: 181 WYDEHYT--NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 66.7 bits (162), Expect = 9e-15
Identities = 20/147 (13%), Positives = 46/147 (31%), Gaps = 27/147 (18%)
Query: 19 FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
L + + +++ +++E RV + + L +
Sbjct: 67 ALQKLQGLAVPKVYAWEG----NAVLMELIDAKE-------LYRVRVENPDEVLDMILEE 115
Query: 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPE 138
+ I+H DL N+L+ + + I DF S + + E + +
Sbjct: 116 VAKFYHRGIVHGDLSQYNVLV----SEEGIWIIDFPQSVEVGEEGWRE-------ILERD 164
Query: 139 VLQF-----QRYDEKVDMWSVGAILFE 160
V + Y + D+ S + +
Sbjct: 165 VRNIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 177 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.96 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.77 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.15 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.99 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.25 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.32 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 94.75 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.94 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-46 Score=266.83 Aligned_cols=163 Identities=34% Similarity=0.634 Sum_probs=148.2
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+.+.+|++++++++||||+++++++.+++.+|+||||++||+|.+++.+.+.+++..+..++.|++.||+|||++|+
T Consensus 48 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~i 127 (263)
T d2j4za1 48 GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 127 (263)
T ss_dssp TCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 34677899999999999999999999999999999999999999999999988899999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
+||||||+||++ +..+.++|+|||.+....... .....||+.|+|||.+.+..++.++|+||+|+++|+|++|+.|
T Consensus 128 vHrDiKp~Nill---~~~~~~kl~DFG~a~~~~~~~-~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~P 203 (263)
T d2j4za1 128 IHRDIKPENLLL---GSAGELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 203 (263)
T ss_dssp CCCCCCGGGEEE---CTTSCEEECCCCSCSCCCCCC-CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCT
T ss_pred eeeeecccccee---cCCCCEeecccceeeecCCCc-ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCC
Confidence 999999999999 466789999999997654433 3345689999999999988899999999999999999999999
Q ss_pred CCCCCcc
Q 030430 168 FSVGEEH 174 (177)
Q Consensus 168 f~~~~~~ 174 (177)
|.+.+..
T Consensus 204 f~~~~~~ 210 (263)
T d2j4za1 204 FEANTYQ 210 (263)
T ss_dssp TCCSSHH
T ss_pred CCCCCHH
Confidence 9886644
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-45 Score=270.16 Aligned_cols=166 Identities=37% Similarity=0.688 Sum_probs=135.0
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
.....+.+|++++++++||||+++++++.+++.+|+||||++|++|.+++...+.+++..+..++.|++.||+|||+.|+
T Consensus 49 ~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~i 128 (307)
T d1a06a_ 49 GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 128 (307)
T ss_dssp ------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhcee
Confidence 34567889999999999999999999999999999999999999999999988889999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
+||||||+||++...+..+.++|+|||++.............||+.|+|||.+.+..++.++|+||+||++|+|++|..|
T Consensus 129 iHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~P 208 (307)
T d1a06a_ 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 208 (307)
T ss_dssp CCSCCCGGGEEESSSSTTCCEEECCC------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred eeEEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCC
Confidence 99999999999975556778999999999876655555566799999999999988899999999999999999999999
Q ss_pred CCCCCc
Q 030430 168 FSVGEE 173 (177)
Q Consensus 168 f~~~~~ 173 (177)
|.+.+.
T Consensus 209 f~~~~~ 214 (307)
T d1a06a_ 209 FYDEND 214 (307)
T ss_dssp CCCSSH
T ss_pred CCCCCH
Confidence 987654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-45 Score=265.19 Aligned_cols=162 Identities=31% Similarity=0.586 Sum_probs=146.2
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
...+.+.+|++++++++||||+++++++.+++.+|+||||++|++|.+++.. ..+++..+..++.|++.||+|||++|+
T Consensus 59 ~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~i 137 (293)
T d1yhwa1 59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQV 137 (293)
T ss_dssp SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3467799999999999999999999999999999999999999999998764 479999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~ 166 (177)
+||||||+||++ +..+.++|+|||++....... ......||+.|+|||.+.+..++.++||||+|+++|+|++|+.
T Consensus 138 iHrDiKp~NILl---~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~ 214 (293)
T d1yhwa1 138 IHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214 (293)
T ss_dssp ECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccCCcHHHeEE---CCCCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCC
Confidence 999999999999 456789999999998765433 3445668999999999998889999999999999999999999
Q ss_pred CCCCCCc
Q 030430 167 PFSVGEE 173 (177)
Q Consensus 167 pf~~~~~ 173 (177)
||.+.+.
T Consensus 215 Pf~~~~~ 221 (293)
T d1yhwa1 215 PYLNENP 221 (293)
T ss_dssp TTTTSCH
T ss_pred CCCCCCH
Confidence 9987653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=264.24 Aligned_cols=162 Identities=36% Similarity=0.647 Sum_probs=143.3
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
..+.+.+|++++++++||||+++++++.+++.+|+||||++|++|.+++.....+++..+..++.|++.||+|||++|++
T Consensus 46 ~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~Ii 125 (271)
T d1nvra_ 46 CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT 125 (271)
T ss_dssp ---CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCc
Confidence 45678999999999999999999999999999999999999999999998778899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCC---ccccccCCCccccccccccCCC-CCcchHHHHHHHHHHHHhC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slg~~~~~~~~~ 164 (177)
||||||+||++ +..+.++|+|||++....... ......||+.|+|||.+.+..+ +.++||||+|+++|+|++|
T Consensus 126 HrDiKp~NILl---~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G 202 (271)
T d1nvra_ 126 HRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 202 (271)
T ss_dssp CSCCCGGGEEE---CTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred cCcccHHHEEE---CCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhC
Confidence 99999999999 466789999999997764332 2334568999999999987775 5789999999999999999
Q ss_pred CCCCCCCCc
Q 030430 165 YPPFSVGEE 173 (177)
Q Consensus 165 ~~pf~~~~~ 173 (177)
+.||....+
T Consensus 203 ~~pf~~~~~ 211 (271)
T d1nvra_ 203 ELPWDQPSD 211 (271)
T ss_dssp SCSCSSSST
T ss_pred CCCCCCCCh
Confidence 999977554
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-45 Score=264.83 Aligned_cols=163 Identities=34% Similarity=0.663 Sum_probs=145.8
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
..+.+.+|++++++++||||+++++++.+.+.+|+||||++||+|.+++...+.+++..+..++.|++.||+|||+.|++
T Consensus 51 ~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~ii 130 (288)
T d1uu3a_ 51 KVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGII 130 (288)
T ss_dssp CHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEE
Confidence 45679999999999999999999999999999999999999999999999888999999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCC---ccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~ 165 (177)
||||||+||++ +..+.++|+|||.++...... ......||+.|+|||.+.+..++.++||||+||++|+|++|+
T Consensus 131 HrDiKp~NIll---~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~ 207 (288)
T d1uu3a_ 131 HRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 207 (288)
T ss_dssp CSCCSGGGEEE---CTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred cCcCCcccccc---CCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCC
Confidence 99999999999 467789999999997764332 223456899999999999889999999999999999999999
Q ss_pred CCCCCCCcc
Q 030430 166 PPFSVGEEH 174 (177)
Q Consensus 166 ~pf~~~~~~ 174 (177)
.||.+.+..
T Consensus 208 ~Pf~~~~~~ 216 (288)
T d1uu3a_ 208 PPFRAGNEY 216 (288)
T ss_dssp CSSCCSSHH
T ss_pred CCCCCcCHH
Confidence 999887644
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=269.49 Aligned_cols=164 Identities=33% Similarity=0.552 Sum_probs=147.3
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
++..++.+.+|++++++++||||+++++++.+.+.+|+||||++|++|.+++.+.+.+++..+..++.|++.||.|||++
T Consensus 44 ~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~ 123 (322)
T d1s9ja_ 44 KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123 (322)
T ss_dssp CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 45667889999999999999999999999999999999999999999999999888899999999999999999999975
Q ss_pred -CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhC
Q 030430 86 -HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 86 -~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~ 164 (177)
|++||||||+||++ +..+.++|+|||+|....... ..+..||+.|+|||.+.+..++.++||||+||++++|++|
T Consensus 124 ~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~~-~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G 199 (322)
T d1s9ja_ 124 HKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199 (322)
T ss_dssp HCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHHHHT-C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHS
T ss_pred CCEEccccCHHHeeE---CCCCCEEEeeCCCccccCCCc-cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHC
Confidence 99999999999999 567789999999997654322 2345689999999999999999999999999999999999
Q ss_pred CCCCCCCCc
Q 030430 165 YPPFSVGEE 173 (177)
Q Consensus 165 ~~pf~~~~~ 173 (177)
+.||.+.+.
T Consensus 200 ~~Pf~~~~~ 208 (322)
T d1s9ja_ 200 RYPIPPPDA 208 (322)
T ss_dssp SCCSSCCCT
T ss_pred CCCCCCCCH
Confidence 999987653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.3e-45 Score=269.49 Aligned_cols=168 Identities=32% Similarity=0.574 Sum_probs=151.3
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
.....+.+.+|++++++++||||+++++++.+.+.+|+||||++||+|.+++.. .+.+++..+..++.||+.||+|||+
T Consensus 63 ~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~ 142 (350)
T d1koaa2 63 HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142 (350)
T ss_dssp SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHH
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 445577899999999999999999999999999999999999999999999853 4569999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhC
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~ 164 (177)
+|++||||||+||++.. +..+.++|+|||++.............+|+.|+|||.+.+..++.++||||+||++|+|++|
T Consensus 143 ~~iiHrDiKp~NIll~~-~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G 221 (350)
T d1koaa2 143 NNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 221 (350)
T ss_dssp TTEECCCCCGGGEEESS-TTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred cCCeeeeechhHeeecc-CCCCeEEEeecchheecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhC
Confidence 99999999999999952 23567999999999887766666667799999999999988899999999999999999999
Q ss_pred CCCCCCCCcc
Q 030430 165 YPPFSVGEEH 174 (177)
Q Consensus 165 ~~pf~~~~~~ 174 (177)
..||.+.+..
T Consensus 222 ~~Pf~~~~~~ 231 (350)
T d1koaa2 222 LSPFGGENDD 231 (350)
T ss_dssp SCSSCCSSHH
T ss_pred CCCCCCCCHH
Confidence 9999876554
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-44 Score=256.59 Aligned_cols=163 Identities=33% Similarity=0.624 Sum_probs=143.3
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEee----CCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (177)
.+...+.+.+|++++++++||||+++++++.+ ...+++||||++|++|.+++.+...+++..+..++.|++.||+|
T Consensus 48 ~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~y 127 (270)
T d1t4ha_ 48 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF 127 (270)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHH
Confidence 45567789999999999999999999999865 35689999999999999999988889999999999999999999
Q ss_pred HhhCC--CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHH
Q 030430 82 LNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (177)
Q Consensus 82 lh~~~--~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~ 159 (177)
||++| ++||||||+||++. +..+.++|+|||++...... ......||+.|+|||.+.+ .++.++||||+|+++|
T Consensus 128 LH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~DFGla~~~~~~-~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvily 203 (270)
T d1t4ha_ 128 LHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCML 203 (270)
T ss_dssp HHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHH
T ss_pred HHHCCCCEEeCCcChhhceee--CCCCCEEEeecCcceeccCC-ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHH
Confidence 99999 99999999999995 34668999999999654333 3335569999999998864 6899999999999999
Q ss_pred HHHhCCCCCCCCC
Q 030430 160 ELLNGYPPFSVGE 172 (177)
Q Consensus 160 ~~~~~~~pf~~~~ 172 (177)
+|++|+.||.+..
T Consensus 204 el~~g~~Pf~~~~ 216 (270)
T d1t4ha_ 204 EMATSEYPYSECQ 216 (270)
T ss_dssp HHHHSSCTTTTCS
T ss_pred HHHHCCCCCCCcc
Confidence 9999999997654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-44 Score=263.98 Aligned_cols=164 Identities=32% Similarity=0.540 Sum_probs=150.0
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
..+.+.+|+.+|++++||||+++++++.+...+|+||||++||+|.+++.+...++++.++.++.|++.||+|||++|++
T Consensus 48 ~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~ii 127 (337)
T d1o6la_ 48 EVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 127 (337)
T ss_dssp CHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred HHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCcc
Confidence 35678899999999999999999999999999999999999999999999888999999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCC-CccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
||||||+||++ +..+.++|+|||.++..... .......||+.|+|||.+.+..++.++|+||+||++|+|++|+.|
T Consensus 128 HRDlKP~NILl---~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~p 204 (337)
T d1o6la_ 128 YRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204 (337)
T ss_dssp CCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred ccccCHHHeEe---cCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCC
Confidence 99999999999 56778999999999876443 334456789999999999999999999999999999999999999
Q ss_pred CCCCCccc
Q 030430 168 FSVGEEHQ 175 (177)
Q Consensus 168 f~~~~~~~ 175 (177)
|.+.+..+
T Consensus 205 f~~~~~~~ 212 (337)
T d1o6la_ 205 FYNQDHER 212 (337)
T ss_dssp SCCSSHHH
T ss_pred CCCcCHHH
Confidence 99876543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.5e-44 Score=267.05 Aligned_cols=167 Identities=29% Similarity=0.563 Sum_probs=150.6
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
...+..+.+|++++++++||||+++++++.+++.+|+||||++|++|.+++.... .+++..++.++.|++.||+|||+.
T Consensus 67 ~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~ 146 (352)
T d1koba_ 67 PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 146 (352)
T ss_dssp HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4456788999999999999999999999999999999999999999998776544 599999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCC
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~ 165 (177)
|++||||||+||++.. ...+.++|+|||++.............+++.|+|||.+.+..++.++|||||||++|+|++|.
T Consensus 147 ~iiHRDiKp~NILl~~-~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~ 225 (352)
T d1koba_ 147 SIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 225 (352)
T ss_dssp TEECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSC
T ss_pred Ceeecccccccccccc-cCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCC
Confidence 9999999999999952 245689999999998887766666677999999999999888999999999999999999999
Q ss_pred CCCCCCCcc
Q 030430 166 PPFSVGEEH 174 (177)
Q Consensus 166 ~pf~~~~~~ 174 (177)
.||.+.+..
T Consensus 226 ~Pf~~~~~~ 234 (352)
T d1koba_ 226 SPFAGEDDL 234 (352)
T ss_dssp CSSCCSSHH
T ss_pred CCCCCCCHH
Confidence 999886543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=262.74 Aligned_cols=167 Identities=35% Similarity=0.553 Sum_probs=145.0
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
+....+.+.+|++++++++||||+++++++.+.+.+++||||++||+|.+++.+. ..+++..+..++.|++.||+|||+
T Consensus 49 ~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~ 128 (288)
T d2jfla1 49 SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128 (288)
T ss_dssp SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3455678999999999999999999999999999999999999999999987654 569999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccc-----cCCCCCcchHHHHHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAIL 158 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~-----~~~~~~~~Di~slg~~~ 158 (177)
+|++||||||+||++ +.++.++|+|||++....... ......|++.|+|||.+. ...++.++||||+||++
T Consensus 129 ~~ivHrDiKp~NIll---~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvil 205 (288)
T d2jfla1 129 NKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITL 205 (288)
T ss_dssp TTEECCCCSGGGEEE---CTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHH
T ss_pred CCEEEeecChhheeE---CCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHH
Confidence 999999999999999 466789999999986653321 223456899999999873 44578999999999999
Q ss_pred HHHHhCCCCCCCCCccc
Q 030430 159 FELLNGYPPFSVGEEHQ 175 (177)
Q Consensus 159 ~~~~~~~~pf~~~~~~~ 175 (177)
|+|++|+.||.+.+..+
T Consensus 206 yemltg~~Pf~~~~~~~ 222 (288)
T d2jfla1 206 IEMAEIEPPHHELNPMR 222 (288)
T ss_dssp HHHHHSSCTTTTSCGGG
T ss_pred HHHhhCCCCCCCCCHHH
Confidence 99999999998865543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-44 Score=259.01 Aligned_cols=166 Identities=33% Similarity=0.629 Sum_probs=150.3
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
..+.+.+|++++++++||||+++++++.+.+.+|+||||++|++|.+++...+.+++..++.++.|++.||+|||+.|++
T Consensus 56 ~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~iv 135 (293)
T d1jksa_ 56 SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIA 135 (293)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhccee
Confidence 35789999999999999999999999999999999999999999999999888899999999999999999999999999
Q ss_pred eecCCCCcEEEecCC-CCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 89 HRDLKPENILLSGLD-DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 89 H~~i~~~nil~~~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
||||||+||++...+ ....++++|||.+.............+++.|+|||.+.+..++.++|+||+|+++|+|++|+.|
T Consensus 136 HrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~P 215 (293)
T d1jksa_ 136 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215 (293)
T ss_dssp CCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ecccccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCC
Confidence 999999999996322 2346999999999887666555566789999999999988899999999999999999999999
Q ss_pred CCCCCcc
Q 030430 168 FSVGEEH 174 (177)
Q Consensus 168 f~~~~~~ 174 (177)
|.+.+..
T Consensus 216 f~~~~~~ 222 (293)
T d1jksa_ 216 FLGDTKQ 222 (293)
T ss_dssp SCCSSHH
T ss_pred CCCCCHH
Confidence 9876543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-43 Score=259.25 Aligned_cols=161 Identities=39% Similarity=0.686 Sum_probs=147.6
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
..+.+.+|++++++++||||+++++++.+++.+|+||||+.|++|..++.....++++.+..++.|++.||+|||++|++
T Consensus 47 ~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ii 126 (316)
T d1fota_ 47 QVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDII 126 (316)
T ss_dssp CHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred HHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEE
Confidence 35678999999999999999999999999999999999999999999999888899999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf 168 (177)
||||||+||++ +..+.++|+|||.+....... ....||+.|+|||.+.+..++.++|+||+|+++|+|++|+.||
T Consensus 127 HrDiKp~NILl---~~~g~vkL~DFG~a~~~~~~~--~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf 201 (316)
T d1fota_ 127 YRDLKPENILL---DKNGHIKITDFGFAKYVPDVT--YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 201 (316)
T ss_dssp CCCCCGGGEEE---CTTSCEEECCCSSCEECSSCB--CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred ccccCchheeE---cCCCCEEEecCccceEecccc--ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCC
Confidence 99999999999 567789999999998765433 3456999999999999888999999999999999999999999
Q ss_pred CCCCcc
Q 030430 169 SVGEEH 174 (177)
Q Consensus 169 ~~~~~~ 174 (177)
.+.+..
T Consensus 202 ~~~~~~ 207 (316)
T d1fota_ 202 YDSNTM 207 (316)
T ss_dssp CCSSHH
T ss_pred CCcCHH
Confidence 887643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-44 Score=256.29 Aligned_cols=166 Identities=35% Similarity=0.683 Sum_probs=135.3
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEee--CCeEEEEEecCCCCChHHHHhh----cCCCCHHHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGL 79 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l 79 (177)
++...+.+.+|++++++++||||+++++++.+ ++.+|+||||++||+|.+++.+ ...+++..++.++.|++.||
T Consensus 43 ~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al 122 (269)
T d2java1 43 TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122 (269)
T ss_dssp CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHH
Confidence 55667889999999999999999999998864 4568999999999999999864 35699999999999999999
Q ss_pred HHHhhCC-----CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccCCCCCcchHHH
Q 030430 80 EILNSHH-----IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWS 153 (177)
Q Consensus 80 ~~lh~~~-----~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~s 153 (177)
+|||++| ++||||||+||++ +..+.++|+|||.+....... ......+|+.|+|||.+.+..++.++||||
T Consensus 123 ~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwS 199 (269)
T d2java1 123 KECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWS 199 (269)
T ss_dssp HHHHHHCC---------CCGGGEEE---CTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHH
T ss_pred HHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHh
Confidence 9999976 9999999999999 467789999999998765433 234566899999999998888999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcc
Q 030430 154 VGAILFELLNGYPPFSVGEEH 174 (177)
Q Consensus 154 lg~~~~~~~~~~~pf~~~~~~ 174 (177)
+|+++|+|++|+.||.+.+..
T Consensus 200 lGvilyel~tg~~Pf~~~~~~ 220 (269)
T d2java1 200 LGCLLYELCALMPPFTAFSQK 220 (269)
T ss_dssp HHHHHHHHHHSSCSCCCSSHH
T ss_pred hCHHHHHHhhCCCCCCCCCHH
Confidence 999999999999999886544
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-43 Score=257.12 Aligned_cols=161 Identities=33% Similarity=0.545 Sum_probs=143.3
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
....+.+.+|++++++++||||+++++++.+++.+|+||||+.|++|..++.....+++..+..++.|++.||+|||++|
T Consensus 56 ~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~ 135 (309)
T d1u5ra_ 56 NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135 (309)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34456799999999999999999999999999999999999999999888777788999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCcccccccccc---CCCCCcchHHHHHHHHHHHHh
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF---QRYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~---~~~~~~~Di~slg~~~~~~~~ 163 (177)
++||||||+||+++ ..+.++|+|||.+...... ....||+.|+|||.+.+ ..++.++||||+|+++|+|++
T Consensus 136 iiHrDiKp~NILl~---~~~~~Kl~DFG~a~~~~~~---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~ 209 (309)
T d1u5ra_ 136 MIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 209 (309)
T ss_dssp CBCCCCSGGGEEEE---TTTEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHH
T ss_pred EeccCCCcceEEEC---CCCCEEEeecccccccCCC---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHH
Confidence 99999999999994 6778999999999765432 24568999999999853 357889999999999999999
Q ss_pred CCCCCCCCCc
Q 030430 164 GYPPFSVGEE 173 (177)
Q Consensus 164 ~~~pf~~~~~ 173 (177)
|..||.+.+.
T Consensus 210 g~~Pf~~~~~ 219 (309)
T d1u5ra_ 210 RKPPLFNMNA 219 (309)
T ss_dssp SSCTTTTSCH
T ss_pred CCCCCCCCCH
Confidence 9999987653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-43 Score=256.67 Aligned_cols=166 Identities=25% Similarity=0.491 Sum_probs=137.5
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
++...+.+.+|++++++++||||+++++++.+++.+++||||++||+|.+++... +.+++.++..++.|++.||+|||+
T Consensus 67 ~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~ 146 (299)
T d1jpaa_ 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD 146 (299)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 4556778999999999999999999999999999999999999999999988864 469999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc------ccccCCCccccccccccCCCCCcchHHHHHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA------EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~------~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~ 158 (177)
.|++||||||+||++ +.++.+||+|||+++........ ....+++.|+|||.+.+..++.++||||+|+++
T Consensus 147 ~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl 223 (299)
T d1jpaa_ 147 MNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVM 223 (299)
T ss_dssp TTCCCSCCCGGGEEE---CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHH
T ss_pred CCCccCccccceEEE---CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHH
Confidence 999999999999999 56788999999999766443221 123467889999999888899999999999999
Q ss_pred HHHHh-CCCCCCCCCcc
Q 030430 159 FELLN-GYPPFSVGEEH 174 (177)
Q Consensus 159 ~~~~~-~~~pf~~~~~~ 174 (177)
|||+| |+.||.+.+..
T Consensus 224 ~el~t~g~~Pf~~~~~~ 240 (299)
T d1jpaa_ 224 WEVMSYGERPYWDMTNQ 240 (299)
T ss_dssp HHHHTTSCCTTTTCCHH
T ss_pred HHHHhCCCCCCCCCCHH
Confidence 99998 89999876543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.5e-42 Score=249.94 Aligned_cols=164 Identities=41% Similarity=0.780 Sum_probs=148.1
Q ss_pred hHHHHHHHHHHHHhhCC-CCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 8 HLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
..++++.+|++++++++ ||||+++++++.+++.+|+||||++|++|.+++...+.+++++++.++.|++.||+|||++|
T Consensus 51 ~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ 130 (277)
T d1phka_ 51 ELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 130 (277)
T ss_dssp HHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC
Confidence 35667899999999996 99999999999999999999999999999999998889999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCcccccccccc------CCCCCcchHHHHHHHHHH
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF------QRYDEKVDMWSVGAILFE 160 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~------~~~~~~~Di~slg~~~~~ 160 (177)
++||||||+||++ +.++.++|+|||.+.............|++.|+|||.+.+ ..++.++|+||+|+++++
T Consensus 131 ivHrDlkp~Nill---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilye 207 (277)
T d1phka_ 131 IVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYT 207 (277)
T ss_dssp EECSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHH
T ss_pred CcccccccceEEE---cCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhh
Confidence 9999999999999 5778899999999988766555556678999999998753 235789999999999999
Q ss_pred HHhCCCCCCCCCcc
Q 030430 161 LLNGYPPFSVGEEH 174 (177)
Q Consensus 161 ~~~~~~pf~~~~~~ 174 (177)
|++|+.||.+.++.
T Consensus 208 ml~g~~Pf~~~~~~ 221 (277)
T d1phka_ 208 LLAGSPPFWHRKQM 221 (277)
T ss_dssp HHHSSCSSCCSSHH
T ss_pred hccCCCCCCCCCHH
Confidence 99999999887644
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.2e-43 Score=258.54 Aligned_cols=160 Identities=33% Similarity=0.628 Sum_probs=146.9
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
.+.+.+|++++++++||||+++++++.+....++++||+.|++|.+++.+.+.+++..+..++.|++.||.|||++|++|
T Consensus 85 ~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiH 164 (350)
T d1rdqe_ 85 IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY 164 (350)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEec
Confidence 45788999999999999999999999999999999999999999999998889999999999999999999999999999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~pf~ 169 (177)
|||||+||++ +..+.++|+|||+++...... ....|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.
T Consensus 165 RDIKP~NILl---~~~g~ikL~DFG~a~~~~~~~--~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~ 239 (350)
T d1rdqe_ 165 RDLKPENLLI---DQQGYIQVTDFGFAKRVKGRT--WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239 (350)
T ss_dssp CCCSGGGEEE---CTTSCEEECCCTTCEECSSCB--CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CcCCHHHccc---CCCCCEEeeeceeeeeccccc--ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCC
Confidence 9999999999 467789999999998765433 34568999999999998889999999999999999999999998
Q ss_pred CCCcc
Q 030430 170 VGEEH 174 (177)
Q Consensus 170 ~~~~~ 174 (177)
+.+..
T Consensus 240 ~~~~~ 244 (350)
T d1rdqe_ 240 ADQPI 244 (350)
T ss_dssp CSSHH
T ss_pred CcCHH
Confidence 76543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-43 Score=255.92 Aligned_cols=167 Identities=29% Similarity=0.524 Sum_probs=149.6
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
......+.+|+++|++++||||+++++++.+++.+|+||||++|++|.+++...+ .++++.+..++.|++.||+|||+.
T Consensus 42 ~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~ 121 (321)
T d1tkia_ 42 GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121 (321)
T ss_dssp THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc
Confidence 3445678899999999999999999999999999999999999999999998665 699999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCC
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~ 165 (177)
|++||||||+||++.. +....++++|||.+.............+++.|++||...+..++.++|+||+|+++|+|++|.
T Consensus 122 ~iiHrDlKp~NIll~~-~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~ 200 (321)
T d1tkia_ 122 NIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI 200 (321)
T ss_dssp TEECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSS
T ss_pred CCCcccccccceeecC-CCceEEEEcccchhhccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCC
Confidence 9999999999999952 235579999999998876666555667899999999998888999999999999999999999
Q ss_pred CCCCCCCcc
Q 030430 166 PPFSVGEEH 174 (177)
Q Consensus 166 ~pf~~~~~~ 174 (177)
.||.+.+..
T Consensus 201 ~Pf~~~~~~ 209 (321)
T d1tkia_ 201 NPFLAETNQ 209 (321)
T ss_dssp CTTCCSSHH
T ss_pred CCCCCCCHH
Confidence 999887654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-43 Score=252.89 Aligned_cols=165 Identities=28% Similarity=0.517 Sum_probs=143.3
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
++..++++.+|++++++++||||+++++++.++ ..++||||+++|+|.+++.....+++..+..++.|++.||+|||+.
T Consensus 48 ~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~ 126 (277)
T d1xbba_ 48 DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 126 (277)
T ss_dssp -CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC
Confidence 344567899999999999999999999998655 4689999999999999999888899999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc----cccccCCCccccccccccCCCCCcchHHHHHHHHHHH
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~ 161 (177)
|++||||||+||+++ ..+.++++|||+++....... .....+++.|+|||.+.+..++.++||||+|+++||+
T Consensus 127 ~iiHrDlKp~Nill~---~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~el 203 (277)
T d1xbba_ 127 NFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEA 203 (277)
T ss_dssp TEECSCCSGGGEEEE---ETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHH
T ss_pred CcccCCCcchhhccc---ccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHH
Confidence 999999999999994 567899999999976644322 1234578899999999888899999999999999999
Q ss_pred Hh-CCCCCCCCCcc
Q 030430 162 LN-GYPPFSVGEEH 174 (177)
Q Consensus 162 ~~-~~~pf~~~~~~ 174 (177)
+| |+.||.+.+..
T Consensus 204 lt~g~~Pf~~~~~~ 217 (277)
T d1xbba_ 204 FSYGQKPYRGMKGS 217 (277)
T ss_dssp HTTTCCSSTTCCHH
T ss_pred hhCCCCCCCCCCHH
Confidence 98 89999876543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-43 Score=258.85 Aligned_cols=163 Identities=34% Similarity=0.661 Sum_probs=144.3
Q ss_pred HHHHHHHHHHhh-CCCCceeeEeEEEee----CCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHh
Q 030430 11 SCLDCELNFLSS-VNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 11 ~~~~~e~~~l~~-l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh 83 (177)
..+.+|++++.+ .+||||+++++++.+ +..+|+||||++||+|.+++.+. ..+++..+..++.|++.||+|||
T Consensus 49 ~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH 128 (335)
T d2ozaa1 49 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128 (335)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH
Confidence 567889998655 589999999999875 46789999999999999999864 35999999999999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~ 163 (177)
+.|++||||||+||++...+..+.++|+|||.+.............|++.|+|||.+.+..++.++|+||+||++|+|+|
T Consensus 129 ~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~llt 208 (335)
T d2ozaa1 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 208 (335)
T ss_dssp HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTT
T ss_pred HcCCccccccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhh
Confidence 99999999999999997544567799999999988776666667779999999999998889999999999999999999
Q ss_pred CCCCCCCCCc
Q 030430 164 GYPPFSVGEE 173 (177)
Q Consensus 164 ~~~pf~~~~~ 173 (177)
|+.||.+.+.
T Consensus 209 g~~Pf~~~~~ 218 (335)
T d2ozaa1 209 GYPPFYSNHG 218 (335)
T ss_dssp SSCSCEETTC
T ss_pred CCCCCCCCCH
Confidence 9999977543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=250.76 Aligned_cols=164 Identities=30% Similarity=0.514 Sum_probs=138.1
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
++...+.+.+|++++++++||||+++++++.+ +.+++||||++||+|.+++... ..+++..+..++.|++.||+|||+
T Consensus 44 ~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~ 122 (276)
T d1uwha_ 44 TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122 (276)
T ss_dssp CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhc
Confidence 45567889999999999999999999998755 4579999999999999999755 459999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC---ccccccCCCccccccccccC---CCCCcchHHHHHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQ---RYDEKVDMWSVGAIL 158 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~---~~~~~~Di~slg~~~ 158 (177)
.|++||||||+||+++ ..+.+||+|||++....... ......+|+.|+|||.+.+. .++.++||||+|+++
T Consensus 123 ~~ivHrDlKp~NiLl~---~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l 199 (276)
T d1uwha_ 123 KSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVL 199 (276)
T ss_dssp TTCCCSCCCGGGEEEE---TTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHH
T ss_pred CCEeccccCHHHEEEc---CCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHH
Confidence 9999999999999994 66789999999987654322 22345689999999998543 478899999999999
Q ss_pred HHHHhCCCCCCCCCc
Q 030430 159 FELLNGYPPFSVGEE 173 (177)
Q Consensus 159 ~~~~~~~~pf~~~~~ 173 (177)
|||+||+.||.+.+.
T Consensus 200 ~el~tg~~Pf~~~~~ 214 (276)
T d1uwha_ 200 YELMTGQLPYSNINN 214 (276)
T ss_dssp HHHHHSSCTTTTCCC
T ss_pred HHHHHCCCCCCCCCh
Confidence 999999999987543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=251.41 Aligned_cols=165 Identities=28% Similarity=0.523 Sum_probs=143.7
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
++...+++.+|++++++++||||+++++++.++ .+|+||||++||+|.+++... ..+++..+..++.|++.||+|||+
T Consensus 49 ~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~ 127 (285)
T d1u59a_ 49 EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 127 (285)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 456678899999999999999999999998754 578999999999999987654 569999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc----cccccCCCccccccccccCCCCCcchHHHHHHHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~ 160 (177)
+|++||||||+||+++ ..+.++|+|||++........ .....+++.|+|||.+....++.++||||+|+++||
T Consensus 128 ~~iiHrDlKp~Nill~---~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E 204 (285)
T d1u59a_ 128 KNFVHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWE 204 (285)
T ss_dssp TTEECCCCSGGGEEEE---ETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHH
T ss_pred CCeecCcCchhheeec---cCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHH
Confidence 9999999999999995 567899999999987654332 223447889999999988889999999999999999
Q ss_pred HHh-CCCCCCCCCcc
Q 030430 161 LLN-GYPPFSVGEEH 174 (177)
Q Consensus 161 ~~~-~~~pf~~~~~~ 174 (177)
++| |+.||.+.+..
T Consensus 205 ~lt~G~~Pf~~~~~~ 219 (285)
T d1u59a_ 205 ALSYGQKPYKKMKGP 219 (285)
T ss_dssp HHTTSCCTTTTCCTH
T ss_pred HHhCCCCCCCCCCHH
Confidence 998 89999876543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-42 Score=251.87 Aligned_cols=163 Identities=37% Similarity=0.648 Sum_probs=145.6
Q ss_pred HHHHHHHHHHHh-hCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 10 KSCLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 10 ~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
.+.+..|..++. .++||||+++++++.+++.+|+||||++||+|.+++.....+++..+..++.|++.||+|||++|++
T Consensus 46 ~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~ii 125 (320)
T d1xjda_ 46 VECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIV 125 (320)
T ss_dssp HHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred HHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 445677777665 6899999999999999999999999999999999999888999999999999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
||||||+||++ +..+.++++|||.++...... ......|++.|+|||.+.+..++.++|+||+||++|+|++|+.|
T Consensus 126 HrDikp~NiL~---~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~P 202 (320)
T d1xjda_ 126 YRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 202 (320)
T ss_dssp CCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred eccCcccceee---cCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCC
Confidence 99999999999 567789999999997665433 33346689999999999998999999999999999999999999
Q ss_pred CCCCCccc
Q 030430 168 FSVGEEHQ 175 (177)
Q Consensus 168 f~~~~~~~ 175 (177)
|.+.+..+
T Consensus 203 F~~~~~~~ 210 (320)
T d1xjda_ 203 FHGQDEEE 210 (320)
T ss_dssp SCCSSHHH
T ss_pred CCCCCHHH
Confidence 99876543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=248.62 Aligned_cols=164 Identities=26% Similarity=0.506 Sum_probs=134.6
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
....+.+.+|++++++++||||+++++++.+++.+++||||+++|+|.+++... ..++++.+..++.|++.||+|+|+.
T Consensus 41 ~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~ 120 (263)
T d1sm2a_ 41 AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120 (263)
T ss_dssp SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc
Confidence 334577999999999999999999999999999999999999999999998755 4588999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~ 163 (177)
+++||||||+||++ +.++.+||+|||+++....... .....++..|+|||.+.+..++.++||||+|+++||++|
T Consensus 121 ~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t 197 (263)
T d1sm2a_ 121 CVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 197 (263)
T ss_dssp TCCCTTCSGGGEEE---CGGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHT
T ss_pred ceeecccchhheee---cCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHH
Confidence 99999999999999 5678899999999976644332 223457889999999998899999999999999999999
Q ss_pred C-CCCCCCCCc
Q 030430 164 G-YPPFSVGEE 173 (177)
Q Consensus 164 ~-~~pf~~~~~ 173 (177)
+ .+||...+.
T Consensus 198 ~~~~~~~~~~~ 208 (263)
T d1sm2a_ 198 EGKIPYENRSN 208 (263)
T ss_dssp TSCCTTCSCCH
T ss_pred CCCCCCCCCCH
Confidence 5 666665543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.1e-41 Score=252.44 Aligned_cols=156 Identities=33% Similarity=0.590 Sum_probs=139.4
Q ss_pred HHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCeeecCCC
Q 030430 15 CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKP 94 (177)
Q Consensus 15 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H~~i~~ 94 (177)
.|+++++.++||||+++++++.+.+.+|+||||++|++|.+++.+...+++..++.++.|++.||+|||+.|++||||||
T Consensus 56 ~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP 135 (364)
T d1omwa3 56 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKP 135 (364)
T ss_dssp HHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeecc
Confidence 44677788899999999999999999999999999999999999888899999999999999999999999999999999
Q ss_pred CcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCcccccccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 030430 95 ENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYPPFSVGEE 173 (177)
Q Consensus 95 ~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~~~~~~pf~~~~~ 173 (177)
+||++ +..+.++|+|||++....... .....||+.|+|||.+.. ..++.++|+|||||++|+|++|+.||.+.+.
T Consensus 136 ~NILl---~~~g~iKl~DFGla~~~~~~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 211 (364)
T d1omwa3 136 ANILL---DEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 211 (364)
T ss_dssp GGEEE---CSSSCEEECCCTTCEECSSSC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS
T ss_pred ceeEE---cCCCcEEEeeeceeeecCCCc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH
Confidence 99999 567789999999998765443 334568999999999864 5689999999999999999999999987654
Q ss_pred c
Q 030430 174 H 174 (177)
Q Consensus 174 ~ 174 (177)
.
T Consensus 212 ~ 212 (364)
T d1omwa3 212 K 212 (364)
T ss_dssp S
T ss_pred H
Confidence 3
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-42 Score=254.83 Aligned_cols=166 Identities=29% Similarity=0.507 Sum_probs=142.9
Q ss_pred chhHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-----------------------
Q 030430 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------------- 61 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------------- 61 (177)
+......+.+|++++.++ +||||+++++++.+.+.+++||||++||+|.+++....
T Consensus 80 ~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (325)
T d1rjba_ 80 DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 159 (325)
T ss_dssp ----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC--------------------
T ss_pred CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccC
Confidence 344567789999999998 89999999999999999999999999999999997542
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCcccccc
Q 030430 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPE 138 (177)
Q Consensus 62 ~~~~~~~~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe 138 (177)
.+++..++.++.|++.||+|||++|++||||||+||+++ ..+.++|+|||+++....... .....+++.|+|||
T Consensus 160 ~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~---~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE 236 (325)
T d1rjba_ 160 VLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE 236 (325)
T ss_dssp -CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEE---TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccc---cCCeEEEeeccccccccCCCceeeeccccCCCccCChH
Confidence 378899999999999999999999999999999999994 677899999999976544332 22445789999999
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcc
Q 030430 139 VLQFQRYDEKVDMWSVGAILFELLN-GYPPFSVGEEH 174 (177)
Q Consensus 139 ~~~~~~~~~~~Di~slg~~~~~~~~-~~~pf~~~~~~ 174 (177)
.+.+..++.++||||+|+++|||+| |..||.+.+..
T Consensus 237 ~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 237 SLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred HHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 9988899999999999999999998 89999876543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.2e-42 Score=247.70 Aligned_cols=160 Identities=26% Similarity=0.438 Sum_probs=140.5
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
...+++.+|++++++++||||+++++++.+++.++++|||+++|+|.+++... ..+++..+..++.|++.||+|||+.
T Consensus 55 ~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~ 134 (287)
T d1opja_ 55 MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134 (287)
T ss_dssp SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC
Confidence 34567999999999999999999999999999999999999999999998754 4589999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCcc--ccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~ 163 (177)
|++||||||+||++ +..+.+||+|||+++........ ....++..|+|||.+.+..++.++||||+|+++|+|++
T Consensus 135 ~iiHrDlKp~NILl---~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~ 211 (287)
T d1opja_ 135 NFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211 (287)
T ss_dssp TCCCSCCSGGGEEE---CGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHT
T ss_pred CcccCccccCeEEE---CCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHh
Confidence 99999999999999 56788999999999776544322 23446788999999998899999999999999999999
Q ss_pred CCCCCCC
Q 030430 164 GYPPFSV 170 (177)
Q Consensus 164 ~~~pf~~ 170 (177)
|..||..
T Consensus 212 ~~~p~~~ 218 (287)
T d1opja_ 212 YGMSPYP 218 (287)
T ss_dssp TSCCSST
T ss_pred CCCCCCC
Confidence 7665533
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.3e-42 Score=246.70 Aligned_cols=165 Identities=27% Similarity=0.517 Sum_probs=138.9
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCC----eEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (177)
++.....+.+|++++++++||||+++++++.... .+|+||||++|++|.+++...+.+++..+..++.|++.||+|
T Consensus 47 ~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~ 126 (277)
T d1o6ya_ 47 DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126 (277)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHH
Confidence 3455678999999999999999999999987543 489999999999999999888899999999999999999999
Q ss_pred HhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC----ccccccCCCccccccccccCCCCCcchHHHHHHH
Q 030430 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAI 157 (177)
Q Consensus 82 lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~ 157 (177)
||+.|++||||||+||++. ..+..+++|||.+....... ......|++.|+|||.+.+..+++++||||+|++
T Consensus 127 lH~~~iiHrDiKP~NIll~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 203 (277)
T d1o6ya_ 127 SHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 203 (277)
T ss_dssp HHHTTEECCCCSGGGEEEE---TTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred HHhCCccCccccCcccccC---ccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHH
Confidence 9999999999999999995 56778999999876543322 2334568999999999988889999999999999
Q ss_pred HHHHHhCCCCCCCCCc
Q 030430 158 LFELLNGYPPFSVGEE 173 (177)
Q Consensus 158 ~~~~~~~~~pf~~~~~ 173 (177)
+|+|+||+.||.+.+.
T Consensus 204 lyelltG~~Pf~~~~~ 219 (277)
T d1o6ya_ 204 LYEVLTGEPPFTGDSP 219 (277)
T ss_dssp HHHHHHSSCSCCCSSH
T ss_pred HHHHHhCCCCCCCcCH
Confidence 9999999999987654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=248.12 Aligned_cols=162 Identities=35% Similarity=0.485 Sum_probs=142.6
Q ss_pred HHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCee
Q 030430 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~H 89 (177)
.+.+.+|++++++++||||+++++++.+++.+|+||||+.|+++..+......+++..+..++.|++.||+|||++|++|
T Consensus 44 ~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiH 123 (299)
T d1ua2a_ 44 NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123 (299)
T ss_dssp CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceec
Confidence 45788999999999999999999999999999999999988887777665667999999999999999999999999999
Q ss_pred ecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccC-CCCCcchHHHHHHHHHHHHhCCCC
Q 030430 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPP 167 (177)
Q Consensus 90 ~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~~~~p 167 (177)
|||||+||++ +..+.++|+|||.+....... ......+++.|+|||.+... .++.++||||+||++++|++|..|
T Consensus 124 rDiKp~NIli---~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~p 200 (299)
T d1ua2a_ 124 RDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF 200 (299)
T ss_dssp CCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCCcceEEe---cCCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCC
Confidence 9999999999 567889999999997765443 23345689999999988644 579999999999999999999999
Q ss_pred CCCCCcc
Q 030430 168 FSVGEEH 174 (177)
Q Consensus 168 f~~~~~~ 174 (177)
|.+.++.
T Consensus 201 f~~~~~~ 207 (299)
T d1ua2a_ 201 LPGDSDL 207 (299)
T ss_dssp SCCSSHH
T ss_pred CCCCCHH
Confidence 9876543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-41 Score=239.19 Aligned_cols=166 Identities=25% Similarity=0.488 Sum_probs=145.6
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
....+.+.+|++++++++||||+++++++.+++.+++||||+.+|+|.+++... ..+++..+..++.|++.||+|||+.
T Consensus 40 ~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~ 119 (258)
T d1k2pa_ 40 SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119 (258)
T ss_dssp SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc
Confidence 344678999999999999999999999999999999999999999999986643 5699999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~ 163 (177)
|++||||+|+||++ +..+.++|+|||+++....... .....+++.|+|||.+.+..++.++||||+|+++|||+|
T Consensus 120 ~iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t 196 (258)
T d1k2pa_ 120 QFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 196 (258)
T ss_dssp TBCCSCCSGGGEEE---CTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred CcccccccceeEEE---cCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHh
Confidence 99999999999999 5677899999999976544332 223457888999999998899999999999999999998
Q ss_pred -CCCCCCCCCccc
Q 030430 164 -GYPPFSVGEEHQ 175 (177)
Q Consensus 164 -~~~pf~~~~~~~ 175 (177)
|+.||.+.+..+
T Consensus 197 ~g~~Pf~~~~~~~ 209 (258)
T d1k2pa_ 197 LGKMPYERFTNSE 209 (258)
T ss_dssp TSCCTTTTSCHHH
T ss_pred cCCCCCCCCCHHH
Confidence 899998866543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-41 Score=242.58 Aligned_cols=161 Identities=25% Similarity=0.489 Sum_probs=137.8
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
...+.+.+|++++++++||||+++++++.++ ..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.
T Consensus 50 ~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~ 128 (272)
T d1qpca_ 50 MSPDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128 (272)
T ss_dssp SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCHHHHHHHHHHHHhCCCCCEeEEEeeeccC-CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3467799999999999999999999988654 568999999999999977643 3599999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc--cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~ 163 (177)
|++||||||+||++ +..+.++|+|||+++....... .....+++.|+|||.+.+..++.++||||+|+++|||+|
T Consensus 129 ~ivHrDiKp~NIll---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt 205 (272)
T d1qpca_ 129 NYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205 (272)
T ss_dssp TEECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred CcccCccchhheee---ecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHh
Confidence 99999999999999 5678899999999987654432 233457889999999988889999999999999999999
Q ss_pred CC-CCCCCCC
Q 030430 164 GY-PPFSVGE 172 (177)
Q Consensus 164 ~~-~pf~~~~ 172 (177)
|. +||...+
T Consensus 206 ~~~~~~~~~~ 215 (272)
T d1qpca_ 206 HGRIPYPGMT 215 (272)
T ss_dssp TTCCSSTTCC
T ss_pred CCCCCCCCCC
Confidence 65 5555543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-40 Score=238.13 Aligned_cols=166 Identities=27% Similarity=0.502 Sum_probs=134.4
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
.+..++.+.+|++++++++||||+++++++.+ +.+++||||+++++|.+++... ..+++..+..++.|++.||+|||+
T Consensus 48 ~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~ 126 (273)
T d1mp8a_ 48 SDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126 (273)
T ss_dssp SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcc
Confidence 45567889999999999999999999999864 5689999999999999987654 469999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC--ccccccCCCccccccccccCCCCCcchHHHHHHHHHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~ 162 (177)
.|++||||||+||+++ ..+.++++|||++....... ......+++.|+|||.+.+..++.++||||+|+++|||+
T Consensus 127 ~~iiHrDlKp~NIll~---~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~l 203 (273)
T d1mp8a_ 127 KRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 203 (273)
T ss_dssp TTCCCSCCSGGGEEEE---ETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHH
T ss_pred cCeeccccchhheeec---CCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHH
Confidence 9999999999999995 56789999999997754432 223345788999999999889999999999999999999
Q ss_pred h-CCCCCCCCCccc
Q 030430 163 N-GYPPFSVGEEHQ 175 (177)
Q Consensus 163 ~-~~~pf~~~~~~~ 175 (177)
+ |.+||.+.+..+
T Consensus 204 t~g~~P~~~~~~~~ 217 (273)
T d1mp8a_ 204 MHGVKPFQGVKNND 217 (273)
T ss_dssp TTSCCTTTTCCGGG
T ss_pred hcCCCCCCCCCHHH
Confidence 8 899998876544
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-40 Score=237.02 Aligned_cols=164 Identities=23% Similarity=0.421 Sum_probs=136.1
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (177)
++..+..+.+|++++++++||||+++++++.+.+..++++||+.++++.+++... ..+++..+..++.|++.|++|||+
T Consensus 49 ~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~ 128 (283)
T d1mqba_ 49 TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 128 (283)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccc
Confidence 4455667999999999999999999999999999999999999999999987755 569999999999999999999999
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc----cccccCCCccccccccccCCCCCcchHHHHHHHHHH
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~ 160 (177)
.|++||||||+||++ +.++.+||+|||+++....... .....++..|+|||.+.+..++.++||||+|+++||
T Consensus 129 ~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~e 205 (283)
T d1mqba_ 129 MNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWE 205 (283)
T ss_dssp TTCCCSCCCGGGEEE---CTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHH
T ss_pred cccccCccccceEEE---CCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHH
Confidence 999999999999999 5678899999999976543321 223447889999999998899999999999999999
Q ss_pred HHhCCCC-CCCCC
Q 030430 161 LLNGYPP-FSVGE 172 (177)
Q Consensus 161 ~~~~~~p-f~~~~ 172 (177)
|+++..| |...+
T Consensus 206 l~t~~~~~~~~~~ 218 (283)
T d1mqba_ 206 VMTYGERPYWELS 218 (283)
T ss_dssp HHTTSCCTTTTCC
T ss_pred HHhCCCCccccCC
Confidence 9996555 44433
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=237.50 Aligned_cols=168 Identities=26% Similarity=0.494 Sum_probs=135.8
Q ss_pred ccc-chhHHHHHHHHHHHHhhCCCCceeeEeEEEee-CCeEEEEEecCCCCChHHHHhhcC--CCCHHHHHHHHHHHHHH
Q 030430 3 KKL-NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAG 78 (177)
Q Consensus 3 ~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~ 78 (177)
|.+ +....+.+.+|++++++++||||+++++++.+ .+.+++||||+++|+|.+++.+.. .+++..+.+++.|++.|
T Consensus 36 K~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~a 115 (262)
T d1byga_ 36 KCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 115 (262)
T ss_dssp EECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred EEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhh
Confidence 443 34456789999999999999999999998854 566899999999999999987543 48999999999999999
Q ss_pred HHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHH
Q 030430 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (177)
Q Consensus 79 l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~ 158 (177)
++|||+.+++||||+|+||++ +..+.++++|||.+....... ....++..|+|||.+.+..+++++||||+|+++
T Consensus 116 l~ylH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~~~~~~~--~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il 190 (262)
T d1byga_ 116 MEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILL 190 (262)
T ss_dssp HHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred ccccccCceeccccchHhhee---cCCCCEeecccccceecCCCC--ccccccccCCChHHHhCCCCChHHHHHhHHHHH
Confidence 999999999999999999999 567889999999987654332 233478899999999888999999999999999
Q ss_pred HHHHh-CCCCCCCCCccc
Q 030430 159 FELLN-GYPPFSVGEEHQ 175 (177)
Q Consensus 159 ~~~~~-~~~pf~~~~~~~ 175 (177)
|||+| |.+||...+..+
T Consensus 191 ~el~t~~~~p~~~~~~~~ 208 (262)
T d1byga_ 191 WEIYSFGRVPYPRIPLKD 208 (262)
T ss_dssp HHHHTTSCCSCTTSCGGG
T ss_pred HHHHHCCCCCCCCCCHHH
Confidence 99998 788888765543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-40 Score=239.35 Aligned_cols=166 Identities=30% Similarity=0.472 Sum_probs=141.1
Q ss_pred chhHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc----------------CCCCHHHH
Q 030430 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTA 68 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~ 68 (177)
.+...+.+.+|+++++++ +||||+++++++.+.+.+++||||++||+|.+++... ..+++..+
T Consensus 50 ~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~ 129 (309)
T d1fvra_ 50 SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129 (309)
T ss_dssp -----CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHH
T ss_pred ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHH
Confidence 344567899999999999 7999999999999999999999999999999998643 45899999
Q ss_pred HHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCc
Q 030430 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEK 148 (177)
Q Consensus 69 ~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~ 148 (177)
..++.|++.|++|+|+.|++||||||+||++ +..+.++|+|||++.............++..|+|||.+.+..++.+
T Consensus 130 ~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~---~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~ 206 (309)
T d1fvra_ 130 LHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN 206 (309)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH
T ss_pred HHHHHHHHHHHHhhhcCCccccccccceEEE---cCCCceEEccccccccccccccccceecCCcccchHHhccCCCCcc
Confidence 9999999999999999999999999999999 5677899999999976654444445568889999999988889999
Q ss_pred chHHHHHHHHHHHHhCC-CCCCCCCcc
Q 030430 149 VDMWSVGAILFELLNGY-PPFSVGEEH 174 (177)
Q Consensus 149 ~Di~slg~~~~~~~~~~-~pf~~~~~~ 174 (177)
+||||+|+++|||++|. +||.+.+..
T Consensus 207 sDvwSfGvil~ell~~~~~p~~~~~~~ 233 (309)
T d1fvra_ 207 SDVWSYGVLLWEIVSLGGTPYCGMTCA 233 (309)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred ceeehhHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999965 678765543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-39 Score=238.04 Aligned_cols=164 Identities=26% Similarity=0.425 Sum_probs=139.9
Q ss_pred hHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
...+++.+|++++++++||||+++++++.++. .+++++++.+++|.+++... ..+++..+..++.|++.||+|||+.|
T Consensus 53 ~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ 131 (317)
T d1xkka_ 53 KANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 131 (317)
T ss_dssp CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC
Confidence 34678999999999999999999999998765 56778888899999888765 46999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCCCcchHHHHHHHHHHHHh
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~ 163 (177)
++||||||+||+++ ..+.++|+|||+++....... .....+++.|+|||.+.+..++.++||||+|+++|||+|
T Consensus 132 iiHrDlKp~NIll~---~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t 208 (317)
T d1xkka_ 132 LVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 208 (317)
T ss_dssp CCCSCCCGGGEEEE---ETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred cccCcchhhcceeC---CCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHH
Confidence 99999999999995 567899999999987654332 223457899999999988899999999999999999998
Q ss_pred -CCCCCCCCCccc
Q 030430 164 -GYPPFSVGEEHQ 175 (177)
Q Consensus 164 -~~~pf~~~~~~~ 175 (177)
|..||.+.+..+
T Consensus 209 ~g~~p~~~~~~~~ 221 (317)
T d1xkka_ 209 FGSKPYDGIPASE 221 (317)
T ss_dssp TSCCTTTTSCGGG
T ss_pred CCCCCCCCCCHHH
Confidence 799998866544
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-39 Score=236.95 Aligned_cols=161 Identities=34% Similarity=0.571 Sum_probs=138.3
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
..+++.+|++++++++||||+++++++.+++.+|+||||+.+ ++..++.. ...+++..+..++.|++.||+|||++|
T Consensus 44 ~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~ 122 (298)
T d1gz8a_ 44 VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122 (298)
T ss_dssp CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC
Confidence 467889999999999999999999999999999999999955 55444432 345999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccCC-CCCcchHHHHHHHHHHHHhC
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slg~~~~~~~~~ 164 (177)
++||||||+||++ +..+.++++|||.+....... ......+++.|+|||...... .+.++|+||+|+++|+|++|
T Consensus 123 IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G 199 (298)
T d1gz8a_ 123 VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 199 (298)
T ss_dssp CCCSCCCGGGEEE---CTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred EEccccCchheee---cccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhC
Confidence 9999999999999 466789999999997765433 333456899999999876555 57899999999999999999
Q ss_pred CCCCCCCCc
Q 030430 165 YPPFSVGEE 173 (177)
Q Consensus 165 ~~pf~~~~~ 173 (177)
+.||.+.++
T Consensus 200 ~~Pf~~~~~ 208 (298)
T d1gz8a_ 200 RALFPGDSE 208 (298)
T ss_dssp SCSCCCSSH
T ss_pred CCCCCCCCH
Confidence 999987653
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-40 Score=235.11 Aligned_cols=164 Identities=29% Similarity=0.444 Sum_probs=139.7
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
+...+.+.+|++++++++||||+++++++.++ ..++|+||++++++.+.+... ..+++..+..++.|++.||+|||++
T Consensus 52 ~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~ 130 (273)
T d1u46a_ 52 PEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 130 (273)
T ss_dssp CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC
Confidence 34467899999999999999999999999764 578999999999999887654 4599999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc----cccccCCCccccccccccCCCCCcchHHHHHHHHHHH
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~ 161 (177)
|++||||||+||++. ..+.++|+|||++........ .....++..|+|||.+.+..++.++|+||+|+++|||
T Consensus 131 ~iiHrDikp~NIll~---~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~em 207 (273)
T d1u46a_ 131 RFIHRDLAARNLLLA---TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEM 207 (273)
T ss_dssp TEECSCCCGGGEEEE---ETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHH
T ss_pred CEeeeeecHHHhccc---cccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHH
Confidence 999999999999995 466899999999987644332 2233467789999999988899999999999999999
Q ss_pred Hh-CCCCCCCCCcc
Q 030430 162 LN-GYPPFSVGEEH 174 (177)
Q Consensus 162 ~~-~~~pf~~~~~~ 174 (177)
+| |..||.+.+..
T Consensus 208 lt~G~~Pf~~~~~~ 221 (273)
T d1u46a_ 208 FTYGQEPWIGLNGS 221 (273)
T ss_dssp HTTSCCTTTTCCHH
T ss_pred HhCCCCCCCCcCHH
Confidence 98 89999876544
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-39 Score=234.19 Aligned_cols=160 Identities=23% Similarity=0.402 Sum_probs=132.4
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
..+.+.+|++++++++||||+++++++.++ ..++||||+++|+|..++... +.+++..+..++.|++.||+|||+.|
T Consensus 55 ~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~-~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ 133 (285)
T d1fmka3 55 SPEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 133 (285)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CHHHHHHHHHHHHhcccCCEeEEEEEEecC-CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh
Confidence 357799999999999999999999998654 578999999999999887643 46999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC--ccccccCCCccccccccccCCCCCcchHHHHHHHHHHHHhC
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~~~~~~ 164 (177)
++||||||+||++ +.++.++|+|||+++...... ......+++.|+|||.+....++.++||||+|+++|||++|
T Consensus 134 ivH~DlKp~NIll---~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~ 210 (285)
T d1fmka3 134 YVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 210 (285)
T ss_dssp CCCSCCSGGGEEE---CGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred eecccccceEEEE---CCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhC
Confidence 9999999999999 467789999999997664333 22335578999999999988999999999999999999996
Q ss_pred CCC-CCCCC
Q 030430 165 YPP-FSVGE 172 (177)
Q Consensus 165 ~~p-f~~~~ 172 (177)
..| |.+..
T Consensus 211 ~~p~~~~~~ 219 (285)
T d1fmka3 211 GRVPYPGMV 219 (285)
T ss_dssp TCCSSTTCC
T ss_pred CCCCCCCCC
Confidence 555 44443
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-39 Score=231.98 Aligned_cols=158 Identities=28% Similarity=0.512 Sum_probs=138.5
Q ss_pred HHHHHHHHHHhhCC--CCceeeEeEEEeeCCeEEEEEecCCC-CChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 11 SCLDCELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 11 ~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
.++.+|++++++++ ||||+++++++.+++..++|||++.+ +++.+++.....++++.++.++.|++.||+|||+.|+
T Consensus 52 ~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~i 131 (273)
T d1xwsa_ 52 TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGV 131 (273)
T ss_dssp CEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 44678999999996 89999999999999999999999975 6888888888889999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCC-CCcchHHHHHHHHHHHHhCCC
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYP 166 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slg~~~~~~~~~~~ 166 (177)
+||||||+||++. .+.+.++|+|||.+....... .....||+.|+|||.+.+..+ +.++|+||+|+++|+|++|+.
T Consensus 132 iHrDiKp~NIll~--~~~~~vkl~DFG~a~~~~~~~-~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~ 208 (273)
T d1xwsa_ 132 LHRDIKDENILID--LNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 208 (273)
T ss_dssp ECSCCSGGGEEEE--TTTTEEEECCCTTCEECCSSC-BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred ccccCcccceEEe--cCCCeEEECccccceeccccc-ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCC
Confidence 9999999999996 345689999999997654332 334568999999999876654 567899999999999999999
Q ss_pred CCCCC
Q 030430 167 PFSVG 171 (177)
Q Consensus 167 pf~~~ 171 (177)
||.+.
T Consensus 209 Pf~~~ 213 (273)
T d1xwsa_ 209 PFEHD 213 (273)
T ss_dssp SCCSH
T ss_pred CCCCc
Confidence 99764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-39 Score=236.12 Aligned_cols=162 Identities=35% Similarity=0.529 Sum_probs=137.7
Q ss_pred HHHHHHHHHHHHhhC---CCCceeeEeEEEee-----CCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHH
Q 030430 9 LKSCLDCELNFLSSV---NHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGL 79 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l 79 (177)
....+.+|+++++.+ +||||+++++++.. ....++++|++.++++....... ..+++..++.++.|++.||
T Consensus 50 ~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL 129 (305)
T d1blxa_ 50 MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 129 (305)
T ss_dssp CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHH
Confidence 344567788877766 79999999998853 34789999999877665544433 4599999999999999999
Q ss_pred HHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHH
Q 030430 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (177)
Q Consensus 80 ~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~ 159 (177)
+|||+.|++||||||+||++ +..+.++++|||.+.............||+.|+|||.+.+..++.++|+||+||++|
T Consensus 130 ~yLH~~~ivHrDiKp~NILi---~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ 206 (305)
T d1blxa_ 130 DFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 206 (305)
T ss_dssp HHHHHTTCCCCCCCGGGEEE---CTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred HHHHhCCEEecCCCccEEEE---cCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHH
Confidence 99999999999999999999 567789999999987765555555677999999999999899999999999999999
Q ss_pred HHHhCCCCCCCCCc
Q 030430 160 ELLNGYPPFSVGEE 173 (177)
Q Consensus 160 ~~~~~~~pf~~~~~ 173 (177)
+|++|+.||.+.++
T Consensus 207 ell~g~~pf~~~~~ 220 (305)
T d1blxa_ 207 EMFRRKPLFRGSSD 220 (305)
T ss_dssp HHHHSSCSCCCSSH
T ss_pred HHHHCCCCCCCCCH
Confidence 99999999987754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-39 Score=234.11 Aligned_cols=167 Identities=25% Similarity=0.500 Sum_probs=143.2
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC------------------------
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG------------------------ 61 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------------ 61 (177)
.+...+++.+|++++++++|||++++++++.+....++++|++++++|.+++....
T Consensus 56 ~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 135 (301)
T d1lufa_ 56 SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 135 (301)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------C
T ss_pred ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCC
Confidence 34456789999999999999999999999999999999999999999999986432
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC---ccccccCCCcccccc
Q 030430 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPE 138 (177)
Q Consensus 62 ~~~~~~~~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pe 138 (177)
.++...+..++.|++.||+|||+.|++||||||+||++ +.++.+||+|||++....... ......+++.|+|||
T Consensus 136 ~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILl---d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE 212 (301)
T d1lufa_ 136 PLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE 212 (301)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEE---CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHH
Confidence 37889999999999999999999999999999999999 567889999999987654332 223455788999999
Q ss_pred ccccCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCccc
Q 030430 139 VLQFQRYDEKVDMWSVGAILFELLNGY-PPFSVGEEHQ 175 (177)
Q Consensus 139 ~~~~~~~~~~~Di~slg~~~~~~~~~~-~pf~~~~~~~ 175 (177)
.+.+..++.++||||+|+++|||++|. +||.+.++.+
T Consensus 213 ~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e 250 (301)
T d1lufa_ 213 SIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250 (301)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred HHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH
Confidence 999889999999999999999999985 6787765443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.9e-39 Score=232.36 Aligned_cols=164 Identities=32% Similarity=0.499 Sum_probs=140.0
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
+....++.+|+.++++++||||+++++++.+.+..+++++++.++.+..+....+.+++..+..++.|++.||+|||+.|
T Consensus 41 ~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ 120 (286)
T d1ob3a_ 41 EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120 (286)
T ss_dssp GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc
Confidence 33467899999999999999999999999999999999999987777777666677999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-cccccCCCccccccccccC-CCCCcchHHHHHHHHHHHHhC
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNG 164 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~~~~~~~ 164 (177)
++||||||+||++ +..+.++++|||.+........ .....+++.|+|||.+.+. .++.++|+||+|+++++|++|
T Consensus 121 IvHrDiKp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G 197 (286)
T d1ob3a_ 121 VLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197 (286)
T ss_dssp CCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS
T ss_pred EEecCCCCceeeE---cCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHC
Confidence 9999999999999 4677899999999977654432 3344578899999988654 468999999999999999999
Q ss_pred CCCCCCCCc
Q 030430 165 YPPFSVGEE 173 (177)
Q Consensus 165 ~~pf~~~~~ 173 (177)
+.||.+.++
T Consensus 198 ~~pf~~~~~ 206 (286)
T d1ob3a_ 198 TPLFPGVSE 206 (286)
T ss_dssp SCSCCCSSH
T ss_pred CCCCCCCCH
Confidence 999987654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-38 Score=230.76 Aligned_cols=166 Identities=30% Similarity=0.501 Sum_probs=144.4
Q ss_pred chhHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC----------------CCCHHHH
Q 030430 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTA 68 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~ 68 (177)
.......+.+|...+.++ +||||+++++++.+++..++||||+.+|+|.+++.... .+++.++
T Consensus 58 ~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~ 137 (299)
T d1fgka_ 58 TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 137 (299)
T ss_dssp CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHH
T ss_pred ChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHH
Confidence 445567888899999888 89999999999999999999999999999999997442 4899999
Q ss_pred HHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC---ccccccCCCccccccccccCCC
Q 030430 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRY 145 (177)
Q Consensus 69 ~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~ 145 (177)
..++.|++.||+|||+.|++||||||+||++ +..+.++|+|||.+....... ......+++.|+|||.+.+..+
T Consensus 138 ~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y 214 (299)
T d1fgka_ 138 VSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY 214 (299)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHhhhCCEEeeeecccceee---cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCC
Confidence 9999999999999999999999999999999 567789999999987664432 2233557889999999988899
Q ss_pred CCcchHHHHHHHHHHHHh-CCCCCCCCCcc
Q 030430 146 DEKVDMWSVGAILFELLN-GYPPFSVGEEH 174 (177)
Q Consensus 146 ~~~~Di~slg~~~~~~~~-~~~pf~~~~~~ 174 (177)
+.++||||+|+++|+|++ |.+||.+.+.+
T Consensus 215 ~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~ 244 (299)
T d1fgka_ 215 THQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244 (299)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred CchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence 999999999999999998 68899876543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5e-38 Score=231.45 Aligned_cols=167 Identities=27% Similarity=0.453 Sum_probs=144.0
Q ss_pred ccccchhHHHHHHHHHHHHhhCC-CCceeeEeEEEee--CCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHH
Q 030430 2 LKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78 (177)
Q Consensus 2 l~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~ 78 (177)
+|.++....+++.+|+++|+++. ||||+++++++.. ...+++||||+.+++|.+.. +.+++..++.++.|++.|
T Consensus 65 iK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~a 141 (328)
T d3bqca1 65 VKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKA 141 (328)
T ss_dssp EEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHH
T ss_pred EEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHH
Confidence 56666666788999999999995 9999999999874 45689999999999997753 469999999999999999
Q ss_pred HHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccC-CCCCcchHHHHHHH
Q 030430 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAI 157 (177)
Q Consensus 79 l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~ 157 (177)
|+|||++|++||||||+||+++ .++..++++|||.+.............+++.|+|||.+.+. .++.++|+||+|++
T Consensus 142 L~~LH~~gIvHrDiKp~NILi~--~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~ 219 (328)
T d3bqca1 142 LDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCM 219 (328)
T ss_dssp HHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHH
T ss_pred HHHHhhcccccccccccceEEc--CCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhh
Confidence 9999999999999999999996 34557999999999877665555566789999999998755 46899999999999
Q ss_pred HHHHHhCCCCCCCCCc
Q 030430 158 LFELLNGYPPFSVGEE 173 (177)
Q Consensus 158 ~~~~~~~~~pf~~~~~ 173 (177)
++++++|..||....+
T Consensus 220 l~e~~~g~~pf~~~~~ 235 (328)
T d3bqca1 220 LASMIFRKEPFFHGHD 235 (328)
T ss_dssp HHHHHHTCSSSSCCSS
T ss_pred hHHhccCCCCCCCCch
Confidence 9999999999976543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-37 Score=226.98 Aligned_cols=163 Identities=28% Similarity=0.454 Sum_probs=140.5
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEee-CCeEEEEEecCCCCChHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHh
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILN 83 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh 83 (177)
+....+++.+|++++++++||||+++++++.+ ++.+++||||+++++|.+++... ...+...+..++.|++.||.|+|
T Consensus 68 ~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH 147 (311)
T d1r0pa_ 68 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 147 (311)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc
Confidence 55567889999999999999999999998765 56899999999999999988754 34778889999999999999999
Q ss_pred hCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc-----cccccCCCccccccccccCCCCCcchHHHHHHHH
Q 030430 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (177)
Q Consensus 84 ~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~ 158 (177)
+.+++||||||+||++ +..+.++|+|||++........ .....+++.|+|||.+....++.++||||+|+++
T Consensus 148 ~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl 224 (311)
T d1r0pa_ 148 SKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 224 (311)
T ss_dssp HTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred ccCcccCCccHHhEeE---CCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHH
Confidence 9999999999999999 5678899999999976544321 2234578899999999888899999999999999
Q ss_pred HHHHhCCCCCCCC
Q 030430 159 FELLNGYPPFSVG 171 (177)
Q Consensus 159 ~~~~~~~~pf~~~ 171 (177)
+|+++|..||...
T Consensus 225 ~El~t~~~p~~~~ 237 (311)
T d1r0pa_ 225 WELMTRGAPPYPD 237 (311)
T ss_dssp HHHHTTSCCSCC-
T ss_pred HHHHHCCCCCCCC
Confidence 9999987777543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-38 Score=227.60 Aligned_cols=164 Identities=31% Similarity=0.510 Sum_probs=132.2
Q ss_pred hhHHHHHHHHHHHHhhC-CCCceeeEeEEEee-CCeEEEEEecCCCCChHHHHhhc----------------CCCCHHHH
Q 030430 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTA 68 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~ 68 (177)
....+.+.+|..++.++ +|+||+.+.+++.. +..++++|||+++|+|.+++... ..+++..+
T Consensus 57 ~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~ 136 (299)
T d1ywna1 57 HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136 (299)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHH
T ss_pred cHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHH
Confidence 34456777888888777 68999999998765 45689999999999999999743 23889999
Q ss_pred HHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC---ccccccCCCccccccccccCCC
Q 030430 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRY 145 (177)
Q Consensus 69 ~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~ 145 (177)
..++.|++.||+|||++|++||||||+||++ +..+.+||+|||+++...... ......||+.|+|||.+.+..+
T Consensus 137 ~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 213 (299)
T d1ywna1 137 ICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 213 (299)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHhCCCcCCcCCccceeE---CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCC
Confidence 9999999999999999999999999999999 567889999999997654332 2234568899999999998889
Q ss_pred CCcchHHHHHHHHHHHHhC-CCCCCCCCc
Q 030430 146 DEKVDMWSVGAILFELLNG-YPPFSVGEE 173 (177)
Q Consensus 146 ~~~~Di~slg~~~~~~~~~-~~pf~~~~~ 173 (177)
+.++||||+|+++|||+++ ..||.+...
T Consensus 214 ~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 214 TIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred CcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999986 568876543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-37 Score=231.62 Aligned_cols=160 Identities=32% Similarity=0.479 Sum_probs=134.1
Q ss_pred HHHHHHHHHhhCCCCceeeEeEEEee------CCeEEEEEecCCCCChHHHH---hhcCCCCHHHHHHHHHHHHHHHHHH
Q 030430 12 CLDCELNFLSSVNHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFLQQLGAGLEIL 82 (177)
Q Consensus 12 ~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l---~~~~~~~~~~~~~~~~~i~~~l~~l 82 (177)
...+|++++++++||||+++++++.. ..++++||||++++.+..+. .....+++..++.++.|++.||+||
T Consensus 59 ~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yL 138 (350)
T d1q5ka_ 59 FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138 (350)
T ss_dssp SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 45689999999999999999998843 34689999999665433332 2345699999999999999999999
Q ss_pred hhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCcccccccccc-CCCCCcchHHHHHHHHHHH
Q 030430 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFEL 161 (177)
Q Consensus 83 h~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~~~~~~ 161 (177)
|++|++||||||+||++. .+...++|+|||.+.............++..|+|||.+.+ ..++.++||||+||++++|
T Consensus 139 H~~~IiHrDiKp~NILl~--~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el 216 (350)
T d1q5ka_ 139 HSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 216 (350)
T ss_dssp HTTTEECCCCCGGGEEEC--TTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred HhcCCcccCCCcceEEEe--cCCCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEeh
Confidence 999999999999999995 2345799999999987766665556678999999998764 4689999999999999999
Q ss_pred HhCCCCCCCCCc
Q 030430 162 LNGYPPFSVGEE 173 (177)
Q Consensus 162 ~~~~~pf~~~~~ 173 (177)
++|..||.+.+.
T Consensus 217 ~~g~~pf~~~~~ 228 (350)
T d1q5ka_ 217 LLGQPIFPGDSG 228 (350)
T ss_dssp HHTSCSSCCSSH
T ss_pred hhCCCCCCCCCH
Confidence 999999987654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-38 Score=230.54 Aligned_cols=164 Identities=33% Similarity=0.569 Sum_probs=143.8
Q ss_pred HHHHHHHHHHHHhhCCC-CceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 030430 9 LKSCLDCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 87 (177)
..+.+.+|++++++++| |||+++++++.+...+++++||+.|++|.+++...+.+++..+..++.|++.|++|+|++|+
T Consensus 71 ~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~i 150 (322)
T d1vzoa_ 71 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGI 150 (322)
T ss_dssp SGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCE
Confidence 45678899999999976 89999999999999999999999999999999988899999999999999999999999999
Q ss_pred eeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC--ccccccCCCccccccccccC--CCCCcchHHHHHHHHHHHHh
Q 030430 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ--RYDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 88 ~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~--~~~~~~Di~slg~~~~~~~~ 163 (177)
+||||||+||++ +..+.++|+|||.+....... ......+++.|++||.+.+. .++.++||||+||++|+|++
T Consensus 151 vHrDiKp~Nill---~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyellt 227 (322)
T d1vzoa_ 151 IYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 227 (322)
T ss_dssp CCCCCCGGGEEE---CTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHH
T ss_pred EeccCCccceee---cCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHh
Confidence 999999999999 466789999999997654332 23456688999999988644 46789999999999999999
Q ss_pred CCCCCCCCCccc
Q 030430 164 GYPPFSVGEEHQ 175 (177)
Q Consensus 164 ~~~pf~~~~~~~ 175 (177)
|+.||.+.+..+
T Consensus 228 G~~PF~~~~~~~ 239 (322)
T d1vzoa_ 228 GASPFTVDGEKN 239 (322)
T ss_dssp SSCTTSCTTSCC
T ss_pred CCCCCCCCCHHH
Confidence 999998865543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3e-37 Score=224.03 Aligned_cols=165 Identities=19% Similarity=0.266 Sum_probs=142.1
Q ss_pred hHHHHHHHHHHHHhhCCC-CceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 8 HLKSCLDCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 8 ~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
...+.+.+|++.++.+.| ++++.+++++..+...++|||++ +++|.+++.... .++...+..++.|++.+|++||+.
T Consensus 42 ~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~ 120 (293)
T d1csna_ 42 SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 120 (293)
T ss_dssp TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC
Confidence 345668899999999965 89999999999999999999999 889999987654 599999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCC--CCeeEEEeeeccccccCCCC--------ccccccCCCccccccccccCCCCCcchHHHHH
Q 030430 86 HIIHRDLKPENILLSGLD--DDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVG 155 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~--~~~~~~l~d~~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg 155 (177)
|++||||||+||+++... ..+.++++|||.++...... ......||+.|+|||.+.+..+++++|+||+|
T Consensus 121 giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG 200 (293)
T d1csna_ 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALG 200 (293)
T ss_dssp TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred CceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhh
Confidence 999999999999996422 35679999999997654321 12234689999999999988899999999999
Q ss_pred HHHHHHHhCCCCCCCCCc
Q 030430 156 AILFELLNGYPPFSVGEE 173 (177)
Q Consensus 156 ~~~~~~~~~~~pf~~~~~ 173 (177)
+++++|++|..||.+...
T Consensus 201 ~~l~elltg~~Pf~~~~~ 218 (293)
T d1csna_ 201 HVFMYFLRGSLPWQGLKA 218 (293)
T ss_dssp HHHHHHHHSSCTTSSCCS
T ss_pred HHHHHHHhCCCcCCCccc
Confidence 999999999999986543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-37 Score=225.68 Aligned_cols=167 Identities=26% Similarity=0.360 Sum_probs=134.0
Q ss_pred ccccchhHHHHHHHH--HHHHhhCCCCceeeEeEEEeeCC----eEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHH
Q 030430 2 LKKLNKHLKSCLDCE--LNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75 (177)
Q Consensus 2 l~~~~~~~~~~~~~e--~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i 75 (177)
+|.++.+..+...+| +..+.+++||||+++++++.+.+ .+++||||+++++|.+++++. .++.+.+..++.|+
T Consensus 31 vK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~i 109 (303)
T d1vjya_ 31 VKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALST 109 (303)
T ss_dssp EEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHH
T ss_pred EEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHH
Confidence 455544455554444 44556789999999999986543 689999999999999999864 68999999999999
Q ss_pred HHHHHHHhh--------CCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-----ccccccCCCcccccccccc
Q 030430 76 GAGLEILNS--------HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQF 142 (177)
Q Consensus 76 ~~~l~~lh~--------~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~~~~~~pe~~~~ 142 (177)
+.+++|+|+ .|++||||||+||++ +..+.+||+|||++....... ......|++.|+|||.+..
T Consensus 110 a~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 186 (303)
T d1vjya_ 110 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186 (303)
T ss_dssp HHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTT
T ss_pred HHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccc
Confidence 999999996 589999999999999 567889999999987764432 2234568999999999864
Q ss_pred CC------CCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 030430 143 QR------YDEKVDMWSVGAILFELLNGYPPFSVGE 172 (177)
Q Consensus 143 ~~------~~~~~Di~slg~~~~~~~~~~~pf~~~~ 172 (177)
.. ++.++||||+|+++||++||..||....
T Consensus 187 ~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~ 222 (303)
T d1vjya_ 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222 (303)
T ss_dssp CSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCC
T ss_pred cccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccc
Confidence 32 5668999999999999999998885543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-37 Score=226.36 Aligned_cols=165 Identities=30% Similarity=0.475 Sum_probs=143.0
Q ss_pred chhHHHHHHHHHHHHhhC-CCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcC------------------CCCHH
Q 030430 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG------------------RVPEQ 66 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~ 66 (177)
....+..+.+|+.+++++ +||||+++++++.+....+++|||+++++|.+++.+.. .+++.
T Consensus 66 ~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~ 145 (311)
T d1t46a_ 66 HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145 (311)
T ss_dssp CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHH
T ss_pred CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHH
Confidence 345667899999999999 69999999999999999999999999999999987543 48899
Q ss_pred HHHHHHHHHHHHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccC
Q 030430 67 TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQ 143 (177)
Q Consensus 67 ~~~~~~~~i~~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~ 143 (177)
.+..++.|++.|++|||++|++||||||+||+++ ..+.++++|||.++....... .....+++.|+|||.+.+.
T Consensus 146 ~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~---~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 222 (311)
T d1t46a_ 146 DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC 222 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeeccccccccccc---ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC
Confidence 9999999999999999999999999999999994 677899999999987654322 2234578899999999988
Q ss_pred CCCCcchHHHHHHHHHHHHh-CCCCCCCCCc
Q 030430 144 RYDEKVDMWSVGAILFELLN-GYPPFSVGEE 173 (177)
Q Consensus 144 ~~~~~~Di~slg~~~~~~~~-~~~pf~~~~~ 173 (177)
.++.++||||+|+++++|+| |.+||.+...
T Consensus 223 ~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 223 VYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred CCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 89999999999999999999 5666766544
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-37 Score=228.25 Aligned_cols=161 Identities=33% Similarity=0.564 Sum_probs=139.5
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCC------eEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGL 79 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l 79 (177)
++...+.+.+|+++|++++||||+++++++...+ .+|+||||+ |.+|..+.+ ...+++..++.++.|++.||
T Consensus 57 ~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL 134 (346)
T d1cm8a_ 57 SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGL 134 (346)
T ss_dssp SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHH
Confidence 4455678999999999999999999999987654 579999999 778888765 56899999999999999999
Q ss_pred HHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccC-CCCCcchHHHHHHHH
Q 030430 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAIL 158 (177)
Q Consensus 80 ~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slg~~~ 158 (177)
+|||++|++||||||+||++ +..+.++++|||.+....... ....+++.|+|||.+.+. .++.++|+||+||++
T Consensus 135 ~~LH~~~IiHrDiKp~NIL~---~~~~~~kl~Dfg~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil 209 (346)
T d1cm8a_ 135 RYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQADSEM--TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIM 209 (346)
T ss_dssp HHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCSSC--CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHH
T ss_pred HHHHhCCCcccccCcchhhc---ccccccccccccceeccCCcc--ccccccccccCHHHHcCCCCCCccchhhcchHHH
Confidence 99999999999999999999 567889999999997764432 345589999999988654 468999999999999
Q ss_pred HHHHhCCCCCCCCCc
Q 030430 159 FELLNGYPPFSVGEE 173 (177)
Q Consensus 159 ~~~~~~~~pf~~~~~ 173 (177)
++|++|..||.+.+.
T Consensus 210 ~ell~g~~pf~~~~~ 224 (346)
T d1cm8a_ 210 AEMITGKTLFKGSDH 224 (346)
T ss_dssp HHHHHSSCSSCCSSH
T ss_pred HHHHHCcCCCCCCCh
Confidence 999999999988654
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6e-37 Score=223.02 Aligned_cols=164 Identities=20% Similarity=0.234 Sum_probs=137.1
Q ss_pred HHHHHHHHHHHHhhCCCCc-eeeEeEEEeeCCeEEEEEecCCCCChHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 030430 9 LKSCLDCELNFLSSVNHPN-IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH 86 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (177)
....+..|++++++++|++ ++.+.++..++...++||||+ ++++.+.+.. ...+++..+..++.|++.||+|||++|
T Consensus 45 ~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 123 (299)
T d1ckia_ 45 KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123 (299)
T ss_dssp TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC
Confidence 3467889999999997665 555666778888999999999 6677766654 456999999999999999999999999
Q ss_pred CeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC--------ccccccCCCccccccccccCCCCCcchHHHHHHHH
Q 030430 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (177)
Q Consensus 87 ~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~ 158 (177)
++||||||+||++...+....++++|||.+....... ......||+.|+|||.+.+..++.++||||+|+++
T Consensus 124 iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l 203 (299)
T d1ckia_ 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVL 203 (299)
T ss_dssp EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHH
T ss_pred eeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHH
Confidence 9999999999998654556679999999998764322 12244689999999999988899999999999999
Q ss_pred HHHHhCCCCCCCCCc
Q 030430 159 FELLNGYPPFSVGEE 173 (177)
Q Consensus 159 ~~~~~~~~pf~~~~~ 173 (177)
++|++|+.||.....
T Consensus 204 ~el~tg~~P~~~~~~ 218 (299)
T d1ckia_ 204 MYFNLGSLPWQGLKA 218 (299)
T ss_dssp HHHHHSSCTTCCCC-
T ss_pred HHHHhCCCcccccch
Confidence 999999999977543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-37 Score=223.83 Aligned_cols=165 Identities=23% Similarity=0.428 Sum_probs=142.5
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhc----------CCCCHHHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------GRVPEQTARKFLQQLG 76 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~i~ 76 (177)
......+.+|++++++++||||+++++++......++||||+.+|+|.+++... ..++...+..++.|++
T Consensus 64 ~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia 143 (308)
T d1p4oa_ 64 MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143 (308)
T ss_dssp HHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHH
Confidence 344567899999999999999999999999999999999999999999998643 2368899999999999
Q ss_pred HHHHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCc---cccccCCCccccccccccCCCCCcchHHH
Q 030430 77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWS 153 (177)
Q Consensus 77 ~~l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~Di~s 153 (177)
.||.|||+++++||||||+||++ +.+..++|+|||++........ .....+++.|+|||.+.+..++.++|+||
T Consensus 144 ~gl~~LH~~~ivHrDlk~~NiLl---d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S 220 (308)
T d1p4oa_ 144 DGMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWS 220 (308)
T ss_dssp HHHHHHHHTTCBCSCCSGGGEEE---CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHH
T ss_pred HHHHHHhhCCeeeceEcCCceee---cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCccccccc
Confidence 99999999999999999999999 5778899999999876543322 22335789999999999888999999999
Q ss_pred HHHHHHHHHhC-CCCCCCCCcc
Q 030430 154 VGAILFELLNG-YPPFSVGEEH 174 (177)
Q Consensus 154 lg~~~~~~~~~-~~pf~~~~~~ 174 (177)
+|++++||+|| ..||.+.+..
T Consensus 221 ~G~il~El~t~~~~p~~~~~~~ 242 (308)
T d1p4oa_ 221 FGVVLWEIATLAEQPYQGLSNE 242 (308)
T ss_dssp HHHHHHHHHHTSCCTTTTSCHH
T ss_pred HHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999998 5788776543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-36 Score=225.14 Aligned_cols=162 Identities=31% Similarity=0.529 Sum_probs=135.9
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCC-----eEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (177)
+...+.+.+|+++|++++|||++++++++.... .++++ +++.|++|.+++.. ..+++..+..++.|++.||+|
T Consensus 47 ~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~y 124 (345)
T d1pmea_ 47 QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV-THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKY 124 (345)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE-EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE-EeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHH
Confidence 445667899999999999999999999987543 34555 45669999999874 479999999999999999999
Q ss_pred HhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC----ccccccCCCcccccccccc-CCCCCcchHHHHHH
Q 030430 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGA 156 (177)
Q Consensus 82 lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slg~ 156 (177)
||++|++||||||+||++ +..+.++|+|||.+....... ......+++.|+|||.+.. ..++.++|+||+|+
T Consensus 125 LH~~~iiHRDIKp~NILl---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~ 201 (345)
T d1pmea_ 125 IHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGC 201 (345)
T ss_dssp HHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHH
T ss_pred HHHCCCcCCCCCcceEEE---CCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCc
Confidence 999999999999999999 467789999999987654322 2234558889999998754 45688999999999
Q ss_pred HHHHHHhCCCCCCCCCc
Q 030430 157 ILFELLNGYPPFSVGEE 173 (177)
Q Consensus 157 ~~~~~~~~~~pf~~~~~ 173 (177)
++++|++|..||.+.+.
T Consensus 202 il~eml~g~~pf~~~~~ 218 (345)
T d1pmea_ 202 ILAEMLSNRPIFPGKHY 218 (345)
T ss_dssp HHHHHHHSSCSCCCSSH
T ss_pred eehHHhhCCCCCCCCCH
Confidence 99999999999987653
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-36 Score=223.35 Aligned_cols=164 Identities=25% Similarity=0.444 Sum_probs=136.5
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEee--------CCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--------ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~ 78 (177)
+....++.+|+++|++++|||++++++++.. ....+++||++.++.+.........+++..++.++.|++.|
T Consensus 50 ~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~ 129 (318)
T d3blha1 50 EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129 (318)
T ss_dssp TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHH
Confidence 3345678899999999999999999998754 34689999999777666555555679999999999999999
Q ss_pred HHHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-----ccccccCCCccccccccccC-CCCCcchHH
Q 030430 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMW 152 (177)
Q Consensus 79 l~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~ 152 (177)
|+|||+.|++||||||+||++ +..+.++++|||++....... ......+|+.|+|||.+.+. .++.++|+|
T Consensus 130 l~~lH~~~ivHrDlKp~NILl---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~Diw 206 (318)
T d3blha1 130 LYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLW 206 (318)
T ss_dssp HHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHH
T ss_pred HHHhccCCEEecCcCchheee---cCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcc
Confidence 999999999999999999999 467789999999997654322 22234589999999998654 578999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCc
Q 030430 153 SVGAILFELLNGYPPFSVGEE 173 (177)
Q Consensus 153 slg~~~~~~~~~~~pf~~~~~ 173 (177)
|+|+++++|++|+.||.+.++
T Consensus 207 SlGvil~el~~g~~pf~~~~~ 227 (318)
T d3blha1 207 GAGCIMAEMWTRSPIMQGNTE 227 (318)
T ss_dssp HHHHHHHHHHHSSCSCCCSSH
T ss_pred cCCceeeeHhhCCCCCCCCCH
Confidence 999999999999999987654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-36 Score=217.31 Aligned_cols=162 Identities=31% Similarity=0.507 Sum_probs=142.0
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (177)
++....++.+|+.++++++||||+++++++.+....+++++++.|+++..++...+.+++..+..++.|++.||+|||++
T Consensus 41 ~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~ 120 (292)
T d1unla_ 41 DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120 (292)
T ss_dssp STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcC
Confidence 34557889999999999999999999999999999999999999999999888888899999999999999999999999
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCC-ccccccCCCccccccccccCC-CCCcchHHHHHHHHHHHHh
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLN 163 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slg~~~~~~~~ 163 (177)
|++||||||+||++ +....++++|||.+....... ......++..|.|||.+.... ++.++|+||+|+++++|++
T Consensus 121 ~IvHrDiKP~NIli---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~ 197 (292)
T d1unla_ 121 NVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN 197 (292)
T ss_dssp TEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTT
T ss_pred CEeeecccCccccc---ccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhh
Confidence 99999999999999 456789999999998765443 233344667889999886554 6899999999999999999
Q ss_pred CCCCCCC
Q 030430 164 GYPPFSV 170 (177)
Q Consensus 164 ~~~pf~~ 170 (177)
|+.||..
T Consensus 198 g~~p~~~ 204 (292)
T d1unla_ 198 AGRPLFP 204 (292)
T ss_dssp TSCCSCC
T ss_pred CCCCCCC
Confidence 9988643
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-36 Score=222.32 Aligned_cols=162 Identities=34% Similarity=0.463 Sum_probs=130.5
Q ss_pred chhHHHHHHHHHHHHhhCCCCceeeEeEEEee------CCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHH
Q 030430 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGL 79 (177)
Q Consensus 6 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l 79 (177)
++....++.+|+.++++++||||+++++++.. ...+|+||||+.++.+ +.+ ...+++..++.++.|++.||
T Consensus 56 ~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~-~~~--~~~~~~~~i~~~~~qil~gl 132 (355)
T d2b1pa1 56 NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC-QVI--QMELDHERMSYLLYQMLCGI 132 (355)
T ss_dssp SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHH-HHH--TSCCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHH-Hhh--hcCCCHHHHHHHHHHHHHHH
Confidence 35556789999999999999999999999853 4688999999966544 433 35699999999999999999
Q ss_pred HHHhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCCCcchHHHHHHHHH
Q 030430 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (177)
Q Consensus 80 ~~lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slg~~~~ 159 (177)
+|||++|++||||||+||++ +..+.++++|||.+.............+++.|+|||.+.+..+++++|+||+||+++
T Consensus 133 ~~LH~~giiHrDlKP~Nil~---~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ 209 (355)
T d2b1pa1 133 KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 209 (355)
T ss_dssp HHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred HHhhhcccccccCCcccccc---ccccceeeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHH
Confidence 99999999999999999999 456779999999987766655555667899999999999888999999999999999
Q ss_pred HHHhCCCCCCCCCc
Q 030430 160 ELLNGYPPFSVGEE 173 (177)
Q Consensus 160 ~~~~~~~pf~~~~~ 173 (177)
+|++|+.||.+.++
T Consensus 210 ell~g~~pF~~~~~ 223 (355)
T d2b1pa1 210 EMVRHKILFPGRDY 223 (355)
T ss_dssp HHHHSSCSSCCSSH
T ss_pred HHhhCCCCCCCCCH
Confidence 99999999987653
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-35 Score=218.64 Aligned_cols=161 Identities=31% Similarity=0.499 Sum_probs=131.9
Q ss_pred hhHHHHHHHHHHHHhhCCCCceeeEeEEEeeC-----CeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (177)
....+++.+|++++++++|||++++++++... ...+++++++.|++|.+++. .+.+++..++.++.|++.||+|
T Consensus 58 ~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~ 136 (348)
T d2gfsa1 58 IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKY 136 (348)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHH
Confidence 44566789999999999999999999998632 23455566777999999886 4579999999999999999999
Q ss_pred HhhCCCeeecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCccccccccccCC-CCCcchHHHHHHHHHH
Q 030430 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFE 160 (177)
Q Consensus 82 lh~~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slg~~~~~ 160 (177)
||++|++||||||+||++ +..+.++++|||.+...... .....+++.|+|||...+.. ++.++|+||+|+++++
T Consensus 137 LH~~giiHrDiKp~NILi---~~~~~~kl~dfg~a~~~~~~--~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ 211 (348)
T d2gfsa1 137 IHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 211 (348)
T ss_dssp HHHTTCCCCCCCGGGEEE---CTTCCEEECCC----CCTGG--GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHH
T ss_pred HHhCCCcccccCCccccc---cccccccccccchhcccCcc--cccccccccccCchhhcCCccCCcccchhhhhHHHHH
Confidence 999999999999999999 56788999999998654332 23345788899999876554 5889999999999999
Q ss_pred HHhCCCCCCCCCc
Q 030430 161 LLNGYPPFSVGEE 173 (177)
Q Consensus 161 ~~~~~~pf~~~~~ 173 (177)
|++|..||.+.+.
T Consensus 212 ll~g~~pF~~~~~ 224 (348)
T d2gfsa1 212 LLTGRTLFPGTDH 224 (348)
T ss_dssp HHHSSCSCCCSSH
T ss_pred HHhCCCCCCCCCH
Confidence 9999999987654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=5.3e-29 Score=185.01 Aligned_cols=164 Identities=30% Similarity=0.481 Sum_probs=126.0
Q ss_pred hhHHHHHHHHHHHHhhCC-----------CCceeeEeEEEee--CCeEEEEEecCCCCCh-HHHHh--hcCCCCHHHHHH
Q 030430 7 KHLKSCLDCELNFLSSVN-----------HPNIIRLFDAFQA--ENCIFLVVEFCAGGNL-SSYIR--LHGRVPEQTARK 70 (177)
Q Consensus 7 ~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L-~~~l~--~~~~~~~~~~~~ 70 (177)
....+.+.+|+++++.+. |+||+++++++.. ....++++++...... ..... ....+++..++.
T Consensus 50 ~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 129 (362)
T d1q8ya_ 50 KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129 (362)
T ss_dssp HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHH
T ss_pred ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHH
Confidence 345678899999998885 5789999988753 4456666665544433 22222 234599999999
Q ss_pred HHHHHHHHHHHHhh-CCCeeecCCCCcEEEecCC---CCeeEEEeeeccccccCCCCccccccCCCccccccccccCCCC
Q 030430 71 FLQQLGAGLEILNS-HHIIHRDLKPENILLSGLD---DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD 146 (177)
Q Consensus 71 ~~~~i~~~l~~lh~-~~~~H~~i~~~nil~~~~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~ 146 (177)
++.|++.|++|||+ .|++||||||+||++...+ ....++++|||.+....... ....+++.|+|||.+....++
T Consensus 130 i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~--~~~~gt~~y~aPE~~~~~~~~ 207 (362)
T d1q8ya_ 130 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY--TNSIQTREYRSPEVLLGAPWG 207 (362)
T ss_dssp HHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC--CSCCSCGGGCCHHHHHTCCCC
T ss_pred HHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccccc--ccccccccccChhhccccCCC
Confidence 99999999999998 8999999999999996322 12458999999987654332 345589999999999988899
Q ss_pred CcchHHHHHHHHHHHHhCCCCCCCCC
Q 030430 147 EKVDMWSVGAILFELLNGYPPFSVGE 172 (177)
Q Consensus 147 ~~~Di~slg~~~~~~~~~~~pf~~~~ 172 (177)
.++|+||+|+++++|++|+.||...+
T Consensus 208 ~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 208 CGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp THHHHHHHHHHHHHHHHSSCCC----
T ss_pred ccccccchHHHHHHHHHCCCCCCCCc
Confidence 99999999999999999999997654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.77 E-value=9.7e-20 Score=123.50 Aligned_cols=126 Identities=17% Similarity=0.181 Sum_probs=92.1
Q ss_pred HHHHHHHHHHHHhhCCCCceeeEeEEEeeCCeEEEEEecCCCCChHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCCe
Q 030430 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 88 (177)
......+|.+.+.++.|++++..+++.. .+++||++++..+.+ ++...+..++.|++.++++||+.|++
T Consensus 57 ~~~~~~~e~~~l~~l~~~~v~~~~~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~gii 125 (191)
T d1zara2 57 AIRSARNEFRALQKLQGLAVPKVYAWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIV 125 (191)
T ss_dssp HHHHHHHHHHHHHHTTTSSSCCEEEEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHHccCCCcceEEEecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEE
Confidence 3455678999999999999998876532 278999998765533 44556678999999999999999999
Q ss_pred eecCCCCcEEEecCCCCeeEEEeeeccccccCCCCccccccCCCcccccc-----ccccCCCCCcchHHHHHH
Q 030430 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPE-----VLQFQRYDEKVDMWSVGA 156 (177)
Q Consensus 89 H~~i~~~nil~~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pe-----~~~~~~~~~~~Di~slg~ 156 (177)
|+||||+||+++ + ..++++|||.+.....+.... |.... ......++.++|+||+.-
T Consensus 126 HrDiKP~NILv~---~-~~~~liDFG~a~~~~~~~~~~-------~l~rd~~~~~~~f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 126 HGDLSQYNVLVS---E-EGIWIIDFPQSVEVGEEGWRE-------ILERDVRNIITYFSRTYRTEKDINSAID 187 (191)
T ss_dssp CSCCSTTSEEEE---T-TEEEECCCTTCEETTSTTHHH-------HHHHHHHHHHHHHHHHHCCCCCHHHHHH
T ss_pred EccCChhheeee---C-CCEEEEECCCcccCCCCCcHH-------HHHHHHHHHHHHHcCCCCCcccHHHHHH
Confidence 999999999995 2 348899999886654332211 11110 012355788899999753
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.15 E-value=6.8e-06 Score=56.60 Aligned_cols=47 Identities=9% Similarity=0.014 Sum_probs=37.1
Q ss_pred HHHHHHHHHHHhhCC-CCceeeEeEEEeeCCeEEEEEecCCCCChHHH
Q 030430 10 KSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY 56 (177)
Q Consensus 10 ~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 56 (177)
...+.+|.+.++.+. +--+++++.+..+++..++||++++|.++.+.
T Consensus 53 ~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 53 TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE 100 (263)
T ss_dssp TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccc
Confidence 445788999988874 44468888888888999999999999877553
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.99 E-value=4.1e-06 Score=57.49 Aligned_cols=53 Identities=17% Similarity=0.068 Sum_probs=38.6
Q ss_pred ccccchhHHHHHHHHHHHHhhCCC--CceeeEeEEEeeCCeEEEEEecCCCCChH
Q 030430 2 LKKLNKHLKSCLDCELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAGGNLS 54 (177)
Q Consensus 2 l~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 54 (177)
||.........+..|.+.++.+.. -.+++++.+..+++..+++|++++|.++.
T Consensus 40 lK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 40 VKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp EEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred EEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 344444445568889999988843 33677788878888899999999886653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.25 E-value=0.00035 Score=50.93 Aligned_cols=29 Identities=28% Similarity=0.362 Sum_probs=23.3
Q ss_pred CCeeecCCCCcEEEecCCCCeeEEEeeeccccc
Q 030430 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (177)
Q Consensus 86 ~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~ 118 (177)
.++|||+.+.||+++ + ..++++|+..+..
T Consensus 224 ~LiHGDl~~gNIlv~---~-~~~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFAS---E-HETKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEEC---S-SCEEECCCTTCEE
T ss_pred ceeccCCcCCceeEc---C-CceEEechhhccc
Confidence 589999999999994 2 3488999987643
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.32 E-value=0.0024 Score=46.32 Aligned_cols=38 Identities=16% Similarity=0.141 Sum_probs=26.6
Q ss_pred HHHHHHHHHhhCC-CCceeeEeEEEeeCCeEEEEEecCCCCCh
Q 030430 12 CLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNL 53 (177)
Q Consensus 12 ~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 53 (177)
...+|.++++.+. +.-.+++++++.+ .+|+||++|.++
T Consensus 90 dr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 90 HLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp HHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred HHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence 4568999999884 4334677776643 478999987554
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=94.75 E-value=0.019 Score=40.21 Aligned_cols=43 Identities=12% Similarity=0.084 Sum_probs=27.6
Q ss_pred HHHHHHHHHHHHhhCCCCcee--eEe-----EEEeeCCeEEEEEecCCCC
Q 030430 9 LKSCLDCELNFLSSVNHPNII--RLF-----DAFQAENCIFLVVEFCAGG 51 (177)
Q Consensus 9 ~~~~~~~e~~~l~~l~h~~i~--~~~-----~~~~~~~~~~lv~e~~~~~ 51 (177)
..+.+..|.+.+..|...+++ ... ..+...+..+.+++++.|.
T Consensus 60 s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 60 TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 457788899998888533332 111 1234556788899998763
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.94 E-value=0.028 Score=38.95 Aligned_cols=31 Identities=29% Similarity=0.584 Sum_probs=25.0
Q ss_pred CCCeeecCCCCcEEEecCCCCeeEEEeeeccccc
Q 030430 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (177)
Q Consensus 85 ~~~~H~~i~~~nil~~~~~~~~~~~l~d~~~~~~ 118 (177)
.|++|+|+.++|+++. +....-++||+.++.
T Consensus 183 ~giIHgDl~~dNvl~~---~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFL---GDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcc---cccceeEeccccccc
Confidence 3699999999999995 445567999997754
|